{"meta":{"query_hash":"0ca3a5cb0134","filters":{"venue":"Canadian Journal of Health Technologies"},"cohort_total":660,"direct_labels_cover":1,"predictions_cover":660,"exported":660,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/0ca3a5cb0134","api":"https://metacan.xera.ac/api/v1/cohort?venue=Canadian+Journal+of+Health+Technologies"},"results":[{"id":"W3135045462","doi":"10.51731/cjht.2021.36","title":"Rapid Testing for the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance: A Review of Cost-Effectiveness","year":2021,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Generalizability theory; Sputum; Tuberculosis; Mycobacterium tuberculosis; Pulmonary tuberculosis; Rifampicin; Intensive care medicine; Pathology","score_opus":0.20062675631841173,"score_gpt":0.4380325216952149,"score_spread":0.23740576537680316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135045462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005120036,0.9996431,0.000022808163,0.00010371035,0.000029605408,0.000007744406,0.000032896445,0.0000012319421,0.000107662796],"genre_scores_gemma":[0.0009099875,0.99876654,0.00012805263,0.000085953165,0.000028788647,0.000011736731,0.000030523024,9.579784e-7,0.000037395203],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99809915,0.00056742574,0.00049832376,0.00017325026,0.0005703092,0.0000916343],"domain_scores_gemma":[0.9898279,0.008260706,0.0008755937,0.00008770131,0.0008489111,0.000099364486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041562715,0.0012684327,0.0047179973,0.0069503253,0.0002835739,0.0017437994,0.0015896525,0.0014030488,0.006546136],"category_scores_gemma":[0.014410921,0.0006431904,0.004744765,0.007552007,0.0004965944,0.0013889994,0.00074465206,0.0012197642,0.0005269239],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003387026,0.000061980194,0.0003857424,0.4156052,0.0037981598,0.000091637055,0.000054498847,0.00061038637,0.00016968773,0.0016259282,0.01233696,0.564921],"study_design_scores_gemma":[0.00039151002,0.0005717893,0.006840058,0.62992847,0.03041325,0.0013662865,0.00023743033,0.00056440436,0.00045421498,0.003043932,0.32608822,0.00010049651],"about_ca_topic_score_codex":0.008534537,"about_ca_topic_score_gemma":0.014236157,"teacher_disagreement_score":0.008534537,"about_ca_system_score_codex":0.002751537,"about_ca_system_score_gemma":0.004593325,"threshold_uncertainty_score":0.021980762},"labels":[],"label_agreement":null},{"id":"W3135402457","doi":"10.51731/cjht..24","title":"Canadian Medical Imaging Inventory, 2019–2020","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medical imaging; Medical physics; Context (archaeology); Modalities; Medicine; Single-photon emission computed tomography; Population; Nuclear medicine; Radiology; Geography; Environmental health","score_opus":0.013393033885376455,"score_gpt":0.28849155671092835,"score_spread":0.2750985228255519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135402457","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044152723,0.021266345,0.0011069126,0.1401509,0.008098311,0.00051382504,0.42710608,0.0012596234,0.39608276],"genre_scores_gemma":[0.082581125,0.05281431,0.0119359875,0.05037473,0.0041507552,0.0011199443,0.4567099,0.0005271995,0.33978608],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99265665,0.00037250452,0.00039980753,0.00037315983,0.0049069864,0.0012908961],"domain_scores_gemma":[0.9714916,0.0013420128,0.0008650629,0.00041190945,0.021261927,0.004627448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004323742,0.0008232402,0.0007346355,0.008146718,0.003712794,0.00871662,0.0030602408,0.0023270594,0.06495507],"category_scores_gemma":[0.0182355,0.0005915806,0.00094613456,0.0116167655,0.0012778322,0.0026417822,0.0019357612,0.0028064516,0.015694624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031665088,0.000016739437,0.0021083083,0.00030567808,0.000013526617,0.000044687313,0.00004629106,0.00010749279,0.00004521291,0.006307378,0.9619792,0.028993713],"study_design_scores_gemma":[0.000013527309,0.0000097957445,0.014205157,0.0004784838,0.0000115825105,0.00005325192,0.00022474375,0.000222168,0.00004263197,0.00053820526,0.98417944,0.000021066071],"about_ca_topic_score_codex":0.97107816,"about_ca_topic_score_gemma":0.9797045,"teacher_disagreement_score":0.92605466,"about_ca_system_score_codex":0.073945366,"about_ca_system_score_gemma":0.19712457,"threshold_uncertainty_score":0.5365137},"labels":[],"label_agreement":null},{"id":"W3135881593","doi":"10.51731/cjht..25","title":"Announcing the Canadian Journal of Health Technologies — A New Journal From CADTH","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Publication; Work (physics); Pandemic; Coronavirus disease 2019 (COVID-19); Public relations; Value (mathematics); Health care; Emerging technologies; Publishing; Political science; Medicine; Business; Computer science; Engineering; Advertising","score_opus":0.35191063936906997,"score_gpt":0.3938575603543826,"score_spread":0.04194692098531261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135881593","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032269207,0.07300413,0.00092286256,0.4719972,0.4100557,0.000120824116,0.001341337,0.0003291806,0.041906167],"genre_scores_gemma":[0.0111299325,0.1938535,0.005895257,0.27764702,0.36376393,0.00020952718,0.0028644337,0.0011466857,0.1434897],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95444906,0.0027010099,0.0031536308,0.0016754447,0.035286136,0.0027347426],"domain_scores_gemma":[0.782497,0.035943504,0.005161796,0.008555302,0.116712175,0.051130228],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.020294249,0.0014944936,0.0030372215,0.016566938,0.0096991565,0.03242769,0.0054123034,0.012665952,0.04388438],"category_scores_gemma":[0.09582972,0.0010524386,0.0015443306,0.017879449,0.012316264,0.010173325,0.0046897125,0.013849151,0.018827822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006527644,0.000009574092,0.00006666488,0.00020496723,0.000005709455,0.000031776282,0.00004342764,0.000016769502,0.000034172772,0.0035786848,0.9823527,0.013649114],"study_design_scores_gemma":[0.0000041677995,0.0000032998157,0.00018102447,0.00027180355,0.000004733318,0.000046504276,0.000087311935,0.000019699377,0.000028038487,0.0010336388,0.9983041,0.000015621179],"about_ca_topic_score_codex":0.24583326,"about_ca_topic_score_gemma":0.4445936,"teacher_disagreement_score":0.96757233,"about_ca_system_score_codex":0.032443397,"about_ca_system_score_gemma":0.17644553,"threshold_uncertainty_score":0.48880476},"labels":[],"label_agreement":null},{"id":"W3153217960","doi":"10.51731/cjht.2021.44","title":"Remote Monitoring Programs for Cardiac Conditions in Canada: An Environmental Scan","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autonomy; Medicine; Medical emergency; Business; Environmental resource management; Political science; Environmental science","score_opus":0.03396781544573146,"score_gpt":0.31446787784871577,"score_spread":0.2805000624029843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153217960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11806852,0.56923527,0.0021413933,0.050172288,0.00081089826,0.0014507158,0.17293462,0.0003684683,0.08481782],"genre_scores_gemma":[0.5294144,0.41515085,0.0072996463,0.014128864,0.00021571653,0.00095794495,0.028543696,0.00017991051,0.004108987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9889783,0.0010386492,0.0015953362,0.0008526317,0.0057062167,0.0018287549],"domain_scores_gemma":[0.9205853,0.01773603,0.006147116,0.0009668083,0.049934562,0.0046301982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00667584,0.0005904501,0.001402023,0.0143092405,0.005536643,0.005572683,0.0024154305,0.00093615474,0.0089359535],"category_scores_gemma":[0.027585937,0.0007832737,0.0012863672,0.04496227,0.0022107656,0.002061308,0.0026279495,0.001922373,0.00037223808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006680714,0.0002919465,0.18737496,0.105272844,0.0013699023,0.0014753871,0.008845509,0.0019396613,0.00069325085,0.013439147,0.12746024,0.55116904],"study_design_scores_gemma":[0.00017913025,0.00029653555,0.55825686,0.11098825,0.002174133,0.00095493265,0.018778939,0.0010713971,0.00070604024,0.0016493794,0.30461177,0.00033266898],"about_ca_topic_score_codex":0.99510807,"about_ca_topic_score_gemma":0.9979418,"teacher_disagreement_score":0.115658484,"about_ca_system_score_codex":0.115658484,"about_ca_system_score_gemma":0.35899878,"threshold_uncertainty_score":0.839165},"labels":[],"label_agreement":null},{"id":"W3154216254","doi":"10.51731/cjht.2021.51","title":"Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer: A Clinical Review as Part of a Health Technology Assessment","year":2021,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Calgary","funders":"","keywords":"SABR volatility model; Medicine; Ablative case; Radiation therapy; Adverse effect; Cancer; Radiosurgery; Medical physics; Clinical trial; Oncology; Internal medicine","score_opus":0.13397566216130063,"score_gpt":0.5108018768730298,"score_spread":0.37682621471172917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154216254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046588153,0.9993906,0.000030161986,0.00012088947,0.00007247183,0.0000139431895,0.000023417195,0.0000026563043,0.0002992074],"genre_scores_gemma":[0.0003377059,0.99930274,0.000103412574,0.00010470923,0.00003154525,0.000011040925,0.000024015257,6.2064674e-7,0.0000842047],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99935836,0.00013195806,0.0001579768,0.000066429224,0.00024923283,0.00003602894],"domain_scores_gemma":[0.9977016,0.0012811612,0.00040772144,0.000037173515,0.00051508215,0.000057272904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001681502,0.00083634217,0.0021172755,0.0048259734,0.00032773204,0.0012182067,0.0010565731,0.0010435123,0.005593998],"category_scores_gemma":[0.0034274764,0.00034660782,0.0019326904,0.0059209205,0.0003845957,0.0010901693,0.0005773836,0.001042836,0.00091942225],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008744579,0.000051081257,0.0001944178,0.2890576,0.0006360786,0.000107804684,0.00009225509,0.0002179445,0.0006982273,0.0013519133,0.02473621,0.68276894],"study_design_scores_gemma":[0.00008597794,0.00028668199,0.0030384832,0.24898967,0.0044126543,0.001387893,0.00017738127,0.00015897155,0.0004653858,0.0011740562,0.7397781,0.0000448016],"about_ca_topic_score_codex":0.0045685745,"about_ca_topic_score_gemma":0.010474036,"teacher_disagreement_score":0.005593998,"about_ca_system_score_codex":0.0014335962,"about_ca_system_score_gemma":0.004055164,"threshold_uncertainty_score":0.018713772},"labels":[],"label_agreement":null},{"id":"W3155763117","doi":"10.51731/cjht.2021.56","title":"Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tuberculosis; Stigma (botany); Racism; Indigenous; Colonialism; Genocide; Health care; Immigration; Criminology; Ethnic group; Political science; Medicine; Immigration policy; Gender studies; Sociology; Psychiatry; Law","score_opus":0.06564381358465378,"score_gpt":0.4024585395713658,"score_spread":0.336814725986712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155763117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049764942,0.9317585,0.0018652726,0.007666249,0.0006729543,0.0009575373,0.0009837328,0.000016349366,0.006314491],"genre_scores_gemma":[0.18865213,0.80093706,0.0024244895,0.003438665,0.00016455833,0.0018963809,0.00043618592,0.000039964645,0.0020105485],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9897949,0.007205568,0.0010461771,0.00038737323,0.0009812907,0.00058470055],"domain_scores_gemma":[0.9549058,0.037841905,0.0021093988,0.0006368184,0.003922696,0.00058327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020413883,0.00051140634,0.0016439909,0.005112114,0.0037439493,0.0038497217,0.001588777,0.0013641391,0.0047495523],"category_scores_gemma":[0.031523462,0.00079247606,0.0015288644,0.008881411,0.0027812517,0.0049766893,0.0047484282,0.0022458152,0.00028393182],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018764877,0.00017147324,0.00849015,0.24800256,0.00063334446,0.0020550687,0.4577693,0.00024974873,0.00089597,0.018740715,0.01625962,0.24654438],"study_design_scores_gemma":[0.000021340718,0.000114762646,0.010956967,0.35296178,0.00073223904,0.0015068226,0.47418222,0.00015439438,0.00033651735,0.0024164624,0.1565365,0.000079939105],"about_ca_topic_score_codex":0.032079823,"about_ca_topic_score_gemma":0.07663415,"teacher_disagreement_score":0.032079823,"about_ca_system_score_codex":0.012321027,"about_ca_system_score_gemma":0.021627428,"threshold_uncertainty_score":0.107960284},"labels":[],"label_agreement":null},{"id":"W3156120430","doi":"10.51731/cjht.2021.47","title":"A Call to Action on World Tuberculosis Day","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tuberculosis; Poverty; Medicine; Infectious disease (medical specialty); Call to action; Disease; Public health; Health care; Global health; Environmental health; Economic growth; Family medicine; Nursing; Business; Pathology; Marketing","score_opus":0.07849117626467582,"score_gpt":0.38330438937751055,"score_spread":0.3048132131128347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156120430","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014672749,0.019268215,0.0002861462,0.8489824,0.123261034,0.0000565309,0.0005308867,0.00021848138,0.0072495583],"genre_scores_gemma":[0.0021803437,0.019255714,0.0020502668,0.9082705,0.032592412,0.00012936867,0.0006348421,0.00017625945,0.03471036],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9856204,0.0033249492,0.0010142045,0.0011190908,0.0061158296,0.00280547],"domain_scores_gemma":[0.94074804,0.011760027,0.001999008,0.0022213627,0.015843466,0.027428148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019002449,0.0023982977,0.0030526593,0.0030402204,0.006658544,0.01447137,0.005223742,0.038094226,0.09161253],"category_scores_gemma":[0.042968,0.0010178137,0.005165018,0.002299573,0.0066968496,0.017050318,0.009955806,0.045006145,0.03497427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023341894,0.000029221896,0.000063239866,0.00021349726,0.000011870322,0.00005700059,0.000074762764,0.00001568207,0.000054750526,0.0016847559,0.987946,0.009825806],"study_design_scores_gemma":[0.000023513696,0.000018612966,0.00033294252,0.00044098508,0.000011938513,0.00005707361,0.00034056458,0.00001678811,0.000032460477,0.001174296,0.9975284,0.000022422657],"about_ca_topic_score_codex":0.03941452,"about_ca_topic_score_gemma":0.08312158,"teacher_disagreement_score":0.09161253,"about_ca_system_score_codex":0.009193981,"about_ca_system_score_gemma":0.057234164,"threshold_uncertainty_score":0.30647445},"labels":[],"label_agreement":null},{"id":"W3162401839","doi":"10.51731/cjht.2021.71","title":"Using Health Care Resources Wisely After the COVID-19 Pandemic: Recommendations to Reduce Low-Value Care","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Health care; Medicine; Coronavirus disease 2019 (COVID-19); Business; Medical emergency; Nursing; Political science; Disease; Infectious disease (medical specialty)","score_opus":0.6379998547828083,"score_gpt":0.5730266786023779,"score_spread":0.06497317618043041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162401839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068016414,0.011726305,0.0014531433,0.9243977,0.0134162195,0.00066147436,0.0014827319,0.00047161969,0.045710597],"genre_scores_gemma":[0.00995287,0.032426886,0.025130585,0.86282,0.0032967597,0.001084699,0.0021033576,0.000281421,0.06290338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9683705,0.007487437,0.0020249104,0.0010042418,0.013998356,0.007114598],"domain_scores_gemma":[0.8879895,0.017748134,0.0032021534,0.0018384974,0.051349122,0.0378725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019214623,0.0017518472,0.0012945252,0.004889457,0.009119991,0.013770301,0.009941045,0.023222525,0.033076767],"category_scores_gemma":[0.07005236,0.0013462994,0.0026288982,0.0038365144,0.007925766,0.0074619567,0.00824128,0.023056665,0.013163951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017708739,0.000071001,0.00059330143,0.0005051269,0.000020912332,0.0000685995,0.00029100914,0.000115696166,0.000072132854,0.0033147351,0.96930885,0.025620988],"study_design_scores_gemma":[0.000100770834,0.000026301483,0.0023340925,0.0035694572,0.000053766074,0.000048950646,0.0017548812,0.00020906821,0.00017751227,0.002812002,0.988821,0.00009215812],"about_ca_topic_score_codex":0.75330395,"about_ca_topic_score_gemma":0.9083754,"teacher_disagreement_score":0.95080066,"about_ca_system_score_codex":0.049199354,"about_ca_system_score_gemma":0.36841527,"threshold_uncertainty_score":0.49629778},"labels":[],"label_agreement":null},{"id":"W3166513740","doi":"10.51731/cjht.2021.69","title":"Using Health Care Resources Wisely During and Following the COVID-19 Pandemic","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Health care; Coronavirus disease 2019 (COVID-19); Value (mathematics); Diversity (politics); Public relations; 2019-20 coronavirus outbreak; Medicine; Business; Political science; Nursing; Computer science","score_opus":0.6511773294288565,"score_gpt":0.5520575918547119,"score_spread":0.0991197375741446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166513740","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011621518,0.0080208555,0.00089347735,0.94699687,0.0022547632,0.0000949306,0.00027372062,0.00006973146,0.02977408],"genre_scores_gemma":[0.3698645,0.052217696,0.018560328,0.5454576,0.0033022708,0.0003215576,0.0005665762,0.00020384755,0.009505589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9727993,0.012869746,0.0011305457,0.0006830506,0.0056874473,0.0068299104],"domain_scores_gemma":[0.94273674,0.015824882,0.003992738,0.0015030024,0.016521387,0.019421233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022327567,0.00043616453,0.0008894471,0.0017394628,0.009612684,0.011860361,0.003355207,0.0076347645,0.006641544],"category_scores_gemma":[0.08870779,0.00045121388,0.0010068715,0.0024121613,0.0072678574,0.005807596,0.0059431084,0.010844115,0.0010253687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017689313,0.0002544595,0.02013256,0.0021537966,0.00025066815,0.0009114327,0.020314015,0.0015290477,0.0006045849,0.033808883,0.61937195,0.30049172],"study_design_scores_gemma":[0.00020471198,0.00029416403,0.039522573,0.012393583,0.00024162546,0.0004798523,0.05397676,0.0009851434,0.0010120041,0.025771389,0.864741,0.00037719178],"about_ca_topic_score_codex":0.67256534,"about_ca_topic_score_gemma":0.8721069,"teacher_disagreement_score":0.32743466,"about_ca_system_score_codex":0.041736428,"about_ca_system_score_gemma":0.1742105,"threshold_uncertainty_score":0.658726},"labels":[],"label_agreement":null},{"id":"W3169612600","doi":"10.51731/cjht.2021.77","title":"Treatment Programs for Substance Use Disorder","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Mental health; Cannabis; Addiction; Ambulatory; Ambulatory care; Alcohol use disorder; Health care; Alcohol","score_opus":0.24766749046859404,"score_gpt":0.42142474319252654,"score_spread":0.1737572527239325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169612600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017134275,0.708003,0.0018666622,0.05287961,0.015441812,0.007079697,0.016251959,0.0003531231,0.18098982],"genre_scores_gemma":[0.14828838,0.75604963,0.009176012,0.046958916,0.006098637,0.0074439053,0.008798493,0.00008979432,0.01709632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663264,0.001209222,0.0004843814,0.0002387935,0.0011688703,0.00026615875],"domain_scores_gemma":[0.98933333,0.004256416,0.0022806933,0.0004386009,0.0025945113,0.0010963819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025770906,0.00036422684,0.00090425543,0.0020785944,0.0010076358,0.0012021981,0.0013666963,0.0022171838,0.04862837],"category_scores_gemma":[0.022075294,0.00029702391,0.0032205933,0.0021623918,0.00042706882,0.0009956957,0.0011644319,0.002506331,0.003266378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090601156,0.00091319537,0.005250525,0.05685761,0.0015053934,0.00010635701,0.00015340683,0.000102664344,0.00015226194,0.0021282989,0.16956268,0.7623615],"study_design_scores_gemma":[0.011515654,0.0013194605,0.07072259,0.28135204,0.0043315003,0.00066414784,0.00052479253,0.00023564325,0.0003455094,0.0027799145,0.626135,0.00007372699],"about_ca_topic_score_codex":0.04151946,"about_ca_topic_score_gemma":0.071753815,"teacher_disagreement_score":0.04862837,"about_ca_system_score_codex":0.00272105,"about_ca_system_score_gemma":0.008054574,"threshold_uncertainty_score":0.16267806},"labels":[],"label_agreement":null},{"id":"W3177066024","doi":"10.51731/cjht.2021.73","title":"Visual Examination Frequency for People Taking Ethambutol for Tuberculosis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ethambutol; Guideline; Tuberculosis; Medicine; Visual acuity; Optometry; Family medicine; Isoniazid; Ophthalmology; Pathology","score_opus":0.04304806175371875,"score_gpt":0.3431754952297267,"score_spread":0.3001274334760079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177066024","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08000268,0.09125861,0.009189795,0.20672315,0.0063265157,0.0027692271,0.06439814,0.0038103936,0.5355215],"genre_scores_gemma":[0.57951665,0.08572849,0.04938406,0.09745201,0.0023327305,0.0024809644,0.0315579,0.0007056695,0.1508415],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99782807,0.00028407693,0.00025352082,0.000093385155,0.0012388886,0.0003020487],"domain_scores_gemma":[0.99367493,0.00064259884,0.0009997957,0.000118165306,0.003940824,0.0006237801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015590265,0.00026771627,0.00040129127,0.0016040778,0.0011922909,0.0008411595,0.0011545361,0.0011521402,0.018713364],"category_scores_gemma":[0.007849718,0.00014335293,0.00080719736,0.001005254,0.00032987367,0.0004703832,0.0005602722,0.001281466,0.0038693137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022359086,0.00020087945,0.031558104,0.0011849956,0.000039626833,0.0002612345,0.00024962032,0.0001343155,0.0008380209,0.0006647283,0.68713754,0.27750733],"study_design_scores_gemma":[0.00025682797,0.0004888884,0.34994182,0.005910686,0.00020670179,0.0021092112,0.00091843953,0.0005656952,0.0022958403,0.0009759215,0.63620186,0.00012810818],"about_ca_topic_score_codex":0.46301287,"about_ca_topic_score_gemma":0.6312502,"teacher_disagreement_score":0.46301287,"about_ca_system_score_codex":0.0056939297,"about_ca_system_score_gemma":0.007735883,"threshold_uncertainty_score":0.9206357},"labels":[],"label_agreement":null},{"id":"W3179543896","doi":"10.51731/cjht.2021.90","title":"Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psilocybin; Randomized controlled trial; Psychology; Psychotherapist; MDMA; Anxiety; Hallucinogen; Systematic review; Clinical psychology; Psychiatry; Mood; Medicine; MEDLINE","score_opus":0.051713275694359934,"score_gpt":0.34489962684650094,"score_spread":0.293186351152141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179543896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003044405,0.99517006,0.00012152098,0.00021315394,0.0001433184,0.00044726583,0.00032328762,0.000013489395,0.0005235102],"genre_scores_gemma":[0.053910304,0.9416685,0.0012450423,0.0012333738,0.00013847767,0.0010793079,0.00038413343,0.0000064466763,0.00033439673],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.996588,0.0013282364,0.0011060437,0.00028692218,0.00054005225,0.00015074124],"domain_scores_gemma":[0.99025166,0.006727907,0.0019424419,0.00014298226,0.00078929897,0.00014575772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046244846,0.000845672,0.0055652573,0.0036323227,0.0005011449,0.0013122082,0.0007580247,0.0014252261,0.0038266387],"category_scores_gemma":[0.016048383,0.0004956465,0.0072138165,0.0041398066,0.00056409725,0.0009730532,0.000881151,0.0010330417,0.00025300434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014481355,0.00006436827,0.0005837472,0.914924,0.0147387795,0.00009347574,0.00012924502,0.00007444175,0.00036897638,0.00018463313,0.0014807872,0.06590933],"study_design_scores_gemma":[0.005268181,0.0018928879,0.008902872,0.75760674,0.19638768,0.0005704539,0.00035475392,0.00016647592,0.0008428728,0.0005053866,0.02744398,0.000057802292],"about_ca_topic_score_codex":0.004191485,"about_ca_topic_score_gemma":0.015241091,"teacher_disagreement_score":0.0055652573,"about_ca_system_score_codex":0.0024455125,"about_ca_system_score_gemma":0.0051870253,"threshold_uncertainty_score":0.024456918},"labels":[],"label_agreement":null},{"id":"W3180471204","doi":"10.51731/cjht.2021.82","title":"Smoke-Free Hospital Grounds","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Signage; Legislation; Government (linguistics); Smoking cessation; Mental health; Public health; Smoke; Business; Smoking ban; Medicine; Public relations; Medical emergency; Nursing; Environmental health; Psychology; Political science; Psychiatry; Geography; Advertising; Law","score_opus":0.03624678688214688,"score_gpt":0.3017801262302966,"score_spread":0.2655333393481497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180471204","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12833497,0.0032984274,0.012270096,0.014908024,0.002834486,0.004777344,0.013266378,0.004591791,0.8157185],"genre_scores_gemma":[0.35009685,0.003364734,0.029807093,0.010906469,0.0007679989,0.0029625662,0.010487155,0.00057193957,0.59103525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677926,0.000568698,0.00026091677,0.00022411856,0.0014529373,0.0007139625],"domain_scores_gemma":[0.9934052,0.0008809634,0.00066193315,0.0010567326,0.0015366252,0.0024584443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020254403,0.0003500401,0.00032991203,0.0011719904,0.0035701254,0.0023009519,0.0020344802,0.0014557525,0.14717852],"category_scores_gemma":[0.010043195,0.0003634057,0.0008226693,0.0009598681,0.0009909279,0.0010680803,0.00295753,0.0013123526,0.023348335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030906597,0.0010590018,0.017955666,0.00077834557,0.00003474867,0.00067787163,0.0011749559,0.00034675,0.0018934191,0.018033093,0.42935187,0.52838516],"study_design_scores_gemma":[0.00016929022,0.0005886738,0.0587014,0.00086645543,0.000037807702,0.0006164614,0.00195804,0.00024198923,0.002373941,0.003025646,0.9313375,0.00008277546],"about_ca_topic_score_codex":0.042444296,"about_ca_topic_score_gemma":0.094312266,"teacher_disagreement_score":0.9575557,"about_ca_system_score_codex":0.0036513174,"about_ca_system_score_gemma":0.014789278,"threshold_uncertainty_score":0.4923612},"labels":[],"label_agreement":null},{"id":"W3181006784","doi":"10.51731/cjht.2021.78","title":"Models of Care for Chronic Pain","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Psychosocial; Medicine; Referral; Chronic care; Health care; Medical prescription; Anxiety; Family medicine; Nursing; Physical therapy; Chronic disease; Psychiatry","score_opus":0.031072961903408396,"score_gpt":0.29213347293292324,"score_spread":0.26106051102951483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181006784","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065123932,0.04657769,0.07089292,0.15814994,0.0049528303,0.00181238,0.0014024093,0.0010272451,0.7086721],"genre_scores_gemma":[0.3638727,0.12532882,0.2242781,0.047177352,0.0033773158,0.0058567314,0.0043596523,0.00040872168,0.22534056],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99346536,0.0029633,0.00036777466,0.00043081152,0.0019419595,0.0008309373],"domain_scores_gemma":[0.99480706,0.0013258439,0.00054802315,0.00041019684,0.0014578762,0.0014510851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059480234,0.00087593915,0.000459263,0.0024140107,0.0034180295,0.0072593503,0.0031444351,0.0037024126,0.032771446],"category_scores_gemma":[0.010986632,0.00032503615,0.0016127718,0.0029246008,0.003542192,0.0042002387,0.007979845,0.0038071442,0.006222935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037866543,0.00012485124,0.0022489713,0.001131596,0.00003488752,0.0003251817,0.0029686736,0.0015052871,0.00012098829,0.62156385,0.20812148,0.1618163],"study_design_scores_gemma":[0.000059128513,0.00010663339,0.0014752568,0.0025385073,0.000042630196,0.00065968314,0.0023870938,0.0019840572,0.00007144242,0.11008396,0.8805404,0.000051239924],"about_ca_topic_score_codex":0.035515387,"about_ca_topic_score_gemma":0.05650873,"teacher_disagreement_score":0.035515387,"about_ca_system_score_codex":0.014142171,"about_ca_system_score_gemma":0.033429116,"threshold_uncertainty_score":0.10963136},"labels":[],"label_agreement":null},{"id":"W3183002265","doi":"10.51731/cjht.2021.80","title":"An Overview of Direct-to-Patient Virtual Visits in Canada","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Videoconferencing; Phone; The Internet; Internet privacy; Health literacy; Language barrier; Business; Nursing; Medicine; Medical emergency; Political science; Computer science; Multimedia; World Wide Web","score_opus":0.055360567852470566,"score_gpt":0.35679364491870696,"score_spread":0.3014330770662364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183002265","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1215503,0.5276209,0.004268999,0.055916645,0.0028530133,0.0026782444,0.041251104,0.000985599,0.24287525],"genre_scores_gemma":[0.35835397,0.5637356,0.012284263,0.011152534,0.0006774197,0.0008190535,0.015319565,0.00026779578,0.037389778],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964109,0.00028531655,0.0003080997,0.00023107622,0.0018417021,0.0009228666],"domain_scores_gemma":[0.98856866,0.0008989827,0.0008643677,0.00011122875,0.0056238533,0.00393282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002042368,0.0005601752,0.00063435367,0.007237144,0.0042663235,0.00409794,0.0021406137,0.0008471948,0.01472694],"category_scores_gemma":[0.004709649,0.0006183555,0.0009723808,0.017122857,0.00090097747,0.0010168605,0.0017638727,0.001595663,0.0010535321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038285676,0.00041375888,0.09943015,0.009589236,0.00017327916,0.0010839547,0.0029657097,0.0016020308,0.00079112785,0.016930498,0.23290788,0.6337295],"study_design_scores_gemma":[0.00009235064,0.0002399669,0.3742186,0.008723922,0.00020642886,0.0013052879,0.0045113997,0.0010803667,0.00034533587,0.0008850257,0.60820645,0.00018473096],"about_ca_topic_score_codex":0.99098504,"about_ca_topic_score_gemma":0.9949826,"teacher_disagreement_score":0.8923709,"about_ca_system_score_codex":0.10762913,"about_ca_system_score_gemma":0.24070188,"threshold_uncertainty_score":0.78090763},"labels":[],"label_agreement":null},{"id":"W3183032369","doi":"10.51731/cjht.2021.74","title":"Single-Entry Models in Surgical Services","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Context (archaeology); Action plan; Operations management; Medicine; Health care; Quality management; Process management; Nova scotia; Quality (philosophy); Performance indicator; Medical emergency; Business; Management system; Engineering; Political science; Marketing; Management; Geography","score_opus":0.23486821773053165,"score_gpt":0.44678417177294555,"score_spread":0.2119159540424139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183032369","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2247898,0.0037704806,0.13128719,0.0540403,0.003102668,0.005895699,0.005932438,0.003389634,0.56779176],"genre_scores_gemma":[0.8078433,0.0025691574,0.047065645,0.005884579,0.00068952254,0.0030704553,0.0024004239,0.00048979034,0.1299871],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9791489,0.008199145,0.00096537743,0.003049914,0.0045676823,0.004068897],"domain_scores_gemma":[0.9777939,0.006414063,0.0022115659,0.0036971366,0.0034915234,0.0063919057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015136677,0.0009634284,0.0009897508,0.0025198753,0.0030508547,0.012118422,0.006431749,0.003303749,0.10658548],"category_scores_gemma":[0.027007135,0.0010462556,0.0029667346,0.003907005,0.003290087,0.008975074,0.0105936285,0.0043175444,0.018831424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013245147,0.002888813,0.04558444,0.0011636626,0.00028784972,0.0007728103,0.0049720537,0.029446352,0.00055184565,0.5943417,0.10667754,0.21198843],"study_design_scores_gemma":[0.0020533185,0.0052682185,0.050959583,0.0027264059,0.00034311827,0.0016136114,0.015577259,0.14126585,0.001288911,0.30392858,0.47429714,0.00067786564],"about_ca_topic_score_codex":0.04565355,"about_ca_topic_score_gemma":0.07629424,"teacher_disagreement_score":0.9543464,"about_ca_system_score_codex":0.017214706,"about_ca_system_score_gemma":0.03493467,"threshold_uncertainty_score":0.35656393},"labels":[],"label_agreement":null},{"id":"W3186497210","doi":"10.51731/cjht.2021.99","title":"Palonosetron for Patients Undergoing High or Moderate Emetogenic Chemotherapy","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Nausea and vomiting management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palonosetron; Aprepitant; Ondansetron; Granisetron; Medicine; Dexamethasone; Antiemetic; Chemotherapy-induced nausea and vomiting; Regimen; Nausea; Vomiting; Anesthesia; Pharmacology; Oncology; Internal medicine","score_opus":0.03695637737171747,"score_gpt":0.3024086123804909,"score_spread":0.2654522350087734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186497210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16464287,0.80984473,0.0013950148,0.009927327,0.0005469042,0.0010166783,0.0014386044,0.00004247515,0.011145441],"genre_scores_gemma":[0.8677153,0.124560215,0.0023452148,0.0033067234,0.0004534097,0.0003973233,0.0007365854,0.0000059200997,0.00047929605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731016,0.0015499148,0.000688698,0.000101667756,0.00026729007,0.0000822654],"domain_scores_gemma":[0.9897988,0.0059701516,0.0033102871,0.00012767137,0.00042391135,0.00036913183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003926397,0.00018524076,0.0010184369,0.0007916574,0.0001666318,0.0009218345,0.00025924004,0.0005174278,0.0025654181],"category_scores_gemma":[0.016487509,0.00011562833,0.0015661586,0.0011984925,0.00018150876,0.0005775732,0.00041914877,0.00093102676,0.00012410578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029022044,0.0005351182,0.05517219,0.07548637,0.00896758,0.0010173812,0.00021398177,0.0010340374,0.0020795567,0.0017973471,0.009515962,0.8151584],"study_design_scores_gemma":[0.05651163,0.051134694,0.45517862,0.15403087,0.051333398,0.01109413,0.0014984023,0.0057075713,0.005501692,0.012770607,0.1948469,0.00039148857],"about_ca_topic_score_codex":0.000682128,"about_ca_topic_score_gemma":0.0023281767,"teacher_disagreement_score":0.003926397,"about_ca_system_score_codex":0.00069937884,"about_ca_system_score_gemma":0.0013680552,"threshold_uncertainty_score":0.020765007},"labels":[],"label_agreement":null},{"id":"W3187821863","doi":"10.51731/cjht.2021.112","title":"Harm Reduction Interventions to Prevent Overdose Deaths","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harm reduction; Psychological intervention; Opioid overdose; Public health; Medicine; Harm; Drug overdose; Environmental health; Poison control; Medical emergency; Psychiatry; Opioid; Psychology; Nursing; (+)-Naloxone; Social psychology","score_opus":0.04121654027972695,"score_gpt":0.3486309999741576,"score_spread":0.30741445969443065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187821863","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029938117,0.08394849,0.018994397,0.39489532,0.01028512,0.0038699575,0.0039849747,0.0016181244,0.45246553],"genre_scores_gemma":[0.39604154,0.14208758,0.04275516,0.28489906,0.0071239825,0.006128868,0.005424201,0.00041623408,0.11512335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945497,0.0026019576,0.00022527765,0.00027320225,0.0015078413,0.0008420966],"domain_scores_gemma":[0.9945846,0.001282385,0.0007282877,0.0002527958,0.0019064514,0.0012453588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00457948,0.0007983673,0.0006385822,0.0015808654,0.002642314,0.0020151522,0.0023488733,0.0023597246,0.057084125],"category_scores_gemma":[0.02134102,0.00023119498,0.0014653291,0.0007452161,0.0010006964,0.0020589936,0.006488912,0.0044598565,0.00579286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013101913,0.0011552125,0.0050498988,0.003868153,0.0002141961,0.0001710168,0.0021392335,0.00060423894,0.0002574202,0.0269424,0.33212286,0.62734437],"study_design_scores_gemma":[0.000371385,0.0006455307,0.01964429,0.018916167,0.00026807087,0.00024142963,0.003433425,0.0008290723,0.0005633991,0.03510156,0.91993535,0.000050437717],"about_ca_topic_score_codex":0.0349094,"about_ca_topic_score_gemma":0.08709342,"teacher_disagreement_score":0.9650906,"about_ca_system_score_codex":0.006034183,"about_ca_system_score_gemma":0.017567096,"threshold_uncertainty_score":0.19096541},"labels":[],"label_agreement":null},{"id":"W3190091345","doi":"10.51731/cjht.2021.96","title":"Implementation of Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ablative case; Radiation therapy; Radiosurgery; Medical physics; Prioritization; Stereotactic radiotherapy; Radiation oncology; Cancer; Radiology; Internal medicine; Business","score_opus":0.035829780523377236,"score_gpt":0.36926842939055116,"score_spread":0.3334386488671739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190091345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8689782,0.01762694,0.0014193126,0.05178242,0.00032867794,0.00094413833,0.00314043,0.00018686552,0.05559299],"genre_scores_gemma":[0.9831717,0.006885961,0.0020437257,0.0033940321,0.000024861314,0.00012934952,0.0006160747,0.000040610554,0.0036936435],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99186057,0.0011063503,0.00044850586,0.0004888565,0.0035321666,0.0025636414],"domain_scores_gemma":[0.980327,0.0017511074,0.002023046,0.00017708578,0.009629126,0.006092662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031267742,0.000255547,0.0004280177,0.0012861737,0.007869805,0.0032680612,0.002637153,0.0007192067,0.002912886],"category_scores_gemma":[0.011690773,0.00040899919,0.0006591239,0.0038176298,0.0017329067,0.00093884877,0.0026003974,0.0015561138,0.00014998692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074949104,0.0005572967,0.43673906,0.0065858797,0.00038747766,0.0034803883,0.09300006,0.0032536634,0.004429058,0.013069972,0.05157011,0.38617757],"study_design_scores_gemma":[0.00010350343,0.00043712222,0.7514441,0.0029020533,0.00027574948,0.0006535455,0.11864655,0.0020837097,0.0017193648,0.0007030572,0.12078268,0.00024852803],"about_ca_topic_score_codex":0.99730957,"about_ca_topic_score_gemma":0.9984452,"teacher_disagreement_score":0.20779921,"about_ca_system_score_codex":0.20779921,"about_ca_system_score_gemma":0.46788743,"threshold_uncertainty_score":0.91884065},"labels":[],"label_agreement":null},{"id":"W3190144755","doi":"10.51731/cjht.2021.101","title":"Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Hematopoietic stem cell transplantation; Randomized controlled trial; Transplantation; Disease; Clinical trial; Intensive care medicine; Stem cell; Oncology; Physical therapy; Internal medicine; Immunology","score_opus":0.0689390489209722,"score_gpt":0.2916260853727243,"score_spread":0.22268703645175209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190144755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005969566,0.8983517,0.0027725948,0.04213958,0.0078033395,0.0006286007,0.0010088399,0.00015335843,0.04117235],"genre_scores_gemma":[0.07651657,0.8414322,0.011535323,0.040135857,0.005965822,0.00065651396,0.0022750332,0.000050273055,0.021432385],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99873763,0.0005096226,0.00011877256,0.000084692576,0.00047978453,0.00006946685],"domain_scores_gemma":[0.99837446,0.00070812216,0.00033688097,0.00009330416,0.0003217936,0.00016534717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026570836,0.00026491514,0.00054109487,0.0011311031,0.0003542953,0.00083215674,0.0006118544,0.0008575084,0.013703468],"category_scores_gemma":[0.004449444,0.00008127118,0.0010086803,0.00086637435,0.00073942106,0.0005667868,0.00089794444,0.0017966792,0.0022590463],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087716465,0.00015039483,0.00086489035,0.0069916123,0.00032068384,0.0001476634,0.000048847898,0.0001182555,0.00081046595,0.006134579,0.09546759,0.88806796],"study_design_scores_gemma":[0.0018560862,0.0015477154,0.00781402,0.012612818,0.0006521437,0.0011361165,0.00012701392,0.00037530944,0.0019466352,0.010228316,0.96166086,0.000043003452],"about_ca_topic_score_codex":0.0022886002,"about_ca_topic_score_gemma":0.006498384,"teacher_disagreement_score":0.013703468,"about_ca_system_score_codex":0.0009031137,"about_ca_system_score_gemma":0.0021367702,"threshold_uncertainty_score":0.045842648},"labels":[],"label_agreement":null},{"id":"W3192184107","doi":"10.51731/cjht.2021.113","title":"The Use of Cone Beam CT in Dental, Oral, and Maxillofacial Surgery, and Otolaryngology Settings","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental Radiography and Imaging","field":"Dentistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Otorhinolaryngology; Cone beam computed tomography; Dentistry; Respondent; Oral and maxillofacial surgery; Cone beam ct; Computed tomography; Orthodontics; Radiology; Surgery","score_opus":0.03325664436134857,"score_gpt":0.270137642137522,"score_spread":0.23688099777617344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192184107","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9377084,0.014581069,0.0015975244,0.007722239,0.000187229,0.00031143604,0.0011648702,0.00008550234,0.036641765],"genre_scores_gemma":[0.9860626,0.0075683133,0.0024973291,0.0019279036,0.000049484966,0.00005251632,0.00028198145,0.000027072349,0.001532856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99463475,0.0014469067,0.000475107,0.00040049496,0.0023898836,0.0006528303],"domain_scores_gemma":[0.98372895,0.0047938703,0.003164057,0.00037668445,0.005663074,0.0022733484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032894632,0.00017112697,0.00017324538,0.0017502835,0.0016022017,0.0017019364,0.001071499,0.0005729702,0.003892169],"category_scores_gemma":[0.01879378,0.00032810846,0.0002635824,0.0022002575,0.0010739098,0.00087289436,0.001300431,0.00060316414,0.00049838953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001073855,0.00013406468,0.835468,0.0007942831,0.000028053259,0.0021150988,0.011623739,0.00022313821,0.0014621828,0.00032686157,0.007649514,0.14006771],"study_design_scores_gemma":[0.0000087175395,0.00028334575,0.9458097,0.0013444202,0.000038080645,0.0055877697,0.02725722,0.00044662246,0.00055842346,0.00016644128,0.018445773,0.00005338307],"about_ca_topic_score_codex":0.35074598,"about_ca_topic_score_gemma":0.64499366,"teacher_disagreement_score":0.35074598,"about_ca_system_score_codex":0.0057597444,"about_ca_system_score_gemma":0.013150534,"threshold_uncertainty_score":0.6974088},"labels":[],"label_agreement":null},{"id":"W3193124833","doi":"10.51731/cjht.2021.118","title":"The Portable Neuromodulation Stimulator: Targeting Neuroplasticity for Balance or Gait Deficit","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuromodulation; Physical medicine and rehabilitation; Balance (ability); Gait; Neuroplasticity; Intervention (counseling); Rehabilitation; Medicine; Psychology; Physical therapy; Neuroscience; Psychiatry","score_opus":0.029255961482638954,"score_gpt":0.29496732474485393,"score_spread":0.265711363262215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193124833","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014097741,0.2381558,0.010401108,0.06422626,0.011763329,0.00090258685,0.010756685,0.0021025238,0.647594],"genre_scores_gemma":[0.10474561,0.32685995,0.025724083,0.053950753,0.0059852307,0.0007840226,0.00850468,0.00048726634,0.47295836],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995228,0.000046687812,0.000034884688,0.000032718977,0.00031434264,0.00004855788],"domain_scores_gemma":[0.99898714,0.00026989993,0.000104328145,0.000021559408,0.0005091999,0.000107811444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083895493,0.00036993314,0.0003655433,0.0012550069,0.0004479762,0.0010783153,0.00081169186,0.0016898513,0.041449662],"category_scores_gemma":[0.0020967806,0.00012114768,0.00036067376,0.00074492785,0.00068432983,0.00053759146,0.0005338147,0.0009155941,0.006910789],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043913035,0.00007843429,0.0011227331,0.0012853289,0.00002648805,0.0004228131,0.00004705301,0.000113046764,0.006123669,0.0024171283,0.3703128,0.6176114],"study_design_scores_gemma":[0.00038287923,0.00086388306,0.018564198,0.0015761441,0.000107476364,0.001965912,0.00013936822,0.0004054168,0.006686161,0.0015713497,0.96767265,0.00006459294],"about_ca_topic_score_codex":0.06429671,"about_ca_topic_score_gemma":0.22666356,"teacher_disagreement_score":0.06429671,"about_ca_system_score_codex":0.0021672556,"about_ca_system_score_gemma":0.004029082,"threshold_uncertainty_score":0.13866293},"labels":[],"label_agreement":null},{"id":"W3193234131","doi":"10.51731/cjht.2021.98","title":"Initiation of Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Budget Impact Analysis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antirheumatic drugs; Rheumatoid arthritis; Biosimilar; Medicine; Jurisdiction; Antirheumatic Agents; Drug; Physical therapy; Pharmacology; Internal medicine; Political science","score_opus":0.0309432461624803,"score_gpt":0.3287337595575248,"score_spread":0.29779051339504453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193234131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.757656,0.026287345,0.0058042533,0.009074286,0.00017821555,0.0029163111,0.14151007,0.0001655624,0.056407996],"genre_scores_gemma":[0.9592768,0.008956376,0.0032132156,0.0007223078,0.000043244498,0.00040796303,0.022983463,0.00004470049,0.004351931],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99286735,0.0016740292,0.0004403433,0.00028330533,0.0027383617,0.0019966778],"domain_scores_gemma":[0.98959994,0.0031131688,0.0013584807,0.00026583037,0.004768741,0.0008937586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005878187,0.0009291176,0.0012292601,0.006333277,0.00081190385,0.002566381,0.0012697103,0.0006598337,0.005865096],"category_scores_gemma":[0.016818147,0.00072061515,0.004683736,0.014807694,0.0005104761,0.0007390777,0.0014330981,0.0011371911,0.00025918838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006005807,0.00063888665,0.52413046,0.004900649,0.0134510575,0.00083691475,0.00067594944,0.262393,0.0010294963,0.023514537,0.038260397,0.12416289],"study_design_scores_gemma":[0.0010014194,0.000716894,0.83067006,0.0019494791,0.010697098,0.00037480757,0.0020194252,0.09213682,0.0008512653,0.0025361038,0.05677966,0.00026710625],"about_ca_topic_score_codex":0.95880884,"about_ca_topic_score_gemma":0.94515204,"teacher_disagreement_score":0.080474414,"about_ca_system_score_codex":0.080474414,"about_ca_system_score_gemma":0.06520807,"threshold_uncertainty_score":0.58388543},"labels":[],"label_agreement":null},{"id":"W3194380886","doi":"10.51731/cjht.2021.133","title":"Utilization Patterns of Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Rationale for Improving the Harmonization of Coverage Criteria","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Leflunomide; Antirheumatic drugs; Etanercept; Rheumatoid arthritis; Tocilizumab; Hydroxychloroquine; Sulfasalazine; Antirheumatic Agents; Internal medicine; Disease","score_opus":0.0609078350527339,"score_gpt":0.32256263847655364,"score_spread":0.26165480342381975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194380886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6025229,0.0090397475,0.24585055,0.030421464,0.0005933592,0.047828335,0.008222299,0.00075612037,0.05476527],"genre_scores_gemma":[0.74243605,0.0014867182,0.23430395,0.0043698386,0.00020911121,0.011965529,0.004271438,0.00012429158,0.0008330846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8093913,0.11901144,0.030877875,0.0072319377,0.030243969,0.0032434473],"domain_scores_gemma":[0.8647534,0.045201093,0.027973281,0.018703543,0.040570967,0.002797653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16536668,0.00060101534,0.0013297816,0.00577401,0.0017520207,0.0031082397,0.005124079,0.00137676,0.0008929371],"category_scores_gemma":[0.15990055,0.00087387254,0.002346876,0.0077649914,0.0016907944,0.001904595,0.0041580107,0.00162548,0.0002905002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012671334,0.001370714,0.71599776,0.0013213727,0.001168269,0.00017853458,0.0045485003,0.0134837525,0.0017572786,0.017967554,0.015558837,0.22538039],"study_design_scores_gemma":[0.00048038168,0.0025179912,0.9264472,0.0014141215,0.00045457602,0.0003293699,0.0028395967,0.023060305,0.0024372109,0.0041234875,0.035751164,0.00014463096],"about_ca_topic_score_codex":0.034890883,"about_ca_topic_score_gemma":0.022609344,"teacher_disagreement_score":0.16536668,"about_ca_system_score_codex":0.007391964,"about_ca_system_score_gemma":0.012539145,"threshold_uncertainty_score":0.874553},"labels":[],"label_agreement":null},{"id":"W3196217705","doi":"10.51731/cjht.2021.126","title":"Barricaid Spinal Implant Device","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Implant; Emerging technologies; Business; Medicine; Computer science; Surgery; Artificial intelligence; Physics","score_opus":0.049319214766096145,"score_gpt":0.3386718748373813,"score_spread":0.2893526600712852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196217705","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022887034,0.11271065,0.0042130505,0.031747308,0.0059365737,0.0006558763,0.029473761,0.0024030092,0.7899728],"genre_scores_gemma":[0.31993264,0.12424993,0.015981462,0.036361154,0.0037423556,0.0005558377,0.037081115,0.00058902707,0.46150652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903846,0.000028181747,0.000050828356,0.000055188604,0.00075217977,0.000075172466],"domain_scores_gemma":[0.9988385,0.00024383144,0.00011947918,0.000051004234,0.0005481799,0.00019901682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004114498,0.0003269877,0.00045053306,0.0020166892,0.001076914,0.0011384143,0.00066431187,0.0009660168,0.0801264],"category_scores_gemma":[0.0024277547,0.00017170461,0.00049058726,0.0012180269,0.0004721358,0.0007595439,0.0005995256,0.0012970188,0.013264242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007655088,0.00010387894,0.005198908,0.0010308339,0.000052621002,0.0026002983,0.00008864552,0.000180437,0.003747225,0.0027924918,0.51153624,0.4719029],"study_design_scores_gemma":[0.00012728095,0.0003178368,0.013696801,0.0010363492,0.00006842073,0.007124535,0.00009742705,0.00015884376,0.0015608261,0.0007877707,0.9749697,0.000054209362],"about_ca_topic_score_codex":0.06903167,"about_ca_topic_score_gemma":0.1462935,"teacher_disagreement_score":0.0801264,"about_ca_system_score_codex":0.0023128572,"about_ca_system_score_gemma":0.007571804,"threshold_uncertainty_score":0.26804954},"labels":[],"label_agreement":null},{"id":"W3197948781","doi":"10.51731/cjht.2021.102","title":"Community Pharmacist–Led Medication Reviews","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacist; Medicine; Pharmacy; Context (archaeology); Psychological intervention; Community pharmacist; Nursing; Family medicine; Community pharmacy","score_opus":0.34578656031980903,"score_gpt":0.483134849641905,"score_spread":0.13734828932209597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197948781","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05956758,0.05282121,0.019988453,0.08942742,0.005396688,0.014577892,0.016559383,0.006340688,0.7353207],"genre_scores_gemma":[0.5093642,0.072764836,0.06652097,0.063989624,0.0046503977,0.0065834094,0.01236506,0.00085414486,0.26290733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9806849,0.008136367,0.0019312759,0.0013599192,0.0067549446,0.0011325215],"domain_scores_gemma":[0.9497124,0.011040099,0.007860816,0.0028472543,0.02238157,0.0061578103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009630395,0.00054737856,0.00060515536,0.0031887873,0.0016400222,0.0028275293,0.0022803522,0.0013361488,0.051488075],"category_scores_gemma":[0.044210132,0.00042230898,0.0012631196,0.0027904476,0.0004922225,0.0018284947,0.003104563,0.0016200591,0.009305721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003516138,0.0007421741,0.010199693,0.005530288,0.0003102382,0.0005068643,0.00088396005,0.0003441563,0.0006730777,0.0025034428,0.37661418,0.6013403],"study_design_scores_gemma":[0.0004411551,0.000387292,0.037354983,0.0040543033,0.00022044095,0.0005248961,0.00073131605,0.00065413484,0.0011803907,0.0012471287,0.95311284,0.00009107024],"about_ca_topic_score_codex":0.06888694,"about_ca_topic_score_gemma":0.15845549,"teacher_disagreement_score":0.9922159,"about_ca_system_score_codex":0.0077841515,"about_ca_system_score_gemma":0.032736823,"threshold_uncertainty_score":0.17224479},"labels":[],"label_agreement":null},{"id":"W3198687654","doi":"10.51731/cjht.2021.127","title":"Medications Containing Low-Dose Codeine for the Treatment of Pain and Coughs","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Codeine; Medicine; Medical prescription; Morphine; Narcotic; Pharmacology; Anesthesia","score_opus":0.055967485822450196,"score_gpt":0.353282770741035,"score_spread":0.2973152849185848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198687654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037179359,0.9683147,0.000539385,0.008411824,0.0010424578,0.00021416432,0.0012037664,0.000042247455,0.016513597],"genre_scores_gemma":[0.07871428,0.8932688,0.0039497144,0.015482898,0.0011688643,0.00025510762,0.0014384956,0.00001900711,0.0057027643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635965,0.0012764157,0.0008671712,0.00020105047,0.0011696962,0.00012595355],"domain_scores_gemma":[0.983949,0.007995916,0.004547241,0.00029021452,0.00297004,0.0002476373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003888314,0.00027241526,0.00066654827,0.0018044782,0.0002893986,0.0010926047,0.00067991414,0.0010298275,0.010912827],"category_scores_gemma":[0.019209066,0.00014916711,0.0016066235,0.0016221852,0.000658904,0.001076432,0.0006934918,0.000776811,0.0010303834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012011064,0.00007612634,0.004058558,0.2029602,0.0016905555,0.00019984427,0.00021258247,0.00010914406,0.0016890706,0.0038306194,0.06478232,0.7191899],"study_design_scores_gemma":[0.0013306857,0.0014294443,0.04543273,0.3047916,0.009485141,0.0019665782,0.0007409765,0.00031900825,0.0032597356,0.00300442,0.62814873,0.00009095763],"about_ca_topic_score_codex":0.013638772,"about_ca_topic_score_gemma":0.043882694,"teacher_disagreement_score":0.013638772,"about_ca_system_score_codex":0.0017514486,"about_ca_system_score_gemma":0.0044644936,"threshold_uncertainty_score":0.03650707},"labels":[],"label_agreement":null},{"id":"W3201529651","doi":"10.51731/cjht.2021.149","title":"Heart Function Clinics for Patients With Heart Failure","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Guideline; Psychological intervention; Emergency medicine; Intensive care medicine; Internal medicine; Nursing","score_opus":0.19710736695482547,"score_gpt":0.3817221432970112,"score_spread":0.18461477634218573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201529651","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5646974,0.13435286,0.0046571116,0.16408819,0.0041057807,0.0032915734,0.018501379,0.0004584868,0.10584716],"genre_scores_gemma":[0.94546264,0.020854399,0.0024918101,0.017894989,0.0030030692,0.0012284938,0.0033661195,0.00001950285,0.0056790053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989052,0.00059415394,0.00009015426,0.000085658874,0.00015634586,0.00016847723],"domain_scores_gemma":[0.99293303,0.002262914,0.0021019997,0.00014847434,0.0003460613,0.0022075057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013593419,0.00016119068,0.00032999285,0.00064517494,0.00062548555,0.00096203835,0.00046539205,0.0009742197,0.017130878],"category_scores_gemma":[0.009793785,0.000128171,0.00080027274,0.00073383504,0.00023851784,0.00044829596,0.00081466394,0.001038002,0.0011017512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029235757,0.003420191,0.21900441,0.004478107,0.0010371348,0.0011936603,0.00045379053,0.0010091416,0.000772321,0.006346608,0.21539213,0.543969],"study_design_scores_gemma":[0.010480043,0.0056014266,0.8507379,0.006246799,0.0012766416,0.0025462084,0.00083630515,0.0031521264,0.00043235827,0.008562973,0.11003366,0.00009344453],"about_ca_topic_score_codex":0.008970291,"about_ca_topic_score_gemma":0.01626979,"teacher_disagreement_score":0.017130878,"about_ca_system_score_codex":0.0015627034,"about_ca_system_score_gemma":0.0027715242,"threshold_uncertainty_score":0.057308495},"labels":[],"label_agreement":null},{"id":"W3201749259","doi":"10.51731/cjht.2021.150","title":"Encorafenib in Combination With Binimetinib (Braftovi and Mektovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Metastatic melanoma; Medicine; Business; Test (biology); Marketing; Melanoma; Economic growth; Economics; Cancer research; Health care","score_opus":0.012647135161659275,"score_gpt":0.23328943117980475,"score_spread":0.22064229601814547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201749259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09059951,0.6513574,0.002355198,0.008007199,0.0012802889,0.0004588488,0.0050663045,0.00027857488,0.24059667],"genre_scores_gemma":[0.514043,0.3410143,0.00564162,0.004909323,0.00043045823,0.0001881096,0.005331307,0.00004922041,0.12839259],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977094,0.00005069646,0.000022848419,0.00002998663,0.000091845934,0.00003363241],"domain_scores_gemma":[0.9998235,0.000032850465,0.00004926635,0.000006931669,0.00006236272,0.000025130747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004210755,0.00022769978,0.00023396222,0.00057618675,0.00017428855,0.0005302355,0.000237395,0.0003042775,0.011744136],"category_scores_gemma":[0.0004979126,0.00006913232,0.00040526208,0.0004705792,0.00017603573,0.00031442838,0.00018932058,0.00031844733,0.001308544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015000092,0.00013671402,0.0034044269,0.003186401,0.00032586697,0.00034182693,0.0000445759,0.0004774376,0.015437823,0.0029048156,0.048316862,0.92392325],"study_design_scores_gemma":[0.00076853525,0.002610393,0.032103423,0.0019980585,0.00053484837,0.002605009,0.00013006662,0.0006176455,0.02734565,0.00089043984,0.9303514,0.000044529123],"about_ca_topic_score_codex":0.023898266,"about_ca_topic_score_gemma":0.12565438,"teacher_disagreement_score":0.023898266,"about_ca_system_score_codex":0.0018167244,"about_ca_system_score_gemma":0.0017089801,"threshold_uncertainty_score":0.047518313},"labels":[],"label_agreement":null},{"id":"W3202444222","doi":"10.51731/cjht.2021.157","title":"Pharyngeal Electrical Stimulation for the Treatment of Dysphagia Associated With Neurologic Conditions","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dysphagia Assessment and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dysphagia; Swallowing; Horizon; Stimulation; Medicine; Emerging technologies; Physical medicine and rehabilitation; Intensive care medicine; Computer science; Surgery; Artificial intelligence; Internal medicine; Physics","score_opus":0.06738108330130502,"score_gpt":0.3949480469823885,"score_spread":0.3275669636810835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202444222","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02310327,0.17719607,0.002929113,0.053887207,0.005005001,0.00040024566,0.003949556,0.00046547904,0.7330641],"genre_scores_gemma":[0.2730805,0.3244784,0.0113956,0.033806145,0.0044218306,0.00030552765,0.0048278472,0.00017520766,0.3475089],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999666,0.00004169986,0.000025727266,0.000015483769,0.0002079425,0.000043165426],"domain_scores_gemma":[0.99925536,0.00020046005,0.00008028459,0.000016652219,0.00032375092,0.00012346946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004551102,0.00013837239,0.00017281955,0.0008966151,0.0005612455,0.00046071416,0.00038885043,0.0006054568,0.05245482],"category_scores_gemma":[0.0023443364,0.00004549534,0.00026690733,0.0006550102,0.0003112588,0.00030060345,0.00041509868,0.00053600274,0.0059637227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021419082,0.00011868041,0.0032285445,0.00081757916,0.000019143474,0.0006500608,0.00009615745,0.000099082165,0.0014055917,0.0011662709,0.32795462,0.6642301],"study_design_scores_gemma":[0.00028442923,0.0006443147,0.06443365,0.0025498918,0.000067564055,0.0037737538,0.00042531322,0.0004153426,0.0016472306,0.0019063707,0.9238163,0.000035757796],"about_ca_topic_score_codex":0.07582792,"about_ca_topic_score_gemma":0.28421855,"teacher_disagreement_score":0.07582792,"about_ca_system_score_codex":0.0017489328,"about_ca_system_score_gemma":0.004830512,"threshold_uncertainty_score":0.17547888},"labels":[],"label_agreement":null},{"id":"W3203425821","doi":"10.51731/cjht.2021.168","title":"Nivolumab (Opdivo) in combination with Ipilimumab (Yervoy)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ipilimumab; Nivolumab; Reimbursement; Medicine; Drug; Internal medicine; Oncology; Pharmacology; Immunotherapy; Cancer","score_opus":0.020374842019405787,"score_gpt":0.27163697770100426,"score_spread":0.2512621356815985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203425821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03877813,0.83337617,0.00240338,0.005496336,0.0012300647,0.00033175515,0.0017397619,0.00023510562,0.116409235],"genre_scores_gemma":[0.39055273,0.50169075,0.011048531,0.007693074,0.0006143988,0.00031768708,0.0033276766,0.00005699796,0.084698156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969983,0.000092513634,0.000032254004,0.000039198338,0.00009347517,0.00004280948],"domain_scores_gemma":[0.99981195,0.00003793743,0.000058329402,0.0000075664143,0.000064587985,0.00001968412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072619785,0.00025613388,0.000300437,0.0005914546,0.00015718247,0.00073238055,0.00034504096,0.0003405553,0.0054356037],"category_scores_gemma":[0.00051858166,0.000081217026,0.00050427177,0.0004256518,0.00021680891,0.00038784381,0.0002501083,0.00035573996,0.0012650603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009283766,0.00009144268,0.0027437161,0.0044388627,0.0003632851,0.00020287174,0.000037169397,0.000389759,0.013413161,0.0030278638,0.043809183,0.9305543],"study_design_scores_gemma":[0.0005146129,0.0019405005,0.016661005,0.003678225,0.0006818394,0.0014134853,0.00010761102,0.0005103384,0.019807078,0.0007298154,0.9539231,0.00003236694],"about_ca_topic_score_codex":0.014277907,"about_ca_topic_score_gemma":0.057737205,"teacher_disagreement_score":0.014277907,"about_ca_system_score_codex":0.001729091,"about_ca_system_score_gemma":0.0019979305,"threshold_uncertainty_score":0.028389573},"labels":[],"label_agreement":null},{"id":"W3204294498","doi":"10.51731/cjht.2021.167","title":"Onasemnogene Abeparvovec (Zolgensma)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SMN1; SMA*; Spinal muscular atrophy; Medicine; Family medicine; Food and drug administration; Expert opinion; Intensive care medicine; Medical emergency","score_opus":0.039936633468162064,"score_gpt":0.32346405215871643,"score_spread":0.28352741869055437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204294498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030301902,0.13513306,0.0045609376,0.24843003,0.019116376,0.001939717,0.021679034,0.002582459,0.53625643],"genre_scores_gemma":[0.16390596,0.0658904,0.012033939,0.17326494,0.0035624162,0.0007056636,0.01754524,0.000508725,0.5625827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990351,0.00013385825,0.000042672953,0.00008972747,0.00051473285,0.00018394034],"domain_scores_gemma":[0.99826616,0.00027323535,0.00011501613,0.000048137,0.00079528044,0.0005021797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015933607,0.00028332934,0.00044763874,0.00071562926,0.0009902861,0.0016011953,0.0007283037,0.0029265052,0.032398768],"category_scores_gemma":[0.0032027375,0.00019813508,0.0005961606,0.0004803096,0.0005433389,0.0005426976,0.00068066135,0.0033457328,0.006486478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018997986,0.00017481564,0.0014075106,0.000540154,0.000047621415,0.00061556854,0.00009307118,0.0001655639,0.0041818777,0.007219152,0.72202444,0.26163045],"study_design_scores_gemma":[0.00041321127,0.00018488623,0.001790211,0.0002362141,0.000034494926,0.0002603584,0.000029162333,0.000109322,0.0009816434,0.00036474946,0.9955848,0.000010961645],"about_ca_topic_score_codex":0.09102369,"about_ca_topic_score_gemma":0.28346932,"teacher_disagreement_score":0.09102369,"about_ca_system_score_codex":0.005199029,"about_ca_system_score_gemma":0.010124221,"threshold_uncertainty_score":0.18098772},"labels":[],"label_agreement":null},{"id":"W3206706106","doi":"10.51731/cjht.2021.170","title":"Bone Growth Stimulators for Treatment of Adults with Bone Disease or Injury","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bone fractures and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Low-intensity pulsed ultrasound; Medicine; Context (archaeology); Radiography; Ultrasound; Nonunion; Stimulation; Bone healing; Therapeutic ultrasound; Bone growth; Surgery; Radiology; Internal medicine","score_opus":0.020846551201385385,"score_gpt":0.2969539266862987,"score_spread":0.2761073754849133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206706106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023086742,0.6720201,0.001512311,0.055717997,0.0052261706,0.00087785744,0.0059594954,0.00026463758,0.23533474],"genre_scores_gemma":[0.32096726,0.52076274,0.011795218,0.04565915,0.0043600868,0.0009932211,0.0067975367,0.00007378715,0.08859105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995839,0.000086418615,0.000047141402,0.000025857924,0.00020582743,0.000050848394],"domain_scores_gemma":[0.9991774,0.00020395248,0.0001865566,0.000021888096,0.00025923506,0.00015104588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006451587,0.00021136094,0.00033684153,0.000529672,0.00034131293,0.0003301011,0.0005340083,0.00078341935,0.02706039],"category_scores_gemma":[0.002234811,0.00007509394,0.0005430549,0.0005363436,0.00031669255,0.00021308027,0.00035378616,0.00083412323,0.0018667732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026907027,0.00025603443,0.0035366493,0.009442954,0.00016281662,0.0004735438,0.00013118303,0.00007901324,0.0023275022,0.0030951886,0.22012952,0.7576749],"study_design_scores_gemma":[0.0053074216,0.0026431596,0.051592216,0.011149087,0.0005027315,0.002088234,0.0002839336,0.00021472163,0.0016180665,0.0025839584,0.9219805,0.000036080895],"about_ca_topic_score_codex":0.037062626,"about_ca_topic_score_gemma":0.1556624,"teacher_disagreement_score":0.037062626,"about_ca_system_score_codex":0.001233838,"about_ca_system_score_gemma":0.0038050998,"threshold_uncertainty_score":0.090526044},"labels":[],"label_agreement":null},{"id":"W3209492902","doi":"10.51731/cjht.2021.180","title":"Celebrating Medical Librarians During Canadian Library Month","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Library science; Work (physics); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medical library; Political science; Public relations; Medicine; Engineering; Computer science; Virology","score_opus":0.05334930675110122,"score_gpt":0.3290886376424987,"score_spread":0.27573933089139746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209492902","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071923793,0.032831155,0.0003896073,0.5232411,0.07564215,0.0002149974,0.0028994856,0.0009618273,0.35662732],"genre_scores_gemma":[0.046904203,0.017201021,0.0010586861,0.12725954,0.017230906,0.00014413874,0.0019538337,0.0006295004,0.7876182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842606,0.0014789689,0.0003777832,0.00077955215,0.008971986,0.004131125],"domain_scores_gemma":[0.9602099,0.0011191724,0.00092458306,0.00063911773,0.010795512,0.026311755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009688577,0.00097353593,0.0009179697,0.005401241,0.034705635,0.02123398,0.0030276105,0.0060854745,0.08957064],"category_scores_gemma":[0.012867538,0.0007982741,0.00072465173,0.009537608,0.00578205,0.0040434026,0.00996204,0.0062273038,0.02198655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015289654,0.000015617496,0.00035789845,0.000042831805,0.0000032661676,0.00007046406,0.0006770165,0.000004571559,0.00006263815,0.00084742426,0.9906673,0.0072355336],"study_design_scores_gemma":[0.0000026452449,0.000004993103,0.0015785533,0.00003560736,0.0000019984084,0.000027833417,0.0016585307,0.0000041393964,0.000031687847,0.00006164798,0.9965821,0.00001032276],"about_ca_topic_score_codex":0.8311982,"about_ca_topic_score_gemma":0.9611641,"teacher_disagreement_score":0.16880178,"about_ca_system_score_codex":0.06015123,"about_ca_system_score_gemma":0.11896115,"threshold_uncertainty_score":0.4364298},"labels":[],"label_agreement":null},{"id":"W3209734387","doi":"10.51731/cjht.2021.183","title":"Daunorubicin and Cytarabine Liposome (Vyxeos)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daunorubicin; Cytarabine; Reimbursement; Medicine; Myeloid leukemia; Drug; Vial; Leukemia; Intensive care medicine; Pharmacology; Internal medicine; Health care; Political science; Chemistry","score_opus":0.022976893449378248,"score_gpt":0.28637585964007134,"score_spread":0.2633989661906931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209734387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043057147,0.85889006,0.0053580687,0.0035831255,0.00096408674,0.00044351115,0.001087869,0.00024183872,0.086374246],"genre_scores_gemma":[0.3417189,0.54155236,0.011128215,0.0033679695,0.00023649,0.00034234664,0.0021457581,0.000059227972,0.099448666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.00004240767,0.000016600288,0.000024216544,0.00006986597,0.000025480991],"domain_scores_gemma":[0.9999094,0.000020077623,0.000025859637,0.0000037460654,0.000028582328,0.000012322873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004710991,0.00020997938,0.00020105035,0.0004979555,0.000182239,0.00059876894,0.00022718454,0.0003085607,0.0054225107],"category_scores_gemma":[0.0003101394,0.00006601348,0.00025669052,0.00030365353,0.00022017791,0.00033754762,0.00026018397,0.00034975738,0.0009818447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004410069,0.00008415753,0.00086552475,0.003648354,0.00010805134,0.00021356433,0.00007004913,0.0003196315,0.04325691,0.008857641,0.027745476,0.91438967],"study_design_scores_gemma":[0.00018420487,0.00091876625,0.0044247573,0.0012213407,0.00013666665,0.0011558527,0.00009872441,0.00030742315,0.043878134,0.0005473964,0.947104,0.000022719436],"about_ca_topic_score_codex":0.010943153,"about_ca_topic_score_gemma":0.02911207,"teacher_disagreement_score":0.010943153,"about_ca_system_score_codex":0.0012947287,"about_ca_system_score_gemma":0.0012801357,"threshold_uncertainty_score":0.021758914},"labels":[],"label_agreement":null},{"id":"W3212825246","doi":"10.51731/cjht.2021.197","title":"Biologics in Plaque Psoriasis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ustekinumab; Biosimilar; Certolizumab pegol; Adalimumab; Infliximab; Etanercept; Secukinumab; Ixekizumab; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha","score_opus":0.039873739703723196,"score_gpt":0.3030348355283963,"score_spread":0.26316109582467306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212825246","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015172118,0.859628,0.0006257735,0.040968884,0.011220839,0.000049352693,0.00023381997,0.00007699308,0.085679054],"genre_scores_gemma":[0.0273661,0.807165,0.0018842566,0.052837964,0.015666727,0.00010314358,0.00066346704,0.00006066963,0.0942526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891055,0.00024558234,0.00011785203,0.00010113216,0.0004710767,0.00015379103],"domain_scores_gemma":[0.9988041,0.0003069739,0.00018179382,0.00006877194,0.00043986368,0.00019857186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013581424,0.0006483201,0.0006620094,0.0013469349,0.0008015671,0.0023572787,0.00065337546,0.0027601295,0.017765265],"category_scores_gemma":[0.0022457275,0.00023658766,0.00062434765,0.0010135488,0.0014110348,0.0013890147,0.00141376,0.004213615,0.008942809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002104464,0.00011711553,0.0010316626,0.0020971484,0.000047623635,0.00092204544,0.00022529841,0.00017112418,0.0014966661,0.044724934,0.36828557,0.5806704],"study_design_scores_gemma":[0.00004453424,0.00006876312,0.00094901386,0.00095229625,0.000015509868,0.001476266,0.000059505943,0.000031859923,0.00019788495,0.0042161103,0.99197924,0.00000909319],"about_ca_topic_score_codex":0.0083732875,"about_ca_topic_score_gemma":0.014176598,"teacher_disagreement_score":0.017765265,"about_ca_system_score_codex":0.0026907441,"about_ca_system_score_gemma":0.0031048553,"threshold_uncertainty_score":0.05943072},"labels":[],"label_agreement":null},{"id":"W3215707621","doi":"10.51731/cjht.2021.214","title":"Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep brain stimulation; Essential tremor; Parkinson's disease; Physical medicine and rehabilitation; Neuroscience; Intervention (counseling); Medicine; Disease; Psychology; Psychiatry; Pathology","score_opus":0.0356514606983972,"score_gpt":0.30351253595561967,"score_spread":0.26786107525722247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215707621","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04725824,0.35869262,0.036025833,0.055706907,0.005998825,0.0005744344,0.00379381,0.0014510002,0.49049836],"genre_scores_gemma":[0.402394,0.35524762,0.034027103,0.031036498,0.0029701004,0.00031765824,0.0033557157,0.0003088355,0.17034248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998661,0.000018775354,0.000009507438,0.000012870792,0.00007769235,0.000014962508],"domain_scores_gemma":[0.9998153,0.000065233486,0.000023221257,0.0000064590813,0.000064239284,0.000025541874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027729635,0.00018148126,0.00015887372,0.00039019113,0.00016034479,0.00035811626,0.0002802198,0.0004059569,0.01451627],"category_scores_gemma":[0.00081509916,0.000034348486,0.00022429207,0.00027201505,0.00030435203,0.00025188588,0.0003506446,0.0005615205,0.0015912342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035539022,0.00007952494,0.00085039064,0.0007240846,0.00004882416,0.00023307615,0.00004651753,0.00058030355,0.0053629577,0.004056751,0.10405191,0.88361025],"study_design_scores_gemma":[0.0008642371,0.001901474,0.03445205,0.0021726473,0.00027370953,0.004440268,0.00025066626,0.0055566486,0.010893738,0.018723488,0.9203847,0.00008632765],"about_ca_topic_score_codex":0.0138628,"about_ca_topic_score_gemma":0.055913802,"teacher_disagreement_score":0.01451627,"about_ca_system_score_codex":0.00078603247,"about_ca_system_score_gemma":0.0015299049,"threshold_uncertainty_score":0.04856175},"labels":[],"label_agreement":null},{"id":"W3216749353","doi":"10.51731/cjht.2021.209","title":"Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Women's College Hospital; Nova Scotia Health Authority; University of Calgary; Institute for Clinical Evaluative Sciences; Université Laval; Queen Elizabeth II Health Sciences Centre; University of British Columbia; Public Health Ontario; University of Toronto","funders":"","keywords":"Medical prescription; Pace; Audit; Prescription drug; Specialty; Business; Annual growth %; Medicine; Family medicine; Agricultural economics; Accounting; Pharmacology; Economics; Geography","score_opus":0.0745478460040486,"score_gpt":0.30158214108106585,"score_spread":0.22703429507701725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216749353","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14957605,0.009160934,0.0019388591,0.015646022,0.00029652324,0.00014112814,0.7757243,0.00073973084,0.046776358],"genre_scores_gemma":[0.58437765,0.019088777,0.0059992624,0.002534215,0.00016134488,0.00016442516,0.36317918,0.00018941435,0.024305813],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985857,0.000055543725,0.00009724402,0.00012298085,0.0007714826,0.00036702974],"domain_scores_gemma":[0.99398994,0.00012771532,0.00037153863,0.000063991014,0.005032143,0.00041463904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222177,0.00089252455,0.00045112547,0.0045521534,0.001642775,0.0028099527,0.0012735042,0.00087845663,0.0075886887],"category_scores_gemma":[0.004100496,0.00047309065,0.0016673307,0.012571268,0.00039973538,0.0012050833,0.0010730348,0.0016166822,0.0024421518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084158755,0.00019636148,0.3833767,0.0013941567,0.0007168808,0.0006386942,0.0010663626,0.029134631,0.0006021723,0.015057338,0.4783025,0.08867266],"study_design_scores_gemma":[0.000106098974,0.00007152452,0.73843265,0.00058927824,0.00024305133,0.0003660636,0.0018552624,0.031003995,0.00076151657,0.0013609541,0.22502103,0.00018861839],"about_ca_topic_score_codex":0.9963169,"about_ca_topic_score_gemma":0.9956542,"teacher_disagreement_score":0.06245548,"about_ca_system_score_codex":0.06245548,"about_ca_system_score_gemma":0.064372234,"threshold_uncertainty_score":0.4531483},"labels":[],"label_agreement":null},{"id":"W4200006876","doi":"10.51731/cjht.2021.221","title":"Lung-RADS Versus Pan-Canadian Early Detection of Lung Cancer Study Screening for Patients at High Risk of Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Lung cancer screening; Guideline; Lung; Radiology; National Lung Screening Trial; Medical physics; Oncology; Internal medicine; Pathology","score_opus":0.024937987854469667,"score_gpt":0.32986466822726823,"score_spread":0.3049266803727986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200006876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30061635,0.20530143,0.0038801767,0.063859664,0.005185958,0.006857304,0.1997837,0.0003366799,0.21417876],"genre_scores_gemma":[0.9024248,0.022318507,0.008106411,0.015961193,0.0008418372,0.0021157467,0.031761758,0.00007811562,0.016391683],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9935834,0.003179948,0.0006125782,0.00049392646,0.0017583723,0.0003716887],"domain_scores_gemma":[0.99285805,0.0024795386,0.001515338,0.00024268609,0.0019567984,0.0009475881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006222728,0.00046959406,0.0010042933,0.0010631076,0.000613941,0.0011671714,0.0010613949,0.0011380716,0.009786482],"category_scores_gemma":[0.02251793,0.00019732025,0.0035128468,0.002178103,0.0004354568,0.000545973,0.0007939171,0.0014772986,0.00048475273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16808906,0.0006372846,0.22479536,0.022537937,0.023076095,0.00019697715,0.00041192514,0.0044448054,0.0007830109,0.01708247,0.22395328,0.3139917],"study_design_scores_gemma":[0.056687884,0.0060995035,0.6911614,0.012820974,0.036804475,0.00033881312,0.0006901354,0.00799285,0.0010423616,0.0040479354,0.18200529,0.00030841256],"about_ca_topic_score_codex":0.62611884,"about_ca_topic_score_gemma":0.81865734,"teacher_disagreement_score":0.37388116,"about_ca_system_score_codex":0.012658696,"about_ca_system_score_gemma":0.015168499,"threshold_uncertainty_score":0.75216603},"labels":[],"label_agreement":null},{"id":"W4200067059","doi":"10.51731/cjht.2021.185","title":"Risdiplam (Evrysdi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Spinal muscular atrophy; Physical therapy; Atrophy; Intensive care medicine; Pathology; Political science; Health care; Disease","score_opus":0.03575483784444124,"score_gpt":0.32543619014389263,"score_spread":0.2896813522994514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200067059","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011140058,0.60211915,0.0038120714,0.00756079,0.0035590422,0.00048113486,0.0047240546,0.0018508335,0.36475292],"genre_scores_gemma":[0.19951107,0.4003426,0.009721508,0.012620414,0.0012290145,0.00039062375,0.009624605,0.00036022926,0.3661999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950933,0.00008299761,0.000046436387,0.00009081093,0.00021335004,0.000056933804],"domain_scores_gemma":[0.9997204,0.00004604903,0.00005352341,0.000017733362,0.00011600585,0.000046356625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005463931,0.00053163327,0.00054186594,0.001164063,0.00031336627,0.0009857819,0.0008864525,0.0009830128,0.042785544],"category_scores_gemma":[0.00088411546,0.00017161148,0.00058034586,0.00051254436,0.0004260929,0.00052491523,0.00059160654,0.0013332582,0.0146967685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007177231,0.00013332236,0.00030296246,0.0056294776,0.00010869983,0.00036264063,0.00007378956,0.00020941533,0.010437907,0.0064410847,0.15551308,0.8200699],"study_design_scores_gemma":[0.0002592839,0.00052876264,0.0013724702,0.0016405965,0.000105013445,0.0010950372,0.000049454957,0.000112112066,0.0076329615,0.0004989989,0.98668706,0.000018395023],"about_ca_topic_score_codex":0.008790536,"about_ca_topic_score_gemma":0.023064878,"teacher_disagreement_score":0.042785544,"about_ca_system_score_codex":0.0013604629,"about_ca_system_score_gemma":0.0021694542,"threshold_uncertainty_score":0.14313191},"labels":[],"label_agreement":null},{"id":"W4200081815","doi":"10.51731/cjht.2021.226","title":"Liraglutide (Saxenda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liraglutide; Reimbursement; Medicine; Dyslipidemia; Overweight; Type 2 diabetes; Weight loss; Weight management; Obesity; Diabetes mellitus; Intervention (counseling); Family medicine; Physical therapy; Gerontology; Internal medicine; Health care; Nursing; Endocrinology; Political science","score_opus":0.027145564048585976,"score_gpt":0.27998161503450353,"score_spread":0.25283605098591755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200081815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01005927,0.9492716,0.00082386873,0.0032631925,0.0004841337,0.00014835,0.0021931324,0.00025481122,0.03350166],"genre_scores_gemma":[0.12087951,0.83379394,0.0030128255,0.006100643,0.00041233865,0.00018669087,0.0036859803,0.00003734982,0.031890795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970967,0.00007777003,0.000044791712,0.000031770684,0.000107274645,0.000028734246],"domain_scores_gemma":[0.9996685,0.0000794409,0.000104951134,0.000009193839,0.00009894474,0.000039011356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005170474,0.00027754577,0.0005423426,0.0011866789,0.00021072348,0.0008353692,0.00034876532,0.0004829947,0.008310031],"category_scores_gemma":[0.00081441435,0.00008586602,0.0006252233,0.0009289033,0.00021173147,0.00035553434,0.00023158084,0.0007662672,0.001963408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001740333,0.00008984619,0.0008864465,0.0111808665,0.0003940446,0.0003360111,0.000044360128,0.00020659153,0.004058368,0.0017004205,0.06236981,0.9169929],"study_design_scores_gemma":[0.0013323018,0.0013654985,0.008305841,0.00835921,0.0011675685,0.0020345498,0.000091049595,0.0002698575,0.003504174,0.00054501643,0.97298366,0.000041247065],"about_ca_topic_score_codex":0.013841586,"about_ca_topic_score_gemma":0.057029314,"teacher_disagreement_score":0.013841586,"about_ca_system_score_codex":0.0013267013,"about_ca_system_score_gemma":0.0016570338,"threshold_uncertainty_score":0.027799785},"labels":[],"label_agreement":null},{"id":"W4200199254","doi":"10.51731/cjht.2021.199","title":"Larotrectinib (Vitrakvi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Food and drug administration; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.03795991233794819,"score_gpt":0.31802674102821643,"score_spread":0.2800668286902682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200199254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017206945,0.88536507,0.0010306387,0.004354336,0.00047510563,0.0002643206,0.002671176,0.0002308464,0.08840163],"genre_scores_gemma":[0.24017268,0.68525267,0.003814849,0.0047273184,0.00040301692,0.00018893184,0.004327451,0.000052779884,0.0610604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970394,0.000065847154,0.000023976372,0.000030248682,0.00013808363,0.0000379134],"domain_scores_gemma":[0.99972373,0.00005462617,0.00007802371,0.000006740946,0.00010230556,0.00003456745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062204816,0.0002265702,0.00037116124,0.0009972379,0.00017946413,0.0008139081,0.0003301134,0.00035777688,0.009241907],"category_scores_gemma":[0.00070385373,0.00006565738,0.0004249407,0.0007902567,0.00022171934,0.00030140582,0.00022234702,0.0005104817,0.001481788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005903224,0.00006677989,0.001181435,0.005413421,0.0002014892,0.00017548661,0.00003385324,0.00025760787,0.005753249,0.002012006,0.04605763,0.93825674],"study_design_scores_gemma":[0.00050593767,0.0011677821,0.010227452,0.0030953935,0.00046187296,0.0018769364,0.00008363865,0.0002449162,0.006507319,0.00041004093,0.97539026,0.000028460525],"about_ca_topic_score_codex":0.019187042,"about_ca_topic_score_gemma":0.070827104,"teacher_disagreement_score":0.019187042,"about_ca_system_score_codex":0.002389385,"about_ca_system_score_gemma":0.0017349246,"threshold_uncertainty_score":0.038150728},"labels":[],"label_agreement":null},{"id":"W4200232119","doi":"10.51731/cjht.2021.171","title":"Upadacitinib (Rinvoq)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Methotrexate; Drug; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.035849686157004616,"score_gpt":0.3000880696004551,"score_spread":0.26423838344345046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200232119","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011681886,0.84920377,0.0011480179,0.00526332,0.001121737,0.00029352354,0.0037199114,0.00030068145,0.12726726],"genre_scores_gemma":[0.14821436,0.7607002,0.0036303778,0.0069499873,0.0005076115,0.00025851803,0.0067289867,0.000047720798,0.07296226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962294,0.00008516795,0.000039236536,0.000048421276,0.00015244709,0.00005188522],"domain_scores_gemma":[0.9996449,0.00007339248,0.000093474126,0.000013644868,0.00014045276,0.000034163397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064027915,0.00026034674,0.00035717557,0.0009637213,0.00024536316,0.00096071395,0.00046010167,0.0004872095,0.01664863],"category_scores_gemma":[0.0009661839,0.0000842775,0.0006970805,0.00078179286,0.00025398223,0.0005438158,0.00038175183,0.0005634664,0.0026206968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005978435,0.0000561739,0.00067622005,0.008356476,0.0002289884,0.00014050676,0.00003751844,0.00020606666,0.002777648,0.003361113,0.08887562,0.8946858],"study_design_scores_gemma":[0.00028129842,0.00048903486,0.004683908,0.004109352,0.00038912703,0.00081129035,0.000055160268,0.00015570299,0.00339142,0.00044267962,0.9851687,0.000022274184],"about_ca_topic_score_codex":0.017107233,"about_ca_topic_score_gemma":0.05360118,"teacher_disagreement_score":0.017107233,"about_ca_system_score_codex":0.0017241801,"about_ca_system_score_gemma":0.0025928817,"threshold_uncertainty_score":0.055695176},"labels":[],"label_agreement":null},{"id":"W4200249070","doi":"10.51731/cjht.2021.225","title":"Pembrolizumab (Keytruda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Refractory (planetary science); Drug; Family medicine; Intensive care medicine; Internal medicine; Pharmacology; Political science; Cancer; Health care; Immunotherapy","score_opus":0.027838581508828623,"score_gpt":0.294519728736736,"score_spread":0.26668114722790737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200249070","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009356791,0.851905,0.0017072263,0.0123791,0.002157207,0.00024425588,0.001992245,0.00025837318,0.119999774],"genre_scores_gemma":[0.1361045,0.7271405,0.006635461,0.0143606905,0.001070379,0.00026961358,0.0029077698,0.000046509158,0.111464724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999694,0.00006298596,0.00003321267,0.000044416218,0.00011808943,0.00004728014],"domain_scores_gemma":[0.999653,0.00007365082,0.00008822704,0.000014816458,0.0001230746,0.000047314283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065368257,0.00027173976,0.00026938564,0.00068748416,0.0002584937,0.0008526077,0.00036456698,0.0005340643,0.01327232],"category_scores_gemma":[0.0010069861,0.0000886365,0.00040968874,0.0004667259,0.00028160604,0.00058675586,0.0003614417,0.00075007806,0.0026430967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004462334,0.000051995852,0.00053306017,0.0031703978,0.00010228515,0.0001436091,0.000027371369,0.00011589254,0.0035235411,0.003644153,0.07823038,0.91001123],"study_design_scores_gemma":[0.00022384497,0.00050323014,0.004125999,0.002324597,0.00017474545,0.0007604051,0.000040040293,0.00010242351,0.004307703,0.0005815132,0.98684037,0.000015161594],"about_ca_topic_score_codex":0.017447365,"about_ca_topic_score_gemma":0.054619934,"teacher_disagreement_score":0.017447365,"about_ca_system_score_codex":0.0017570633,"about_ca_system_score_gemma":0.0021596055,"threshold_uncertainty_score":0.044400334},"labels":[],"label_agreement":null},{"id":"W4200299004","doi":"10.51731/cjht.2021.216","title":"Thank You to Our Readers and Contributors","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Public relations; Engineering ethics; Library science; Political science; Medical education; Medicine; Computer science; Engineering","score_opus":0.013936325513447655,"score_gpt":0.23345826423553198,"score_spread":0.21952193872208434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200299004","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047033414,0.017385693,0.0016200851,0.39997718,0.5397108,0.00018981355,0.0009691423,0.0016544524,0.038022466],"genre_scores_gemma":[0.0060387645,0.013375999,0.005177744,0.25137344,0.20294225,0.00032738002,0.0015336145,0.0021284423,0.51710236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98901236,0.0019758665,0.0004623409,0.0013162253,0.0063116783,0.000921637],"domain_scores_gemma":[0.8778234,0.007627671,0.0030321982,0.0034248254,0.08787681,0.020215001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007710456,0.0018161011,0.0018104651,0.0027837749,0.006711739,0.016206117,0.0025739,0.004877236,0.11777393],"category_scores_gemma":[0.07865046,0.0007361566,0.0012657866,0.0020840256,0.0025658512,0.008200276,0.005392158,0.0109030735,0.13996433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006039313,0.000004241442,0.000050644005,0.000036821395,0.0000019982392,0.000031014617,0.00007271264,0.0000055090554,0.00004040666,0.00025800735,0.9913726,0.008120048],"study_design_scores_gemma":[0.0000030331705,0.0000041558396,0.00010076873,0.00007049687,0.000004599942,0.00009953701,0.00026223483,0.000012495201,0.000044406643,0.00032648508,0.9990583,0.000013485432],"about_ca_topic_score_codex":0.010983451,"about_ca_topic_score_gemma":0.024562312,"teacher_disagreement_score":0.11777393,"about_ca_system_score_codex":0.0039604376,"about_ca_system_score_gemma":0.011241169,"threshold_uncertainty_score":0.39399302},"labels":[],"label_agreement":null},{"id":"W4200303884","doi":"10.51731/cjht.2021.152","title":"Encorafenib (Braftovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Cetuximab; Drug class; Drug; Family medicine; Business; Pharmacology; Economic growth; Internal medicine; Economics; Cancer; Health care","score_opus":0.01682635852450084,"score_gpt":0.24471893124743535,"score_spread":0.2278925727229345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200303884","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061401617,0.8622086,0.0012555693,0.002862123,0.00038943603,0.00020087633,0.0030690145,0.00015924472,0.068453506],"genre_scores_gemma":[0.41139954,0.523621,0.0030247974,0.0024775413,0.00018844214,0.00013017528,0.003839671,0.00002283535,0.0552961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998399,0.000024894292,0.000012396958,0.000020416997,0.00007983262,0.000022471273],"domain_scores_gemma":[0.9998666,0.000021856686,0.0000369697,0.0000040165514,0.000052223313,0.000018336654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028276883,0.0002534689,0.00023511227,0.0007257025,0.00019437191,0.00046556888,0.00017042272,0.00024595574,0.0056449748],"category_scores_gemma":[0.00037069654,0.00005468369,0.000263504,0.00059059303,0.00012689654,0.00023119962,0.00014704623,0.00029801243,0.0007795358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007208248,0.000102605474,0.002593715,0.003114514,0.00022204904,0.00029791103,0.000032647982,0.0004676023,0.014563826,0.0017179358,0.022203,0.95396346],"study_design_scores_gemma":[0.00035473998,0.0017040352,0.024829237,0.0015891317,0.00042752526,0.0032748145,0.000110084744,0.00037028315,0.021972373,0.0005499132,0.9447883,0.000029733159],"about_ca_topic_score_codex":0.016251719,"about_ca_topic_score_gemma":0.1021363,"teacher_disagreement_score":0.016251719,"about_ca_system_score_codex":0.0015853794,"about_ca_system_score_gemma":0.0012878856,"threshold_uncertainty_score":0.03231424},"labels":[],"label_agreement":null},{"id":"W4200307909","doi":"10.51731/cjht.2021.200","title":"Incobotulinumtoxina (Xeomin)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Political science","score_opus":0.026164403066828188,"score_gpt":0.27842274531123146,"score_spread":0.25225834224440324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200307909","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007527736,0.75490785,0.0015573604,0.014796228,0.0033799754,0.0001862341,0.002572224,0.00021874078,0.21485363],"genre_scores_gemma":[0.0663417,0.6917381,0.0053265644,0.013708958,0.0008347623,0.00015455332,0.0025373925,0.00005278781,0.21930514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994704,0.00006393572,0.000043640306,0.000041624004,0.00031042224,0.00007005537],"domain_scores_gemma":[0.99926466,0.00015442706,0.00011372096,0.000016994001,0.00039797663,0.000052144907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009045834,0.0003268403,0.00028817725,0.0010951713,0.00039623547,0.00096699107,0.0004974626,0.00071843434,0.018504944],"category_scores_gemma":[0.0013398807,0.00009259897,0.00047144663,0.00082401134,0.00050441985,0.0005368776,0.0003764494,0.00052824547,0.0031988458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018404049,0.00003929952,0.0013217854,0.0047088196,0.000070065114,0.0002278417,0.000056761673,0.00010012399,0.0045254896,0.0064596375,0.18110792,0.80119824],"study_design_scores_gemma":[0.000033874945,0.00022492047,0.008904005,0.0022534323,0.00008329489,0.0005412739,0.00008453055,0.000086903,0.0029809885,0.00051063934,0.98428094,0.000015264615],"about_ca_topic_score_codex":0.12516889,"about_ca_topic_score_gemma":0.32643098,"teacher_disagreement_score":0.12516889,"about_ca_system_score_codex":0.00354383,"about_ca_system_score_gemma":0.0049359803,"threshold_uncertainty_score":0.24888062},"labels":[],"label_agreement":null},{"id":"W4200446389","doi":"10.51731/cjht.2021.229","title":"Self-Sampling Devices for HPV Testing","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sampling (signal processing); Cervical cancer screening; Medicine; Cancer screening; Cervical cancer; Test (biology); Cancer; Family medicine; Medical physics; Computer science; Internal medicine","score_opus":0.17188453703624765,"score_gpt":0.4087846352444208,"score_spread":0.23690009820817318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200446389","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055022996,0.033138353,0.036228698,0.026879992,0.0075744367,0.0073260367,0.039169453,0.005151096,0.78950906],"genre_scores_gemma":[0.2247836,0.030752422,0.09967807,0.030045656,0.0011202396,0.0047113476,0.02537673,0.0008432084,0.5826887],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942334,0.0014803765,0.00044639892,0.00047622013,0.0029803398,0.00038327064],"domain_scores_gemma":[0.9934007,0.0020997452,0.00073165295,0.0007444723,0.0026834006,0.000340089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00543657,0.000416732,0.00043092438,0.0021200518,0.0008995086,0.001426277,0.0015139905,0.001158003,0.10864197],"category_scores_gemma":[0.012251565,0.00035677775,0.00076984224,0.0015644007,0.00060430146,0.0010036377,0.0016441592,0.00094339723,0.028590493],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037665383,0.0002824698,0.017470667,0.0017691365,0.00002879225,0.00020356638,0.0009656906,0.00006180487,0.0032793204,0.0041528707,0.24790451,0.72350454],"study_design_scores_gemma":[0.00010409456,0.00058717735,0.032550763,0.0014989122,0.00006254587,0.0010371935,0.0010319962,0.00025760432,0.007804707,0.000923683,0.95407844,0.00006286539],"about_ca_topic_score_codex":0.03134656,"about_ca_topic_score_gemma":0.045623884,"teacher_disagreement_score":0.10864197,"about_ca_system_score_codex":0.0017380118,"about_ca_system_score_gemma":0.0041498756,"threshold_uncertainty_score":0.3634436},"labels":[],"label_agreement":null},{"id":"W4200452605","doi":"10.51731/cjht.2021.222","title":"An Overview of Emerging Point-of-Care Tests for Differentiating Bacterial and Viral Infections","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Point-of-care testing; Antibiotic resistance; Intensive care medicine; Point of care; Antimicrobial stewardship; Medicine; Antibiotics; Psychological intervention; Antibiotic Stewardship; Health care; Diagnostic test; Stewardship (theology); Risk analysis (engineering); Immunology; Biology; Pediatrics; Pathology; Nursing; Microbiology","score_opus":0.03145847286048498,"score_gpt":0.3149869575421082,"score_spread":0.2835284846816232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200452605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011029282,0.9740737,0.004794885,0.005877433,0.0012343948,0.00014631587,0.00052860787,0.00020899261,0.012032724],"genre_scores_gemma":[0.005420178,0.9716043,0.012785455,0.0043884586,0.001495069,0.00017271527,0.0009995468,0.000043420347,0.0030908538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957331,0.0011486895,0.00081520504,0.00037942926,0.0016404316,0.0002831028],"domain_scores_gemma":[0.98784196,0.0070595415,0.0011722094,0.00018148652,0.0033447605,0.00040000572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004752321,0.0012767883,0.0012910339,0.009175208,0.00044359907,0.002378376,0.0015166489,0.0025316903,0.0067920964],"category_scores_gemma":[0.010822511,0.00065999286,0.0020932078,0.004538266,0.0006694443,0.0036999967,0.0011251094,0.0028221537,0.0034193292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022152696,0.00012921207,0.0033827573,0.014440091,0.00013771093,0.0005796348,0.00020147613,0.00046069117,0.00176852,0.004786852,0.0572997,0.91659194],"study_design_scores_gemma":[0.000030319372,0.00058983004,0.00712698,0.024879863,0.0003512766,0.005623176,0.00029914215,0.00064190733,0.0017959018,0.0033148704,0.9552511,0.000095666306],"about_ca_topic_score_codex":0.003865493,"about_ca_topic_score_gemma":0.0069538048,"teacher_disagreement_score":0.009175208,"about_ca_system_score_codex":0.0020297542,"about_ca_system_score_gemma":0.002763828,"threshold_uncertainty_score":0.025133014},"labels":[],"label_agreement":null},{"id":"W4200599422","doi":"10.51731/cjht.2021.201","title":"Givosiran (Givlaari)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.011996671435491423,"score_gpt":0.24832633320240988,"score_spread":0.23632966176691844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200599422","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016012715,0.63872236,0.0036157982,0.010077783,0.0037091188,0.00042790134,0.004072779,0.001301202,0.3220604],"genre_scores_gemma":[0.14719884,0.49550655,0.007970127,0.013870699,0.0010316566,0.00034504337,0.008126654,0.000228192,0.32572222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998692,0.000019350655,0.000010762272,0.000027964692,0.000052424446,0.000020224403],"domain_scores_gemma":[0.9998889,0.000020407251,0.000021390817,0.0000068513145,0.000037539405,0.000024921974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024474866,0.00039241643,0.00028180238,0.0009475522,0.00027507814,0.0006536894,0.0005429729,0.00092579407,0.033548094],"category_scores_gemma":[0.00043192768,0.00011150349,0.0003983376,0.000508289,0.00028790536,0.00042616602,0.00050882174,0.0011516864,0.012677183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051928515,0.00012009691,0.00029740477,0.0027424302,0.000057353715,0.00047075274,0.000061525156,0.00019289102,0.015101055,0.006297161,0.14270747,0.8314327],"study_design_scores_gemma":[0.00016906085,0.0004002275,0.0012625639,0.0008960004,0.00006107867,0.001284177,0.00004130205,0.00011363822,0.0065597943,0.0006948272,0.98849803,0.000019356643],"about_ca_topic_score_codex":0.00990784,"about_ca_topic_score_gemma":0.020536598,"teacher_disagreement_score":0.033548094,"about_ca_system_score_codex":0.00091599766,"about_ca_system_score_gemma":0.0011621636,"threshold_uncertainty_score":0.112229526},"labels":[],"label_agreement":null},{"id":"W4200625024","doi":"10.51731/cjht.2021.145","title":"Durvalumab (Imfinzi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Carboplatin; Medicine; Etoposide; Authorization; Cisplatin; Intensive care medicine; Political science; Cancer; Surgery; Chemotherapy; Internal medicine; Law; Computer science; Computer security","score_opus":0.0508276305137164,"score_gpt":0.36922993545455696,"score_spread":0.31840230494084054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200625024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023153257,0.8789621,0.0015006708,0.004393875,0.0008566611,0.00015848527,0.0017410528,0.00017532535,0.089058496],"genre_scores_gemma":[0.28295317,0.6222809,0.005342944,0.0065082815,0.0004938481,0.00021162962,0.003644885,0.000036803856,0.07852751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988365,0.00002133061,0.000012078571,0.00001981814,0.000045600354,0.000017536027],"domain_scores_gemma":[0.9999063,0.000025000394,0.000029323208,0.0000033926667,0.000021388621,0.000014640597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003333061,0.00020185036,0.00022890355,0.00032254655,0.00012574105,0.0004380414,0.0003203606,0.00027279288,0.006479558],"category_scores_gemma":[0.00050319935,0.000044858298,0.00024943674,0.00026490554,0.00012601555,0.0003002792,0.00018488485,0.00042095085,0.0011949269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008027906,0.000051599953,0.00070730544,0.0027298888,0.000110241475,0.00016599138,0.00003932273,0.00014555706,0.005282581,0.0030741652,0.047217228,0.93967336],"study_design_scores_gemma":[0.0005874319,0.00062443834,0.004690406,0.0016417413,0.00023584145,0.0015211285,0.000046084864,0.0001828941,0.0061799777,0.0005803218,0.98369825,0.000011465732],"about_ca_topic_score_codex":0.008440932,"about_ca_topic_score_gemma":0.031068683,"teacher_disagreement_score":0.008440932,"about_ca_system_score_codex":0.0012704132,"about_ca_system_score_gemma":0.00096118863,"threshold_uncertainty_score":0.021676302},"labels":[],"label_agreement":null},{"id":"W4205118191","doi":"10.51731/cjht.2022.240","title":"Tucatinib (Tukysa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Capecitabine; Trastuzumab; Pertuzumab; Medicine; Trastuzumab emtansine; Oncology; Internal medicine; Breast cancer; Cancer; Political science; Colorectal cancer","score_opus":0.08428908766939776,"score_gpt":0.38703315185344067,"score_spread":0.3027440641840429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205118191","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03997964,0.8129088,0.0012466299,0.0043040817,0.0010238682,0.00042212434,0.0046999785,0.0005599967,0.13485484],"genre_scores_gemma":[0.4584352,0.4497861,0.002591441,0.0043941285,0.00047808816,0.00033077347,0.009457692,0.000044244465,0.074482344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998548,0.00002365965,0.000013453276,0.000022711682,0.000055967823,0.000029335208],"domain_scores_gemma":[0.99990535,0.000014124038,0.00002637105,0.0000041372527,0.000028210397,0.000021806085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023661858,0.00028229124,0.00034036167,0.0010731202,0.00033225596,0.0007511549,0.00028997142,0.00039381275,0.010325639],"category_scores_gemma":[0.00039178308,0.00007769139,0.00045976893,0.0008721323,0.00016962687,0.0003393945,0.00029980863,0.00070835353,0.0021417057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090238114,0.00013780399,0.0011302701,0.0038786214,0.00019340994,0.00029279603,0.000042830332,0.00053733645,0.008050029,0.0031841553,0.07317497,0.90847534],"study_design_scores_gemma":[0.0007473258,0.0009992182,0.008519319,0.0021345492,0.00040317274,0.0026851755,0.000060320428,0.0005212216,0.0074878503,0.00062738213,0.9757816,0.000032848984],"about_ca_topic_score_codex":0.013146488,"about_ca_topic_score_gemma":0.046071492,"teacher_disagreement_score":0.013146488,"about_ca_system_score_codex":0.0016327656,"about_ca_system_score_gemma":0.0015905814,"threshold_uncertainty_score":0.03454268},"labels":[],"label_agreement":null},{"id":"W4205164313","doi":"10.51731/cjht.2022.238","title":"Approaches to Evaluations of Virtual Care in Primary Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Scope (computer science); Quality (philosophy); Economic evaluation; Resource (disambiguation); Medicine; Nursing; Computer science; Political science","score_opus":0.12000296628863219,"score_gpt":0.35253272883362585,"score_spread":0.23252976254499366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205164313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023529768,0.41334137,0.1256676,0.06333749,0.0027397762,0.05887025,0.0063970545,0.00053801114,0.3055787],"genre_scores_gemma":[0.31213713,0.13876206,0.39405033,0.027543861,0.00060329377,0.11668275,0.0024049373,0.0002598783,0.007555759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5542173,0.3912403,0.026464554,0.0055531184,0.019862598,0.0026622615],"domain_scores_gemma":[0.48320228,0.45832765,0.017558658,0.0100572705,0.028925583,0.0019285113],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25513715,0.0015713449,0.0032955331,0.028945722,0.0040785912,0.019856602,0.006153963,0.0044623856,0.01949168],"category_scores_gemma":[0.33935344,0.0019378113,0.0040018493,0.026317267,0.007850275,0.016012814,0.0135203535,0.0043975194,0.002098116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006443581,0.0004199874,0.0038594515,0.19502741,0.0013204907,0.0005728867,0.02897812,0.0015544404,0.00046820505,0.19348319,0.020571563,0.55309993],"study_design_scores_gemma":[0.0010505235,0.0011471732,0.008437435,0.46834165,0.0022365914,0.00059232523,0.051108707,0.0017993108,0.0015390512,0.112159714,0.35137364,0.00021383008],"about_ca_topic_score_codex":0.011930678,"about_ca_topic_score_gemma":0.026650967,"teacher_disagreement_score":0.25513715,"about_ca_system_score_codex":0.039294034,"about_ca_system_score_gemma":0.045510404,"threshold_uncertainty_score":0.9185485},"labels":[],"label_agreement":null},{"id":"W4205185159","doi":"10.51731/cjht.2021.124","title":"Fedratinib (Inrebic)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Reimbursement; Medicine; Ruxolitinib; Polycythemia vera; Disease; Essential thrombocythemia; Family medicine; Intensive care medicine; Internal medicine; Health care; Political science","score_opus":0.0371294891938039,"score_gpt":0.3059198913794901,"score_spread":0.26879040218568623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205185159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012121605,0.55106825,0.0023816247,0.012621855,0.0039077704,0.0006325145,0.012040791,0.001601082,0.40362448],"genre_scores_gemma":[0.16981657,0.41284072,0.009875924,0.020678524,0.0019826654,0.00047421534,0.029109113,0.00019557905,0.3550266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996364,0.000056978686,0.000034184035,0.000057998852,0.00015817334,0.00005625534],"domain_scores_gemma":[0.9996877,0.000032793578,0.00006750909,0.000012863587,0.00013757992,0.00006165848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005274774,0.00045943027,0.00041704474,0.0011684997,0.000352822,0.0010217568,0.00061958114,0.0008074794,0.039882034],"category_scores_gemma":[0.00085259345,0.00010385501,0.0004897355,0.0006561827,0.00026616125,0.0006130978,0.00048154715,0.0008942892,0.013514344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006032831,0.000083005245,0.0004465543,0.0025050144,0.00006761839,0.00015897273,0.000025022506,0.00013629168,0.0033155144,0.0026223874,0.20117734,0.78885907],"study_design_scores_gemma":[0.0002482969,0.0003062983,0.0018252503,0.00088830857,0.00006855242,0.0007215547,0.00001583822,0.000104670224,0.0020359198,0.00031217985,0.99345917,0.0000140076045],"about_ca_topic_score_codex":0.012950538,"about_ca_topic_score_gemma":0.031196387,"teacher_disagreement_score":0.039882034,"about_ca_system_score_codex":0.0017131062,"about_ca_system_score_gemma":0.0023301325,"threshold_uncertainty_score":0.13341868},"labels":[],"label_agreement":null},{"id":"W4205218195","doi":"10.51731/cjht.2021.189","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Reimbursement; Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Drug; Regulator; Internal medicine; Pharmacology; Gene; Political science; Genetics; Biology","score_opus":0.025529726591794456,"score_gpt":0.3199476655061916,"score_spread":0.2944179389143971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205218195","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012584549,0.8519048,0.0021996927,0.011752327,0.0017032041,0.00030001372,0.0027745375,0.00022581806,0.116555065],"genre_scores_gemma":[0.15143326,0.7260498,0.008281758,0.009245315,0.001091135,0.00026991044,0.0033644373,0.000051356732,0.10021305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993723,0.00016163701,0.00008770034,0.000059238064,0.00025003887,0.0000691105],"domain_scores_gemma":[0.9991479,0.0002750253,0.0002657007,0.000030764688,0.00021369921,0.00006686882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010333537,0.00018500246,0.00031517266,0.00086175825,0.0001823221,0.00085100956,0.0003594814,0.00052794593,0.014695738],"category_scores_gemma":[0.0024389196,0.00007169455,0.0007616422,0.0006494289,0.00040323526,0.00045584422,0.00027295473,0.000633279,0.0020491993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068758795,0.000056621502,0.0014408146,0.0045031235,0.00023890159,0.00020459414,0.000035465113,0.00016645939,0.0024884492,0.005886961,0.061829504,0.92246145],"study_design_scores_gemma":[0.00056013354,0.00064981333,0.009220142,0.0053394055,0.00035268738,0.0012671144,0.000073300165,0.00017869748,0.002684278,0.0010313127,0.9786187,0.000024447107],"about_ca_topic_score_codex":0.015948858,"about_ca_topic_score_gemma":0.05697711,"teacher_disagreement_score":0.015948858,"about_ca_system_score_codex":0.0015419202,"about_ca_system_score_gemma":0.0025283704,"threshold_uncertainty_score":0.04916215},"labels":[],"label_agreement":null},{"id":"W4205459220","doi":"10.51731/cjht.2022.243","title":"Romosozumab (Evenity)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Osteoporosis; Family medicine; Internal medicine; Political science; Health care","score_opus":0.04943136175459083,"score_gpt":0.29029929716573705,"score_spread":0.2408679354111462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205459220","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023548333,0.83076316,0.0026017916,0.006512909,0.0013616711,0.0004303015,0.0025701402,0.0004986775,0.13171303],"genre_scores_gemma":[0.21826527,0.6723438,0.007671328,0.010482163,0.0007156716,0.00039395347,0.003996699,0.000065796936,0.08606543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999796,0.000034551587,0.00001971266,0.000034012057,0.00008309089,0.00003268665],"domain_scores_gemma":[0.9998241,0.000033271775,0.00005607755,0.000006195825,0.000056628407,0.000023773346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041298903,0.0002776326,0.0002645184,0.00071421143,0.00019332208,0.0004916204,0.000332727,0.00048306194,0.0077542495],"category_scores_gemma":[0.0005624166,0.000069077294,0.00041977235,0.0003331749,0.00025208408,0.00034992048,0.00025450194,0.0005150982,0.0020324606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077777065,0.0000889005,0.00051787525,0.004894331,0.000102646874,0.00023891301,0.000039892115,0.00014259087,0.012275029,0.0036418887,0.06296138,0.9143188],"study_design_scores_gemma":[0.00052901526,0.000998201,0.0044745114,0.00260187,0.000264367,0.0018039858,0.000048709724,0.00017093173,0.010091341,0.00063823286,0.97834957,0.000029248631],"about_ca_topic_score_codex":0.01012523,"about_ca_topic_score_gemma":0.028815854,"teacher_disagreement_score":0.01012523,"about_ca_system_score_codex":0.00093840127,"about_ca_system_score_gemma":0.0012834314,"threshold_uncertainty_score":0.025940478},"labels":[],"label_agreement":null},{"id":"W4205491995","doi":"10.51731/cjht.2022.245","title":"The Small House Model to Support Older Adults in Long-Term Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Autonomy; Context (archaeology); Consistency (knowledge bases); Long-term care; Flexibility (engineering); Replication (statistics); Interpersonal communication; Psychology; Public relations; Medicine; Social psychology; Computer science; Nursing; Political science; Economics; Management; Geography; Developmental psychology","score_opus":0.04307020147026734,"score_gpt":0.3537077130101118,"score_spread":0.3106375115398444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205491995","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30259082,0.14739746,0.031709258,0.079534635,0.00851574,0.001617671,0.0014614655,0.00086803315,0.4263049],"genre_scores_gemma":[0.80321753,0.083147354,0.04302498,0.017247709,0.0010593126,0.0008643631,0.0011408179,0.0001517137,0.050146222],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986791,0.0005323375,0.000059373317,0.00006823206,0.0004482436,0.0002127025],"domain_scores_gemma":[0.9980876,0.00037442663,0.00017425604,0.00008988001,0.0004155641,0.0008582011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019070657,0.00027270394,0.00020885102,0.000598239,0.0018030411,0.0015997345,0.0013959017,0.00077703426,0.009300553],"category_scores_gemma":[0.00558754,0.00008746329,0.0005663192,0.0009369936,0.0008979586,0.0016616264,0.003839517,0.0011825947,0.0012901262],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016382919,0.0005993957,0.009848213,0.0030496153,0.00007338237,0.00066967646,0.012394547,0.0003038224,0.00043800022,0.020727625,0.11768282,0.834049],"study_design_scores_gemma":[0.00020500462,0.0007937234,0.05978805,0.010766883,0.0002479714,0.0020214512,0.01696848,0.00069918897,0.0004185266,0.009478662,0.89853513,0.00007681004],"about_ca_topic_score_codex":0.11473289,"about_ca_topic_score_gemma":0.3868098,"teacher_disagreement_score":0.11473289,"about_ca_system_score_codex":0.004204569,"about_ca_system_score_gemma":0.013621924,"threshold_uncertainty_score":0.22813016},"labels":[],"label_agreement":null},{"id":"W4205632133","doi":"10.51731/cjht.2021.187","title":"Brexucabtagene Autoleucel (Tecartus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mantle cell lymphoma; Chimeric antigen receptor; Bruton's tyrosine kinase; Medicine; CD19; Lymphoma; Drug; Immunotherapy; Cell therapy; Oncology; Tyrosine kinase; Pharmacology; Immunology; Internal medicine; Cell; Antigen; Receptor; Cancer; Biology; Health care; Political science","score_opus":0.05133370576819875,"score_gpt":0.3399551668119211,"score_spread":0.2886214610437224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205632133","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0151214935,0.95621204,0.0010340156,0.0016958023,0.00024306666,0.0001356416,0.00092231407,0.00007161627,0.024564035],"genre_scores_gemma":[0.19172241,0.77681714,0.0038842203,0.0022938787,0.0002452254,0.00019562579,0.002190762,0.000039347426,0.022611322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945194,0.00012832528,0.00003532262,0.00003705502,0.00030465674,0.00004274135],"domain_scores_gemma":[0.9995004,0.00017680554,0.00012083772,0.000014356069,0.00014540507,0.000042245487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009652477,0.00017277984,0.00038259962,0.0010045575,0.0001924241,0.0007809853,0.00030666965,0.00037701902,0.0038076872],"category_scores_gemma":[0.0009814225,0.000057266454,0.00042884328,0.00082192296,0.00024122128,0.0002754209,0.0001609474,0.00052983715,0.00056299934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055378623,0.00008313233,0.0012284192,0.0056184665,0.00023595987,0.00021928137,0.000048241258,0.00046235262,0.008193943,0.0038216172,0.026860477,0.95267445],"study_design_scores_gemma":[0.00024248796,0.0010191619,0.007440902,0.002721509,0.00032567087,0.0014884947,0.00007103351,0.00023886607,0.008046385,0.00036371427,0.97802246,0.000019368914],"about_ca_topic_score_codex":0.014800473,"about_ca_topic_score_gemma":0.054793444,"teacher_disagreement_score":0.9851995,"about_ca_system_score_codex":0.0022415004,"about_ca_system_score_gemma":0.0019845804,"threshold_uncertainty_score":0.029428601},"labels":[],"label_agreement":null},{"id":"W4206026441","doi":"10.51731/cjht.2021.174","title":"Budesonide (Jorveza)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Eosinophilic esophagitis; Budesonide; Medicine; Family medicine; Pathological; Intensive care medicine; Internal medicine; Asthma; Political science; Disease; Health care","score_opus":0.028695296492239186,"score_gpt":0.2956068445170824,"score_spread":0.26691154802484324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206026441","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056373305,0.88181305,0.0009101843,0.008217746,0.0033163014,0.00015564662,0.0024899733,0.00021063084,0.09724916],"genre_scores_gemma":[0.08065945,0.7471179,0.0035289086,0.01039494,0.0012083355,0.00013984497,0.0043344973,0.00004229262,0.15257385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996711,0.000046505596,0.000040370058,0.000047341866,0.00016149995,0.000033200442],"domain_scores_gemma":[0.999721,0.000053211257,0.000063242864,0.000009450468,0.000110439396,0.00004258935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050250074,0.00027526388,0.00038320117,0.00071382936,0.00027090294,0.00068633136,0.0004153314,0.00061463186,0.016463704],"category_scores_gemma":[0.0008182571,0.000082008504,0.00044843677,0.00045258843,0.00025111975,0.00030331127,0.00031383868,0.0007292597,0.005629173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005457338,0.00006154964,0.0007379863,0.005332383,0.00010275443,0.0002697922,0.00003330912,0.00006120733,0.005075069,0.0024663461,0.11523446,0.8700794],"study_design_scores_gemma":[0.00021788338,0.00045897867,0.0063185217,0.0018580821,0.00014319236,0.0009484034,0.00005133706,0.000045332457,0.0023008257,0.0002528333,0.9873892,0.00001535722],"about_ca_topic_score_codex":0.022846816,"about_ca_topic_score_gemma":0.08280071,"teacher_disagreement_score":0.022846816,"about_ca_system_score_codex":0.0009083694,"about_ca_system_score_gemma":0.0015300157,"threshold_uncertainty_score":0.05507654},"labels":[],"label_agreement":null},{"id":"W4206440127","doi":"10.51731/cjht.2021.173","title":"Venetoclax (Venclexta)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Reimbursement; Medicine; Cytarabine; Azacitidine; Drug; Intensive care medicine; Family medicine; Chemotherapy; Psychiatry; Internal medicine; Leukemia; Political science","score_opus":0.041498930668248404,"score_gpt":0.3312813472294035,"score_spread":0.2897824165611551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206440127","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015740357,0.85103995,0.0011606482,0.0045370655,0.0012681774,0.00037277682,0.004310294,0.00036114748,0.12120962],"genre_scores_gemma":[0.23371333,0.6503048,0.0062466175,0.0070546637,0.0012186789,0.00041367547,0.009058242,0.00012277214,0.091867305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964106,0.00009382092,0.000022302662,0.0000449491,0.00015080385,0.000047131554],"domain_scores_gemma":[0.99960333,0.000112040165,0.0000952045,0.000016498385,0.00008626375,0.00008665848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005496531,0.00017867173,0.00031636207,0.0007995451,0.00032166066,0.0009675822,0.00038339777,0.0004908667,0.020176098],"category_scores_gemma":[0.0011732549,0.00007595291,0.00036896125,0.00087413733,0.00027328124,0.000334474,0.00028602252,0.0012344068,0.0019006542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009588475,0.00013120628,0.0011618028,0.004935967,0.00014160019,0.00026691143,0.000053408046,0.00024106998,0.0027413317,0.006124627,0.14049657,0.84274656],"study_design_scores_gemma":[0.0007530027,0.0005183281,0.0044358536,0.0027172158,0.00017675821,0.0011499892,0.000043540407,0.0001240754,0.0014011294,0.00059885427,0.98806727,0.000013943077],"about_ca_topic_score_codex":0.020779865,"about_ca_topic_score_gemma":0.08227157,"teacher_disagreement_score":0.020779865,"about_ca_system_score_codex":0.0012511589,"about_ca_system_score_gemma":0.0022912887,"threshold_uncertainty_score":0.0674957},"labels":[],"label_agreement":null},{"id":"W4206540052","doi":"10.51731/cjht.2021.169","title":"Human Insulin (Entuzity KwikPen)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Glycemic; Human insulin; Insulin; Medicine; Diabetes mellitus; Drug; Subcutaneous injection; Drug class; Intensive care medicine; Pharmacology; Business; Internal medicine; Endocrinology; Political science; Law","score_opus":0.051685198503898896,"score_gpt":0.3460382872987443,"score_spread":0.2943530887948454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206540052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010364368,0.52383447,0.0043138987,0.005184237,0.0027283523,0.0004261886,0.003045166,0.00076988497,0.44933343],"genre_scores_gemma":[0.09354304,0.39132842,0.009374606,0.00751255,0.00047497285,0.00028195838,0.0053022285,0.00020932057,0.4919729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960226,0.000054491284,0.00003713829,0.00006965375,0.00019030049,0.00004615979],"domain_scores_gemma":[0.99975413,0.000042816217,0.000055503388,0.00001355104,0.00009660477,0.000037293932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004774914,0.00049532176,0.0002993551,0.0011497434,0.0003025618,0.0009917133,0.0005277716,0.0007531052,0.041401353],"category_scores_gemma":[0.00079770683,0.00015569615,0.0003886429,0.0007361419,0.00032140405,0.0006736635,0.0005873898,0.00085817784,0.013233932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006124803,0.00008582142,0.00043271607,0.004335149,0.000054530505,0.00040367394,0.00005453883,0.00012593475,0.009004866,0.0057416963,0.09646034,0.8826882],"study_design_scores_gemma":[0.0001202447,0.000191187,0.0018121084,0.0012844561,0.000058568618,0.00080321654,0.000052272455,0.00006369245,0.0049294285,0.00027948135,0.99039173,0.000013480715],"about_ca_topic_score_codex":0.018468414,"about_ca_topic_score_gemma":0.04475347,"teacher_disagreement_score":0.041401353,"about_ca_system_score_codex":0.0013869407,"about_ca_system_score_gemma":0.0022073374,"threshold_uncertainty_score":0.13850135},"labels":[],"label_agreement":null},{"id":"W4206713533","doi":"10.51731/cjht.2021.119","title":"Patiromer (Veltassa)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Hyperkalemia; Medicine; Kidney disease; Intensive care medicine; Renal function; Internal medicine; Economic growth; Health care","score_opus":0.020893355207893323,"score_gpt":0.27613870349549574,"score_spread":0.2552453482876024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206713533","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0115069905,0.18890736,0.0029617033,0.013674974,0.0048515243,0.000839096,0.013302429,0.0033354075,0.76062053],"genre_scores_gemma":[0.109865986,0.19391161,0.0087355515,0.020032195,0.0014780286,0.00049005955,0.020951625,0.00075831654,0.64377666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995846,0.000050515027,0.000038132923,0.00007674333,0.00019614112,0.000053891094],"domain_scores_gemma":[0.9996013,0.00004987228,0.000061661565,0.000025852927,0.0001628262,0.00009856723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042141217,0.00044521716,0.00044604403,0.0014264568,0.00049736636,0.0013198038,0.0012571346,0.0011461683,0.1295964],"category_scores_gemma":[0.0012872344,0.0002004392,0.00070590526,0.0007151824,0.00044119742,0.0008294347,0.0009063183,0.0016687575,0.032053877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008827193,0.00019437684,0.0005117877,0.0042512408,0.00008504907,0.00045875128,0.000075033066,0.00014574087,0.0061993143,0.008010564,0.38904083,0.5901446],"study_design_scores_gemma":[0.00028244714,0.0002151878,0.0010428771,0.00086980476,0.00005444272,0.00050851906,0.0000455947,0.00006901825,0.0017318758,0.00047388184,0.9946936,0.00001272678],"about_ca_topic_score_codex":0.022938203,"about_ca_topic_score_gemma":0.052489,"teacher_disagreement_score":0.1295964,"about_ca_system_score_codex":0.0011722473,"about_ca_system_score_gemma":0.0031903016,"threshold_uncertainty_score":0.43354315},"labels":[],"label_agreement":null},{"id":"W4206742742","doi":"10.51731/cjht.2022.242","title":"Renal Denervation for People With Hypertension","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denervation; Horizon; Intervention (counseling); Medicine; Focus (optics); Information technology; Emerging technologies; Business; Computer science; Intensive care medicine; Nursing; Internal medicine; Artificial intelligence","score_opus":0.048663808432929556,"score_gpt":0.2672997802750063,"score_spread":0.21863597184207673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206742742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08799448,0.7242878,0.0005214672,0.0363342,0.0032649087,0.00048503943,0.005000581,0.0001313507,0.14198019],"genre_scores_gemma":[0.4118637,0.5274255,0.0022804465,0.024977874,0.004622826,0.0003628193,0.0029513224,0.000031600935,0.025483793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995962,0.00008688136,0.00003372956,0.000025808822,0.00018125876,0.000076153825],"domain_scores_gemma":[0.9994535,0.00014967099,0.00010413226,0.000019976145,0.00013453605,0.0001382547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007720381,0.000117888725,0.00041440126,0.00054395787,0.00080240046,0.0006008636,0.00024860623,0.0005457506,0.011183957],"category_scores_gemma":[0.0019772623,0.00007048652,0.0006159819,0.000921946,0.00018433845,0.0002974816,0.00030118867,0.0007924885,0.0010668173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020369955,0.0005988361,0.040871404,0.005273506,0.00031328853,0.0006164906,0.00044628457,0.00003237756,0.0006676287,0.001832171,0.14412463,0.8031864],"study_design_scores_gemma":[0.0028078537,0.0041814977,0.48143786,0.019776214,0.002574553,0.005169469,0.0015041869,0.00022431595,0.00092433847,0.0037356734,0.4775876,0.00007637008],"about_ca_topic_score_codex":0.048517756,"about_ca_topic_score_gemma":0.12524995,"teacher_disagreement_score":0.048517756,"about_ca_system_score_codex":0.0009930374,"about_ca_system_score_gemma":0.003490531,"threshold_uncertainty_score":0.09647071},"labels":[],"label_agreement":null},{"id":"W4206754378","doi":"10.51731/cjht.2022.237","title":"Azacitidine (Onureg)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Azacitidine; Medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Family medicine; Internal medicine; Political science","score_opus":0.035742845196911094,"score_gpt":0.3107890114319356,"score_spread":0.27504616623502454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206754378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015471694,0.90937155,0.0004834554,0.0018413366,0.00029444927,0.00017662263,0.001722898,0.00011045154,0.070527494],"genre_scores_gemma":[0.18601239,0.7594974,0.003730219,0.0039206687,0.00032716466,0.000167122,0.004137025,0.000026679174,0.04218135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997211,0.000055592987,0.000028814211,0.000038831633,0.00012809216,0.000027489416],"domain_scores_gemma":[0.9998054,0.000047707883,0.000053811164,0.000008737741,0.00005794292,0.000026454027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038269008,0.00023054672,0.00042208377,0.0010356886,0.00030910096,0.0006317138,0.00035849505,0.00043929275,0.008025057],"category_scores_gemma":[0.00066302466,0.00007766464,0.00044130592,0.00090798043,0.00015001782,0.00024120475,0.00023195408,0.00050956215,0.0013804927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058282044,0.00007856491,0.0014442087,0.0036016647,0.00017077707,0.00015912314,0.000052923802,0.00015313733,0.004136532,0.0013128669,0.02490531,0.9634021],"study_design_scores_gemma":[0.0004465944,0.0009859261,0.014562327,0.002945573,0.00061347004,0.0016974244,0.00007755556,0.00011145467,0.004067997,0.0003583169,0.9741166,0.000016709391],"about_ca_topic_score_codex":0.023259042,"about_ca_topic_score_gemma":0.12288703,"teacher_disagreement_score":0.023259042,"about_ca_system_score_codex":0.0014283627,"about_ca_system_score_gemma":0.0017809946,"threshold_uncertainty_score":0.046247303},"labels":[],"label_agreement":null},{"id":"W4207042641","doi":"10.51731/cjht.2022.246","title":"Adalimumab for the Treatment of Adults With Non-Infectious Uveitis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Adalimumab; Medicine; Adverse effect; Uveitis; Placebo; Visual acuity; Clinical trial; Ophthalmology; Internal medicine; Pathology; Disease","score_opus":0.013442396937158168,"score_gpt":0.258994131870903,"score_spread":0.2455517349337448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207042641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014061485,0.99661875,0.000058351976,0.0005588645,0.000162076,0.00011932877,0.00033123847,0.000009162609,0.00073610654],"genre_scores_gemma":[0.059856635,0.93374413,0.0010419199,0.002894624,0.0005027215,0.00056610885,0.00071345665,0.000009298929,0.00067108334],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528766,0.0022940827,0.0012168896,0.00024192233,0.0007788545,0.00018067191],"domain_scores_gemma":[0.99148726,0.0045999466,0.0028829975,0.00011118179,0.00072091544,0.00019776002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061816047,0.0006740254,0.0033938147,0.0033665965,0.00030635903,0.0014098275,0.0008289393,0.0014293159,0.0044879075],"category_scores_gemma":[0.015118384,0.00038317798,0.006534821,0.0026399838,0.00031810658,0.0009665747,0.00072004955,0.0013095958,0.00027188228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063253185,0.000110952504,0.0025223682,0.61512864,0.029933207,0.00020522242,0.00017435165,0.00026517172,0.00049287284,0.00084415707,0.017542602,0.3264551],"study_design_scores_gemma":[0.02307902,0.0029303646,0.03414988,0.6218044,0.15374678,0.0013033515,0.00039815443,0.0007962959,0.001005966,0.0022133638,0.15843287,0.00013955204],"about_ca_topic_score_codex":0.005933313,"about_ca_topic_score_gemma":0.015729269,"teacher_disagreement_score":0.0061816047,"about_ca_system_score_codex":0.0021365993,"about_ca_system_score_gemma":0.0036718722,"threshold_uncertainty_score":0.032691777},"labels":[],"label_agreement":null},{"id":"W4210372584","doi":"10.51731/cjht.2022.252","title":"Pembrolizumab (Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Esophagus; Adenocarcinoma; Chemotherapy; Drug; Oncology; Internal medicine; General surgery; Intensive care medicine; Cancer; Pharmacology; Immunotherapy","score_opus":0.03679924395480353,"score_gpt":0.3275468292165374,"score_spread":0.29074758526173383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210372584","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008700907,0.8728309,0.0014365372,0.0072833947,0.0016362793,0.00024112413,0.0013413292,0.00024210363,0.10628744],"genre_scores_gemma":[0.15199885,0.7161943,0.005512872,0.011766229,0.0009220225,0.00027318322,0.0023709855,0.000041739153,0.110919826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976665,0.00005035015,0.000027248136,0.00004126283,0.00008010345,0.000034398385],"domain_scores_gemma":[0.99977857,0.000048443413,0.00006552537,0.000009667528,0.000068675705,0.000029071465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042222705,0.00026349345,0.00023176773,0.0005817783,0.0002260448,0.0007223829,0.00031675838,0.0004980635,0.015118562],"category_scores_gemma":[0.0008585378,0.00008661553,0.0003629809,0.0004032864,0.00021588539,0.00058798806,0.00032081295,0.0006876073,0.003152861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049476576,0.000047605237,0.00041567846,0.0035488433,0.00010066232,0.00014021022,0.000027562151,0.00009784967,0.0033498283,0.002754066,0.063661255,0.9253617],"study_design_scores_gemma":[0.00028773316,0.00049425423,0.0033924987,0.0022623679,0.00017849052,0.0009200856,0.000035651454,0.00008731339,0.0037933069,0.00050821056,0.9880271,0.0000128846705],"about_ca_topic_score_codex":0.009167955,"about_ca_topic_score_gemma":0.024615789,"teacher_disagreement_score":0.015118562,"about_ca_system_score_codex":0.0011977782,"about_ca_system_score_gemma":0.0012785041,"threshold_uncertainty_score":0.050576627},"labels":[],"label_agreement":null},{"id":"W4210408999","doi":"10.51731/cjht.2022.250","title":"Idecabtagene Vicleucel (Abecma)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Pharmacology; Intensive care medicine; Health care; Political science","score_opus":0.0544646208570626,"score_gpt":0.33944166122287556,"score_spread":0.28497704036581295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210408999","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0126437135,0.67641604,0.0030150427,0.010198402,0.0029041157,0.0005730009,0.005502223,0.00052139256,0.2882261],"genre_scores_gemma":[0.1929424,0.4996087,0.015288592,0.0206231,0.0017903715,0.0006595145,0.01143513,0.00017783362,0.25747436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960726,0.00007311203,0.000028950515,0.00004262058,0.00019282637,0.00005530704],"domain_scores_gemma":[0.99935263,0.00013575907,0.00013541071,0.00002028891,0.00023173587,0.00012415147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009470729,0.00031098918,0.00035138702,0.00091825303,0.00030623958,0.0010274579,0.00051012344,0.0007020891,0.019218937],"category_scores_gemma":[0.001232985,0.00010342243,0.00048805622,0.00055690913,0.0003743441,0.00040544235,0.00024445623,0.00074779993,0.004141448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093716197,0.00009923067,0.00086912484,0.002647056,0.00011788598,0.00021679966,0.000029405437,0.00017571528,0.0059358287,0.005387638,0.17018437,0.81339985],"study_design_scores_gemma":[0.0004320502,0.0006191546,0.0029023911,0.0008867826,0.00010101413,0.0005996101,0.000023661,0.000121413046,0.004237904,0.00037310983,0.9896876,0.00001521915],"about_ca_topic_score_codex":0.029685428,"about_ca_topic_score_gemma":0.11255678,"teacher_disagreement_score":0.029685428,"about_ca_system_score_codex":0.0026568107,"about_ca_system_score_gemma":0.004702015,"threshold_uncertainty_score":0.0642938},"labels":[],"label_agreement":null},{"id":"W4210818248","doi":"10.51731/cjht.2022.249","title":"Trientine hydrochloride (MAR-Trientine)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Trace Elements in Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Pharmacology; Political science; Health care","score_opus":0.023178401082968866,"score_gpt":0.28176101977115875,"score_spread":0.2585826186881899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210818248","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010873645,0.79835564,0.0020082113,0.008748787,0.003162973,0.00020558965,0.0014423211,0.00028506052,0.17491773],"genre_scores_gemma":[0.120080866,0.5951832,0.0068065645,0.009362661,0.001074019,0.00018579661,0.0020205225,0.000062709914,0.26522368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996074,0.00007205285,0.000042100066,0.00004766338,0.0001944166,0.00003637593],"domain_scores_gemma":[0.9996425,0.00007334969,0.00010029453,0.000011648963,0.00013407446,0.000038074264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055157626,0.00034179355,0.00027913932,0.00096999964,0.0003484627,0.0008057991,0.00046612904,0.0008048445,0.019256089],"category_scores_gemma":[0.00084706076,0.000092167305,0.0003817185,0.0005131811,0.0003673282,0.00050823187,0.00035519234,0.0006869543,0.0051199966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002853262,0.000075568736,0.00042819264,0.0048362818,0.00008516484,0.0005343758,0.00006608286,0.000111375644,0.011171954,0.0030825855,0.108109996,0.87121314],"study_design_scores_gemma":[0.00006889617,0.00053755264,0.002787008,0.0012564502,0.00008060856,0.001629388,0.00007637924,0.00006869233,0.0064016078,0.00032574352,0.98675203,0.000015607053],"about_ca_topic_score_codex":0.015446713,"about_ca_topic_score_gemma":0.05034535,"teacher_disagreement_score":0.019256089,"about_ca_system_score_codex":0.0011192369,"about_ca_system_score_gemma":0.0016216872,"threshold_uncertainty_score":0.06441802},"labels":[],"label_agreement":null},{"id":"W4210833548","doi":"10.51731/cjht.2022.253","title":"Zanubrutinib (Brukinsa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lymphoplasmacytic Lymphoma; Medicine; Family medicine; Waldenstrom macroglobulinemia; Political science; Lymphoma; Internal medicine; Health care","score_opus":0.04150092911836314,"score_gpt":0.31990717976881616,"score_spread":0.27840625065045305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210833548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010101333,0.9540854,0.00040767502,0.0018385538,0.00025553643,0.00011060027,0.0010433913,0.000078565834,0.03207898],"genre_scores_gemma":[0.15496881,0.8116512,0.0026888137,0.0024165434,0.00020570551,0.00013474938,0.0019634278,0.000020745523,0.02594998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966955,0.0000746887,0.000030707863,0.000032513868,0.0001551712,0.00003730379],"domain_scores_gemma":[0.9997844,0.00004207352,0.000067845125,0.000006407078,0.00007619156,0.000023169972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005878777,0.00022588666,0.00035225166,0.0008823629,0.00024800724,0.0007186298,0.00022775104,0.00024040436,0.004316694],"category_scores_gemma":[0.0007105752,0.00006987503,0.00040209672,0.00085800374,0.00016502863,0.0002605829,0.00018253154,0.00042600112,0.00092522707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048575364,0.00004960213,0.0010545395,0.0051242164,0.0002123813,0.00011119015,0.00003733084,0.00026580368,0.0046557654,0.0017941323,0.03363687,0.9525723],"study_design_scores_gemma":[0.00042001274,0.0006723021,0.011579187,0.0037636561,0.00062573596,0.0012026895,0.000082208346,0.00020607955,0.0032134512,0.0004707007,0.977743,0.0000210686],"about_ca_topic_score_codex":0.02167887,"about_ca_topic_score_gemma":0.13475533,"teacher_disagreement_score":0.02167887,"about_ca_system_score_codex":0.0017220662,"about_ca_system_score_gemma":0.0019914298,"threshold_uncertainty_score":0.043105364},"labels":[],"label_agreement":null},{"id":"W4211162484","doi":"10.51731/cjht.2022.261","title":"Luspatercept (Reblozyl)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Vial; Erythropoietin; Anemia; Family medicine; Intensive care medicine; Surgery; Internal medicine; Political science; Health care","score_opus":0.020763465349534972,"score_gpt":0.25531746887963913,"score_spread":0.23455400353010417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211162484","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02303582,0.8951897,0.001827807,0.0028646241,0.00037962574,0.0002471615,0.0020241917,0.0003539689,0.07407708],"genre_scores_gemma":[0.26962543,0.6401914,0.0053455895,0.0056351773,0.0005406049,0.00023043489,0.0051939157,0.00007480862,0.07316274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973935,0.000051622603,0.000024239554,0.000032887696,0.00012131457,0.000030633604],"domain_scores_gemma":[0.9997241,0.000059241793,0.00009607092,0.000009219233,0.00007685806,0.000034548513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053314754,0.00033627826,0.00040096583,0.00095570274,0.00017698511,0.00073829165,0.0003569776,0.0004373238,0.009810512],"category_scores_gemma":[0.00053123134,0.0000832137,0.0003956108,0.00073934003,0.00019051376,0.00044738708,0.0001647926,0.0005721574,0.002772993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082485616,0.00009215315,0.00061060174,0.004373104,0.00013952474,0.00025927045,0.000030566618,0.00022248646,0.010894688,0.0010031373,0.029011073,0.95253855],"study_design_scores_gemma":[0.0008181357,0.0022739344,0.0087045925,0.002507042,0.00046282052,0.005132037,0.00006133888,0.00031407463,0.013719402,0.0004806916,0.96549326,0.00003271962],"about_ca_topic_score_codex":0.004259535,"about_ca_topic_score_gemma":0.01763649,"teacher_disagreement_score":0.009810512,"about_ca_system_score_codex":0.0011713158,"about_ca_system_score_gemma":0.0009063416,"threshold_uncertainty_score":0.03281939},"labels":[],"label_agreement":null},{"id":"W4213234585","doi":"10.51731/cjht.2022.268","title":"Macitentan and Tadalafil (Opsynvi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tadalafil; Reimbursement; Medicine; Drug; Pharmacology; Internal medicine; Intensive care medicine; Erectile dysfunction; Health care; Political science","score_opus":0.019308314263558897,"score_gpt":0.2680454822482027,"score_spread":0.2487371679846438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213234585","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01933234,0.72291756,0.001721375,0.01484891,0.00510411,0.0003258789,0.0029983975,0.0003444346,0.23240708],"genre_scores_gemma":[0.178633,0.58882535,0.0059312354,0.019450897,0.002294499,0.0003497927,0.0055136154,0.00007448362,0.1989272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974996,0.000055616914,0.000043549724,0.000027876074,0.000092909795,0.00003012042],"domain_scores_gemma":[0.99967146,0.0000807606,0.00009611929,0.000012771725,0.00009543597,0.00004342894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005102465,0.0002124927,0.00021397076,0.00073261047,0.00020828725,0.00087318465,0.00040012042,0.00054921006,0.019387376],"category_scores_gemma":[0.0009933846,0.000083966566,0.00050541444,0.00041887534,0.0002505883,0.0003268883,0.0003596696,0.00061886554,0.0036385476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064772874,0.000095909134,0.00080316287,0.004055893,0.00011054507,0.00019826228,0.000047448,0.00008624659,0.0032379585,0.0065293945,0.0704854,0.9137021],"study_design_scores_gemma":[0.0004379807,0.0009258687,0.007957307,0.002638849,0.00026091514,0.0008138042,0.000059361813,0.00016620035,0.0035075499,0.00082215376,0.98239076,0.000019261248],"about_ca_topic_score_codex":0.005686683,"about_ca_topic_score_gemma":0.021398423,"teacher_disagreement_score":0.019387376,"about_ca_system_score_codex":0.00070913974,"about_ca_system_score_gemma":0.0013958599,"threshold_uncertainty_score":0.064857185},"labels":[],"label_agreement":null},{"id":"W4213381093","doi":"10.51731/cjht.2022.265","title":"Temperature Management in Patients After Cardiac Arrest","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Targeted temperature management; Medicine; Hypothermia; Randomized controlled trial; Intensive care medicine; Clinical trial; Emergency medicine; Resuscitation; Internal medicine; Cardiopulmonary resuscitation; Return of spontaneous circulation","score_opus":0.006923285693652438,"score_gpt":0.2431828823527025,"score_spread":0.23625959665905005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213381093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008122305,0.98618156,0.00024220493,0.002342194,0.00058530347,0.0001578672,0.0009416115,0.0000118373755,0.0014151024],"genre_scores_gemma":[0.3114759,0.6768474,0.0018285922,0.006100445,0.0009722681,0.00057232566,0.001752501,0.00001636743,0.00043414443],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99365187,0.0032044572,0.0014894885,0.00045013204,0.0010000396,0.00020388875],"domain_scores_gemma":[0.99007416,0.005638738,0.0025923704,0.00023649044,0.0012538017,0.00020452865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063743587,0.0004994979,0.0024542676,0.0016999478,0.00033554202,0.0015781989,0.0008988356,0.0013364523,0.0020158112],"category_scores_gemma":[0.029165328,0.0003345116,0.006824165,0.0022438779,0.00035384062,0.00069066224,0.0005616385,0.0014216197,0.00014497334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009696165,0.0002509932,0.045528755,0.43123528,0.15804832,0.00019802079,0.00042763414,0.0016192965,0.0004378556,0.0019529416,0.030098367,0.32050636],"study_design_scores_gemma":[0.015616047,0.0027692409,0.14891401,0.4162485,0.3336471,0.0005591822,0.00061647,0.0017688078,0.0012741125,0.0038532205,0.0744716,0.0002616272],"about_ca_topic_score_codex":0.03310312,"about_ca_topic_score_gemma":0.06305565,"teacher_disagreement_score":0.03310312,"about_ca_system_score_codex":0.0036268928,"about_ca_system_score_gemma":0.0054075127,"threshold_uncertainty_score":0.06582087},"labels":[],"label_agreement":null},{"id":"W4213428070","doi":"10.51731/cjht.2022.269","title":"An Overview of Smartphone Apps","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"mHealth; Flexibility (engineering); Internet privacy; Mobile apps; App store; Health care; Computer science; World Wide Web; Medicine; Psychological intervention; Nursing","score_opus":0.13881431718338155,"score_gpt":0.45340942049109967,"score_spread":0.3145951033077181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213428070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009859046,0.65426296,0.017691819,0.009729318,0.0027256622,0.0014336094,0.018628832,0.0042044385,0.2814643],"genre_scores_gemma":[0.023835046,0.8062701,0.03860899,0.007568631,0.0015986098,0.0016365644,0.021976927,0.0009061031,0.09759897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981567,0.00027825666,0.00035008995,0.00020743163,0.00085299165,0.00015451909],"domain_scores_gemma":[0.9955937,0.0019318665,0.00029045093,0.00014163779,0.0018432364,0.00019904874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013647785,0.0015662333,0.0007157142,0.010074115,0.00092120585,0.0031857754,0.0011187738,0.0024899822,0.03284391],"category_scores_gemma":[0.0053852443,0.0008727912,0.0010861162,0.008038463,0.00034172204,0.006188774,0.001805047,0.0017872645,0.026573466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010650048,0.00006809865,0.0014483617,0.007111807,0.000029797657,0.00036081634,0.0005084082,0.0002888267,0.0016212892,0.0052123987,0.15570047,0.82754314],"study_design_scores_gemma":[0.000007165868,0.000083495084,0.002474274,0.004145187,0.000038464976,0.0011201005,0.00019882337,0.00020409716,0.0004186061,0.0010335967,0.99024373,0.000032490254],"about_ca_topic_score_codex":0.0033573029,"about_ca_topic_score_gemma":0.004654803,"teacher_disagreement_score":0.03284391,"about_ca_system_score_codex":0.0007710731,"about_ca_system_score_gemma":0.0016323809,"threshold_uncertainty_score":0.10987383},"labels":[],"label_agreement":null},{"id":"W4214613706","doi":"10.51731/cjht.2022.271","title":"Estradiol (Imvexxy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Gynecology; Political science","score_opus":0.25931164362329445,"score_gpt":0.4654075142819565,"score_spread":0.20609587065866203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214613706","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050183213,0.56184375,0.0024947382,0.012439702,0.0020041664,0.0005339706,0.007221629,0.00089856796,0.40754512],"genre_scores_gemma":[0.08103938,0.52633655,0.010060072,0.019475462,0.001066826,0.00045348445,0.00861454,0.00016556503,0.35278818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945956,0.00011776958,0.000060703,0.00006508768,0.00024563458,0.000051260624],"domain_scores_gemma":[0.99949396,0.00015318504,0.00011549359,0.000021078307,0.0001474856,0.00006877732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007733919,0.00033334646,0.00035233932,0.0012362448,0.0002894102,0.0010167152,0.00068295316,0.0008964412,0.06809611],"category_scores_gemma":[0.0017515769,0.00014420609,0.00039009162,0.00070713536,0.00038558966,0.00046278356,0.00058607257,0.0007983985,0.015814124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003416669,0.0000617598,0.00033544915,0.005248041,0.00004273478,0.00016377309,0.00005712675,0.00008228551,0.002321379,0.0041598207,0.17397854,0.81320745],"study_design_scores_gemma":[0.00013940361,0.0001514621,0.001031766,0.0017057526,0.00004309541,0.00036831506,0.000035145014,0.000031823874,0.0014594103,0.000271023,0.9947548,0.000007995604],"about_ca_topic_score_codex":0.022864519,"about_ca_topic_score_gemma":0.056379225,"teacher_disagreement_score":0.06809611,"about_ca_system_score_codex":0.0014485187,"about_ca_system_score_gemma":0.0026156823,"threshold_uncertainty_score":0.22780412},"labels":[],"label_agreement":null},{"id":"W4214667444","doi":"10.51731/cjht.2022.270","title":"Emerging Drugs for Generalized Myasthenia Gravis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Myasthenia gravis; Tolerability; Medicine; Weakness; Thymectomy; Clinical trial; Muscle weakness; Disease; Intensive care medicine; Adverse effect; Internal medicine; Pediatrics; Surgery","score_opus":0.02277857378249926,"score_gpt":0.2957274180510737,"score_spread":0.27294884426857446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214667444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016907318,0.9709391,0.00041805566,0.0053535085,0.0012968058,0.000055559725,0.000311185,0.00010148208,0.019833645],"genre_scores_gemma":[0.010627841,0.9483086,0.0017453051,0.01051215,0.0022099745,0.00007722158,0.0008869602,0.000033140543,0.025598792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997826,0.00003717773,0.00002737761,0.000024453335,0.00009829352,0.00002996531],"domain_scores_gemma":[0.999713,0.00008701001,0.00007803202,0.0000074476175,0.00007561443,0.00003887519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042881363,0.0004948329,0.00047802608,0.0017799821,0.00022392625,0.0008076783,0.00033344023,0.00096600666,0.0150685655],"category_scores_gemma":[0.00061355403,0.00013508459,0.0006991143,0.0008205531,0.00021234567,0.00092579494,0.0004944345,0.0012800046,0.0052993936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015816353,0.00009036784,0.00043750386,0.00404701,0.0000593322,0.00062777294,0.00005415737,0.00012261647,0.0024432268,0.0028526196,0.09046904,0.8986382],"study_design_scores_gemma":[0.0001340405,0.0003413147,0.0016664789,0.0019855534,0.000089313064,0.002365041,0.000039798477,0.0000910905,0.0005680056,0.0010701247,0.9916367,0.000012589917],"about_ca_topic_score_codex":0.0010408781,"about_ca_topic_score_gemma":0.004601486,"teacher_disagreement_score":0.0150685655,"about_ca_system_score_codex":0.0006533428,"about_ca_system_score_gemma":0.0006980291,"threshold_uncertainty_score":0.050409377},"labels":[],"label_agreement":null},{"id":"W4214668728","doi":"10.51731/cjht.2021.146","title":"Semaglutide (Rybelsus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Reimbursement; Medicine; Metformin; Glycemic; Drug; Type 2 diabetes; Family medicine; Diabetes mellitus; Pharmacology; Political science; Health care; Endocrinology","score_opus":0.03820972258412177,"score_gpt":0.34213541595885694,"score_spread":0.3039256933747352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214668728","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041574452,0.6586211,0.005678269,0.010913588,0.0032359106,0.00048971426,0.0076669464,0.0020091394,0.2698109],"genre_scores_gemma":[0.29587227,0.42388853,0.011833516,0.01881911,0.00087816815,0.00030092552,0.0127618555,0.00021430333,0.23543142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998155,0.00003683342,0.000021952388,0.00003757028,0.00006370323,0.000024482937],"domain_scores_gemma":[0.9998734,0.000018528508,0.000028210196,0.000006542196,0.00004724855,0.000026029078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037401414,0.00033242136,0.00035535614,0.00067509734,0.0002087971,0.00069927855,0.00036069166,0.00051067077,0.018580945],"category_scores_gemma":[0.0003546586,0.00009427364,0.00051278406,0.0005256254,0.00025968012,0.00039466872,0.0003384602,0.0008250822,0.0071786526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013241229,0.00016224544,0.00074391515,0.0048324754,0.0001501202,0.00042413414,0.000049905313,0.0002994322,0.014638413,0.00470759,0.116198175,0.85646945],"study_design_scores_gemma":[0.00078480743,0.0009363026,0.0038728097,0.0014929633,0.00022256831,0.0016477542,0.000063389576,0.00028189656,0.008518444,0.0007687095,0.9813805,0.000029885829],"about_ca_topic_score_codex":0.01140682,"about_ca_topic_score_gemma":0.036358178,"teacher_disagreement_score":0.018580945,"about_ca_system_score_codex":0.000817784,"about_ca_system_score_gemma":0.0015464363,"threshold_uncertainty_score":0.06215942},"labels":[],"label_agreement":null},{"id":"W4214842935","doi":"10.51731/cjht.2022.274","title":"Emerging Drugs for Amyotrophic Lateral Sclerosis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amyotrophic lateral sclerosis; Riluzole; Medicine; Drug development; Intensive care medicine; Disease; Drug; Pharmacology; Internal medicine","score_opus":0.05475330339128814,"score_gpt":0.31522112388974727,"score_spread":0.2604678204984591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214842935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004570893,0.7894555,0.0019889812,0.03064645,0.0085147945,0.0003556873,0.002439776,0.00063633104,0.16139162],"genre_scores_gemma":[0.02052458,0.774846,0.0064613246,0.03240828,0.0056859488,0.00038377504,0.0051135877,0.000101843594,0.1544746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961096,0.000052466716,0.000032560863,0.000043533455,0.00020068215,0.000059807775],"domain_scores_gemma":[0.9995291,0.00005792796,0.00008082714,0.00001667242,0.00018704528,0.00012849501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007134975,0.0008100449,0.00051796396,0.0013277004,0.0004162026,0.0012047229,0.0007547663,0.0016803137,0.03357618],"category_scores_gemma":[0.00073253026,0.00015730032,0.0007629865,0.0006689863,0.00033101093,0.0009326369,0.00090502814,0.0022279613,0.014079868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037411295,0.0002535608,0.00034313044,0.0018297173,0.00004825161,0.00042989667,0.00004720201,0.00014225433,0.004368742,0.007064196,0.30202046,0.68307847],"study_design_scores_gemma":[0.00020047248,0.00031952176,0.0006166924,0.00063650444,0.000030459694,0.0005460941,0.000014229278,0.0000799796,0.0005773574,0.0010313271,0.9959389,0.000008447928],"about_ca_topic_score_codex":0.0019906124,"about_ca_topic_score_gemma":0.009684671,"teacher_disagreement_score":0.03357618,"about_ca_system_score_codex":0.0013187639,"about_ca_system_score_gemma":0.0013923143,"threshold_uncertainty_score":0.11232352},"labels":[],"label_agreement":null},{"id":"W4214854916","doi":"10.51731/cjht.2022.276","title":"Mecasermin (Increlex)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Medicine; Basal (medicine); Growth hormone receptor; Drug; Growth hormone; Internal medicine; Pediatrics; Hormone; Pharmacology; Bioinformatics; Biology; Political science; Health care","score_opus":0.026084293684478944,"score_gpt":0.26119219399365445,"score_spread":0.2351079003091755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214854916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018975493,0.91250366,0.0010181764,0.0026254035,0.0004468452,0.0002195304,0.0023448442,0.0002883098,0.06157769],"genre_scores_gemma":[0.22347403,0.7011035,0.0051542236,0.0054631154,0.00041700408,0.00027599582,0.004679459,0.00007870886,0.059353992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997756,0.00004000828,0.000023652497,0.000031307256,0.000104241044,0.000025182804],"domain_scores_gemma":[0.99963164,0.0001127637,0.00009062684,0.000011364362,0.00009610328,0.0000575125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044003795,0.00027854092,0.00038350522,0.001259032,0.00018450092,0.000725689,0.00038805872,0.00050636247,0.011513364],"category_scores_gemma":[0.0008989071,0.00009310322,0.0004223329,0.000747261,0.00020889983,0.00042348326,0.00024383658,0.0007395222,0.0018667466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094010297,0.000116819756,0.0010760047,0.0052523343,0.00017404997,0.00036532106,0.000035774076,0.00014504482,0.005569105,0.0012324566,0.027466808,0.95762616],"study_design_scores_gemma":[0.00085112604,0.0018708352,0.009954824,0.003993024,0.000547201,0.0043119295,0.000103668295,0.00021880833,0.011216814,0.00040371786,0.9664904,0.000037565187],"about_ca_topic_score_codex":0.011562731,"about_ca_topic_score_gemma":0.04245479,"teacher_disagreement_score":0.011562731,"about_ca_system_score_codex":0.0014856544,"about_ca_system_score_gemma":0.0013463957,"threshold_uncertainty_score":0.038515985},"labels":[],"label_agreement":null},{"id":"W4214889379","doi":"10.51731/cjht.2022.275","title":"Galcanezumab (Emgality)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Medicine; Family medicine; Medical physics; Psychiatry; Political science; Health care","score_opus":0.04504464360644382,"score_gpt":0.3045848520118984,"score_spread":0.25954020840545455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214889379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019869773,0.8973737,0.0006576658,0.004783088,0.0009649073,0.000523884,0.003733163,0.00020490916,0.07188891],"genre_scores_gemma":[0.298936,0.6334856,0.004303437,0.009916101,0.00082969863,0.0005553731,0.006342998,0.00004445008,0.04558641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993845,0.00014055338,0.000057567526,0.00006577967,0.00027815322,0.00007345675],"domain_scores_gemma":[0.9993963,0.00012058502,0.00012032621,0.000017660757,0.00027340674,0.000071615694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010045464,0.00032624352,0.0005052518,0.0016053031,0.0003484986,0.0010622123,0.0005311726,0.00053140684,0.008491584],"category_scores_gemma":[0.0016289413,0.00008827354,0.0007612326,0.001058389,0.00029294268,0.00044318804,0.00035321157,0.00068293785,0.0013626446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014162499,0.00010253151,0.0018698205,0.0081129875,0.0004234044,0.00013362558,0.00004718152,0.00013774405,0.0024508613,0.001485306,0.054751467,0.92906874],"study_design_scores_gemma":[0.0017096358,0.0016373036,0.016574506,0.00715241,0.0016497045,0.0015643403,0.00013469672,0.000193513,0.003722016,0.00063005823,0.9649891,0.000042729338],"about_ca_topic_score_codex":0.028060239,"about_ca_topic_score_gemma":0.1563424,"teacher_disagreement_score":0.028060239,"about_ca_system_score_codex":0.0026414369,"about_ca_system_score_gemma":0.0031432975,"threshold_uncertainty_score":0.05579382},"labels":[],"label_agreement":null},{"id":"W4220683091","doi":"10.51731/cjht.2022.280","title":"Osimertinib (Tagrisso)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Reimbursement; Medicine; Oncology; Lung cancer; Exon; Drug; Adjuvant; Stage (stratigraphy); Internal medicine; Family medicine; Cancer; Pharmacology; Adenocarcinoma; Political science; Gene; Biology; Genetics","score_opus":0.025149900397469595,"score_gpt":0.3347979546627587,"score_spread":0.3096480542652891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220683091","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060650755,0.71529025,0.0014920996,0.0051349616,0.00087800884,0.00035617297,0.005230774,0.000339137,0.21062784],"genre_scores_gemma":[0.48298338,0.38823473,0.0038244384,0.0050105494,0.00039659033,0.00021489436,0.0077195307,0.000043025073,0.111572884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997944,0.000028607456,0.000021010615,0.000023060622,0.00010049074,0.0000325206],"domain_scores_gemma":[0.9998691,0.00001981566,0.000041549214,0.0000050559556,0.000047032558,0.000017265535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003359567,0.00022967461,0.00021081812,0.0007062716,0.00019631606,0.00052038085,0.00018090816,0.00028824815,0.005884585],"category_scores_gemma":[0.00034902792,0.000044518052,0.00028349902,0.00070586184,0.00013337955,0.0002324312,0.0001761803,0.00027979532,0.0013433357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062526076,0.00006720247,0.0017178592,0.0019734986,0.000093884235,0.00018252287,0.000043720516,0.00026673274,0.0075691817,0.0025385167,0.04907983,0.9358417],"study_design_scores_gemma":[0.0003558768,0.0007906039,0.011525329,0.0010229107,0.0002855309,0.0015336259,0.000081033526,0.00022971994,0.008621822,0.0003982829,0.9751384,0.000016857612],"about_ca_topic_score_codex":0.015600014,"about_ca_topic_score_gemma":0.0762411,"teacher_disagreement_score":0.015600014,"about_ca_system_score_codex":0.0019647756,"about_ca_system_score_gemma":0.0019635726,"threshold_uncertainty_score":0.031018436},"labels":[],"label_agreement":null},{"id":"W4220707728","doi":"10.51731/cjht.2022.296","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Adjuvant; Vial; Cancer drugs; Internal medicine; Cancer; Oncology; Intensive care medicine; General surgery; Health care; Political science","score_opus":0.03837833158930708,"score_gpt":0.32678229831197575,"score_spread":0.28840396672266866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220707728","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0176121,0.76293224,0.0027676115,0.011577334,0.0037180588,0.00036089038,0.003154039,0.00037725057,0.19750048],"genre_scores_gemma":[0.2313258,0.59975886,0.010076037,0.018483413,0.00155486,0.00043542281,0.006008531,0.00011143672,0.13224564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967575,0.00007187152,0.00003147083,0.00004676002,0.00012357421,0.00005061381],"domain_scores_gemma":[0.9997049,0.00004787906,0.00005650837,0.00001198346,0.00013759869,0.00004106867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006071343,0.00032529872,0.0003229136,0.0005956017,0.0002741769,0.00096770015,0.0004336474,0.0004857747,0.009835386],"category_scores_gemma":[0.0008778379,0.000077011966,0.00048196956,0.00042755762,0.00028388095,0.0005159321,0.00040319067,0.000672218,0.00305859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040407118,0.000051681985,0.0009142374,0.0027322425,0.00008427488,0.00009161563,0.000029823308,0.00018563519,0.0035096875,0.0031688234,0.08578811,0.9030398],"study_design_scores_gemma":[0.00014910412,0.0004013965,0.0028708205,0.0018071639,0.000117854586,0.0005605085,0.000039538736,0.00015159912,0.0043995283,0.0006220091,0.98886603,0.000014570603],"about_ca_topic_score_codex":0.016172808,"about_ca_topic_score_gemma":0.046107825,"teacher_disagreement_score":0.016172808,"about_ca_system_score_codex":0.0017512944,"about_ca_system_score_gemma":0.0025225433,"threshold_uncertainty_score":0.032902658},"labels":[],"label_agreement":null},{"id":"W4220805300","doi":"10.51731/cjht.2022.294","title":"Chlormethine Gel (Ledaga)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mycosis fungoides; Medicine; Dermatology; Family medicine; Lymphoma; Political science; Health care; Pathology","score_opus":0.043338427330568426,"score_gpt":0.33290281317614867,"score_spread":0.28956438584558025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220805300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027155798,0.7578383,0.005332058,0.00684219,0.0023990483,0.0005364668,0.0020872476,0.000894513,0.19691435],"genre_scores_gemma":[0.3642001,0.37861407,0.014253868,0.01234896,0.0010108614,0.00046030103,0.0032521277,0.00018454363,0.22567527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962926,0.00009414983,0.000024730665,0.000064875116,0.0001484675,0.00003848639],"domain_scores_gemma":[0.9997682,0.000059275546,0.000062066705,0.0000085987895,0.000068405614,0.000033479024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004081357,0.00039194705,0.0002936706,0.001055742,0.00038802245,0.0005974933,0.0006163459,0.0008927517,0.019991416],"category_scores_gemma":[0.0005955557,0.000108047294,0.0004357051,0.0003739421,0.00038405732,0.00041786773,0.00041406797,0.00076030573,0.0038667838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012692533,0.00019637818,0.0010003522,0.007978064,0.0000992089,0.0008050936,0.00011392225,0.00016189502,0.042000074,0.0042063775,0.10590951,0.83625984],"study_design_scores_gemma":[0.00036286897,0.0012897572,0.0059798714,0.0026497727,0.00015197859,0.0029817577,0.0001338237,0.00025501478,0.033985823,0.00040362036,0.9517656,0.000040156647],"about_ca_topic_score_codex":0.01322001,"about_ca_topic_score_gemma":0.034275793,"teacher_disagreement_score":0.98678,"about_ca_system_score_codex":0.0011298486,"about_ca_system_score_gemma":0.0011639778,"threshold_uncertainty_score":0.06687796},"labels":[],"label_agreement":null},{"id":"W4220860894","doi":"10.51731/cjht.2022.290","title":"Electrospun Healing Fibres for the Management of Burns and Wounds","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Operations management; Business; Health care; Medicine; Process management; Medical emergency; Knowledge management; Computer science; Engineering; Political science","score_opus":0.03278403749782005,"score_gpt":0.3111249747798966,"score_spread":0.27834093728207654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220860894","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03408572,0.47404033,0.01597025,0.01666645,0.0073013986,0.0005735053,0.0011648228,0.0007604431,0.44943708],"genre_scores_gemma":[0.19017003,0.42351118,0.026240038,0.01191254,0.00285183,0.0003499494,0.0012456999,0.0003145536,0.34340414],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995783,0.000041165567,0.000019916699,0.00003262601,0.00029887573,0.000029177148],"domain_scores_gemma":[0.999648,0.000079105266,0.00006459655,0.000014176451,0.00013529451,0.00005889519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068422285,0.00020999879,0.00017192216,0.00094276643,0.0004252795,0.00047614082,0.00030302396,0.00054494693,0.032866627],"category_scores_gemma":[0.0010201095,0.000086611486,0.00027843576,0.0004137026,0.00035452135,0.0005602268,0.0005018428,0.0007574059,0.0040993607],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039743164,0.00019197217,0.00046229587,0.0022573874,0.00003975444,0.00063805166,0.0001228596,0.00016931939,0.042539537,0.004782703,0.105961055,0.8424376],"study_design_scores_gemma":[0.00021932775,0.0014974116,0.010603156,0.0022511955,0.00008880559,0.004731472,0.00037149157,0.00063414284,0.056236234,0.003950018,0.91935855,0.000058155154],"about_ca_topic_score_codex":0.004809869,"about_ca_topic_score_gemma":0.026208766,"teacher_disagreement_score":0.032866627,"about_ca_system_score_codex":0.0006813925,"about_ca_system_score_gemma":0.0010619006,"threshold_uncertainty_score":0.10994983},"labels":[],"label_agreement":null},{"id":"W4220871701","doi":"10.51731/cjht.2022.286","title":"Alpelisib (Piqray)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Fulvestrant; Medicine; Regimen; Family medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Gynecology; Political science; Estrogen receptor; Health care","score_opus":0.024443423046101077,"score_gpt":0.29228039434484965,"score_spread":0.26783697129874856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220871701","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0200724,0.9087329,0.001368046,0.0040785614,0.0005109022,0.00030011625,0.0022440562,0.0003405498,0.0623525],"genre_scores_gemma":[0.3113209,0.6135136,0.004539379,0.006636602,0.0005359001,0.00035564558,0.0046923086,0.000054320597,0.058351338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966395,0.00007647391,0.000035212146,0.000042532774,0.00014183825,0.000040074065],"domain_scores_gemma":[0.9997528,0.000045891597,0.00008271673,0.000008547094,0.0000752644,0.00003476271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062084646,0.00031875778,0.0004032462,0.00078748696,0.00019995742,0.00066807744,0.0003704851,0.00043968298,0.0107695],"category_scores_gemma":[0.00077071873,0.0000844627,0.0005653352,0.0005846591,0.00019657961,0.00032669917,0.00025338528,0.0007525327,0.0025256106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016369924,0.00011212446,0.0008360955,0.004842498,0.00024288113,0.0002722818,0.000041529554,0.00034665936,0.007374043,0.0019482749,0.0334916,0.94885504],"study_design_scores_gemma":[0.0022475203,0.0025989793,0.008502759,0.0026981486,0.00050557463,0.0029387001,0.00007127538,0.00031547874,0.0067547313,0.0006908844,0.97264296,0.000032920383],"about_ca_topic_score_codex":0.008544994,"about_ca_topic_score_gemma":0.03198641,"teacher_disagreement_score":0.0107695,"about_ca_system_score_codex":0.001360141,"about_ca_system_score_gemma":0.0015597726,"threshold_uncertainty_score":0.03602755},"labels":[],"label_agreement":null},{"id":"W4220947098","doi":"10.51731/cjht.2022.282","title":"Vacuum-Induced Uterine Tamponade for Postpartum Hemorrhage","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Medicine; Emerging technologies; Information technology; Business; Operations management; Obstetrics; Computer science; Engineering; Physics","score_opus":0.04756414374399462,"score_gpt":0.3256637272484906,"score_spread":0.27809958350449593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220947098","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07109879,0.63899094,0.0046868892,0.031980723,0.007526478,0.00028561568,0.0011403607,0.0008989914,0.24339116],"genre_scores_gemma":[0.6443037,0.28756282,0.0063305725,0.013695355,0.0041681984,0.00016176762,0.001264462,0.00010355537,0.042409576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998673,0.000024423383,0.000011459854,0.000010984402,0.000054313896,0.000031439267],"domain_scores_gemma":[0.99980193,0.000056988778,0.000040358675,0.000010507586,0.00003110618,0.00005911259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018193274,0.000113749185,0.0002166056,0.0004363473,0.00036278024,0.00033058834,0.0002502867,0.00033584156,0.011350814],"category_scores_gemma":[0.0013496411,0.000044790755,0.00032905198,0.0002777504,0.0002248683,0.00016391547,0.0002098849,0.00061977725,0.0013331078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071982376,0.00013768848,0.005030553,0.0009782296,0.0000663109,0.004020146,0.000060264127,0.00006709863,0.001896834,0.0025562535,0.10644725,0.8780196],"study_design_scores_gemma":[0.0010983548,0.002459479,0.14129248,0.0060898853,0.00035561065,0.06922976,0.00047356883,0.0013684311,0.0050937827,0.005748964,0.7666931,0.0000965855],"about_ca_topic_score_codex":0.011608382,"about_ca_topic_score_gemma":0.025230642,"teacher_disagreement_score":0.011608382,"about_ca_system_score_codex":0.00086595875,"about_ca_system_score_gemma":0.0019171314,"threshold_uncertainty_score":0.03797227},"labels":[],"label_agreement":null},{"id":"W4221003624","doi":"10.51731/cjht.2022.285","title":"2022 Health Technology Trends to Watch: Top 10 List","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ministry of Health; Alberta Health Services","funders":"","keywords":"Health care; Government (linguistics); Equity (law); Emerging technologies; Health technology; Business; Public relations; Knowledge management; Internet privacy; Computer science; Political science","score_opus":0.1581079539453819,"score_gpt":0.4694129010248179,"score_spread":0.311304947079436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221003624","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004474732,0.040306546,0.003939201,0.13148093,0.037506808,0.0016112099,0.19151469,0.0071517574,0.58201414],"genre_scores_gemma":[0.037230536,0.07284293,0.016018478,0.10678591,0.008841225,0.0013893092,0.28238112,0.0021804697,0.47233003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934755,0.00015556901,0.00027456222,0.00022610735,0.0043593585,0.0015089667],"domain_scores_gemma":[0.9669319,0.000861636,0.0009297357,0.00033464024,0.023269547,0.007672496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029660452,0.0015570363,0.0009971543,0.008381277,0.0033938258,0.0094812075,0.0021784368,0.0046024383,0.08852213],"category_scores_gemma":[0.011690162,0.0006521946,0.0013686625,0.009540452,0.0010228783,0.0036956682,0.0028902967,0.0040611364,0.051853225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021175827,0.00001637693,0.0006169785,0.0002881768,0.0000067192395,0.000024538493,0.00001596633,0.000045497934,0.0001121824,0.0012376035,0.96997327,0.027641576],"study_design_scores_gemma":[0.000020437774,0.000020516434,0.0046988325,0.0003923987,0.000016757775,0.0000399738,0.00008137826,0.00013278767,0.00016112912,0.00042716353,0.993982,0.000026623567],"about_ca_topic_score_codex":0.57872355,"about_ca_topic_score_gemma":0.74175084,"teacher_disagreement_score":0.57872355,"about_ca_system_score_codex":0.01539972,"about_ca_system_score_gemma":0.081085026,"threshold_uncertainty_score":0.84751487},"labels":[],"label_agreement":null},{"id":"W4221024616","doi":"10.51731/cjht.2022.283","title":"Artificial Intelligence for the Prediction of Sepsis in Adults","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Data science; Focus (optics); Computer science; Artificial intelligence; Intervention (counseling); Information technology; Emerging technologies; Decision support system; Knowledge management; Medicine; Nursing; Mathematics","score_opus":0.1396070954475354,"score_gpt":0.3522876855848396,"score_spread":0.21268059013730417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221024616","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033200383,0.7123464,0.055897813,0.091942355,0.00474329,0.0007700217,0.024585884,0.0015936014,0.07492019],"genre_scores_gemma":[0.42288217,0.44005638,0.0899286,0.0125036575,0.0039481376,0.0007136027,0.015344879,0.0002094314,0.0144131705],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982736,0.0006809325,0.00015702887,0.00012325692,0.0006863935,0.00007875077],"domain_scores_gemma":[0.99306244,0.0046486333,0.00055492384,0.00016416828,0.0013674956,0.0002022733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039054018,0.0005935653,0.00076286145,0.0037734124,0.00028714602,0.0019850244,0.00064810173,0.0008735221,0.006525243],"category_scores_gemma":[0.026870847,0.00019476096,0.0008153718,0.0025609268,0.0003201038,0.0010292085,0.0005608388,0.0017709966,0.0019001033],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006977009,0.00017911094,0.03917192,0.0023373684,0.00073320087,0.00019864668,0.000072836374,0.012721823,0.00038140465,0.009367542,0.14187503,0.79226345],"study_design_scores_gemma":[0.00058068754,0.0015497233,0.17907855,0.019599613,0.0024250527,0.0013904122,0.0007059756,0.26684082,0.0036142583,0.108232036,0.4155768,0.00040604145],"about_ca_topic_score_codex":0.051191505,"about_ca_topic_score_gemma":0.05137891,"teacher_disagreement_score":0.051191505,"about_ca_system_score_codex":0.0019520452,"about_ca_system_score_gemma":0.0042570136,"threshold_uncertainty_score":0.10178709},"labels":[],"label_agreement":null},{"id":"W4223528166","doi":"10.51731/cjht.2022.308","title":"Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Electroconvulsive therapy; Ketamine; Randomized controlled trial; Anesthesia; Medicine; Population; Major depressive disorder; Midazolam; Psychiatry; Internal medicine; Sedation","score_opus":0.02261003534631208,"score_gpt":0.2848191236407537,"score_spread":0.2622090882944416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223528166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42355007,0.5090653,0.0016431242,0.0182561,0.005036591,0.005480025,0.0024810093,0.00016775866,0.034320023],"genre_scores_gemma":[0.8206451,0.14834477,0.0035678975,0.015603157,0.0018064575,0.003243976,0.001615844,0.000013395407,0.0051593985],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99940264,0.00030692565,0.00011602827,0.000060240043,0.00006589175,0.000048265392],"domain_scores_gemma":[0.9994418,0.00012648688,0.00022814675,0.00002413577,0.00004755043,0.00013184668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009989528,0.00024441406,0.00060764374,0.00020596222,0.0002628318,0.00022737807,0.0003215009,0.00067112496,0.0047102277],"category_scores_gemma":[0.001831281,0.00013713283,0.0009195265,0.00030181214,0.00020329202,0.00029307036,0.0002711272,0.000802841,0.0005368658],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11705423,0.0043099597,0.029946448,0.023968287,0.0032853421,0.00056363124,0.00022797847,0.00019799765,0.004853224,0.0015698337,0.054778256,0.75924486],"study_design_scores_gemma":[0.39798608,0.12310203,0.29237732,0.012872664,0.0055519417,0.0030184088,0.0005524988,0.0011909762,0.0031282266,0.0018151043,0.1583073,0.00009743496],"about_ca_topic_score_codex":0.0010417853,"about_ca_topic_score_gemma":0.0026599613,"teacher_disagreement_score":0.0047102277,"about_ca_system_score_codex":0.000359443,"about_ca_system_score_gemma":0.0006558992,"threshold_uncertainty_score":0.015757263},"labels":[],"label_agreement":null},{"id":"W4224215079","doi":"10.51731/cjht.2022.314","title":"Systemic Thrombolysis and Endovascular Therapy for Large Vessel Occlusion Acute Ischemic Stroke","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Thrombolysis; Medicine; Occlusion; Cardiology; Internal medicine; Ischemic stroke; Endovascular treatment; Stroke (engine); Ischemia; Radiology; Myocardial infarction","score_opus":0.015682566305057412,"score_gpt":0.26992432699642177,"score_spread":0.25424176069136434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224215079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007619795,0.98336226,0.0001320034,0.0034501534,0.0006482593,0.00005252997,0.00030748258,0.000005700886,0.004421839],"genre_scores_gemma":[0.19192874,0.79622394,0.0009787274,0.004888149,0.0038100285,0.00014830742,0.0008606987,0.000009172851,0.0011522375],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9907602,0.004279914,0.0014881718,0.0006708643,0.002412141,0.00038876297],"domain_scores_gemma":[0.98315465,0.011205999,0.002811428,0.00034877716,0.0018382823,0.0006407873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006813941,0.00038518079,0.0027900415,0.0013446292,0.00046053674,0.0016323071,0.000697217,0.0011928576,0.0054774145],"category_scores_gemma":[0.025691153,0.00024561453,0.0031500838,0.0022574111,0.00089594466,0.0008994263,0.0006165639,0.002402164,0.00033745382],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021673728,0.0005171938,0.027453216,0.13550559,0.030993486,0.0004651747,0.00030085107,0.0008467685,0.00054416107,0.0073666256,0.030025907,0.74430734],"study_design_scores_gemma":[0.033674758,0.009085886,0.3566549,0.24863891,0.08694988,0.002659885,0.00086796115,0.0013278387,0.0011285536,0.013238069,0.2454702,0.000303116],"about_ca_topic_score_codex":0.021692578,"about_ca_topic_score_gemma":0.061649527,"teacher_disagreement_score":0.021692578,"about_ca_system_score_codex":0.0028888488,"about_ca_system_score_gemma":0.006873172,"threshold_uncertainty_score":0.043132603},"labels":[],"label_agreement":null},{"id":"W4224225208","doi":"10.51731/cjht.2022.313","title":"Rituximab for the Treatment of Primary Membranous Nephropathy","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Alberta Kidney Disease Network; Dalhousie University; University Health Network; University of Toronto; University of Calgary; Queen's University","funders":"Omeros Corporation","keywords":"Rituximab; Membranous nephropathy; Medicine; Cyclophosphamide; Tacrolimus; Internal medicine; Calcineurin; Nephrotic syndrome; Randomized controlled trial; Glomerulonephritis; Transplantation; Chemotherapy; Kidney; Lymphoma","score_opus":0.028530532914259162,"score_gpt":0.2749723424120416,"score_spread":0.24644180949778244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224225208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011098118,0.99704784,0.00009987473,0.00056176644,0.00014896967,0.000024279469,0.000047496604,0.0000064432306,0.0009535223],"genre_scores_gemma":[0.05282371,0.94177306,0.0007724268,0.0027929142,0.0005563775,0.000100457735,0.00020397968,0.0000061119044,0.0009709051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984504,0.0008322962,0.00024900355,0.00012201039,0.00027307842,0.00007321501],"domain_scores_gemma":[0.99847454,0.0008755913,0.0003924036,0.000025641473,0.00018088969,0.00005083432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018567259,0.0003215245,0.0012168301,0.0012924414,0.00020338682,0.000705255,0.000554501,0.0009354955,0.0039574085],"category_scores_gemma":[0.0034977847,0.0001391845,0.0022892698,0.0007756337,0.00029751987,0.0005152699,0.0004172507,0.0011293709,0.00045594393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003257851,0.00017485065,0.0018217092,0.17504132,0.007001464,0.0005889411,0.00018304592,0.0005226888,0.002430527,0.0032566534,0.045442298,0.7602787],"study_design_scores_gemma":[0.007963912,0.004160949,0.017939245,0.1862761,0.032217998,0.00779754,0.00035152398,0.0010569205,0.005065311,0.008014373,0.72903115,0.00012493922],"about_ca_topic_score_codex":0.0018674139,"about_ca_topic_score_gemma":0.0039973157,"teacher_disagreement_score":0.0039574085,"about_ca_system_score_codex":0.0009932437,"about_ca_system_score_gemma":0.0014190124,"threshold_uncertainty_score":0.013238907},"labels":[],"label_agreement":null},{"id":"W4224231288","doi":"10.51731/cjht.2022.306","title":"Estradiol and Progesterone (Bijuva)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Estrogen; Progestogen; Medicine; Drug; Menopause; Gynecology; Vasomotor; Internal medicine; Endocrinology; Pharmacology; Political science","score_opus":0.050181892010300155,"score_gpt":0.31238240330216327,"score_spread":0.2622005112918631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224231288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047453726,0.94297177,0.00035763884,0.0028869587,0.0005829517,0.00017144029,0.0020589256,0.00006039117,0.046164643],"genre_scores_gemma":[0.087150514,0.8603749,0.0024035242,0.003688689,0.00036427382,0.00016653987,0.0020182282,0.000021547288,0.04381175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988888,0.00020396768,0.000093831884,0.00006653525,0.00067313283,0.00007372525],"domain_scores_gemma":[0.9993293,0.00017061073,0.0001460082,0.000019423383,0.00026859526,0.0000659543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093497813,0.00025278324,0.00041239554,0.0015951914,0.0004682265,0.0009635616,0.00039354406,0.0004923121,0.011105395],"category_scores_gemma":[0.0019847504,0.000110149325,0.00049351517,0.0015993203,0.0003749825,0.0003058139,0.00037848795,0.0005960424,0.0016375545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006492542,0.000078887206,0.0017038985,0.010532864,0.00017592439,0.00019776994,0.00007137421,0.00010754052,0.002922466,0.0040364405,0.05213891,0.9273847],"study_design_scores_gemma":[0.00016757597,0.00034760582,0.008237373,0.0030775147,0.00025410077,0.0008773313,0.000095351774,0.000037495985,0.0020053377,0.00038798133,0.98449546,0.00001698328],"about_ca_topic_score_codex":0.086359866,"about_ca_topic_score_gemma":0.263976,"teacher_disagreement_score":0.086359866,"about_ca_system_score_codex":0.0022542463,"about_ca_system_score_gemma":0.005129926,"threshold_uncertainty_score":0.17171437},"labels":[],"label_agreement":null},{"id":"W4224241935","doi":"10.51731/cjht.2022.304","title":"Triheptanoin (Dojolvi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Calorie; Medicine; Family medicine; Business; Political science; Internal medicine","score_opus":0.011449612610456014,"score_gpt":0.24088423567639278,"score_spread":0.22943462306593676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224241935","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014284379,0.7455998,0.0026438984,0.011288785,0.0034096995,0.0003541267,0.003666241,0.0004958728,0.21825722],"genre_scores_gemma":[0.16797741,0.5986674,0.007928901,0.01643636,0.0011658899,0.00029970787,0.0061127366,0.00013644999,0.2012752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976665,0.00003481455,0.000025384687,0.000034967885,0.00010949803,0.00002870778],"domain_scores_gemma":[0.99976164,0.000039535276,0.000054534703,0.000010152279,0.00009209399,0.00004196581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003086242,0.00022489317,0.00024698832,0.00076880195,0.00026162024,0.0005726759,0.0004056857,0.0005769966,0.01767569],"category_scores_gemma":[0.0006075719,0.00006657334,0.0003198244,0.00044472152,0.00029170222,0.0003440831,0.00038187104,0.0007069501,0.0045722537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005414899,0.000091311085,0.00046514126,0.003243206,0.00006890734,0.00024363465,0.000035389607,0.00008613575,0.0074841245,0.0038257334,0.080548145,0.9033668],"study_design_scores_gemma":[0.00019756565,0.00043270123,0.0027574038,0.0013813617,0.000086022264,0.0009628682,0.00005039666,0.000101103935,0.0067024855,0.0006045489,0.98670757,0.000016012198],"about_ca_topic_score_codex":0.018182661,"about_ca_topic_score_gemma":0.05566356,"teacher_disagreement_score":0.018182661,"about_ca_system_score_codex":0.0010497415,"about_ca_system_score_gemma":0.0016706,"threshold_uncertainty_score":0.059131086},"labels":[],"label_agreement":null},{"id":"W4224246511","doi":"10.51731/cjht.2022.311","title":"Colchicine (Myinfla)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Antithrombotic; Medicine; Drug; Drug class; Colchicine; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.021402850192954282,"score_gpt":0.26422724025130406,"score_spread":0.24282439005834977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224246511","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0100236675,0.9032662,0.0011114236,0.006141055,0.0019881541,0.00019676024,0.0017607954,0.00027780686,0.07523417],"genre_scores_gemma":[0.15513667,0.7335086,0.00489743,0.013990455,0.0016754762,0.00022812978,0.0035610779,0.00006977972,0.08693239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977475,0.000046834542,0.000022308624,0.000042469754,0.00008563537,0.000027933636],"domain_scores_gemma":[0.9997447,0.000057373058,0.00007242757,0.00000781531,0.0000710418,0.000046614616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031555662,0.00038293697,0.00029935624,0.00091494404,0.00028364095,0.0005836413,0.00039398324,0.0007029002,0.01846032],"category_scores_gemma":[0.000537175,0.00008697342,0.00040899258,0.00045499095,0.00032064688,0.00037207082,0.00030182453,0.0008101294,0.003260484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082952395,0.00012249191,0.0004691951,0.007256219,0.00012763128,0.00032815646,0.00004709639,0.00012528854,0.012430981,0.0023716337,0.10987618,0.8660156],"study_design_scores_gemma":[0.00046530637,0.0017160873,0.006949243,0.003423107,0.00020499075,0.0022623867,0.000080045575,0.00015124097,0.010094778,0.00046487903,0.9741469,0.00004095313],"about_ca_topic_score_codex":0.013203201,"about_ca_topic_score_gemma":0.04546603,"teacher_disagreement_score":0.01846032,"about_ca_system_score_codex":0.001028061,"about_ca_system_score_gemma":0.001094325,"threshold_uncertainty_score":0.061755955},"labels":[],"label_agreement":null},{"id":"W4224279217","doi":"10.51731/cjht.2022.312","title":"Inclisiran (Leqvio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Drug class; Statin; Ldl cholesterol; Physical therapy; Internal medicine; Intensive care medicine; Cholesterol; Pharmacology; Political science; Health care","score_opus":0.023769985502235004,"score_gpt":0.2676920870916604,"score_spread":0.24392210158942543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224279217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013032031,0.52319455,0.002298573,0.009261413,0.0029987965,0.0009822516,0.007755965,0.0012341379,0.43924218],"genre_scores_gemma":[0.11942678,0.37533954,0.008573484,0.01883305,0.0014265414,0.00091799715,0.013453985,0.0003779452,0.4616506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994815,0.0001153671,0.00004894146,0.00009867241,0.00019434781,0.00006115664],"domain_scores_gemma":[0.99957114,0.00008867235,0.00008217072,0.000019445617,0.0001490874,0.000089460926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007520993,0.0005536149,0.00057457836,0.0013130308,0.00046678286,0.0015482795,0.0010437001,0.0015403947,0.06891062],"category_scores_gemma":[0.001421713,0.00018032745,0.0007907961,0.00073056045,0.00040067238,0.0008890333,0.00066019414,0.0016890882,0.016283548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017237021,0.00026429872,0.00051339285,0.00700947,0.00012295182,0.00038369405,0.000116498624,0.00019318738,0.0052428907,0.006348725,0.16503158,0.8130497],"study_design_scores_gemma":[0.00078193954,0.00051312445,0.00097232306,0.0022030529,0.00011556135,0.00059877615,0.00005882549,0.00009191203,0.0019455885,0.0005053694,0.99219257,0.000021020052],"about_ca_topic_score_codex":0.014375639,"about_ca_topic_score_gemma":0.03897897,"teacher_disagreement_score":0.06891062,"about_ca_system_score_codex":0.0016085084,"about_ca_system_score_gemma":0.0030638375,"threshold_uncertainty_score":0.23052901},"labels":[],"label_agreement":null},{"id":"W4224283527","doi":"10.51731/cjht.2022.305","title":"Isatuximab (Sarclisa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Carfilzomib; Medicine; Family medicine; Multiple myeloma; Political science; Internal medicine; Health care; Bortezomib","score_opus":0.05283725872536472,"score_gpt":0.3347017299084163,"score_spread":0.2818644711830516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224283527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019489892,0.8128191,0.0034707175,0.007615518,0.002057453,0.00028659482,0.0025376477,0.0011849867,0.15053803],"genre_scores_gemma":[0.23809615,0.5550583,0.007905755,0.014994013,0.0015385037,0.0002989244,0.010467109,0.00011162041,0.17152968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997378,0.000044907523,0.000021287631,0.000037054022,0.00011152985,0.000047387213],"domain_scores_gemma":[0.99981457,0.00002161133,0.00005690895,0.000006423987,0.00006462093,0.000036000834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046457714,0.0004305811,0.00029488796,0.0008788024,0.00023085093,0.0006924793,0.00039145732,0.00047210522,0.014165159],"category_scores_gemma":[0.00038864271,0.00009433857,0.00040203275,0.0006352675,0.00023154508,0.00037631867,0.00040257923,0.0007325598,0.0060011093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047964128,0.00009888409,0.0007413443,0.0029849021,0.00010114935,0.00022691311,0.000036907742,0.00030122892,0.0082626585,0.002113743,0.12256978,0.8620829],"study_design_scores_gemma":[0.00026718096,0.00072021317,0.0036141379,0.0010560512,0.00011708774,0.0011973564,0.00003314728,0.00019580794,0.005964264,0.0003398779,0.98648006,0.00001491063],"about_ca_topic_score_codex":0.0060081817,"about_ca_topic_score_gemma":0.017284367,"teacher_disagreement_score":0.014165159,"about_ca_system_score_codex":0.0011326504,"about_ca_system_score_gemma":0.001429467,"threshold_uncertainty_score":0.047387183},"labels":[],"label_agreement":null},{"id":"W4224297523","doi":"10.51731/cjht.2022.301","title":"Robotic-Assisted Surgical Systems for Hip Arthroplasty","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Arthroplasty; Medicine; Hip arthroplasty; Randomized controlled trial; Surgical procedures; Psychological intervention; Evidence-based medicine; Physical therapy; Medical physics; Surgery; Nursing; Alternative medicine","score_opus":0.04069836747639381,"score_gpt":0.2880870641095675,"score_spread":0.2473886966331737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224297523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027498403,0.91564035,0.0034262436,0.010377527,0.0022111123,0.0002618188,0.0011142405,0.00019774621,0.06402102],"genre_scores_gemma":[0.075625435,0.8802028,0.01424582,0.0095247235,0.0023225143,0.00034122242,0.0014719527,0.000052547068,0.01621302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729186,0.00092231936,0.00032610554,0.00013173606,0.0012092995,0.000118602096],"domain_scores_gemma":[0.9967174,0.0015145665,0.00061381137,0.00014438409,0.00089339144,0.00011637989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002402044,0.00038858363,0.0004477416,0.00167424,0.00037008376,0.0010226215,0.00079180085,0.0008762322,0.023108868],"category_scores_gemma":[0.008101758,0.00015060388,0.0015541095,0.0013605484,0.0007261117,0.0007958224,0.00092799845,0.0009189896,0.0028547253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003198327,0.000053004464,0.0013829006,0.022079874,0.00032256366,0.00024045102,0.00009743297,0.00042872777,0.00056648673,0.009853749,0.07711226,0.8875428],"study_design_scores_gemma":[0.00030637658,0.0005316928,0.01224497,0.025297582,0.0005378833,0.002656262,0.00021515926,0.0003259313,0.0013439147,0.0057504424,0.95072037,0.000069413174],"about_ca_topic_score_codex":0.020759314,"about_ca_topic_score_gemma":0.051967267,"teacher_disagreement_score":0.023108868,"about_ca_system_score_codex":0.0021744303,"about_ca_system_score_gemma":0.0047573466,"threshold_uncertainty_score":0.07730687},"labels":[],"label_agreement":null},{"id":"W4224310496","doi":"10.51731/cjht.2022.319","title":"Ravulizumab (Ultomiris)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Paroxysmal nocturnal hemoglobinuria; Medicine; Family medicine; Business; Political science; Health care; Internal medicine","score_opus":0.024986177415764328,"score_gpt":0.26288143086091187,"score_spread":0.23789525344514753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224310496","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010785152,0.8777325,0.002293196,0.0070538516,0.0016508468,0.00018615808,0.001004136,0.0005825221,0.09871162],"genre_scores_gemma":[0.14508343,0.69046956,0.0086909365,0.014150148,0.0014906055,0.00022753517,0.0025818632,0.000093092596,0.13721289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997261,0.00005029393,0.000024246932,0.000040539457,0.00011610391,0.000042789135],"domain_scores_gemma":[0.9997738,0.000041901614,0.00006619681,0.000009948587,0.00007673195,0.000031470314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006410112,0.00034288035,0.00028447644,0.00076507457,0.00022370179,0.0006859266,0.00042850754,0.0005742378,0.010308534],"category_scores_gemma":[0.0006163618,0.00009194066,0.00046809332,0.00041237354,0.00030371375,0.00040833242,0.0003075237,0.00067624036,0.003630929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003000998,0.00005595697,0.0003564494,0.0022094212,0.000069543086,0.00016723409,0.000028725752,0.00011885176,0.008494889,0.0025302903,0.06857477,0.9170939],"study_design_scores_gemma":[0.00023573906,0.0008570334,0.0044267857,0.0013011313,0.00014905639,0.0012661556,0.00004194101,0.00016736613,0.0097966045,0.000635502,0.9810999,0.00002276864],"about_ca_topic_score_codex":0.010753925,"about_ca_topic_score_gemma":0.027420206,"teacher_disagreement_score":0.010753925,"about_ca_system_score_codex":0.0013170958,"about_ca_system_score_gemma":0.0014971358,"threshold_uncertainty_score":0.03448546},"labels":[],"label_agreement":null},{"id":"W4224312449","doi":"10.51731/cjht.2022.317","title":"Enablers for Remote Monitoring Programs for Cardiac Conditions: Lessons From the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Telehealth; Reimbursement; Health care; Telemedicine; SAFER; Government (linguistics); Process management; Medicine; Medical emergency; Political science; Computer security; Computer science","score_opus":0.2054077679335343,"score_gpt":0.4365523792371471,"score_spread":0.23114461130361283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224312449","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048698973,0.0127495555,0.0047910246,0.86977434,0.0034352683,0.0003186006,0.0007323685,0.00044357276,0.059056327],"genre_scores_gemma":[0.7077267,0.053761266,0.02189021,0.19020131,0.0032430384,0.000847342,0.0013104192,0.00038221735,0.020637516],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99227715,0.0034836468,0.00023092415,0.00033555942,0.0014440402,0.00222871],"domain_scores_gemma":[0.97723824,0.009895584,0.0007739718,0.00074337015,0.004402307,0.006946518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011971307,0.00063110417,0.00043604936,0.00089719443,0.004597144,0.0060161888,0.002657972,0.0041558174,0.0078344215],"category_scores_gemma":[0.026067367,0.00033361194,0.0013605768,0.0010496896,0.002990926,0.0060173096,0.0063208817,0.009150913,0.0011817134],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027936074,0.0012970696,0.026287608,0.0021389378,0.00008661417,0.0020963768,0.016311532,0.00319492,0.0007996385,0.05489174,0.44281125,0.4498051],"study_design_scores_gemma":[0.0003334156,0.001051936,0.053266328,0.0072130533,0.00018961067,0.0012024335,0.06505581,0.0048083854,0.0023604229,0.040272295,0.82393974,0.00030652594],"about_ca_topic_score_codex":0.12445217,"about_ca_topic_score_gemma":0.20382252,"teacher_disagreement_score":0.12445217,"about_ca_system_score_codex":0.010944014,"about_ca_system_score_gemma":0.03968351,"threshold_uncertainty_score":0.24745554},"labels":[],"label_agreement":null},{"id":"W4224317855","doi":"10.51731/cjht.2022.315","title":"Emerging Multi-Cancer Early Detection Technologies","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Emerging technologies; Test (biology); Risk analysis (engineering); Cancer; Cancer screening; Clinical decision support system; Computer science; Medicine; Data science; Decision support system; Artificial intelligence; Political science","score_opus":0.01654254130916333,"score_gpt":0.27130229027534947,"score_spread":0.25475974896618614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224317855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029574353,0.48571315,0.17899872,0.086099,0.005790757,0.0020879821,0.023864929,0.0057985075,0.18207254],"genre_scores_gemma":[0.26158607,0.3215846,0.2937931,0.035777472,0.0029455766,0.0015200491,0.018169092,0.0007007867,0.063923255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929883,0.0014295668,0.00035171062,0.0006849801,0.00392894,0.00061658357],"domain_scores_gemma":[0.9784534,0.007912383,0.0015678994,0.0009823648,0.00970831,0.0013755537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011225131,0.00088678626,0.0012435064,0.005607882,0.0007711502,0.0038680367,0.002943791,0.0020896092,0.015580568],"category_scores_gemma":[0.01566131,0.0005385646,0.0013001313,0.004496119,0.0010897939,0.002680022,0.0028806112,0.0024790082,0.003442642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007556746,0.00017886517,0.011894101,0.0039783996,0.00018028471,0.00047817003,0.00032856798,0.002602879,0.006690968,0.03126115,0.09690374,0.8447472],"study_design_scores_gemma":[0.0002491539,0.0008436618,0.0150936935,0.0048512192,0.00057259353,0.0026379158,0.0005750256,0.009926621,0.021476539,0.027333142,0.91617286,0.00026758574],"about_ca_topic_score_codex":0.08118926,"about_ca_topic_score_gemma":0.11216125,"teacher_disagreement_score":0.08118926,"about_ca_system_score_codex":0.009413754,"about_ca_system_score_gemma":0.013471792,"threshold_uncertainty_score":0.1614334},"labels":[],"label_agreement":null},{"id":"W4224321083","doi":"10.51731/cjht.2022.318","title":"Tirzepatide for Type 2 Diabetes Mellitus","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Metformin; Type 2 diabetes; Medicine; Type 2 Diabetes Mellitus; Diabetes mellitus; Glycemic; Liraglutide; Insulin; Endocrinology; Internal medicine; Clinical trial; Pharmacology","score_opus":0.039217028697575984,"score_gpt":0.29623674319022597,"score_spread":0.25701971449265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224321083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017309636,0.6862294,0.0030473028,0.036422182,0.0077634524,0.0003187909,0.0018972523,0.0010627691,0.24594924],"genre_scores_gemma":[0.16367732,0.5994288,0.006830248,0.043777898,0.0068813185,0.00043522962,0.0037618724,0.00017823774,0.17502904],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998499,0.000029237422,0.000017213451,0.000021931924,0.000056192865,0.000025636396],"domain_scores_gemma":[0.9998312,0.000029482318,0.000036519305,0.000008277164,0.00004594122,0.000048596907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026008376,0.00041807673,0.00036760917,0.00045594154,0.00025891425,0.00040886548,0.0003731076,0.00070749497,0.019560216],"category_scores_gemma":[0.0005384247,0.00007709301,0.00050730957,0.00039702762,0.00014096749,0.0003033992,0.00033819152,0.0014536877,0.0074912026],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012097516,0.0002715858,0.00071330025,0.0011464402,0.000079097765,0.0010339894,0.00003692742,0.00008653025,0.0050351257,0.0027149038,0.23506373,0.75260866],"study_design_scores_gemma":[0.0008196573,0.0007428136,0.0041247495,0.0007460463,0.000109989436,0.0028639273,0.000029354454,0.00018168412,0.0015268554,0.0012610019,0.9875737,0.000020340276],"about_ca_topic_score_codex":0.0018567389,"about_ca_topic_score_gemma":0.005146611,"teacher_disagreement_score":0.019560216,"about_ca_system_score_codex":0.00055546535,"about_ca_system_score_gemma":0.00059404265,"threshold_uncertainty_score":0.06543547},"labels":[],"label_agreement":null},{"id":"W4225002517","doi":"10.51731/cjht.2022.320","title":"Pertuzumab (Perjeta)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Reimbursement; Trastuzumab; Medicine; Breast cancer; Oncology; Family medicine; Internal medicine; Cancer; Political science; Health care","score_opus":0.0735274290851781,"score_gpt":0.364587629344771,"score_spread":0.2910602002595929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225002517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011256107,0.835979,0.0023727485,0.004621663,0.0016848877,0.00024037703,0.0017309226,0.0008068606,0.14130744],"genre_scores_gemma":[0.16698417,0.638497,0.0052680443,0.01060354,0.0013571222,0.00031144053,0.0049018185,0.00014420523,0.1719327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956614,0.00006267915,0.000037741338,0.00006833117,0.00021465427,0.000050484716],"domain_scores_gemma":[0.9997011,0.00004767885,0.000079091675,0.000013833425,0.00011378203,0.00004440446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005293165,0.0004346067,0.00039136066,0.0015864869,0.00028686092,0.001094287,0.0005883519,0.00065088633,0.0144335],"category_scores_gemma":[0.0008950381,0.00015107852,0.00046273504,0.00090586673,0.00028715288,0.0006509806,0.00044554682,0.00081893575,0.0056219418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004036564,0.00008924887,0.0003711647,0.0030673759,0.00010425964,0.0002098256,0.000036830188,0.00015415794,0.005199847,0.002772613,0.087132394,0.90045863],"study_design_scores_gemma":[0.00015928494,0.0004237463,0.0019854216,0.00091166276,0.00014054634,0.0016662913,0.000019346246,0.000100443176,0.00554112,0.0004433323,0.98859286,0.000015909418],"about_ca_topic_score_codex":0.006446367,"about_ca_topic_score_gemma":0.012347232,"teacher_disagreement_score":0.0144335,"about_ca_system_score_codex":0.0013150991,"about_ca_system_score_gemma":0.0015639726,"threshold_uncertainty_score":0.04828489},"labels":[],"label_agreement":null},{"id":"W4225016550","doi":"10.51731/cjht.2022.321","title":"Harmonization of Public Coverage Policies for Biologic Drugs in the Treatment of Rheumatoid Arthritis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Department of Veterans Affairs","keywords":"Veterans Affairs; Medicine; Public administration; Political science; Internal medicine","score_opus":0.09433791284355138,"score_gpt":0.2939799318032812,"score_spread":0.19964201895972983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225016550","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05029925,0.008155507,0.063845016,0.40015122,0.008628426,0.01094522,0.009227119,0.0031315815,0.44561672],"genre_scores_gemma":[0.367785,0.0048212544,0.11102344,0.39561275,0.0041669747,0.012824072,0.012733149,0.0010040627,0.09002931],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9215314,0.026802097,0.0062696724,0.004598843,0.028090445,0.012707585],"domain_scores_gemma":[0.8746778,0.035715822,0.010353473,0.0120678125,0.049915724,0.017269403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.108161904,0.00078477326,0.0011879982,0.004605741,0.0027715282,0.01031301,0.0072605703,0.0097473515,0.012221739],"category_scores_gemma":[0.11670044,0.0013475124,0.0027325817,0.0036626938,0.0027737683,0.0054089515,0.007974935,0.008048385,0.0032899946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006831207,0.0011971323,0.016876128,0.0009664528,0.00032179386,0.00043087025,0.0034785038,0.007927751,0.003546504,0.16365093,0.57682365,0.2240972],"study_design_scores_gemma":[0.00067960104,0.0005133074,0.047006156,0.0022823398,0.00016349186,0.00023229855,0.0020299666,0.004303042,0.001676574,0.01987097,0.9210375,0.0002047501],"about_ca_topic_score_codex":0.063116014,"about_ca_topic_score_gemma":0.04940353,"teacher_disagreement_score":0.9763643,"about_ca_system_score_codex":0.023635658,"about_ca_system_score_gemma":0.085619256,"threshold_uncertainty_score":0.57202166},"labels":[],"label_agreement":null},{"id":"W4226048218","doi":"10.51731/cjht.2022.300","title":"Trientine Hydrochloride (Waymade-Trientine)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Alcoholism and Thiamine Deficiency","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Pharmacology; Political science; Health care","score_opus":0.02498569634888081,"score_gpt":0.2713715913024547,"score_spread":0.24638589495357388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226048218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015710996,0.75958943,0.0029829324,0.008315767,0.0038180838,0.00033514842,0.002505457,0.00044793056,0.20629427],"genre_scores_gemma":[0.16893247,0.50907177,0.009828946,0.010184877,0.0010314799,0.00026481878,0.0036784548,0.00011031407,0.29689685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955505,0.000076341195,0.000053679967,0.000057091915,0.00022169348,0.000036002613],"domain_scores_gemma":[0.9996094,0.0000792033,0.00011475669,0.00001829554,0.0001350306,0.00004337624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005827511,0.000311995,0.00027712272,0.0010022159,0.000298423,0.00079243747,0.00047963837,0.0009504383,0.019670587],"category_scores_gemma":[0.0008611402,0.00011409594,0.0004611329,0.0005700133,0.00045215807,0.0005708693,0.00035339632,0.00072139164,0.0048026685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004240827,0.00008331877,0.0005663049,0.0052679484,0.00014198692,0.0005633213,0.00007253455,0.00013507526,0.015502708,0.0035651112,0.117737405,0.8559402],"study_design_scores_gemma":[0.00012635431,0.000666065,0.0037778395,0.0012853139,0.000101998456,0.0017818441,0.00007432309,0.00007645905,0.008488402,0.00031611376,0.98328215,0.000023095714],"about_ca_topic_score_codex":0.014358016,"about_ca_topic_score_gemma":0.05661929,"teacher_disagreement_score":0.019670587,"about_ca_system_score_codex":0.0011431342,"about_ca_system_score_gemma":0.0016997148,"threshold_uncertainty_score":0.06580466},"labels":[],"label_agreement":null},{"id":"W4226209919","doi":"10.51731/cjht.2021.182","title":"Budesonide-Glycopyrronium-Formoterol Fumarate Dihydrate (Breztri Aerosphere)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Budesonide; Medicine; Formoterol; Reimbursement; Formoterol Fumarate; Inhalation; COPD; Bronchitis; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.02514401861931176,"score_gpt":0.2996405781778909,"score_spread":0.27449655955857916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226209919","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010763968,0.9556396,0.0009898662,0.0024255242,0.0004996969,0.00023876487,0.0011972243,0.0000693692,0.028176066],"genre_scores_gemma":[0.1881927,0.76918536,0.0050011664,0.0028240576,0.0003770478,0.000199532,0.0019894622,0.000023587141,0.032207135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990876,0.00017915475,0.00007171711,0.000055992117,0.00053562963,0.00006995191],"domain_scores_gemma":[0.9996276,0.00007751634,0.00009256193,0.000008308999,0.00016042287,0.000033548047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008464451,0.00026585843,0.00045936895,0.00081863184,0.0002642575,0.00061560684,0.00033070968,0.00039300308,0.0042315936],"category_scores_gemma":[0.0009291915,0.00008838405,0.0006035581,0.00056590827,0.00019289179,0.00022114928,0.00017213785,0.00037994288,0.000834599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093273196,0.00010070259,0.0025755449,0.012506028,0.0005353556,0.00036003432,0.000047961923,0.00028703615,0.01280627,0.0022480695,0.040727098,0.92687315],"study_design_scores_gemma":[0.0005734825,0.0013194097,0.027457317,0.0045602713,0.0008640934,0.0016237376,0.0001301632,0.00023158357,0.008667514,0.00026781237,0.9542709,0.000033760974],"about_ca_topic_score_codex":0.06407765,"about_ca_topic_score_gemma":0.2657975,"teacher_disagreement_score":0.06407765,"about_ca_system_score_codex":0.0022275024,"about_ca_system_score_gemma":0.0037841864,"threshold_uncertainty_score":0.12740934},"labels":[],"label_agreement":null},{"id":"W4226349190","doi":"10.51731/cjht.2022.302","title":"Sacituzumab Govitecan (Trodelvy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Metastatic breast cancer; Family medicine; Breast cancer; Cancer; Internal medicine; Political science; Health care","score_opus":0.028862155386624497,"score_gpt":0.27560738489170655,"score_spread":0.24674522950508204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226349190","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03329242,0.6189238,0.004445855,0.012085328,0.0034729135,0.0004551129,0.0029919606,0.00056952843,0.32376316],"genre_scores_gemma":[0.2817764,0.46273112,0.00908329,0.012681497,0.00111715,0.00023562074,0.00531344,0.00010594483,0.22695564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996276,0.000056539036,0.000022270076,0.00004257339,0.0002154265,0.000035535693],"domain_scores_gemma":[0.9997086,0.000047419417,0.00005977279,0.000011444886,0.00013748404,0.000035223227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061239087,0.00023897558,0.00022518713,0.0008376565,0.00022113706,0.00082548364,0.00036917254,0.0005569983,0.01272886],"category_scores_gemma":[0.00068861456,0.00007985861,0.00032535332,0.0005072046,0.00041757183,0.00038179022,0.00024657138,0.000540312,0.0035086514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040876048,0.00006590922,0.000712757,0.0022514397,0.00006800224,0.00020955756,0.000055237844,0.000215703,0.02122448,0.006898317,0.092037246,0.8758526],"study_design_scores_gemma":[0.00011969938,0.0005300993,0.0026828707,0.0007333616,0.000058139543,0.00077427033,0.000045574492,0.00015628591,0.012325184,0.0004446413,0.9821165,0.000013383231],"about_ca_topic_score_codex":0.0172724,"about_ca_topic_score_gemma":0.04808425,"teacher_disagreement_score":0.0172724,"about_ca_system_score_codex":0.0016791703,"about_ca_system_score_gemma":0.0020793036,"threshold_uncertainty_score":0.042582333},"labels":[],"label_agreement":null},{"id":"W4226350874","doi":"10.51731/cjht.2021.195","title":"Risperidone for Extended-Release Injectable Suspension (Perseris)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Risperidone; Suspension (topology); Medicine; Schizophrenia (object-oriented programming); Drug; Family medicine; Psychiatry; Political science; Health care; Law","score_opus":0.07352042089892238,"score_gpt":0.37762996240698504,"score_spread":0.3041095415080627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226350874","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01192481,0.86005825,0.0015779646,0.0056722844,0.0014114013,0.00024272811,0.00420605,0.00033796852,0.11456864],"genre_scores_gemma":[0.17487569,0.70055616,0.009411109,0.012730399,0.0008750018,0.00025026058,0.0050786436,0.00009220446,0.0961305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993772,0.00013640348,0.00009062296,0.00006493222,0.00029181782,0.000039119222],"domain_scores_gemma":[0.9992254,0.00018750846,0.00027297647,0.00002206512,0.00025051928,0.000041518266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010874894,0.0002387952,0.00029277347,0.0007704044,0.00022951173,0.0005900456,0.00043504708,0.00047322325,0.009244548],"category_scores_gemma":[0.0012250942,0.00009144707,0.00073677563,0.0006304134,0.00029477748,0.00037596293,0.00025619176,0.000553097,0.001783207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006669252,0.0000787563,0.0008880217,0.006902047,0.00017335798,0.00024908927,0.000093329036,0.000086742955,0.0036379523,0.0035582336,0.0982183,0.88544726],"study_design_scores_gemma":[0.00041206952,0.0013847065,0.012676044,0.004829629,0.0004526894,0.001753314,0.00010333648,0.00016500104,0.005991995,0.0007036779,0.9714892,0.000038312064],"about_ca_topic_score_codex":0.025490763,"about_ca_topic_score_gemma":0.10901871,"teacher_disagreement_score":0.025490763,"about_ca_system_score_codex":0.0014272499,"about_ca_system_score_gemma":0.0027064944,"threshold_uncertainty_score":0.05068475},"labels":[],"label_agreement":null},{"id":"W4229014886","doi":"10.51731/cjht.2022.326","title":"Cemiplimab (Libtayo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Law","score_opus":0.021304337892339723,"score_gpt":0.25486189224374,"score_spread":0.2335575543514003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229014886","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022427203,0.6654208,0.0033188593,0.010625677,0.0034119056,0.00079674117,0.004568984,0.0010707075,0.28835922],"genre_scores_gemma":[0.22966129,0.39667985,0.012897252,0.020486299,0.0017786458,0.0011928948,0.0125475,0.00018063463,0.32457554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997222,0.000056821373,0.000025670306,0.0000523459,0.00009152571,0.000051522362],"domain_scores_gemma":[0.99974066,0.00003495677,0.00006935627,0.000012042295,0.00007617557,0.00006685709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005286129,0.00055247947,0.00042732502,0.0010840414,0.00035496033,0.0010654128,0.0005164935,0.00087010866,0.031613644],"category_scores_gemma":[0.00059600605,0.00017520013,0.00044516198,0.00057206216,0.0003349916,0.00057274144,0.0005685095,0.0010739174,0.010103311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014493631,0.00018333996,0.00068067206,0.0029928756,0.00008149935,0.0003460094,0.000048256286,0.00019448472,0.018711263,0.0039045291,0.15054674,0.82086104],"study_design_scores_gemma":[0.0007644617,0.0015616948,0.0025436387,0.001050659,0.000081243496,0.001989889,0.00003930695,0.00012752226,0.011581444,0.00039161008,0.97984743,0.000021020922],"about_ca_topic_score_codex":0.005208792,"about_ca_topic_score_gemma":0.013836653,"teacher_disagreement_score":0.031613644,"about_ca_system_score_codex":0.001363841,"about_ca_system_score_gemma":0.0019665968,"threshold_uncertainty_score":0.10575819},"labels":[],"label_agreement":null},{"id":"W4230831017","doi":"10.51731/cjht.2021.125","title":"Dinutuximab (Unituxin)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Irinotecan; Temozolomide; Drug; Refractory (planetary science); Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Cancer; Chemotherapy; Health care; Political science","score_opus":0.040142133268399514,"score_gpt":0.3211656653900405,"score_spread":0.281023532121641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230831017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02182377,0.9246463,0.0010501988,0.001751496,0.0005141591,0.0001619865,0.0010396384,0.000113846494,0.04889853],"genre_scores_gemma":[0.29966497,0.63236845,0.004717076,0.0036685038,0.00027527675,0.00027894508,0.00260008,0.00002782361,0.056398913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997265,0.00006970507,0.000023862447,0.000031634892,0.000118042706,0.000030409085],"domain_scores_gemma":[0.999819,0.0000401709,0.000053182324,0.000005679434,0.000055539025,0.000026472357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053165003,0.0002411659,0.00030471728,0.0008470611,0.00020988529,0.00051982957,0.00026909608,0.00025958286,0.0051754857],"category_scores_gemma":[0.00055651093,0.000064036794,0.0003085801,0.00065408077,0.00014425794,0.00024596654,0.000263343,0.00041371386,0.0006391247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006319965,0.00006071828,0.0012514509,0.0050128307,0.00018450822,0.00014599017,0.000033623113,0.00040260964,0.0034699657,0.0020136617,0.023827268,0.96296537],"study_design_scores_gemma":[0.0003642886,0.0012172781,0.009151523,0.003179828,0.0004412136,0.001790453,0.0000619666,0.00029567038,0.008252253,0.0004519865,0.9747722,0.000021470665],"about_ca_topic_score_codex":0.010274677,"about_ca_topic_score_gemma":0.0494747,"teacher_disagreement_score":0.010274677,"about_ca_system_score_codex":0.0015960345,"about_ca_system_score_gemma":0.0012356314,"threshold_uncertainty_score":0.02042973},"labels":[],"label_agreement":null},{"id":"W4236572722","doi":"10.51731/cjht.2021.158","title":"Pembrolizumab (Keytruda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Microsatellite instability; Medicine; Drug; Colorectal cancer; Family medicine; Cancer; Political science; Internal medicine; Pharmacology; Health care","score_opus":0.03147129701916846,"score_gpt":0.2973980097060925,"score_spread":0.265926712686924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236572722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012977167,0.9671181,0.000403277,0.0016776733,0.0002100946,0.000084266205,0.00052018283,0.000036137037,0.01697319],"genre_scores_gemma":[0.18283573,0.7977668,0.0025444035,0.0022189347,0.00017200055,0.00010776615,0.0008151301,0.00001052152,0.013528763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997892,0.000050896295,0.000022987515,0.000023728824,0.000086718486,0.000026501271],"domain_scores_gemma":[0.99979776,0.000048603346,0.00006931276,0.0000059305085,0.00005644758,0.000021866144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044523898,0.00015429393,0.00027197407,0.0006432557,0.0001822095,0.00057327584,0.00019916642,0.00025365336,0.0025769584],"category_scores_gemma":[0.00067332207,0.00006165348,0.00031752486,0.0005551269,0.00012602734,0.0002826742,0.00016480344,0.000382766,0.00041431494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007367213,0.000058812042,0.0014655184,0.004822178,0.0002558404,0.00017686715,0.000041929467,0.00021058871,0.0059156,0.0014454434,0.015780943,0.96908945],"study_design_scores_gemma":[0.0005421545,0.0016028886,0.018843407,0.0061133374,0.0010147978,0.002464319,0.00012857273,0.00024142611,0.007812169,0.0005314557,0.96067595,0.000029585262],"about_ca_topic_score_codex":0.015068664,"about_ca_topic_score_gemma":0.08530686,"teacher_disagreement_score":0.015068664,"about_ca_system_score_codex":0.0015661996,"about_ca_system_score_gemma":0.0014523476,"threshold_uncertainty_score":0.029961884},"labels":[],"label_agreement":null},{"id":"W4239689275","doi":"10.51731/cjht..29","title":"List of 2021 Health Technology Trends to Watch","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telemedicine; Wearable computer; Health care; Health technology; Emerging technologies; Psychological intervention; Wearable technology; Biomedical technology; Business; Disruptive technology; Digital health; Medicine; Computer science; Internet privacy; Engineering; Nursing; Political science","score_opus":0.2160682696672634,"score_gpt":0.5024861054777943,"score_spread":0.2864178358105309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239689275","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022901203,0.07221841,0.0026246775,0.028254077,0.02144102,0.0013551431,0.5776073,0.004059411,0.29014996],"genre_scores_gemma":[0.012981946,0.11657961,0.008336383,0.029053675,0.007944575,0.0020613736,0.6307578,0.0013410063,0.19094357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803907,0.00010973591,0.0002497174,0.00016800815,0.0011213304,0.00031210747],"domain_scores_gemma":[0.9835466,0.0016507346,0.0015096556,0.00027163114,0.010563069,0.0024582027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015150107,0.0012076579,0.0014054893,0.012455886,0.0012363413,0.004384832,0.001509995,0.0025729022,0.17477953],"category_scores_gemma":[0.014051506,0.00055367616,0.001469869,0.017724905,0.00032522058,0.003184502,0.0016110705,0.0022625744,0.09035856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004371455,0.000014582936,0.00056373526,0.0017458717,0.000016479527,0.000037755628,0.000018098392,0.000063804415,0.00011244521,0.0010799709,0.9251451,0.071158454],"study_design_scores_gemma":[0.000044703298,0.00004236607,0.0059878933,0.0024997615,0.00004628616,0.00008544097,0.000057446006,0.0001281699,0.0001530794,0.0006172713,0.9903156,0.000022041528],"about_ca_topic_score_codex":0.06864831,"about_ca_topic_score_gemma":0.104537435,"teacher_disagreement_score":0.17477953,"about_ca_system_score_codex":0.0033821303,"about_ca_system_score_gemma":0.013801944,"threshold_uncertainty_score":0.5846958},"labels":[],"label_agreement":null},{"id":"W4245623554","doi":"10.51731/cjht.2021.120","title":"Dupilumab (Dupixent)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Exhaled nitric oxide; Asthma; Dupilumab; Eosinophilic; Corticosteroid; Intensive care medicine; Internal medicine; Pathology; Health care","score_opus":0.02243943704668856,"score_gpt":0.2888968110201964,"score_spread":0.2664573739735078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245623554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019515457,0.7649398,0.0019543155,0.006395273,0.0021873314,0.0007486346,0.008942599,0.0007201238,0.19459651],"genre_scores_gemma":[0.28214464,0.49279878,0.007947769,0.015466767,0.0018235309,0.00091774954,0.016447052,0.00014396395,0.18230975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996687,0.00005543538,0.000021154496,0.0000460901,0.00016074725,0.00004783014],"domain_scores_gemma":[0.99968195,0.00005759993,0.00005482722,0.0000109619505,0.00012536164,0.000069265676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054964784,0.00042266014,0.0004322248,0.00097633415,0.0003873029,0.0010464451,0.00052589504,0.000591429,0.01990181],"category_scores_gemma":[0.0007330652,0.000119133154,0.0005447174,0.0006158632,0.00021238739,0.00046123815,0.0003269341,0.0008830282,0.005175189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007982305,0.00010428393,0.0007084408,0.0035004322,0.00009389945,0.00024195782,0.000047856804,0.00015512023,0.0031775243,0.0019791906,0.14066368,0.84852946],"study_design_scores_gemma":[0.00071336655,0.00062769465,0.0027453466,0.0013021065,0.00018815025,0.0013820647,0.000028834493,0.00013599299,0.0022618622,0.00028235323,0.99031526,0.000016971499],"about_ca_topic_score_codex":0.0137385335,"about_ca_topic_score_gemma":0.044518374,"teacher_disagreement_score":0.01990181,"about_ca_system_score_codex":0.001610977,"about_ca_system_score_gemma":0.0019809569,"threshold_uncertainty_score":0.06657821},"labels":[],"label_agreement":null},{"id":"W4252977245","doi":"10.51731/cjht.2021.50","title":"Hybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Hypoglycemia; Glycated hemoglobin; Medicine; Diabetes mellitus; Insulin delivery; Type 1 diabetes; Type 2 diabetes; Diabetes management; Insulin pump; Insulin pen; Blood Glucose Self-Monitoring; Pregnancy; Intensive care medicine; Internal medicine; Endocrinology; Continuous glucose monitoring","score_opus":0.026918641346176598,"score_gpt":0.2764264444354746,"score_spread":0.24950780308929799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252977245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13599363,0.41050595,0.048112117,0.09814147,0.0070499647,0.0026583562,0.008750302,0.0032966502,0.2854916],"genre_scores_gemma":[0.7030408,0.17504843,0.05519584,0.021731216,0.0021327427,0.0011972858,0.0047251396,0.0001914943,0.03673703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811673,0.0005196625,0.00010491952,0.00012414655,0.0008941544,0.00024033661],"domain_scores_gemma":[0.99728906,0.00054962735,0.00032451807,0.00015293987,0.0012420916,0.0004417566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025233522,0.00039095702,0.00052793487,0.00097519153,0.00086545356,0.0014386284,0.0012029462,0.00090443256,0.013531322],"category_scores_gemma":[0.0068821968,0.00016415697,0.0017868043,0.0010510614,0.0005733029,0.0010800224,0.0013997963,0.0013372997,0.0016305527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012071789,0.00047325587,0.013643173,0.0036139379,0.00036034398,0.00042968953,0.00030252204,0.0005187162,0.0014836523,0.005338816,0.07688131,0.89574736],"study_design_scores_gemma":[0.0016985281,0.003206671,0.11460448,0.011666094,0.0015807558,0.0032870506,0.0011241914,0.004475994,0.0026410557,0.0081858,0.8472943,0.00023506988],"about_ca_topic_score_codex":0.20370378,"about_ca_topic_score_gemma":0.25728306,"teacher_disagreement_score":0.20370378,"about_ca_system_score_codex":0.0069887987,"about_ca_system_score_gemma":0.008750528,"threshold_uncertainty_score":0.40503615},"labels":[],"label_agreement":null},{"id":"W4254385872","doi":"10.51731/cjht.2021.122","title":"Luspatercept (Reblozyl)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Anemia; Drug; Beta thalassemia; Thalassemia; Family medicine; Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.017452272563012378,"score_gpt":0.2652066078259932,"score_spread":0.24775433526298082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254385872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014469934,0.80228925,0.0024122389,0.0068495926,0.00117267,0.0002552533,0.0027087345,0.0006193981,0.16922286],"genre_scores_gemma":[0.17864503,0.62604594,0.0065403883,0.014786065,0.0011056201,0.00023703343,0.0068341903,0.00010376033,0.16570199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997242,0.00004830653,0.000025230427,0.00004556835,0.000121050274,0.00003554544],"domain_scores_gemma":[0.99972767,0.00006161128,0.00007996072,0.000009738805,0.000081010905,0.000039933057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048859033,0.00040280476,0.00038483005,0.0008680835,0.00021430256,0.0008437277,0.0004976049,0.0006254969,0.020442087],"category_scores_gemma":[0.0006275106,0.00008443629,0.00044782143,0.0005738348,0.00027238694,0.0006205089,0.00024519945,0.0007742539,0.006938165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051926187,0.00008640823,0.000379752,0.0035830354,0.00007210829,0.00023486177,0.000028832552,0.00014398538,0.009218154,0.0015539177,0.08314124,0.90103847],"study_design_scores_gemma":[0.00044173983,0.0011438071,0.004259735,0.0017827549,0.0001814988,0.0028902355,0.00004557089,0.00019606535,0.010580631,0.0004555427,0.97799575,0.000026757496],"about_ca_topic_score_codex":0.006069951,"about_ca_topic_score_gemma":0.01984143,"teacher_disagreement_score":0.020442087,"about_ca_system_score_codex":0.001264363,"about_ca_system_score_gemma":0.0010621668,"threshold_uncertainty_score":0.06838566},"labels":[],"label_agreement":null},{"id":"W4280537120","doi":"10.51731/cjht.2022.337","title":"Clinical Classification and Interventions for Post–COVID-19 Condition: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Coronavirus disease 2019 (COVID-19); Medicine; Quality of life (healthcare); MEDLINE; 2019-20 coronavirus outbreak; Nursing; Disease; Pathology; Political science","score_opus":0.3130877014900466,"score_gpt":0.5501135969586873,"score_spread":0.23702589546864072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280537120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009673189,0.99854785,0.00007133767,0.0004381521,0.00016393892,0.00009789352,0.00007168692,0.0000053812946,0.0005070611],"genre_scores_gemma":[0.0013051194,0.9977259,0.00024752846,0.0002985934,0.00006208836,0.00013281604,0.00007399662,0.0000024608091,0.00015146055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965397,0.0010987613,0.0010174614,0.0002773802,0.00088882196,0.0001778804],"domain_scores_gemma":[0.98332363,0.012992719,0.0015508899,0.00020909039,0.0017197428,0.0002039525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006687787,0.0013325436,0.0037368294,0.008307556,0.0010048422,0.002818726,0.0017781494,0.0024086195,0.009775195],"category_scores_gemma":[0.03066186,0.000702332,0.0049736793,0.008483811,0.0008187118,0.0025901082,0.0017053757,0.0019219064,0.00096543116],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012545798,0.000059944537,0.0004196199,0.57585144,0.001107286,0.000058784153,0.0002648022,0.00020903217,0.00011699337,0.0017822998,0.017615847,0.40238842],"study_design_scores_gemma":[0.000053667733,0.00005049465,0.001622344,0.9132613,0.0030615283,0.00014127164,0.00025312902,0.000076544224,0.00008148868,0.0005427019,0.080837205,0.000018408722],"about_ca_topic_score_codex":0.021301702,"about_ca_topic_score_gemma":0.043462705,"teacher_disagreement_score":0.021301702,"about_ca_system_score_codex":0.0053974977,"about_ca_system_score_gemma":0.01581704,"threshold_uncertainty_score":0.04235542},"labels":[],"label_agreement":null},{"id":"W4280551961","doi":"10.51731/cjht.2022.329","title":"Somatrogon (Ngenla)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.08723218125982363,"score_gpt":0.37803992502831396,"score_spread":0.29080774376849033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280551961","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04081831,0.8705115,0.0011105044,0.002383655,0.00057646225,0.00027578362,0.0022364277,0.0003339889,0.08175339],"genre_scores_gemma":[0.29792318,0.6084077,0.006702952,0.0053429515,0.00034782005,0.0003530697,0.004398185,0.00007195835,0.076452136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983025,0.00003152983,0.000013048271,0.000018743338,0.00008481353,0.000021609194],"domain_scores_gemma":[0.99979764,0.00005765787,0.000051985284,0.0000072026955,0.000044157685,0.000041456085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042585656,0.00027025182,0.00026163846,0.0010021873,0.00021002423,0.0005751396,0.00028753176,0.00037498397,0.010379411],"category_scores_gemma":[0.00051685184,0.00006049388,0.00037239783,0.0006022103,0.00028495744,0.0003398719,0.00034245878,0.00056113687,0.0018871273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010660014,0.0001625951,0.0010995871,0.005513806,0.00011080728,0.0003625367,0.00007172742,0.00017535928,0.0115568945,0.0017257434,0.024312746,0.9538423],"study_design_scores_gemma":[0.00076733547,0.0027528335,0.012309345,0.004291639,0.00038677038,0.003219632,0.00019441529,0.0001869479,0.013137934,0.0006190262,0.96209615,0.00003799838],"about_ca_topic_score_codex":0.0073581175,"about_ca_topic_score_gemma":0.034203347,"teacher_disagreement_score":0.010379411,"about_ca_system_score_codex":0.001193526,"about_ca_system_score_gemma":0.0015113595,"threshold_uncertainty_score":0.034722567},"labels":[],"label_agreement":null},{"id":"W4280593482","doi":"10.51731/cjht.2022.330","title":"An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Biomarker; Medicine; Cognitive decline; Amyloid beta; Amyloid (mycology); Alzheimer's disease; Bioinformatics; Neuroscience; Pathology; Dementia; Psychology; Biology","score_opus":0.11877353355568293,"score_gpt":0.3797878448533067,"score_spread":0.26101431129762376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280593482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074529473,0.96883404,0.0065103266,0.005573128,0.0015598207,0.0001383113,0.0002294447,0.00026557987,0.016143998],"genre_scores_gemma":[0.0036950123,0.9729725,0.013552663,0.0023869798,0.0013474794,0.00012365762,0.00040009076,0.00003783409,0.005483769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775785,0.00034461875,0.00019579499,0.0002314345,0.001275876,0.00019445592],"domain_scores_gemma":[0.9964567,0.0011793674,0.00020475306,0.00010898596,0.0017930189,0.0002571649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037805806,0.0015068385,0.0012626234,0.0066422643,0.0008814226,0.002644588,0.0020638814,0.0025187691,0.009396047],"category_scores_gemma":[0.003978253,0.0006382485,0.0014157804,0.003975063,0.00096454984,0.0029406126,0.0012858902,0.003113716,0.004904379],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001841995,0.00016837132,0.0011220543,0.008057478,0.00009919595,0.0004592985,0.00010941534,0.00040457686,0.005098448,0.008131194,0.06400576,0.91216],"study_design_scores_gemma":[0.000027421562,0.00023562441,0.00214842,0.0038659447,0.0001310026,0.0021847463,0.00012425051,0.00066626526,0.002772861,0.004264833,0.98350084,0.00007776184],"about_ca_topic_score_codex":0.016076114,"about_ca_topic_score_gemma":0.022527983,"teacher_disagreement_score":0.016076114,"about_ca_system_score_codex":0.0036616812,"about_ca_system_score_gemma":0.0048128325,"threshold_uncertainty_score":0.031965077},"labels":[],"label_agreement":null},{"id":"W4280598676","doi":"10.51731/cjht.2022.331","title":"Daratumumab (Darzalex SC)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Reimbursement; Medicine; Bortezomib; Dexamethasone; Family medicine; Internal medicine; Multiple myeloma; Political science; Health care","score_opus":0.016960740101297875,"score_gpt":0.27010467136470573,"score_spread":0.25314393126340784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280598676","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011271739,0.85180914,0.0015439021,0.008276275,0.0025870886,0.0002275593,0.0025507824,0.00035479505,0.12137864],"genre_scores_gemma":[0.15841882,0.6785572,0.007259237,0.015372027,0.0014239778,0.0002906138,0.005946503,0.000057304333,0.13267426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979585,0.000044718487,0.000024625528,0.000029948336,0.00008033393,0.000024524821],"domain_scores_gemma":[0.99977154,0.000047383026,0.00005708375,0.0000081852295,0.00008441003,0.00003142295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004310396,0.0003104897,0.0002706765,0.000569283,0.00019249217,0.00069024315,0.00025003438,0.00041591917,0.014480806],"category_scores_gemma":[0.0007171493,0.00007138232,0.0003477313,0.00048751076,0.00015830484,0.00032879453,0.00027911592,0.00043825232,0.0046304544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046325062,0.00004705181,0.0005271224,0.0024814766,0.00009130875,0.00014661971,0.00001990229,0.00009521675,0.0030553131,0.0020063533,0.10908024,0.88198614],"study_design_scores_gemma":[0.0003101332,0.0004615173,0.0028946162,0.0011257762,0.0001276734,0.0010005945,0.000021220312,0.000093724,0.0035197989,0.0004493015,0.9899852,0.000010415465],"about_ca_topic_score_codex":0.0052997577,"about_ca_topic_score_gemma":0.015675748,"teacher_disagreement_score":0.014480806,"about_ca_system_score_codex":0.0008294525,"about_ca_system_score_gemma":0.0011454872,"threshold_uncertainty_score":0.04844308},"labels":[],"label_agreement":null},{"id":"W4281481605","doi":"10.51731/cjht.2022.341","title":"An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Applications of artificial intelligence; Artificial intelligence; Health care; Computer science; Knowledge management; Political science","score_opus":0.2523961664306744,"score_gpt":0.4510323125373515,"score_spread":0.19863614610667707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281481605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014406124,0.8915253,0.016820554,0.0036571934,0.0012116494,0.000101321166,0.00017020047,0.00014656883,0.08492662],"genre_scores_gemma":[0.015497484,0.93762213,0.021343352,0.0022869748,0.0019192976,0.00013170361,0.0002976953,0.000047113106,0.020854289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992618,0.0001357954,0.00009350989,0.000093213755,0.0003449534,0.00007069315],"domain_scores_gemma":[0.9988134,0.0007494865,0.000070334085,0.000045590266,0.00024228713,0.00007883965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084489636,0.0006878338,0.00054696214,0.0035681976,0.00062531274,0.0032296493,0.0011057125,0.0022725232,0.008979673],"category_scores_gemma":[0.0013324154,0.00050015753,0.0007409235,0.0038702127,0.0008427953,0.0035592674,0.001265695,0.0020454475,0.0033046359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009458689,0.00017521318,0.0009911879,0.010910978,0.000069086374,0.00054581976,0.00042600423,0.0033787352,0.0027401408,0.18872735,0.047827043,0.7441138],"study_design_scores_gemma":[0.0000050671006,0.00010143668,0.0010062085,0.0029319294,0.000022422884,0.00076150504,0.00011587737,0.0015419815,0.0005158953,0.014851899,0.9781165,0.00002922488],"about_ca_topic_score_codex":0.0027317903,"about_ca_topic_score_gemma":0.002668826,"teacher_disagreement_score":0.008979673,"about_ca_system_score_codex":0.0016034555,"about_ca_system_score_gemma":0.0017305136,"threshold_uncertainty_score":0.030040026},"labels":[],"label_agreement":null},{"id":"W4281718991","doi":"10.51731/cjht.2022.356","title":"Utilization of Old- Versus New-Generation Biologics for Plaque Psoriasis for Public and Private Payers in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Biosimilar; Medicine; Formulary; Ustekinumab; Generic drug; Orphan drug; Family medicine; Infliximab; Pharmacology; Drug; Internal medicine","score_opus":0.1329166001152631,"score_gpt":0.31660010990601506,"score_spread":0.18368350979075196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281718991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3701987,0.36938918,0.0009277933,0.097069554,0.0017687947,0.00044909783,0.033679154,0.00025079894,0.12626699],"genre_scores_gemma":[0.88414633,0.080675915,0.0012979441,0.015506088,0.0003514934,0.00008190791,0.005879837,0.00008978519,0.011970759],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944865,0.00046268755,0.00035481167,0.00047134192,0.0031632376,0.001061438],"domain_scores_gemma":[0.9855671,0.0017427125,0.002159996,0.00019724415,0.006754408,0.0035784987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033358466,0.00024000314,0.0005871405,0.002752953,0.0022715577,0.0037655944,0.0014307091,0.0009829876,0.0068356213],"category_scores_gemma":[0.008615903,0.0002973248,0.0010638519,0.004572017,0.001056005,0.0009440267,0.0009969291,0.0015262972,0.00033508585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002190437,0.0003556812,0.30282053,0.0068909023,0.00080012175,0.0006389867,0.00311209,0.0005640137,0.0020077187,0.012082924,0.16819234,0.5003443],"study_design_scores_gemma":[0.0005241324,0.00040130666,0.7461444,0.004777364,0.0009362754,0.0008071202,0.005356582,0.0012984395,0.0013140107,0.00095022406,0.23725887,0.00023117215],"about_ca_topic_score_codex":0.9851952,"about_ca_topic_score_gemma":0.9934602,"teacher_disagreement_score":0.08679069,"about_ca_system_score_codex":0.08679069,"about_ca_system_score_gemma":0.14628722,"threshold_uncertainty_score":0.6297135},"labels":[],"label_agreement":null},{"id":"W4281773966","doi":"10.51731/cjht.2022.350","title":"Lorlatinib (Lorbrena)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Intensive care medicine; Political science; Pharmacology; Health care","score_opus":0.0271931516960458,"score_gpt":0.33553377938504764,"score_spread":0.30834062768900183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281773966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01660225,0.701547,0.0028711963,0.017398959,0.001726327,0.00032701355,0.005129378,0.0009953866,0.2534025],"genre_scores_gemma":[0.2656063,0.4862843,0.005991109,0.0173968,0.0013993289,0.00029784482,0.010383456,0.00010037372,0.21254049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973947,0.00005177565,0.00002157264,0.00004374824,0.000098581506,0.000044828947],"domain_scores_gemma":[0.99981827,0.000024804458,0.00004791094,0.000007265085,0.00006712205,0.000034616703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044770233,0.00035766914,0.00032248907,0.0007584644,0.0002728881,0.0007903682,0.00041748054,0.0005290446,0.01799406],"category_scores_gemma":[0.0006109972,0.00007985434,0.00036544574,0.00045602676,0.00024352269,0.00054432196,0.0003968261,0.0008321298,0.006296197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004574256,0.00006641108,0.00050626823,0.0019835783,0.00006308035,0.00015239096,0.00003067584,0.00027044333,0.0051642484,0.0027285973,0.12150731,0.8670697],"study_design_scores_gemma":[0.00018463015,0.00041124233,0.0023391882,0.00083094864,0.000067031164,0.000910348,0.000022030537,0.00016276701,0.0034815548,0.00033438354,0.9912407,0.000015232714],"about_ca_topic_score_codex":0.013601822,"about_ca_topic_score_gemma":0.034557577,"teacher_disagreement_score":0.01799406,"about_ca_system_score_codex":0.0019497483,"about_ca_system_score_gemma":0.0015748319,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4281779657","doi":"10.51731/cjht.2022.357","title":"Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Throat; Nose; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Sampling (signal processing); Coronavirus disease 2019 (COVID-19); Dermatology; Surgery; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.10906093829135867,"score_gpt":0.33203393979504237,"score_spread":0.2229730015036837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281779657","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25359356,0.098937064,0.05645073,0.07934721,0.02053918,0.012103955,0.06903324,0.0023460689,0.40764898],"genre_scores_gemma":[0.6301597,0.07355406,0.10756659,0.04369511,0.0036626766,0.0039642067,0.030009294,0.00088354596,0.10650493],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9533949,0.014650359,0.00760416,0.0023274787,0.020980226,0.0010429603],"domain_scores_gemma":[0.83568937,0.05558004,0.027344534,0.013425518,0.06571995,0.0022405759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037665606,0.0005203181,0.0007640094,0.003532746,0.00090757693,0.0035070614,0.0020021743,0.0015533358,0.015847785],"category_scores_gemma":[0.084113814,0.00033662163,0.0008602754,0.0031697343,0.0017933181,0.0016594866,0.0013439935,0.0010504018,0.005853278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013256461,0.0005765963,0.18886802,0.022138622,0.0005898665,0.0028117455,0.0039047308,0.0003120002,0.008643004,0.004877187,0.22480083,0.5411518],"study_design_scores_gemma":[0.00016451543,0.0012618486,0.23533522,0.010439919,0.00044849468,0.003846636,0.0056545716,0.0007290636,0.030626765,0.0019722402,0.70937485,0.00014590404],"about_ca_topic_score_codex":0.019623427,"about_ca_topic_score_gemma":0.038039744,"teacher_disagreement_score":0.037665606,"about_ca_system_score_codex":0.0020614404,"about_ca_system_score_gemma":0.0067226393,"threshold_uncertainty_score":0.19919711},"labels":[],"label_agreement":null},{"id":"W4281800226","doi":"10.51731/cjht.2022.343","title":"Enfortumab Vedotin (Padcev)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Urothelial cancer; Drug; Anticancer drug; Internal medicine; Oncology; Cancer; Pharmacology; Political science","score_opus":0.3542821329863515,"score_gpt":0.4064495632101858,"score_spread":0.052167430223834355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281800226","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049615998,0.8436947,0.0045743096,0.008905019,0.00060917955,0.00047314537,0.005021492,0.00018457742,0.08692164],"genre_scores_gemma":[0.5229232,0.4388963,0.006162956,0.002411358,0.00024587233,0.00026474168,0.003500259,0.000029956864,0.025565416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995427,0.00017185848,0.000031081006,0.000028667157,0.00018590396,0.000039766826],"domain_scores_gemma":[0.9993113,0.00024954573,0.00018768113,0.000021166183,0.00016541632,0.00006491563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010240093,0.00016143154,0.00022216224,0.00061140495,0.00013633697,0.0006749427,0.00025044402,0.000254864,0.005076115],"category_scores_gemma":[0.0021032658,0.000046554374,0.00036261772,0.00071522803,0.00018723725,0.00029834363,0.00021881108,0.00057587825,0.00034697284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008045373,0.00006999947,0.0026615,0.0032184718,0.00026227898,0.00015132337,0.00002366899,0.0014273636,0.0012007233,0.009269931,0.032526404,0.94838375],"study_design_scores_gemma":[0.0008464456,0.0012035262,0.015850581,0.006209071,0.0006047527,0.0018984044,0.00011889312,0.0018651299,0.0044469363,0.0039647277,0.9629611,0.000030429308],"about_ca_topic_score_codex":0.014088172,"about_ca_topic_score_gemma":0.043803595,"teacher_disagreement_score":0.014088172,"about_ca_system_score_codex":0.002246932,"about_ca_system_score_gemma":0.0029623485,"threshold_uncertainty_score":0.028012335},"labels":[],"label_agreement":null},{"id":"W4281872990","doi":"10.51731/cjht.2022.346","title":"Bimekizumab (Bimzelx)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Plaque psoriasis; Family medicine; Psoriasis; Intensive care medicine; Dermatology; Political science; Health care","score_opus":0.024982866814554368,"score_gpt":0.24319567992768074,"score_spread":0.21821281311312637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281872990","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013410824,0.73381835,0.005310545,0.012296587,0.0059458446,0.000529275,0.003445571,0.000970943,0.22427212],"genre_scores_gemma":[0.17948286,0.4942191,0.013108345,0.02602094,0.0033734434,0.0006108176,0.00845537,0.00013333405,0.2745958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996251,0.000059703765,0.000029284281,0.000053929627,0.000169938,0.00006197419],"domain_scores_gemma":[0.9997788,0.000034836597,0.000060348528,0.000009637567,0.00007032972,0.000046156496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006382345,0.00045877535,0.0003653186,0.00077912025,0.00029527367,0.0007734977,0.0006234887,0.00080834544,0.023776043],"category_scores_gemma":[0.0006589549,0.000120704186,0.0005182242,0.00038102356,0.00028081887,0.000517976,0.000589379,0.0008942952,0.008887793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004875711,0.00014122628,0.00044028097,0.002391263,0.000060507085,0.00017858292,0.000028780976,0.0002357733,0.0087528555,0.0039777737,0.13224532,0.8510601],"study_design_scores_gemma":[0.00024724595,0.0006963289,0.0017701716,0.0007104647,0.00005859722,0.0010277153,0.000023316255,0.00015097605,0.0075372793,0.0006303608,0.9871338,0.000013729214],"about_ca_topic_score_codex":0.0041901832,"about_ca_topic_score_gemma":0.007449631,"teacher_disagreement_score":0.023776043,"about_ca_system_score_codex":0.0011458489,"about_ca_system_score_gemma":0.0013466893,"threshold_uncertainty_score":0.07953882},"labels":[],"label_agreement":null},{"id":"W4281919354","doi":"10.51731/cjht.2022.351","title":"Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Thrombolysis; Stroke (engine); Significant difference; Pediatrics; Internal medicine; Myocardial infarction","score_opus":0.02880504133659749,"score_gpt":0.28438681696450346,"score_spread":0.25558177562790596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281919354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002994837,0.98922896,0.00030675012,0.0022067027,0.00075922173,0.000108176246,0.00030384905,0.000020385174,0.0040710964],"genre_scores_gemma":[0.05905785,0.9328965,0.0011516251,0.0029667704,0.0009767457,0.00018817994,0.0006021103,0.0000096972335,0.002150609],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.996962,0.0015130267,0.0005680699,0.00019305738,0.0006360467,0.000127673],"domain_scores_gemma":[0.99652964,0.0021592167,0.0007462127,0.00009056249,0.00039171992,0.00008281951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035488599,0.00054927735,0.0017848,0.0017678442,0.0001805902,0.00078468875,0.00075080106,0.001002224,0.007075611],"category_scores_gemma":[0.008773861,0.00020932592,0.0033295662,0.0015498106,0.0004977676,0.00069008226,0.00042014045,0.0012830782,0.00083523354],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056639845,0.00017029533,0.0010705515,0.08127275,0.0040006945,0.0002537485,0.00005980574,0.00027703916,0.000828794,0.0022593266,0.021162735,0.88298035],"study_design_scores_gemma":[0.028046755,0.014323027,0.06591713,0.25361717,0.050564118,0.002844534,0.0003596228,0.001006871,0.0062720757,0.008000307,0.5688155,0.00023283028],"about_ca_topic_score_codex":0.0028760717,"about_ca_topic_score_gemma":0.0056948857,"teacher_disagreement_score":0.007075611,"about_ca_system_score_codex":0.0014632862,"about_ca_system_score_gemma":0.0020750426,"threshold_uncertainty_score":0.023670256},"labels":[],"label_agreement":null},{"id":"W4282562487","doi":"10.51731/cjht.2022.358","title":"Pemigatinib (Pemazyre)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Health care","score_opus":0.02520408554022498,"score_gpt":0.2769138192359095,"score_spread":0.25170973369568456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282562487","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069831135,0.81286377,0.0015611395,0.01137966,0.00199456,0.00022922459,0.002371908,0.0002961107,0.16232045],"genre_scores_gemma":[0.09835389,0.7593932,0.0052303886,0.011513837,0.0011368069,0.0002221869,0.0035395678,0.000040868432,0.120569274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973613,0.000052377294,0.000030551404,0.000034951543,0.0001106935,0.000035269033],"domain_scores_gemma":[0.9997317,0.00006397457,0.00006607066,0.000010338551,0.000093262744,0.000034582434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046111795,0.00027807444,0.00025994072,0.00068775576,0.00024849697,0.0007341764,0.00031572575,0.00050678785,0.020711115],"category_scores_gemma":[0.00089987804,0.000075544216,0.00041429893,0.00045687062,0.00020080648,0.0005769394,0.00033511108,0.0006393392,0.004785755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024264735,0.000041694253,0.00044036887,0.0034054338,0.00008588933,0.00014998777,0.000023231105,0.00010270769,0.0025462748,0.0023314746,0.1100328,0.88059753],"study_design_scores_gemma":[0.00010835103,0.00022764705,0.0026677544,0.001397748,0.000092814815,0.0007951306,0.000031102118,0.00006323707,0.0025175498,0.00038551103,0.9917036,0.000009547033],"about_ca_topic_score_codex":0.006668423,"about_ca_topic_score_gemma":0.021289246,"teacher_disagreement_score":0.020711115,"about_ca_system_score_codex":0.0009694046,"about_ca_system_score_gemma":0.001231821,"threshold_uncertainty_score":0.06928563},"labels":[],"label_agreement":null},{"id":"W4282963206","doi":"10.51731/cjht.2022.361","title":"Utilization of Cholinesterase Inhibitors for Alzheimer Disease in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Galantamine; Donepezil; Rivastigmine; Cholinesterase; Medicine; Dementia; Formulary; Disease; Gerontology; Pharmacology; Internal medicine","score_opus":0.19897771612527607,"score_gpt":0.40317106518684337,"score_spread":0.2041933490615673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81203026,0.020600935,0.000721616,0.018371927,0.00035652603,0.00044355067,0.092158,0.00017752021,0.05513957],"genre_scores_gemma":[0.95682937,0.013825924,0.0012033015,0.003351782,0.00006148132,0.00011453439,0.015865233,0.000042927586,0.008705509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971546,0.00012881598,0.00022360188,0.00023951856,0.0014444169,0.0008091287],"domain_scores_gemma":[0.99384004,0.00021680395,0.0007472364,0.00007359274,0.0037017444,0.0014206755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010868659,0.0003134616,0.00050980964,0.0031454933,0.0031073329,0.0020769502,0.0011736338,0.0004765693,0.0034108204],"category_scores_gemma":[0.0035515404,0.0003753654,0.0009658512,0.008591515,0.00066429155,0.0005690278,0.0012517852,0.0011298175,0.0003263872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027911642,0.00015076342,0.859998,0.000805816,0.00039057533,0.00055845355,0.0022682634,0.0008491841,0.00046832443,0.0029735756,0.05935414,0.07190386],"study_design_scores_gemma":[0.00005059206,0.00007460434,0.96568686,0.0005453669,0.00014736988,0.0002599109,0.0032026854,0.0010573212,0.00024102586,0.00018849237,0.02847107,0.00007470451],"about_ca_topic_score_codex":0.99828583,"about_ca_topic_score_gemma":0.99881905,"teacher_disagreement_score":0.08262582,"about_ca_system_score_codex":0.08262582,"about_ca_system_score_gemma":0.1632804,"threshold_uncertainty_score":0.5994951},"labels":[],"label_agreement":null},{"id":"W4282977469","doi":"10.51731/cjht.2022.362","title":"Alpha1-Proteinase Inhibitor (Human) (Zemaira)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Proteinase inhibitor; Drug; Medicine; Intensive care medicine; Pharmacology; Chemistry; Health care; Political science; Enzyme","score_opus":0.13544595912281798,"score_gpt":0.39591952761530447,"score_spread":0.2604735684924865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016565591,0.8177964,0.0011130819,0.01034035,0.0011202751,0.00028607337,0.0054086396,0.0002011791,0.14716835],"genre_scores_gemma":[0.1994171,0.63395166,0.0064212084,0.00830994,0.0006474358,0.00022522052,0.005890719,0.00004965949,0.14508712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994548,0.000105762265,0.000049067967,0.000041799412,0.00029043114,0.000058040492],"domain_scores_gemma":[0.99907756,0.00019036919,0.00022984423,0.000025386018,0.00039602778,0.000080860154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298154,0.0002496968,0.0003153963,0.00077243586,0.0002872961,0.00091186794,0.00043049024,0.00053592125,0.013951257],"category_scores_gemma":[0.0016456243,0.00008081113,0.00053911103,0.00074079254,0.00034909663,0.00035427354,0.00022477741,0.0005829384,0.0022069141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010671329,0.00008515633,0.0033566519,0.0064201537,0.00032296634,0.00014703287,0.000061087405,0.00017253788,0.0046448866,0.0036738662,0.11977805,0.8602705],"study_design_scores_gemma":[0.0004447785,0.0011007093,0.033047065,0.0039152983,0.0005708238,0.0007670981,0.00011813737,0.00022441699,0.005755258,0.0004169204,0.9536068,0.000032741704],"about_ca_topic_score_codex":0.117576115,"about_ca_topic_score_gemma":0.38080844,"teacher_disagreement_score":0.117576115,"about_ca_system_score_codex":0.0033085602,"about_ca_system_score_gemma":0.004707505,"threshold_uncertainty_score":0.23378348},"labels":[],"label_agreement":null},{"id":"W4283122442","doi":"10.51731/cjht.2022.363","title":"Prasterone (Intrarosa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemistry and Bioactive Compounds","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug class; Family medicine; Drug; Gynecology; Political science; Pharmacology; Health care","score_opus":0.025356679755541955,"score_gpt":0.25199272577962206,"score_spread":0.2266360460240801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283122442","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014751115,0.8357563,0.002538026,0.0048858696,0.0025971557,0.00024061432,0.002258614,0.00040166004,0.1365706],"genre_scores_gemma":[0.16628899,0.673934,0.006571549,0.008436309,0.0011303971,0.00020027807,0.003127876,0.00007581123,0.14023481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999739,0.000047152582,0.000026784917,0.000039127415,0.00012131106,0.000026613303],"domain_scores_gemma":[0.99979657,0.000046554123,0.000056050718,0.000011147021,0.0000663574,0.000023337554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042605272,0.0003362672,0.00027414842,0.0007392731,0.00022954587,0.0005526014,0.0003548304,0.00043081428,0.020367835],"category_scores_gemma":[0.0004244897,0.00008863531,0.00045846426,0.00043974127,0.00033925957,0.0004168021,0.00034841403,0.0005432382,0.0049191834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000758098,0.00007384354,0.0004452864,0.00768333,0.00008562031,0.00041436162,0.00005714595,0.00015601073,0.026341505,0.0053581973,0.069198705,0.88942796],"study_design_scores_gemma":[0.00015029282,0.0011775146,0.002657698,0.0014541799,0.00011385027,0.0014874691,0.00006273764,0.00007512531,0.014368429,0.0005130903,0.9779202,0.00001951454],"about_ca_topic_score_codex":0.0051010232,"about_ca_topic_score_gemma":0.016577188,"teacher_disagreement_score":0.020367835,"about_ca_system_score_codex":0.0007047867,"about_ca_system_score_gemma":0.0012167646,"threshold_uncertainty_score":0.06813717},"labels":[],"label_agreement":null},{"id":"W4283271171","doi":"10.51731/cjht.2022.364","title":"Tralokinumab (Adtralza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Medical prescription; Family medicine; Atopic dermatitis; Nursing; Dermatology; Political science; Health care","score_opus":0.02398316503482601,"score_gpt":0.28358858184129304,"score_spread":0.25960541680646704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283271171","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007691861,0.6917941,0.0021391644,0.010487951,0.00407764,0.00044080755,0.005233809,0.0007715823,0.2773631],"genre_scores_gemma":[0.12375086,0.5371867,0.008511073,0.020530874,0.0015629996,0.00040725013,0.010429188,0.000117028925,0.29750404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996753,0.00005347707,0.000029349696,0.000054486947,0.00014072935,0.00004672915],"domain_scores_gemma":[0.99968994,0.000047848127,0.00006209909,0.000011699416,0.00013655321,0.000051835825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005408291,0.0004179689,0.0002508505,0.00088765775,0.00031730937,0.00091051054,0.0005741655,0.00077415694,0.03345424],"category_scores_gemma":[0.00070919987,0.000109091685,0.00053039775,0.00046774896,0.00031072038,0.00057459093,0.00036053726,0.00081164006,0.00923392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039600718,0.00007009561,0.0003206496,0.004276865,0.00006443337,0.00016717415,0.000032216547,0.00009832001,0.005580614,0.0034569127,0.22227933,0.7632573],"study_design_scores_gemma":[0.00018967895,0.00031951763,0.0017835061,0.0011151347,0.00007211557,0.00063367333,0.000021353782,0.000067055575,0.0023243264,0.00022613091,0.9932352,0.000012291646],"about_ca_topic_score_codex":0.017991757,"about_ca_topic_score_gemma":0.060856897,"teacher_disagreement_score":0.03345424,"about_ca_system_score_codex":0.0014262219,"about_ca_system_score_gemma":0.002579553,"threshold_uncertainty_score":0.11191559},"labels":[],"label_agreement":null},{"id":"W4283529023","doi":"10.51731/cjht.2022.372","title":"Health System Readiness Report: The Availability of Privately Funded IV Infusion Clinics in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Business; Scale (ratio); Medicine; Tracking (education); Healthcare system; Medical emergency; Family medicine; Health care; Political science; Psychology; Geography; Computer science","score_opus":0.244985086455644,"score_gpt":0.3822351515037907,"score_spread":0.1372500650481467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283529023","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36129692,0.0062210895,0.0012744891,0.054563876,0.0004458085,0.00081153814,0.47866952,0.00049310847,0.096223705],"genre_scores_gemma":[0.8497277,0.0066162623,0.0031908604,0.006951225,0.00016563591,0.00034224885,0.10730365,0.00011364669,0.025588848],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99524397,0.00022830119,0.00029427838,0.00025935797,0.0027814424,0.0011926689],"domain_scores_gemma":[0.9712478,0.0023887975,0.0028623252,0.00034523927,0.016366422,0.0067893565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022515515,0.00028114917,0.000422878,0.002985719,0.0030068206,0.0035400318,0.0015914198,0.000668102,0.008144788],"category_scores_gemma":[0.011304744,0.00037013175,0.0007388509,0.0061456775,0.0007003653,0.0010670322,0.0014261316,0.0019529401,0.0006267772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022825302,0.00019389592,0.4544675,0.0010092263,0.00028268804,0.00038614005,0.0018515702,0.0019750462,0.00029061837,0.0052285516,0.47074974,0.06333675],"study_design_scores_gemma":[0.00004734526,0.00006576906,0.9226177,0.00038411413,0.000091367576,0.00012222974,0.0037230663,0.001531108,0.00021073254,0.00027025532,0.07085228,0.00008396908],"about_ca_topic_score_codex":0.99660814,"about_ca_topic_score_gemma":0.9978573,"teacher_disagreement_score":0.92847896,"about_ca_system_score_codex":0.07152103,"about_ca_system_score_gemma":0.17541777,"threshold_uncertainty_score":0.5189238},"labels":[],"label_agreement":null},{"id":"W4284892562","doi":"10.51731/cjht.2022.384","title":"Platform, Basket, and Umbrella Trial Designs: Stakeholder Perspectives of Novel Therapeutics","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Telus (Canada); Canadian Agency for Drugs and Technologies in Health; University of Manitoba; University of Toronto","funders":"","keywords":"Clinical trial; Protocol (science); Stakeholder engagement; Medicine; Alternative medicine; Stakeholder; Medical physics; Engineering ethics; Public relations; Engineering; Internal medicine; Political science; Pathology","score_opus":0.3202342750032946,"score_gpt":0.3883024218095185,"score_spread":0.06806814680622392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284892562","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008448797,0.032980055,0.030843526,0.8952751,0.003691851,0.0008171547,0.00021301309,0.000070722184,0.02765978],"genre_scores_gemma":[0.43624833,0.028365878,0.11709799,0.3936214,0.011434966,0.0076482403,0.00018898686,0.0002693196,0.0051248325],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.3364236,0.6125552,0.01079243,0.0063734874,0.029357927,0.0044973176],"domain_scores_gemma":[0.2035442,0.739522,0.011289952,0.010773713,0.025515756,0.009354372],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6146475,0.0012199507,0.00274438,0.0035216024,0.0069980174,0.026729792,0.0054205954,0.018547423,0.008489713],"category_scores_gemma":[0.51412225,0.0014446973,0.0022534647,0.0032519752,0.030192595,0.023061005,0.014233688,0.020853993,0.0007422362],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017548308,0.00024377544,0.0034314122,0.0025814017,0.00034541293,0.00019653192,0.015985424,0.0012010301,0.0005178613,0.7952583,0.035206035,0.14327803],"study_design_scores_gemma":[0.0017651095,0.001649442,0.0033064985,0.0106691,0.00054011884,0.00044586716,0.017795384,0.004285048,0.0009809933,0.805721,0.15253185,0.00030950183],"about_ca_topic_score_codex":0.007345993,"about_ca_topic_score_gemma":0.011588216,"teacher_disagreement_score":0.3853525,"about_ca_system_score_codex":0.020473655,"about_ca_system_score_gemma":0.05132986,"threshold_uncertainty_score":0.47520828},"labels":[],"label_agreement":null},{"id":"W4285090912","doi":"10.51731/cjht.2022.388","title":"Fostamatinib (Tavalisse)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Health care; Law","score_opus":0.038057505034988996,"score_gpt":0.3107436991759175,"score_spread":0.2726861941409285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285090912","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011687949,0.8070576,0.0014715771,0.015972225,0.0020551437,0.0002496234,0.0039538634,0.00033581725,0.15721612],"genre_scores_gemma":[0.189024,0.6837859,0.005408575,0.013642854,0.0011936512,0.0002607981,0.0073427926,0.000057920955,0.09928344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995442,0.00008289783,0.00006460752,0.0000656791,0.00018838054,0.000054276],"domain_scores_gemma":[0.99968505,0.00006403232,0.00007371741,0.0000100149355,0.00012970372,0.00003748829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006177436,0.00029220045,0.00037607763,0.00089081057,0.00032582204,0.0007631621,0.0004070264,0.00062898267,0.014640977],"category_scores_gemma":[0.0010476166,0.0000725284,0.0005446032,0.0008294797,0.0002501293,0.00055387797,0.00036085397,0.00065723545,0.0032175744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052986754,0.000048693146,0.00068069826,0.004587082,0.00013961835,0.0001866357,0.000049510636,0.00014615868,0.0027419145,0.0034580694,0.10883682,0.878595],"study_design_scores_gemma":[0.00023030049,0.0003613694,0.0027032467,0.0011354851,0.00014567444,0.0009862434,0.000040015988,0.00007302936,0.0025403905,0.0005794145,0.9911935,0.000011335916],"about_ca_topic_score_codex":0.009457404,"about_ca_topic_score_gemma":0.033733133,"teacher_disagreement_score":0.014640977,"about_ca_system_score_codex":0.001488284,"about_ca_system_score_gemma":0.0018403856,"threshold_uncertainty_score":0.048978984},"labels":[],"label_agreement":null},{"id":"W4285394931","doi":"10.51731/cjht.2022.390","title":"Diacetylmorphine for Adults With Opioid Dependence","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Hydromorphone; Methadone; Medicine; Opioid; Opioid use disorder; Guideline; Anesthesia; Agonist; Pharmacology; Internal medicine","score_opus":0.01574886368000027,"score_gpt":0.2653063064427987,"score_spread":0.2495574427627984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285394931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27306786,0.3663757,0.00243191,0.07089787,0.004117835,0.001481576,0.008022129,0.000393203,0.27321196],"genre_scores_gemma":[0.771259,0.12952442,0.0047413283,0.035261482,0.0018188322,0.0004910021,0.0039416063,0.000037895283,0.052924376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999082,0.000024707244,0.000013658046,0.000008424347,0.000025583744,0.000019365107],"domain_scores_gemma":[0.9997683,0.000034051784,0.000068132045,0.0000079808815,0.0000375187,0.00008390077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001946297,0.000094015726,0.00014783535,0.00017331097,0.0003219951,0.00019722337,0.0002038106,0.00044700791,0.01640394],"category_scores_gemma":[0.0008924876,0.000048984395,0.00030334998,0.00019854849,0.00009499901,0.00019914647,0.00023082626,0.00051507197,0.0017289403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018783215,0.00063639705,0.031252548,0.0029429465,0.00012050314,0.0021413334,0.00018876926,0.000056430927,0.002580629,0.001326955,0.15238611,0.8044891],"study_design_scores_gemma":[0.0029810704,0.0045994264,0.2576499,0.0058764303,0.0004590388,0.013524426,0.0006117282,0.00034000882,0.0024243398,0.0016360596,0.70985174,0.000045791272],"about_ca_topic_score_codex":0.0064320415,"about_ca_topic_score_gemma":0.03070792,"teacher_disagreement_score":0.01640394,"about_ca_system_score_codex":0.0004756595,"about_ca_system_score_gemma":0.00097154366,"threshold_uncertainty_score":0.054876685},"labels":[],"label_agreement":null},{"id":"W4285596414","doi":"10.51731/cjht.2022.392","title":"Trace Amine-Associated Receptor 1 Agonists for Schizophrenia","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antipsychotic; Medicine; Partial agonist; Agonist; Pharmacology; Clinical trial; Dopamine receptor D2; Schizophrenia (object-oriented programming); Internal medicine; Psychiatry; Dopamine; Receptor","score_opus":0.01674535363351529,"score_gpt":0.2506839181679237,"score_spread":0.2339385645344084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285596414","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057968576,0.77365166,0.0050340355,0.05159727,0.0066834856,0.00055471726,0.002044186,0.0008446788,0.10162143],"genre_scores_gemma":[0.29628798,0.58819693,0.011199874,0.024758298,0.0032621305,0.0005596693,0.0025606123,0.00010429682,0.07307016],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998337,0.000047940335,0.000019506528,0.000014959426,0.00005800488,0.000025827612],"domain_scores_gemma":[0.9997503,0.00004017519,0.00006561513,0.000010389605,0.000059709477,0.00007369931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005638419,0.00045457174,0.0005253074,0.00043584176,0.00028079905,0.00033880788,0.0003041119,0.0005445026,0.01351903],"category_scores_gemma":[0.0004885198,0.00007352344,0.0006427226,0.00025057254,0.0002228411,0.00023579497,0.00037868897,0.0013499324,0.0033674047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031115522,0.0004991648,0.0010524956,0.0031945843,0.00016828049,0.0011898271,0.00009734081,0.00017264168,0.024489338,0.005084435,0.09203572,0.86890465],"study_design_scores_gemma":[0.0046800333,0.0068085315,0.019751035,0.0032371427,0.0004583855,0.006047669,0.0001648533,0.00062832364,0.0065891095,0.008360608,0.94318384,0.00009057646],"about_ca_topic_score_codex":0.0023612776,"about_ca_topic_score_gemma":0.008289987,"teacher_disagreement_score":0.01351903,"about_ca_system_score_codex":0.0008587545,"about_ca_system_score_gemma":0.0013641956,"threshold_uncertainty_score":0.04522562},"labels":[],"label_agreement":null},{"id":"W4285597427","doi":"10.51731/cjht.2022.391","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Health care; Pharmacology","score_opus":0.026523375509340825,"score_gpt":0.33789754651757126,"score_spread":0.31137417100823045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285597427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07086163,0.83057743,0.0012261453,0.00487111,0.00050751935,0.00031870327,0.0038330364,0.0002648955,0.08753948],"genre_scores_gemma":[0.4994636,0.44207522,0.0025452508,0.0041639726,0.00023694622,0.00020499104,0.005025664,0.00003213873,0.04625219],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997913,0.000041492527,0.0000213944,0.000026788925,0.000093338065,0.000025632355],"domain_scores_gemma":[0.99987113,0.00002553424,0.000034040444,0.0000041866365,0.000046717178,0.000018348528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042342517,0.00023353117,0.00032761335,0.0007380877,0.00017545541,0.0005529965,0.0002358712,0.00027718532,0.0036658796],"category_scores_gemma":[0.00042887905,0.000060668524,0.00039159448,0.00056013704,0.0001456409,0.000284914,0.00016959534,0.000423405,0.0008889379],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009883104,0.000101553655,0.0022173477,0.003259012,0.0004068064,0.00023544472,0.000046117162,0.00066191936,0.009069645,0.0018887967,0.03327429,0.94785076],"study_design_scores_gemma":[0.0008198135,0.0020555796,0.018737305,0.0024234673,0.0009278858,0.0032025205,0.00011776893,0.00065785093,0.0145293465,0.0008148274,0.9556705,0.000043184846],"about_ca_topic_score_codex":0.01006937,"about_ca_topic_score_gemma":0.07490043,"teacher_disagreement_score":0.01006937,"about_ca_system_score_codex":0.0016667036,"about_ca_system_score_gemma":0.0014533312,"threshold_uncertainty_score":0.020021498},"labels":[],"label_agreement":null},{"id":"W4285801062","doi":"10.51731/cjht.2022.397","title":"Improving Access to Primary Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary care; Psychological intervention; Incentive; Nursing; Health care; Medicine; Family medicine; Political science","score_opus":0.06777947422113127,"score_gpt":0.4033509992311163,"score_spread":0.335571525009985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285801062","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15284826,0.34921402,0.0020377913,0.11360163,0.0024055904,0.0012810583,0.032067366,0.00046625469,0.34607798],"genre_scores_gemma":[0.758308,0.1793184,0.0051701306,0.026385376,0.0012903613,0.00096153596,0.0067996583,0.00006276612,0.021703789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997315,0.0004157583,0.00016751872,0.00027502992,0.0010385144,0.0007881919],"domain_scores_gemma":[0.99418855,0.0014620996,0.00075630506,0.0001511102,0.0019623123,0.0014797245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029929115,0.00019064004,0.0006461839,0.0026109,0.001347642,0.0018581385,0.0010430545,0.0008947162,0.037672743],"category_scores_gemma":[0.015877912,0.00017504618,0.0010414802,0.0037886272,0.0005266296,0.0011523794,0.0017034231,0.00103006,0.0010538533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028454707,0.00047630313,0.08889019,0.028788032,0.0006289996,0.00042502687,0.0020358404,0.00030252663,0.00044453185,0.006101836,0.117707774,0.7539144],"study_design_scores_gemma":[0.00039585435,0.00050808495,0.62242234,0.038437583,0.0012131385,0.0005775262,0.0027023773,0.00034305858,0.0003435066,0.0022366229,0.33077765,0.00004228398],"about_ca_topic_score_codex":0.50124043,"about_ca_topic_score_gemma":0.6893196,"teacher_disagreement_score":0.9897798,"about_ca_system_score_codex":0.01022023,"about_ca_system_score_gemma":0.027453652,"threshold_uncertainty_score":0.99664575},"labels":[],"label_agreement":null},{"id":"W4286685301","doi":"10.51731/cjht.2022.403","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Oncology; Drug; Esophageal adenocarcinoma; Internal medicine; Gastroesophageal Junction; Adenocarcinoma; Intensive care medicine; Pharmacology; Cancer; Political science; Immunotherapy","score_opus":0.03897734126157233,"score_gpt":0.22951305929578625,"score_spread":0.19053571803421393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286685301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015673513,0.63235444,0.0051513594,0.02526827,0.004615146,0.0003531078,0.006397016,0.00046366968,0.30972344],"genre_scores_gemma":[0.3039563,0.46655196,0.011827708,0.023235608,0.002277145,0.00045058972,0.009190186,0.00013160007,0.18237892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996555,0.0000999825,0.000026836778,0.000050883667,0.000116249044,0.000050503724],"domain_scores_gemma":[0.9996375,0.00008019062,0.00007472699,0.000016415936,0.00013575438,0.000055468234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063784653,0.00028379136,0.0002657611,0.00053081784,0.00022950124,0.00095778104,0.00038134624,0.0005425541,0.014563104],"category_scores_gemma":[0.0012183691,0.000067304674,0.00047790393,0.0004970507,0.0002804689,0.0004949336,0.00042231358,0.00071952376,0.003026321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037631375,0.000041905572,0.0011381787,0.0019601376,0.0001008456,0.00010057207,0.000024465226,0.0004025157,0.001234727,0.010209654,0.14977309,0.8346375],"study_design_scores_gemma":[0.00011361773,0.00018829816,0.0026557362,0.0012845804,0.000081693244,0.00037024062,0.000025360347,0.00024768515,0.0013550546,0.0015534518,0.99211323,0.00001107791],"about_ca_topic_score_codex":0.022510836,"about_ca_topic_score_gemma":0.04878048,"teacher_disagreement_score":0.022510836,"about_ca_system_score_codex":0.001990437,"about_ca_system_score_gemma":0.0025998014,"threshold_uncertainty_score":0.048718452},"labels":[],"label_agreement":null},{"id":"W4289525250","doi":"10.51731/cjht.2022.406","title":"Models of Care for People Re-Entering the Community After Incarceration","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Community service; Service delivery framework; Medicine; Service (business); Nursing; Gerontology; Political science; Business; Public relations","score_opus":0.0677947611427661,"score_gpt":0.3676326857130322,"score_spread":0.2998379245702661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289525250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2019263,0.53478354,0.010939201,0.033880554,0.0021281491,0.0018097677,0.0023200545,0.00019690242,0.21201555],"genre_scores_gemma":[0.5651577,0.3998486,0.018132364,0.005254647,0.000220494,0.0016478095,0.0012658555,0.000046881592,0.008425536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642545,0.0018550926,0.00044744648,0.0001915673,0.0008294379,0.0002509958],"domain_scores_gemma":[0.98786175,0.008431843,0.0018740983,0.00030700056,0.0011510693,0.00037422174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005869419,0.00050641096,0.00064972916,0.0036455519,0.0019567376,0.0052606524,0.0019686297,0.0016751465,0.005971009],"category_scores_gemma":[0.020456111,0.00019196556,0.002126286,0.0052829324,0.0010112157,0.0038813078,0.0026703228,0.0012159854,0.00057781686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039266105,0.00047453598,0.031265687,0.056820873,0.0006076636,0.0022675944,0.08762394,0.00197935,0.0004702028,0.081281506,0.027543802,0.7092722],"study_design_scores_gemma":[0.00025920078,0.00072190055,0.026736496,0.16798307,0.0027960788,0.002948402,0.12833966,0.0017663599,0.0007677815,0.020770917,0.6466625,0.00024768317],"about_ca_topic_score_codex":0.015735965,"about_ca_topic_score_gemma":0.047334317,"teacher_disagreement_score":0.015735965,"about_ca_system_score_codex":0.009211707,"about_ca_system_score_gemma":0.013931015,"threshold_uncertainty_score":0.06683588},"labels":[],"label_agreement":null},{"id":"W4291001560","doi":"10.51731/cjht.2022.412","title":"Understanding the Portrait of Dementia Care in Canada: A CADTH Panel of Experts","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health, Medicine and Society","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Portrait; Health care; Medicine; Gerontology; Disease; Panel discussion; Nursing; Family medicine; Political science; Business; Geography","score_opus":0.18976275944799337,"score_gpt":0.35774223045434494,"score_spread":0.16797947100635158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291001560","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010865946,0.038349304,0.001097735,0.9170247,0.008663124,0.00022959385,0.00028741686,0.000056987905,0.023425251],"genre_scores_gemma":[0.38780344,0.11903426,0.013132133,0.4378285,0.0049583563,0.0005371548,0.0011594967,0.0002252496,0.03532134],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9811428,0.0034308054,0.0008740285,0.0010817135,0.008417078,0.0050535393],"domain_scores_gemma":[0.9433287,0.0035040434,0.0011024667,0.00043460718,0.03302721,0.01860295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019449515,0.0010346067,0.0009692735,0.0044803764,0.031720996,0.013967087,0.005016021,0.0081429435,0.003825481],"category_scores_gemma":[0.023883214,0.0009803623,0.0011972311,0.005956372,0.011832318,0.0044555417,0.0071049235,0.018892644,0.0005160359],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000056459765,0.00007186291,0.011925863,0.0007208362,0.000053187563,0.0013449545,0.06601174,0.0005056062,0.00094100664,0.0077042934,0.83863217,0.072032146],"study_design_scores_gemma":[0.000014199929,0.000021981203,0.018803846,0.0021585096,0.000039306433,0.00061831716,0.08974919,0.00034853938,0.00018490895,0.0031486484,0.8847704,0.00014227549],"about_ca_topic_score_codex":0.97361755,"about_ca_topic_score_gemma":0.991823,"teacher_disagreement_score":0.8061323,"about_ca_system_score_codex":0.19386768,"about_ca_system_score_gemma":0.36654755,"threshold_uncertainty_score":0.9349992},"labels":[],"label_agreement":null},{"id":"W4291002011","doi":"10.51731/cjht.2022.415","title":"Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Hyaluronidase; Recombinant DNA; Antibody; Medicine; Drug; Human immunodeficiency virus (HIV); Immunology; Pharmacology; Chemistry; Enzyme; Political science; Biochemistry","score_opus":0.028845260575301228,"score_gpt":0.3002388141577398,"score_spread":0.27139355358243855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291002011","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012680647,0.65609306,0.005052199,0.011253485,0.0024582846,0.00041335347,0.0039685676,0.0004970811,0.30758324],"genre_scores_gemma":[0.13515887,0.5095576,0.017790847,0.010771109,0.00065935886,0.00036097923,0.006105422,0.00018126924,0.31941456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998483,0.00029501488,0.00013513699,0.00008228364,0.0008541238,0.00015045285],"domain_scores_gemma":[0.99826187,0.00032748788,0.0003069331,0.000061020884,0.000919195,0.00012355555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018776575,0.00044651577,0.00035648805,0.0017168607,0.000336983,0.0012758686,0.00084008166,0.00093716144,0.015397983],"category_scores_gemma":[0.0021889275,0.00013213443,0.00055303,0.0010929857,0.0007025928,0.00059156906,0.00036546268,0.000575263,0.0036222239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031395492,0.00008898723,0.0017140573,0.004712487,0.000115808594,0.00022861255,0.00008811161,0.0002780635,0.012373716,0.011992307,0.16216452,0.8059295],"study_design_scores_gemma":[0.00005844048,0.0002581413,0.0053702854,0.0013613359,0.00009718938,0.00036066218,0.00009796426,0.00014394103,0.0075566,0.00043299937,0.9842427,0.000019767096],"about_ca_topic_score_codex":0.21675588,"about_ca_topic_score_gemma":0.42971173,"teacher_disagreement_score":0.21675588,"about_ca_system_score_codex":0.006530931,"about_ca_system_score_gemma":0.012008397,"threshold_uncertainty_score":0.43098843},"labels":[],"label_agreement":null},{"id":"W4291002222","doi":"10.51731/cjht.2022.414","title":"An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Profiling (computer programming); Emerging technologies; Clinical trial; Health care; Medicine; Data science; Computer science; Pathology; Political science","score_opus":0.0449433329869874,"score_gpt":0.33271092312586953,"score_spread":0.28776759013888215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291002222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008291843,0.8515313,0.035987586,0.045346413,0.0040291096,0.0006414067,0.00367178,0.0010298159,0.056933288],"genre_scores_gemma":[0.0067704064,0.913132,0.04947868,0.015123692,0.0033987635,0.0006781256,0.0031296639,0.00016806152,0.008120548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959495,0.001446793,0.00045793792,0.0004002184,0.0015291946,0.00021634446],"domain_scores_gemma":[0.9850884,0.0085753435,0.0007368182,0.00049945246,0.004263102,0.0008369122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00857659,0.0014084036,0.0010507826,0.008561466,0.0006724262,0.0032466361,0.0015878176,0.0026576421,0.013707413],"category_scores_gemma":[0.015090002,0.0007202313,0.0013508596,0.006836518,0.0011728834,0.003217686,0.002015043,0.0036106827,0.0051562786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008408031,0.000051286363,0.0015056136,0.00447707,0.00009872034,0.00016325217,0.00012910702,0.000650927,0.0007116452,0.016723081,0.13711272,0.8382924],"study_design_scores_gemma":[0.000016286625,0.00008731518,0.00226734,0.006576079,0.00008518539,0.0005893564,0.00008301708,0.0005554274,0.00043173542,0.010026874,0.9792333,0.00004805077],"about_ca_topic_score_codex":0.015591952,"about_ca_topic_score_gemma":0.021481754,"teacher_disagreement_score":0.015591952,"about_ca_system_score_codex":0.0048267823,"about_ca_system_score_gemma":0.00749853,"threshold_uncertainty_score":0.04585582},"labels":[],"label_agreement":null},{"id":"W4291152226","doi":"10.51731/cjht.2022.416","title":"Ospemifene (Osphena)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Genitourinary system; Menopause; Urinary incontinence; Drug class; Gynecology; Intensive care medicine; Drug; Family medicine; Internal medicine; Surgery; Psychiatry; Political science","score_opus":0.007426298641069915,"score_gpt":0.22763024574935395,"score_spread":0.22020394710828403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291152226","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016054654,0.825624,0.001681796,0.0058394526,0.0018185575,0.00027521187,0.003958807,0.00036779718,0.14437969],"genre_scores_gemma":[0.140298,0.63887316,0.0037195687,0.0080912765,0.0009011951,0.00022762705,0.005638635,0.000048946455,0.20220153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998129,0.00003792119,0.000016137867,0.000030730604,0.00007481698,0.000027532058],"domain_scores_gemma":[0.999866,0.000023924296,0.00003942825,0.000004866638,0.000040536277,0.000025239422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120587,0.00031533407,0.00029426866,0.0007894796,0.00030387973,0.00053763756,0.0002939297,0.00051708095,0.02722286],"category_scores_gemma":[0.0003539783,0.00008136268,0.00037381737,0.0004888321,0.00023304939,0.00036091037,0.00028023557,0.00061030634,0.0050819484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060072105,0.00008349946,0.0004970771,0.004292124,0.00008282873,0.00025462316,0.000036034184,0.00021184506,0.0059226253,0.003771213,0.07407008,0.9101774],"study_design_scores_gemma":[0.00025433637,0.0006674616,0.0031014562,0.0009900341,0.000093479495,0.0009920633,0.000045259636,0.00008648433,0.0037822824,0.0005202881,0.989451,0.000015907684],"about_ca_topic_score_codex":0.007960541,"about_ca_topic_score_gemma":0.026760384,"teacher_disagreement_score":0.02722286,"about_ca_system_score_codex":0.0008161095,"about_ca_system_score_gemma":0.0012257998,"threshold_uncertainty_score":0.09106958},"labels":[],"label_agreement":null},{"id":"W4292714772","doi":"10.51731/cjht.2022.425","title":"Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Procurement; Disease; Modalities; Medicine; Epidemiology; Product (mathematics); Family medicine; Intensive care medicine; Business; Pathology; Sociology","score_opus":0.1100831696613066,"score_gpt":0.4017112021239375,"score_spread":0.2916280324626309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292714772","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000401927,0.008339678,0.00034706973,0.98358107,0.00482984,0.000015678197,0.00042028356,0.000041742227,0.002022702],"genre_scores_gemma":[0.03523632,0.054110967,0.010602605,0.87409,0.015055054,0.0001926262,0.0023474086,0.00024040327,0.008124688],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94781905,0.016421132,0.0039508464,0.0032877615,0.01934671,0.0091744065],"domain_scores_gemma":[0.71121764,0.085395284,0.0056314142,0.007282815,0.120361194,0.07011162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09699822,0.0016605377,0.0022706436,0.0044155708,0.013576932,0.02028,0.011299293,0.025138332,0.020955298],"category_scores_gemma":[0.15998265,0.0012412593,0.0024410659,0.0068769217,0.016751567,0.025421064,0.009615535,0.03370815,0.0033811969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054702934,0.000042636628,0.0021429549,0.00041987002,0.000031495565,0.00028705347,0.0014680907,0.00029165205,0.00006342282,0.032097146,0.93351233,0.029588655],"study_design_scores_gemma":[0.00007694805,0.000048605096,0.0047529065,0.004356129,0.000064500324,0.00044706475,0.012891394,0.0006597687,0.00012993661,0.020458087,0.9558713,0.00024329146],"about_ca_topic_score_codex":0.8822116,"about_ca_topic_score_gemma":0.91901386,"teacher_disagreement_score":0.9283814,"about_ca_system_score_codex":0.07161862,"about_ca_system_score_gemma":0.31979173,"threshold_uncertainty_score":0.51963186},"labels":[],"label_agreement":null},{"id":"W4293206881","doi":"10.51731/cjht.2022.428","title":"Ripretinib (Qinlock)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Reimbursement; Sunitinib; Medicine; Imatinib; GiST; Drug; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Stromal cell; Political science; Cancer; Colorectal cancer; Health care","score_opus":0.03815395286686855,"score_gpt":0.31151360899872066,"score_spread":0.2733596561318521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293206881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016380932,0.578506,0.0036265159,0.009854222,0.0022612398,0.00084327057,0.00843639,0.001446711,0.37864473],"genre_scores_gemma":[0.19103856,0.49241254,0.009941367,0.019379135,0.0013779665,0.00073170237,0.020975092,0.0002723355,0.26387137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996674,0.00005457107,0.000027658862,0.000058445134,0.00013895718,0.000052985702],"domain_scores_gemma":[0.9998029,0.000031369233,0.000048442744,0.0000093046165,0.000065764674,0.000042280284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054943596,0.00044175104,0.00045847305,0.0009884961,0.0003228336,0.0010678509,0.0006766075,0.00070009637,0.04163395],"category_scores_gemma":[0.0006793954,0.000110262394,0.0006366413,0.0006427841,0.00032646442,0.00078287115,0.0005961697,0.0011360369,0.012927152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006770036,0.00011170277,0.00039135243,0.003904773,0.00008922468,0.00023608425,0.00005881872,0.00027521746,0.007327484,0.00510569,0.14513083,0.83669186],"study_design_scores_gemma":[0.00053015933,0.0005733488,0.0012415753,0.00096843677,0.000092618284,0.0009765295,0.000033392098,0.000121964775,0.0034829995,0.00078721903,0.9911726,0.000019106414],"about_ca_topic_score_codex":0.0046021985,"about_ca_topic_score_gemma":0.012856181,"teacher_disagreement_score":0.04163395,"about_ca_system_score_codex":0.0012075532,"about_ca_system_score_gemma":0.001790709,"threshold_uncertainty_score":0.13927937},"labels":[],"label_agreement":null},{"id":"W4293207290","doi":"10.51731/cjht.2022.427","title":"Amifampridine phosphate (Firdapse)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Drug class; Family medicine; Political science; Pharmacology; Health care; Law","score_opus":0.02205549360723137,"score_gpt":0.26410860124144964,"score_spread":0.24205310763421828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293207290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010047742,0.8416014,0.001182906,0.008771313,0.0018539487,0.00014475454,0.0017478241,0.0002231871,0.13442689],"genre_scores_gemma":[0.14085151,0.70088726,0.0060974727,0.013328589,0.0013049535,0.00016736187,0.0030459205,0.00004160412,0.13427527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997011,0.000055640143,0.00003126387,0.000038493745,0.00013647998,0.000037110658],"domain_scores_gemma":[0.99964166,0.00009057315,0.00009569451,0.000009633313,0.000119836914,0.000042525906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004763245,0.0002752232,0.0002953815,0.00068971637,0.00026711432,0.0005697586,0.00038171577,0.0006388863,0.016433826],"category_scores_gemma":[0.0009579713,0.000073673844,0.00042971736,0.00040557806,0.00027334585,0.00032097596,0.00022918811,0.000632866,0.003349758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048593874,0.000071261595,0.0007107153,0.0040128524,0.0000802306,0.00032226037,0.000031025986,0.00009567319,0.0044328724,0.0019468429,0.09626596,0.8915444],"study_design_scores_gemma":[0.0002558944,0.0009608041,0.009336252,0.0022882626,0.00015838044,0.002020764,0.000056354733,0.000109690714,0.0049134213,0.00034659778,0.97953266,0.000020820553],"about_ca_topic_score_codex":0.02904233,"about_ca_topic_score_gemma":0.10165395,"teacher_disagreement_score":0.02904233,"about_ca_system_score_codex":0.0014472847,"about_ca_system_score_gemma":0.0022335567,"threshold_uncertainty_score":0.05774659},"labels":[],"label_agreement":null},{"id":"W4293724035","doi":"10.51731/cjht.2022.431","title":"Faricimab (Vabysmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macular degeneration; Medicine; Drug; Public health; Optometry; Drug treatment; Ophthalmology; Internal medicine; Pharmacology; Pathology","score_opus":0.3579371651390985,"score_gpt":0.40850366225846313,"score_spread":0.05056649711936462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293724035","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060500685,0.28505093,0.006896984,0.06562653,0.0053472826,0.00064136856,0.011753857,0.0018574217,0.562325],"genre_scores_gemma":[0.6089197,0.07950263,0.009936515,0.028830178,0.0023173888,0.00045437677,0.01599337,0.00012295211,0.25392288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972624,0.00007054097,0.000021380118,0.00004815613,0.00008221193,0.00005144166],"domain_scores_gemma":[0.9996264,0.00008061914,0.00008774783,0.000026880543,0.000055818437,0.00012259232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004934119,0.0002780283,0.0003034527,0.0003720912,0.00021804508,0.0006413623,0.00039932423,0.000978111,0.036618285],"category_scores_gemma":[0.0013705441,0.00008820185,0.0003427323,0.00021884384,0.00017879868,0.00038618137,0.00039679394,0.0012058422,0.011242822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015500393,0.00021174343,0.0015193522,0.00066706643,0.000097162934,0.00040144115,0.000022902555,0.0004946622,0.0048276903,0.006023596,0.22287616,0.7613081],"study_design_scores_gemma":[0.0016994126,0.0013489127,0.009263434,0.0007023366,0.000080173915,0.0026991032,0.000025155192,0.000633594,0.0031124405,0.0027203308,0.977689,0.00002604366],"about_ca_topic_score_codex":0.0026681519,"about_ca_topic_score_gemma":0.004367708,"teacher_disagreement_score":0.9991728,"about_ca_system_score_codex":0.00082720804,"about_ca_system_score_gemma":0.0006869936,"threshold_uncertainty_score":0.12250042},"labels":[],"label_agreement":null},{"id":"W4294193007","doi":"10.51731/cjht.2022.434","title":"Current Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Formulary; Reimbursement; Business; Drug; Pharmacology; Medicine; Health care; Economic growth; Economics","score_opus":0.048603727892597356,"score_gpt":0.3054348629377528,"score_spread":0.2568311350451554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294193007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877073,0.00094125554,0.0000908954,0.00041375626,0.0000053550016,0.000023368506,0.008510306,0.000016006014,0.002291823],"genre_scores_gemma":[0.995598,0.0009648966,0.0001465047,0.00011145064,0.0000067207498,0.000015803158,0.002686337,0.000004900714,0.00046538113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999076,0.000070816306,0.00013932693,0.00016374118,0.00035989904,0.00019016748],"domain_scores_gemma":[0.9961506,0.00024114993,0.0017726567,0.000078859804,0.0010947571,0.00066196016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235895,0.00013909495,0.00022809114,0.0016228465,0.00055626244,0.00090945495,0.0007155546,0.00042017928,0.0017820352],"category_scores_gemma":[0.002158727,0.00017624296,0.00055803056,0.0033613946,0.00048976165,0.0004908901,0.0003962181,0.0003952446,0.00027450622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007620246,0.00002382483,0.9938685,0.000045928336,0.000053892152,0.00007866991,0.00027801437,0.00011269535,0.00022787525,0.000058963255,0.0007354542,0.004440067],"study_design_scores_gemma":[0.0000025459976,0.00003178122,0.9982451,0.000026119817,0.000015991518,0.00013569384,0.0005040259,0.00021993803,0.000069301546,0.000009627987,0.0007328681,0.000006948383],"about_ca_topic_score_codex":0.7270656,"about_ca_topic_score_gemma":0.80110854,"teacher_disagreement_score":0.7270656,"about_ca_system_score_codex":0.0057972115,"about_ca_system_score_gemma":0.004213283,"threshold_uncertainty_score":0.5490835},"labels":[],"label_agreement":null},{"id":"W4294292647","doi":"10.51731/cjht.2022.433","title":"Cemiplimab (Libtayo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Lung cancer; Oncology; Family medicine; Political science; Health care","score_opus":0.023578534964492186,"score_gpt":0.3292358113351322,"score_spread":0.30565727637064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294292647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027997538,0.56950045,0.0045621637,0.012067831,0.003144057,0.0013810922,0.0072504836,0.0017343472,0.37236205],"genre_scores_gemma":[0.30184576,0.3198125,0.018190121,0.023813363,0.0017823855,0.0017898524,0.019749867,0.00028028147,0.31273586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962974,0.0000811748,0.00004035973,0.00006584528,0.000121555226,0.00006123622],"domain_scores_gemma":[0.9995753,0.000058404647,0.000115083865,0.000018711342,0.00012877882,0.00010365447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006624376,0.0005797024,0.00045212443,0.0013971307,0.000384026,0.0013321686,0.0006206432,0.00093268574,0.031078592],"category_scores_gemma":[0.0009550329,0.00019835359,0.0004819691,0.0006081237,0.00036514262,0.00065748853,0.0006226289,0.0010726526,0.009610546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013287073,0.00018623375,0.0010648174,0.0029506292,0.00009520566,0.00028073473,0.000051882016,0.00020677182,0.0125058275,0.0037245103,0.14332448,0.83428025],"study_design_scores_gemma":[0.0009765547,0.0014663899,0.0030568473,0.0013529283,0.0000938136,0.001825137,0.000040730312,0.00015639036,0.008640677,0.00038520672,0.98198134,0.000023984292],"about_ca_topic_score_codex":0.0066571655,"about_ca_topic_score_gemma":0.017398564,"teacher_disagreement_score":0.031078592,"about_ca_system_score_codex":0.0016016276,"about_ca_system_score_gemma":0.002711828,"threshold_uncertainty_score":0.10396832},"labels":[],"label_agreement":null},{"id":"W4295095326","doi":"10.51731/cjht.2022.439","title":"Post-Market Drug Evaluation","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cornerstone; Government (linguistics); Work (physics); Key (lock); Drug; Business; Risk analysis (engineering); Public relations; Data science; Computer science; Medicine; Engineering; Political science; Computer security; Pharmacology; Geography","score_opus":0.26796293488843287,"score_gpt":0.4061658416834237,"score_spread":0.1382029067949908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295095326","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011419645,0.026920218,0.0096261185,0.24417551,0.034497313,0.024790606,0.045694806,0.0024470098,0.60042876],"genre_scores_gemma":[0.1322677,0.02507637,0.023568457,0.19496934,0.017242732,0.01694208,0.037049554,0.0013678881,0.5515159],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93603,0.023014404,0.005239462,0.0024564033,0.026582578,0.006677205],"domain_scores_gemma":[0.75631773,0.030817967,0.01085902,0.021931075,0.15607819,0.023995964],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.065891705,0.0009896377,0.0020492072,0.0036722,0.0029925827,0.008601935,0.0031939493,0.005990475,0.11755692],"category_scores_gemma":[0.16305818,0.00076576497,0.003209514,0.0026692778,0.001481961,0.003650011,0.0041220947,0.005860286,0.031151406],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014679462,0.0003015696,0.00162591,0.0008952724,0.00017845645,0.00011964774,0.00012493819,0.000093382,0.00017136068,0.0067251404,0.84698826,0.14130817],"study_design_scores_gemma":[0.0008425258,0.00064624514,0.00825127,0.0011567327,0.00015688212,0.00013686673,0.00011888228,0.00021991,0.00051052554,0.0018627272,0.9860512,0.000046266432],"about_ca_topic_score_codex":0.049551003,"about_ca_topic_score_gemma":0.088511065,"teacher_disagreement_score":0.9847783,"about_ca_system_score_codex":0.015221722,"about_ca_system_score_gemma":0.060432415,"threshold_uncertainty_score":0.3932671},"labels":[],"label_agreement":null},{"id":"W4295743166","doi":"10.51731/cjht.2022.443","title":"Letter to the Editor Regarding CADTH rapid review: Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thrombolysis; Medicine; Stroke (engine); Acute stroke; Ischemic stroke; Intensive care medicine; Tissue plasminogen activator; Cardiology; Internal medicine; Ischemia; Myocardial infarction; Engineering","score_opus":0.018517441139092254,"score_gpt":0.2782553962394906,"score_spread":0.2597379551003983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295743166","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014080647,0.0032737018,0.000099368444,0.8890062,0.10627924,0.000041854055,0.00016057433,0.000051511226,0.0009467988],"genre_scores_gemma":[0.0018033412,0.0032207659,0.0002821425,0.850642,0.14027654,0.00008767842,0.00006367369,0.000049226914,0.0035746207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898296,0.0024851733,0.0022229636,0.00093440077,0.0038261283,0.0007017275],"domain_scores_gemma":[0.93812734,0.023070347,0.0049288534,0.0012143006,0.028162483,0.0044966917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010349581,0.0012099324,0.0032475358,0.002845789,0.0029218073,0.005206648,0.0037628603,0.037988536,0.00728301],"category_scores_gemma":[0.09980315,0.00127186,0.002172644,0.0020489087,0.0021975562,0.00405799,0.0013969822,0.025312634,0.0076812045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031025873,0.000005628997,0.00009752688,0.00013508473,0.00001560342,0.00036792134,0.000026837444,0.000012067157,0.00003262921,0.00022971719,0.99658847,0.0024575153],"study_design_scores_gemma":[0.00025547703,0.000065921646,0.0011941929,0.0017986734,0.00014181573,0.003882064,0.00026605875,0.00033374966,0.00031886154,0.0022949679,0.98932856,0.00011964825],"about_ca_topic_score_codex":0.011989647,"about_ca_topic_score_gemma":0.019314114,"teacher_disagreement_score":0.9908584,"about_ca_system_score_codex":0.009141613,"about_ca_system_score_gemma":0.011816995,"threshold_uncertainty_score":0.06632733},"labels":[],"label_agreement":null},{"id":"W4295745635","doi":"10.51731/cjht.2022.441","title":"Dostarlimab (Jemperli)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microsatellite instability; Medicine; Oncology; Internal medicine; Regimen; Quality of life (healthcare); Disease; Clinical trial; Endometrial cancer; Cancer; Gynecology; Biology","score_opus":0.027585593118772716,"score_gpt":0.28097659240452916,"score_spread":0.2533909992857564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295745635","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048397373,0.45965877,0.0053631645,0.054716654,0.0062263627,0.0013707557,0.006833067,0.0027252154,0.41470864],"genre_scores_gemma":[0.44935524,0.17984356,0.017304132,0.07243787,0.0024091576,0.0013384834,0.013777889,0.0002828516,0.26325077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996847,0.00008176324,0.00003717544,0.00005586051,0.00009374066,0.000046753303],"domain_scores_gemma":[0.9997129,0.00006613755,0.000076154436,0.00001874818,0.00006439665,0.000061721046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005398621,0.00027414842,0.00045558592,0.00058120466,0.00024721897,0.0005646056,0.00073518354,0.0008323138,0.026475364],"category_scores_gemma":[0.00098394,0.00013851456,0.00046920095,0.00026526419,0.0003194246,0.0004332755,0.0004509806,0.0015928979,0.0065775434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002182755,0.00023431782,0.0009003856,0.0022953122,0.00014546391,0.00036705998,0.00004642899,0.00026335515,0.006485333,0.0037295534,0.17511989,0.80823016],"study_design_scores_gemma":[0.0045151412,0.0028856972,0.0053341766,0.0012672759,0.000172848,0.0029721216,0.0000479273,0.00055602,0.006618574,0.00174317,0.97384405,0.00004294447],"about_ca_topic_score_codex":0.0018951901,"about_ca_topic_score_gemma":0.006430198,"teacher_disagreement_score":0.026475364,"about_ca_system_score_codex":0.0008649106,"about_ca_system_score_gemma":0.00077706674,"threshold_uncertainty_score":0.088568926},"labels":[],"label_agreement":null},{"id":"W4295972090","doi":"10.51731/cjht.2022.442","title":"Avalglucosidase Alfa (Nexviazyme)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Vial; Political science; Health care","score_opus":0.036770565799471355,"score_gpt":0.3129541320836914,"score_spread":0.27618356628422003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295972090","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008047312,0.8157864,0.002748465,0.006604788,0.002104683,0.00025460316,0.0026588475,0.00036622037,0.16142865],"genre_scores_gemma":[0.09654512,0.72502375,0.008733235,0.010274087,0.00095346785,0.00028026075,0.0059451926,0.000085382475,0.1521595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996911,0.000056956324,0.000040804116,0.000040553583,0.00013740954,0.00003325181],"domain_scores_gemma":[0.9996232,0.000081445825,0.00010389518,0.000013584251,0.00013127984,0.0000465643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007197737,0.0003633976,0.00027402875,0.00084939937,0.00020810025,0.0008578426,0.00037861985,0.0006899238,0.01887329],"category_scores_gemma":[0.0009151646,0.000092296425,0.0005292716,0.00053780334,0.0003185178,0.0005311625,0.00039807567,0.00068528234,0.005013071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063906115,0.000056468933,0.0005708699,0.0039043569,0.00007206455,0.00024943313,0.00003282014,0.00013037548,0.0051241308,0.0038840298,0.10059765,0.88473874],"study_design_scores_gemma":[0.00019878159,0.00031986056,0.0019847967,0.001385067,0.00007238206,0.00083047454,0.000027802944,0.00006451242,0.002633706,0.00040623033,0.99206585,0.000010539441],"about_ca_topic_score_codex":0.011694343,"about_ca_topic_score_gemma":0.028452117,"teacher_disagreement_score":0.01887329,"about_ca_system_score_codex":0.0012267114,"about_ca_system_score_gemma":0.0019829925,"threshold_uncertainty_score":0.06313747},"labels":[],"label_agreement":null},{"id":"W4295972175","doi":"10.51731/cjht.2022.445","title":"Cenegermin (OXERVATE)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Keratitis; Ophthalmology; Political science; Health care","score_opus":0.02495012981780162,"score_gpt":0.28234762652661577,"score_spread":0.2573974967088142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295972175","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033078168,0.66324764,0.0022000722,0.0042197355,0.0011013729,0.0005902577,0.0050743613,0.0008023876,0.28968605],"genre_scores_gemma":[0.26166388,0.34062082,0.007035178,0.004454907,0.00038281363,0.00026019648,0.0072424696,0.00014731319,0.37819237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996971,0.000040465588,0.000017204353,0.000040128438,0.00015830532,0.000046895977],"domain_scores_gemma":[0.99979144,0.000026403122,0.000044015174,0.00000738083,0.0000854161,0.000045366138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048190923,0.0004055299,0.0003193628,0.0011095015,0.0003209298,0.0007394595,0.0003853376,0.00066333945,0.029468639],"category_scores_gemma":[0.0005764101,0.00010295122,0.00025694005,0.0007012629,0.00023391783,0.00033472857,0.00039266175,0.00060207344,0.0053732535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070035295,0.0001349275,0.00062951806,0.0036725437,0.00004365837,0.00035722562,0.000061213905,0.00014859319,0.017218834,0.0026914284,0.07751961,0.89682215],"study_design_scores_gemma":[0.00040296133,0.00068509567,0.0058242907,0.0015967332,0.00007548434,0.0012553148,0.0000874362,0.00010545642,0.0090432335,0.00029325174,0.980613,0.0000176192],"about_ca_topic_score_codex":0.04484774,"about_ca_topic_score_gemma":0.14211942,"teacher_disagreement_score":0.04484774,"about_ca_system_score_codex":0.0014979123,"about_ca_system_score_gemma":0.0027366802,"threshold_uncertainty_score":0.09858239},"labels":[],"label_agreement":null},{"id":"W4296106206","doi":"10.51731/cjht.2022.438","title":"Response to Letter to Editor From the Canadian Stroke Consortium","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Thrombolysis; Acute stroke; Medicine; Systematic review; MEDLINE; Tissue plasminogen activator; Political science; Engineering; Psychiatry; Internal medicine","score_opus":0.019552516331999434,"score_gpt":0.2689430503336739,"score_spread":0.24939053400167444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296106206","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007386676,0.001092258,0.00007079816,0.89116913,0.106017634,0.000047139532,0.00019843833,0.00008261726,0.0012480773],"genre_scores_gemma":[0.00078470574,0.00087259227,0.00017277426,0.9462593,0.046045125,0.000086473476,0.000085848005,0.000053071064,0.005640191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98760813,0.0014976135,0.0018707791,0.0012456058,0.0064354637,0.0013424455],"domain_scores_gemma":[0.93743414,0.01280649,0.0033762592,0.0011630222,0.036829267,0.00839078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0123301875,0.0017171819,0.0034840915,0.0024576986,0.005349976,0.0065606837,0.006176764,0.046592187,0.022783821],"category_scores_gemma":[0.103439815,0.0014547325,0.0026874729,0.0024081625,0.003351161,0.004695947,0.002712932,0.04155738,0.016614472],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000936616,0.0000024611572,0.000038712522,0.00003464041,0.0000038839116,0.00005842217,0.00001270739,0.0000064334877,0.0000096236345,0.000077619814,0.9989116,0.0008344801],"study_design_scores_gemma":[0.00008110042,0.000022499265,0.0008927728,0.00048272187,0.00003436436,0.00044842853,0.0002686821,0.00014875695,0.00011218403,0.0005783609,0.9968459,0.000084103565],"about_ca_topic_score_codex":0.08030304,"about_ca_topic_score_gemma":0.11012411,"teacher_disagreement_score":0.08030304,"about_ca_system_score_codex":0.016047094,"about_ca_system_score_gemma":0.035024077,"threshold_uncertainty_score":0.15967125},"labels":[],"label_agreement":null},{"id":"W4296633325","doi":"10.51731/cjht.2022.453","title":"Zanubrutinib (Brukinsa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.04150092911836314,"score_gpt":0.31990717976881616,"score_spread":0.27840625065045305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296633325","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008943563,0.8562845,0.0012798248,0.007511475,0.0015163657,0.00021085242,0.002388056,0.0003136824,0.12155177],"genre_scores_gemma":[0.123456426,0.7346691,0.0050568623,0.008263004,0.0006708086,0.000226646,0.004235601,0.000059477206,0.123362094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967504,0.00007125098,0.000031120508,0.000044955086,0.00013289807,0.000044827982],"domain_scores_gemma":[0.99977356,0.00003956494,0.00006666923,0.000009088064,0.00008213682,0.000029081219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052597147,0.00031176963,0.00031713184,0.0007780386,0.00030501635,0.0008127263,0.0003575043,0.00039584545,0.015045794],"category_scores_gemma":[0.0007479004,0.000087779204,0.00047583296,0.0005672941,0.0002920857,0.00041024544,0.00035252835,0.0006366185,0.0036654093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044708588,0.000047532438,0.0004830089,0.004464881,0.00010040187,0.00010694188,0.00003432087,0.000187383,0.0049207597,0.0034571735,0.11773412,0.8680164],"study_design_scores_gemma":[0.00019228335,0.00033331613,0.003611285,0.0019938028,0.00014940834,0.00048537645,0.000039763327,0.00010983624,0.0027057338,0.0004658228,0.9898996,0.000013842314],"about_ca_topic_score_codex":0.022446636,"about_ca_topic_score_gemma":0.095324546,"teacher_disagreement_score":0.022446636,"about_ca_system_score_codex":0.0015628061,"about_ca_system_score_gemma":0.0021429525,"threshold_uncertainty_score":0.050333202},"labels":[],"label_agreement":null},{"id":"W4296755162","doi":"10.51731/cjht.2022.452","title":"Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vagus nerve stimulation; Neurostimulation; Vagus nerve; Telemedicine; Medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Neuroscience; Health care; Stimulation; Psychology; Disease; Internal medicine","score_opus":0.14003503661401626,"score_gpt":0.40596641072547324,"score_spread":0.26593137411145695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296755162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02352131,0.7053322,0.0034624452,0.030877477,0.0055071395,0.0005731644,0.0034075738,0.00031823278,0.22700033],"genre_scores_gemma":[0.20693731,0.723928,0.009087774,0.014457537,0.004652816,0.0003397884,0.0034609993,0.00013162705,0.03700422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995383,0.00010200126,0.00005332273,0.00003209177,0.00019731624,0.000076962875],"domain_scores_gemma":[0.9988707,0.00061131804,0.00014396044,0.000032865635,0.0002351934,0.0001059761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008522633,0.00026053024,0.00047213896,0.0010739439,0.000502684,0.00087308936,0.00038633787,0.000989772,0.0252653],"category_scores_gemma":[0.0029504183,0.000078966994,0.0006870866,0.0006867802,0.00040547503,0.0004937838,0.0005229241,0.0013358544,0.0021709949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009605856,0.00018237779,0.0035094495,0.0053672595,0.000192633,0.0013387011,0.00020770694,0.00022824483,0.0030812935,0.0035166952,0.11825702,0.863158],"study_design_scores_gemma":[0.0008671386,0.0020900222,0.05700099,0.023992967,0.00052553124,0.011474674,0.000888328,0.00075813784,0.005342258,0.0068870075,0.8900373,0.00013561624],"about_ca_topic_score_codex":0.022164775,"about_ca_topic_score_gemma":0.07318534,"teacher_disagreement_score":0.0252653,"about_ca_system_score_codex":0.0018959199,"about_ca_system_score_gemma":0.003346186,"threshold_uncertainty_score":0.08452088},"labels":[],"label_agreement":null},{"id":"W4297168865","doi":"10.51731/cjht.2022.454","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Reimbursement; Medicine; Cystic fibrosis; Internal medicine; Health care; Cystic fibrosis transmembrane conductance regulator","score_opus":0.023544233250175982,"score_gpt":0.3075235823898118,"score_spread":0.28397934913963585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297168865","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008201327,0.952486,0.0006754036,0.002275873,0.0003146912,0.00020350589,0.0014732643,0.000052184645,0.034317877],"genre_scores_gemma":[0.12674291,0.83492863,0.0048550977,0.0024251472,0.00026497507,0.0002012071,0.0020670928,0.000021368776,0.028493544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981342,0.00044042678,0.00018597906,0.00009301023,0.0010018385,0.00014452782],"domain_scores_gemma":[0.99835485,0.0004370478,0.00042867853,0.00003847378,0.000652028,0.000088892855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018664296,0.00031541134,0.0005736989,0.0020200904,0.0003598685,0.0012756007,0.00040639637,0.0005051979,0.0066196905],"category_scores_gemma":[0.0032669476,0.00011082444,0.0010339194,0.0017431986,0.00037337572,0.00043625597,0.00027292868,0.0005257457,0.00074025337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072542654,0.000085734566,0.003631009,0.0120044565,0.00088422466,0.00022144016,0.00007052636,0.00038757033,0.0032923657,0.004573677,0.033622675,0.9405009],"study_design_scores_gemma":[0.00044881908,0.0010366592,0.026687317,0.013019204,0.0017070933,0.0012965887,0.00024073505,0.00027087977,0.0033075497,0.0007902686,0.9511543,0.000040741797],"about_ca_topic_score_codex":0.07424487,"about_ca_topic_score_gemma":0.3250142,"teacher_disagreement_score":0.07424487,"about_ca_system_score_codex":0.0044405647,"about_ca_system_score_gemma":0.0075997533,"threshold_uncertainty_score":0.14762539},"labels":[],"label_agreement":null},{"id":"W4298003152","doi":"10.51731/cjht.2022.456","title":"Delayed Tuberculin Skin Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tuberculin; Guideline; Tuberculosis; Skin test; Disease; Intensive care medicine; Internal medicine; Pathology","score_opus":0.06370473140508465,"score_gpt":0.3398150714843604,"score_spread":0.27611034007927576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298003152","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031551387,0.1661923,0.04238573,0.10140494,0.01628568,0.0041334233,0.0102802925,0.0025360787,0.6252302],"genre_scores_gemma":[0.41946924,0.1364849,0.057507236,0.17054099,0.0051468527,0.002714105,0.0086975945,0.00043135948,0.19900778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973672,0.0007581388,0.00033543434,0.00033211056,0.00089959666,0.0003076616],"domain_scores_gemma":[0.9949327,0.001410655,0.0007247354,0.00034665555,0.0020562515,0.0005290963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022170816,0.0005008648,0.0006844035,0.0007371848,0.00064006436,0.0013869103,0.0015377158,0.0025629923,0.02408714],"category_scores_gemma":[0.009819085,0.00028578073,0.0013042402,0.0004953648,0.00070483034,0.0010481627,0.0009202084,0.0024149928,0.0065947585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006729467,0.00030589377,0.007038641,0.0048076804,0.00013451157,0.0014423715,0.0002649626,0.00034084762,0.0028042924,0.0055292775,0.3894444,0.5872142],"study_design_scores_gemma":[0.00049322133,0.0009101739,0.014115312,0.008604034,0.00024359618,0.0058251987,0.00030324535,0.00038299675,0.0034197387,0.0032046998,0.9624128,0.000085187894],"about_ca_topic_score_codex":0.021928947,"about_ca_topic_score_gemma":0.035053894,"teacher_disagreement_score":0.02408714,"about_ca_system_score_codex":0.0018295654,"about_ca_system_score_gemma":0.0031927924,"threshold_uncertainty_score":0.08057946},"labels":[],"label_agreement":null},{"id":"W4298144359","doi":"10.51731/cjht.2022.458","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Reimbursement; Medicine; Sorafenib; Drug; Thyroid cancer; Thyroid carcinoma; Oncology; Intensive care medicine; Internal medicine; Family medicine; Thyroid; Pharmacology; Political science; Health care","score_opus":0.058540830483123155,"score_gpt":0.34950562165247157,"score_spread":0.2909647911693484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298144359","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046965778,0.7443618,0.002610883,0.010880396,0.0017138631,0.00034348728,0.005453569,0.0007104229,0.18695973],"genre_scores_gemma":[0.36394122,0.48813763,0.0045026797,0.011641006,0.00072789495,0.00026357404,0.0093634315,0.00007563949,0.12134687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998287,0.000034838,0.000019814652,0.000029490144,0.000063749154,0.000023348768],"domain_scores_gemma":[0.9998696,0.000027876964,0.000036013116,0.00000519324,0.000041692045,0.000019577677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036002893,0.00025736124,0.0002659814,0.00060825126,0.00015804362,0.0005975868,0.0003055988,0.0003294412,0.01007043],"category_scores_gemma":[0.00042585333,0.00006050242,0.00040491068,0.00040386274,0.00019361335,0.000434639,0.0002653512,0.00047619463,0.0028001028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056105194,0.00006611705,0.0008225705,0.0028135104,0.00018776995,0.00016231905,0.000032651595,0.00034040507,0.0063739577,0.0027780298,0.07354529,0.9123163],"study_design_scores_gemma":[0.00038617774,0.0009525169,0.0047746864,0.0013545732,0.0002680826,0.0014852323,0.00005273616,0.00031350073,0.00915871,0.00087097235,0.98035824,0.00002463035],"about_ca_topic_score_codex":0.0039057937,"about_ca_topic_score_gemma":0.018206134,"teacher_disagreement_score":0.01007043,"about_ca_system_score_codex":0.0010031521,"about_ca_system_score_gemma":0.0009941633,"threshold_uncertainty_score":0.033688962},"labels":[],"label_agreement":null},{"id":"W4298144373","doi":"10.51731/cjht.2022.457","title":"Cannabis for Opioid Use Disorder","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Opioid use disorder; Psychiatry; Craving; Medicine; Opioid; Opioid-Related Disorders; Guideline; Addiction; Opioid epidemic","score_opus":0.034688417354724825,"score_gpt":0.3194146966780997,"score_spread":0.28472627932337485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298144373","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011910984,0.529974,0.0009752314,0.1031898,0.012862907,0.001303584,0.016362673,0.00025181464,0.32316902],"genre_scores_gemma":[0.17349553,0.5194538,0.0059914673,0.12454208,0.008783275,0.0016734359,0.015817648,0.00011102062,0.15013175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988444,0.0003108257,0.0001928417,0.00009311405,0.0004225758,0.00013613317],"domain_scores_gemma":[0.99725914,0.0007347231,0.00047575065,0.00013757279,0.00091464195,0.0004780465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011769673,0.00017798631,0.0003233098,0.0009896581,0.0009264678,0.0008331783,0.00056282495,0.0011527389,0.055934764],"category_scores_gemma":[0.0065450417,0.000105730294,0.0008648748,0.0007152018,0.00046277602,0.00041566096,0.00086148694,0.0012663347,0.005451539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003956536,0.0000902652,0.0050604795,0.007238696,0.0001670837,0.00028828476,0.00011989051,0.000023798673,0.00035031413,0.0039326823,0.39446595,0.5878669],"study_design_scores_gemma":[0.0003913518,0.00020146157,0.035752695,0.013973229,0.0003172653,0.0011661559,0.0001554721,0.000038285252,0.00020726264,0.001966009,0.9458052,0.000025561283],"about_ca_topic_score_codex":0.04408856,"about_ca_topic_score_gemma":0.14045435,"teacher_disagreement_score":0.055934764,"about_ca_system_score_codex":0.001643505,"about_ca_system_score_gemma":0.005964565,"threshold_uncertainty_score":0.18712038},"labels":[],"label_agreement":null},{"id":"W4301396928","doi":"10.51731/cjht.2022.462","title":"Internet-Delivered Cognitive Behavioural Therapy for the Management of Chronic Non-Cancer Pain","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multidisciplinary approach; Chronic pain; Cognition; Psychotherapist; Medicine; Cancer pain; Health care; The Internet; Psychology; Alternative medicine; Psychiatry","score_opus":0.0831387336667072,"score_gpt":0.38138037753319115,"score_spread":0.29824164386648394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301396928","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034717247,0.8920942,0.0055697076,0.011303473,0.0013032209,0.01595754,0.0054587875,0.00031238832,0.033283435],"genre_scores_gemma":[0.2263094,0.698218,0.034512028,0.010606895,0.0010071145,0.023056282,0.0028577491,0.00004522985,0.003387359],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9865913,0.008217905,0.0017484477,0.00052644924,0.0026604664,0.00025547773],"domain_scores_gemma":[0.9705189,0.023384416,0.0037244982,0.00041049402,0.0016561229,0.00030555524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012966487,0.0005355015,0.00155743,0.007703845,0.0005309815,0.0017338671,0.00079274003,0.0014418653,0.004635549],"category_scores_gemma":[0.03620614,0.00035563437,0.003503595,0.004320202,0.00039560348,0.0018112771,0.001615209,0.0017321819,0.0005570868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009437295,0.0004677798,0.0021953136,0.12736334,0.0029729386,0.000095516894,0.00061073503,0.00051101454,0.0003358919,0.001446433,0.006909666,0.85614765],"study_design_scores_gemma":[0.011638616,0.009444948,0.06069978,0.70526445,0.030675866,0.0012640707,0.0015172315,0.0034163338,0.0018572063,0.0058484194,0.1681092,0.00026383766],"about_ca_topic_score_codex":0.003446936,"about_ca_topic_score_gemma":0.0074622678,"teacher_disagreement_score":0.012966487,"about_ca_system_score_codex":0.0035290197,"about_ca_system_score_gemma":0.0048786993,"threshold_uncertainty_score":0.06857413},"labels":[],"label_agreement":null},{"id":"W4301397008","doi":"10.51731/cjht.2022.461","title":"Lisocabtagene Maraleucel (Breyanzi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lymphoma; Follicular lymphoma; Medicine; Drug; Chimeric antigen receptor; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy; Pharmacology; Political science","score_opus":0.05164566627031014,"score_gpt":0.3287784616090058,"score_spread":0.27713279533869567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301397008","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022146089,0.5468979,0.003987518,0.011406234,0.0023999882,0.00061769877,0.004692677,0.0019989233,0.40585294],"genre_scores_gemma":[0.18136524,0.2102684,0.006808868,0.0092667,0.00093938544,0.00043206103,0.0063844156,0.00028066407,0.58425426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997311,0.00004880731,0.0000133287795,0.000050093706,0.000117444986,0.000039231207],"domain_scores_gemma":[0.9997272,0.00005174115,0.00005084589,0.000012459965,0.000088574365,0.000069192356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005045843,0.0004557197,0.00048087924,0.0011219756,0.00043123093,0.000976918,0.00057472923,0.0010149876,0.06617518],"category_scores_gemma":[0.0006866801,0.00013317978,0.00043478986,0.0006340704,0.00050245,0.00045039458,0.0005165455,0.0012481272,0.018895486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014944801,0.00021507965,0.0006552803,0.002963968,0.00006588926,0.0005785087,0.00009560882,0.00021705781,0.01677796,0.0053071682,0.13066663,0.84096235],"study_design_scores_gemma":[0.00034842268,0.00068806316,0.001602395,0.0004921191,0.000048400663,0.001015506,0.000036311114,0.00010946169,0.0049175886,0.00027288945,0.9904558,0.000012990352],"about_ca_topic_score_codex":0.016639858,"about_ca_topic_score_gemma":0.047255155,"teacher_disagreement_score":0.06617518,"about_ca_system_score_codex":0.0018038814,"about_ca_system_score_gemma":0.0022579944,"threshold_uncertainty_score":0.22137803},"labels":[],"label_agreement":null},{"id":"W4304811002","doi":"10.51731/cjht.2022.464","title":"Lenvatinib and Pembrolizumab (Lenvima and Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Organisation for Research and Treatment of Cancer; Eisai Canada; Eisai; Memorial Sloan-Kettering Cancer Center","keywords":"Pembrolizumab; Lenvatinib; Reimbursement; Medicine; Internal medicine; Systemic therapy; Oncology; Intensive care medicine; Immunotherapy; Cancer; Political science","score_opus":0.024963822927379118,"score_gpt":0.2793609517246027,"score_spread":0.25439712879722354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304811002","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013072128,0.7924158,0.0011251403,0.01246054,0.0015642842,0.000479949,0.005038844,0.00017125909,0.17367204],"genre_scores_gemma":[0.16676491,0.661223,0.008377526,0.013751227,0.0009673273,0.0005732608,0.008651379,0.000062433515,0.13962895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991844,0.00020940755,0.000100345846,0.00007779043,0.00033977072,0.00008818434],"domain_scores_gemma":[0.9990637,0.00020676138,0.00027842692,0.000027802053,0.00032717347,0.00009615104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012236399,0.00034038522,0.0003969489,0.0013615264,0.00030411565,0.0013166418,0.00043092683,0.0006662999,0.016090633],"category_scores_gemma":[0.0020920378,0.0001437396,0.000778862,0.0011670936,0.00035643234,0.0006930204,0.00046573684,0.0006618797,0.0024880583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001137591,0.00010472012,0.002840317,0.0065358793,0.00041934734,0.00018160156,0.00005412299,0.00019438016,0.0032970589,0.0057405867,0.10448645,0.8750079],"study_design_scores_gemma":[0.00044746074,0.0010551964,0.017432582,0.0035236755,0.0004799853,0.0007540315,0.00011023091,0.00014422674,0.002918267,0.0009231269,0.97218543,0.00002577821],"about_ca_topic_score_codex":0.03577743,"about_ca_topic_score_gemma":0.13723664,"teacher_disagreement_score":0.03577743,"about_ca_system_score_codex":0.0027546787,"about_ca_system_score_gemma":0.0045700795,"threshold_uncertainty_score":0.07113832},"labels":[],"label_agreement":null},{"id":"W4304889388","doi":"10.51731/cjht.2022.466","title":"Cariprazine (Vraylar)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care; Law","score_opus":0.08329596807437746,"score_gpt":0.3756888814833445,"score_spread":0.29239291340896706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304889388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011089192,0.8437018,0.0015456604,0.00677207,0.001020184,0.00020379829,0.0025826443,0.00041315134,0.13267155],"genre_scores_gemma":[0.16513702,0.6932353,0.0065489844,0.013264003,0.00081135833,0.00017132488,0.0039681843,0.000057076468,0.11680676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996958,0.00006998087,0.00003251134,0.00006466817,0.00009918345,0.00003794786],"domain_scores_gemma":[0.99977046,0.000053035958,0.00007528913,0.0000082137085,0.00006590909,0.0000271218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050415593,0.00035812292,0.0002535987,0.00076902873,0.00024234902,0.0005681306,0.0004717413,0.00055220124,0.01953447],"category_scores_gemma":[0.0007614434,0.00008873096,0.00043597686,0.00045344303,0.0002698432,0.00031885202,0.00034771638,0.0005448605,0.0047268816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061569514,0.00007627894,0.0004869017,0.007370969,0.00013843559,0.0002404057,0.00005615801,0.00016330424,0.0066573406,0.004597761,0.097868085,0.8817287],"study_design_scores_gemma":[0.00029196698,0.00075936515,0.004643748,0.0022667171,0.00020452116,0.001383914,0.00005088958,0.00010127747,0.004915452,0.00040854793,0.98495525,0.000018381448],"about_ca_topic_score_codex":0.020186666,"about_ca_topic_score_gemma":0.05859915,"teacher_disagreement_score":0.020186666,"about_ca_system_score_codex":0.0011276895,"about_ca_system_score_gemma":0.0015127589,"threshold_uncertainty_score":0.06534928},"labels":[],"label_agreement":null},{"id":"W4306165741","doi":"10.51731/cjht.2022.467","title":"Selinexor (Xpovio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dexamethasone; Multiple myeloma; Drug; Drug class; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Internal medicine","score_opus":0.039031156922889484,"score_gpt":0.33490013292492893,"score_spread":0.29586897600203943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306165741","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029341307,0.79492134,0.0033839564,0.009015828,0.0016391601,0.00043031105,0.0034918522,0.000518689,0.15725762],"genre_scores_gemma":[0.24242225,0.5775577,0.006955508,0.014115853,0.0008620446,0.0004031254,0.006764849,0.000077162156,0.1508416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999803,0.000047601923,0.000021683209,0.000031786138,0.00007485186,0.000021053678],"domain_scores_gemma":[0.99984145,0.000039256644,0.000049098937,0.0000058416103,0.000038760125,0.000025539426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046953993,0.00029857722,0.0002741061,0.000597638,0.0001578546,0.00059819454,0.00036379832,0.0004220552,0.01657585],"category_scores_gemma":[0.0004991143,0.000067443325,0.00046400575,0.0003259062,0.0002476573,0.0004877925,0.00034991046,0.0007241488,0.0030391973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072479306,0.00010204638,0.00061508105,0.0040832027,0.00013708447,0.00022184114,0.000042509088,0.00029823903,0.0072962064,0.0039413814,0.05637424,0.9261635],"study_design_scores_gemma":[0.0007768025,0.0016838872,0.0038811578,0.0023838102,0.00018841446,0.0014343327,0.00006179253,0.00023901829,0.009075417,0.0010470491,0.97920483,0.000023416791],"about_ca_topic_score_codex":0.0027017929,"about_ca_topic_score_gemma":0.011489174,"teacher_disagreement_score":0.01657585,"about_ca_system_score_codex":0.0006103794,"about_ca_system_score_gemma":0.0008409831,"threshold_uncertainty_score":0.05545169},"labels":[],"label_agreement":null},{"id":"W4306861656","doi":"10.51731/cjht.2022.476","title":"The Vital Role of Medical Librarians in a Time of Information Overload","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Information overload; Nature versus nurture; Health information; Field (mathematics); Medical information; Value (mathematics); Medical library; Knowledge management; Public relations; Library science; Political science; Computer science; Health care; World Wide Web; Sociology","score_opus":0.03755430122874671,"score_gpt":0.3850373701056179,"score_spread":0.3474830688768712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306861656","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022371719,0.012496372,0.0005686966,0.9524699,0.0062363455,0.00002073155,0.000038141265,0.00017703968,0.025755635],"genre_scores_gemma":[0.123836115,0.024213886,0.007112574,0.76096624,0.021877375,0.00012272724,0.00013406415,0.0005495272,0.06118745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9327687,0.028594278,0.003147636,0.003198909,0.02288892,0.00940166],"domain_scores_gemma":[0.8457958,0.041760556,0.008845909,0.006485318,0.02870588,0.06840656],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0453722,0.0006948969,0.001622478,0.0068078027,0.053431883,0.06347056,0.003485214,0.018718315,0.018104305],"category_scores_gemma":[0.07863153,0.0017074252,0.00090951036,0.007916933,0.04837234,0.040197883,0.03173962,0.019355705,0.009118634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008192069,0.00007037224,0.00240336,0.000444572,0.000033466476,0.0007159493,0.054847572,0.000042756175,0.00046175087,0.038435612,0.8324697,0.069993004],"study_design_scores_gemma":[0.000024257075,0.000032977132,0.0015728489,0.00047410055,0.000013307355,0.00046080328,0.04250282,0.000055252327,0.00013158024,0.015910434,0.93872195,0.00009958336],"about_ca_topic_score_codex":0.080618314,"about_ca_topic_score_gemma":0.14669454,"teacher_disagreement_score":0.93652946,"about_ca_system_score_codex":0.027267534,"about_ca_system_score_gemma":0.08262047,"threshold_uncertainty_score":0.239954},"labels":[],"label_agreement":null},{"id":"W4307130134","doi":"10.51731/cjht.2022.478","title":"Ruxolitinib (Jakavi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Ruxolitinib; Medicine; Family medicine; Drug; Pharmacology; Internal medicine; Political science; Health care; Myelofibrosis","score_opus":0.04092840541870764,"score_gpt":0.3241599007891345,"score_spread":0.28323149537042686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307130134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008288004,0.81151307,0.0014832729,0.009836032,0.0016373708,0.00018182254,0.0027111524,0.00034270313,0.16400656],"genre_scores_gemma":[0.13038611,0.7172322,0.0048925816,0.012168864,0.0012801387,0.00018855504,0.0048917863,0.000057410474,0.12890238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996245,0.00007239213,0.00004064155,0.00004909521,0.00016015976,0.0000531622],"domain_scores_gemma":[0.99966097,0.00006245429,0.00010059218,0.000012111092,0.00012653659,0.000037287537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056379463,0.00028807425,0.00030230085,0.0008161367,0.0002496192,0.0009670454,0.0003907696,0.000442536,0.015610318],"category_scores_gemma":[0.0008680654,0.00008337017,0.00039946835,0.0006121137,0.00025889472,0.0004981637,0.00039038554,0.00057278207,0.004121081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027381477,0.000040253173,0.00062909804,0.002948553,0.00007872647,0.00010521083,0.000027738437,0.00011340474,0.0025091039,0.0029995465,0.1013109,0.8889636],"study_design_scores_gemma":[0.00011182352,0.0002615725,0.003395297,0.0018682749,0.00012036254,0.00055539515,0.000031040163,0.00009744301,0.0026883283,0.00039060853,0.9904665,0.000013379369],"about_ca_topic_score_codex":0.013558196,"about_ca_topic_score_gemma":0.044934295,"teacher_disagreement_score":0.015610318,"about_ca_system_score_codex":0.0013148999,"about_ca_system_score_gemma":0.0019340133,"threshold_uncertainty_score":0.052221656},"labels":[],"label_agreement":null},{"id":"W4307544781","doi":"10.51731/cjht.2022.480","title":"Upadacitinib (Rinvoq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Atopic dermatitis; Drug; Intensive care medicine; Pharmacology; Health care; Dermatology; Political science","score_opus":0.027848523310344625,"score_gpt":0.2896456162540784,"score_spread":0.26179709294373377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307544781","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013774844,0.6025092,0.0021221654,0.011585066,0.0026207308,0.000508202,0.008144919,0.0009188301,0.35781598],"genre_scores_gemma":[0.20172034,0.56954443,0.0051824525,0.015263988,0.0010377051,0.00040944826,0.015265961,0.0001221476,0.19145344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996903,0.00005625842,0.000026460062,0.000041896357,0.00013886565,0.000046247533],"domain_scores_gemma":[0.9996929,0.000046522582,0.00006570303,0.000013944601,0.00013757395,0.00004348266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005022541,0.00028573468,0.00030578853,0.0008816112,0.0002771108,0.00091739214,0.0005661632,0.0005867833,0.03132566],"category_scores_gemma":[0.0008704756,0.000087842935,0.00057749863,0.0006384955,0.00028530814,0.0005793762,0.00045970865,0.0006747928,0.0060551683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043221258,0.000048639613,0.00043670658,0.0040204334,0.00009448082,0.00014932331,0.000026294314,0.0001533796,0.0024835828,0.003086967,0.1823805,0.80668753],"study_design_scores_gemma":[0.00021728854,0.00026206678,0.002665936,0.0016483922,0.00011816861,0.0006385034,0.000029744337,0.00012082712,0.0021369397,0.00036004366,0.9917874,0.000014593718],"about_ca_topic_score_codex":0.01588549,"about_ca_topic_score_gemma":0.04603519,"teacher_disagreement_score":0.03132566,"about_ca_system_score_codex":0.0015175793,"about_ca_system_score_gemma":0.0020387939,"threshold_uncertainty_score":0.1047948},"labels":[],"label_agreement":null},{"id":"W4307750735","doi":"10.51731/cjht.2022.479","title":"Sodium Phenylbutyrate-Ursodoxicoltaurine (Albrioza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Phenylbutyrate; Medicine; Amyotrophic lateral sclerosis; Family medicine; Intensive care medicine; Physical therapy; Internal medicine; Political science","score_opus":0.04368086776676324,"score_gpt":0.30455680359388193,"score_spread":0.2608759358271187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307750735","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021693654,0.7499205,0.003747105,0.0128805395,0.0025192068,0.00046686092,0.0028971983,0.0004094147,0.20546563],"genre_scores_gemma":[0.18048754,0.6321392,0.011230651,0.011864816,0.0007924945,0.0003103247,0.0033718408,0.00010493681,0.15969817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956304,0.00008583865,0.000054198194,0.000046458284,0.0002044494,0.000045975918],"domain_scores_gemma":[0.9995285,0.00008192388,0.0001077545,0.000018282268,0.00022301759,0.000040547064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584576,0.0002818749,0.00030045706,0.0008261919,0.00032771894,0.0007160314,0.0005429141,0.0007160062,0.011222401],"category_scores_gemma":[0.0009093232,0.000115831615,0.0004537098,0.00057145813,0.0004544374,0.0003474655,0.00029515036,0.0005044244,0.0034457848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008621595,0.00010431718,0.0015214277,0.005779357,0.0001219924,0.00048580978,0.00006694048,0.00015469157,0.032686055,0.0043585417,0.07469314,0.87916553],"study_design_scores_gemma":[0.00025546952,0.0014896048,0.008330997,0.0020763474,0.00021329445,0.001276539,0.00012477406,0.00014112363,0.027865063,0.00036960733,0.9578264,0.000030674164],"about_ca_topic_score_codex":0.055170238,"about_ca_topic_score_gemma":0.20374112,"teacher_disagreement_score":0.055170238,"about_ca_system_score_codex":0.0018970971,"about_ca_system_score_gemma":0.0035764414,"threshold_uncertainty_score":0.109698236},"labels":[],"label_agreement":null},{"id":"W4308203378","doi":"10.51731/cjht.2022.492","title":"Robotic Surgical Systems for Orthopedics","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Orthopedic surgery; Medicine; Joint replacement; Arthroplasty; Learning curve; Knee replacement; Medical physics; Physical therapy; Surgery; Computer science","score_opus":0.037791713216540714,"score_gpt":0.3081298103642984,"score_spread":0.27033809714775764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308203378","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003317545,0.09866055,0.27612343,0.029533181,0.024122994,0.00092292245,0.004029864,0.034331486,0.528958],"genre_scores_gemma":[0.0669145,0.11457067,0.23644646,0.01697599,0.018426126,0.0015463141,0.009871702,0.004125447,0.53112274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975921,0.00037573616,0.00022330543,0.00024864599,0.0014335742,0.00012659834],"domain_scores_gemma":[0.99636555,0.0007953314,0.00032089505,0.000595822,0.0013707931,0.000551555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016333463,0.0015038549,0.00078669976,0.0019665866,0.0007529631,0.0030246337,0.0014952096,0.0024239165,0.14116034],"category_scores_gemma":[0.0059009376,0.0004531531,0.0010016069,0.0011837893,0.001174066,0.0027667906,0.0033718403,0.0027106677,0.0954358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101885504,0.000060845574,0.0005024176,0.0011821873,0.00004493027,0.00030052057,0.00013457611,0.0013583399,0.0045200256,0.022780413,0.34065482,0.62835914],"study_design_scores_gemma":[0.000026122134,0.00006798621,0.00037260744,0.000278664,0.000014961304,0.00091492786,0.00003196841,0.0010205273,0.00076030334,0.008501767,0.9879776,0.00003251504],"about_ca_topic_score_codex":0.0009948034,"about_ca_topic_score_gemma":0.0012131857,"teacher_disagreement_score":0.14116034,"about_ca_system_score_codex":0.00095819647,"about_ca_system_score_gemma":0.0022551417,"threshold_uncertainty_score":0.4722284},"labels":[],"label_agreement":null},{"id":"W4308495322","doi":"10.51731/cjht.2022.489","title":"Rapid Syphilis Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Syphilis Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Syphilis; Point-of-care testing; Medicine; Point of care; Psychological intervention; Health care; Test (biology); Human immunodeficiency virus (HIV); Family medicine; Nursing; Immunology","score_opus":0.08241587287447642,"score_gpt":0.2993597272150131,"score_spread":0.21694385434053665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308495322","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01138585,0.18138273,0.014041136,0.026552763,0.007877967,0.0017366804,0.08071678,0.0079303365,0.66837585],"genre_scores_gemma":[0.17208913,0.3007903,0.043386072,0.039007574,0.0049630534,0.0015036571,0.10643057,0.0015580427,0.3302716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969169,0.0004203461,0.00020002107,0.00028956743,0.0018324855,0.00034067215],"domain_scores_gemma":[0.99408793,0.0014560028,0.0006117226,0.00028792492,0.003058438,0.0004979164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022984454,0.00094723,0.000979942,0.0044039935,0.00067516626,0.0019194164,0.0017318453,0.0014283648,0.10867381],"category_scores_gemma":[0.009737585,0.00038889455,0.00086220144,0.0022067418,0.0003581069,0.001241953,0.0010184345,0.0014040552,0.036636632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033266898,0.00013380763,0.0067499904,0.0018913185,0.000059447713,0.00052591896,0.00011375303,0.00016080776,0.0011691692,0.0024260092,0.47644636,0.5099908],"study_design_scores_gemma":[0.00008032599,0.00021821233,0.012020809,0.0031897554,0.00010125842,0.003293309,0.00013910678,0.00022885646,0.0021321885,0.0011667351,0.97738236,0.000047121255],"about_ca_topic_score_codex":0.02945667,"about_ca_topic_score_gemma":0.036694832,"teacher_disagreement_score":0.10867381,"about_ca_system_score_codex":0.0020071466,"about_ca_system_score_gemma":0.0029232302,"threshold_uncertainty_score":0.36355013},"labels":[],"label_agreement":null},{"id":"W4308495428","doi":"10.51731/cjht.2022.491","title":"Mogamulizumab (Poteligeo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Drug; Vial; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.04859463929211724,"score_gpt":0.333019264260428,"score_spread":0.2844246249683108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308495428","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016834568,0.7963225,0.0027774642,0.011373205,0.0021936335,0.0003604109,0.002318308,0.0004979356,0.16732194],"genre_scores_gemma":[0.19679262,0.6053106,0.01059316,0.016473826,0.0011941497,0.0004322287,0.0044474443,0.000109563676,0.16464639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966824,0.000053835087,0.000028036342,0.000044560726,0.00015115208,0.000054226854],"domain_scores_gemma":[0.99972695,0.00004751295,0.000074615884,0.000011496983,0.00009475021,0.000044696048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000628453,0.00036344296,0.00033846908,0.00093766704,0.00029473365,0.0008417584,0.00042432197,0.00067689124,0.012272466],"category_scores_gemma":[0.00074088183,0.000104605206,0.0004472726,0.0005477964,0.0004010377,0.00048461548,0.00043266983,0.00069457316,0.003452593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059950247,0.000069591304,0.0006991996,0.0030308135,0.00010234499,0.00029292188,0.000036953104,0.00011687384,0.009329427,0.0040236427,0.09295922,0.8887395],"study_design_scores_gemma":[0.00032816033,0.0006968361,0.0062590707,0.0017790787,0.00018582978,0.0012947635,0.000040773295,0.00012776122,0.006984162,0.0006062786,0.9816761,0.000021181108],"about_ca_topic_score_codex":0.020854853,"about_ca_topic_score_gemma":0.06495436,"teacher_disagreement_score":0.020854853,"about_ca_system_score_codex":0.0019280023,"about_ca_system_score_gemma":0.0030580114,"threshold_uncertainty_score":0.04146695},"labels":[],"label_agreement":null},{"id":"W4309408407","doi":"10.51731/cjht.2022.496","title":"Nusinersen (Spinraza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; SMA*; Medicine; Intrathecal; Spinal muscular atrophy; Food and drug administration; Family medicine; Intensive care medicine; Surgery; Political science; Medical emergency; Pathology; Computer science; Disease; Health care","score_opus":0.036934496013959386,"score_gpt":0.3159404689860767,"score_spread":0.2790059729721173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309408407","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008470033,0.4347058,0.0020936104,0.008846159,0.005650323,0.0003804479,0.004874607,0.0019263511,0.5330526],"genre_scores_gemma":[0.07891998,0.23853514,0.0053898115,0.010866454,0.0011291443,0.00021875542,0.006626175,0.00034037736,0.6579741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955744,0.0000543567,0.000038154983,0.00010246418,0.00019348135,0.00005413084],"domain_scores_gemma":[0.999613,0.00007159174,0.00005669566,0.000025678692,0.000116557145,0.00011649736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052844035,0.0007058935,0.00062612916,0.0010971224,0.0005161156,0.0013212922,0.0008025619,0.0017687576,0.13364547],"category_scores_gemma":[0.0010698803,0.00021414364,0.00046641726,0.0005448958,0.00050414103,0.00076632196,0.00090343214,0.0014382907,0.04872315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007825198,0.00012025218,0.00044551713,0.0057868543,0.00008000627,0.00059547345,0.00012162501,0.00021075248,0.007718591,0.008028388,0.21250118,0.7636089],"study_design_scores_gemma":[0.00017278834,0.00024944576,0.0008048798,0.00096703327,0.00004592967,0.0006570071,0.00004880635,0.000056802994,0.0023445287,0.00058175693,0.9940586,0.000012338718],"about_ca_topic_score_codex":0.012002509,"about_ca_topic_score_gemma":0.034865953,"teacher_disagreement_score":0.13364547,"about_ca_system_score_codex":0.0010572029,"about_ca_system_score_gemma":0.0028676575,"threshold_uncertainty_score":0.44708866},"labels":[],"label_agreement":null},{"id":"W4309585197","doi":"10.51731/cjht.2022.499","title":"Faricimab (Vabysmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Macular degeneration; Family medicine; Drug; Optometry; Ophthalmology; Political science; Pharmacology; Law","score_opus":0.02466755399370983,"score_gpt":0.29017029338089645,"score_spread":0.2655027393871866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309585197","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013220188,0.8969168,0.0010908112,0.0049114744,0.0013251246,0.00013439053,0.0012785128,0.0001911733,0.080931544],"genre_scores_gemma":[0.23524334,0.63425785,0.0042088046,0.011165018,0.00083339843,0.00014669492,0.0041421284,0.00003294602,0.10996986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998087,0.000032734366,0.000017689592,0.000035073826,0.00007122966,0.000034537305],"domain_scores_gemma":[0.99985564,0.000026490474,0.00004613522,0.000006224805,0.000042307078,0.000023128947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000331587,0.0003177441,0.00025440418,0.0005174295,0.00023838732,0.0005315036,0.00035206586,0.0006165143,0.013078224],"category_scores_gemma":[0.00046673504,0.00007625357,0.00037923342,0.00029651888,0.00019232834,0.00033538786,0.0002693854,0.0005231874,0.0033514493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059240573,0.00007908368,0.00058425404,0.0027889898,0.00009490848,0.0002633429,0.00002907454,0.00016947994,0.012124564,0.0021939122,0.061747923,0.91933215],"study_design_scores_gemma":[0.0003437887,0.0010937478,0.0077666133,0.0020739927,0.00014045586,0.0021707022,0.000054736174,0.00014347587,0.009779102,0.00052044133,0.9758897,0.000023269064],"about_ca_topic_score_codex":0.014013994,"about_ca_topic_score_gemma":0.037540067,"teacher_disagreement_score":0.014013994,"about_ca_system_score_codex":0.0011523576,"about_ca_system_score_gemma":0.0010167296,"threshold_uncertainty_score":0.043751},"labels":[],"label_agreement":null},{"id":"W4309585704","doi":"10.51731/cjht.2022.498","title":"Prostate-Specific Membrane Antigen PET-CT Imaging for the Staging of Prostate Cancer in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Staffing; Context (archaeology); Glutamate carboxypeptidase II; PET-CT; Medical physics; Nuclear medicine; Cancer; Positron emission tomography; Nursing; Internal medicine","score_opus":0.03150406660229012,"score_gpt":0.31069015037118786,"score_spread":0.27918608376889775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309585704","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082740024,0.16819084,0.012147901,0.25717413,0.006998717,0.0019183379,0.048507046,0.001819441,0.42050356],"genre_scores_gemma":[0.64634484,0.13337412,0.029611113,0.04489656,0.0016672716,0.00062166696,0.03208488,0.00072145,0.11067806],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99804854,0.00016045138,0.00009766566,0.00014288259,0.0010863249,0.00046403534],"domain_scores_gemma":[0.99219066,0.00022728236,0.00027617518,0.0001039188,0.0054047867,0.0017972563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020582646,0.00041670972,0.0004255798,0.0019811937,0.0028456103,0.001953852,0.0018859287,0.00090663135,0.015710285],"category_scores_gemma":[0.0038158859,0.0005086949,0.00086557673,0.003530006,0.00093697355,0.00079935614,0.0016536415,0.0023407727,0.0018369247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031930307,0.00022191678,0.08556371,0.0016863865,0.00015149135,0.0016004452,0.00069044414,0.0020384234,0.0028411876,0.01269308,0.5859113,0.30628234],"study_design_scores_gemma":[0.0002925424,0.00029170525,0.39572507,0.0026919085,0.00017372826,0.0024100975,0.0013347428,0.004056045,0.0014003362,0.0025104906,0.58889544,0.00021793971],"about_ca_topic_score_codex":0.99247414,"about_ca_topic_score_gemma":0.9959532,"teacher_disagreement_score":0.99247414,"about_ca_system_score_codex":0.06110362,"about_ca_system_score_gemma":0.18940927,"threshold_uncertainty_score":0.44333988},"labels":[],"label_agreement":null},{"id":"W4310214325","doi":"10.51731/cjht.2022.510","title":"Asciminib (Scemblix)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Myeloid leukemia; Drug; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.03483540550133837,"score_gpt":0.2954047634783444,"score_spread":0.260569357977006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310214325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019436873,0.68341446,0.0025560597,0.012949907,0.0029407025,0.0006553895,0.0073261647,0.0008377877,0.26988265],"genre_scores_gemma":[0.17131594,0.5695688,0.0070884177,0.018441377,0.0018200049,0.00049248995,0.014726393,0.00009418161,0.2164524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981016,0.000035959256,0.0000146874345,0.000027606096,0.00008109064,0.00003060301],"domain_scores_gemma":[0.9998306,0.000025447443,0.000040823044,0.000005539972,0.000054562028,0.000042886022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032816382,0.0004166184,0.0002869665,0.000816491,0.00027656287,0.00074231473,0.0003576105,0.00052132265,0.026712557],"category_scores_gemma":[0.00046500977,0.00007919791,0.00040778358,0.0005873484,0.00025433625,0.0004415332,0.00036634027,0.0007884556,0.0068264315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000758866,0.00010564632,0.00042990452,0.0034126001,0.00008555059,0.00017204702,0.00003247159,0.00024068862,0.006026591,0.0032013503,0.2086243,0.77690995],"study_design_scores_gemma":[0.0005361432,0.0006621278,0.0020956043,0.0010322769,0.000070520786,0.0008269859,0.000021712518,0.00014091699,0.003333424,0.00042963223,0.9908371,0.000013439298],"about_ca_topic_score_codex":0.006467793,"about_ca_topic_score_gemma":0.025103891,"teacher_disagreement_score":0.99876225,"about_ca_system_score_codex":0.001237724,"about_ca_system_score_gemma":0.0016866126,"threshold_uncertainty_score":0.08936244},"labels":[],"label_agreement":null},{"id":"W4310215188","doi":"10.51731/cjht.2022.508","title":"Cariprazine (Vraylar)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bipolar disorder; Mania; Psychiatry; Depression (economics); Bipolar I disorder; Medicine; Psychology; Clinical psychology; Lithium (medication)","score_opus":0.023222157234161444,"score_gpt":0.2766494257988006,"score_spread":0.25342726856463915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310215188","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07142335,0.34580255,0.0050345967,0.03557453,0.0036791929,0.0018193603,0.011069527,0.004046527,0.5215504],"genre_scores_gemma":[0.55758995,0.14529634,0.019410623,0.050316684,0.0016833966,0.0008647902,0.011555993,0.00022497395,0.2130573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956506,0.00011012465,0.00003528278,0.000099092016,0.00013152321,0.00005885016],"domain_scores_gemma":[0.99965465,0.0000694998,0.000078614095,0.0000272717,0.00007963961,0.00009037311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066264754,0.0003695093,0.00044843953,0.0007432417,0.00043006978,0.00059618644,0.0009668017,0.0012450656,0.034742717],"category_scores_gemma":[0.0012680594,0.00015722803,0.0005727908,0.00036831372,0.00033329814,0.0003299995,0.00046533838,0.0013829014,0.0073935976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038214137,0.0005379323,0.00096912176,0.0034061105,0.00024190205,0.0004605047,0.00007239159,0.00019194843,0.0070701586,0.0063769696,0.1483724,0.8284791],"study_design_scores_gemma":[0.008693837,0.0058915126,0.014429412,0.0020363885,0.00038986508,0.004605627,0.00011233334,0.00049814663,0.007980592,0.0014961348,0.95378923,0.00007694272],"about_ca_topic_score_codex":0.012107707,"about_ca_topic_score_gemma":0.036482397,"teacher_disagreement_score":0.99878025,"about_ca_system_score_codex":0.0012197781,"about_ca_system_score_gemma":0.0012862459,"threshold_uncertainty_score":0.11622596},"labels":[],"label_agreement":null},{"id":"W4310215203","doi":"10.51731/cjht.2022.507","title":"Dostarlimab (Jemperli)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Regimen; Family medicine; Drug; Internal medicine; Pharmacology; Political science; Health care; Law","score_opus":0.03632230262593499,"score_gpt":0.30076741970064014,"score_spread":0.26444511707470514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310215203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014365387,0.774045,0.0023584994,0.010599066,0.0021912747,0.0005901148,0.0027173369,0.00059848785,0.1925349],"genre_scores_gemma":[0.18972391,0.58937854,0.009654483,0.021144269,0.0014994696,0.0006604935,0.005834449,0.00011285022,0.18199156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971753,0.00006945939,0.000032331416,0.00004369541,0.00010703871,0.000030022911],"domain_scores_gemma":[0.9997482,0.00006422339,0.00007606334,0.000010131676,0.00006553131,0.000035872534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057986676,0.00030246546,0.00031098386,0.00074400345,0.00018611428,0.0005966839,0.0004495241,0.0006029403,0.021440193],"category_scores_gemma":[0.00090980117,0.00010709263,0.0005097006,0.00031381744,0.00025486617,0.00044773924,0.0002954612,0.00071052444,0.0046344427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008520222,0.000104861,0.00039339965,0.004446258,0.00011948078,0.00015133026,0.000036893176,0.00014303743,0.0054109045,0.0028479653,0.09777585,0.887718],"study_design_scores_gemma":[0.001100243,0.0018844698,0.0036591443,0.0024345745,0.00021452458,0.0014448097,0.0000384854,0.00022920656,0.007213908,0.00066657446,0.9810906,0.000023388346],"about_ca_topic_score_codex":0.003425467,"about_ca_topic_score_gemma":0.013247657,"teacher_disagreement_score":0.9991301,"about_ca_system_score_codex":0.0008699185,"about_ca_system_score_gemma":0.0011261491,"threshold_uncertainty_score":0.071724534},"labels":[],"label_agreement":null},{"id":"W4311150483","doi":"10.51731/cjht.2022.512","title":"Canadian Trends in Estimated Pharmaceutical Drug Purchases and Projections: 2023","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Audit; Annual growth %; Specialty; Private sector; Agricultural economics; Medicine; Accounting; Economics; Economic growth; Family medicine","score_opus":0.11798662010314265,"score_gpt":0.34642342254702213,"score_spread":0.22843680244387948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150483","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15106949,0.011165548,0.007887132,0.013464755,0.0007693799,0.0002176488,0.7164236,0.001696969,0.09730553],"genre_scores_gemma":[0.57324594,0.015863761,0.014956451,0.0020221993,0.0002059278,0.00016758825,0.36449188,0.00036422815,0.028682051],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979704,0.00006500255,0.00008583372,0.00015899606,0.0013889994,0.0003308928],"domain_scores_gemma":[0.9928705,0.00012486443,0.0002270112,0.00009432555,0.0064082583,0.00027506577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015347938,0.0011810518,0.0004446672,0.0043428787,0.0015607978,0.003365787,0.0014632829,0.0006578022,0.008842438],"category_scores_gemma":[0.004558437,0.00046268073,0.0018040977,0.009285925,0.00039634632,0.0012534496,0.00091617275,0.0015019759,0.0022943146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004982144,0.00015809025,0.2844387,0.0011887543,0.0008445865,0.00046624863,0.0007890331,0.042681787,0.00084499986,0.016204001,0.5177363,0.13414928],"study_design_scores_gemma":[0.00007926588,0.00008676819,0.53305954,0.0006101299,0.00028531352,0.00035878835,0.001435842,0.050858356,0.0018994643,0.0020555968,0.40899435,0.00027658374],"about_ca_topic_score_codex":0.99570763,"about_ca_topic_score_gemma":0.9931004,"teacher_disagreement_score":0.9450708,"about_ca_system_score_codex":0.054929193,"about_ca_system_score_gemma":0.067955896,"threshold_uncertainty_score":0.3985411},"labels":[],"label_agreement":null},{"id":"W4311150526","doi":"10.51731/cjht.2022.523","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Atezolizumab; Carboplatin; Medicine; Intensive care medicine; Family medicine; Political science; Cancer; Surgery; Internal medicine; Chemotherapy; Health care; Law","score_opus":0.037319562789226685,"score_gpt":0.3405334726099894,"score_spread":0.3032139098207627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150526","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013742325,0.78286594,0.0027056797,0.0076015713,0.0023342886,0.00038851713,0.004027869,0.0004242202,0.18590966],"genre_scores_gemma":[0.17895485,0.56627655,0.008103583,0.014965719,0.0015510826,0.00040051845,0.010329872,0.00008992954,0.21932787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996599,0.000059742066,0.000040372342,0.00004880695,0.00014823719,0.00004293537],"domain_scores_gemma":[0.9996433,0.00007634371,0.00009405324,0.00001125372,0.00013400681,0.00004094749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069133594,0.0003416276,0.000277604,0.00083294214,0.00022774083,0.00077210215,0.00042552565,0.00067958276,0.015711067],"category_scores_gemma":[0.00096875045,0.00008381761,0.0005054356,0.0004572248,0.00022651104,0.00043337303,0.00036091555,0.0005591593,0.003952029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005905076,0.000075976306,0.00073464,0.0039752363,0.00008428381,0.00015719191,0.00004057549,0.0001737371,0.00783198,0.0031615838,0.10188982,0.8812844],"study_design_scores_gemma":[0.00031995118,0.00073954085,0.003004292,0.0014934756,0.00013781535,0.0008216071,0.000033416934,0.00010222208,0.0054000267,0.00026491238,0.98766965,0.0000132232035],"about_ca_topic_score_codex":0.01147475,"about_ca_topic_score_gemma":0.028001674,"teacher_disagreement_score":0.015711067,"about_ca_system_score_codex":0.001276471,"about_ca_system_score_gemma":0.0019757526,"threshold_uncertainty_score":0.05255878},"labels":[],"label_agreement":null},{"id":"W4311618837","doi":"10.51731/cjht.2022.525","title":"Pembrolizumab (Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Breast cancer; Stage (stratigraphy); Family medicine; Oncology; Cancer; Internal medicine; Health care; Political science","score_opus":0.029407668507255985,"score_gpt":0.2953782050532903,"score_spread":0.2659705365460343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311618837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006945343,0.8451452,0.0010844134,0.012478172,0.0022647774,0.0002515672,0.0021468825,0.00019929832,0.1294843],"genre_scores_gemma":[0.10757265,0.75623596,0.0046925177,0.015263456,0.0011210177,0.0002820864,0.0026266717,0.000038443242,0.1121671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997167,0.000067697634,0.000033824796,0.00004107268,0.00009975632,0.00004093452],"domain_scores_gemma":[0.9995757,0.000110557696,0.00010869698,0.000015956186,0.00014200277,0.00004714587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006845418,0.00025448325,0.00026160403,0.0006520974,0.00024398284,0.0008128498,0.00034432168,0.0005410446,0.017444331],"category_scores_gemma":[0.0013966186,0.00008480942,0.00041547616,0.00047494212,0.0002626354,0.0006189384,0.0003516992,0.00065895705,0.0029079362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060142163,0.000046202415,0.00044152647,0.0051633217,0.00012837653,0.00010961792,0.000031142405,0.000074464835,0.0023333307,0.003684916,0.11224257,0.8751431],"study_design_scores_gemma":[0.00032703154,0.0005080429,0.0036941562,0.0037363833,0.00023794275,0.0005362061,0.00004169946,0.000069725385,0.002647954,0.0005950478,0.98759276,0.000013015284],"about_ca_topic_score_codex":0.015125329,"about_ca_topic_score_gemma":0.046763044,"teacher_disagreement_score":0.017444331,"about_ca_system_score_codex":0.001412565,"about_ca_system_score_gemma":0.0020941005,"threshold_uncertainty_score":0.05835712},"labels":[],"label_agreement":null},{"id":"W4311705407","doi":"10.51731/cjht.2022.516","title":"Subtypes of Post–COVID-19 Condition: A Review of the Emerging Evidence","year":2022,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Coronavirus disease 2019 (COVID-19); Chronic condition; Intensive care medicine; Multiple sclerosis; Chronic fatigue syndrome; Pathology; Immunology; Psychiatry; Infectious disease (medical specialty)","score_opus":0.15117052414923002,"score_gpt":0.436791541482021,"score_spread":0.285621017332791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311705407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040688846,0.9983974,0.00006189253,0.0005515185,0.00013206094,0.000011758133,0.0000598192,0.0000030153064,0.00037567475],"genre_scores_gemma":[0.003842095,0.9947463,0.0002654309,0.0006336534,0.00027050756,0.000018440198,0.00013218056,0.000002585508,0.00008877866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982622,0.0002693244,0.0006724262,0.0002942181,0.00038670626,0.00011503565],"domain_scores_gemma":[0.99170095,0.005755963,0.0013345825,0.00010448418,0.0009062264,0.00019768742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002654343,0.0009093848,0.0025623706,0.00656619,0.00066275016,0.0021595203,0.0016669323,0.0017779099,0.0039901305],"category_scores_gemma":[0.010125627,0.00056405424,0.0028431113,0.006255563,0.0009949565,0.0032712827,0.0010927244,0.002039943,0.00059228024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057986233,0.00010614909,0.014519803,0.208265,0.0013260889,0.0011262906,0.00061425864,0.00029827812,0.00034495152,0.00428765,0.033308674,0.73522294],"study_design_scores_gemma":[0.00013955256,0.00030489906,0.041092053,0.44223973,0.009012513,0.01690592,0.002293215,0.00043181266,0.00039152973,0.006195987,0.48085076,0.0001419783],"about_ca_topic_score_codex":0.0056728525,"about_ca_topic_score_gemma":0.008868333,"teacher_disagreement_score":0.00656619,"about_ca_system_score_codex":0.001734393,"about_ca_system_score_gemma":0.0034539714,"threshold_uncertainty_score":0.014037669},"labels":[],"label_agreement":null},{"id":"W4311719624","doi":"10.51731/cjht.2022.520","title":"Pembrolizumab in Combination With Lenvatinib (Keytruda and Lenvima)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Reimbursement; Internal medicine; Oncology; Sorafenib; Cancer; Immunotherapy; Hepatocellular carcinoma","score_opus":0.02804367635266003,"score_gpt":0.2806465541397167,"score_spread":0.25260287778705665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311719624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0415524,0.7914856,0.001607896,0.008526854,0.0014624954,0.00039066584,0.0018220821,0.00019215852,0.1529598],"genre_scores_gemma":[0.42627957,0.43743905,0.0076230136,0.0096219415,0.0010296908,0.00033761087,0.0034291372,0.00004173805,0.11419832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977905,0.0000640472,0.000025217763,0.000033218726,0.00006752956,0.000030871382],"domain_scores_gemma":[0.99987614,0.000025130874,0.000042749827,0.0000052517457,0.00003261308,0.000018008695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004396658,0.00020307928,0.0002277567,0.0005800859,0.0001748435,0.00059444655,0.0002389592,0.00037381594,0.011175286],"category_scores_gemma":[0.0005271125,0.00007974385,0.0004059256,0.00044210092,0.00014984926,0.00041657095,0.00023260167,0.00040013168,0.0019040122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015774176,0.00018972556,0.002037003,0.0034843034,0.00037628517,0.00031999234,0.000037180253,0.00022691177,0.011337792,0.0024610802,0.05324103,0.92471135],"study_design_scores_gemma":[0.0011827778,0.0035798622,0.017361002,0.0026549988,0.000724161,0.0026821287,0.00010183932,0.0003124249,0.012197525,0.0009016628,0.95827633,0.00002535143],"about_ca_topic_score_codex":0.005190412,"about_ca_topic_score_gemma":0.02458607,"teacher_disagreement_score":0.011175286,"about_ca_system_score_codex":0.0010243868,"about_ca_system_score_gemma":0.0008819578,"threshold_uncertainty_score":0.037385046},"labels":[],"label_agreement":null},{"id":"W4311969069","doi":"10.51731/cjht.2022.522","title":"Tepotinib (Tepmetko)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Health care; Political science","score_opus":0.02609199232944256,"score_gpt":0.33716446812680095,"score_spread":0.3110724757973584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311969069","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028917642,0.39303938,0.0036509386,0.013947038,0.0032618898,0.00060476863,0.011128069,0.0012175826,0.5442327],"genre_scores_gemma":[0.24081187,0.34754744,0.0070277536,0.015069775,0.0009938843,0.0003807469,0.015867755,0.00015970996,0.3721411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998049,0.000023571583,0.000015332575,0.000032586628,0.000088733774,0.000034930094],"domain_scores_gemma":[0.9998472,0.000019293473,0.000031110525,0.0000071673794,0.000057897283,0.000037364007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031788406,0.00035713965,0.00026933325,0.0007762116,0.0003048864,0.00086368975,0.0004507102,0.00057509745,0.028209062],"category_scores_gemma":[0.0004909355,0.00009226589,0.0003754649,0.00046164612,0.00024027446,0.0006972791,0.00046998926,0.0006843859,0.008106902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005328186,0.00007803168,0.0005654181,0.0024762955,0.00007686852,0.00031679444,0.00003961904,0.00024765564,0.010834359,0.003953107,0.17373487,0.80714405],"study_design_scores_gemma":[0.00018398695,0.00038739401,0.0026085346,0.00078870746,0.000056815777,0.0012327335,0.000028847915,0.00016432165,0.004798646,0.00044595858,0.98928833,0.000015640606],"about_ca_topic_score_codex":0.008174944,"about_ca_topic_score_gemma":0.02684349,"teacher_disagreement_score":0.028209062,"about_ca_system_score_codex":0.001279533,"about_ca_system_score_gemma":0.0016543154,"threshold_uncertainty_score":0.094368696},"labels":[],"label_agreement":null},{"id":"W4312063023","doi":"10.51731/cjht.2022.524","title":"Semaglutide (Wegovy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Overweight; Semaglutide; Dyslipidemia; Obesity; Type 2 diabetes; Weight loss; Body mass index; Comorbidity; Obstructive sleep apnea; Diabetes mellitus; Physical therapy; Internal medicine; Health care; Endocrinology","score_opus":0.02399447771287723,"score_gpt":0.2672215931424719,"score_spread":0.2432271154295947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312063023","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020858683,0.79439396,0.002809404,0.0075966157,0.002320493,0.00038207817,0.005174225,0.0008471982,0.16561724],"genre_scores_gemma":[0.18002675,0.6298171,0.0069606206,0.017854817,0.0008665408,0.0003331862,0.009941807,0.00011747133,0.15408164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.000038576167,0.00002797804,0.00003444444,0.00007964967,0.0000307976],"domain_scores_gemma":[0.9998292,0.00003166667,0.000042824617,0.0000073240594,0.000055821183,0.00003322204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034594725,0.00030441443,0.0003397127,0.0007879039,0.0002203186,0.0006785008,0.00035841716,0.00057712855,0.017185993],"category_scores_gemma":[0.0005081795,0.00007680478,0.0005092878,0.0006309518,0.00027471618,0.00051833387,0.00030926045,0.0007327823,0.0044934712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077607017,0.00007664149,0.0005903051,0.004192686,0.00012673649,0.00016367437,0.000028038983,0.00015338071,0.004166735,0.002436235,0.08522883,0.9020608],"study_design_scores_gemma":[0.0006331121,0.0008518582,0.0053546377,0.0025339825,0.0002524906,0.0010221504,0.000058195812,0.00019464837,0.0043576574,0.000686546,0.9840285,0.000026178752],"about_ca_topic_score_codex":0.013917325,"about_ca_topic_score_gemma":0.0498944,"teacher_disagreement_score":0.017185993,"about_ca_system_score_codex":0.0008655005,"about_ca_system_score_gemma":0.0018090438,"threshold_uncertainty_score":0.057492852},"labels":[],"label_agreement":null},{"id":"W4312116747","doi":"10.51731/cjht.2022.530","title":"Post‒COVID-19 Condition Treatment and Management Rapid Scoping Review","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychological intervention; Coronavirus disease 2019 (COVID-19); Medical diagnosis; Intensive care medicine; MEDLINE; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Psychiatry; Pathology; Disease; Infectious disease (medical specialty)","score_opus":0.03501929585761541,"score_gpt":0.36177684109723995,"score_spread":0.3267575452396245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312116747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073835294,0.95514685,0.0015448842,0.0137154125,0.004619127,0.0028497484,0.0043207826,0.00016099152,0.016903842],"genre_scores_gemma":[0.0059196455,0.97439486,0.0043396903,0.0051369867,0.0010691325,0.002612341,0.0025886628,0.00006321289,0.0038753883],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98832744,0.0035750186,0.003894213,0.0005932249,0.0030886494,0.0005214746],"domain_scores_gemma":[0.9308782,0.038175926,0.0075610452,0.0018048313,0.02069568,0.00088431174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015650164,0.0010759215,0.003054208,0.011797439,0.0014267191,0.005003165,0.0023058413,0.0031033442,0.029114138],"category_scores_gemma":[0.09233485,0.0008475476,0.0044591604,0.010416947,0.00077851576,0.004963597,0.0032814404,0.0027070194,0.004246381],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015208792,0.000043415257,0.0006821869,0.42594057,0.0010861901,0.0002874398,0.00086932513,0.000287181,0.0003482622,0.0035850687,0.15060475,0.41611353],"study_design_scores_gemma":[0.000039260165,0.00003769443,0.00097015116,0.74438584,0.0013010334,0.00015239393,0.00035156138,0.00005716898,0.00011788225,0.00094365893,0.25161922,0.000024222873],"about_ca_topic_score_codex":0.018250726,"about_ca_topic_score_gemma":0.04740699,"teacher_disagreement_score":0.029114138,"about_ca_system_score_codex":0.0072588422,"about_ca_system_score_gemma":0.02610417,"threshold_uncertainty_score":0.09739643},"labels":[],"label_agreement":null},{"id":"W4312116758","doi":"10.51731/cjht.2022.528","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Medullary thyroid cancer; Family medicine; Disease; Thyroid cancer; Cancer; Intensive care medicine; Internal medicine; Health care; Political science","score_opus":0.3815832281513177,"score_gpt":0.4162456149719361,"score_spread":0.034662386820618396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312116758","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04631746,0.63420105,0.008012251,0.0351164,0.0014875977,0.00033456727,0.012963514,0.00061462505,0.26095253],"genre_scores_gemma":[0.49666986,0.38987163,0.006247722,0.009745639,0.0008694165,0.00023475711,0.009653238,0.00006549854,0.08664225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974924,0.00008079254,0.000022811173,0.000035329962,0.00008856542,0.000023275372],"domain_scores_gemma":[0.9996753,0.00012430969,0.00007520862,0.000011215295,0.00008059394,0.000033440436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006672483,0.00022340253,0.00023403561,0.0005341641,0.000119816934,0.0006153677,0.00023062718,0.0003407854,0.010539379],"category_scores_gemma":[0.0011228368,0.00004391366,0.0004090261,0.00048369964,0.00020996516,0.00040885984,0.00025347952,0.0004760884,0.0016825021],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053510437,0.00004140583,0.0014335972,0.002192886,0.00025889705,0.00009486335,0.000021209307,0.0011046068,0.0011553846,0.007977862,0.09997476,0.8852093],"study_design_scores_gemma":[0.00046705152,0.00077647774,0.013497242,0.0029571452,0.00048268176,0.0012778388,0.00007315487,0.0017965987,0.0045242053,0.004769267,0.96933985,0.000038538994],"about_ca_topic_score_codex":0.010758716,"about_ca_topic_score_gemma":0.034208663,"teacher_disagreement_score":0.010758716,"about_ca_system_score_codex":0.0014061099,"about_ca_system_score_gemma":0.0015771631,"threshold_uncertainty_score":0.035257757},"labels":[],"label_agreement":null},{"id":"W4313202305","doi":"10.51731/cjht.2022.531","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Drug; Adjuvant; Oncology; Internal medicine; Cancer; Pharmacology; Immunotherapy; Political science","score_opus":0.030712421897495686,"score_gpt":0.29070101617694755,"score_spread":0.25998859427945187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313202305","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016192248,0.7976988,0.0023523641,0.010507644,0.0030654452,0.00035253557,0.0028082728,0.0003277724,0.16669494],"genre_scores_gemma":[0.22265743,0.6257207,0.008975299,0.01744083,0.0014595013,0.0004211232,0.0053138537,0.00009152391,0.117919736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965847,0.00008212713,0.000030978572,0.00004617401,0.00013033775,0.000051926316],"domain_scores_gemma":[0.99970704,0.000049293314,0.00005967678,0.000010865276,0.00013064686,0.000042468375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061648514,0.00031962077,0.0003389053,0.0006231522,0.00028703845,0.00096227997,0.00043300114,0.0005005057,0.009359042],"category_scores_gemma":[0.0008687662,0.00007850172,0.00051500375,0.00044123526,0.00028582814,0.00048520693,0.00039752733,0.0006741279,0.00273559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044104608,0.000057729645,0.0009300074,0.0032188557,0.00009610571,0.000094579285,0.00003327208,0.0002003185,0.0034893628,0.003061687,0.08583316,0.90254396],"study_design_scores_gemma":[0.00017448988,0.00046775653,0.003121367,0.0021108747,0.00013110707,0.00056140014,0.000041338953,0.0001581236,0.003651152,0.0006085073,0.9889577,0.000016260794],"about_ca_topic_score_codex":0.019146899,"about_ca_topic_score_gemma":0.05594778,"teacher_disagreement_score":0.019146899,"about_ca_system_score_codex":0.0018576105,"about_ca_system_score_gemma":0.0026405049,"threshold_uncertainty_score":0.038070858},"labels":[],"label_agreement":null},{"id":"W4313202375","doi":"10.51731/cjht.2022.532","title":"Abemaciclib (Verzenio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Breast cancer; Disease; Internal medicine; Oncology; Drug; Cancer; Pharmacology; Health care; Political science","score_opus":0.025378513830842764,"score_gpt":0.2975466509263467,"score_spread":0.2721681370955039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313202375","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048520748,0.7665565,0.0017497697,0.0031659622,0.0007456014,0.0007070221,0.003506274,0.000473219,0.17457497],"genre_scores_gemma":[0.4436835,0.47091565,0.00478466,0.005404377,0.00047414095,0.00036575273,0.004566952,0.000077644254,0.0697274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997842,0.00003931734,0.000021959993,0.000033733362,0.00009702852,0.000023845805],"domain_scores_gemma":[0.99984634,0.00003192185,0.000048014153,0.0000064198916,0.000041011455,0.000026238624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002864537,0.00022741948,0.00040223228,0.0009411092,0.00021614986,0.0007404993,0.00031264292,0.00032336096,0.012609801],"category_scores_gemma":[0.0004776332,0.00007750299,0.00032594943,0.0006419986,0.00020670866,0.00041557496,0.00020712198,0.0006309556,0.0018607838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017244687,0.00018643151,0.0006116598,0.005264173,0.00012968272,0.0002196587,0.000039757928,0.00018932442,0.011024261,0.002689402,0.033786926,0.94413435],"study_design_scores_gemma":[0.0018780603,0.002588285,0.009691917,0.0035339994,0.00055189314,0.002842996,0.00009015777,0.00040097814,0.011020587,0.001076283,0.9662801,0.00004465628],"about_ca_topic_score_codex":0.0063827266,"about_ca_topic_score_gemma":0.02684446,"teacher_disagreement_score":0.012609801,"about_ca_system_score_codex":0.000990024,"about_ca_system_score_gemma":0.0010444989,"threshold_uncertainty_score":0.042183995},"labels":[],"label_agreement":null},{"id":"W4313287828","doi":"10.51731/cjht.2022.526","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lung Health Foundation","keywords":"Reimbursement; Atezolizumab; Medicine; Adjuvant; Oncology; Adjuvant chemotherapy; Lung cancer; Internal medicine; Drug; Cancer; Intensive care medicine; Pharmacology; Immunotherapy; Political science","score_opus":0.03595807640146948,"score_gpt":0.23053323532801037,"score_spread":0.1945751589265409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313287828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017272383,0.71007705,0.0051222215,0.016735615,0.0031889123,0.00042040725,0.007476295,0.0005480018,0.23915909],"genre_scores_gemma":[0.25852543,0.47119346,0.00998531,0.018037431,0.002384232,0.00043275583,0.013434272,0.00010306876,0.22590414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968946,0.0000743539,0.000041289833,0.000045779147,0.00011482412,0.000034360648],"domain_scores_gemma":[0.9995121,0.00012527007,0.00014518091,0.000016467155,0.0001485008,0.00005265345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007235566,0.00029651998,0.00025001555,0.0006676401,0.0001667135,0.00078670506,0.00036631653,0.0006398594,0.018816551],"category_scores_gemma":[0.0013541385,0.000071953866,0.0004964794,0.00041351296,0.00020442561,0.0004701873,0.00033593058,0.00058894267,0.0039343103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071066665,0.00006015116,0.0010435468,0.0029270863,0.00011130481,0.00011422459,0.00002650828,0.00034449153,0.0028880269,0.005071682,0.12743655,0.8592658],"study_design_scores_gemma":[0.00038066294,0.00067951943,0.0034463904,0.0014617024,0.00014646444,0.0006705062,0.000025099447,0.00024049428,0.0030589066,0.0006768451,0.98920023,0.000013199563],"about_ca_topic_score_codex":0.006486453,"about_ca_topic_score_gemma":0.013174709,"teacher_disagreement_score":0.018816551,"about_ca_system_score_codex":0.0011595738,"about_ca_system_score_gemma":0.001501993,"threshold_uncertainty_score":0.06294769},"labels":[],"label_agreement":null},{"id":"W4313649019","doi":"10.51731/cjht.2023.534","title":"Pralsetinib (Gavreto)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.0401246982092405,"score_gpt":0.37572661462384405,"score_spread":0.3356019164146036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313649019","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027798265,0.7279083,0.0031481192,0.013714767,0.0018673872,0.00049092236,0.004040723,0.0009511044,0.2200804],"genre_scores_gemma":[0.30111837,0.51648474,0.00897645,0.01489461,0.0010375548,0.0003723427,0.0076024616,0.00011624917,0.14939725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979395,0.000040698593,0.000014221654,0.000036482437,0.00009173695,0.000022931461],"domain_scores_gemma":[0.9998634,0.00002632469,0.00003563766,0.000007589917,0.00004250691,0.000024487703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045770252,0.00024490576,0.00025013142,0.0005420798,0.00019625992,0.00064998993,0.0003793164,0.000475371,0.011764021],"category_scores_gemma":[0.0005846416,0.00007337523,0.00038950806,0.00036247377,0.00020537863,0.00039233398,0.00029894154,0.0007678223,0.0029476578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000673392,0.000117723495,0.0005942428,0.0022767016,0.000114011455,0.00020165263,0.000042225056,0.00020198523,0.007510053,0.003518265,0.10265775,0.88209194],"study_design_scores_gemma":[0.00058444025,0.0005652479,0.0022410217,0.0009613224,0.00012636153,0.0010086893,0.00003070192,0.00017247703,0.004614332,0.00062672107,0.98905367,0.000015117832],"about_ca_topic_score_codex":0.006200211,"about_ca_topic_score_gemma":0.017569475,"teacher_disagreement_score":0.011764021,"about_ca_system_score_codex":0.0010930639,"about_ca_system_score_gemma":0.0012363808,"threshold_uncertainty_score":0.039354563},"labels":[],"label_agreement":null},{"id":"W4315853248","doi":"10.51731/cjht.2023.538","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Lung cancer; Oncology; Intensive care medicine; Clinical trial; Cancer; Overall survival; Internal medicine; Stage (stratigraphy); Surgery","score_opus":0.06750447713632651,"score_gpt":0.38564942484924675,"score_spread":0.31814494771292023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315853248","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042248152,0.67463124,0.0039552813,0.032583255,0.0034211245,0.0008953116,0.007929203,0.002422124,0.2319144],"genre_scores_gemma":[0.44146794,0.31324747,0.012178356,0.036438722,0.0015329996,0.00096715405,0.012903594,0.0002760069,0.18098767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997136,0.00008828382,0.000030247937,0.000044379613,0.00007846451,0.000045077246],"domain_scores_gemma":[0.9996866,0.00010244948,0.00009163041,0.000019630008,0.00004620949,0.000053510277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068990403,0.000247351,0.0005134607,0.00085925503,0.00023359199,0.00079568743,0.00077099557,0.0009564962,0.030041924],"category_scores_gemma":[0.0013159523,0.00011613863,0.0004959539,0.0005130307,0.0004214409,0.00050246314,0.00048910733,0.0015344752,0.007792362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046049687,0.00031039145,0.0009174904,0.005098086,0.00018607466,0.00045419784,0.000053079893,0.0002691535,0.009851806,0.007517175,0.14238052,0.82835704],"study_design_scores_gemma":[0.005437574,0.0033484672,0.006809928,0.002002799,0.00029728477,0.0022496083,0.00008889103,0.00047620139,0.009412357,0.0019025452,0.967917,0.000057368783],"about_ca_topic_score_codex":0.003824618,"about_ca_topic_score_gemma":0.009430827,"teacher_disagreement_score":0.030041924,"about_ca_system_score_codex":0.0009520176,"about_ca_system_score_gemma":0.0009610421,"threshold_uncertainty_score":0.100500286},"labels":[],"label_agreement":null},{"id":"W4316037650","doi":"10.51731/cjht.2023.539","title":"Faricimab (Vabysmo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Family medicine; Political science; Diabetes mellitus; Diabetic retinopathy; Health care","score_opus":0.04056564087290863,"score_gpt":0.3272458019378994,"score_spread":0.2866801610649908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316037650","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013590626,0.8853304,0.0012431667,0.005315866,0.0014472494,0.00014698866,0.0015108836,0.00023136585,0.09118344],"genre_scores_gemma":[0.23773777,0.6165137,0.00449566,0.011467546,0.0008419018,0.00015357063,0.004711465,0.000038980266,0.124039344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998117,0.000029793498,0.000016611702,0.000035347974,0.00007047929,0.000036150323],"domain_scores_gemma":[0.99986076,0.000023129749,0.000041611755,0.000006222664,0.000044236895,0.000024056684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003112992,0.0003384255,0.0002616871,0.00052470434,0.00025578515,0.0005350033,0.00036440676,0.0006205997,0.014297596],"category_scores_gemma":[0.00043670766,0.00007865668,0.0003763771,0.00031465958,0.00019653443,0.00033361863,0.00027305883,0.0005797805,0.0041230423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000576692,0.00008499914,0.00057279377,0.0026398464,0.00008772792,0.00028623594,0.000029815546,0.0001745392,0.014335805,0.0021801644,0.07037549,0.90865594],"study_design_scores_gemma":[0.0003040289,0.00093700737,0.007101858,0.0017290578,0.00012164338,0.002102886,0.000049053502,0.00012983357,0.01065006,0.0004618289,0.9763907,0.000022093831],"about_ca_topic_score_codex":0.01606078,"about_ca_topic_score_gemma":0.040493477,"teacher_disagreement_score":0.01606078,"about_ca_system_score_codex":0.0012205121,"about_ca_system_score_gemma":0.0010951057,"threshold_uncertainty_score":0.047830224},"labels":[],"label_agreement":null},{"id":"W4316095980","doi":"10.51731/cjht.2023.540","title":"Identifying Overused Lab Tests in Hospital Settings: A Delphi Study","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Blood Services; Canadian Association of Emergency Physicians","keywords":"Medicine; Medical laboratory; Test (biology); Medical diagnosis; Health care; Nursing; Pathology","score_opus":0.5239739004730818,"score_gpt":0.5427200456900964,"score_spread":0.018746145217014565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316095980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97479826,0.00020784963,0.004079559,0.0034863614,0.000060725364,0.009988617,0.0002948954,0.000017877674,0.007065799],"genre_scores_gemma":[0.9649616,0.0006566983,0.008955907,0.0054163407,0.000041148836,0.018347867,0.00019150438,0.000019086357,0.001409788],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.93650013,0.047274113,0.003750205,0.0015809347,0.0033810176,0.0075136344],"domain_scores_gemma":[0.9224995,0.05104927,0.0027902348,0.0016068027,0.017845703,0.004208497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0816621,0.0007026266,0.00066409,0.0027557663,0.0058154035,0.0025199591,0.001604478,0.002474568,0.0050511644],"category_scores_gemma":[0.07118384,0.0008615017,0.0009403568,0.0018679891,0.0033097083,0.0029001902,0.006529957,0.0024550406,0.000786885],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015367245,0.0047123744,0.10457648,0.0035648567,0.00016826532,0.0027340394,0.76452565,0.0018405097,0.0029412566,0.0065262723,0.01418768,0.09268593],"study_design_scores_gemma":[0.0003861598,0.0035266017,0.047719326,0.0016752547,0.00008077739,0.0005215928,0.9193171,0.0032800976,0.0011719625,0.0021137334,0.020020043,0.0001872972],"about_ca_topic_score_codex":0.014521876,"about_ca_topic_score_gemma":0.021687355,"teacher_disagreement_score":0.0816621,"about_ca_system_score_codex":0.010048014,"about_ca_system_score_gemma":0.018267272,"threshold_uncertainty_score":0.43187565},"labels":[],"label_agreement":null},{"id":"W4316805821","doi":"10.51731/cjht.2023.541","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vial; Pembrolizumab; Medicine; Reimbursement; Nephrectomy; Renal cell carcinoma; Adjuvant; Resection; Surgery; Internal medicine; Kidney; Cancer; Immunotherapy","score_opus":0.07187227101914873,"score_gpt":0.37928811297744913,"score_spread":0.3074158419583004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316805821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014812299,0.94614875,0.00095549505,0.0018863378,0.00034996233,0.00018402857,0.0007300296,0.000103261395,0.034829758],"genre_scores_gemma":[0.25204885,0.7086948,0.00458724,0.003158801,0.0002478435,0.00021524416,0.0011778888,0.000025845547,0.029843459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997179,0.00005993271,0.000028842656,0.00003674131,0.00012005173,0.00003656025],"domain_scores_gemma":[0.9997845,0.000042126765,0.00007209566,0.000009174567,0.00006625215,0.000025837873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048972684,0.00022157162,0.00026011575,0.000764696,0.00021554274,0.0007273139,0.00023880477,0.0003546745,0.0041720984],"category_scores_gemma":[0.00074284576,0.00008430241,0.00032037706,0.0005517367,0.00017042353,0.000461068,0.00024395793,0.0004718913,0.00085731474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059824827,0.00006177354,0.0007444898,0.0041164346,0.0001545241,0.00016360176,0.00003746344,0.00018125857,0.00888154,0.0018970725,0.017210443,0.9659532],"study_design_scores_gemma":[0.00045016813,0.0013094626,0.007768838,0.0037072476,0.00052140845,0.0023154402,0.00008698026,0.00019188462,0.013899148,0.00058317377,0.969144,0.000022265684],"about_ca_topic_score_codex":0.009364375,"about_ca_topic_score_gemma":0.036726575,"teacher_disagreement_score":0.009364375,"about_ca_system_score_codex":0.0014615579,"about_ca_system_score_gemma":0.0012186895,"threshold_uncertainty_score":0.018619716},"labels":[],"label_agreement":null},{"id":"W4317508600","doi":"10.51731/cjht.2023.543","title":"Ruxolitinib (Jakavi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Ruxolitinib; Medicine; Family medicine; Drug; Refractory (planetary science); Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.04997393762946757,"score_gpt":0.3201934607321535,"score_spread":0.27021952310268593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317508600","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070503172,0.8715427,0.001107348,0.0069780643,0.001137932,0.00014499266,0.0022022875,0.00022236757,0.10961398],"genre_scores_gemma":[0.11294874,0.79162127,0.003947952,0.009158381,0.0010078202,0.00015817638,0.0040482595,0.00004195468,0.07706747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999622,0.00007671467,0.000044608238,0.000045012675,0.00016121365,0.00005041815],"domain_scores_gemma":[0.99962974,0.0000799413,0.00011092497,0.000012294181,0.00013076016,0.000036397287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061930396,0.00026855222,0.00031342875,0.00086061936,0.00022030156,0.00091417675,0.0003718304,0.00038527476,0.011879483],"category_scores_gemma":[0.0009743093,0.00007514752,0.0004373359,0.0006669568,0.00023682171,0.00045477433,0.00035680973,0.0005156185,0.0025107863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027521935,0.000036554244,0.00065209036,0.0038443494,0.000109558256,0.00008385843,0.000026903588,0.00013234038,0.0019068362,0.002920722,0.081344806,0.9086668],"study_design_scores_gemma":[0.00012655833,0.00028779838,0.0042496608,0.0028466892,0.00018053006,0.0005525057,0.00003728885,0.00012560636,0.0023445163,0.00046244854,0.9887715,0.000014891272],"about_ca_topic_score_codex":0.015497085,"about_ca_topic_score_gemma":0.052092496,"teacher_disagreement_score":0.015497085,"about_ca_system_score_codex":0.0013902885,"about_ca_system_score_gemma":0.0021134808,"threshold_uncertainty_score":0.0397408},"labels":[],"label_agreement":null},{"id":"W4317608316","doi":"10.51731/cjht.2023.545","title":"Tafasitamab (Minjuvi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lenalidomide; Medicine; Refractory (planetary science); Lymphoma; Intensive care medicine; Oncology; Internal medicine; Political science; Health care; Multiple myeloma","score_opus":0.04215647556844165,"score_gpt":0.325645451494131,"score_spread":0.28348897592568933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317608316","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013364545,0.8719094,0.00094469596,0.008152312,0.001833889,0.00021822992,0.0025835542,0.00032155702,0.1006718],"genre_scores_gemma":[0.20977205,0.6396187,0.0053930054,0.015292209,0.0012900083,0.00035526083,0.006308587,0.00005406275,0.12191617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998142,0.000038583483,0.000019868614,0.000032342035,0.00006033852,0.000034733166],"domain_scores_gemma":[0.99978846,0.000039906856,0.00006939737,0.0000070513984,0.000059995848,0.000035276535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004184423,0.00026697808,0.00026451284,0.0008431235,0.00026531174,0.0006454056,0.00041435618,0.0005179721,0.016188277],"category_scores_gemma":[0.00069375057,0.00008379196,0.0005795816,0.00048330743,0.00021519016,0.000386779,0.0002952117,0.00056301785,0.002467666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008829388,0.00006404331,0.00065552455,0.0033908954,0.0001790309,0.00014813703,0.00003030525,0.000119659715,0.0035329002,0.002131936,0.09240846,0.89645624],"study_design_scores_gemma":[0.0004070385,0.00070165674,0.0043861936,0.0020470207,0.00022378782,0.0009838489,0.000029605775,0.00009651089,0.0023622285,0.0004555238,0.9882929,0.000013775832],"about_ca_topic_score_codex":0.014988347,"about_ca_topic_score_gemma":0.055193182,"teacher_disagreement_score":0.016188277,"about_ca_system_score_codex":0.0016956467,"about_ca_system_score_gemma":0.0017000531,"threshold_uncertainty_score":0.05415511},"labels":[],"label_agreement":null},{"id":"W4317830857","doi":"10.51731/cjht.2023.547","title":"Empagliflozin (Jardiance)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Empagliflozin; Medicine; Drug class; Family medicine; Drug; Intensive care medicine; Health care; Pharmacology; Political science","score_opus":0.03664097978150487,"score_gpt":0.30055596266128615,"score_spread":0.26391498287978127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317830857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014499935,0.7879127,0.0048757624,0.013171937,0.0028685583,0.00040462354,0.0049150633,0.0005912197,0.17076018],"genre_scores_gemma":[0.1449775,0.66413707,0.011283212,0.016908687,0.0013210938,0.0003232061,0.0067969984,0.00006871618,0.15418357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996245,0.00006300584,0.000042382013,0.000056085715,0.00017393369,0.000039940056],"domain_scores_gemma":[0.99968386,0.00006574306,0.00008629177,0.000011696813,0.0001193117,0.000033187003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006471265,0.00022488761,0.00027892677,0.0006880603,0.00021793037,0.00070766185,0.0003443732,0.00051088305,0.013547925],"category_scores_gemma":[0.0010575273,0.000092957285,0.00037038818,0.0005518087,0.0002552908,0.0004933164,0.00037959003,0.00055721076,0.0030052257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050351874,0.000060715065,0.00047776784,0.0043756166,0.00007807919,0.000102380545,0.000025493891,0.00010559561,0.003259088,0.002744206,0.11343158,0.87483597],"study_design_scores_gemma":[0.0001925693,0.0003865345,0.00484982,0.00155354,0.00012355458,0.00047848863,0.000026073058,0.00013996122,0.0028793481,0.0003204783,0.98903173,0.000017999084],"about_ca_topic_score_codex":0.015936896,"about_ca_topic_score_gemma":0.034363333,"teacher_disagreement_score":0.015936896,"about_ca_system_score_codex":0.0010983015,"about_ca_system_score_gemma":0.001704286,"threshold_uncertainty_score":0.04532236},"labels":[],"label_agreement":null},{"id":"W4317884461","doi":"10.51731/cjht.2023.549","title":"Abrocitinib (Cibinqo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Atopic dermatitis; Refractory (planetary science); Drug; Family medicine; Dermatology; Pharmacology; Health care; Political science","score_opus":0.34411209858443714,"score_gpt":0.507443061392487,"score_spread":0.16333096280804982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317884461","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028625582,0.39984527,0.0036423695,0.050045438,0.003283705,0.00094348734,0.0077997553,0.0011250048,0.53045243],"genre_scores_gemma":[0.07070615,0.6236456,0.02624624,0.049187552,0.0016296888,0.0009799608,0.017730327,0.0002592806,0.20961522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986929,0.00022680133,0.00016883627,0.00013568717,0.0006408128,0.00013488646],"domain_scores_gemma":[0.9973441,0.00052313355,0.00046009547,0.00008371209,0.0012054399,0.0003835089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021840597,0.00035407313,0.00046957657,0.0014556686,0.00045511694,0.002003115,0.0012186646,0.0013718904,0.03805345],"category_scores_gemma":[0.005894186,0.0001571462,0.0008282824,0.0011773687,0.0005411173,0.0008709253,0.00090759894,0.0016492554,0.013090218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012655741,0.00004167892,0.0003766053,0.0034693074,0.00003745578,0.00009065237,0.00005226297,0.00009890613,0.0008205955,0.0037629069,0.29378977,0.69733334],"study_design_scores_gemma":[0.00009859135,0.000071247334,0.0013114478,0.0019543695,0.000040527422,0.00022461393,0.000018058128,0.000044404587,0.0004292838,0.00038996502,0.9954086,0.000008911995],"about_ca_topic_score_codex":0.04498165,"about_ca_topic_score_gemma":0.14106691,"teacher_disagreement_score":0.04498165,"about_ca_system_score_codex":0.0041049826,"about_ca_system_score_gemma":0.009746482,"threshold_uncertainty_score":0.12730145},"labels":[],"label_agreement":null},{"id":"W4317934516","doi":"10.51731/cjht.2023.553","title":"Cabozantinib (Cabometyx)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cabozantinib; Reimbursement; Medicine; Refractory (planetary science); Drug; Intensive care medicine; Family medicine; Oncology; Medical physics; Internal medicine; Cancer; Pharmacology; Political science; Health care","score_opus":0.45878445805100243,"score_gpt":0.4447541549510803,"score_spread":0.014030303099922148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317934516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009286239,0.74966115,0.0029600833,0.026047686,0.0016449736,0.00023597626,0.008955106,0.0002910077,0.20091775],"genre_scores_gemma":[0.22982706,0.6408483,0.006981836,0.009376138,0.0016323661,0.00024796798,0.008588194,0.00006993424,0.10242816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994917,0.0001389431,0.00004795402,0.000046813737,0.00022890612,0.00004580625],"domain_scores_gemma":[0.9989392,0.00036014314,0.00025142968,0.000030569063,0.00032698145,0.000091665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010956023,0.00031642153,0.0003178798,0.0009946219,0.00022635947,0.0011110335,0.00028958076,0.0005365126,0.0154976435],"category_scores_gemma":[0.0029887839,0.000066536784,0.00042737348,0.0010167229,0.00033933413,0.00045845666,0.00027427837,0.0005814329,0.0021168382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007417205,0.000035744943,0.0014306699,0.003945562,0.00017443577,0.00007344073,0.000025761097,0.00039275235,0.00091520394,0.012415097,0.20019889,0.7796507],"study_design_scores_gemma":[0.000302423,0.00034221789,0.012122084,0.0034085496,0.00029383154,0.0004656094,0.00005100031,0.00045201508,0.0013612527,0.0022365616,0.97894233,0.00002201233],"about_ca_topic_score_codex":0.06346018,"about_ca_topic_score_gemma":0.11871193,"teacher_disagreement_score":0.06346018,"about_ca_system_score_codex":0.0034456637,"about_ca_system_score_gemma":0.0036937147,"threshold_uncertainty_score":0.1261816},"labels":[],"label_agreement":null},{"id":"W4317934829","doi":"10.51731/cjht.2023.551","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Reimbursement; Medicine; Regimen; Adjuvant; Oncology; Breast cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Cancer; Health care","score_opus":0.10286531305846934,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317934829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016183332,0.747167,0.0015477058,0.008441798,0.0015340731,0.0003091224,0.0030221855,0.00021549076,0.22157937],"genre_scores_gemma":[0.20513052,0.5653984,0.004420662,0.008187304,0.00068714964,0.00021609858,0.0047614696,0.00005083552,0.21114756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999653,0.000071878516,0.000026601116,0.000036016954,0.00017072914,0.000041750605],"domain_scores_gemma":[0.99972576,0.000054327604,0.00005138863,0.000008711993,0.00012702383,0.000032726683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169733,0.00021860925,0.00024161696,0.00080988865,0.00020520734,0.0006623139,0.00032411463,0.00031566314,0.010699157],"category_scores_gemma":[0.00076663535,0.00006474984,0.0003032572,0.0005941234,0.0002311033,0.00032253642,0.00025479402,0.00043187372,0.0015065561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039087638,0.000044232936,0.00096400926,0.0025044794,0.00009532553,0.00015509661,0.00003710672,0.0003244801,0.0031156072,0.0052278657,0.08635024,0.90079063],"study_design_scores_gemma":[0.00015785317,0.00024119964,0.0041625435,0.001324285,0.00009870542,0.00040641893,0.000031017866,0.0001548474,0.003952825,0.00040743125,0.98905116,0.000011724337],"about_ca_topic_score_codex":0.037437502,"about_ca_topic_score_gemma":0.118663855,"teacher_disagreement_score":0.037437502,"about_ca_system_score_codex":0.0032830548,"about_ca_system_score_gemma":0.0028770566,"threshold_uncertainty_score":0.07443917},"labels":[],"label_agreement":null},{"id":"W4318067260","doi":"10.51731/cjht.2023.554","title":"Maribavir (Livtencity)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Intensive care medicine; Family medicine; Health care; Political science; Biology","score_opus":0.07485179050639802,"score_gpt":0.3509333658957975,"score_spread":0.2760815753893995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318067260","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017765168,0.72538286,0.0030077447,0.0063666124,0.0021034533,0.0005819979,0.003370168,0.0010244816,0.24039762],"genre_scores_gemma":[0.2925093,0.49427396,0.013975281,0.0134614725,0.0009027358,0.0005981404,0.0072822636,0.00020244191,0.17679437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997844,0.000047282567,0.000018319799,0.000035737725,0.00008344066,0.00003077422],"domain_scores_gemma":[0.99984133,0.00003117675,0.00003370349,0.0000077145505,0.00005420568,0.00003173096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045522305,0.0003942293,0.00030629768,0.00082100596,0.00031305486,0.0008976617,0.0005474527,0.0006628816,0.020273918],"category_scores_gemma":[0.00061416044,0.00013775285,0.000542926,0.00041441707,0.0002667181,0.000421511,0.00042458298,0.0009786185,0.0045790626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005526698,0.00011462375,0.0006247412,0.003087592,0.000098305594,0.00016567402,0.00005169365,0.00019691602,0.0081790425,0.0033963514,0.068996444,0.914536],"study_design_scores_gemma":[0.00029592362,0.0005850811,0.0029265792,0.0019904086,0.0001424088,0.0010694155,0.000052698295,0.0001954979,0.0061212503,0.0005775631,0.98602235,0.000020791449],"about_ca_topic_score_codex":0.01661071,"about_ca_topic_score_gemma":0.047495034,"teacher_disagreement_score":0.020273918,"about_ca_system_score_codex":0.0013645191,"about_ca_system_score_gemma":0.001816184,"threshold_uncertainty_score":0.06782305},"labels":[],"label_agreement":null},{"id":"W4318817604","doi":"10.51731/cjht.2023.556","title":"Lutetium (¹⁷⁷Lu) Oxodotreotide (Lutathera)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Reimbursement; Lutetium; Medicine; Neuroendocrine tumors; Somatostatin receptor; Medical physics; Somatostatin; Intensive care medicine; Internal medicine; Political science; Chemistry; Health care","score_opus":0.0492802878119603,"score_gpt":0.35629339758249134,"score_spread":0.30701310977053103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318817604","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019122845,0.7935578,0.0038032564,0.007975055,0.0020316867,0.00024789537,0.0020774107,0.00031459742,0.17086947],"genre_scores_gemma":[0.21610372,0.5796146,0.010605315,0.012189095,0.0009689337,0.00026168747,0.003102864,0.00013464982,0.17701925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996897,0.00006656599,0.00002639603,0.00003930073,0.00014074534,0.000037341208],"domain_scores_gemma":[0.9995509,0.00016368643,0.00009520486,0.00001775164,0.000121613586,0.00005081288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010711884,0.00022276526,0.00027885658,0.0005781705,0.00023000462,0.00082971016,0.00038630105,0.00057470484,0.013388428],"category_scores_gemma":[0.0010438304,0.00008872689,0.00037097337,0.00050398154,0.00043931938,0.00052435865,0.00028273163,0.0005075703,0.0026720809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077859766,0.00005993454,0.0016573688,0.0037983907,0.00008199529,0.00035350828,0.00006443918,0.00019513507,0.016942384,0.004537076,0.054734115,0.9167971],"study_design_scores_gemma":[0.00021144743,0.0012400795,0.0070717256,0.0018668368,0.00018273162,0.0015964399,0.00011315008,0.00020668305,0.016867083,0.00057133945,0.9700382,0.00003436098],"about_ca_topic_score_codex":0.022729088,"about_ca_topic_score_gemma":0.06354921,"teacher_disagreement_score":0.9772709,"about_ca_system_score_codex":0.0018956168,"about_ca_system_score_gemma":0.0024044297,"threshold_uncertainty_score":0.045193613},"labels":[],"label_agreement":null},{"id":"W4319082132","doi":"10.51731/cjht.2023.558","title":"Cariprazine (Vraylar)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Psychiatry; Placebo; Clinical trial; Medicine; Psychology; Alternative medicine; Internal medicine; Pathology","score_opus":0.05148672534158338,"score_gpt":0.33917598324148673,"score_spread":0.28768925789990335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319082132","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039326135,0.39878067,0.00626245,0.07364116,0.006377585,0.002057128,0.011644075,0.0040117423,0.45789903],"genre_scores_gemma":[0.37904683,0.17363295,0.026356844,0.09082958,0.0032806844,0.0016805299,0.0149347205,0.0003610679,0.3098769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916375,0.00024363211,0.00006260476,0.00017943468,0.0002646065,0.00008591039],"domain_scores_gemma":[0.99925166,0.00022179894,0.00015523139,0.000059483944,0.00015450842,0.00015735987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014840347,0.00043565672,0.0006632883,0.000964175,0.0004863931,0.00095204526,0.0010132741,0.0020144081,0.029474368],"category_scores_gemma":[0.002497892,0.00018249029,0.00063857826,0.00043374623,0.00038137118,0.00044953413,0.0004981528,0.0019913455,0.008810138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026431368,0.00034943712,0.0005155336,0.0025031767,0.00014914521,0.00041880022,0.0000707482,0.00015166435,0.005529025,0.0077237254,0.24319443,0.7367512],"study_design_scores_gemma":[0.0037611534,0.001936737,0.0046749846,0.001181487,0.00016928732,0.0019954771,0.000051384406,0.00020895246,0.0037799599,0.0010858278,0.9811131,0.00004164511],"about_ca_topic_score_codex":0.006904793,"about_ca_topic_score_gemma":0.023017626,"teacher_disagreement_score":0.029474368,"about_ca_system_score_codex":0.0012293801,"about_ca_system_score_gemma":0.0016660406,"threshold_uncertainty_score":0.09860164},"labels":[],"label_agreement":null},{"id":"W4319438676","doi":"10.51731/cjht.2023.561","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Vial; Family medicine; Internal medicine; Cancer; Political science","score_opus":0.42098361643813637,"score_gpt":0.4337388593827365,"score_spread":0.01275524294460012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438676","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029646823,0.92226046,0.002114365,0.0050903694,0.00028685137,0.00027741617,0.0029897152,0.00006263369,0.03727144],"genre_scores_gemma":[0.42412013,0.55343,0.004976174,0.0019191602,0.00019186249,0.00025006957,0.0019965817,0.000013489373,0.013102572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994479,0.0002256035,0.000049686998,0.00004023906,0.00018877619,0.000047885747],"domain_scores_gemma":[0.9993862,0.00022299516,0.00020584148,0.000017959781,0.00012499643,0.000041981344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012062852,0.00020741644,0.0002856794,0.0008476127,0.00014066389,0.00076570845,0.00016821575,0.0002702848,0.0035615445],"category_scores_gemma":[0.0023111436,0.000060312723,0.0004362217,0.0009680954,0.00015884904,0.0003930381,0.00022381316,0.00037252242,0.0003005367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010876817,0.00007022148,0.0039152526,0.0054528513,0.0006873098,0.0001042912,0.000027243941,0.0010828008,0.0013440411,0.0055611734,0.022544986,0.9581222],"study_design_scores_gemma":[0.0012488473,0.0028494962,0.08925785,0.019850595,0.0033880824,0.0026997249,0.00024795518,0.0025265068,0.0063662007,0.0051961793,0.8662981,0.00007045633],"about_ca_topic_score_codex":0.022589948,"about_ca_topic_score_gemma":0.06322064,"teacher_disagreement_score":0.022589948,"about_ca_system_score_codex":0.0023507066,"about_ca_system_score_gemma":0.002060595,"threshold_uncertainty_score":0.044916928},"labels":[],"label_agreement":null},{"id":"W4319438804","doi":"10.51731/cjht.2023.559","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Atopic dermatitis; Dermatology; Drug; Reimbursement; Methotrexate; Azathioprine; Disease; Family medicine; Surgery; Pharmacology; Internal medicine; Health care","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438804","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034116305,0.132059,0.0058159204,0.03875124,0.0082273325,0.0017636939,0.017552784,0.005069718,0.756644],"genre_scores_gemma":[0.31916535,0.058467895,0.022360675,0.06377513,0.0052488297,0.0014779788,0.03721678,0.00056689605,0.49172044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991986,0.00010107915,0.000040904764,0.00012797053,0.00038325007,0.00014815551],"domain_scores_gemma":[0.9990121,0.00014703596,0.00012913179,0.000061870836,0.0002723418,0.00037754956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008776514,0.00050276524,0.00047670715,0.0011127001,0.0008223425,0.0014392444,0.0009271155,0.0016275995,0.05674232],"category_scores_gemma":[0.0015227173,0.0002210131,0.00067344913,0.00046196373,0.00030415595,0.00068545085,0.0006328889,0.0018942587,0.020649608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008963448,0.00027905498,0.0011974475,0.0006410055,0.00003898872,0.0004215415,0.000044286655,0.000116468786,0.0051921424,0.0021755118,0.4812655,0.5077317],"study_design_scores_gemma":[0.0008104015,0.00059649564,0.0028743315,0.00028532202,0.000056468467,0.0019916985,0.000018356244,0.0002351554,0.0027185583,0.00036723906,0.9900287,0.00001730987],"about_ca_topic_score_codex":0.0063051376,"about_ca_topic_score_gemma":0.02039715,"teacher_disagreement_score":0.05674232,"about_ca_system_score_codex":0.0015281105,"about_ca_system_score_gemma":0.0018810744,"threshold_uncertainty_score":0.18982202},"labels":[],"label_agreement":null},{"id":"W4319438907","doi":"10.51731/cjht.2023.562","title":"Specialized Clinics and Health Care Professional Resources for Post–COVID-19 Condition in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Specialty; Referral; Jurisdiction; Health care; Medicine; Family medicine; Nursing; Political science","score_opus":0.3371586172653225,"score_gpt":0.4733619029530325,"score_spread":0.13620328568771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438907","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2280588,0.44853187,0.0017861798,0.03757556,0.0010454671,0.0013232994,0.09379546,0.0003770565,0.18750641],"genre_scores_gemma":[0.67446464,0.27776933,0.008701524,0.009528798,0.00022337593,0.0007391782,0.01911824,0.00008126732,0.009373684],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99682415,0.0003569236,0.00040292693,0.0003080388,0.0011187597,0.0009891407],"domain_scores_gemma":[0.9807897,0.00480419,0.0022187775,0.00025470377,0.008199795,0.003732894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019428781,0.0003101214,0.00066692696,0.0068944753,0.004106669,0.003148422,0.0017201606,0.0006967238,0.012327441],"category_scores_gemma":[0.0100701265,0.00045995656,0.00072845013,0.017020114,0.0010964416,0.0012717558,0.0018646535,0.0009904495,0.00040408855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025486032,0.000176733,0.22183536,0.039877683,0.00040659544,0.0019079531,0.010964808,0.0007251203,0.0006049536,0.011685245,0.13659786,0.57496285],"study_design_scores_gemma":[0.00013577173,0.00014796497,0.6144936,0.04205856,0.000660149,0.0016775447,0.03620778,0.00043981822,0.000385972,0.0015530059,0.30207387,0.0001658797],"about_ca_topic_score_codex":0.9864451,"about_ca_topic_score_gemma":0.99562067,"teacher_disagreement_score":0.95377123,"about_ca_system_score_codex":0.046228763,"about_ca_system_score_gemma":0.19357488,"threshold_uncertainty_score":0.33541477},"labels":[],"label_agreement":null},{"id":"W4319438997","doi":"10.51731/cjht.2023.560","title":"Tezepelumab (Tezspire)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Asthma; Family medicine; Political science; Health care; Internal medicine","score_opus":0.1247266686164449,"score_gpt":0.4093796100074597,"score_spread":0.2846529413910148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438997","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014898708,0.74255496,0.0028632435,0.017781904,0.0033943735,0.0004505902,0.0053041945,0.0005015784,0.21225038],"genre_scores_gemma":[0.15534048,0.6318753,0.0065483986,0.017148683,0.0014429427,0.00024316381,0.0052627046,0.000066547436,0.1820718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999703,0.000055326316,0.00003139674,0.000035304212,0.00013740738,0.000037655613],"domain_scores_gemma":[0.99965084,0.000074601885,0.0000873114,0.000009880942,0.00013746913,0.00003976783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051825726,0.00027990632,0.0002719305,0.00080253277,0.00025359483,0.0007940952,0.00036678094,0.0005547265,0.020531576],"category_scores_gemma":[0.00089243794,0.00007949133,0.0005943887,0.0004440143,0.00026982932,0.00040514042,0.0002840767,0.0006507871,0.004432772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057003286,0.00006507922,0.00057438266,0.004328349,0.00012865769,0.00018852213,0.00003352657,0.00011356449,0.0043845796,0.0025997998,0.1432773,0.84373623],"study_design_scores_gemma":[0.00035542954,0.0005782647,0.005663596,0.0020554024,0.00020832504,0.001112536,0.000045619185,0.00013673095,0.0041424874,0.00041820007,0.9852647,0.000018773964],"about_ca_topic_score_codex":0.017504554,"about_ca_topic_score_gemma":0.07016777,"teacher_disagreement_score":0.020531576,"about_ca_system_score_codex":0.0013068906,"about_ca_system_score_gemma":0.0017911359,"threshold_uncertainty_score":0.068684936},"labels":[],"label_agreement":null},{"id":"W4319599123","doi":"10.51731/cjht.2023.565","title":"Entrectinib (Rozlytrek)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Internal medicine; Drug; Receptor tyrosine kinase; Intensive care medicine; Family medicine; Pharmacology; Receptor; Health care","score_opus":0.057363275288919775,"score_gpt":0.2583792644691913,"score_spread":0.20101598918027153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319599123","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040564932,0.7812302,0.006786318,0.013065461,0.0005326167,0.00027768975,0.011377427,0.00019561258,0.1459697],"genre_scores_gemma":[0.48275247,0.46455812,0.0042306297,0.0018588986,0.00034983808,0.00014140304,0.0060418337,0.000032370303,0.04003443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996344,0.000099372584,0.000029224711,0.00003130185,0.00017297202,0.000032693435],"domain_scores_gemma":[0.99960965,0.00015045851,0.000098998295,0.000011170837,0.0001023992,0.000027346938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087781326,0.00020897372,0.00028103875,0.0007518908,0.000121449906,0.0007536519,0.00020031426,0.00030424615,0.0061383834],"category_scores_gemma":[0.0011991714,0.00005001349,0.00041046727,0.0009141393,0.00017059261,0.00034281268,0.00019227498,0.00041824888,0.00061272306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081426086,0.00005844719,0.0037603527,0.004529879,0.000527682,0.00015996648,0.000027363385,0.0058500255,0.0011728073,0.021210961,0.067544214,0.89434403],"study_design_scores_gemma":[0.0003960278,0.00052486634,0.023252996,0.0031991885,0.0006851797,0.0011058388,0.000093456816,0.0036183374,0.0031647407,0.0041259197,0.95979244,0.00004094617],"about_ca_topic_score_codex":0.022845225,"about_ca_topic_score_gemma":0.05685911,"teacher_disagreement_score":0.022845225,"about_ca_system_score_codex":0.0030972078,"about_ca_system_score_gemma":0.002491226,"threshold_uncertainty_score":0.04542452},"labels":[],"label_agreement":null},{"id":"W4319752050","doi":"10.51731/cjht.2023.570","title":"Cariprazine (Vraylar)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Bipolar disorder; Mania; Psychiatry; Medicine; Depression (economics); Political science; Lithium (medication); Health care","score_opus":0.12154661428356324,"score_gpt":0.40884815167057953,"score_spread":0.2873015373870163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319752050","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014553123,0.74715686,0.0026374452,0.008204323,0.0014791228,0.00042915565,0.00487324,0.0008765514,0.21979022],"genre_scores_gemma":[0.22552834,0.5733294,0.009715258,0.01491021,0.0010055177,0.000349974,0.007882184,0.00010149792,0.16717756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971384,0.00006369382,0.000028803754,0.000071596776,0.000086672684,0.000035379417],"domain_scores_gemma":[0.99980754,0.00003886826,0.000054469427,0.0000091750935,0.0000588343,0.000031088293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004276934,0.0003871547,0.00030146676,0.00089113734,0.00026966137,0.00063521665,0.0005886831,0.00063957536,0.029757157],"category_scores_gemma":[0.0007366065,0.00010207437,0.0004629329,0.0005275541,0.00023356838,0.0003496504,0.00039375405,0.0006988971,0.008069744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067824445,0.00013066804,0.0004733253,0.006606106,0.00013157087,0.00030137488,0.000054745098,0.00019642554,0.0063817673,0.0050956877,0.12164036,0.8583097],"study_design_scores_gemma":[0.00042568345,0.00064854894,0.003157728,0.0018022663,0.00016013248,0.0014299864,0.000040222934,0.00010760798,0.004123889,0.0004901675,0.98759556,0.000018095592],"about_ca_topic_score_codex":0.01062967,"about_ca_topic_score_gemma":0.026734184,"teacher_disagreement_score":0.029757157,"about_ca_system_score_codex":0.0009782643,"about_ca_system_score_gemma":0.0012160555,"threshold_uncertainty_score":0.099547684},"labels":[],"label_agreement":null},{"id":"W4319981881","doi":"10.51731/cjht.2023.571","title":"Sotrovimab for the Treatment of COVID-19","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Observational study; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Clinical study; Medicine; Internal medicine; Virology; Disease","score_opus":0.13221696115913442,"score_gpt":0.4217765383629842,"score_spread":0.2895595772038497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319981881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10025091,0.71977437,0.005340355,0.04002528,0.008093828,0.0013928479,0.005691017,0.0002577736,0.119173616],"genre_scores_gemma":[0.7234063,0.20275626,0.0076439497,0.039155465,0.0034974818,0.0008317208,0.0040362,0.00007303493,0.01859958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990314,0.0004479303,0.00017027739,0.00007285713,0.00019795689,0.000079609614],"domain_scores_gemma":[0.998623,0.0005646889,0.00043671203,0.00010045986,0.00018069724,0.00009453562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019171004,0.00020519817,0.00048828236,0.0004620873,0.0002330074,0.00070797594,0.0005126428,0.00083791313,0.008356577],"category_scores_gemma":[0.0032672023,0.000076237215,0.0009383096,0.00042601474,0.00035362566,0.0004231401,0.00038503518,0.0009616911,0.00089141895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01776483,0.00036886556,0.010015352,0.013168716,0.0018681773,0.0014317612,0.00017408926,0.00046656732,0.008928952,0.008957862,0.10682608,0.8300288],"study_design_scores_gemma":[0.009075619,0.008818647,0.03962144,0.008900786,0.0025318924,0.005738102,0.00021198606,0.0010746624,0.010453922,0.005782781,0.90771013,0.00007998367],"about_ca_topic_score_codex":0.0018601125,"about_ca_topic_score_gemma":0.0046840254,"teacher_disagreement_score":0.008356577,"about_ca_system_score_codex":0.0007888493,"about_ca_system_score_gemma":0.0010065463,"threshold_uncertainty_score":0.027955532},"labels":[],"label_agreement":null},{"id":"W4320036799","doi":"10.51731/cjht.2023.572","title":"Design, Rationale, and Preliminary Results of the Canadian Homozygous Familial Hypercholesterolemia Registry: 2008 to 2022 Update","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Medicine; Patient registry; Orphan drug; Disease; Atherosclerotic cardiovascular disease; Disease registry; Apheresis; Pediatrics; Intensive care medicine; Cholesterol; Family medicine; Internal medicine; Bioinformatics","score_opus":0.0310804090823588,"score_gpt":0.2634483542726371,"score_spread":0.23236794519027829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320036799","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055197548,0.008873373,0.02185337,0.018673971,0.0036703844,0.5194555,0.3188165,0.00064023875,0.052819073],"genre_scores_gemma":[0.11644842,0.0057102516,0.06887346,0.016512102,0.001182261,0.6058057,0.17225167,0.0003210262,0.012895093],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9646488,0.013069507,0.0046476712,0.0028720014,0.01115707,0.0036050137],"domain_scores_gemma":[0.9171874,0.008526119,0.005097594,0.005816985,0.056550976,0.00682085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06834426,0.001905129,0.0015980698,0.005714321,0.0047144657,0.00519877,0.004032137,0.0019155206,0.010502968],"category_scores_gemma":[0.07902796,0.0018878308,0.0021293955,0.0091091255,0.0018635668,0.0017014919,0.003587841,0.0018653424,0.003937477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012001902,0.0015219158,0.325896,0.009485365,0.0014338866,0.00064687984,0.0031121606,0.0032025808,0.0008901706,0.01583997,0.4353575,0.1906117],"study_design_scores_gemma":[0.008291395,0.0019693545,0.50349945,0.009969586,0.00283136,0.00043053317,0.0025365173,0.0029179852,0.001678024,0.0027278205,0.46269712,0.00045089424],"about_ca_topic_score_codex":0.7408818,"about_ca_topic_score_gemma":0.82956207,"teacher_disagreement_score":0.2591182,"about_ca_system_score_codex":0.04663844,"about_ca_system_score_gemma":0.16090325,"threshold_uncertainty_score":0.5212884},"labels":[],"label_agreement":null},{"id":"W4320918436","doi":"10.51731/cjht.2023.573","title":"Pegvaliase (Palynziq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Phenylalanine; Medicine; Blood concentration; Drug; Internal medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.02057033651950258,"score_gpt":0.27688851353246663,"score_spread":0.25631817701296405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320918436","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026977126,0.6611654,0.0049202,0.015101075,0.0023341924,0.00062957057,0.0054628393,0.0014354946,0.28197405],"genre_scores_gemma":[0.2765905,0.43812382,0.010093336,0.019245896,0.00084076606,0.00054324337,0.009671079,0.00017837735,0.24471304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998468,0.000030343215,0.000016494598,0.000027651693,0.00005754957,0.000021190332],"domain_scores_gemma":[0.9998504,0.000025904885,0.000049483857,0.000006924541,0.0000384162,0.00002890166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037662426,0.00027466618,0.00023889015,0.0004615515,0.00016936845,0.00049958006,0.0004223621,0.00051081314,0.02320395],"category_scores_gemma":[0.0006485398,0.00008477328,0.00036481294,0.00034673902,0.00024223076,0.00039461587,0.00033939027,0.00071543833,0.004908968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010608628,0.000075280586,0.0007002526,0.0018420436,0.000110219895,0.00022654077,0.000024065524,0.0001716388,0.0039286357,0.0027947787,0.10408495,0.8849808],"study_design_scores_gemma":[0.0008711908,0.0009414714,0.0069411634,0.0015157214,0.00014154363,0.0019245186,0.000042693562,0.00025838945,0.0050002886,0.00067319896,0.98166704,0.000022794713],"about_ca_topic_score_codex":0.012959934,"about_ca_topic_score_gemma":0.02671188,"teacher_disagreement_score":0.02320395,"about_ca_system_score_codex":0.0016512021,"about_ca_system_score_gemma":0.001375365,"threshold_uncertainty_score":0.07762492},"labels":[],"label_agreement":null},{"id":"W4321496229","doi":"10.51731/cjht.2023.575","title":"Wastewater Surveillance for Communicable Diseases","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Wastewater; Population; Environmental health; Epidemiological surveillance; Medicine; Epidemiology; Environmental science; Environmental engineering; Pathology","score_opus":0.07479812435245925,"score_gpt":0.3358515198332107,"score_spread":0.26105339548075146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321496229","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03302875,0.11066602,0.013391805,0.05640766,0.007580083,0.002028455,0.17502777,0.00412647,0.59774303],"genre_scores_gemma":[0.3272256,0.15417267,0.037653897,0.039992653,0.0031017617,0.0015475736,0.18482243,0.0005218199,0.2509617],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983461,0.0001979817,0.00015893932,0.0001561654,0.00087499706,0.00026593398],"domain_scores_gemma":[0.9958255,0.00026825967,0.00044887268,0.000108885244,0.0029797864,0.00036871168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014276372,0.0006131814,0.00045499788,0.0037576067,0.000877513,0.001455555,0.0010654447,0.000828261,0.034556653],"category_scores_gemma":[0.0037589406,0.00016959985,0.0006523501,0.0028675364,0.000290222,0.0007131433,0.0014723712,0.0007774271,0.007562235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011931047,0.000089821035,0.05774762,0.0020002457,0.000066771616,0.0002621482,0.00021623154,0.00023828882,0.0015855582,0.002779463,0.44848233,0.4864123],"study_design_scores_gemma":[0.00003604627,0.00016941053,0.14735386,0.0027242543,0.00008172556,0.00044685652,0.00051676313,0.00046355822,0.0019892103,0.0010238934,0.8451546,0.000039853567],"about_ca_topic_score_codex":0.22524117,"about_ca_topic_score_gemma":0.2294132,"teacher_disagreement_score":0.22524117,"about_ca_system_score_codex":0.004059413,"about_ca_system_score_gemma":0.009346954,"threshold_uncertainty_score":0.44786024},"labels":[],"label_agreement":null},{"id":"W4321496367","doi":"10.51731/cjht.2023.576","title":"Ozanimod (Zeposia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Family medicine; Internal medicine; Political science; Health care","score_opus":0.01615046927160108,"score_gpt":0.2630801344444975,"score_spread":0.24692966517289644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321496367","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018552106,0.4979384,0.004084262,0.011163534,0.0062573976,0.0011199868,0.007845538,0.0021155204,0.45092326],"genre_scores_gemma":[0.14622147,0.39033356,0.0072536715,0.014950173,0.0014074945,0.0006927798,0.011860794,0.00025185134,0.42702818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976176,0.000040740502,0.000020173246,0.000044870838,0.00009735854,0.00003514859],"domain_scores_gemma":[0.9998072,0.000025541327,0.000039714578,0.000009048923,0.000062431136,0.000056158002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003806801,0.00047080353,0.00044447294,0.0009838467,0.00031119294,0.00088677224,0.00058659597,0.00097420206,0.078444496],"category_scores_gemma":[0.0007050265,0.00012829022,0.00047788327,0.0006001227,0.0004019833,0.0007094442,0.00077622605,0.0011011652,0.014826319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016789491,0.00014371514,0.00034923962,0.0053508906,0.000082379884,0.00031572932,0.00005277121,0.00015056046,0.008442085,0.0063171224,0.16975208,0.80736464],"study_design_scores_gemma":[0.0005307962,0.0006815175,0.0014062139,0.0009800001,0.00007613336,0.0005731208,0.00004884692,0.00009372434,0.0044947737,0.00064521487,0.9904535,0.000016054266],"about_ca_topic_score_codex":0.00650202,"about_ca_topic_score_gemma":0.012458281,"teacher_disagreement_score":0.078444496,"about_ca_system_score_codex":0.00082754076,"about_ca_system_score_gemma":0.0016580967,"threshold_uncertainty_score":0.26242298},"labels":[],"label_agreement":null},{"id":"W4321597293","doi":"10.51731/cjht.2023.577","title":"Pitolisant Hydrochloride (Wakix)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Narcolepsy; Cataplexy; Medicine; Psychiatry; Political science; Modafinil; Health care","score_opus":0.2579957923937001,"score_gpt":0.5011647147126034,"score_spread":0.2431689223189033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321597293","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023897085,0.8226435,0.0029000312,0.0065383944,0.0019482044,0.0003352749,0.0025811817,0.00048563952,0.13867067],"genre_scores_gemma":[0.17728409,0.67336136,0.0054477695,0.0076037706,0.0007310965,0.00023079664,0.0030042264,0.000054816388,0.13228208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998512,0.00002086767,0.000015989774,0.000023559867,0.0000714376,0.000017013253],"domain_scores_gemma":[0.9998659,0.00002707647,0.000045803474,0.000004869042,0.000042177755,0.000014161083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002669572,0.00030805072,0.0002006991,0.00079529895,0.00024069245,0.00040848428,0.0003688276,0.00047824666,0.014695933],"category_scores_gemma":[0.00039633727,0.00008171218,0.00033503215,0.0004313035,0.0002896517,0.00044723466,0.00035486845,0.000548968,0.0029469808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052463764,0.00008804316,0.00051360147,0.008176738,0.00009399483,0.0005581451,0.000053106218,0.0001274003,0.017741673,0.0037000845,0.068506606,0.8999159],"study_design_scores_gemma":[0.00024299514,0.0015798828,0.0089061605,0.0028065129,0.00018487046,0.002759155,0.000112515874,0.00020159243,0.0155372415,0.0007412689,0.96689993,0.00002785213],"about_ca_topic_score_codex":0.009211468,"about_ca_topic_score_gemma":0.03142323,"teacher_disagreement_score":0.014695933,"about_ca_system_score_codex":0.0006785399,"about_ca_system_score_gemma":0.0010827339,"threshold_uncertainty_score":0.049162805},"labels":[],"label_agreement":null},{"id":"W4321790146","doi":"10.51731/cjht.2023.581","title":"Dalbavancin (Xydalba)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bacterial Identification and Susceptibility Testing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Streptococcus anginosus; Dalbavancin; Streptococcus dysgalactiae; Microbiology; Streptococcus; Medicine; Enterococcus faecalis; Clindamycin; Enterococcus; Streptococcus pyogenes; Staphylococcus aureus; Vancomycin; Linezolid; Streptococcus agalactiae; Antibiotics; Biology; Bacteria","score_opus":0.03387587921961897,"score_gpt":0.291212006580458,"score_spread":0.257336127360839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321790146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04138001,0.78621536,0.007867057,0.005180296,0.0020264538,0.00049990683,0.0033966491,0.0010245446,0.1524097],"genre_scores_gemma":[0.48012733,0.37441614,0.009831632,0.006623027,0.00035621837,0.00028253353,0.005172693,0.00008242419,0.12310801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998018,0.000043945376,0.000019939589,0.000035490266,0.000068897185,0.000029942803],"domain_scores_gemma":[0.99984133,0.000028947687,0.000040996943,0.0000059171743,0.000054445092,0.000028258943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024407894,0.00030210926,0.0002382637,0.0007351471,0.00017503834,0.0006502427,0.00043246057,0.00038032845,0.011612392],"category_scores_gemma":[0.0005141255,0.00010640928,0.00026692438,0.0003759321,0.00023871417,0.00029176145,0.00032911534,0.0004120731,0.002239994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006945322,0.00012917187,0.0014141686,0.003932142,0.000094578725,0.00026675235,0.000041233518,0.00040904485,0.031426497,0.0051780213,0.04451391,0.9119],"study_design_scores_gemma":[0.00033495313,0.0012731315,0.00809618,0.0013117242,0.000120384706,0.001931114,0.0000719743,0.00054344547,0.032392368,0.00074336986,0.953152,0.00002931073],"about_ca_topic_score_codex":0.009464058,"about_ca_topic_score_gemma":0.025035243,"teacher_disagreement_score":0.011612392,"about_ca_system_score_codex":0.0012776374,"about_ca_system_score_gemma":0.0014165377,"threshold_uncertainty_score":0.038847327},"labels":[],"label_agreement":null},{"id":"W4321850144","doi":"10.51731/cjht.2023.583","title":"Edaravone Oral Suspension (Radicava)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Edaravone; Amyotrophic lateral sclerosis; Suspension (topology); Medicine; Intensive care medicine; Pharmacology; Internal medicine; Political science; Disease; Health care","score_opus":0.09077613698380728,"score_gpt":0.35837008768806955,"score_spread":0.2675939507042623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850144","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012401005,0.85053617,0.0013911871,0.008877283,0.0025315147,0.00036821185,0.0033470835,0.00016916185,0.120378315],"genre_scores_gemma":[0.11960468,0.74691105,0.005601279,0.010963619,0.00086678175,0.00026382916,0.00451619,0.000062722975,0.11120984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992654,0.00014584466,0.000085747306,0.000068702066,0.00037165108,0.00006263352],"domain_scores_gemma":[0.99925417,0.00017533473,0.0001491607,0.000019424922,0.00035748878,0.00004445688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012404444,0.00030431547,0.00042066665,0.001016382,0.0003381077,0.0010362945,0.0005578067,0.00078558846,0.012876372],"category_scores_gemma":[0.0016042367,0.00010312779,0.000809558,0.00077454315,0.00045746897,0.0004361425,0.0003284424,0.000665008,0.0020061715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010114184,0.000100446756,0.00088270963,0.008891492,0.0002350035,0.00018660365,0.000047803685,0.00011445186,0.005609626,0.0036546127,0.10178218,0.87748367],"study_design_scores_gemma":[0.00053721527,0.0014344498,0.007222242,0.0052287444,0.00044049215,0.0006570071,0.000107530395,0.0000980954,0.0061033284,0.000491525,0.9776499,0.000029299383],"about_ca_topic_score_codex":0.05209717,"about_ca_topic_score_gemma":0.1709698,"teacher_disagreement_score":0.05209717,"about_ca_system_score_codex":0.002273584,"about_ca_system_score_gemma":0.0043159705,"threshold_uncertainty_score":0.103587866},"labels":[],"label_agreement":null},{"id":"W4321850145","doi":"10.51731/cjht.2023.584","title":"Dental Sealants for the Prevention of Dental Caries","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental Health and Care Utilization","field":"Dentistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sealant; Dentistry; Medicine; Molar; Materials science","score_opus":0.042477260995364606,"score_gpt":0.34320494903714555,"score_spread":0.30072768804178096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850145","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011127492,0.78890806,0.009432128,0.037573792,0.0037263257,0.0020978733,0.0036089087,0.00044130557,0.14308402],"genre_scores_gemma":[0.13811915,0.7007788,0.07584237,0.020409355,0.001030413,0.0015770791,0.0028932402,0.00018004702,0.059169568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.974261,0.0045189233,0.0021012276,0.00069435715,0.017431473,0.000993098],"domain_scores_gemma":[0.9872285,0.0017326255,0.0018479462,0.00044608486,0.008178949,0.0005658602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016035594,0.0006212312,0.0009613901,0.0037550607,0.0018332562,0.0023438102,0.0018829592,0.00180056,0.0073353956],"category_scores_gemma":[0.015214861,0.00037672618,0.0014822256,0.0023741515,0.0010197569,0.000718411,0.001494182,0.0022768506,0.0017691203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038973457,0.00053578796,0.00497315,0.017516606,0.0002373046,0.00024294207,0.0011524132,0.00016559548,0.0066494173,0.01693758,0.13681252,0.8143869],"study_design_scores_gemma":[0.00012890823,0.00042491488,0.022914363,0.010599643,0.00035252993,0.00040690185,0.00047318175,0.00011254678,0.00428889,0.0022271818,0.9580059,0.00006497986],"about_ca_topic_score_codex":0.27235293,"about_ca_topic_score_gemma":0.49751133,"teacher_disagreement_score":0.27235293,"about_ca_system_score_codex":0.007169415,"about_ca_system_score_gemma":0.029513499,"threshold_uncertainty_score":0.5415353},"labels":[],"label_agreement":null},{"id":"W4322628486","doi":"10.51731/cjht.2023.588","title":"Mepolizumab (Nucala)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mepolizumab; Medicine; Nasal administration; Sinusitis; Intensive care medicine; Family medicine; Surgery; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.05100338439174335,"score_gpt":0.3310257490628313,"score_spread":0.28002236467108793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628486","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00664017,0.9158272,0.0013869077,0.005890047,0.0010622306,0.0001298028,0.0013379918,0.00019132927,0.067534335],"genre_scores_gemma":[0.09590706,0.8159103,0.0052267076,0.008268696,0.0009098065,0.00019001421,0.0023435033,0.00003885515,0.071205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997036,0.00005635185,0.00003517592,0.00004193241,0.00012746808,0.000035443558],"domain_scores_gemma":[0.99974257,0.000057508463,0.000079678444,0.000008559225,0.000084938845,0.000026703141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005098789,0.00028255352,0.00029717007,0.0006246661,0.00020861957,0.0005665419,0.00034634062,0.0004443268,0.01068457],"category_scores_gemma":[0.0007141032,0.000082093014,0.00037941767,0.0003977686,0.00023226858,0.00041208923,0.00033550186,0.00054791674,0.0023048874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003911823,0.000044641452,0.0004474974,0.0047305822,0.00008584947,0.00019064145,0.000027100123,0.00009233143,0.005021254,0.0024684255,0.066470675,0.92002976],"study_design_scores_gemma":[0.00015823274,0.0005005827,0.006027467,0.0027619319,0.00017697093,0.0013619211,0.00003649161,0.00011821928,0.0050014537,0.0003919319,0.9834487,0.000016120603],"about_ca_topic_score_codex":0.014464388,"about_ca_topic_score_gemma":0.04088003,"teacher_disagreement_score":0.014464388,"about_ca_system_score_codex":0.0010046135,"about_ca_system_score_gemma":0.0014547858,"threshold_uncertainty_score":0.035743475},"labels":[],"label_agreement":null},{"id":"W4322628564","doi":"10.51731/cjht.2023.586","title":"Guselkumab (Tremfya)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Psoriatic arthritis; Antirheumatic drugs; Drug; Methotrexate; Family medicine; Rheumatoid arthritis; Antirheumatic Agents; Surgery; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.14677292511683313,"score_gpt":0.4164534900742946,"score_spread":0.2696805649574615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628564","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01552944,0.81054366,0.0020257318,0.010302591,0.002031103,0.0002714946,0.0026290466,0.0004938174,0.15617305],"genre_scores_gemma":[0.18373592,0.59721315,0.0058930647,0.01800268,0.0010895274,0.00029796676,0.005169237,0.000077344164,0.18852116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997563,0.000051633077,0.000020613903,0.00003785191,0.00009570375,0.000037978065],"domain_scores_gemma":[0.9997718,0.000044486867,0.00006528379,0.000008381537,0.000068052344,0.000042038657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055514864,0.0002831792,0.00028138384,0.00073333975,0.00022555437,0.00062375795,0.00042433754,0.0006587238,0.022768479],"category_scores_gemma":[0.0006343821,0.000080557074,0.00053567404,0.00045521717,0.00034553738,0.00047722703,0.00040386734,0.00075763545,0.0066643497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007582228,0.00009929944,0.00048068585,0.0046267533,0.000105175495,0.00027925172,0.000042999345,0.000114582166,0.0068274825,0.0039622467,0.110512406,0.87219095],"study_design_scores_gemma":[0.00041764948,0.0008699347,0.0042243684,0.0017056705,0.00014330437,0.0015309404,0.000044455184,0.0001034614,0.0051411563,0.00065993954,0.9851394,0.000019644753],"about_ca_topic_score_codex":0.006833793,"about_ca_topic_score_gemma":0.021808239,"teacher_disagreement_score":0.022768479,"about_ca_system_score_codex":0.0011180477,"about_ca_system_score_gemma":0.0013079036,"threshold_uncertainty_score":0.07616812},"labels":[],"label_agreement":null},{"id":"W4322726485","doi":"10.51731/cjht.2022.589","title":"Point-of-Care Tests for Pancreatitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatitis; Endoscopic retrograde cholangiopancreatography; Point of care; Medicine; Acute pancreatitis; Point (geometry); Test (biology); Point-of-care testing; Health care; Service (business); Intensive care medicine; Business; Pathology; Internal medicine; Political science; Biology; Mathematics; Marketing","score_opus":0.041378879018475076,"score_gpt":0.3270817336030432,"score_spread":0.2857028545845681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322726485","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06979315,0.14159214,0.028818188,0.046550937,0.0064971996,0.0022625404,0.036315255,0.004415322,0.66375524],"genre_scores_gemma":[0.55504084,0.120878145,0.07124425,0.029723503,0.005131036,0.0013778339,0.04038462,0.0006657919,0.17555398],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99839044,0.00024596506,0.0001752674,0.000100142635,0.0008934781,0.00019468927],"domain_scores_gemma":[0.9966731,0.0004956255,0.00047288174,0.00011520543,0.0019203926,0.0003228552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012193815,0.00040746437,0.0005279019,0.0028251237,0.00054619083,0.0011534535,0.00080319983,0.00084667583,0.03193311],"category_scores_gemma":[0.0059295455,0.00014549003,0.00056705246,0.0020416463,0.0003066951,0.0005516964,0.0006422076,0.00084683596,0.008680162],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007072847,0.00018569203,0.08910858,0.000928624,0.000097144766,0.0020362467,0.0001849166,0.0002768173,0.003483491,0.0030058222,0.5518456,0.34813976],"study_design_scores_gemma":[0.00017707222,0.0007203531,0.2760046,0.0025896914,0.00019828007,0.009673146,0.00045157052,0.0011659337,0.005464116,0.0022425745,0.70118606,0.00012661505],"about_ca_topic_score_codex":0.033151336,"about_ca_topic_score_gemma":0.043689474,"teacher_disagreement_score":0.033151336,"about_ca_system_score_codex":0.0013761471,"about_ca_system_score_gemma":0.0016184603,"threshold_uncertainty_score":0.10682684},"labels":[],"label_agreement":null},{"id":"W4323360573","doi":"10.51731/cjht.2022.590","title":"2023 Watch List: Top 10 Precision Medicine Technologies and Issues","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; York University; Hospital for Sick Children; University of Toronto; SickKids Foundation; Cancer Care Ontario","funders":"","keywords":"Precision medicine; Health care; Scope (computer science); Equity (law); Health equity; Mental health; Medicine; Computer science; Political science","score_opus":0.3294868882497334,"score_gpt":0.4438877261962957,"score_spread":0.1144008379465623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323360573","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020716854,0.0934107,0.01106039,0.32962918,0.14052385,0.0014327705,0.019902874,0.0058444156,0.39612412],"genre_scores_gemma":[0.01160198,0.13239,0.030139852,0.26548666,0.043574933,0.0015540291,0.040517934,0.002723102,0.47201148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.989838,0.0008203293,0.00076420273,0.0006039714,0.006318011,0.0016556046],"domain_scores_gemma":[0.9387437,0.007974774,0.0023866303,0.0014452608,0.039562337,0.009887272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010072204,0.0018165333,0.001484229,0.004704662,0.0042366497,0.0127283335,0.003937535,0.011372046,0.09626165],"category_scores_gemma":[0.029547812,0.0009246344,0.002074321,0.004681947,0.0019634024,0.0076969657,0.0036429241,0.009127622,0.0569817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035023488,0.000029267545,0.0002878387,0.00033891114,0.000006223301,0.0000700281,0.000021137148,0.00007025426,0.00031385347,0.004329268,0.94349134,0.051006902],"study_design_scores_gemma":[0.000016241182,0.000029162535,0.0005243435,0.0005951645,0.000010457264,0.00008594551,0.00004046474,0.00008259106,0.00021257563,0.0013477034,0.997035,0.000020386884],"about_ca_topic_score_codex":0.045842335,"about_ca_topic_score_gemma":0.08755567,"teacher_disagreement_score":0.09626165,"about_ca_system_score_codex":0.0081754895,"about_ca_system_score_gemma":0.03842655,"threshold_uncertainty_score":0.32202733},"labels":[],"label_agreement":null},{"id":"W4323569680","doi":"10.51731/cjht.2022.591","title":"Automatic Stop Orders for Opioids","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Medical prescription; Opioid; Context (archaeology); Medicine; Adverse effect; Pharmacology; Internal medicine","score_opus":0.03600269691823518,"score_gpt":0.32803725950607904,"score_spread":0.2920345625878439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323569680","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24497136,0.1581183,0.027035763,0.07121926,0.010897754,0.006129387,0.03144435,0.004668098,0.4455157],"genre_scores_gemma":[0.8128536,0.053400937,0.033737995,0.035662424,0.0035001726,0.0021116112,0.012077523,0.00056884455,0.046086818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887179,0.0034864205,0.0017593546,0.000587362,0.0045326846,0.0009162637],"domain_scores_gemma":[0.95722806,0.018640015,0.010436745,0.0035398575,0.00815014,0.0020051121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059004477,0.00042500778,0.00073149183,0.0015165319,0.0013138347,0.0022626582,0.00204385,0.0012091652,0.03408919],"category_scores_gemma":[0.0453371,0.0003766996,0.0020918187,0.0016161867,0.0009311554,0.0016548391,0.0012737202,0.0024584644,0.0030863995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032187975,0.0011111689,0.034312487,0.013528122,0.0009510891,0.0005569249,0.0009861131,0.00070746744,0.0012137833,0.013759812,0.13441066,0.7952436],"study_design_scores_gemma":[0.003022342,0.003192106,0.20018747,0.022553755,0.0018211538,0.0019665237,0.0015475098,0.0018708217,0.005553168,0.009633393,0.74836946,0.00028226819],"about_ca_topic_score_codex":0.052826606,"about_ca_topic_score_gemma":0.08674068,"teacher_disagreement_score":0.052826606,"about_ca_system_score_codex":0.004731788,"about_ca_system_score_gemma":0.014877585,"threshold_uncertainty_score":0.11403966},"labels":[],"label_agreement":null},{"id":"W4323925622","doi":"10.51731/cjht.2022.594","title":"Dexamethasone Intravitreal Implant (Ozurdex)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Dexamethasone; Implant; Drug; Intensive care medicine; Ophthalmology; Pharmacology; Surgery; Internal medicine; Diabetic retinopathy; Diabetes mellitus; Health care; Political science; Endocrinology","score_opus":0.035897500427676775,"score_gpt":0.3247893953953579,"score_spread":0.28889189496768114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323925622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006483574,0.9223744,0.0009001786,0.0053154784,0.0015679256,0.00015386961,0.0013910158,0.000109744295,0.06170391],"genre_scores_gemma":[0.09125367,0.8380339,0.0038873453,0.008194123,0.0007807915,0.00013688153,0.0021250576,0.00003314685,0.05555509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994733,0.00010084962,0.00006408423,0.000052838877,0.00025446413,0.000054446544],"domain_scores_gemma":[0.9994184,0.00016219281,0.00016626998,0.000014826506,0.00019612085,0.00004222402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007525589,0.0002803876,0.00035494796,0.00094639556,0.00025790042,0.0008611513,0.00042842014,0.00047047337,0.011421477],"category_scores_gemma":[0.00097654713,0.00007460032,0.0006220049,0.00071875483,0.00035655586,0.00036049206,0.0003128093,0.00062487036,0.0017343707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066143146,0.000084004685,0.0011936844,0.0070653586,0.00020502407,0.00025483657,0.000033883978,0.00010949989,0.0042345766,0.0040166792,0.08388465,0.8982563],"study_design_scores_gemma":[0.0003896555,0.0009874149,0.009999516,0.0046927817,0.00052751217,0.0013087591,0.00012552236,0.00014284623,0.007069996,0.0005646161,0.97416127,0.000030128871],"about_ca_topic_score_codex":0.035581905,"about_ca_topic_score_gemma":0.11371346,"teacher_disagreement_score":0.035581905,"about_ca_system_score_codex":0.0020486815,"about_ca_system_score_gemma":0.002987511,"threshold_uncertainty_score":0.07074964},"labels":[],"label_agreement":null},{"id":"W4324149309","doi":"10.51731/cjht.2022.596","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Bevacizumab; Test (biology); Family medicine; Intensive care medicine; Chemotherapy; Cancer; Internal medicine; Health care; Immunotherapy; Political science","score_opus":0.038417204387254815,"score_gpt":0.3117376367690041,"score_spread":0.2733204323817493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324149309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012786473,0.84764796,0.001925205,0.008908291,0.0017042622,0.0002957363,0.0021620833,0.00030401166,0.12426595],"genre_scores_gemma":[0.18637627,0.6790373,0.0072869407,0.012628591,0.0008978549,0.00031161384,0.0033417947,0.000050490347,0.11006908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976486,0.00004977039,0.000026355101,0.000042144904,0.000081724495,0.000035087647],"domain_scores_gemma":[0.9997503,0.00005710165,0.00007142091,0.000011390429,0.000077293465,0.000032401433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050063664,0.00026743053,0.00023453352,0.00061422604,0.00021362159,0.00071351515,0.00032933697,0.00047330785,0.013045209],"category_scores_gemma":[0.0008784412,0.00008628545,0.000338889,0.0003904503,0.00024746894,0.0005705114,0.00032584192,0.0006425652,0.0028394298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005522528,0.000052258103,0.0005131743,0.0032737283,0.0001098101,0.00013924707,0.000030184103,0.00011607242,0.004358391,0.0032694524,0.068018466,0.919567],"study_design_scores_gemma":[0.00031966108,0.00065549486,0.0042819604,0.0022315355,0.00019492321,0.0009837191,0.000040211868,0.00011409493,0.0056210635,0.00061109127,0.9849304,0.000015957285],"about_ca_topic_score_codex":0.011472068,"about_ca_topic_score_gemma":0.031862773,"teacher_disagreement_score":0.013045209,"about_ca_system_score_codex":0.0013840853,"about_ca_system_score_gemma":0.0015203122,"threshold_uncertainty_score":0.043640614},"labels":[],"label_agreement":null},{"id":"W4327621571","doi":"10.51731/cjht.2023.597","title":"Eptinezumab (Vyepti)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Drug class; Medicine; Family medicine; Drug; Psychiatry; Political science; Health care; Law","score_opus":0.06256858349756063,"score_gpt":0.3386118358547654,"score_spread":0.2760432523572048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327621571","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019431608,0.8807127,0.0018443484,0.007825171,0.0015792068,0.0002683186,0.0022354105,0.00029201637,0.085811086],"genre_scores_gemma":[0.2335921,0.6592108,0.006236611,0.009934732,0.0010169086,0.0003226269,0.00369856,0.000051493298,0.08593613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997577,0.00007138474,0.000031454387,0.000035042616,0.00007968983,0.000024624447],"domain_scores_gemma":[0.99973696,0.000083046136,0.00007574319,0.000009099691,0.00006613726,0.000028931638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005792969,0.00020132949,0.00029995045,0.0005333394,0.00015251304,0.0005574182,0.00025227858,0.0004465452,0.014468093],"category_scores_gemma":[0.0009550274,0.00006266429,0.0004443253,0.0003341269,0.00020147234,0.00041672782,0.000256532,0.00046326374,0.002383525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012601911,0.00006230666,0.0008812437,0.0055662063,0.00015511521,0.0001968663,0.000036251527,0.000088338835,0.0044013173,0.002175721,0.06777956,0.91739696],"study_design_scores_gemma":[0.0010125635,0.0019296594,0.011523353,0.00534399,0.00048704495,0.002200617,0.00008101245,0.0001815549,0.0062706945,0.00070014084,0.9702434,0.000025965288],"about_ca_topic_score_codex":0.0042338427,"about_ca_topic_score_gemma":0.011931307,"teacher_disagreement_score":0.014468093,"about_ca_system_score_codex":0.000714591,"about_ca_system_score_gemma":0.00087214477,"threshold_uncertainty_score":0.04840064},"labels":[],"label_agreement":null},{"id":"W4327698971","doi":"10.51731/cjht.2023.599","title":"Formulary Management of Targeted Immune Modulators in Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Infliximab; Biosimilar; Tofacitinib; Adalimumab; Ustekinumab; Formulary; Vedolizumab; Pharmacology; Immunology; Internal medicine; Rheumatoid arthritis; Disease","score_opus":0.02723269619042964,"score_gpt":0.29722217123173855,"score_spread":0.26998947504130894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327698971","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04119893,0.20737766,0.010980103,0.3393551,0.010016734,0.0010240627,0.0012098262,0.00087998185,0.38795757],"genre_scores_gemma":[0.36090422,0.20400861,0.052135684,0.16255172,0.01577096,0.0008437051,0.0052539576,0.0004196225,0.19811149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998187,0.0004681976,0.00017040496,0.00008214698,0.0008317466,0.0002604588],"domain_scores_gemma":[0.997619,0.00037969896,0.0005678807,0.00012135503,0.0007603578,0.0005516393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002317051,0.00018475673,0.00038478567,0.0006793358,0.0009644194,0.001964124,0.0007688965,0.0017093029,0.01751398],"category_scores_gemma":[0.005593727,0.00012770218,0.0005630533,0.0006035529,0.0006938256,0.0016212603,0.0016209803,0.0018645843,0.004162129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044837478,0.00022606048,0.004617874,0.0008573765,0.000032422657,0.0015377933,0.00032729428,0.00026395582,0.0021468669,0.010276858,0.387594,0.5916711],"study_design_scores_gemma":[0.00023359887,0.00043596295,0.0045719687,0.0009707909,0.000037390397,0.0018910991,0.00027519898,0.00033365734,0.0010262772,0.0026649642,0.9875403,0.000018738707],"about_ca_topic_score_codex":0.008960149,"about_ca_topic_score_gemma":0.022666737,"teacher_disagreement_score":0.01751398,"about_ca_system_score_codex":0.0028274609,"about_ca_system_score_gemma":0.0030514083,"threshold_uncertainty_score":0.058590114},"labels":[],"label_agreement":null},{"id":"W4328121497","doi":"10.51731/cjht.2023.600","title":"An Overview of Clinical Applications of Virtual and Augmented Reality","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological intervention; Anxiety; Mental health; Medicine; Intervention (counseling); Virtual reality; Health care; Autism spectrum disorder; Psychiatry; Autism; Computer science; Human–computer interaction","score_opus":0.17253962374510123,"score_gpt":0.4711807475025072,"score_spread":0.298641123757406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328121497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001463414,0.95576596,0.0056973607,0.0026059418,0.0006148439,0.00011601042,0.00035702388,0.00019161611,0.03318775],"genre_scores_gemma":[0.012493237,0.9662823,0.011949283,0.0018327984,0.0008600412,0.00016707723,0.00052621565,0.000061333645,0.005827674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979265,0.0005116718,0.00030700356,0.00019420078,0.00093841366,0.00012224143],"domain_scores_gemma":[0.99690396,0.0017710897,0.00021952651,0.00011670413,0.00086001895,0.00012870392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022724895,0.00089522696,0.00077164534,0.006644058,0.00042334505,0.002484527,0.001144542,0.0016970849,0.0133633],"category_scores_gemma":[0.0044837976,0.00046658266,0.0013482093,0.0042838836,0.00073298794,0.0019358674,0.0014255566,0.0013791281,0.0035102987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095766976,0.00005180563,0.0007753409,0.005356229,0.00005262055,0.0002064692,0.00015692734,0.00034186666,0.00093242404,0.0034999703,0.019012664,0.9695179],"study_design_scores_gemma":[0.00003109641,0.00032124927,0.00608054,0.0131835425,0.00015562268,0.0071541397,0.0003641594,0.00056046265,0.0017124392,0.0039996495,0.96634245,0.000094720875],"about_ca_topic_score_codex":0.004343648,"about_ca_topic_score_gemma":0.0060421587,"teacher_disagreement_score":0.0133633,"about_ca_system_score_codex":0.0012479466,"about_ca_system_score_gemma":0.0020302064,"threshold_uncertainty_score":0.044704676},"labels":[],"label_agreement":null},{"id":"W4353076861","doi":"10.51731/cjht.2023.603","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Chemotherapy; Oncology; Disease; Internal medicine; Breast cancer; Test (biology); Family medicine; Cancer; Health care; Immunotherapy; Political science","score_opus":0.038417204387254815,"score_gpt":0.3117376367690041,"score_spread":0.2733204323817493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353076861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013424475,0.81540674,0.0020536722,0.011984803,0.0022092601,0.00036337902,0.0028778384,0.00036981315,0.15130998],"genre_scores_gemma":[0.196829,0.6443436,0.007560398,0.01640976,0.0011546429,0.00037798312,0.004179822,0.000053549342,0.12909126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997484,0.000055674092,0.000029361585,0.000041392494,0.00008879632,0.000036453646],"domain_scores_gemma":[0.99970144,0.000067601824,0.00008528249,0.000012947161,0.00009334285,0.000039337785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053624366,0.00024349809,0.0002427454,0.0005722989,0.00021309064,0.00067467644,0.0003402939,0.00047894698,0.014700733],"category_scores_gemma":[0.0010356669,0.000084189785,0.0003783251,0.0003646622,0.0002287085,0.0005419305,0.00031569385,0.0006536943,0.0029363197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006277532,0.000052902647,0.0005756749,0.0033902961,0.00011508217,0.00012723696,0.000023482504,0.000100150704,0.003165815,0.0027543283,0.08207544,0.90699196],"study_design_scores_gemma":[0.00040736664,0.00069354405,0.005193246,0.0025862418,0.00021934387,0.0008954587,0.00003494196,0.000118064505,0.0044207973,0.00061020034,0.98480517,0.000015552912],"about_ca_topic_score_codex":0.010328591,"about_ca_topic_score_gemma":0.03074959,"teacher_disagreement_score":0.014700733,"about_ca_system_score_codex":0.0012399182,"about_ca_system_score_gemma":0.0014120002,"threshold_uncertainty_score":0.0491789},"labels":[],"label_agreement":null},{"id":"W4360949189","doi":"10.51731/cjht.2023.607","title":"Living With Type 2 Diabetes","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Diabetes Canada","keywords":"Reimbursement; Psychosocial; Medicine; Quality of life (healthcare); Type 2 diabetes; Polypharmacy; Type 1 diabetes; Diabetes mellitus; Nursing; Gerontology; Intensive care medicine; Psychiatry; Health care; Political science","score_opus":0.02818776541507773,"score_gpt":0.2793533771637474,"score_spread":0.2511656117486697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360949189","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010032762,0.14046118,0.0037104762,0.50786966,0.030951511,0.0012119658,0.008399744,0.00021425668,0.29714853],"genre_scores_gemma":[0.09277706,0.16425581,0.006460377,0.59925807,0.013555822,0.0028778058,0.0057408027,0.00023151678,0.11484267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943679,0.0022394098,0.0006668237,0.0005193015,0.0016006385,0.00060594664],"domain_scores_gemma":[0.9924446,0.0024539316,0.0008762548,0.00026305948,0.0025410028,0.001421144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003433924,0.00035436676,0.00039248547,0.0010692395,0.0032262772,0.0029808728,0.00063298753,0.0015806697,0.02466528],"category_scores_gemma":[0.017531112,0.00017034294,0.0007408776,0.0012630286,0.0015017493,0.003188587,0.0028340789,0.003716186,0.0029603238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036159134,0.000018830342,0.0027432537,0.0023589942,0.000035362187,0.00043416442,0.007008201,0.000040330546,0.00013131007,0.01073824,0.83694696,0.13950822],"study_design_scores_gemma":[0.0000063676184,0.000017601775,0.0016423855,0.0025178418,0.000019805537,0.0002672127,0.002311136,0.0000120315835,0.00002861882,0.0005886025,0.9925747,0.00001383636],"about_ca_topic_score_codex":0.08589438,"about_ca_topic_score_gemma":0.20573574,"teacher_disagreement_score":0.08589438,"about_ca_system_score_codex":0.007027058,"about_ca_system_score_gemma":0.017843105,"threshold_uncertainty_score":0.17078882},"labels":[],"label_agreement":null},{"id":"W4361205476","doi":"10.51731/cjht.2023.608","title":"Formulary Management of Biologics in Plaque Psoriasis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Biosimilar; Medicine; Formulary; Plaque psoriasis; Biologic Agents; Infliximab; Psoriasis; Family medicine; Tumor necrosis factor alpha; Internal medicine; Dermatology; Disease","score_opus":0.04817312372920696,"score_gpt":0.31702777676995286,"score_spread":0.2688546530407459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361205476","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032853406,0.49520743,0.01594126,0.14141405,0.012075586,0.000917366,0.0007346553,0.0008312344,0.30002496],"genre_scores_gemma":[0.34943977,0.38237664,0.039726306,0.08252862,0.020512782,0.0010200064,0.001982291,0.00031844483,0.12209522],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879813,0.00034741164,0.00015094233,0.00007446663,0.00052554783,0.0001034951],"domain_scores_gemma":[0.9988815,0.00028658425,0.00031348318,0.00007376986,0.00029544355,0.00014915543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014440769,0.0002322309,0.00043960277,0.0006547821,0.00061191915,0.0015617937,0.0007339697,0.0014798534,0.0126793105],"category_scores_gemma":[0.003806027,0.00013716433,0.0005547823,0.00035495323,0.0005178262,0.0012198536,0.001274753,0.001855392,0.004270533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000489491,0.00022464411,0.0012689434,0.0012576553,0.00004668972,0.0012269398,0.0001945765,0.0002479813,0.003086101,0.008712541,0.17261745,0.810627],"study_design_scores_gemma":[0.00040467273,0.00062734465,0.002572905,0.0018718292,0.000082168,0.004096774,0.0001609333,0.00053336035,0.0025444583,0.0050380225,0.9820447,0.000022764803],"about_ca_topic_score_codex":0.001216578,"about_ca_topic_score_gemma":0.00276223,"teacher_disagreement_score":0.99893045,"about_ca_system_score_codex":0.0010695319,"about_ca_system_score_gemma":0.0009659487,"threshold_uncertainty_score":0.042416513},"labels":[],"label_agreement":null},{"id":"W4361268230","doi":"10.51731/cjht.2023.612","title":"Brolucizumab (Beovu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Drug; Family medicine; Political science; Pharmacology; Diabetes mellitus; Diabetic retinopathy; Health care","score_opus":0.03906193496694753,"score_gpt":0.3253698351831276,"score_spread":0.2863079002161801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361268230","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012537554,0.79864746,0.0020459404,0.011558214,0.0028522282,0.00037210283,0.0033028373,0.00040427354,0.16827945],"genre_scores_gemma":[0.19003753,0.5741024,0.008149569,0.023562416,0.001683762,0.0004745975,0.008927821,0.00009195536,0.19297002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996489,0.00005896932,0.000027885488,0.00005323879,0.00014624055,0.000064773405],"domain_scores_gemma":[0.9997427,0.000038466136,0.00007403074,0.0000084583135,0.00009798785,0.00003844153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057164003,0.00036903706,0.00030405534,0.0006459237,0.00027986095,0.0006796618,0.00047130554,0.00073270197,0.014942326],"category_scores_gemma":[0.00078251393,0.00010260917,0.0005151645,0.00035063125,0.00027141353,0.00038754463,0.00040617448,0.0008237954,0.004736106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006510666,0.00011120287,0.00091391156,0.0033191433,0.00009488239,0.00022071612,0.000040745486,0.00020878954,0.008976023,0.0045827595,0.167573,0.8133078],"study_design_scores_gemma":[0.00021833672,0.0006871859,0.0028329084,0.0014146189,0.000090524685,0.0007931439,0.000026767288,0.000100672085,0.004601048,0.00031278332,0.98890775,0.0000142992685],"about_ca_topic_score_codex":0.024835646,"about_ca_topic_score_gemma":0.050143763,"teacher_disagreement_score":0.024835646,"about_ca_system_score_codex":0.0016952406,"about_ca_system_score_gemma":0.0019645193,"threshold_uncertainty_score":0.049987018},"labels":[],"label_agreement":null},{"id":"W4361283772","doi":"10.51731/cjht.2023.610","title":"Darolutamide (Nubeqa)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Docetaxel; Prostate cancer; Medicine; Drug; Drug class; Family medicine; Cancer; Pharmacology; Political science; Internal medicine; Health care","score_opus":0.06536889916657437,"score_gpt":0.3642351572893772,"score_spread":0.2988662581228029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361283772","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046591638,0.86799073,0.001241196,0.010001645,0.001655872,0.00020810218,0.0029387148,0.00024173403,0.111062855],"genre_scores_gemma":[0.086586244,0.7473378,0.0060688234,0.017553395,0.0007158698,0.0002475521,0.005687734,0.00007288089,0.1357296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995315,0.00009118098,0.00004214656,0.00005413336,0.0002199788,0.00006106318],"domain_scores_gemma":[0.99939036,0.00009723462,0.00011012305,0.000018727123,0.00031405833,0.00006957187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008644299,0.00029718707,0.0003585742,0.0008777789,0.0003915691,0.00085224217,0.00054423715,0.0006425976,0.015194428],"category_scores_gemma":[0.0015732379,0.00010133207,0.00050236355,0.00074887497,0.00043218778,0.0005344172,0.00048473102,0.00084742036,0.0032184815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003776727,0.000057889214,0.0005593545,0.0043564197,0.000077144075,0.00014290708,0.00005826751,0.00016816297,0.0035901377,0.0062679215,0.17826599,0.8060781],"study_design_scores_gemma":[0.000079947735,0.00017535484,0.0016128453,0.0010701736,0.000043265874,0.0002473409,0.000024928402,0.000045294924,0.0013671048,0.00030159272,0.9950228,0.0000094363795],"about_ca_topic_score_codex":0.076926224,"about_ca_topic_score_gemma":0.22104317,"teacher_disagreement_score":0.92307377,"about_ca_system_score_codex":0.0029911576,"about_ca_system_score_gemma":0.0054875906,"threshold_uncertainty_score":0.15295696},"labels":[],"label_agreement":null},{"id":"W4362698908","doi":"10.51731/cjht.2023.615","title":"Low-Level Laser Treatment for Lower Back Pain","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Laser Applications in Dentistry and Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Low back pain; Medicine; Health care; Physical therapy; Alternative medicine; Pathology","score_opus":0.08412602082015072,"score_gpt":0.3493078580773847,"score_spread":0.265181837257234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362698908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024488406,0.6608796,0.0047481717,0.017668849,0.0024879198,0.00020307541,0.0007910654,0.00046292733,0.28827003],"genre_scores_gemma":[0.24364753,0.59526855,0.008887712,0.012154001,0.0016921457,0.00014237118,0.0010257306,0.00010441678,0.13707756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972934,0.000022060214,0.000011010972,0.000012661302,0.00019291042,0.00003201976],"domain_scores_gemma":[0.9998301,0.000046456295,0.000025558727,0.000005165336,0.0000699748,0.000022700555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025953236,0.00012004052,0.00018325332,0.0007283259,0.00048413558,0.000474986,0.0003065957,0.00052185386,0.03186668],"category_scores_gemma":[0.000560466,0.0000475672,0.0002679374,0.00053141086,0.0002801394,0.0002471775,0.00026627266,0.00049765914,0.003602492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021994114,0.00012909195,0.0014471821,0.0014654292,0.000028136765,0.0005908843,0.00007460127,0.00008538904,0.0062436284,0.0021664023,0.10784279,0.87970644],"study_design_scores_gemma":[0.00024695144,0.00086578354,0.044818874,0.003537165,0.00012910925,0.010219132,0.00039524274,0.0007437806,0.0070047397,0.0031220657,0.92886496,0.000052265586],"about_ca_topic_score_codex":0.030645594,"about_ca_topic_score_gemma":0.10161136,"teacher_disagreement_score":0.03186668,"about_ca_system_score_codex":0.0013816686,"about_ca_system_score_gemma":0.0018164122,"threshold_uncertainty_score":0.106604636},"labels":[],"label_agreement":null},{"id":"W4364378002","doi":"10.51731/cjht.2023.616","title":"Belimumab (Benlysta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Belimumab; Reimbursement; Vial; Lupus nephritis; Medicine; Family medicine; Drug; Pharmacology; Internal medicine; Political science; Chemistry; Immunology","score_opus":0.11443310875397324,"score_gpt":0.3097521052128289,"score_spread":0.1953189964588557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364378002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016900536,0.7512031,0.0074828076,0.040937096,0.0023777229,0.00019267693,0.0055627185,0.00059221266,0.17475103],"genre_scores_gemma":[0.3665159,0.42985085,0.012155452,0.021549206,0.0021142778,0.00032147532,0.006913515,0.00011090624,0.1604684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999554,0.00015088363,0.000027690825,0.000053974258,0.00015694894,0.000056561406],"domain_scores_gemma":[0.99951005,0.0001638281,0.00011753743,0.000016556956,0.00011437404,0.00007772218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087623345,0.00025623915,0.00032901907,0.0006748674,0.0002657226,0.00080133183,0.00032846397,0.0005977081,0.0256242],"category_scores_gemma":[0.0014017192,0.000077850615,0.00041506963,0.00053586584,0.00032648433,0.0005408123,0.00047715197,0.0009676191,0.005371442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009295413,0.00008376374,0.0012089871,0.0024077748,0.00014176368,0.00018245571,0.000033118762,0.00056942017,0.0020787653,0.013839187,0.15438347,0.82414174],"study_design_scores_gemma":[0.00037156395,0.0005454011,0.0062273014,0.0018501012,0.0001432411,0.0012541312,0.00004976361,0.0006722362,0.0029147456,0.0043538525,0.9815916,0.000026110833],"about_ca_topic_score_codex":0.009164447,"about_ca_topic_score_gemma":0.024591088,"teacher_disagreement_score":0.0256242,"about_ca_system_score_codex":0.0015554752,"about_ca_system_score_gemma":0.0015519328,"threshold_uncertainty_score":0.08572143},"labels":[],"label_agreement":null},{"id":"W4365513626","doi":"10.51731/cjht.2023.618","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Atopic dermatitis; Medicine; Medical prescription; Drug; Family medicine; Intensive care medicine; Dermatology; Psychiatry; Pharmacology; Health care; Political science","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010040492,0.71994776,0.0028468303,0.01000037,0.0042866236,0.00051951635,0.0052289763,0.00081141194,0.24631803],"genre_scores_gemma":[0.1426874,0.5385779,0.009218204,0.021732606,0.0024905617,0.00056493713,0.009068069,0.00016305929,0.27549738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996227,0.00005882623,0.000026273716,0.00006461721,0.00017341695,0.000054238346],"domain_scores_gemma":[0.999676,0.00005596619,0.00005902296,0.000012268818,0.00013088524,0.00006599178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005360252,0.00051393814,0.0004190944,0.0011611831,0.00051802787,0.0011147684,0.0005648373,0.0008396475,0.033894263],"category_scores_gemma":[0.00073855,0.00012563905,0.00060801744,0.0005938573,0.00034166893,0.00060123164,0.0005212804,0.0011171609,0.009616752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041685696,0.00008783422,0.00034394555,0.0034846698,0.00005599367,0.00022527348,0.000052153628,0.000107520296,0.004753216,0.0030474458,0.18289495,0.8045301],"study_design_scores_gemma":[0.00016389256,0.00033141294,0.0013971161,0.00091929745,0.000073183786,0.0008603997,0.00002475472,0.00007836513,0.0030534395,0.0002691399,0.9928149,0.000013974405],"about_ca_topic_score_codex":0.015526131,"about_ca_topic_score_gemma":0.044020407,"teacher_disagreement_score":0.033894263,"about_ca_system_score_codex":0.001535801,"about_ca_system_score_gemma":0.0017933933,"threshold_uncertainty_score":0.113387644},"labels":[],"label_agreement":null},{"id":"W4366348155","doi":"10.51731/cjht.2023.619","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.0440627496326552,"score_gpt":0.30769963027935077,"score_spread":0.26363688064669555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366348155","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020151867,0.76413685,0.0032040158,0.009250297,0.0013847414,0.00045460337,0.0035755893,0.0012762379,0.19656576],"genre_scores_gemma":[0.24212651,0.5005731,0.007725681,0.012584554,0.0008431371,0.00039056502,0.0070530875,0.00020822906,0.22849515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997693,0.000039529546,0.000017286895,0.00003604747,0.0001015643,0.000036320253],"domain_scores_gemma":[0.99979323,0.000042884418,0.000058784553,0.000009763036,0.00005579395,0.000039551916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046146527,0.0003431755,0.00038785083,0.0008922474,0.00021839714,0.0008019552,0.0004929347,0.0007210047,0.020339327],"category_scores_gemma":[0.00065175624,0.00010150363,0.00036263448,0.00046213792,0.00036059573,0.0004883945,0.0003465748,0.00089534937,0.007129839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009260814,0.00011469376,0.00041540258,0.0037367751,0.000074059055,0.00035993784,0.000053986347,0.00023214029,0.019068792,0.0041110585,0.097092025,0.873815],"study_design_scores_gemma":[0.00060475187,0.0011577368,0.0028848415,0.0012230043,0.000121570614,0.0015777603,0.000044433902,0.00021859558,0.013132407,0.0004698359,0.9785371,0.000027994674],"about_ca_topic_score_codex":0.012072282,"about_ca_topic_score_gemma":0.035202216,"teacher_disagreement_score":0.020339327,"about_ca_system_score_codex":0.0013621652,"about_ca_system_score_gemma":0.001545356,"threshold_uncertainty_score":0.06804186},"labels":[],"label_agreement":null},{"id":"W4366416036","doi":"10.51731/cjht.2023.622","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dupilumab; Medicine; Asthma; Family medicine; Intensive care medicine; Immunology; Health care; Political science","score_opus":0.12354451478203543,"score_gpt":0.40744865768828953,"score_spread":0.2839041429062541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366416036","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010510358,0.6151329,0.0027163473,0.014137558,0.0042072134,0.0005956232,0.00787347,0.0009185701,0.343908],"genre_scores_gemma":[0.146792,0.4640609,0.009981102,0.02656681,0.0025486532,0.0005670246,0.012293931,0.00018626555,0.3370032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999585,0.00007075677,0.000030443194,0.00006367407,0.00019366998,0.00005656359],"domain_scores_gemma":[0.99950325,0.00008840078,0.00008634566,0.00001655143,0.00020575509,0.000099594065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067323993,0.00045829298,0.00038846993,0.0011032437,0.0004748409,0.0011352911,0.0005746046,0.00081549847,0.03941222],"category_scores_gemma":[0.0010219042,0.00011870021,0.0005633595,0.0005964598,0.00034485548,0.0005961046,0.00048264448,0.0009790168,0.010461309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004604446,0.00007549692,0.00043494356,0.0031005635,0.00005990409,0.00018697344,0.000055379936,0.000083335726,0.0034217392,0.0031863833,0.2261486,0.76278627],"study_design_scores_gemma":[0.00017355403,0.00032182853,0.0016956277,0.0009946078,0.000070695736,0.0006262071,0.000024992149,0.0000666477,0.0020341428,0.00024569946,0.993733,0.0000129458385],"about_ca_topic_score_codex":0.022655237,"about_ca_topic_score_gemma":0.065791205,"teacher_disagreement_score":0.03941222,"about_ca_system_score_codex":0.0018108779,"about_ca_system_score_gemma":0.0025717155,"threshold_uncertainty_score":0.13184702},"labels":[],"label_agreement":null},{"id":"W4366583939","doi":"10.51731/cjht.2023.624","title":"Lemborexant (Dayvigo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.03488945574877507,"score_gpt":0.32283845210793494,"score_spread":0.2879489963591599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366583939","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01801607,0.83473754,0.0012517867,0.007159572,0.0012565177,0.00030924115,0.002664223,0.0005447336,0.1340602],"genre_scores_gemma":[0.20630455,0.60654074,0.004453385,0.01720836,0.00078910653,0.00033478133,0.0049374695,0.00007824518,0.15935332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998331,0.00004032423,0.000016749857,0.00002965399,0.00005333408,0.000026850817],"domain_scores_gemma":[0.9998679,0.000028800032,0.000041571202,0.0000045186407,0.000034772253,0.000022369717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031215808,0.00029304213,0.00024407265,0.0006775506,0.00025217567,0.0005268877,0.0005209106,0.0006110228,0.026924927],"category_scores_gemma":[0.00046612683,0.00008061478,0.00048369484,0.0003939384,0.00022887126,0.00039598873,0.00040913664,0.00060229184,0.004234375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011672965,0.00015131525,0.0005571843,0.008558685,0.00015077766,0.00035553644,0.00005972555,0.00012050323,0.009590906,0.0027210822,0.11060962,0.8659574],"study_design_scores_gemma":[0.00055966247,0.0015739894,0.00886076,0.003613222,0.00021992817,0.0017235022,0.00010332391,0.00014103754,0.0067789177,0.00051746424,0.97587717,0.000030978823],"about_ca_topic_score_codex":0.01010751,"about_ca_topic_score_gemma":0.03785164,"teacher_disagreement_score":0.026924927,"about_ca_system_score_codex":0.0009791763,"about_ca_system_score_gemma":0.0008950504,"threshold_uncertainty_score":0.09007287},"labels":[],"label_agreement":null},{"id":"W4366768571","doi":"10.51731/cjht.2023.629","title":"Anifrolumab (Saphnelo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Autoantibody; Intensive care medicine; Immunology; Pharmacology; Political science; Health care; Antibody","score_opus":0.05748737273041901,"score_gpt":0.34252555837844345,"score_spread":0.2850381856480244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366768571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022835262,0.6242603,0.004502282,0.0109386,0.0052804183,0.00069653575,0.0054361722,0.0011381602,0.32491216],"genre_scores_gemma":[0.20853919,0.49387214,0.010344423,0.017985826,0.0023849546,0.00061225705,0.008203714,0.00013131631,0.2579262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972624,0.00004808344,0.000022630824,0.00004616688,0.000119613316,0.00003721998],"domain_scores_gemma":[0.999721,0.00005788357,0.00005697867,0.000011857692,0.0000962288,0.000056058823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045413754,0.00043588458,0.00031840542,0.0008263178,0.00033225503,0.00075869134,0.00046309837,0.00059053564,0.0269824],"category_scores_gemma":[0.0005632261,0.00007936151,0.0005615673,0.0003676458,0.00025803348,0.0004921727,0.00034167024,0.0008526686,0.0074583944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004044669,0.00012964294,0.00023875522,0.0026309302,0.00005791348,0.00013172018,0.000024064972,0.00015080335,0.0035935184,0.0016632035,0.09763851,0.8933365],"study_design_scores_gemma":[0.00039633692,0.0006797816,0.002675374,0.0014271995,0.00010449748,0.0011293695,0.000030003455,0.0002099768,0.0043785837,0.00073563214,0.9882111,0.000022136222],"about_ca_topic_score_codex":0.007031381,"about_ca_topic_score_gemma":0.023130402,"teacher_disagreement_score":0.0269824,"about_ca_system_score_codex":0.0009477359,"about_ca_system_score_gemma":0.0014626127,"threshold_uncertainty_score":0.090265095},"labels":[],"label_agreement":null},{"id":"W4366769075","doi":"10.51731/cjht.2023.628","title":"Tebentafusp (Kimmtrak)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Law","score_opus":0.038676213736566545,"score_gpt":0.3310579482046647,"score_spread":0.2923817344680982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366769075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018879963,0.6775064,0.00284878,0.0086735515,0.0019847825,0.00045528953,0.0035974488,0.00086300774,0.2851909],"genre_scores_gemma":[0.1945494,0.43664786,0.006830076,0.009332577,0.0008737476,0.0003679537,0.0056759347,0.00012403046,0.34559843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998229,0.00003059202,0.000013995472,0.00003328538,0.000073552634,0.000025783896],"domain_scores_gemma":[0.99980813,0.000036615686,0.000055424607,0.000009409787,0.000049150567,0.00004138905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003356775,0.00039003178,0.0002768676,0.00075119286,0.00027876007,0.000567643,0.00043672722,0.00065607857,0.042366322],"category_scores_gemma":[0.0006196213,0.00010496052,0.0003529359,0.00046375304,0.00028431756,0.0004947723,0.0003512589,0.0008458158,0.010004797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006191121,0.000093107235,0.0004206302,0.002482291,0.000070126305,0.0003878967,0.00004378505,0.00023779077,0.011345812,0.0034852854,0.113463745,0.8673503],"study_design_scores_gemma":[0.00053911086,0.001074157,0.0038201974,0.0011734827,0.00008292486,0.0020074688,0.00004636034,0.0002230921,0.008996139,0.00060504134,0.9814093,0.000022800943],"about_ca_topic_score_codex":0.012094892,"about_ca_topic_score_gemma":0.040991623,"teacher_disagreement_score":0.042366322,"about_ca_system_score_codex":0.0011280978,"about_ca_system_score_gemma":0.0016082757,"threshold_uncertainty_score":0.14172947},"labels":[],"label_agreement":null},{"id":"W4366987390","doi":"10.51731/cjht.2023.631","title":"Lumasiran (Oxlumo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Primary hyperoxaluria; Medicine; Family medicine; Intensive care medicine; Internal medicine; Political science; Health care","score_opus":0.04658851933332053,"score_gpt":0.32063157609817267,"score_spread":0.27404305676485213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366987390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025506742,0.7451056,0.0019654687,0.0061388016,0.0016915039,0.0003023248,0.0021821177,0.0006884678,0.21641889],"genre_scores_gemma":[0.27104238,0.5207939,0.0073510623,0.015467073,0.0011534784,0.0003291025,0.0044974,0.00010791891,0.1792577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986124,0.000033543696,0.000012197621,0.000024739753,0.00004918014,0.000019070347],"domain_scores_gemma":[0.99989045,0.00002776023,0.000031813484,0.0000041567196,0.000025811914,0.000019882145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032230405,0.00030511292,0.00023365501,0.00071344816,0.00022499783,0.0005930583,0.0003614527,0.0004988846,0.026206046],"category_scores_gemma":[0.0004453553,0.00007698487,0.00032797022,0.0003746222,0.00024271278,0.00037773582,0.00030207264,0.00055816566,0.0047524767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087839656,0.00012536747,0.00049263664,0.004247233,0.000074378855,0.00032976706,0.000043030635,0.00014191805,0.013399154,0.004581999,0.07648247,0.89920366],"study_design_scores_gemma":[0.0005481025,0.0018483241,0.004671406,0.0024532399,0.00016319766,0.0023699803,0.00005326847,0.00017485041,0.011735914,0.00060142967,0.9753552,0.000025062953],"about_ca_topic_score_codex":0.0053319447,"about_ca_topic_score_gemma":0.015286768,"teacher_disagreement_score":0.026206046,"about_ca_system_score_codex":0.00078252517,"about_ca_system_score_gemma":0.0008415258,"threshold_uncertainty_score":0.08766794},"labels":[],"label_agreement":null},{"id":"W4366987477","doi":"10.51731/cjht.2023.630","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Clinical trial; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine; Oncology; Alternative medicine; Pathology","score_opus":0.038920565652946666,"score_gpt":0.28553241571776977,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366987477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04448324,0.5072168,0.006641853,0.068224706,0.0122637525,0.001553338,0.010326782,0.002509069,0.3467804],"genre_scores_gemma":[0.58043253,0.1381537,0.021499498,0.09177865,0.009435375,0.0014231891,0.021072311,0.00022001346,0.13598482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932206,0.00015764569,0.000080741374,0.00009991332,0.00023975504,0.00009982284],"domain_scores_gemma":[0.9988972,0.00023614313,0.00028257002,0.00005977077,0.00032085433,0.00020344138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011762634,0.00042130632,0.0005265865,0.0008178861,0.00037629248,0.0010499281,0.00088660454,0.0011931293,0.0142029645],"category_scores_gemma":[0.002064231,0.00013349383,0.0006433247,0.0004568212,0.00039386403,0.000366308,0.0004526704,0.0013963784,0.004726045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003680987,0.00026124608,0.0027519828,0.0020268157,0.0001712475,0.00045691832,0.00004084686,0.00033795068,0.0048812917,0.00400845,0.2272551,0.7541272],"study_design_scores_gemma":[0.0033709677,0.003334826,0.008346679,0.0013769651,0.00026358842,0.00263604,0.000044326403,0.00058792625,0.006338269,0.0011062742,0.9725625,0.00003176366],"about_ca_topic_score_codex":0.0063870554,"about_ca_topic_score_gemma":0.011312837,"teacher_disagreement_score":0.0142029645,"about_ca_system_score_codex":0.0018822496,"about_ca_system_score_gemma":0.0020281302,"threshold_uncertainty_score":0.047513604},"labels":[],"label_agreement":null},{"id":"W4367024202","doi":"10.51731/cjht.2021.218","title":"Chlormethine Gel (Ledaga)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mycosis fungoides; Medicine; Dermatology; Cutaneous T-cell lymphoma; Lymphoma; Clinical trial; Internal medicine","score_opus":0.04797523497754828,"score_gpt":0.3494243519555125,"score_spread":0.3014491169779642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367024202","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11948989,0.22355174,0.016880782,0.03297685,0.007056659,0.0018090603,0.006255515,0.005302444,0.586677],"genre_scores_gemma":[0.5464455,0.057928924,0.024366908,0.025328588,0.0011755467,0.00070057664,0.0051472974,0.00037461935,0.33853203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953866,0.00009310177,0.000029235793,0.00008186598,0.00020451169,0.000052735406],"domain_scores_gemma":[0.9995783,0.00009152904,0.00008821229,0.000022702827,0.00012088231,0.00009850125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041558032,0.0003196817,0.00033832487,0.0008432865,0.00056197506,0.00057623157,0.0008023722,0.0012287755,0.03708056],"category_scores_gemma":[0.0009463198,0.00017168168,0.0004585618,0.00025522412,0.00044712448,0.000374856,0.00057068304,0.0013730824,0.0068241945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003122458,0.00068122684,0.0018190761,0.0022978627,0.0000979754,0.001587147,0.00011317268,0.00016165295,0.06377472,0.004717299,0.19885054,0.7227769],"study_design_scores_gemma":[0.0014881433,0.003081259,0.008744549,0.0010071914,0.00013711085,0.005589987,0.00013035211,0.0007083172,0.04224705,0.0008456872,0.93595177,0.00006863259],"about_ca_topic_score_codex":0.009153165,"about_ca_topic_score_gemma":0.020407243,"teacher_disagreement_score":0.03708056,"about_ca_system_score_codex":0.000793537,"about_ca_system_score_gemma":0.0010752698,"threshold_uncertainty_score":0.1240468},"labels":[],"label_agreement":null},{"id":"W4367052365","doi":"10.51731/cjht.2023.633","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Vial; Drug; Package insert; Intensive care medicine; Internal medicine; Cancer; Pharmacology; Health care; Political science; Immunotherapy","score_opus":0.04594901997250975,"score_gpt":0.318084219682552,"score_spread":0.2721351997100423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367052365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013068035,0.7896431,0.0026840281,0.015252952,0.0029523408,0.00028304575,0.0023884287,0.0004297602,0.17329822],"genre_scores_gemma":[0.1831215,0.6070273,0.007633748,0.015319222,0.0013671893,0.00032121153,0.0033349437,0.000075201075,0.18179968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981266,0.000036640027,0.000019760384,0.000031339277,0.00006794534,0.0000317119],"domain_scores_gemma":[0.99980336,0.000041642714,0.000049056674,0.00001007184,0.00006442975,0.000031356205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039581527,0.00023560776,0.00024198121,0.00061695895,0.00025650972,0.0006800149,0.00033360682,0.0005271575,0.017818604],"category_scores_gemma":[0.00076736993,0.00008262265,0.00031812265,0.00036680597,0.00023352876,0.0005147554,0.00034578223,0.0007413155,0.0044582966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000458024,0.000053082313,0.00045847113,0.0021086342,0.000065689834,0.00023854613,0.000028617742,0.00009601026,0.0042688856,0.0033771112,0.0905132,0.8983337],"study_design_scores_gemma":[0.0002077646,0.00039832355,0.0033527862,0.001266259,0.000094636576,0.0012103129,0.0000351311,0.00008746811,0.004300368,0.0006109564,0.98842245,0.00001346161],"about_ca_topic_score_codex":0.009586901,"about_ca_topic_score_gemma":0.024569634,"teacher_disagreement_score":0.017818604,"about_ca_system_score_codex":0.0011413145,"about_ca_system_score_gemma":0.0011065677,"threshold_uncertainty_score":0.059609175},"labels":[],"label_agreement":null},{"id":"W4367298040","doi":"10.51731/cjht.2023.635","title":"Durvalumab (Imfinzi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Gemcitabine; Medicine; Chemotherapy; Drug; Intensive care medicine; Oncology; Internal medicine; Cancer; Pharmacology; Political science; Health care; Immunotherapy","score_opus":0.06131565145675124,"score_gpt":0.25897425253254247,"score_spread":0.19765860107579122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367298040","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03163516,0.7468324,0.0044032983,0.014090539,0.0025472383,0.0003022273,0.0058079516,0.0006993017,0.19368188],"genre_scores_gemma":[0.37786478,0.4303995,0.008658013,0.013120141,0.0012580801,0.00041800088,0.009767588,0.000104315564,0.15840963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989986,0.00001773712,0.000009621551,0.000019932115,0.000035926387,0.00001695488],"domain_scores_gemma":[0.99991,0.000021137215,0.00002525888,0.0000047941776,0.00001876472,0.000020108619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033075034,0.00027396082,0.00034173604,0.0003704574,0.00014089639,0.00055465486,0.00035346657,0.00040428335,0.0143747525],"category_scores_gemma":[0.0005726044,0.000059629154,0.00030191374,0.00026654522,0.00014225703,0.00037587012,0.00027299297,0.0008359071,0.0035426044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010481066,0.00006438915,0.000557403,0.0015920481,0.000112085894,0.0002066502,0.000029312305,0.00025383502,0.0034862466,0.004637779,0.09324423,0.8947679],"study_design_scores_gemma":[0.0010398843,0.0004792207,0.0030532668,0.0009256776,0.00016908004,0.0014991866,0.000024807108,0.00032693855,0.004169711,0.0015057456,0.9867932,0.0000133584845],"about_ca_topic_score_codex":0.0037877904,"about_ca_topic_score_gemma":0.01134262,"teacher_disagreement_score":0.9988946,"about_ca_system_score_codex":0.0011054408,"about_ca_system_score_gemma":0.0006892013,"threshold_uncertainty_score":0.04808837},"labels":[],"label_agreement":null},{"id":"W4367315644","doi":"10.51731/cjht.2023.636","title":"Berotralstat (Orladeyo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Hereditary angioedema; Political science; Health care","score_opus":0.051064160185393434,"score_gpt":0.3160557353830847,"score_spread":0.26499157519769123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367315644","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019898921,0.73966295,0.0018486228,0.009015463,0.0022449987,0.00042193377,0.0034269914,0.0005580843,0.22292197],"genre_scores_gemma":[0.15102488,0.56816715,0.005871434,0.010891653,0.00086912856,0.00032694588,0.0054640532,0.000096937576,0.25728792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997738,0.000034662073,0.000021840593,0.00003772003,0.00009485728,0.00003713184],"domain_scores_gemma":[0.9997377,0.00005025117,0.00008259574,0.000009106199,0.00008117691,0.000039232356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000405298,0.0002897498,0.0002955446,0.0005998831,0.00024714565,0.0005932067,0.00041398584,0.00063116197,0.028444229],"category_scores_gemma":[0.000561124,0.00008746454,0.00037845044,0.00035843902,0.0002334221,0.0004220554,0.00031425245,0.00067933387,0.0063933562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011500536,0.0001535064,0.0005832024,0.0060789553,0.00010498019,0.00030334326,0.000035621917,0.00012138365,0.008936802,0.0028839645,0.11348496,0.8661632],"study_design_scores_gemma":[0.0006699906,0.0013055223,0.0074919346,0.002391978,0.0002054055,0.0012248023,0.000056499764,0.00013878246,0.0073266067,0.00042024037,0.97874,0.000028274962],"about_ca_topic_score_codex":0.012469185,"about_ca_topic_score_gemma":0.047170963,"teacher_disagreement_score":0.028444229,"about_ca_system_score_codex":0.0010347585,"about_ca_system_score_gemma":0.0014819539,"threshold_uncertainty_score":0.09515542},"labels":[],"label_agreement":null},{"id":"W4367315717","doi":"10.51731/cjht.2023.634","title":"Deferiprone (Ferriprox)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Deferiprone; Medicine; Drug; Family medicine; Intensive care medicine; Political science; Pharmacology; Health care; Thalassemia; Internal medicine","score_opus":0.18781634468781483,"score_gpt":0.4288984082819613,"score_spread":0.24108206359414647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367315717","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015002678,0.84158653,0.0039943797,0.01660182,0.002257885,0.00023009129,0.0024200408,0.0002827487,0.11762381],"genre_scores_gemma":[0.24355961,0.58341587,0.00949016,0.014050735,0.0017797945,0.00019301024,0.0041321875,0.00003798901,0.14334068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971324,0.00006556384,0.000029055598,0.00004040635,0.00011874513,0.00003303716],"domain_scores_gemma":[0.99961084,0.0001278502,0.00010045763,0.000011946675,0.00010326221,0.000045655914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006725444,0.0002561456,0.00024989402,0.000548816,0.00021735679,0.0005578841,0.0004008785,0.00040832465,0.014572742],"category_scores_gemma":[0.0011678081,0.00006064915,0.0003209861,0.000278521,0.00024515155,0.00035812004,0.0002763968,0.00039927362,0.0027360637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049878156,0.00006233126,0.0011337398,0.004177948,0.00009136387,0.0003149513,0.00005570748,0.0001929687,0.0040993006,0.0056769555,0.08897342,0.89472264],"study_design_scores_gemma":[0.00016778056,0.00055535405,0.0033606552,0.0018209325,0.000119000215,0.0013992192,0.000059663613,0.00019029007,0.004200242,0.0009911249,0.98711884,0.000016921496],"about_ca_topic_score_codex":0.013393492,"about_ca_topic_score_gemma":0.030189676,"teacher_disagreement_score":0.014572742,"about_ca_system_score_codex":0.0010707089,"about_ca_system_score_gemma":0.0015223409,"threshold_uncertainty_score":0.0487507},"labels":[],"label_agreement":null},{"id":"W4375951830","doi":"10.51731/cjht.2023.638","title":"Objective Assessment System for Cognitive Function","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Rehabilitation; Service (business); Function (biology); Horizon; Time horizon; Knowledge management; Information technology; Health care; Computer science; Medicine; Business; Marketing; Political science; Physical therapy","score_opus":0.16686765054654018,"score_gpt":0.4814488522793862,"score_spread":0.31458120173284604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375951830","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063931145,0.00219513,0.18308109,0.001649538,0.0007556296,0.015533025,0.45372948,0.045431137,0.23369378],"genre_scores_gemma":[0.2705533,0.002351886,0.28043866,0.0022851853,0.00037221322,0.033665687,0.2657271,0.004105781,0.14050017],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966534,0.00063895,0.0007154993,0.00041838852,0.0014013351,0.00017241592],"domain_scores_gemma":[0.9881224,0.002548832,0.0009776106,0.00075177645,0.007220448,0.00037888243],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004039121,0.0011177587,0.00088129035,0.004856673,0.00055901863,0.0018654739,0.0010826106,0.0007645262,0.054054223],"category_scores_gemma":[0.018484186,0.00031592025,0.0008952125,0.0021296446,0.00025281435,0.001368697,0.0019777091,0.00084672385,0.027339078],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016700611,0.00047102373,0.050038375,0.001833051,0.0002550953,0.00015592822,0.0010797497,0.0015743029,0.003780008,0.008938418,0.27451774,0.6556863],"study_design_scores_gemma":[0.0007843182,0.0010832781,0.25139612,0.0018413162,0.00042865056,0.00083515875,0.0011595662,0.019125788,0.01077295,0.012403801,0.69966954,0.0004995905],"about_ca_topic_score_codex":0.023169847,"about_ca_topic_score_gemma":0.023218766,"teacher_disagreement_score":0.9959609,"about_ca_system_score_codex":0.0015628434,"about_ca_system_score_gemma":0.0036193014,"threshold_uncertainty_score":0.1808294},"labels":[],"label_agreement":null},{"id":"W4376114963","doi":"10.51731/cjht.2023.640","title":"Olaparib (Lynparza)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Reimbursement; Medicine; Oncology; Germline; Internal medicine; BRCA mutation; Adjuvant; Drug; Human Epidermal Growth Factor Receptor 2; Chemotherapy; Breast cancer; Gynecology; Cancer; Pharmacology; Political science; Genetics; Biology","score_opus":0.06684353766478728,"score_gpt":0.3530063722913855,"score_spread":0.2861628346265982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376114963","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008359717,0.75402063,0.0022607264,0.010557493,0.0024149006,0.0003144279,0.0028817432,0.0005504636,0.21863984],"genre_scores_gemma":[0.14199999,0.6731222,0.006416909,0.019091683,0.001238338,0.00031156032,0.005368292,0.00009193524,0.15235902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997687,0.000044484907,0.00002873057,0.00004582069,0.000084081745,0.00002831791],"domain_scores_gemma":[0.9997522,0.000050476203,0.000066719964,0.000010851723,0.00008191917,0.000037774655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047305302,0.00029322968,0.0002711792,0.00062283454,0.00028895473,0.00095420657,0.00040203732,0.00059606315,0.023486804],"category_scores_gemma":[0.0006880019,0.00010020609,0.00037991133,0.0004573508,0.00026087402,0.00047790853,0.00039952394,0.00082348374,0.0064155487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051018834,0.00005588149,0.0002808439,0.0035690712,0.000056779634,0.00021792651,0.0000332057,0.0001854453,0.004801567,0.004142197,0.10976578,0.87638116],"study_design_scores_gemma":[0.00022506356,0.00036581277,0.0014294421,0.0012015179,0.00006270613,0.0009017407,0.000026918924,0.000095687494,0.0029109418,0.00063112203,0.9921359,0.000013161869],"about_ca_topic_score_codex":0.006041005,"about_ca_topic_score_gemma":0.018128132,"teacher_disagreement_score":0.023486804,"about_ca_system_score_codex":0.0010968434,"about_ca_system_score_gemma":0.00167104,"threshold_uncertainty_score":0.07857114},"labels":[],"label_agreement":null},{"id":"W4376143644","doi":"10.51731/cjht.2023.644","title":"Amivantamab (Rybrevant)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Epidermal growth factor receptor; Oncology; Drug; Chemotherapy; Disease; Lung cancer; Internal medicine; Intensive care medicine; Cancer; Pharmacology; Political science; Health care","score_opus":0.03132594971319125,"score_gpt":0.3619167096172947,"score_spread":0.33059075990410347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376143644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020290341,0.81466126,0.0028151225,0.008134396,0.0022976436,0.000311678,0.0014537302,0.0004184146,0.1496174],"genre_scores_gemma":[0.21794067,0.6226181,0.0069733527,0.012024262,0.0012718454,0.00039099582,0.004444671,0.00007529605,0.1342608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997695,0.000055230303,0.000022986229,0.000040002386,0.00007987017,0.000032425953],"domain_scores_gemma":[0.9998534,0.00003456244,0.000041388037,0.0000068218237,0.00003870108,0.000025079591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004196983,0.00030832895,0.0002994173,0.0006321236,0.0002027618,0.0006241505,0.00042762674,0.0007278604,0.013124866],"category_scores_gemma":[0.00059701235,0.00009061124,0.00053020066,0.00035021134,0.00022989303,0.0004937991,0.00032412919,0.00097131834,0.004008368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059833645,0.00009493241,0.00039183884,0.0025937737,0.000104610546,0.00032664824,0.000041960444,0.00026788528,0.011803089,0.005176842,0.06084256,0.91775745],"study_design_scores_gemma":[0.00038468846,0.0009963382,0.0026357658,0.0011240357,0.00012670613,0.002211482,0.000028923374,0.00020455371,0.007245585,0.0007484383,0.9842679,0.000025509506],"about_ca_topic_score_codex":0.0051745554,"about_ca_topic_score_gemma":0.015570926,"teacher_disagreement_score":0.013124866,"about_ca_system_score_codex":0.0008700846,"about_ca_system_score_gemma":0.0010322684,"threshold_uncertainty_score":0.043906987},"labels":[],"label_agreement":null},{"id":"W4376144093","doi":"10.51731/cjht.2023.641","title":"Privately Operated Medical Imaging Facilities Across Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metropolitan area; Medical imaging; Payment; Positron emission tomography; Census; Nuclear medicine; Computed tomography; Medicine; Medical physics; Single-photon emission computed tomography; Business; Radiology; Finance; Environmental health","score_opus":0.02660114225238389,"score_gpt":0.31861868320395953,"score_spread":0.2920175409515756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376144093","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16270226,0.02243024,0.008053786,0.033042952,0.0012406893,0.0011248165,0.061284896,0.0034525634,0.7066678],"genre_scores_gemma":[0.57789326,0.013005697,0.012151594,0.013614562,0.00029171316,0.00034788158,0.025753582,0.0005430588,0.35639873],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975262,0.0001405541,0.00009592053,0.0002676725,0.001036505,0.0009331406],"domain_scores_gemma":[0.9883072,0.0004884118,0.00074136956,0.00033447484,0.005471808,0.0046567153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205492,0.0004323814,0.00027644399,0.0014127021,0.004705285,0.0026995107,0.0016837624,0.00065291015,0.053901978],"category_scores_gemma":[0.0041177766,0.0004552395,0.00042667415,0.003725754,0.0010255445,0.00076440704,0.0018341385,0.0007966271,0.004354172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004598005,0.00012475107,0.082084656,0.0009855623,0.00009864359,0.0010425709,0.0013590246,0.0010214847,0.002406256,0.02179254,0.6283417,0.2602831],"study_design_scores_gemma":[0.00011410797,0.000102313046,0.19574548,0.00065434066,0.00006257016,0.0009247141,0.0021665345,0.0012715214,0.0008641877,0.0011316721,0.7968636,0.00009893895],"about_ca_topic_score_codex":0.98215103,"about_ca_topic_score_gemma":0.9894357,"teacher_disagreement_score":0.053901978,"about_ca_system_score_codex":0.040278126,"about_ca_system_score_gemma":0.15197204,"threshold_uncertainty_score":0.2922396},"labels":[],"label_agreement":null},{"id":"W4376644329","doi":"10.51731/cjht.2023.649","title":"Extrapolating Clinical Evidence Within Economic Evaluations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; University of Ottawa; Canadian Agency for Drugs and Technologies in Health; Western University","funders":"","keywords":"Extrapolation; Econometrics; Computer science; Economics; Statistics; Mathematics","score_opus":0.7121975685384159,"score_gpt":0.5586665753917054,"score_spread":0.15353099314671048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376644329","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024798386,0.13024998,0.6773433,0.07363245,0.00577924,0.016173417,0.0064782617,0.0009923022,0.0645526],"genre_scores_gemma":[0.3287058,0.05878595,0.57391864,0.013367786,0.0035522592,0.014818955,0.0032347236,0.0005607077,0.0030550926],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.4484816,0.48047924,0.0332975,0.0071200836,0.028560804,0.0020608245],"domain_scores_gemma":[0.19894868,0.71876633,0.023525791,0.032215808,0.02490274,0.0016406352],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43955117,0.0035924928,0.008324469,0.012236808,0.0014108865,0.016256317,0.0052787918,0.0061176443,0.0089990515],"category_scores_gemma":[0.7587867,0.0022420753,0.007116818,0.008698551,0.0054826825,0.017966269,0.012667634,0.012857337,0.0022790767],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030334815,0.00059581315,0.015682044,0.032176316,0.010772811,0.0009515444,0.0040564258,0.07762825,0.00053661474,0.21094777,0.025759952,0.61785907],"study_design_scores_gemma":[0.0013821087,0.0014214513,0.0070217154,0.062257353,0.0051511074,0.000519633,0.0013323724,0.045016725,0.001999803,0.79937595,0.07408434,0.00043743214],"about_ca_topic_score_codex":0.004723787,"about_ca_topic_score_gemma":0.003502102,"teacher_disagreement_score":0.5604488,"about_ca_system_score_codex":0.0077784304,"about_ca_system_score_gemma":0.017412918,"threshold_uncertainty_score":0.6911332},"labels":[],"label_agreement":null},{"id":"W4376876736","doi":"10.51731/cjht.2023.650","title":"Overview of Health Technology Assessment Processes for Time-Limited Recommendations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Context (archaeology); Interim; Excellence; Agency (philosophy); Business; Health care; Medicine; Waiver; Inclusion (mineral); Political science; Geography","score_opus":0.528444175915969,"score_gpt":0.5012615904239898,"score_spread":0.027182585491979272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376876736","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005748771,0.10641478,0.46322203,0.10790734,0.0034255013,0.11879657,0.027064385,0.0058412035,0.16157943],"genre_scores_gemma":[0.027099634,0.055533357,0.8388073,0.009182703,0.0011718578,0.049933963,0.010094193,0.000597955,0.0075791506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6444014,0.20184143,0.08028048,0.008678705,0.05951447,0.0052835355],"domain_scores_gemma":[0.40769348,0.33937097,0.064916596,0.031047821,0.14920776,0.007763387],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.33065048,0.0032278541,0.003604351,0.029020233,0.0033175363,0.022219341,0.009237519,0.0072874045,0.029508509],"category_scores_gemma":[0.49655867,0.0033055737,0.012193507,0.035914015,0.0030173755,0.014357584,0.012695137,0.010544856,0.012011871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052242324,0.00034727502,0.003951987,0.03159855,0.0012435964,0.00039598357,0.0039873933,0.006767245,0.00062815234,0.08842075,0.07535956,0.7867771],"study_design_scores_gemma":[0.00070347654,0.00065024715,0.009609558,0.076815926,0.0013659154,0.0006315546,0.002391772,0.008819075,0.0027054374,0.0823739,0.81356794,0.00036519207],"about_ca_topic_score_codex":0.016132737,"about_ca_topic_score_gemma":0.011874049,"teacher_disagreement_score":0.33065048,"about_ca_system_score_codex":0.024717016,"about_ca_system_score_gemma":0.08783647,"threshold_uncertainty_score":0.8254271},"labels":[],"label_agreement":null},{"id":"W4377096713","doi":"10.51731/cjht.2023.655","title":"Lutetium (¹⁷⁷Lu) Vipivotide Tetraxetan (Pluvicto)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabazitaxel; Prostate cancer; Medicine; Taxane; Oncology; Clinical trial; Drug; Internal medicine; Cancer; Androgen deprivation therapy; Pharmacology; Political science; Breast cancer; Health care","score_opus":0.05330637484045283,"score_gpt":0.3480798382205606,"score_spread":0.2947734633801078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377096713","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025896579,0.8222652,0.0060574138,0.005242572,0.001773847,0.00018904387,0.0015925749,0.0004295708,0.13655317],"genre_scores_gemma":[0.3171165,0.49819922,0.01324331,0.0083212545,0.0007501016,0.00027536883,0.0032899259,0.00018916043,0.15861517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998398,0.000035186953,0.000013820681,0.00002631423,0.00006483182,0.000019984132],"domain_scores_gemma":[0.9998324,0.00006231909,0.000041451436,0.000007530043,0.00003729123,0.000018932007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006257348,0.00017104606,0.00020785873,0.0004146573,0.00014540002,0.0005759378,0.00039632877,0.00043172904,0.011223089],"category_scores_gemma":[0.0006234813,0.00008783305,0.0002473963,0.0004176815,0.0003503865,0.0004117531,0.00023198726,0.0005184176,0.0021798136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010550366,0.000059892052,0.0012893361,0.0039635855,0.000089674424,0.00039224006,0.000056749286,0.00034213823,0.029118238,0.0066214693,0.051200993,0.9058106],"study_design_scores_gemma":[0.00037183013,0.0014979918,0.004415129,0.0013123236,0.0001689838,0.0020595158,0.000086488435,0.000271376,0.036067072,0.00068075146,0.95304114,0.000027386784],"about_ca_topic_score_codex":0.011984993,"about_ca_topic_score_gemma":0.022951474,"teacher_disagreement_score":0.011984993,"about_ca_system_score_codex":0.0011897682,"about_ca_system_score_gemma":0.001438847,"threshold_uncertainty_score":0.037544906},"labels":[],"label_agreement":null},{"id":"W4377099138","doi":"10.51731/cjht.2023.653","title":"Finerenone (Kerendia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Kidney disease; Intensive care medicine; Renal function; Disease; Myocardial infarction; Emergency medicine; Health care; Internal medicine","score_opus":0.48365951493252024,"score_gpt":0.4412437580011146,"score_spread":0.042415756931405646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377099138","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07262838,0.7868225,0.0026179056,0.0054372065,0.0007755718,0.0008444081,0.006222858,0.00025489274,0.12439621],"genre_scores_gemma":[0.5667032,0.37136295,0.0044065407,0.0038718744,0.0003482237,0.0002578204,0.0036605997,0.000029361194,0.049359303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977463,0.00005339814,0.000024144523,0.00004010963,0.000084896135,0.000022829901],"domain_scores_gemma":[0.9997085,0.000104119696,0.000097538286,0.000011737139,0.00004361999,0.000034537465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045786554,0.00014621418,0.0003270557,0.0007614753,0.00016475286,0.00058399275,0.00024191178,0.0002733138,0.01339578],"category_scores_gemma":[0.0010391141,0.00006285245,0.0005451896,0.00045337126,0.00015467219,0.00029531954,0.0002857952,0.00065273314,0.00071033114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017864514,0.00023894318,0.0021562893,0.008079783,0.00038111815,0.00025588894,0.000054891352,0.00064432825,0.0032726072,0.0073567997,0.025834419,0.94993854],"study_design_scores_gemma":[0.0036263983,0.0040929737,0.039703134,0.009678773,0.0015660514,0.0035250424,0.00021452694,0.00086076575,0.0047787293,0.0032633385,0.92861885,0.00007143798],"about_ca_topic_score_codex":0.006155445,"about_ca_topic_score_gemma":0.027823089,"teacher_disagreement_score":0.01339578,"about_ca_system_score_codex":0.00066443085,"about_ca_system_score_gemma":0.00097253884,"threshold_uncertainty_score":0.044813395},"labels":[],"label_agreement":null},{"id":"W4377099143","doi":"10.51731/cjht.2023.654","title":"Pegcetacoplan (Empaveli)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Paroxysmal nocturnal hemoglobinuria; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.13707269510445716,"score_gpt":0.41165148832113124,"score_spread":0.2745787932166741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377099143","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010427183,0.83582073,0.0018667793,0.011167356,0.0018891302,0.00024513967,0.0016463997,0.00028678967,0.13665052],"genre_scores_gemma":[0.10191451,0.7871567,0.005813574,0.011446487,0.0011053672,0.00018782272,0.0028593165,0.000046942965,0.08946924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975985,0.000041427804,0.00002726578,0.000031708045,0.00011209705,0.000027591443],"domain_scores_gemma":[0.9997521,0.000056601704,0.000073699855,0.0000090693575,0.000078383695,0.000030191028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000518845,0.00023610317,0.00026698064,0.00060950796,0.00018147174,0.00059741165,0.00029741126,0.00044105257,0.013598239],"category_scores_gemma":[0.0008836392,0.000067680994,0.00048138233,0.00050180167,0.00022069263,0.0004795826,0.00028412923,0.00057737227,0.0023468004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003448961,0.000038323175,0.00036459728,0.002888193,0.00009710019,0.00012582642,0.000018069797,0.000081546794,0.0015082476,0.001648143,0.06802044,0.9248646],"study_design_scores_gemma":[0.00030261636,0.0005289433,0.005947257,0.0023847518,0.00020020556,0.0012156337,0.000038499966,0.00014970428,0.0026333083,0.00047716417,0.9861079,0.000014019259],"about_ca_topic_score_codex":0.009886589,"about_ca_topic_score_gemma":0.028785527,"teacher_disagreement_score":0.013598239,"about_ca_system_score_codex":0.0012076428,"about_ca_system_score_gemma":0.0016756711,"threshold_uncertainty_score":0.045490623},"labels":[],"label_agreement":null},{"id":"W4379422197","doi":"10.51731/cjht.2023.664","title":"An Overview of Pharmacogenomic Testing for Psychiatric Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Generalizability theory; Medicine; Guideline; Genetic testing; Health care; Personalized medicine; Test (biology); Psychiatry; Psychology; Bioinformatics; Pharmacology","score_opus":0.32274797548898837,"score_gpt":0.507439021635251,"score_spread":0.18469104614626264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379422197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041426954,0.9615468,0.0061140954,0.01690218,0.0013888981,0.00014129655,0.00064708845,0.00026104914,0.01258435],"genre_scores_gemma":[0.0021432352,0.9780612,0.007405498,0.006678657,0.0023788027,0.00014130898,0.00065677287,0.000048317295,0.0024861854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975304,0.00079650315,0.00045543368,0.00028759698,0.00079876656,0.00013132587],"domain_scores_gemma":[0.9893607,0.0073523032,0.0007178146,0.00022465884,0.0019303465,0.0004142681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042926874,0.0012636207,0.0012597007,0.007062575,0.00050149276,0.0018843919,0.0013666912,0.0027404088,0.010898178],"category_scores_gemma":[0.009353009,0.0006486134,0.002070019,0.00446673,0.0009204228,0.0027949375,0.0012978733,0.004151766,0.0047786636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010824185,0.0000975367,0.0011850139,0.011175602,0.00017504762,0.0004576707,0.00010410053,0.00046765097,0.0007772289,0.007884245,0.10766212,0.8699055],"study_design_scores_gemma":[0.00004317489,0.00019726744,0.0034436472,0.01684245,0.00025659916,0.003268064,0.000079136335,0.0004709644,0.00047194597,0.010152468,0.96471137,0.00006299937],"about_ca_topic_score_codex":0.006838915,"about_ca_topic_score_gemma":0.012926659,"teacher_disagreement_score":0.010898178,"about_ca_system_score_codex":0.0026633095,"about_ca_system_score_gemma":0.0044332286,"threshold_uncertainty_score":0.036458015},"labels":[],"label_agreement":null},{"id":"W4379881935","doi":"10.51731/cjht.2023.665","title":"Hybrid Operating Room Suites","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Operating theater; Suite; Neurosurgery; Cardiothoracic surgery; Medical physics; Surgery; Vascular surgery; Cardiac surgery","score_opus":0.06293747887892315,"score_gpt":0.3345494473028057,"score_spread":0.2716119684238826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379881935","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07788169,0.19297509,0.043393474,0.01688587,0.009302794,0.0010785467,0.03514285,0.0053039575,0.61803573],"genre_scores_gemma":[0.43411198,0.26036865,0.07154946,0.022593832,0.0061854455,0.0013009256,0.05628071,0.0014433935,0.14616565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985991,0.000156326,0.0001500499,0.00015457254,0.0006263446,0.00031365527],"domain_scores_gemma":[0.9946067,0.0010547073,0.0008807856,0.00018890412,0.0013578495,0.0019110582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010898665,0.00041497857,0.00029939847,0.0021510136,0.00082487304,0.0014677913,0.0013205255,0.00062893174,0.05784181],"category_scores_gemma":[0.0042630737,0.0002378656,0.0008321786,0.0026023125,0.00040328078,0.0016291195,0.0017966613,0.0013224373,0.008997916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045872657,0.00019881726,0.017679406,0.0023337128,0.0000863014,0.0011057566,0.00028553366,0.0013774416,0.001107414,0.0073908335,0.26300105,0.7049751],"study_design_scores_gemma":[0.000098546945,0.0002881754,0.032461606,0.0030776192,0.00010018202,0.0068111294,0.00072907394,0.0005950171,0.0009723934,0.0022644429,0.95248836,0.00011339677],"about_ca_topic_score_codex":0.023498261,"about_ca_topic_score_gemma":0.053543866,"teacher_disagreement_score":0.05784181,"about_ca_system_score_codex":0.0027216463,"about_ca_system_score_gemma":0.005941202,"threshold_uncertainty_score":0.1935001},"labels":[],"label_agreement":null},{"id":"W4380090156","doi":"10.51731/cjht.2023.666","title":"Ravulizumab (Ultomiris)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Thrombotic microangiopathy; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care; Internal medicine","score_opus":0.038824719566165525,"score_gpt":0.2936630351160758,"score_spread":0.25483831554991027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380090156","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010802181,0.88333124,0.0026142302,0.0070653553,0.001533626,0.00018431421,0.0009873606,0.0005762941,0.09290547],"genre_scores_gemma":[0.16002874,0.6941941,0.010285807,0.013183328,0.0014918713,0.00024719516,0.0025324568,0.00009315797,0.11794342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970657,0.000056572848,0.00002816055,0.000040570067,0.00012539965,0.0000427449],"domain_scores_gemma":[0.99975973,0.000046902045,0.00007118495,0.000010969466,0.000080090904,0.000031174033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065415894,0.00032772298,0.00029017054,0.0007979593,0.0002139763,0.0006722746,0.00041158416,0.00059218565,0.009947185],"category_scores_gemma":[0.00062547275,0.00009087135,0.00046539647,0.00043905101,0.00030471786,0.00039343812,0.0002976876,0.00071095827,0.0035395254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030001815,0.00005761194,0.00034323503,0.0020314567,0.00006679916,0.00017447544,0.000026142967,0.00012636543,0.008041263,0.0025453614,0.055606823,0.9306805],"study_design_scores_gemma":[0.00025978757,0.0008907259,0.0044492846,0.0013625248,0.00015807891,0.0014884347,0.000040627805,0.0002022109,0.0114710545,0.0007100338,0.9789423,0.000025057963],"about_ca_topic_score_codex":0.008980288,"about_ca_topic_score_gemma":0.022198325,"teacher_disagreement_score":0.009947185,"about_ca_system_score_codex":0.001295778,"about_ca_system_score_gemma":0.0014224409,"threshold_uncertainty_score":0.033276618},"labels":[],"label_agreement":null},{"id":"W4380152961","doi":"10.51731/cjht.2023.668","title":"Brexucabtagene Autoleucel (Tecartus)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Chimeric antigen receptor; Drug; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Cancer; Immunotherapy","score_opus":0.06782205487796064,"score_gpt":0.3562780262120117,"score_spread":0.2884559713340511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380152961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03366643,0.78830564,0.0051005334,0.008229233,0.0014661908,0.00045529802,0.003827197,0.0005154727,0.15843394],"genre_scores_gemma":[0.3317381,0.47033408,0.011590282,0.008847881,0.0007620734,0.00046340554,0.007683232,0.0001817344,0.16839913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995426,0.000099164376,0.000027875582,0.00003991653,0.00024250238,0.000048030197],"domain_scores_gemma":[0.99962366,0.00009933579,0.00008718305,0.00001876282,0.00012370653,0.000047264373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000878014,0.00020603609,0.00028528203,0.00076749164,0.00023332464,0.00078425073,0.0004021431,0.00055851345,0.011610133],"category_scores_gemma":[0.0008554698,0.000069767906,0.00037709164,0.0005483041,0.0003591517,0.00033190107,0.00024185899,0.0006347743,0.0023118628],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071276695,0.00011366083,0.0014299297,0.0034316725,0.00012996553,0.00036929562,0.00006296355,0.00031810615,0.02668967,0.0073019145,0.1077146,0.8517255],"study_design_scores_gemma":[0.00019980944,0.00088049774,0.0064611323,0.000955706,0.00008821585,0.001480499,0.00005224802,0.00020503173,0.01960579,0.0003248387,0.96972704,0.000019175604],"about_ca_topic_score_codex":0.025039934,"about_ca_topic_score_gemma":0.060665347,"teacher_disagreement_score":0.025039934,"about_ca_system_score_codex":0.001876574,"about_ca_system_score_gemma":0.0019645465,"threshold_uncertainty_score":0.049788356},"labels":[],"label_agreement":null},{"id":"W4380203508","doi":"10.51731/cjht.2023.667","title":"Axicabtagene Ciloleucel (Yescarta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemoimmunotherapy; Reimbursement; Medicine; Lymphoma; Drug; Refractory (planetary science); Oncology; Intensive care medicine; Internal medicine; Pharmacology; Health care; Rituximab; Political science","score_opus":0.07583853752595779,"score_gpt":0.35787496221602544,"score_spread":0.2820364246900676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380203508","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02543784,0.6080985,0.0023223169,0.01387976,0.002517675,0.0007423409,0.0063083153,0.00071452896,0.33997875],"genre_scores_gemma":[0.23760776,0.40428025,0.008284527,0.019846264,0.0011994023,0.0007027326,0.010562005,0.00016267557,0.31735447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974805,0.000042076645,0.000020933123,0.000031953376,0.00012326203,0.00003365567],"domain_scores_gemma":[0.9997236,0.000055268076,0.000060375703,0.000009357965,0.00009760946,0.00005376762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045756227,0.00024541252,0.00026580138,0.00074231083,0.00025133218,0.0007425893,0.00044436427,0.0006175428,0.028777955],"category_scores_gemma":[0.0006955131,0.00008204261,0.00038629866,0.0004545841,0.00032280435,0.0003923416,0.00028666764,0.000595799,0.0046975026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012112554,0.00013653786,0.000973531,0.0037165717,0.00009383831,0.00023924182,0.000034177883,0.0001580746,0.010785496,0.004084606,0.16161945,0.81694716],"study_design_scores_gemma":[0.0006023819,0.0011440938,0.004467091,0.000878264,0.00011195612,0.00062576396,0.00004101624,0.00017076236,0.0060115866,0.00034680223,0.9855834,0.000016960652],"about_ca_topic_score_codex":0.017206743,"about_ca_topic_score_gemma":0.07261575,"teacher_disagreement_score":0.028777955,"about_ca_system_score_codex":0.001557321,"about_ca_system_score_gemma":0.002465878,"threshold_uncertainty_score":0.09627187},"labels":[],"label_agreement":null},{"id":"W4380610182","doi":"10.51731/cjht.2023.669","title":"Deep Brain Stimulation Surgery Programs in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep brain stimulation; Medicine; Movement disorders; Thalamic stimulator; Stimulation; Essential tremor; Population; Dyskinesia; Parkinson's disease; Disease; Neuroscience; Psychiatry; Psychology; Internal medicine","score_opus":0.06529880742081656,"score_gpt":0.2862933284433369,"score_spread":0.22099452102252032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380610182","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21414939,0.030935217,0.0033728434,0.1549977,0.004615922,0.001662706,0.056323465,0.0015709632,0.5323718],"genre_scores_gemma":[0.5387342,0.040816475,0.0075431326,0.059033845,0.0007555666,0.000926031,0.026156094,0.00036515517,0.32566953],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99862385,0.000048568876,0.00004700127,0.00009404688,0.0006134411,0.00057304284],"domain_scores_gemma":[0.9928271,0.00023587476,0.00021650431,0.00004725258,0.002526877,0.004146349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055581995,0.0003371533,0.00026253227,0.0014737254,0.0043007904,0.0017030371,0.001394399,0.0008415162,0.039316975],"category_scores_gemma":[0.0022702722,0.00035379527,0.0006109672,0.002256926,0.000764735,0.0005443227,0.0016533841,0.0012362702,0.003039252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025585387,0.00033171973,0.05898901,0.001123337,0.000074928175,0.0009487286,0.0011464114,0.0009686615,0.0015113744,0.012405512,0.62253517,0.29970923],"study_design_scores_gemma":[0.00031060964,0.0002425591,0.23761213,0.0013285718,0.00007168057,0.0009082007,0.003255445,0.0017173357,0.00070087006,0.00147494,0.7522571,0.00012057658],"about_ca_topic_score_codex":0.9870439,"about_ca_topic_score_gemma":0.99533397,"teacher_disagreement_score":0.059585564,"about_ca_system_score_codex":0.059585564,"about_ca_system_score_gemma":0.25140652,"threshold_uncertainty_score":0.43232554},"labels":[],"label_agreement":null},{"id":"W4381856846","doi":"10.51731/cjht.2023.670","title":"Mavacamten (Camzyos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bristol-Myers Squibb","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Law; Health care","score_opus":0.04622634454255619,"score_gpt":0.31361005498168254,"score_spread":0.26738371043912634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381856846","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012399795,0.7480888,0.0008504595,0.009803729,0.003543524,0.00044377643,0.0042196247,0.00056524266,0.22008508],"genre_scores_gemma":[0.12584558,0.55111444,0.0037409733,0.015798826,0.0015701748,0.0004842114,0.0067064883,0.00013789788,0.29460135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997644,0.000043038297,0.000022738453,0.000045893703,0.00009287464,0.000031050156],"domain_scores_gemma":[0.9996762,0.00006283053,0.00006846778,0.000013845976,0.00010209417,0.00007646427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035585716,0.000346401,0.0004156287,0.001038213,0.00044698658,0.0010251064,0.0005870406,0.0009880399,0.06492678],"category_scores_gemma":[0.0012493393,0.00011734578,0.00043823395,0.0007386295,0.00030626147,0.00066048646,0.00055871316,0.0011461197,0.010421216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010392797,0.00012618936,0.0006003708,0.0049227076,0.00010291499,0.00025817417,0.000088999615,0.00009466807,0.0036971075,0.005369437,0.20083568,0.78286445],"study_design_scores_gemma":[0.00043840703,0.00047853094,0.0030996697,0.0020877735,0.000118455224,0.0005119147,0.0000608966,0.00006882396,0.0014176795,0.00051426445,0.99119097,0.000012587908],"about_ca_topic_score_codex":0.013268131,"about_ca_topic_score_gemma":0.046175923,"teacher_disagreement_score":0.06492678,"about_ca_system_score_codex":0.0009390188,"about_ca_system_score_gemma":0.0021185,"threshold_uncertainty_score":0.21720171},"labels":[],"label_agreement":null},{"id":"W4382682016","doi":"10.51731/cjht.2023.675","title":"Rapid HIV Self-Testing","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Fingerstick; Medicine; Test (biology); Hiv test; Immunology; Environmental health; Population; Biology; Diabetes mellitus","score_opus":0.051113276834115345,"score_gpt":0.28879388868164285,"score_spread":0.2376806118475275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382682016","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030367225,0.027221868,0.02373042,0.017483812,0.012446586,0.013689092,0.06735913,0.011513258,0.7961886],"genre_scores_gemma":[0.13774197,0.020771822,0.06277085,0.02546216,0.0022367386,0.0059682066,0.05810382,0.00078683544,0.68615764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967559,0.0004889491,0.000148938,0.00050675124,0.0017356023,0.00036382684],"domain_scores_gemma":[0.9963812,0.0004941479,0.00028760772,0.0003097344,0.0020004977,0.0005268986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028340507,0.00085136236,0.0007406771,0.0017826511,0.0010282936,0.0019511777,0.0019526501,0.0014816413,0.1133461],"category_scores_gemma":[0.0060329875,0.00047828883,0.00073087204,0.0007410545,0.00040769784,0.0009866068,0.0019284087,0.0019942436,0.053190045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002565544,0.0003005812,0.014020113,0.0007003117,0.000045047553,0.0002987646,0.00026826328,0.00012564629,0.0018515454,0.0033823205,0.57977575,0.39897516],"study_design_scores_gemma":[0.00015214215,0.000546611,0.026149273,0.0011544072,0.000057767575,0.0018510587,0.000314779,0.0008605173,0.0050161807,0.0015902144,0.9622282,0.00007887507],"about_ca_topic_score_codex":0.017020313,"about_ca_topic_score_gemma":0.02021465,"teacher_disagreement_score":0.9829797,"about_ca_system_score_codex":0.001550734,"about_ca_system_score_gemma":0.0026821436,"threshold_uncertainty_score":0.3791805},"labels":[],"label_agreement":null},{"id":"W4384030746","doi":"10.51731/cjht.2023.687","title":"Crisantaspase Recombinant (Rylaze)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Regimen; Lymphoblastic Leukemia; Recombinant DNA; Drug; Lymphoma; Intensive care medicine; Pharmacology; Leukemia; Internal medicine; Political science; Biology; Health care","score_opus":0.13544321487633465,"score_gpt":0.4133315752594893,"score_spread":0.2778883603831547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384030746","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027488127,0.7687036,0.004968517,0.007263959,0.0019419016,0.0005492324,0.004378608,0.00057295634,0.18413298],"genre_scores_gemma":[0.26972604,0.5516284,0.012705014,0.007839894,0.00075104024,0.00033691514,0.0070780106,0.00014042396,0.14979428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995964,0.000099418285,0.000045293487,0.000054798118,0.00016029569,0.000043800672],"domain_scores_gemma":[0.9995828,0.00007707193,0.00012377783,0.00002155016,0.00014872235,0.000046036588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009184736,0.0003374638,0.00030617652,0.0008940835,0.00021399485,0.0006771177,0.0005154558,0.00067783153,0.0171456],"category_scores_gemma":[0.00085788884,0.00010196775,0.00060279894,0.0005457888,0.00041583952,0.00048005168,0.00033801957,0.00077037833,0.003899545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012189847,0.00017902568,0.0010500822,0.006860269,0.00017719124,0.00053988944,0.00008276094,0.00026499442,0.0377428,0.0069317156,0.09923997,0.8457124],"study_design_scores_gemma":[0.00035285222,0.00151063,0.0041382536,0.0013695018,0.0001810125,0.0018048288,0.000086962464,0.00013508747,0.019260192,0.00039957283,0.9707354,0.000025732643],"about_ca_topic_score_codex":0.017249268,"about_ca_topic_score_gemma":0.04145836,"teacher_disagreement_score":0.017249268,"about_ca_system_score_codex":0.001394931,"about_ca_system_score_gemma":0.0020629496,"threshold_uncertainty_score":0.057357788},"labels":[],"label_agreement":null},{"id":"W4384068853","doi":"10.51731/cjht.2023.684","title":"Nivolumab (Opdivo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Biosimilar; Medicine; Oncology; Chemotherapy; Drug; Lung cancer; Intensive care medicine; Cancer; Internal medicine; Family medicine; Immunotherapy; Pharmacology; Political science; Health care","score_opus":0.05628373340307806,"score_gpt":0.25281661706094033,"score_spread":0.19653288365786226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384068853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020766884,0.72450817,0.005246445,0.021583274,0.003069626,0.00039540807,0.005380001,0.0003448376,0.21870528],"genre_scores_gemma":[0.35576665,0.49626985,0.012033725,0.01594865,0.0018790785,0.00047388137,0.0070476704,0.00010928065,0.11047123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960965,0.00013627125,0.000032184944,0.000048505583,0.00012504488,0.00004840124],"domain_scores_gemma":[0.99951565,0.00013319371,0.000100448065,0.000019961864,0.00017152914,0.000059125654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000884909,0.000296166,0.0002987791,0.0005544038,0.00020463837,0.0009985099,0.00036426383,0.0004936504,0.010541075],"category_scores_gemma":[0.0015555195,0.00006471823,0.0005347538,0.00046445028,0.0002771116,0.00048553103,0.000361051,0.00064564985,0.0020295205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053605327,0.000049489052,0.0016040595,0.002452046,0.00016511681,0.00007430243,0.000025141257,0.00053375284,0.0013094425,0.00791712,0.10458264,0.88075083],"study_design_scores_gemma":[0.000235196,0.00049977953,0.006130962,0.0030543937,0.0002195852,0.000530458,0.000048522295,0.00058673724,0.0025955003,0.0024518052,0.98362535,0.00002166945],"about_ca_topic_score_codex":0.023914833,"about_ca_topic_score_gemma":0.049685646,"teacher_disagreement_score":0.023914833,"about_ca_system_score_codex":0.0021564737,"about_ca_system_score_gemma":0.00261964,"threshold_uncertainty_score":0.047551274},"labels":[],"label_agreement":null},{"id":"W4384298936","doi":"10.51731/cjht.2023.691","title":"Xylazine Test Strips for Drug Checking","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Xylazine; Adulterant; Tranquilizer; Medicine; Drug; Pharmacology; Toxicology; Ketamine; Anesthesia; Biology","score_opus":0.12249321699272242,"score_gpt":0.3783318420089495,"score_spread":0.25583862501622706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384298936","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.080247715,0.08461165,0.13467829,0.1221247,0.025702348,0.006479861,0.011388855,0.031610634,0.50315595],"genre_scores_gemma":[0.24032913,0.040669743,0.19012159,0.07510933,0.002612282,0.0016753989,0.009531433,0.0036760506,0.43627506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922793,0.0014633802,0.00038493462,0.0006687786,0.004698713,0.00050497975],"domain_scores_gemma":[0.9928092,0.0014193672,0.0010231882,0.00061930023,0.0035444337,0.0005845712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003936755,0.001239744,0.00076261937,0.0018398874,0.0010119206,0.0015098447,0.0028686926,0.0037150863,0.056142665],"category_scores_gemma":[0.009132047,0.0010208694,0.0007591325,0.00087428733,0.0015581249,0.0014319229,0.0017420356,0.0027265563,0.042543262],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00135146,0.00041160366,0.012271587,0.0017333773,0.00007458203,0.002944828,0.0007024843,0.0004499916,0.09328809,0.0048769005,0.51913846,0.3627566],"study_design_scores_gemma":[0.00015141314,0.00090940984,0.011104631,0.0009297736,0.0000657,0.0040976168,0.0005204001,0.001262773,0.07623118,0.0013917321,0.90323997,0.0000954774],"about_ca_topic_score_codex":0.011036422,"about_ca_topic_score_gemma":0.022501485,"teacher_disagreement_score":0.056142665,"about_ca_system_score_codex":0.0017026002,"about_ca_system_score_gemma":0.0027368288,"threshold_uncertainty_score":0.1878159},"labels":[],"label_agreement":null},{"id":"W4384342683","doi":"10.51731/cjht.2023.690","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.038920565652946666,"score_gpt":0.28553241571776977,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384342683","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060401903,0.9047361,0.0015518379,0.0062900414,0.0023135475,0.0001775937,0.0012159694,0.0002636976,0.07741101],"genre_scores_gemma":[0.14373554,0.73463106,0.0075692274,0.018926926,0.003096768,0.00033195489,0.004826991,0.000060753835,0.08682068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996867,0.000057729656,0.000033179884,0.00004470397,0.00013416621,0.000043568572],"domain_scores_gemma":[0.99965405,0.0000658352,0.00009584649,0.00001019603,0.00012646899,0.000047721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005632755,0.00042694106,0.00031780105,0.0007927158,0.00024879875,0.0008086428,0.00048157835,0.00070719636,0.011851351],"category_scores_gemma":[0.00076810777,0.00008748173,0.0004998627,0.00043935582,0.00024584765,0.00039299388,0.00032365488,0.0006587511,0.0035694372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004763694,0.00007372741,0.00059472676,0.003943323,0.000093331815,0.00019193905,0.000030780615,0.00019908755,0.0053581903,0.0023904785,0.11734989,0.86929816],"study_design_scores_gemma":[0.00018655616,0.0007436597,0.0022705186,0.0016511411,0.00013713521,0.0011236178,0.000027917758,0.00014240712,0.004077572,0.00033356622,0.9892932,0.00001258064],"about_ca_topic_score_codex":0.00891847,"about_ca_topic_score_gemma":0.015134033,"teacher_disagreement_score":0.011851351,"about_ca_system_score_codex":0.0013192879,"about_ca_system_score_gemma":0.0016052786,"threshold_uncertainty_score":0.039646685},"labels":[],"label_agreement":null},{"id":"W4384405989","doi":"10.51731/cjht.2023.693","title":"Individuals’ Access to Medical Imaging Results via Patient Portals","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patient portal; Health care; Medical emergency; Health information; Medical imaging; Information sharing; Medicine; Business; World Wide Web; Computer science; Political science; Radiology","score_opus":0.056162133225843514,"score_gpt":0.38937245162847517,"score_spread":0.33321031840263166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384405989","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14520088,0.0032293894,0.023548111,0.08450973,0.0011007456,0.0007549025,0.013533587,0.00923454,0.7188882],"genre_scores_gemma":[0.71090746,0.005743405,0.050261505,0.019946063,0.0009832678,0.0004537438,0.010565722,0.0019576717,0.19918121],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99584323,0.0018170308,0.00043371212,0.0002768297,0.0010703176,0.0005589315],"domain_scores_gemma":[0.96554226,0.011844338,0.002331697,0.0048899967,0.008456832,0.006934836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007226894,0.00023244068,0.0002935407,0.0015960633,0.0022822374,0.0043874765,0.0010452972,0.0011073458,0.08243042],"category_scores_gemma":[0.037413195,0.0003667715,0.00044227412,0.0019866535,0.001133359,0.0039009026,0.0040421626,0.0010223117,0.01658214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039707322,0.00023753452,0.057681963,0.00035694405,0.000044822656,0.0014067952,0.012129381,0.00027125055,0.0012694026,0.014118763,0.55396026,0.35812578],"study_design_scores_gemma":[0.000079872916,0.0000957598,0.022797858,0.00040584736,0.000027355016,0.0011062517,0.0059488644,0.00036122414,0.00096919684,0.0035115592,0.96459156,0.00010470001],"about_ca_topic_score_codex":0.07076007,"about_ca_topic_score_gemma":0.11729127,"teacher_disagreement_score":0.08243042,"about_ca_system_score_codex":0.0031772796,"about_ca_system_score_gemma":0.008798861,"threshold_uncertainty_score":0.27575725},"labels":[],"label_agreement":null},{"id":"W4385128883","doi":"10.51731/cjht.2023.696","title":"An Overview of Emerging Trends and Technologies in Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Tofacitinib; Ulcerative colitis; Adalimumab; Inflammatory bowel disease; Internal medicine; Intensive care medicine; Biologic Agents; Infliximab; Disease","score_opus":0.028245657557853323,"score_gpt":0.31947360643540945,"score_spread":0.29122794887755615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385128883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006740961,0.96072173,0.0017716371,0.015303075,0.0040649064,0.000044395336,0.00022910404,0.00014329216,0.01704772],"genre_scores_gemma":[0.0038443285,0.97377354,0.003787925,0.006688193,0.0051404913,0.000050708295,0.00041131108,0.00004306119,0.0062604444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984401,0.0003945033,0.00024948825,0.00017981877,0.0005834889,0.00015261765],"domain_scores_gemma":[0.997152,0.0012056704,0.00031561506,0.00008614352,0.0008145011,0.00042604114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024125045,0.0008205563,0.00076377107,0.0046465695,0.00067828095,0.0034939374,0.00070644025,0.0021046253,0.012427845],"category_scores_gemma":[0.004275112,0.00035022316,0.00097317924,0.004695091,0.00070796005,0.004221659,0.0017414493,0.0033300724,0.0049616755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074405645,0.00006420129,0.0012208542,0.006207367,0.000044654265,0.00034588992,0.00020675609,0.00027821277,0.000676534,0.01070465,0.13043389,0.8497426],"study_design_scores_gemma":[0.000006438238,0.000058204783,0.0010994929,0.0037598512,0.00003039934,0.00078614836,0.00015031846,0.00008832184,0.00016577553,0.0027026366,0.9911342,0.00001819939],"about_ca_topic_score_codex":0.0021923794,"about_ca_topic_score_gemma":0.0038149813,"teacher_disagreement_score":0.012427845,"about_ca_system_score_codex":0.001992577,"about_ca_system_score_gemma":0.0026770756,"threshold_uncertainty_score":0.041575253},"labels":[],"label_agreement":null},{"id":"W4385143328","doi":"10.51731/cjht.2023.697","title":"Selumetinib (Koselugo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Selumetinib; Neurofibromatosis; Medicine; Family medicine; Health care; Political science; Cancer; Pathology; Internal medicine","score_opus":0.056215157197167076,"score_gpt":0.3495927522428396,"score_spread":0.2933775950456725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385143328","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01635928,0.75417525,0.001963744,0.015251004,0.0027725482,0.00031632272,0.005944588,0.0005025492,0.20271479],"genre_scores_gemma":[0.14819182,0.658641,0.007266892,0.020998573,0.0012295758,0.00030243868,0.010488293,0.00010620516,0.1527753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996754,0.00006207456,0.000030101233,0.000036426663,0.00015076474,0.000045252204],"domain_scores_gemma":[0.9996915,0.000053225926,0.00007314414,0.000009874036,0.0001171744,0.000055086286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006347026,0.00041192665,0.00032918566,0.0009449031,0.0003131638,0.0010153658,0.00043457065,0.0005705503,0.0157048],"category_scores_gemma":[0.0009601397,0.0000808092,0.0005634347,0.00066709414,0.00033811945,0.00062658073,0.00052807503,0.0006938273,0.0037047279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004903625,0.000050990577,0.0011333369,0.002850974,0.00013100417,0.00023548816,0.000050985913,0.00016795717,0.0041855797,0.004445249,0.15469234,0.8315658],"study_design_scores_gemma":[0.00018772313,0.00037509427,0.00345875,0.0014922639,0.00013703384,0.0007255391,0.000054602053,0.00010257451,0.0031576664,0.0005900833,0.98970056,0.000018001605],"about_ca_topic_score_codex":0.015264368,"about_ca_topic_score_gemma":0.05756013,"teacher_disagreement_score":0.0157048,"about_ca_system_score_codex":0.0017088198,"about_ca_system_score_gemma":0.002309305,"threshold_uncertainty_score":0.0525378},"labels":[],"label_agreement":null},{"id":"W4385360042","doi":"10.51731/cjht.2023.700","title":"Fostemsavir (Rukobia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Human immunodeficiency virus (HIV); Regimen; Family medicine; Drug; Intensive care medicine; Pharmacology; Political science; Surgery; Health care; Law","score_opus":0.0469626711215796,"score_gpt":0.3081190507480522,"score_spread":0.2611563796264726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385360042","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01952154,0.83835375,0.0025349658,0.0033821044,0.0013212084,0.00030994852,0.002274296,0.00037381955,0.13192837],"genre_scores_gemma":[0.24073666,0.6543871,0.008872726,0.0057975315,0.0005434631,0.0002889117,0.0039165406,0.00006179626,0.0853953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985456,0.000036531303,0.000015202219,0.000025490317,0.000045390076,0.000022685137],"domain_scores_gemma":[0.99990535,0.000021450496,0.000027690654,0.0000036853608,0.000027615124,0.000014143663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032429578,0.00036966187,0.0002619672,0.00060586515,0.00019867082,0.00053316884,0.0003775913,0.00044906282,0.014790799],"category_scores_gemma":[0.00041437912,0.0000973797,0.00033121897,0.0003072529,0.00018895141,0.0003999624,0.00025757065,0.00052064605,0.0027530089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062438333,0.000078404395,0.00034948855,0.0039604185,0.000070414615,0.00019205957,0.000047760237,0.00025459824,0.008899982,0.0048078173,0.039385963,0.94132864],"study_design_scores_gemma":[0.00027650644,0.0007038411,0.0026429316,0.0023459594,0.00014129667,0.0014725907,0.00006478609,0.00023759612,0.009727079,0.0006912513,0.9816745,0.000021637963],"about_ca_topic_score_codex":0.0060124886,"about_ca_topic_score_gemma":0.016124988,"teacher_disagreement_score":0.014790799,"about_ca_system_score_codex":0.0008656832,"about_ca_system_score_gemma":0.0010542811,"threshold_uncertainty_score":0.04948014},"labels":[],"label_agreement":null},{"id":"W4385457285","doi":"10.51731/cjht.2023.704","title":"Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Emergency department; Psychological intervention; Medicine; Suicide attempt; Suicidal ideation; Suicide prevention; Harm; Family medicine; Psychiatry; Medical emergency; Poison control; Psychology","score_opus":0.04573004631640684,"score_gpt":0.33967454473677566,"score_spread":0.29394449842036885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385457285","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008587454,0.98574466,0.0001449227,0.0017118134,0.00047032215,0.0003591634,0.000842443,0.00001790766,0.002121365],"genre_scores_gemma":[0.06908259,0.92432237,0.0015620654,0.0024676346,0.000318082,0.00081706233,0.00085272134,0.000008000276,0.0005696224],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9965958,0.0016514391,0.0007661519,0.0001807983,0.0006508245,0.00015500066],"domain_scores_gemma":[0.9807809,0.012691387,0.0042185443,0.00025214476,0.0016931873,0.00036390068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046351906,0.00039068543,0.0017722787,0.002173975,0.00033625806,0.0010430177,0.0010197529,0.0013415874,0.004939602],"category_scores_gemma":[0.032839727,0.00038481265,0.0041578864,0.0020587915,0.0003170732,0.0013871698,0.0008641779,0.0012615132,0.00034445184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012642394,0.00013091981,0.011934762,0.5455594,0.0055155684,0.00026372317,0.0009723147,0.00016268514,0.00015396508,0.00085938396,0.021599028,0.41158405],"study_design_scores_gemma":[0.0019198809,0.0009402134,0.05227919,0.8473196,0.018032253,0.00084594806,0.0014969975,0.00017225432,0.00041717265,0.0005979861,0.07592464,0.000053940625],"about_ca_topic_score_codex":0.014290852,"about_ca_topic_score_gemma":0.043722592,"teacher_disagreement_score":0.014290852,"about_ca_system_score_codex":0.0018632618,"about_ca_system_score_gemma":0.0055611897,"threshold_uncertainty_score":0.028415322},"labels":[],"label_agreement":null},{"id":"W4385457407","doi":"10.51731/cjht.2023.703","title":"Difelikefalin (Korsuva)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kidney disease; Placebo; Quality of life (healthcare); Intensive care medicine; Randomized controlled trial; Hemodialysis; Dialysis; Clinical trial; Physical therapy; Internal medicine; Alternative medicine; Pathology","score_opus":0.0353784729194209,"score_gpt":0.3163723597125678,"score_spread":0.28099388679314685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385457407","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09950414,0.35262132,0.006912871,0.02250479,0.009688202,0.001108701,0.009874741,0.004504479,0.4932808],"genre_scores_gemma":[0.56238025,0.118089795,0.011308713,0.020352438,0.0016147649,0.0006147405,0.013386279,0.00038738188,0.27186564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996865,0.00005375773,0.000032567266,0.00007121837,0.00009901544,0.00005698529],"domain_scores_gemma":[0.9997962,0.00002911665,0.00004348691,0.000016174637,0.000053626543,0.00006143168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038676293,0.0006071948,0.00063518883,0.0010795842,0.0004900434,0.00066932436,0.00068302965,0.0012206098,0.04519526],"category_scores_gemma":[0.00065510604,0.00016612351,0.00065984257,0.00041925765,0.0003520816,0.000522607,0.0007326108,0.0016849315,0.014757366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004132619,0.0005575001,0.0010208426,0.0026034885,0.00012433607,0.0014520885,0.00008207257,0.00025788872,0.023388715,0.0055475603,0.1013493,0.85948366],"study_design_scores_gemma":[0.0030002196,0.0035692938,0.006850596,0.0010099047,0.00012852484,0.0075699133,0.000105386236,0.0004744559,0.020356312,0.0019989116,0.95487887,0.000057635752],"about_ca_topic_score_codex":0.0020973922,"about_ca_topic_score_gemma":0.0041580875,"teacher_disagreement_score":0.04519526,"about_ca_system_score_codex":0.0007112968,"about_ca_system_score_gemma":0.0007475644,"threshold_uncertainty_score":0.1511932},"labels":[],"label_agreement":null},{"id":"W4385507009","doi":"10.51731/cjht.2023.705","title":"Palovarotene (Sohonos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Environmental Science and Water Management","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Reimbursement; Myositis ossificans; Heterotopic ossification; Medicine; Family medicine; Surgery; Political science; Health care","score_opus":0.018139003928827516,"score_gpt":0.22989192398204505,"score_spread":0.21175292005321755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385507009","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022448191,0.83706045,0.0020134288,0.005484458,0.0035403767,0.00037918836,0.002514037,0.00036069128,0.12619925],"genre_scores_gemma":[0.21348752,0.65216523,0.0044680405,0.009327039,0.0012319221,0.0003099881,0.0033788125,0.00006393504,0.11556753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997621,0.000052171566,0.000032303236,0.000047638216,0.0000810273,0.000024694778],"domain_scores_gemma":[0.9997938,0.000048104026,0.000071747214,0.000009882469,0.00004812885,0.000028252589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003774324,0.00033243245,0.00024330706,0.00074210006,0.00020994333,0.0005426927,0.00034349333,0.0005242459,0.02111665],"category_scores_gemma":[0.00055102113,0.00010637844,0.00047264737,0.00042013323,0.00025268542,0.0003894633,0.0002870828,0.0005525693,0.003702893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010582819,0.0001538787,0.00056898245,0.0060023405,0.00013175984,0.00032122742,0.00003379841,0.0001894969,0.017273253,0.0035102498,0.041580763,0.929176],"study_design_scores_gemma":[0.0006658979,0.002459406,0.006028071,0.002451444,0.0001942077,0.0017474453,0.000057251375,0.00010804556,0.010979728,0.0008975347,0.97438055,0.000030396175],"about_ca_topic_score_codex":0.003550786,"about_ca_topic_score_gemma":0.012796402,"teacher_disagreement_score":0.02111665,"about_ca_system_score_codex":0.00043139065,"about_ca_system_score_gemma":0.0009022279,"threshold_uncertainty_score":0.07064223},"labels":[],"label_agreement":null},{"id":"W4385552853","doi":"10.51731/cjht.2023.706","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Refractory (planetary science); Antibody therapy; Intensive care medicine; Pharmacology; Antibody; Immunology; Health care; Monoclonal antibody; Political science","score_opus":0.0766381167478992,"score_gpt":0.36080694697566534,"score_spread":0.2841688302277662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385552853","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018585175,0.690366,0.0028883668,0.010292054,0.003669745,0.00054488593,0.0053563034,0.0009243153,0.26737309],"genre_scores_gemma":[0.1997112,0.46771485,0.008570236,0.01835847,0.0013946462,0.0005422614,0.012068679,0.00020458808,0.29143506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973935,0.0000291045,0.000019705341,0.000035215544,0.00013368475,0.000042951193],"domain_scores_gemma":[0.9996985,0.000047874462,0.00006134998,0.000010537305,0.0001133455,0.000068347836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004344468,0.0002780262,0.00030996266,0.00090940984,0.00026426103,0.0010235992,0.0004810968,0.00064900535,0.02075148],"category_scores_gemma":[0.0005149517,0.00008253541,0.00040805148,0.00058178883,0.00033375475,0.0004546324,0.00031181067,0.00066109456,0.004216927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074123655,0.00009624154,0.0008865274,0.0032720347,0.000079680285,0.00023434487,0.000036471178,0.00015636331,0.010525295,0.004538561,0.1609277,0.8185055],"study_design_scores_gemma":[0.00030277707,0.0006605342,0.003339732,0.00069472764,0.00007540269,0.0006150668,0.00003135859,0.0001412139,0.0050633545,0.0002588345,0.98880184,0.0000151598315],"about_ca_topic_score_codex":0.024794914,"about_ca_topic_score_gemma":0.08992351,"teacher_disagreement_score":0.97520506,"about_ca_system_score_codex":0.0022713696,"about_ca_system_score_gemma":0.0033143405,"threshold_uncertainty_score":0.069420576},"labels":[],"label_agreement":null},{"id":"W4385699997","doi":"10.51731/cjht.2023.711","title":"Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunization; Medicine; Pregnancy; Cost effectiveness; Pediatrics; Immunology; Antibody; Biology","score_opus":0.16878689120907156,"score_gpt":0.47053173141393045,"score_spread":0.3017448402048589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385699997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6186416,0.34250888,0.004646154,0.008374068,0.0004946827,0.0014635901,0.008455586,0.00008574582,0.015329612],"genre_scores_gemma":[0.9700714,0.025919342,0.0018906606,0.00030990897,0.000061258565,0.00020105019,0.0010061323,0.000006730335,0.000533454],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961008,0.0027531865,0.0002681008,0.00013775966,0.0004797218,0.00026044316],"domain_scores_gemma":[0.9947373,0.004103608,0.00050766196,0.00007373677,0.000382963,0.00019470119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055220537,0.0006471062,0.0013905196,0.0020571004,0.00019227387,0.0011737021,0.00069095916,0.0008135181,0.0028719627],"category_scores_gemma":[0.016496435,0.00031089108,0.0041394546,0.0014363123,0.0002841685,0.00065804395,0.00050228403,0.0008716916,0.00006565244],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05775977,0.0015472749,0.06981576,0.044951126,0.051283512,0.0009852727,0.00026567082,0.27653012,0.0015723644,0.013911809,0.008651053,0.47272626],"study_design_scores_gemma":[0.02422378,0.036219455,0.40469703,0.049476895,0.13932298,0.0021334658,0.0011217481,0.28860614,0.004397968,0.01839897,0.030960128,0.0004414853],"about_ca_topic_score_codex":0.06685354,"about_ca_topic_score_gemma":0.074295916,"teacher_disagreement_score":0.06685354,"about_ca_system_score_codex":0.010643629,"about_ca_system_score_gemma":0.0050753085,"threshold_uncertainty_score":0.13292879},"labels":[],"label_agreement":null},{"id":"W4385783269","doi":"10.51731/cjht.2023.712","title":"Artificial Intelligence in Prehospital Emergency Health Care","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Health care; Staffing; Artificial intelligence; Conversation; Computer science; Medical emergency; Medicine; Nursing; Psychology","score_opus":0.16465164067272786,"score_gpt":0.43723823429574343,"score_spread":0.27258659362301557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385783269","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040225177,0.24725129,0.013969285,0.63482875,0.0054335096,0.000110753135,0.00014805108,0.00015350412,0.09408233],"genre_scores_gemma":[0.3848488,0.40501505,0.042075153,0.12847012,0.018555012,0.00063347805,0.00051663886,0.00016322461,0.019722503],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99040926,0.0065867403,0.00040368014,0.00060400885,0.0014836321,0.0005127298],"domain_scores_gemma":[0.9716069,0.022508493,0.00095034443,0.0009329818,0.0024892031,0.0015121419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011919609,0.00062835205,0.0010323515,0.0023490922,0.0021030866,0.008159772,0.0023260964,0.0066686347,0.0067378054],"category_scores_gemma":[0.026240932,0.00039412224,0.0006472968,0.0028296178,0.011527101,0.009592785,0.003385543,0.008929414,0.0012809138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107552245,0.00015188199,0.0046544373,0.002062902,0.00010939034,0.00053032,0.0021718622,0.005381383,0.00012955882,0.58152384,0.17346449,0.22971243],"study_design_scores_gemma":[0.000044534398,0.000049097285,0.0020154077,0.0029258153,0.000023253944,0.00035682772,0.0018781637,0.0038216405,0.00012193369,0.68622065,0.3024744,0.00006823969],"about_ca_topic_score_codex":0.0054867477,"about_ca_topic_score_gemma":0.003182871,"teacher_disagreement_score":0.011919609,"about_ca_system_score_codex":0.005557217,"about_ca_system_score_gemma":0.005269793,"threshold_uncertainty_score":0.063037634},"labels":[],"label_agreement":null},{"id":"W4385876561","doi":"10.51731/cjht.2023.713","title":"Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Hyperbaric oxygen; Medicine; Intensive care medicine; Adverse effect; Randomized controlled trial; Oxygen therapy; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Clinical trial; Internal medicine; Surgery; Disease","score_opus":0.0762789059156902,"score_gpt":0.3845148688191601,"score_spread":0.3082359629034699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385876561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002082621,0.8590662,0.00090854213,0.12586288,0.007339861,0.00005747329,0.0001612015,0.00006471899,0.0044565615],"genre_scores_gemma":[0.015568772,0.9078191,0.0023578422,0.04559749,0.025570301,0.000107200045,0.00016836458,0.000039108232,0.0027718232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832636,0.0005150441,0.00029782238,0.00023757425,0.00049181766,0.0001312544],"domain_scores_gemma":[0.9923753,0.0037375544,0.0010833341,0.00015212595,0.0020559442,0.0005958039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027169369,0.0005652657,0.0017427356,0.0009847479,0.0008667244,0.0031293314,0.0011559647,0.0049962243,0.007455921],"category_scores_gemma":[0.0074286363,0.0002699029,0.0012555203,0.00069218175,0.0018987636,0.006817465,0.0009501469,0.005614752,0.0024983254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005760245,0.0003685499,0.0056992183,0.022499492,0.00026819785,0.001306624,0.0004066706,0.00019975433,0.0012241807,0.008146783,0.15038836,0.80891615],"study_design_scores_gemma":[0.0002610593,0.0009590248,0.011695041,0.04909756,0.0008689992,0.010541278,0.0034608378,0.00103468,0.0013685249,0.021948446,0.8985802,0.00018448991],"about_ca_topic_score_codex":0.0017919836,"about_ca_topic_score_gemma":0.0045541395,"teacher_disagreement_score":0.007455921,"about_ca_system_score_codex":0.001101066,"about_ca_system_score_gemma":0.0029268155,"threshold_uncertainty_score":0.024942517},"labels":[],"label_agreement":null},{"id":"W4385876563","doi":"10.51731/cjht.2023.714","title":"Utilization of Opioid Agonist Therapies in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; (+)-Naloxone; Methadone; Opioid use disorder; Medicine; Population; Opioid; Agonist; Public health; Pharmacology; Internal medicine; Environmental health","score_opus":0.03982585123833438,"score_gpt":0.2987935455343681,"score_spread":0.2589676942960337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385876563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74086165,0.033063825,0.0005187432,0.023056662,0.00051370665,0.0005595413,0.07912598,0.00022028195,0.12207966],"genre_scores_gemma":[0.94930845,0.022249324,0.00086861936,0.0059753023,0.000121051526,0.000112559,0.012927983,0.00005528117,0.008381437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651587,0.00013169835,0.00024885475,0.00029414965,0.0018331168,0.00097632897],"domain_scores_gemma":[0.99213624,0.00036160825,0.001370447,0.00011396058,0.004115628,0.0019021818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069042336,0.00026390023,0.0005636823,0.002944943,0.0036144727,0.0024099995,0.0013965,0.00057586917,0.010171386],"category_scores_gemma":[0.0049930084,0.00033327623,0.0009226846,0.008665252,0.00069647486,0.0006871953,0.0013054133,0.001553128,0.0004980977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025178984,0.00020219827,0.82305944,0.0010028321,0.00041273353,0.00062878465,0.0019756635,0.00053075945,0.00046637314,0.003811383,0.07706267,0.09059537],"study_design_scores_gemma":[0.000058120804,0.00006940789,0.941336,0.00096419477,0.00018318994,0.0004700135,0.003310806,0.0007331728,0.00019735753,0.00025806218,0.052349605,0.00007006416],"about_ca_topic_score_codex":0.99591774,"about_ca_topic_score_gemma":0.99727243,"teacher_disagreement_score":0.06646346,"about_ca_system_score_codex":0.06646346,"about_ca_system_score_gemma":0.1282425,"threshold_uncertainty_score":0.48222846},"labels":[],"label_agreement":null},{"id":"W4385966998","doi":"10.51731/cjht.2023.715","title":"Risankizumab (Skyrizi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Pharmacotherapy; Intensive care medicine; Drug; Physical therapy; Internal medicine; Pharmacology; Health care","score_opus":0.0153356177688009,"score_gpt":0.2638520298573586,"score_spread":0.2485164120885577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385966998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024966512,0.6783463,0.0033829634,0.011875563,0.003702465,0.0007808137,0.008480634,0.0012650762,0.26719964],"genre_scores_gemma":[0.26082847,0.4253027,0.009438636,0.020366263,0.0018630098,0.0005753384,0.018215904,0.00013448895,0.26327518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996061,0.00007437045,0.000046064888,0.000052666386,0.00016833999,0.0000524392],"domain_scores_gemma":[0.99967897,0.00004549143,0.000085723914,0.000012315194,0.00012646624,0.000051099563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006052969,0.0003819371,0.00032280775,0.0007409235,0.0002235406,0.00071042863,0.0004316204,0.0006231656,0.022037335],"category_scores_gemma":[0.00064553943,0.00010952049,0.000620093,0.00037550053,0.0002700357,0.0003488787,0.00041812033,0.00068353105,0.0071691396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013269132,0.00010483637,0.0011971656,0.0044981614,0.00015863279,0.00021326146,0.000043573415,0.0002488984,0.009075299,0.003871935,0.14976722,0.8294942],"study_design_scores_gemma":[0.00066369,0.0011992153,0.0045676515,0.0014480198,0.00019843101,0.0009211791,0.000039687908,0.00017030799,0.0060065705,0.00043926382,0.984324,0.00002209226],"about_ca_topic_score_codex":0.007945726,"about_ca_topic_score_gemma":0.023290899,"teacher_disagreement_score":0.022037335,"about_ca_system_score_codex":0.0012689003,"about_ca_system_score_gemma":0.0020990956,"threshold_uncertainty_score":0.07372218},"labels":[],"label_agreement":null},{"id":"W4386162778","doi":"10.51731/cjht.2023.720","title":"Deucravacitinib (Sotyktu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.036647230691082354,"score_gpt":0.2688750822448455,"score_spread":0.23222785155376316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386162778","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15708211,0.3588101,0.0057591936,0.052312434,0.011863595,0.0016830638,0.011044088,0.003226952,0.39821848],"genre_scores_gemma":[0.7375557,0.06651022,0.0068985056,0.027961656,0.0014356489,0.00076313777,0.010998163,0.00016677994,0.14771019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995652,0.00009022965,0.00004037106,0.00008383981,0.0001161972,0.00010418084],"domain_scores_gemma":[0.99967754,0.00006068174,0.00005286349,0.000026779951,0.0000757522,0.000106316504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060318114,0.00026638032,0.00075488456,0.00047892088,0.00037448722,0.0007946933,0.00074033136,0.0011090983,0.014789131],"category_scores_gemma":[0.0007690903,0.00014914064,0.00075615395,0.00033723094,0.00035986834,0.0005221604,0.00043535972,0.0018197931,0.0035937221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049725715,0.00035958274,0.002089912,0.0019016729,0.00026023368,0.0004435791,0.000051814914,0.0006930111,0.009839873,0.0052024308,0.20164584,0.77253944],"study_design_scores_gemma":[0.0063027195,0.0046794056,0.009384413,0.0006840908,0.00025647972,0.003318922,0.000061284285,0.0014688647,0.012018281,0.0020955668,0.95965433,0.00007562412],"about_ca_topic_score_codex":0.004647679,"about_ca_topic_score_gemma":0.02012815,"teacher_disagreement_score":0.014789131,"about_ca_system_score_codex":0.0020286678,"about_ca_system_score_gemma":0.001311478,"threshold_uncertainty_score":0.049474597},"labels":[],"label_agreement":null},{"id":"W4386251552","doi":"10.51731/cjht.2023.724","title":"Upadacitinib (Rinvoq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Antirheumatic drugs; Ankylosing spondylitis; Drug; Drug class; Intensive care medicine; Pharmacology; Disease; Internal medicine; Antirheumatic Agents; Health care","score_opus":0.04937382254902658,"score_gpt":0.31749931197059955,"score_spread":0.268125489421573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386251552","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01248644,0.7654806,0.0014894279,0.009935217,0.0020709652,0.0003998247,0.006101397,0.0005497013,0.20148636],"genre_scores_gemma":[0.17018668,0.68507266,0.0042325286,0.012410487,0.0009238905,0.0003861109,0.011072551,0.00007235076,0.11564274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967825,0.000068859445,0.00003269091,0.000041377116,0.00012859155,0.000050343537],"domain_scores_gemma":[0.9996611,0.000060792765,0.00008690682,0.000013374764,0.00013383232,0.00004408219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058641843,0.0002829905,0.00036144478,0.0009689471,0.0002597611,0.0009420216,0.00050961657,0.0005654317,0.025408356],"category_scores_gemma":[0.0009727056,0.000085540916,0.0006827352,0.0007135366,0.0002613328,0.00056398654,0.00044107865,0.00066689134,0.0044592237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065133476,0.000058226662,0.00054363796,0.0058658607,0.00016703573,0.00013307207,0.00002578114,0.00016723611,0.0020015484,0.0029126438,0.1375873,0.8498862],"study_design_scores_gemma":[0.00037321018,0.00045673104,0.00391639,0.0031648048,0.00027016582,0.0007925654,0.000042107164,0.00014834109,0.0025296933,0.0004994885,0.9877862,0.000020301315],"about_ca_topic_score_codex":0.012221429,"about_ca_topic_score_gemma":0.038382918,"teacher_disagreement_score":0.025408356,"about_ca_system_score_codex":0.001500169,"about_ca_system_score_gemma":0.002141982,"threshold_uncertainty_score":0.08499944},"labels":[],"label_agreement":null},{"id":"W4386254370","doi":"10.51731/cjht.2023.723","title":"Avacopan (Tavneos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Microscopic polyangiitis; Granulomatosis with polyangiitis; Prednisone; Internal medicine; Vasculitis; Quality of life (healthcare); Anti-neutrophil cytoplasmic antibody; Clinical trial; ANCA-Associated Vasculitis; Disease","score_opus":0.028708038472559826,"score_gpt":0.2930848554154779,"score_spread":0.2643768169429181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386254370","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03452131,0.14729375,0.005097846,0.04480687,0.0079013705,0.0013865054,0.014660068,0.004963061,0.7393692],"genre_scores_gemma":[0.2844919,0.119821444,0.019584857,0.07445965,0.0034815432,0.0020482969,0.030668596,0.00095361046,0.46449012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958855,0.00009341923,0.000033569686,0.00006688798,0.00015573666,0.000061822524],"domain_scores_gemma":[0.9993007,0.00012623092,0.00011480279,0.00003798774,0.00014541928,0.00027470928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071784813,0.00024773594,0.00040141866,0.00054476754,0.00034977504,0.0010240703,0.0007146131,0.0010558522,0.06547958],"category_scores_gemma":[0.0018573091,0.00012582753,0.0005713835,0.00035482974,0.00030295664,0.0005769597,0.00084224856,0.0021075457,0.012356289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022635378,0.00027788157,0.0010651462,0.0009849888,0.000082524966,0.00025985308,0.00003641788,0.00016167591,0.0021353364,0.0052373055,0.3180855,0.6694099],"study_design_scores_gemma":[0.004006596,0.0010634866,0.004744848,0.00081215124,0.00009458786,0.0009299526,0.00003092,0.00029492582,0.0010965914,0.0016968626,0.98520964,0.000019439796],"about_ca_topic_score_codex":0.0053267404,"about_ca_topic_score_gemma":0.017676983,"teacher_disagreement_score":0.06547958,"about_ca_system_score_codex":0.0010653188,"about_ca_system_score_gemma":0.0014331467,"threshold_uncertainty_score":0.219051},"labels":[],"label_agreement":null},{"id":"W4386331644","doi":"10.51731/cjht.2023.726","title":"Vericiguat (Verquvo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Decompensation; Medicine; Heart failure; Intensive care medicine; Diuretic; Ejection fraction; Drug class; Drug; Internal medicine; Health care; Pharmacology; Political science","score_opus":0.2190525147232995,"score_gpt":0.4353519264052075,"score_spread":0.21629941168190797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386331644","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01151389,0.45153666,0.002669737,0.02085625,0.005423569,0.0009254939,0.016673394,0.0032484364,0.4871526],"genre_scores_gemma":[0.18795799,0.25348392,0.009128647,0.03388015,0.0017955394,0.0008452301,0.025963549,0.0005666111,0.48637834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937505,0.00013415265,0.000050155013,0.00012086648,0.0002469637,0.00007279869],"domain_scores_gemma":[0.999199,0.00019831021,0.000162936,0.00004652958,0.00024038345,0.00015290504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009888338,0.00042860906,0.0005945034,0.0010521775,0.00037394764,0.0016198709,0.0011724075,0.001801906,0.115966186],"category_scores_gemma":[0.0028935832,0.00016360037,0.0005297001,0.0007831749,0.0005056727,0.00088095333,0.00076371356,0.0018352554,0.016579652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015803747,0.00013043631,0.00043984404,0.003854547,0.00007964778,0.00022501443,0.00006495903,0.00012289929,0.0030596536,0.005984806,0.3161096,0.6683482],"study_design_scores_gemma":[0.0015230498,0.00055323046,0.0019590824,0.002201153,0.0000917658,0.00041358045,0.00004449802,0.00015584646,0.0014112793,0.0009201727,0.99070376,0.000022567861],"about_ca_topic_score_codex":0.03241497,"about_ca_topic_score_gemma":0.07654434,"teacher_disagreement_score":0.115966186,"about_ca_system_score_codex":0.0018425321,"about_ca_system_score_gemma":0.0033230896,"threshold_uncertainty_score":0.38794553},"labels":[],"label_agreement":null},{"id":"W4386331753","doi":"10.51731/cjht.2023.727","title":"Atogepant (Qulipta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Medicine; Drug class; Family medicine; Drug; Psychiatry; Political science; Health care","score_opus":0.06980154237411829,"score_gpt":0.3372905315972303,"score_spread":0.26748898922311204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386331753","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020213645,0.7848996,0.0016442834,0.008311141,0.0028190624,0.0006510698,0.005878847,0.00041564737,0.17516682],"genre_scores_gemma":[0.18392822,0.6831977,0.0054770545,0.01675782,0.0016537388,0.00073821755,0.0077724536,0.0000767403,0.10039808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997484,0.00006148495,0.000023694027,0.000040177565,0.00009406116,0.000032157594],"domain_scores_gemma":[0.9997428,0.000085358355,0.00006376423,0.00000855141,0.00005936461,0.00004015772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004888274,0.0002671846,0.00036459195,0.0007761273,0.0003122959,0.00081182254,0.00038349262,0.000675916,0.033969335],"category_scores_gemma":[0.0010120373,0.000083601604,0.0006851478,0.0006186117,0.00021796799,0.0005292653,0.00038635207,0.0010165065,0.0045135813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001889748,0.00019396583,0.0005436529,0.011005566,0.0002804628,0.00025358103,0.000061976396,0.0001384903,0.0039321836,0.003606209,0.105309404,0.87278473],"study_design_scores_gemma":[0.0025613592,0.0025255864,0.006312593,0.0072971205,0.00077599875,0.0016716206,0.00009850656,0.000215624,0.0029776236,0.001408235,0.97412443,0.00003147366],"about_ca_topic_score_codex":0.0055220746,"about_ca_topic_score_gemma":0.016914802,"teacher_disagreement_score":0.033969335,"about_ca_system_score_codex":0.0005966219,"about_ca_system_score_gemma":0.0010561077,"threshold_uncertainty_score":0.11363876},"labels":[],"label_agreement":null},{"id":"W4386569541","doi":"10.51731/cjht.2023.732","title":"Dapagliflozin","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dapagliflozin; Reimbursement; Medicine; Kidney disease; Intensive care medicine; Renal function; Drug; Disease; Internal medicine; Pharmacology; Endocrinology; Diabetes mellitus; Economic growth; Health care; Economics","score_opus":0.03969015294780756,"score_gpt":0.2983118014589129,"score_spread":0.25862164851110536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386569541","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067945663,0.8601306,0.0019932617,0.013850204,0.0028071173,0.00017676558,0.004452963,0.0002649085,0.10952956],"genre_scores_gemma":[0.08812894,0.8076688,0.0040915124,0.015380985,0.0019016777,0.00023149706,0.0063657514,0.000033389366,0.07619752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979395,0.000033593748,0.00002291017,0.000029918649,0.000088174456,0.00003144215],"domain_scores_gemma":[0.99977237,0.000054735785,0.000043291726,0.000007645496,0.00009794666,0.000023982475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034266026,0.00019772365,0.0002715828,0.00053269824,0.00017044824,0.0005899536,0.000252877,0.00034389566,0.014163914],"category_scores_gemma":[0.0007879448,0.00006452504,0.0003780799,0.00045551907,0.00016233795,0.00032497974,0.00020915932,0.0006396811,0.0022002368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044510685,0.000044986704,0.00035080648,0.004610983,0.000100776444,0.00007435609,0.000021401976,0.00013366913,0.0011680493,0.0029221738,0.15977538,0.83035237],"study_design_scores_gemma":[0.00021826345,0.00020259258,0.002895964,0.0020162605,0.00019361392,0.00027030267,0.000018834757,0.00013525171,0.0010206955,0.0005622191,0.99245644,0.000009561845],"about_ca_topic_score_codex":0.0135686975,"about_ca_topic_score_gemma":0.03237994,"teacher_disagreement_score":0.014163914,"about_ca_system_score_codex":0.0011154765,"about_ca_system_score_gemma":0.0016002678,"threshold_uncertainty_score":0.04738301},"labels":[],"label_agreement":null},{"id":"W4386569617","doi":"10.51731/cjht.2023.731","title":"Telephone Triage Services in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Health care; Hotline; Medicine; Nursing; Medical emergency; Business; Political science; Telecommunications; Computer science","score_opus":0.022015028654886196,"score_gpt":0.2801131795225354,"score_spread":0.2580981508676492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386569617","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34435466,0.10107877,0.0033749403,0.10222364,0.003755823,0.0018688892,0.0531431,0.0010352688,0.38916504],"genre_scores_gemma":[0.8454421,0.06805579,0.005180286,0.018636158,0.00038744844,0.0005363514,0.014956327,0.00018397736,0.046621475],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975368,0.00015344482,0.00016079315,0.00024181459,0.0009929755,0.00091427733],"domain_scores_gemma":[0.99038106,0.000586699,0.00066546816,0.00011135512,0.005039832,0.0032155106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010451997,0.00029455638,0.00033074344,0.002829053,0.0053841616,0.0025701309,0.0020447585,0.00079202343,0.020225344],"category_scores_gemma":[0.0065094763,0.0003551658,0.0004988793,0.007948459,0.000946062,0.0010458466,0.0018222809,0.0015274326,0.0011009559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026548788,0.00019957559,0.12850107,0.002987058,0.00009238875,0.0015521062,0.007603193,0.000812093,0.0005456525,0.015599579,0.43937615,0.40246573],"study_design_scores_gemma":[0.00014309767,0.00017416471,0.5259177,0.0051655914,0.00015119404,0.0014395377,0.021914313,0.0019920485,0.00030052842,0.0019034127,0.44073147,0.000166901],"about_ca_topic_score_codex":0.9958028,"about_ca_topic_score_gemma":0.9973212,"teacher_disagreement_score":0.916746,"about_ca_system_score_codex":0.083253995,"about_ca_system_score_gemma":0.24901874,"threshold_uncertainty_score":0.60405284},"labels":[],"label_agreement":null},{"id":"W4386688264","doi":"10.51731/cjht.2023.734","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Reimbursement; Metastatic breast cancer; Oncology; Chemotherapy; Breast cancer; Internal medicine; Disease; Adjuvant; Cancer; Intensive care medicine; Health care","score_opus":0.10286531305846934,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386688264","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014070055,0.60926634,0.0016729643,0.014491741,0.0023067826,0.00033879385,0.004393535,0.0003163357,0.3531434],"genre_scores_gemma":[0.18546133,0.48526156,0.005414978,0.015264137,0.0010306305,0.00023575904,0.006763228,0.00006955956,0.3004988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996227,0.00007800184,0.000029756464,0.000035594403,0.00019123023,0.0000425755],"domain_scores_gemma":[0.9996043,0.00007998831,0.00007232664,0.000011996775,0.00018251156,0.00004887093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072561885,0.00020975225,0.00021923815,0.0007593105,0.00019858975,0.00068379194,0.0003525598,0.0003697271,0.014469038],"category_scores_gemma":[0.0010672042,0.00006995764,0.00029350937,0.0005208009,0.00025328892,0.00035087453,0.0002666029,0.0004580703,0.0020968085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000357525,0.000037598806,0.0008889298,0.0020559023,0.00007427438,0.00012529375,0.00003231553,0.0001920481,0.0023811895,0.0050862916,0.14629428,0.84247434],"study_design_scores_gemma":[0.00012730937,0.00018796723,0.0034399442,0.0010357946,0.000066835084,0.0002918772,0.000022662682,0.00010005062,0.0024055745,0.00035544016,0.99195766,0.000008904403],"about_ca_topic_score_codex":0.03482638,"about_ca_topic_score_gemma":0.11139958,"teacher_disagreement_score":0.03482638,"about_ca_system_score_codex":0.0027950597,"about_ca_system_score_gemma":0.0028400293,"threshold_uncertainty_score":0.069247305},"labels":[],"label_agreement":null},{"id":"W4386751852","doi":"10.51731/cjht.2023.736","title":"Somatropin for Short Stature","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Idiopathic short stature; Guideline; Short stature; Medicine; Growth hormone; Context (archaeology); Somatropin; Pediatrics; Growth hormone treatment; Small for gestational age; Hormone; Endocrinology; Intensive care medicine; Gestational age; Biology; Pregnancy; Pathology","score_opus":0.05128207835179631,"score_gpt":0.3225026465746606,"score_spread":0.2712205682228643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386751852","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019415194,0.3166636,0.0019722977,0.1837882,0.00956229,0.00037477873,0.003067161,0.00045928924,0.46469727],"genre_scores_gemma":[0.2624919,0.30644327,0.013284246,0.17028336,0.006312674,0.00033977654,0.005854988,0.0001980603,0.23479167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961877,0.00007408449,0.00004571152,0.00002407613,0.00017886529,0.0000584792],"domain_scores_gemma":[0.9990707,0.00021828157,0.00011022786,0.00003480612,0.0003320363,0.00023395939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006842095,0.00016207315,0.00017528317,0.00063636375,0.0005808929,0.00048018392,0.00044889865,0.00080208963,0.015938818],"category_scores_gemma":[0.0022821603,0.0000581493,0.0002770799,0.00052311784,0.0005331742,0.00019976037,0.0005456897,0.0011310278,0.0031021528],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013705474,0.00007632494,0.007327894,0.000790792,0.000025998685,0.0014232798,0.00019364836,0.000055428063,0.0011383285,0.0052794707,0.49468577,0.48886606],"study_design_scores_gemma":[0.00011004469,0.00015099967,0.030003704,0.0018887417,0.000032581214,0.003747826,0.00019790012,0.00006790475,0.0005623938,0.0016533488,0.9615678,0.000016742813],"about_ca_topic_score_codex":0.0800696,"about_ca_topic_score_gemma":0.23057029,"teacher_disagreement_score":0.0800696,"about_ca_system_score_codex":0.0018681295,"about_ca_system_score_gemma":0.005206191,"threshold_uncertainty_score":0.1592071},"labels":[],"label_agreement":null},{"id":"W4386777097","doi":"10.51731/cjht.2023.737","title":"Foslevodopa-Foscarbidopa (Vyalev)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dyskinesia; Levodopa; Medicine; Disease; Drug; Parkinson's disease; Intensive care medicine; Psychiatry; Political science; Internal medicine; Health care","score_opus":0.042815861914998116,"score_gpt":0.3039787385316636,"score_spread":0.2611628766166655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386777097","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019405855,0.7009924,0.0028701688,0.007918845,0.0020952437,0.00035395363,0.0045541506,0.00042649903,0.26138282],"genre_scores_gemma":[0.25932324,0.49713385,0.009411878,0.009714805,0.0006717626,0.00028648204,0.006603159,0.00009802125,0.2167568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997099,0.000043754586,0.000029087218,0.000035811754,0.00014577172,0.00003573015],"domain_scores_gemma":[0.99971634,0.000052824114,0.000054886077,0.0000076294955,0.00013756013,0.00003066745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005075807,0.00026591623,0.0002596143,0.00092286704,0.00031683387,0.000803786,0.00051438535,0.0005830437,0.01654278],"category_scores_gemma":[0.0006248585,0.00007601812,0.00035729766,0.0005651604,0.00033945756,0.0003837356,0.00031698708,0.00048460675,0.0024228632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007299306,0.00008277979,0.0011557916,0.0043693124,0.00008941799,0.0004097174,0.00005190691,0.00013674672,0.009667556,0.0066572046,0.08009827,0.8965514],"study_design_scores_gemma":[0.00015909226,0.0006057417,0.0059968485,0.0013659247,0.00009229911,0.0010344773,0.00008031653,0.00012567326,0.009263341,0.00045916447,0.9808003,0.00001685669],"about_ca_topic_score_codex":0.03944936,"about_ca_topic_score_gemma":0.13659528,"teacher_disagreement_score":0.03944936,"about_ca_system_score_codex":0.002257511,"about_ca_system_score_gemma":0.002411575,"threshold_uncertainty_score":0.078439474},"labels":[],"label_agreement":null},{"id":"W4386890226","doi":"10.51731/cjht.2023.739","title":"Optimizing the Use of Iodinated Contrast Media: Conservation Strategies Used Across Canada During the 2022 Shortage","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic shortage; Contrast (vision); Dosing; Medicine; Iodinated contrast media; Iodinated contrast; Adverse effect; Sustainability; Radiology; Computed tomography; Computer science; Pharmacology","score_opus":0.03422663134946923,"score_gpt":0.25090922571688146,"score_spread":0.21668259436741222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386890226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82843953,0.020337272,0.0032589196,0.09627878,0.00040629247,0.00033300158,0.002033529,0.00036234592,0.04855035],"genre_scores_gemma":[0.971574,0.0077874674,0.0036125157,0.008989516,0.000056360084,0.000046585512,0.00054744247,0.00006123175,0.0073248455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981469,0.00018759155,0.00010720229,0.00011652247,0.00078671164,0.0006550099],"domain_scores_gemma":[0.9948514,0.00036376683,0.0006603287,0.000060536808,0.0023586098,0.0017052814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001988604,0.00023837414,0.00020333253,0.0012266635,0.0038253414,0.0021619434,0.0015223374,0.00074884854,0.0031596574],"category_scores_gemma":[0.0065318034,0.00022185975,0.00030255516,0.0020717275,0.0013152193,0.00090443814,0.0015966615,0.0009967302,0.00022337952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004974764,0.00027250126,0.45819739,0.0013249309,0.00008399632,0.0031697748,0.014969714,0.002602493,0.0065228296,0.0036502192,0.07902217,0.42968655],"study_design_scores_gemma":[0.00004241807,0.00026002215,0.8005318,0.001198818,0.00007489551,0.0017473025,0.029760825,0.0027477657,0.0032071036,0.0008524464,0.15939787,0.00017864021],"about_ca_topic_score_codex":0.9818038,"about_ca_topic_score_gemma":0.98660916,"teacher_disagreement_score":0.054218065,"about_ca_system_score_codex":0.054218065,"about_ca_system_score_gemma":0.10766353,"threshold_uncertainty_score":0.39338148},"labels":[],"label_agreement":null},{"id":"W4387139635","doi":"10.51731/cjht.2023.745","title":"Difelikefalin (Korsuva)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Kidney disease; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.0353784729194209,"score_gpt":0.3163723597125678,"score_spread":0.28099388679314685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387139635","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035659745,0.7867286,0.0019238451,0.005677953,0.0019233882,0.00027983906,0.0029075455,0.00050149823,0.1643976],"genre_scores_gemma":[0.41529086,0.43783936,0.005863213,0.00868468,0.00075709185,0.00024273596,0.005420308,0.000071810944,0.1258299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997986,0.000037363938,0.00002131314,0.000037217706,0.000071232746,0.000034225694],"domain_scores_gemma":[0.9998498,0.00003176126,0.000046420584,0.0000060417565,0.000037843824,0.000028093764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003048088,0.0003764397,0.000312095,0.0007577603,0.00024405893,0.000460782,0.000404166,0.0005592859,0.020973042],"category_scores_gemma":[0.00049603713,0.000080759746,0.00042684824,0.0003699871,0.0002550057,0.00039408094,0.0002844382,0.0005855224,0.003623575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012945017,0.00014559895,0.00070865906,0.004560711,0.000102101265,0.0004724605,0.0000417781,0.0001747454,0.012622111,0.0026595977,0.054079153,0.9231387],"study_design_scores_gemma":[0.0010371334,0.00286359,0.009434741,0.002602608,0.00021844365,0.0049990546,0.00014010411,0.00027035226,0.017683825,0.0009127279,0.9598017,0.000035696525],"about_ca_topic_score_codex":0.0050290697,"about_ca_topic_score_gemma":0.018384041,"teacher_disagreement_score":0.020973042,"about_ca_system_score_codex":0.00084533,"about_ca_system_score_gemma":0.0009346401,"threshold_uncertainty_score":0.07016188},"labels":[],"label_agreement":null},{"id":"W4387219070","doi":"10.51731/cjht.2023.746","title":"Perspectives and Experiences Regarding the Impacts of Emergency Department Overcrowding: A Rapid Qualitative Review","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Harm; Medicine; Health care; Dignity; Burnout; Nursing; Psychology; Medical emergency; Social psychology; Clinical psychology; Political science","score_opus":0.07338817551188323,"score_gpt":0.40818421945540106,"score_spread":0.3347960439435178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387219070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24616595,0.6896955,0.011407465,0.018730173,0.0012445854,0.004219931,0.0042536915,0.00006919795,0.024213562],"genre_scores_gemma":[0.5206934,0.4518292,0.008550244,0.006827741,0.00015894574,0.007184181,0.0009152665,0.00010297406,0.003738012],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97133565,0.02097875,0.0032172347,0.0008941976,0.0023439766,0.0012301435],"domain_scores_gemma":[0.91608644,0.072159335,0.0032181214,0.00088076683,0.0068483334,0.00080705626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040361993,0.00071705156,0.0022657672,0.008570879,0.0042106565,0.0051365057,0.0018099542,0.001765361,0.0039620106],"category_scores_gemma":[0.067700714,0.0012813818,0.0021771395,0.0126753105,0.0036320572,0.0073069134,0.006419277,0.0021776666,0.0003475399],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016643085,0.000051105395,0.0050271163,0.13459168,0.00036690553,0.002511101,0.7638336,0.00024140677,0.0012536463,0.007803821,0.005409388,0.07874388],"study_design_scores_gemma":[0.000019230678,0.00009080781,0.0032935005,0.12615101,0.00031283387,0.0010718746,0.79138005,0.00007600428,0.00034607842,0.0009931255,0.07619743,0.000068059206],"about_ca_topic_score_codex":0.014946432,"about_ca_topic_score_gemma":0.025768967,"teacher_disagreement_score":0.040361993,"about_ca_system_score_codex":0.009408643,"about_ca_system_score_gemma":0.017885674,"threshold_uncertainty_score":0.21345711},"labels":[],"label_agreement":null},{"id":"W4387402610","doi":"10.51731/cjht.2023.748","title":"Budesonide Extended Release for Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Budesonide; Ulcerative colitis; Medicine; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Clinical trial; Corticosteroid; Gastroenterology; Disease; Alternative medicine; Pathology","score_opus":0.017084894008127578,"score_gpt":0.2815914837279059,"score_spread":0.2645065897197783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387402610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015063857,0.9750124,0.00036347425,0.0128911,0.0018263261,0.00017980963,0.00067017553,0.000026300751,0.0075239963],"genre_scores_gemma":[0.043274786,0.92016613,0.0035966996,0.018588755,0.0019062572,0.00020601199,0.0016954256,0.000023499153,0.010542474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964561,0.0008978848,0.0004931471,0.00019087584,0.0016428224,0.0003190441],"domain_scores_gemma":[0.9956175,0.0013103085,0.0005436884,0.000095755975,0.0020892553,0.00034347764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052083917,0.00037847532,0.0014614947,0.0026993002,0.0007461164,0.0015046305,0.00079792325,0.0017859405,0.0043990705],"category_scores_gemma":[0.0072028115,0.00028520127,0.0015762984,0.0018901133,0.0008040755,0.00057561893,0.0007153333,0.002476869,0.00085961825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019696585,0.000117198055,0.0016848851,0.025971042,0.00062209,0.00072096975,0.00017699332,0.00023130867,0.002108824,0.009169355,0.20271541,0.7545122],"study_design_scores_gemma":[0.001362539,0.00034270104,0.009001038,0.018968381,0.0010103311,0.0007345735,0.00009040598,0.00013845885,0.00078691303,0.0010333898,0.9664679,0.00006329141],"about_ca_topic_score_codex":0.21084563,"about_ca_topic_score_gemma":0.43087202,"teacher_disagreement_score":0.21084563,"about_ca_system_score_codex":0.007807459,"about_ca_system_score_gemma":0.026093567,"threshold_uncertainty_score":0.41923678},"labels":[],"label_agreement":null},{"id":"W4387775935","doi":"10.51731/cjht.2023.752","title":"Semaglutide for Type 2 Diabetes (2 mg)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Discontinuation; Medicine; Placebo; Adverse effect; Diabetes mellitus; Type 2 diabetes; Glycemic; Internal medicine; Randomized controlled trial; Dulaglutide; Endocrinology; Exenatide; Alternative medicine; Liraglutide","score_opus":0.05726240410101599,"score_gpt":0.3232356622110811,"score_spread":0.2659732581100651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387775935","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5614473,0.26153842,0.00405968,0.01246167,0.0049946583,0.0016087396,0.009807009,0.0021350349,0.14194745],"genre_scores_gemma":[0.87472576,0.05280561,0.005494592,0.011554409,0.0011022135,0.0005233,0.0056311903,0.00006238012,0.048100587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990237,0.0000405374,0.000009431904,0.000014338059,0.000021196523,0.0000121127805],"domain_scores_gemma":[0.9998915,0.000024249626,0.000026327265,0.0000042911524,0.000012479828,0.000041042735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040366544,0.00023687295,0.00044971736,0.00027707143,0.00013850293,0.000314951,0.00017392632,0.00040714673,0.015072132],"category_scores_gemma":[0.0003913245,0.00006710088,0.00052059616,0.00024149768,0.000139474,0.00019224583,0.00013135794,0.00054900226,0.0018835113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064973906,0.0014148671,0.007174083,0.0049734027,0.0007949252,0.00044977615,0.000053881286,0.00025320318,0.008249317,0.0012632378,0.067562655,0.8428368],"study_design_scores_gemma":[0.21945176,0.123066865,0.18657859,0.0039857444,0.0035566164,0.0048995577,0.0002499085,0.002840693,0.01999111,0.0027769124,0.43246907,0.00013322673],"about_ca_topic_score_codex":0.0012485654,"about_ca_topic_score_gemma":0.004438839,"teacher_disagreement_score":0.015072132,"about_ca_system_score_codex":0.00030894805,"about_ca_system_score_gemma":0.00033821698,"threshold_uncertainty_score":0.050421298},"labels":[],"label_agreement":null},{"id":"W4387814323","doi":"10.51731/cjht.2023.758","title":"Use of MRI and CT in Private Imaging Facilities in Canada (2021-2023)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Payment; Business; Government (linguistics); Coronavirus disease 2019 (COVID-19); Private insurance; Finance; Private sector; Health care; Medicine; Health insurance; Economic growth; Economics","score_opus":0.04931627375963663,"score_gpt":0.29953974809018835,"score_spread":0.2502234743305517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387814323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68479204,0.0153483795,0.0019949784,0.06314651,0.0008765562,0.0004840648,0.13115866,0.00089803827,0.10130073],"genre_scores_gemma":[0.94492483,0.007891798,0.0026828968,0.0073085767,0.00017095059,0.00012943071,0.019262454,0.000094165014,0.017534854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854434,0.00006729132,0.000058121714,0.000090196576,0.0005949422,0.00064519595],"domain_scores_gemma":[0.9950193,0.00016552533,0.0005997815,0.000072414245,0.001582784,0.0025600563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062098075,0.00020690978,0.00019175337,0.0013878134,0.0019512055,0.0016045636,0.0012536638,0.00064048637,0.008197216],"category_scores_gemma":[0.0036293126,0.00031045717,0.0005465257,0.002262331,0.0006995708,0.00061884784,0.0012442654,0.0011520677,0.0009310587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004108463,0.00019690131,0.5729888,0.00072857447,0.000095911804,0.0012358517,0.0012118458,0.0012493313,0.0015130495,0.003782447,0.25921732,0.1573691],"study_design_scores_gemma":[0.000059611928,0.0000773376,0.9214582,0.0006107231,0.000045657216,0.0010190845,0.002178106,0.0019381874,0.00050363736,0.00047968447,0.07156604,0.0000637985],"about_ca_topic_score_codex":0.99171466,"about_ca_topic_score_gemma":0.9957426,"teacher_disagreement_score":0.047099337,"about_ca_system_score_codex":0.047099337,"about_ca_system_score_gemma":0.0890945,"threshold_uncertainty_score":0.3417312},"labels":[],"label_agreement":null},{"id":"W4387821300","doi":"10.51731/cjht.2023.760","title":"Cost-Effectiveness of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Infants","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Cost effectiveness; Economic evaluation; Population; Medicine; Environmental health; Immunization; Economic cost; Cost–benefit analysis; Demography; Immunology; Biology; Antibody; Psychology; Economics","score_opus":0.17974875024272932,"score_gpt":0.4554738111971024,"score_spread":0.2757250609543731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387821300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47998512,0.47752613,0.0042946213,0.008640085,0.0005071835,0.0018065632,0.005514448,0.000074231866,0.02165151],"genre_scores_gemma":[0.95267487,0.04335207,0.0020057976,0.00039168354,0.000060129143,0.00016937568,0.00072834064,0.000006913141,0.0006108284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995174,0.0033822067,0.00034717857,0.00011767462,0.00066341093,0.00031564906],"domain_scores_gemma":[0.9944965,0.004089724,0.0005961546,0.00007361832,0.00047104448,0.00027293115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007440981,0.0005733004,0.0014583444,0.0019124391,0.00023249343,0.0016108605,0.00072359,0.00069508963,0.0024011186],"category_scores_gemma":[0.021990329,0.00027495518,0.0036106196,0.0015727046,0.0003629285,0.00062260305,0.0005832373,0.0010918716,0.000052226613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07907622,0.001211884,0.049108334,0.056393217,0.04627934,0.0008569509,0.00033892333,0.18885176,0.0015920348,0.017798303,0.007630752,0.55086225],"study_design_scores_gemma":[0.03504055,0.043206535,0.31518608,0.08699013,0.18385583,0.0024005957,0.0022327316,0.23620662,0.00672537,0.025579203,0.062032588,0.00054377475],"about_ca_topic_score_codex":0.12193388,"about_ca_topic_score_gemma":0.19089045,"teacher_disagreement_score":0.12193388,"about_ca_system_score_codex":0.015395679,"about_ca_system_score_gemma":0.0100016035,"threshold_uncertainty_score":0.24244827},"labels":[],"label_agreement":null},{"id":"W4387821399","doi":"10.51731/cjht.2023.756","title":"Equity in Health Technology Assessment","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Redress; Equity (law); Health equity; Health care; Psychological intervention; Health technology; Business; Public relations; Public economics; Actuarial science; Political science; Medicine; Nursing; Economic growth; Economics","score_opus":0.5030334889143961,"score_gpt":0.5219491030484097,"score_spread":0.018915614134013548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387821399","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055304165,0.068603046,0.11808522,0.36454183,0.0062196986,0.00044904655,0.0009634347,0.000250815,0.43535647],"genre_scores_gemma":[0.71732175,0.05434988,0.05669036,0.09881285,0.015457848,0.0014325009,0.0009353581,0.00035316226,0.054646302],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9368055,0.042146437,0.0026056403,0.0039492296,0.011854284,0.0026388778],"domain_scores_gemma":[0.9299571,0.04986856,0.002779454,0.0065554935,0.009010401,0.0018289948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07797087,0.0009092908,0.0012397647,0.0048685535,0.0020409944,0.01029597,0.0019704846,0.0061247544,0.012473083],"category_scores_gemma":[0.1405479,0.0005421583,0.0010659985,0.003707163,0.014182549,0.011334435,0.008023174,0.007964963,0.0012208284],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011662766,0.0000107968335,0.000761699,0.000099709316,0.00003350515,0.00001494088,0.00015234784,0.0007667786,0.000015291633,0.9470237,0.016996734,0.034112785],"study_design_scores_gemma":[0.000019261559,0.000034522596,0.0010879553,0.000725288,0.000030829353,0.00006924199,0.00017345225,0.0016525717,0.0001467915,0.88075376,0.11528477,0.000021620774],"about_ca_topic_score_codex":0.015647542,"about_ca_topic_score_gemma":0.007719272,"teacher_disagreement_score":0.07797087,"about_ca_system_score_codex":0.011281456,"about_ca_system_score_gemma":0.012836147,"threshold_uncertainty_score":0.4123543},"labels":[],"label_agreement":null},{"id":"W4387845563","doi":"10.51731/cjht.2023.761","title":"Emergency Department Overcrowding in Canada: Multistakeholder Dialogue","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Accountability; Burnout; Health care; Medicine; Distress; Nursing; Medical emergency; Psychology; Political science","score_opus":0.05736666045693938,"score_gpt":0.3012940200363951,"score_spread":0.24392735957945572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387845563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5545543,0.0051203477,0.0018766007,0.3980069,0.0025601068,0.00026545714,0.00026429418,0.00010473408,0.037247345],"genre_scores_gemma":[0.94338185,0.0023136055,0.0010710983,0.046179608,0.00025146385,0.00010493536,0.00005033365,0.000055518874,0.0065916087],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98015267,0.008749156,0.00057642616,0.0010397012,0.0031881023,0.006294069],"domain_scores_gemma":[0.9431866,0.020778371,0.002022918,0.0005971927,0.0078029693,0.025611961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016735308,0.00062406063,0.00091262854,0.0017278468,0.06721471,0.011446961,0.0034564245,0.008079743,0.0038273789],"category_scores_gemma":[0.030363029,0.0010366273,0.0007865506,0.0026526998,0.016790237,0.004769275,0.011039492,0.018168516,0.0002495226],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010527921,0.00011905863,0.008809916,0.00022306555,0.000030045803,0.0038852377,0.93646395,0.0001750808,0.0006831504,0.0051768157,0.030282926,0.014045431],"study_design_scores_gemma":[0.000015799542,0.000049355614,0.0061326195,0.00039865833,0.000014880153,0.0005443661,0.8904752,0.00021554706,0.00019943518,0.00083184254,0.101023756,0.000098441844],"about_ca_topic_score_codex":0.94937456,"about_ca_topic_score_gemma":0.9742783,"teacher_disagreement_score":0.84284806,"about_ca_system_score_codex":0.15715192,"about_ca_system_score_gemma":0.21458231,"threshold_uncertainty_score":0.9775843},"labels":[],"label_agreement":null},{"id":"W4387845984","doi":"10.51731/cjht.2023.762","title":"Avacopan (Tavneos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Microscopic polyangiitis; Granulomatosis with polyangiitis; Vasculitis; Intensive care medicine; Proteinase 3; Internal medicine; Political science; Health care","score_opus":0.028708038472559826,"score_gpt":0.2930848554154779,"score_spread":0.2643768169429181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387845984","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03287807,0.83408916,0.0014304898,0.003430518,0.0017729858,0.0004340182,0.0038758828,0.00039747008,0.12169144],"genre_scores_gemma":[0.29668745,0.6169528,0.004902899,0.0053847814,0.00075395266,0.00041843974,0.0060313074,0.00009070321,0.06877782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997485,0.00005749537,0.00002499347,0.0000349149,0.000105468156,0.000028525668],"domain_scores_gemma":[0.9997583,0.00006214474,0.00006546214,0.000008056341,0.000059484144,0.000046577836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040223455,0.00022799178,0.00033309168,0.00069278927,0.00021087039,0.0007894415,0.0003154348,0.00042725654,0.014991676],"category_scores_gemma":[0.00088714453,0.000068066365,0.0004715111,0.0006142064,0.00016818495,0.00033668726,0.00028077737,0.0007716354,0.0021176392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012633541,0.00012595172,0.00086170976,0.005843532,0.00019096855,0.00032313776,0.000040610958,0.0002285773,0.0036920563,0.002544005,0.056884512,0.92800164],"study_design_scores_gemma":[0.00152883,0.0014481314,0.006828212,0.0043536117,0.00041469684,0.0024029543,0.00007028092,0.00022417282,0.0027157203,0.00081816304,0.9791734,0.00002184189],"about_ca_topic_score_codex":0.0052222502,"about_ca_topic_score_gemma":0.021732097,"teacher_disagreement_score":0.014991676,"about_ca_system_score_codex":0.0007540258,"about_ca_system_score_gemma":0.0009526772,"threshold_uncertainty_score":0.050152123},"labels":[],"label_agreement":null},{"id":"W4387972807","doi":"10.51731/cjht.2023.770","title":"Ravulizumab (Ultomiris)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Myasthenia gravis; Medicine; Drug; Family medicine; Pharmacology; Political science; Internal medicine; Law; Health care","score_opus":0.038404020202156816,"score_gpt":0.31029660472795734,"score_spread":0.2718925845258005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387972807","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009242678,0.8740601,0.0019667877,0.006890176,0.0015327426,0.00018675014,0.0010147756,0.00053478155,0.104571305],"genre_scores_gemma":[0.14150663,0.7130676,0.0076511954,0.013986324,0.0014026784,0.00025373526,0.002586462,0.00008190311,0.119463444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970156,0.000058167265,0.000029413233,0.00004404951,0.00012208083,0.000044692446],"domain_scores_gemma":[0.9997681,0.000047623325,0.00006815445,0.0000101261785,0.000072872346,0.00003320797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006508733,0.00032790363,0.0002997492,0.0007920619,0.00021674483,0.00065248186,0.00044180852,0.0005812129,0.01146356],"category_scores_gemma":[0.000723958,0.00008706901,0.0005189053,0.0004821212,0.00027446906,0.00041039445,0.00031604315,0.0007007128,0.00378652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003069868,0.000050452192,0.0002994319,0.0024062109,0.000068551795,0.00016315177,0.000027066064,0.0001048894,0.0048649507,0.002291951,0.06156279,0.92785364],"study_design_scores_gemma":[0.00034999283,0.00080423075,0.0041430225,0.0017178648,0.0001837668,0.0013778489,0.000038514103,0.00015152906,0.0057867575,0.0005965141,0.9848269,0.000022997929],"about_ca_topic_score_codex":0.010451707,"about_ca_topic_score_gemma":0.029112963,"teacher_disagreement_score":0.01146356,"about_ca_system_score_codex":0.0012630257,"about_ca_system_score_gemma":0.0015213034,"threshold_uncertainty_score":0.03834939},"labels":[],"label_agreement":null},{"id":"W4388131049","doi":"10.51731/cjht.2023.772","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Medical prescription; Dupilumab; Population; Disease; Pediatrics; Dermatology; Family medicine; Internal medicine; Pharmacology","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388131049","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011349924,0.08707851,0.003334274,0.031434346,0.00870128,0.0011083799,0.015597117,0.004676402,0.8367198],"genre_scores_gemma":[0.11312691,0.048489515,0.011479063,0.07086963,0.0050074263,0.0011083374,0.03588279,0.0006301472,0.7134062],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934405,0.00007523943,0.000035002537,0.00011715089,0.0003004536,0.00012806545],"domain_scores_gemma":[0.99913174,0.00009722503,0.00011551286,0.00004749105,0.00027875756,0.00032931668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006903148,0.00066944776,0.00053174427,0.00087047025,0.0008215573,0.0015675178,0.0010836378,0.0023303786,0.115120776],"category_scores_gemma":[0.0012224265,0.00025877013,0.00067615433,0.0003817544,0.0003540436,0.0008641741,0.00073417043,0.0022989835,0.05185467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054364576,0.00017314847,0.00042669327,0.0005036561,0.00002491687,0.00030608286,0.000026431175,0.00007607537,0.003561982,0.0019427834,0.69252104,0.2998935],"study_design_scores_gemma":[0.00049887155,0.00030017353,0.0012203171,0.00022139402,0.000026717073,0.0008659337,0.000009836294,0.0001211487,0.0014660426,0.00028487857,0.99497247,0.000012306243],"about_ca_topic_score_codex":0.006851671,"about_ca_topic_score_gemma":0.019662956,"teacher_disagreement_score":0.115120776,"about_ca_system_score_codex":0.0015031842,"about_ca_system_score_gemma":0.0017103057,"threshold_uncertainty_score":0.38511735},"labels":[],"label_agreement":null},{"id":"W4388203943","doi":"10.51731/cjht.2023.765","title":"Deucravacitinib (Sotyktu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Plaque psoriasis; Family medicine; Psoriasis; Intensive care medicine; Dermatology; Political science; Health care","score_opus":0.45862118258732837,"score_gpt":0.44120919426623084,"score_spread":0.017411988321097527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388203943","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01644605,0.7744475,0.0025640745,0.020023176,0.0018088943,0.00024990502,0.0076149027,0.0002765516,0.17656897],"genre_scores_gemma":[0.2822383,0.60705024,0.0051634014,0.008586535,0.00096867344,0.00026305058,0.008600308,0.000058381665,0.08707112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948275,0.00014276624,0.00004642125,0.00006571785,0.00020451841,0.000057641417],"domain_scores_gemma":[0.9992428,0.00025147872,0.00016238964,0.000023623665,0.00024804924,0.00007171362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009774519,0.00024296793,0.00033624412,0.00068827346,0.00017864567,0.0008200004,0.00029018213,0.00050750596,0.012504764],"category_scores_gemma":[0.0020310993,0.00005588066,0.00051760365,0.00073275255,0.0002751621,0.0004674528,0.00027300077,0.0005631292,0.0016311201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172002,0.000040032104,0.0010429015,0.003945152,0.0002225543,0.00007551749,0.00002299644,0.00055809534,0.001084613,0.0063290684,0.13575822,0.8503036],"study_design_scores_gemma":[0.00029124643,0.0005465493,0.010379673,0.0025981297,0.00028825685,0.0005740046,0.000046218804,0.0005594046,0.0029331218,0.0014058624,0.9803483,0.00002929704],"about_ca_topic_score_codex":0.030103391,"about_ca_topic_score_gemma":0.091235265,"teacher_disagreement_score":0.030103391,"about_ca_system_score_codex":0.0025861436,"about_ca_system_score_gemma":0.0029195356,"threshold_uncertainty_score":0.059856355},"labels":[],"label_agreement":null},{"id":"W4388205527","doi":"10.51731/cjht.2023.768","title":"Interventions Intended to Alleviate Emergency Department Overcrowding","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Medicine; Health care; Medical emergency; Nursing; Political science","score_opus":0.07940633953554911,"score_gpt":0.3793811944753877,"score_spread":0.2999748549398386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013423356,0.9496164,0.0012461981,0.01630137,0.002477326,0.0016492337,0.002046676,0.00011581768,0.013123638],"genre_scores_gemma":[0.12805626,0.84346145,0.008708396,0.013272674,0.0009146282,0.0019499995,0.0011123087,0.000040311323,0.0024838722],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99396086,0.0028817572,0.0007844769,0.0004310586,0.0013414209,0.0006004311],"domain_scores_gemma":[0.9862422,0.008887008,0.0012725905,0.0003046749,0.0028932441,0.00040036885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054075825,0.00086234603,0.001837312,0.0022823624,0.00093037856,0.0026569434,0.001252517,0.0021259715,0.00694369],"category_scores_gemma":[0.03456639,0.00049377535,0.0039947494,0.0023297577,0.00084217236,0.001822241,0.0012913382,0.0025864288,0.0004261557],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011179575,0.0005446843,0.0062198765,0.3646709,0.005508383,0.00028592936,0.0017682485,0.0010165886,0.0005266032,0.0065745157,0.044077273,0.56768894],"study_design_scores_gemma":[0.0021364465,0.0009133571,0.02446659,0.6840791,0.019766752,0.00034225482,0.0031932632,0.00077378075,0.0012431276,0.0036191419,0.25934854,0.00011770454],"about_ca_topic_score_codex":0.10456087,"about_ca_topic_score_gemma":0.21954452,"teacher_disagreement_score":0.10456087,"about_ca_system_score_codex":0.0077497186,"about_ca_system_score_gemma":0.023536073,"threshold_uncertainty_score":0.20790446},"labels":[],"label_agreement":null},{"id":"W4388224263","doi":"10.51731/cjht.2023.773","title":"Roflumilast (Zoryve)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Roflumilast; Reimbursement; Intertriginous; Medicine; Psoriasis; Plaque psoriasis; Family medicine; Dermatology; Internal medicine; Political science; COPD; Health care; Disease","score_opus":0.0316320951458392,"score_gpt":0.26019278478805236,"score_spread":0.22856068964221316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388224263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016077464,0.83487463,0.0028092628,0.006561181,0.0016884505,0.00038385292,0.0028478382,0.0009808869,0.13377641],"genre_scores_gemma":[0.20261893,0.60349447,0.0066868844,0.010068557,0.0009869332,0.00042586296,0.005785766,0.00013706398,0.16979553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997019,0.000051669278,0.0000290258,0.000058278725,0.00011020552,0.000048785456],"domain_scores_gemma":[0.9998423,0.00003327682,0.000049085305,0.000008096045,0.000047729172,0.000019571393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004153215,0.00035395467,0.00046597645,0.0010096143,0.00028040982,0.00074520585,0.00060228264,0.0007411046,0.024147738],"category_scores_gemma":[0.00047995395,0.00011822161,0.00058527186,0.00052822253,0.00031148473,0.00053828204,0.0003666446,0.00081395975,0.007069634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008567353,0.00010737175,0.00031566637,0.004644564,0.000083620405,0.00032257775,0.00004508987,0.00013175311,0.017591238,0.0022683674,0.07386756,0.8997655],"study_design_scores_gemma":[0.00059388636,0.0014660378,0.003915828,0.0014613714,0.00017254661,0.0026148313,0.00005982515,0.0001621117,0.01274567,0.0004747612,0.9763,0.000033171375],"about_ca_topic_score_codex":0.00956658,"about_ca_topic_score_gemma":0.02152119,"teacher_disagreement_score":0.024147738,"about_ca_system_score_codex":0.0010034293,"about_ca_system_score_gemma":0.0008507627,"threshold_uncertainty_score":0.080782294},"labels":[],"label_agreement":null},{"id":"W4388231839","doi":"10.51731/cjht.2023.774","title":"Tisagenlecleucel (Kymriah)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Food and drug administration; Drug; Intensive care medicine; Medical emergency; Pharmacology; Political science; Health care","score_opus":0.07828658743759795,"score_gpt":0.36425421196518165,"score_spread":0.28596762452758373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388231839","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014067245,0.33823773,0.0032805745,0.010416052,0.004746808,0.00064870465,0.0086155385,0.0017597083,0.61822766],"genre_scores_gemma":[0.11850852,0.168533,0.0061429734,0.013692148,0.0009957114,0.00039393522,0.014177531,0.00028897403,0.6772672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966717,0.00003955877,0.000020865142,0.000047267513,0.00017139684,0.00005379331],"domain_scores_gemma":[0.9996693,0.000042770058,0.00005015361,0.000013843755,0.00013111635,0.00009278419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046308272,0.00042676646,0.00036483555,0.0009656188,0.00042563438,0.0009840417,0.0005521125,0.0009908029,0.085346214],"category_scores_gemma":[0.0006122584,0.00011527406,0.0004140867,0.0006092367,0.0004292459,0.0005466494,0.00054929906,0.0010041139,0.024126116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218528,0.000109966226,0.0004958573,0.002366894,0.000053142834,0.00026485816,0.00005427612,0.00018803867,0.010849454,0.0062664878,0.29684013,0.681989],"study_design_scores_gemma":[0.0001348192,0.000326807,0.0009821949,0.00034724668,0.000023996574,0.00033361567,0.000023225959,0.000079291574,0.0030346839,0.00027208502,0.9944332,0.000008810351],"about_ca_topic_score_codex":0.021731531,"about_ca_topic_score_gemma":0.061742887,"teacher_disagreement_score":0.085346214,"about_ca_system_score_codex":0.0017012585,"about_ca_system_score_gemma":0.0030555062,"threshold_uncertainty_score":0.28551155},"labels":[],"label_agreement":null},{"id":"W4388293257","doi":"10.51731/cjht.2023.776","title":"Buprenorphine-Naloxone Film Versus Tablets for Opioid Use Disorder","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Opioid use disorder; Medicine; (+)-Naloxone; Sublingual administration; Methadone; Substance abuse; Psychiatry; Opioid; Anesthesia; Internal medicine","score_opus":0.049734694388451496,"score_gpt":0.31446750619373415,"score_spread":0.26473281180528263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388293257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047708144,0.9578911,0.00032065093,0.017451063,0.0024259673,0.0030882154,0.0022330617,0.00005046027,0.011768682],"genre_scores_gemma":[0.05299736,0.9086532,0.002974976,0.025449596,0.0022537934,0.0030064296,0.0007759268,0.000054479806,0.0038343088],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905033,0.00419975,0.0033006635,0.0003830279,0.0013480473,0.00026526002],"domain_scores_gemma":[0.9740217,0.018221386,0.004937033,0.00023629017,0.00208706,0.00049660384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0093954215,0.00043210658,0.0038410346,0.004896666,0.00058435573,0.0032034575,0.0016473973,0.0039392575,0.024631364],"category_scores_gemma":[0.037047874,0.00046781142,0.0033269562,0.004310777,0.0010459422,0.0029687579,0.0012751654,0.0016822955,0.0018065829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030453142,0.00011221904,0.0007392936,0.67040765,0.002242171,0.00019323236,0.00057316426,0.00005992537,0.0005565684,0.0019536421,0.020117933,0.29999885],"study_design_scores_gemma":[0.0030293234,0.0015419632,0.005003998,0.8385373,0.008248954,0.00030914068,0.0011958979,0.00014111941,0.00042214527,0.0015156681,0.14000191,0.000052601477],"about_ca_topic_score_codex":0.0061259274,"about_ca_topic_score_gemma":0.019194437,"teacher_disagreement_score":0.024631364,"about_ca_system_score_codex":0.0039342525,"about_ca_system_score_gemma":0.005313662,"threshold_uncertainty_score":0.08240008},"labels":[],"label_agreement":null},{"id":"W4388584866","doi":"10.51731/cjht.2023.781","title":"Is Canada Prepared for the Surge of Dementia?","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Medicine; Health care; Disease; Intensive care medicine; Pathology","score_opus":0.4215623356377443,"score_gpt":0.42275789423132526,"score_spread":0.0011955585935809476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388584866","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021036207,0.011697581,0.000116582945,0.9578803,0.0070158686,0.000028346763,0.0014506099,0.000060107064,0.019647093],"genre_scores_gemma":[0.0962485,0.06309024,0.0022191324,0.7760233,0.0054032253,0.00013115171,0.003129059,0.00026638655,0.0534889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99138343,0.00078206375,0.00031587144,0.00064160663,0.0028938982,0.00398307],"domain_scores_gemma":[0.96606153,0.0014992739,0.0011292889,0.00041192034,0.016939979,0.013958028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004317809,0.00071862736,0.00093810394,0.0029702897,0.022414029,0.017365573,0.003041708,0.010206978,0.045905635],"category_scores_gemma":[0.019835519,0.0006444096,0.0013331255,0.0063175936,0.009412248,0.008898447,0.0056016874,0.012922138,0.0055911154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066147986,0.00004036264,0.00977047,0.0005930938,0.000054816384,0.0006813901,0.0018471943,0.00008145657,0.00013658241,0.016925571,0.9252804,0.04452245],"study_design_scores_gemma":[0.000041814183,0.000025281799,0.015552881,0.0018444043,0.000057902853,0.00038272564,0.016027525,0.0001235487,0.00015692759,0.004678367,0.9609577,0.00015093882],"about_ca_topic_score_codex":0.9788907,"about_ca_topic_score_gemma":0.98435163,"teacher_disagreement_score":0.8852981,"about_ca_system_score_codex":0.11470191,"about_ca_system_score_gemma":0.35680446,"threshold_uncertainty_score":0.8322245},"labels":[],"label_agreement":null},{"id":"W4388730911","doi":"10.51731/cjht.2023.782","title":"Belzutifan (Welireg)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Disease; Renal cell carcinoma; Intensive care medicine; General surgery; Family medicine; Oncology; Internal medicine; Health care; Political science","score_opus":0.020255065632725184,"score_gpt":0.2776337747908749,"score_spread":0.25737870915814975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388730911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01748115,0.5297996,0.003316071,0.020659326,0.004068344,0.00055796216,0.0074634515,0.0020717392,0.41458234],"genre_scores_gemma":[0.15939218,0.26565105,0.008279477,0.019749237,0.0010040008,0.00034038647,0.012317611,0.00023854684,0.53302747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997888,0.000025253506,0.000010601824,0.000044872395,0.000087822875,0.00004257855],"domain_scores_gemma":[0.99981207,0.000023026021,0.000031100357,0.000007705033,0.000068375484,0.00005771036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042197114,0.00049341,0.0004040778,0.0011392056,0.0005582306,0.0007933265,0.0005484092,0.0010930409,0.06336112],"category_scores_gemma":[0.0005696138,0.00014338682,0.00039025286,0.00053529715,0.0004054,0.0006785141,0.0004992718,0.0014351638,0.015309567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009749102,0.00016736005,0.00049968506,0.0021078174,0.000058596375,0.00039475606,0.0000822161,0.00020867265,0.011612837,0.006458341,0.25114205,0.72629267],"study_design_scores_gemma":[0.0003907862,0.00048488477,0.0020062672,0.00066836004,0.000045880588,0.0008632942,0.00004472055,0.00010577962,0.0031438759,0.0007083989,0.99151915,0.000018533987],"about_ca_topic_score_codex":0.021797001,"about_ca_topic_score_gemma":0.06376902,"teacher_disagreement_score":0.06336112,"about_ca_system_score_codex":0.001759673,"about_ca_system_score_gemma":0.0021939573,"threshold_uncertainty_score":0.21196407},"labels":[],"label_agreement":null},{"id":"W4388764420","doi":"10.51731/cjht.2023.784","title":"Upadacitinib (Rinvoq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Drug; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.4912516269531884,"score_gpt":0.445118357760833,"score_spread":0.046133269192355386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388764420","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01224619,0.71236736,0.0035159728,0.01746698,0.001958782,0.00036621993,0.010620012,0.0005758811,0.2408826],"genre_scores_gemma":[0.23272038,0.62826246,0.0059130467,0.009676854,0.0011464221,0.0003807086,0.014794907,0.00009367734,0.10701157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995216,0.00013571818,0.000042219966,0.000055144304,0.0001964215,0.0000490241],"domain_scores_gemma":[0.99940777,0.00014929964,0.00013970098,0.000026117541,0.00021589427,0.000061251354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008450425,0.00027985187,0.0003398617,0.0009530168,0.00023244113,0.0010601352,0.00042619993,0.0005484429,0.02165072],"category_scores_gemma":[0.0019498356,0.00007632873,0.0006002963,0.001011871,0.00029775512,0.0005782871,0.00047107783,0.00068073114,0.003061156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050893694,0.000031795033,0.0007019506,0.0036897976,0.00015640678,0.00009515481,0.000018207056,0.0003581708,0.00071381463,0.0058268555,0.15180258,0.8360962],"study_design_scores_gemma":[0.00027346096,0.00030998918,0.0066356403,0.0032911126,0.00026741705,0.0006628206,0.000038867547,0.0004220151,0.0017455586,0.0013234419,0.9850043,0.000025393827],"about_ca_topic_score_codex":0.02326176,"about_ca_topic_score_gemma":0.051944163,"teacher_disagreement_score":0.02326176,"about_ca_system_score_codex":0.0021353036,"about_ca_system_score_gemma":0.0027355016,"threshold_uncertainty_score":0.07242894},"labels":[],"label_agreement":null},{"id":"W4388865013","doi":"10.51731/cjht.2023.786","title":"Emergency Department Overcrowding: An Environmental Scan of Contributing Factors and a Summary of Systematic Review Evidence on Interventions","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Dalhousie University","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Mental health; Interdependence; Medicine; Health care; Medical emergency; Nursing; Psychiatry; Political science","score_opus":0.09846319209688296,"score_gpt":0.3700545313891586,"score_spread":0.27159133929227564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388865013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005193979,0.9977417,0.00012360653,0.0008238397,0.000070696035,0.00013040421,0.0002850355,0.000006836824,0.0002985332],"genre_scores_gemma":[0.007734065,0.9902192,0.00061698694,0.0007334242,0.00006596903,0.00037465716,0.00019773286,0.000006199708,0.000051758707],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98194194,0.006715149,0.006538062,0.0013668444,0.0027992225,0.0006388904],"domain_scores_gemma":[0.87562925,0.10293914,0.011661205,0.0013435062,0.0075085256,0.00091842405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0267325,0.001849437,0.0074450416,0.02512837,0.00097071286,0.0039677597,0.0025414906,0.002034997,0.006225492],"category_scores_gemma":[0.10594415,0.0020667836,0.010676136,0.02597023,0.0018369919,0.0050573796,0.003388503,0.002894753,0.00044722357],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024403755,0.000040108043,0.002025947,0.8662993,0.00564542,0.00009310169,0.0006307598,0.000221788,0.00008168435,0.0013069897,0.0039324434,0.11947836],"study_design_scores_gemma":[0.000088089895,0.00012187481,0.0052431356,0.9528953,0.016579213,0.00018102821,0.00070869835,0.00008925127,0.00010009844,0.00072328467,0.023237357,0.000032601936],"about_ca_topic_score_codex":0.025203595,"about_ca_topic_score_gemma":0.06048002,"teacher_disagreement_score":0.0267325,"about_ca_system_score_codex":0.010496642,"about_ca_system_score_gemma":0.028752577,"threshold_uncertainty_score":0.14137667},"labels":[],"label_agreement":null},{"id":"W4388942633","doi":"10.51731/cjht.2023.789","title":"Implications of ChatGPT on Radiology Workflow","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workflow; Burnout; Medicine; Patient safety; Patient care; Interventional radiology; Medical diagnosis; Productivity; Overtime; Radiology; Medical physics; Health care; Nursing; Computer science","score_opus":0.06568450223921185,"score_gpt":0.36595350241913344,"score_spread":0.3002690001799216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388942633","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06544846,0.0058218287,0.018306892,0.8039888,0.0071983314,0.00085920055,0.0016948418,0.001958754,0.094722904],"genre_scores_gemma":[0.71269816,0.00984657,0.057531938,0.17175265,0.0034096257,0.0014564191,0.0018210831,0.0009752791,0.040508162],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95196205,0.020064207,0.0035602201,0.0024811737,0.015397843,0.0065346127],"domain_scores_gemma":[0.76538527,0.10389577,0.016576651,0.011826444,0.06440926,0.037906628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03639631,0.0006068748,0.00043592363,0.0018614375,0.009796662,0.009229768,0.0066413735,0.0051593124,0.028988065],"category_scores_gemma":[0.16361238,0.0005972585,0.001307779,0.0027536834,0.005664561,0.006429275,0.007527793,0.0055724694,0.0057339775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068688235,0.00085276674,0.0546422,0.00209929,0.000087683555,0.0041895327,0.027704645,0.004060508,0.0011266648,0.038769647,0.49587733,0.36990285],"study_design_scores_gemma":[0.0004128639,0.00062081893,0.072858,0.0072618607,0.00014909766,0.0039676935,0.08313181,0.011879702,0.0027923132,0.045414485,0.7709156,0.0005957517],"about_ca_topic_score_codex":0.30197462,"about_ca_topic_score_gemma":0.35788858,"teacher_disagreement_score":0.30197462,"about_ca_system_score_codex":0.037418406,"about_ca_system_score_gemma":0.1209641,"threshold_uncertainty_score":0.6004339},"labels":[],"label_agreement":null},{"id":"W4388998480","doi":"10.51731/cjht.2023.790","title":"Nelarabine (Atriance)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Intensive care medicine; Psychiatry; Political science; Health care","score_opus":0.04358283942503465,"score_gpt":0.330934496541233,"score_spread":0.28735165711619837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388998480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010522527,0.75847536,0.0029135407,0.005551182,0.0025438736,0.0004177805,0.0026727077,0.0006576058,0.2162454],"genre_scores_gemma":[0.16597177,0.55576545,0.009705036,0.016341366,0.0010808622,0.0004496227,0.007137809,0.00013531378,0.2434128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977,0.000051325813,0.00002609364,0.00004589085,0.00007041025,0.00003630151],"domain_scores_gemma":[0.9998357,0.000038652815,0.000038079987,0.000011896752,0.0000500425,0.000025611816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044699278,0.00034079712,0.0002806457,0.0006893809,0.00025369448,0.0005703222,0.0005763678,0.00064553635,0.02550617],"category_scores_gemma":[0.0005230403,0.000104414765,0.0004624916,0.0004112516,0.00023943857,0.0003825819,0.00037850326,0.0007760652,0.007382094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000587821,0.000087090026,0.00029577757,0.0036119714,0.00008370352,0.000247198,0.00003385316,0.0002469666,0.009258043,0.0040547233,0.10764215,0.87385064],"study_design_scores_gemma":[0.00017452482,0.00034375643,0.00088997424,0.00076534634,0.000060865874,0.0007381341,0.000014576401,0.000048356407,0.0048167747,0.00028884612,0.9918507,0.0000082005],"about_ca_topic_score_codex":0.009736453,"about_ca_topic_score_gemma":0.02579676,"teacher_disagreement_score":0.02550617,"about_ca_system_score_codex":0.0012145275,"about_ca_system_score_gemma":0.0013566349,"threshold_uncertainty_score":0.08532661},"labels":[],"label_agreement":null},{"id":"W4388998485","doi":"10.51731/cjht.2023.791","title":"Emergency Department Overcrowding in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jewish General Hospital; Dalhousie University","keywords":"Overcrowding; Health care; Emergency department; Population; Medicine; Business; Nursing; Environmental health; Political science; Law","score_opus":0.032649997697894916,"score_gpt":0.3018785889419661,"score_spread":0.2692285912440712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388998485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038806207,0.6731704,0.0013396459,0.20529127,0.005096532,0.001002763,0.03362057,0.00013596454,0.041536607],"genre_scores_gemma":[0.46667427,0.4521678,0.004837225,0.058513496,0.0018915416,0.0006438921,0.010251896,0.00011141018,0.004908534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857901,0.0019871672,0.0021054735,0.0010956795,0.0071014045,0.0019201358],"domain_scores_gemma":[0.91799146,0.009529509,0.0072948104,0.0009454971,0.056469537,0.007769107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012019433,0.00051036204,0.0017167977,0.004411217,0.0046644807,0.005323558,0.00300088,0.001465606,0.0050947713],"category_scores_gemma":[0.039325047,0.0006626352,0.0020572953,0.011202095,0.0023091938,0.001532037,0.0024492422,0.003345895,0.00025039745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000812728,0.00014045587,0.12035509,0.055585768,0.0021508895,0.0006690577,0.005864589,0.0015587437,0.00039509207,0.012640139,0.42469397,0.3751334],"study_design_scores_gemma":[0.00036358318,0.00028525575,0.46020836,0.10250147,0.0027479767,0.0006072363,0.0091438675,0.0013960329,0.0005502134,0.0029557694,0.41874203,0.0004982289],"about_ca_topic_score_codex":0.99469155,"about_ca_topic_score_gemma":0.99725455,"teacher_disagreement_score":0.1384349,"about_ca_system_score_codex":0.1384349,"about_ca_system_score_gemma":0.3880149,"threshold_uncertainty_score":0.9992934},"labels":[],"label_agreement":null},{"id":"W4389196199","doi":"10.51731/cjht.2023.793","title":"Zanubrutinib (Brukinsa)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.06634469539270238,"score_gpt":0.35787450985986713,"score_spread":0.29152981446716475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389196199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072907996,0.8611789,0.0009798952,0.006782179,0.0013369423,0.00018613457,0.0021481477,0.00026849838,0.119828515],"genre_scores_gemma":[0.09831566,0.7710857,0.00440213,0.0079319235,0.00064024964,0.00020055368,0.00398314,0.000053822947,0.113386765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966586,0.00006644365,0.000031504387,0.000047411555,0.00014133152,0.000047468016],"domain_scores_gemma":[0.9997657,0.000040983912,0.000066504996,0.000008772964,0.00008602422,0.000032005602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005265318,0.00031635034,0.00034285046,0.0008867203,0.00034458205,0.0008578995,0.0003707616,0.00041724282,0.015450593],"category_scores_gemma":[0.00077398913,0.00009069293,0.0005076547,0.0006539626,0.00030544327,0.00042349577,0.00034980022,0.00069545576,0.003979292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004183425,0.00005034997,0.0004472221,0.0048391456,0.00009595491,0.00010663655,0.000040520972,0.00016081949,0.0048250146,0.0034416283,0.1247934,0.860781],"study_design_scores_gemma":[0.00018748669,0.00029396496,0.0033449966,0.0020742824,0.00014126039,0.00047434156,0.000040086914,0.00008797973,0.002135702,0.0004094123,0.9907974,0.000013236696],"about_ca_topic_score_codex":0.027431881,"about_ca_topic_score_gemma":0.12313917,"teacher_disagreement_score":0.027431881,"about_ca_system_score_codex":0.0017416701,"about_ca_system_score_gemma":0.0024611882,"threshold_uncertainty_score":0.05454439},"labels":[],"label_agreement":null},{"id":"W4389196223","doi":"10.51731/cjht.2023.794","title":"Cenobamate (Xcopri)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Epilepsy; Family medicine; Psychiatry; Political science; Health care","score_opus":0.054626572332850426,"score_gpt":0.3494819304024781,"score_spread":0.2948553580696277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389196223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013905336,0.7756895,0.0015178883,0.008480575,0.0020203,0.00043858372,0.0042304858,0.0004601827,0.19325711],"genre_scores_gemma":[0.1222743,0.68682086,0.005711377,0.010843299,0.0009580239,0.00034304408,0.0065417187,0.00008388509,0.16642351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997588,0.000040142437,0.000026407397,0.000036358688,0.000106093394,0.00003217919],"domain_scores_gemma":[0.9997048,0.00005061736,0.000077312056,0.000010583458,0.00010580809,0.00005081353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044875854,0.00034068225,0.00033771884,0.0009219575,0.00027190847,0.00068368576,0.0005353385,0.00068472483,0.03305762],"category_scores_gemma":[0.0010281256,0.00008576986,0.0005030552,0.0005640744,0.0002721572,0.00049346057,0.00044144058,0.0008708768,0.005593141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011092,0.00010349997,0.0004946743,0.006050692,0.00011034213,0.00024079386,0.000040580293,0.00013311452,0.0049222987,0.0034660052,0.0942949,0.88903385],"study_design_scores_gemma":[0.0008943328,0.0010727856,0.0037785324,0.003482976,0.00020942934,0.0011171862,0.00005336566,0.00012042974,0.0044566127,0.0005965842,0.9841957,0.000021976963],"about_ca_topic_score_codex":0.021559991,"about_ca_topic_score_gemma":0.079806365,"teacher_disagreement_score":0.03305762,"about_ca_system_score_codex":0.0014853659,"about_ca_system_score_gemma":0.0026107123,"threshold_uncertainty_score":0.11058879},"labels":[],"label_agreement":null},{"id":"W4389388127","doi":"10.51731/cjht.2023.797","title":"Technologies to Increase Freedom for People Living With Dementia","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Aging, Elder Care, and Social Issues","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Gerontology; Mood; Long-term care; Activities of daily living; Medicine; Quality of life (healthcare); Population; Psychology; Disease; Psychiatry; Nursing; Environmental health","score_opus":0.038576442582911624,"score_gpt":0.3544173313489428,"score_spread":0.3158408887660312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389388127","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010206379,0.18527181,0.013876287,0.27359667,0.023329789,0.0004424586,0.0012796842,0.0021266781,0.48987016],"genre_scores_gemma":[0.16439104,0.47894868,0.033834428,0.118045226,0.024013266,0.0011177815,0.0021441092,0.0006121947,0.17689316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982356,0.00058117736,0.00011340999,0.00011283089,0.0006919631,0.00026504073],"domain_scores_gemma":[0.9970149,0.0011326212,0.00026709324,0.00023349132,0.00071044744,0.0006414864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022860016,0.00074053457,0.00041686944,0.0014582562,0.0015165211,0.00560181,0.0010846148,0.004076405,0.03050782],"category_scores_gemma":[0.010448892,0.0001958632,0.00086971006,0.0010585816,0.0014526712,0.010005537,0.0037377118,0.0024801146,0.013851522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005771902,0.00013018053,0.0015297518,0.0015391533,0.000024169418,0.0002989089,0.0018377131,0.00014861468,0.00054226426,0.030928792,0.3299567,0.6330061],"study_design_scores_gemma":[0.000007866156,0.00006003597,0.0010212205,0.0013249079,0.000013959014,0.00049545505,0.0010040547,0.000044838715,0.00021706884,0.006675704,0.9891155,0.000019482834],"about_ca_topic_score_codex":0.0010920657,"about_ca_topic_score_gemma":0.0016531039,"teacher_disagreement_score":0.03050782,"about_ca_system_score_codex":0.0009440923,"about_ca_system_score_gemma":0.0013827804,"threshold_uncertainty_score":0.10205889},"labels":[],"label_agreement":null},{"id":"W4389675176","doi":"10.51731/cjht.2023.800","title":"Artificial Intelligence–Enhanced Rapid Response Electroencephalography for the Identification of Nonconvulsive Seizure","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Electroencephalography; Medicine; Epilepsy; Intensive care; Intensive care unit; Intensive care medicine; Medical emergency; Psychiatry","score_opus":0.05747205686476836,"score_gpt":0.3278756556508445,"score_spread":0.2704035987860761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389675176","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17368829,0.21004938,0.5179793,0.024739679,0.0037695852,0.00097474176,0.0022858698,0.009811205,0.056702025],"genre_scores_gemma":[0.72495824,0.061790686,0.19112033,0.006155251,0.0021766494,0.00042718207,0.0019797971,0.00041047082,0.01098138],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999458,0.00016525517,0.00005561282,0.000077867844,0.00021410729,0.000029094592],"domain_scores_gemma":[0.9989354,0.0005304179,0.00013822601,0.00005683874,0.00030054993,0.00003857649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008434577,0.00048583775,0.00039436162,0.0008163712,0.000065306696,0.0006974267,0.00040593796,0.0005064037,0.0025826085],"category_scores_gemma":[0.005592462,0.00011032634,0.00040689763,0.00046977805,0.00022888718,0.00066751934,0.00031009153,0.0008231092,0.0015028049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005789572,0.0001183482,0.011036601,0.0007878575,0.00015713676,0.00090039626,0.00006300748,0.0031203697,0.012736421,0.0016384961,0.02716356,0.94169885],"study_design_scores_gemma":[0.0008632122,0.0032190217,0.20216438,0.0032858795,0.0010095536,0.035356607,0.0005892443,0.39583603,0.064720236,0.03939035,0.25307432,0.0004911573],"about_ca_topic_score_codex":0.0009203215,"about_ca_topic_score_gemma":0.0014364552,"teacher_disagreement_score":0.0025826085,"about_ca_system_score_codex":0.00029020596,"about_ca_system_score_gemma":0.0002534817,"threshold_uncertainty_score":0.008639693},"labels":[],"label_agreement":null},{"id":"W4389675210","doi":"10.51731/cjht.2023.798","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Medicine; Medical prescription; Atopic dermatitis; Syringe; Pharmacy; Dermatology; Family medicine; Intensive care medicine; Pharmacology; Psychiatry; Health care","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389675210","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014515623,0.5311018,0.0027466826,0.010437658,0.0043276753,0.0008125763,0.009742917,0.0013395649,0.42497554],"genre_scores_gemma":[0.18695766,0.32480338,0.008597607,0.024104891,0.0023523709,0.0007050948,0.01632602,0.00020625233,0.43594682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996536,0.00005313612,0.00002266607,0.00005666428,0.00016130165,0.000052629726],"domain_scores_gemma":[0.9996722,0.000045393786,0.000058262543,0.0000123624495,0.00013204594,0.00007976513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051070313,0.00054020924,0.0003860822,0.0010768345,0.00048609663,0.0010571415,0.0005758727,0.0008384826,0.048087392],"category_scores_gemma":[0.00070546573,0.00013456673,0.00055531395,0.0005280622,0.00031575313,0.000535464,0.00047779942,0.00095222297,0.01399024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059806794,0.000101310274,0.00047505207,0.0027980444,0.000059682778,0.00023356796,0.00004298117,0.00009039013,0.004818867,0.002445698,0.24674694,0.7415894],"study_design_scores_gemma":[0.0003020438,0.0004953476,0.002044876,0.0007778595,0.000078088684,0.0008891215,0.000022087072,0.00008363141,0.00300839,0.0002215645,0.99206287,0.000014090516],"about_ca_topic_score_codex":0.017277582,"about_ca_topic_score_gemma":0.04901756,"teacher_disagreement_score":0.048087392,"about_ca_system_score_codex":0.0015982973,"about_ca_system_score_gemma":0.0018112737,"threshold_uncertainty_score":0.16086835},"labels":[],"label_agreement":null},{"id":"W4389937533","doi":"10.51731/cjht.2023.802","title":"Artificial Intelligence Decision Support Tools for End-of-Life Care Planning Conversations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Advance care planning; Palliative care; End-of-life care; Optimism; Psychological intervention; Quality of life (healthcare); Medicine; Nudge theory; Psychology; Nursing; Social psychology","score_opus":0.36450220059285143,"score_gpt":0.47032201141076235,"score_spread":0.10581981081791092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389937533","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024525423,0.0016082749,0.78976125,0.008449326,0.0009831722,0.0025136224,0.00990341,0.11229183,0.049963694],"genre_scores_gemma":[0.11303565,0.00096088817,0.86394304,0.0015203627,0.0002371543,0.0012105266,0.007938029,0.0017087361,0.009445595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963421,0.0013414369,0.00055474427,0.000503042,0.0010791215,0.00017944419],"domain_scores_gemma":[0.9743061,0.019245695,0.0012536605,0.0016799661,0.002774231,0.0007402334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053569204,0.0016348789,0.00075410417,0.0030384243,0.00076084206,0.0054506655,0.0026352284,0.0017168861,0.020562414],"category_scores_gemma":[0.032125752,0.00062147836,0.0011984885,0.0017649117,0.0005267436,0.0036894386,0.002489892,0.0025014111,0.0083489735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012022047,0.0011174757,0.005515436,0.0018505502,0.00024626325,0.0019109761,0.0020757453,0.027338492,0.0057381336,0.042233463,0.13789158,0.7728797],"study_design_scores_gemma":[0.000758685,0.00035915014,0.0036142478,0.0014652186,0.00024962588,0.0014503445,0.0009454166,0.3711347,0.01910405,0.13214946,0.46842578,0.00034329653],"about_ca_topic_score_codex":0.0015877254,"about_ca_topic_score_gemma":0.0017849258,"teacher_disagreement_score":0.020562414,"about_ca_system_score_codex":0.0011470179,"about_ca_system_score_gemma":0.0017983621,"threshold_uncertainty_score":0.06878811},"labels":[],"label_agreement":null},{"id":"W4389950523","doi":"10.51731/cjht.2023.801","title":"Early Intervention Programs for Adolescents and Young Adults With Eating Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intervention (counseling); Eating disorders; Psychological intervention; Young adult; Medicine; MEDLINE; Gerontology; Psychology; Psychiatry","score_opus":0.02341429607863432,"score_gpt":0.31158700291537383,"score_spread":0.2881727068367395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389950523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16896136,0.5289461,0.0035023736,0.23382616,0.006262303,0.007536431,0.00199327,0.00014391865,0.048828054],"genre_scores_gemma":[0.4395227,0.4682968,0.02535011,0.04855467,0.002222166,0.0092922235,0.000938118,0.00005836718,0.0057648416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927867,0.0050619342,0.00086200965,0.00016822027,0.0006193975,0.0005016395],"domain_scores_gemma":[0.97600377,0.018871084,0.0017441235,0.00026613494,0.0016982962,0.0014166188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011814129,0.00035847936,0.000702313,0.0020342323,0.0015229653,0.0017295321,0.0011293676,0.002075899,0.009456519],"category_scores_gemma":[0.05868225,0.00033069865,0.0015610058,0.0013796043,0.00077606476,0.0031372134,0.0035160398,0.0029271757,0.0004002078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008030819,0.0010536598,0.010740481,0.087526344,0.00046574746,0.0014105123,0.021564629,0.000352583,0.0003044248,0.006119225,0.05280129,0.81685793],"study_design_scores_gemma":[0.002231083,0.0025629674,0.037437424,0.49105632,0.0019501142,0.0018350044,0.05002179,0.0004920064,0.0008665389,0.009858549,0.40154743,0.00014075713],"about_ca_topic_score_codex":0.0055240756,"about_ca_topic_score_gemma":0.016313324,"teacher_disagreement_score":0.011814129,"about_ca_system_score_codex":0.002638765,"about_ca_system_score_gemma":0.011191204,"threshold_uncertainty_score":0.062479854},"labels":[],"label_agreement":null},{"id":"W4390051729","doi":"10.51731/cjht.2023.807","title":"Perspectives and Experiences Regarding the Creation of Arteriovenous Fistulas for Hemodialysis Access: A Rapid Qualitative Review","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Coaching; Psychological intervention; Health care; Nursing; Medicine; Hemodialysis; Agency (philosophy); End stage renal disease; Psychology; Medical education; Surgery","score_opus":0.07332529046648495,"score_gpt":0.40626458094094714,"score_spread":0.3329392904744622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390051729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3323383,0.59625894,0.006727545,0.028029835,0.0015105812,0.0016580872,0.002393843,0.00004475194,0.031038161],"genre_scores_gemma":[0.6248441,0.35606328,0.0045730956,0.006961238,0.00013848973,0.0022686468,0.00057355885,0.00007470633,0.0045028813],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98177,0.014552925,0.0010954184,0.0005260453,0.0012217839,0.0008337939],"domain_scores_gemma":[0.9502942,0.043609772,0.0018071098,0.00038407836,0.003140885,0.00076394435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024353199,0.00052532513,0.0012356185,0.0031214668,0.0039336225,0.0042955377,0.0014537832,0.0015440601,0.0038854398],"category_scores_gemma":[0.033432152,0.00069503736,0.0012635365,0.005428712,0.0035040146,0.006439469,0.0047343937,0.0023297279,0.00032863533],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008875842,0.00004147379,0.0030956625,0.03688803,0.000120986544,0.0016414196,0.8890127,0.00011055459,0.00073556055,0.0073992126,0.006200954,0.054664686],"study_design_scores_gemma":[0.000010243314,0.000049898914,0.002197579,0.036060072,0.000086797896,0.0007261295,0.89193153,0.000045742767,0.00021680351,0.00077269255,0.06786602,0.000036417037],"about_ca_topic_score_codex":0.01159605,"about_ca_topic_score_gemma":0.027040817,"teacher_disagreement_score":0.024353199,"about_ca_system_score_codex":0.0074228304,"about_ca_system_score_gemma":0.011429853,"threshold_uncertainty_score":0.12879354},"labels":[],"label_agreement":null},{"id":"W4390059465","doi":"10.51731/cjht.2023.808","title":"Screening for Colorectal Cancer in Individuals Younger Than 50 Years","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colorectal cancer; Incidence (geometry); Colonoscopy; Retrospective cohort study; Cohort; Cancer; Colorectal cancer screening; Cohort study; Demography; Internal medicine","score_opus":0.05186125323701863,"score_gpt":0.3356508133531266,"score_spread":0.28378956011610795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390059465","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044148263,0.60022014,0.0004289303,0.3067259,0.0106879575,0.000289348,0.006266425,0.000048385857,0.031184603],"genre_scores_gemma":[0.2624709,0.6190518,0.0019799464,0.09784769,0.00903038,0.0004031392,0.003969646,0.00003322516,0.005213221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692196,0.000975853,0.0006521088,0.00027657513,0.00087979506,0.00029373873],"domain_scores_gemma":[0.9884543,0.004525712,0.0032737534,0.00030523425,0.002613789,0.0008273068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004196545,0.00013939315,0.00072620925,0.0020403478,0.0006479053,0.0011738468,0.0007944245,0.0016444956,0.006625529],"category_scores_gemma":[0.028622743,0.00023995164,0.0009317491,0.0028116463,0.00067055307,0.0023410644,0.00078269705,0.0013412909,0.00075570476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004511691,0.000093307295,0.22673404,0.032041434,0.00056226837,0.0007762157,0.0021319648,0.0001151509,0.0003169126,0.0036913063,0.26409093,0.4689952],"study_design_scores_gemma":[0.00015485867,0.00023907756,0.5463744,0.13379034,0.0012233045,0.0018845914,0.005535879,0.00018592276,0.00031809637,0.0026586442,0.30754447,0.00009038927],"about_ca_topic_score_codex":0.06559143,"about_ca_topic_score_gemma":0.10776339,"teacher_disagreement_score":0.93440855,"about_ca_system_score_codex":0.0016707988,"about_ca_system_score_gemma":0.004329709,"threshold_uncertainty_score":0.13041925},"labels":[],"label_agreement":null},{"id":"W4390059615","doi":"10.51731/cjht.2023.804","title":"Setmelanotide (Imcivree)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Proprotein convertase; Medicine; Kexin; Drug; Obesity; Orphan drug; Internal medicine; Pediatrics; Intensive care medicine; Family medicine; Bioinformatics; Pharmacology; Biology; Health care; Political science","score_opus":0.01622868157685836,"score_gpt":0.2618929886096289,"score_spread":0.24566430703277053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390059615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03235137,0.68619287,0.0030029821,0.008031034,0.004036459,0.0005599081,0.007986593,0.0006927717,0.25714606],"genre_scores_gemma":[0.3035475,0.46715382,0.009634795,0.01706375,0.0016941323,0.0005558717,0.012150253,0.0001241476,0.18807578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998363,0.00003138458,0.000020214731,0.000025878371,0.00006488732,0.000021234899],"domain_scores_gemma":[0.99985206,0.00003477787,0.00004135326,0.0000065087756,0.000035317727,0.00002995242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032631442,0.0002542148,0.000281797,0.0005437531,0.00015683677,0.0006782913,0.00032753308,0.000496584,0.02869586],"category_scores_gemma":[0.00055231334,0.000069366215,0.000494516,0.00035546115,0.00015638326,0.0003275237,0.00025964226,0.00064847176,0.0036192653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013454186,0.00009874201,0.0006095785,0.0035796317,0.00014824898,0.0002544865,0.000023408571,0.00019634928,0.0060277353,0.0022351702,0.06529382,0.9201874],"study_design_scores_gemma":[0.0014356048,0.0018794116,0.008413445,0.004144071,0.00034764674,0.0024409404,0.00006192472,0.00042124512,0.008001806,0.00091949094,0.971891,0.00004353065],"about_ca_topic_score_codex":0.005179804,"about_ca_topic_score_gemma":0.017183641,"teacher_disagreement_score":0.02869586,"about_ca_system_score_codex":0.0009462928,"about_ca_system_score_gemma":0.00093893294,"threshold_uncertainty_score":0.095997214},"labels":[],"label_agreement":null},{"id":"W4390113947","doi":"10.51731/cjht.2023.806","title":"Andexanet Alfa (Ondexxya)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Observational study; Intensive care medicine; Prothrombin complex concentrate; Internal medicine; Warfarin","score_opus":0.12907333391532777,"score_gpt":0.3707171932327033,"score_spread":0.24164385931737553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390113947","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009082149,0.65685743,0.0035104512,0.077738285,0.014972707,0.0010129435,0.012014996,0.0005612138,0.22424981],"genre_scores_gemma":[0.111278154,0.5924582,0.019761179,0.10950197,0.0046451814,0.0018951165,0.014546874,0.0002488021,0.14566462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878377,0.00035423058,0.00029805175,0.00010413069,0.00037926168,0.00008062134],"domain_scores_gemma":[0.9972543,0.001022257,0.00075879507,0.00012677557,0.00066487247,0.00017294784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959674,0.00019578573,0.0005607041,0.00070746365,0.00040892608,0.0010830159,0.0007123699,0.0011926345,0.02159883],"category_scores_gemma":[0.0052721235,0.0001288161,0.0011854193,0.0006120886,0.00042053172,0.00057456846,0.000598217,0.001900723,0.0036865007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014994395,0.0000624153,0.00056414073,0.01184595,0.00024971098,0.00019958313,0.00007354832,0.00012119547,0.0013024375,0.0077778585,0.2739154,0.70238835],"study_design_scores_gemma":[0.0009305451,0.00023397683,0.0020682921,0.0058420734,0.00025120968,0.0003346332,0.00003649407,0.000053142987,0.0005958866,0.00088742183,0.9887515,0.00001476951],"about_ca_topic_score_codex":0.015761813,"about_ca_topic_score_gemma":0.038328968,"teacher_disagreement_score":0.02159883,"about_ca_system_score_codex":0.0015781544,"about_ca_system_score_gemma":0.004109738,"threshold_uncertainty_score":0.07225531},"labels":[],"label_agreement":null},{"id":"W4390908813","doi":"10.51731/cjht.2024.816","title":"Endobronchial Valves for the Management of Severe Emphysema","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Evidence-based medicine; Quality of life (healthcare); Evidence-based practice; Systematic review; Intensive care medicine; Clinical trial; MEDLINE; Surgery; Alternative medicine; Internal medicine; Pathology; Nursing","score_opus":0.031266743592285345,"score_gpt":0.33279344402821964,"score_spread":0.3015267004359343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390908813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000844613,0.9723446,0.00024762005,0.019396776,0.0032574632,0.00022164406,0.00029490705,0.000014056339,0.0033783861],"genre_scores_gemma":[0.017780159,0.9498253,0.0029303164,0.020902362,0.0056937654,0.0004930535,0.00038592372,0.000020358571,0.0019687836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899934,0.0043596923,0.0026651572,0.00044060583,0.002252271,0.0002888813],"domain_scores_gemma":[0.9289869,0.05259047,0.009733924,0.0009148052,0.0068897656,0.00088399707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014565649,0.00055921875,0.0024574215,0.0032463046,0.0005422201,0.0033353043,0.0016918691,0.0045014704,0.013298855],"category_scores_gemma":[0.073504314,0.0003708929,0.003490126,0.0018437314,0.0013634526,0.0044883443,0.0015164136,0.0032900025,0.0016240266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013357184,0.0001007233,0.0016342576,0.36287647,0.0017198127,0.00030253452,0.00058214646,0.00015056094,0.0006209441,0.0059121163,0.07122864,0.553536],"study_design_scores_gemma":[0.0013448634,0.00059936586,0.007513496,0.70506585,0.0043630544,0.0009310618,0.00078528124,0.00018124146,0.00060431275,0.005298349,0.27323666,0.000076577235],"about_ca_topic_score_codex":0.0033308088,"about_ca_topic_score_gemma":0.008834457,"teacher_disagreement_score":0.014565649,"about_ca_system_score_codex":0.0024635918,"about_ca_system_score_gemma":0.0068373443,"threshold_uncertainty_score":0.07703143},"labels":[],"label_agreement":null},{"id":"W4390918971","doi":"10.51731/cjht.2024.815","title":"Average Volume of MRI Exams Conducted per Hour Across Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workflow; Volume (thermodynamics); Mri scan; Medical physics; Variety (cybernetics); Medicine; Magnetic resonance imaging; Computer science; Statistics; Radiology; Database; Artificial intelligence; Mathematics; Physics","score_opus":0.021059491304500234,"score_gpt":0.29591242062202966,"score_spread":0.2748529293175294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390918971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46618077,0.036348708,0.010999467,0.031269014,0.0014235821,0.0004354298,0.23633747,0.0046102665,0.21239524],"genre_scores_gemma":[0.8823703,0.020909198,0.0072144573,0.0043530283,0.00036215247,0.00011950085,0.041981496,0.000626114,0.04206372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973768,0.00024260729,0.00020305348,0.0003082878,0.0012295338,0.00063970836],"domain_scores_gemma":[0.9905212,0.00062099117,0.0009137712,0.0001663138,0.005888068,0.001889617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009620544,0.00034032387,0.00038631854,0.0026777529,0.0011191271,0.0019763496,0.0013134505,0.00028922068,0.010473286],"category_scores_gemma":[0.007620669,0.00028029433,0.0006420124,0.0048479647,0.0005231031,0.00066693046,0.0008334042,0.00067679706,0.0017604529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000551889,0.00007338099,0.40912384,0.0013611167,0.00038250443,0.0007139125,0.0014563181,0.0049713473,0.0020786603,0.0051381085,0.32790303,0.24624592],"study_design_scores_gemma":[0.00003902628,0.00009275183,0.84242857,0.00053137226,0.00013668175,0.00091498165,0.0019588606,0.0024633093,0.0016482996,0.0005334965,0.14912382,0.00012873362],"about_ca_topic_score_codex":0.972749,"about_ca_topic_score_gemma":0.9755803,"teacher_disagreement_score":0.027251005,"about_ca_system_score_codex":0.02524221,"about_ca_system_score_gemma":0.035411216,"threshold_uncertainty_score":0.18314588},"labels":[],"label_agreement":null},{"id":"W4390975747","doi":"10.51731/cjht.2024.817","title":"Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketamine; Suicidal ideation; Depression (economics); Psychiatry; Mental health; Psychology; Dissociative; Treatment-resistant depression; Hallucinogen; Clinical psychology; Placebo; Medicine; Psychotherapist; Major depressive disorder; Suicide prevention; Poison control; Alternative medicine; Medical emergency","score_opus":0.023666098261682037,"score_gpt":0.30075208039739043,"score_spread":0.2770859821357084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390975747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091876966,0.9972791,0.000030770174,0.0016295385,0.00035824985,0.00001705458,0.000059129492,0.000005697401,0.00052858057],"genre_scores_gemma":[0.00077027985,0.99722004,0.00013326852,0.001238596,0.00036536355,0.000030079433,0.000061021183,0.0000031398176,0.00017826345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772614,0.0005866069,0.00097448815,0.00013153037,0.0004884516,0.00009278106],"domain_scores_gemma":[0.98816854,0.006084046,0.002924107,0.00013331222,0.002383467,0.00030656476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004816648,0.00084460253,0.0027348853,0.005110145,0.000394627,0.0023883916,0.0016362127,0.002887109,0.006450941],"category_scores_gemma":[0.012487789,0.00077165605,0.0023248664,0.0047586695,0.0006773476,0.0037379463,0.001176371,0.0021117195,0.0020817064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002454247,0.000049417857,0.00049085193,0.11868516,0.0003975101,0.00018187522,0.00016955352,0.00009563243,0.00021664398,0.0010145216,0.058118902,0.82033443],"study_design_scores_gemma":[0.0002408768,0.0003323,0.0047347127,0.34436047,0.0021889831,0.0015992408,0.0003243561,0.000116610456,0.00014324384,0.0010464868,0.6448655,0.000047176207],"about_ca_topic_score_codex":0.006720971,"about_ca_topic_score_gemma":0.018227046,"teacher_disagreement_score":0.006720971,"about_ca_system_score_codex":0.0027342767,"about_ca_system_score_gemma":0.0044589317,"threshold_uncertainty_score":0.025473177},"labels":[],"label_agreement":null},{"id":"W4391134430","doi":"10.51731/cjht.2024.819","title":"Axicabtagene Ciloleucel (Yescarta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.05406790230311775,"score_gpt":0.35301510937500535,"score_spread":0.2989472070718876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391134430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017396271,0.6821057,0.0021014048,0.014112054,0.0023572107,0.0005191668,0.004426296,0.00046057565,0.2765212],"genre_scores_gemma":[0.19330707,0.53427756,0.008458857,0.018700326,0.0012858772,0.0005004411,0.007512386,0.00013117035,0.23582639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958295,0.00007468515,0.000037092796,0.000041307216,0.0002131018,0.0000509618],"domain_scores_gemma":[0.9995365,0.00010106581,0.000097638294,0.000014279453,0.0001870431,0.00006346463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006875222,0.0002383687,0.000282609,0.000906349,0.0002746908,0.0009148219,0.00043855887,0.0006192279,0.026324172],"category_scores_gemma":[0.0010588064,0.00008030305,0.0004567735,0.00055382785,0.00038336831,0.0004964115,0.000334519,0.0005963092,0.004133161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006851303,0.00009008591,0.00088852394,0.004199779,0.00009456249,0.00020427446,0.000039190974,0.00013122169,0.008354233,0.00460265,0.13950375,0.84120643],"study_design_scores_gemma":[0.00028522982,0.0008157103,0.004593364,0.0012674045,0.00011886791,0.00056865736,0.00005116952,0.00013946589,0.005740189,0.00040034775,0.98600256,0.000017040224],"about_ca_topic_score_codex":0.021341674,"about_ca_topic_score_gemma":0.08744776,"teacher_disagreement_score":0.026324172,"about_ca_system_score_codex":0.0018575151,"about_ca_system_score_gemma":0.003088228,"threshold_uncertainty_score":0.08806318},"labels":[],"label_agreement":null},{"id":"W4391257731","doi":"10.51731/cjht.2024.822","title":"Tremelimumab (Imjudo) in Combination With Durvalumab (Imfinzi)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Nivolumab; Cancer; Immunotherapy","score_opus":0.03239914303394808,"score_gpt":0.24205544899604506,"score_spread":0.20965630596209697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391257731","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046746608,0.71140313,0.0053017363,0.028372437,0.0011539884,0.00024323056,0.0045023477,0.00014964191,0.20212689],"genre_scores_gemma":[0.49406174,0.41859075,0.011029701,0.008054735,0.0009640693,0.0001466644,0.0032813523,0.00003585702,0.0638351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969304,0.00010603442,0.000024687799,0.000029467337,0.00011259525,0.00003423406],"domain_scores_gemma":[0.99948466,0.00018845915,0.00014527886,0.00001593097,0.0001223309,0.000043376866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010053627,0.00018300852,0.00023800443,0.00065018167,0.00013806793,0.00066068734,0.0002392868,0.0003406079,0.0061785737],"category_scores_gemma":[0.0015644267,0.00005690325,0.00036939766,0.00062550197,0.00023978973,0.00036193785,0.0002175245,0.00035268028,0.00066006486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011268387,0.00006856751,0.006391473,0.003353288,0.00039736874,0.00027749222,0.00004077784,0.0011834966,0.0033930826,0.018580409,0.07762723,0.88755995],"study_design_scores_gemma":[0.00063967274,0.001309696,0.03898118,0.004095979,0.0008254999,0.0017701252,0.00013299116,0.0022011432,0.008446559,0.0043357834,0.9372165,0.00004501052],"about_ca_topic_score_codex":0.029302912,"about_ca_topic_score_gemma":0.104421005,"teacher_disagreement_score":0.029302912,"about_ca_system_score_codex":0.0025337576,"about_ca_system_score_gemma":0.0026261166,"threshold_uncertainty_score":0.058264732},"labels":[],"label_agreement":null},{"id":"W4391449146","doi":"10.51731/cjht.2024.824","title":"Somapacitan (Sogroya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Coconut Research and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.029090092646117484,"score_gpt":0.308740247536233,"score_spread":0.2796501548901155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391449146","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011795363,0.32793546,0.0031652087,0.005276289,0.004265829,0.00037074377,0.004087271,0.0014828584,0.6416209],"genre_scores_gemma":[0.10638605,0.26537806,0.0146571845,0.01142983,0.0008755063,0.00025521696,0.009103869,0.00047150478,0.59144276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963546,0.000046475652,0.000027313396,0.00007644381,0.00017169864,0.00004258469],"domain_scores_gemma":[0.99965596,0.000042519296,0.00005514204,0.000019091614,0.00014822501,0.00007896925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003984223,0.00053162116,0.00052494975,0.0014170497,0.00075630745,0.0015021025,0.0007147769,0.0010275244,0.061811384],"category_scores_gemma":[0.00071497215,0.00021242951,0.00043516405,0.0010965603,0.00059596996,0.0007201699,0.0008483564,0.0012022142,0.018191637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042044566,0.00009851484,0.0006869366,0.004117418,0.0000407157,0.00043294375,0.00012728042,0.00012917747,0.012319472,0.014753402,0.22759935,0.7392742],"study_design_scores_gemma":[0.00003859407,0.00014464668,0.0008695188,0.00057967234,0.000027161672,0.00041821352,0.000045068053,0.00004432937,0.0026125063,0.00038243874,0.99482995,0.000007834896],"about_ca_topic_score_codex":0.027668796,"about_ca_topic_score_gemma":0.096025705,"teacher_disagreement_score":0.061811384,"about_ca_system_score_codex":0.0015750831,"about_ca_system_score_gemma":0.0034047605,"threshold_uncertainty_score":0.20677972},"labels":[],"label_agreement":null},{"id":"W4391716904","doi":"10.51731/cjht.2024.826","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Reimbursement; Combination therapy; Cystic fibrosis transmembrane conductance regulator; Pharmacology; Internal medicine; Health care","score_opus":0.023704979657390646,"score_gpt":0.33266858670483407,"score_spread":0.3089636070474434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391716904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003563511,0.9683294,0.00059541396,0.0014775774,0.00036338743,0.00018225392,0.0011336501,0.00004857447,0.024306208],"genre_scores_gemma":[0.04468628,0.926864,0.0029096864,0.0018050077,0.00022627455,0.00017431813,0.0014423484,0.00001962151,0.021872407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984921,0.00034149707,0.0001892087,0.00010944682,0.00072619086,0.00014140931],"domain_scores_gemma":[0.9986345,0.00038203775,0.000339529,0.00004120223,0.0005288249,0.000073955736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017160664,0.0004334199,0.00071292993,0.0020520145,0.0003247481,0.001547368,0.00049237214,0.0006118961,0.008243408],"category_scores_gemma":[0.002500036,0.00012883637,0.0014278493,0.0018513078,0.00043644276,0.00061210466,0.00031940299,0.0006968786,0.0011218811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048938027,0.00006336418,0.0014917485,0.02089078,0.0007676802,0.0002216615,0.00007349238,0.0004480428,0.0024929263,0.005017521,0.042053383,0.92599],"study_design_scores_gemma":[0.00021453081,0.00042219355,0.008056061,0.012694873,0.0010361688,0.0007417625,0.000117285555,0.00016844932,0.0015400283,0.0006891355,0.9742939,0.000025647232],"about_ca_topic_score_codex":0.058067363,"about_ca_topic_score_gemma":0.2089363,"teacher_disagreement_score":0.058067363,"about_ca_system_score_codex":0.00445694,"about_ca_system_score_gemma":0.007215606,"threshold_uncertainty_score":0.11545873},"labels":[],"label_agreement":null},{"id":"W4391723447","doi":"10.51731/cjht.2024.825","title":"Ibrutinib (Imbruvica)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Reimbursement; Medicine; Drug; Chronic lymphocytic leukemia; Oncology; Family medicine; Internal medicine; Leukemia; Pharmacology; Political science; Health care","score_opus":0.0390365717984071,"score_gpt":0.34989368745113497,"score_spread":0.3108571156527279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723447","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004829762,0.88109815,0.0012586594,0.0060072546,0.001581496,0.00013928948,0.0019256745,0.00035615012,0.102803476],"genre_scores_gemma":[0.116315834,0.7408956,0.0061870795,0.011217626,0.0012133119,0.00022629819,0.0052963,0.00008826816,0.11855966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996648,0.00006889057,0.00003323077,0.00005324867,0.00012470533,0.000055181983],"domain_scores_gemma":[0.99978346,0.000041514486,0.00006867984,0.000008643986,0.00006886196,0.000028844957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005868129,0.0004983361,0.00040909668,0.00087311974,0.00023830871,0.0008392336,0.00059918937,0.00063927553,0.016902737],"category_scores_gemma":[0.0006752197,0.000105691484,0.00052393344,0.00067959575,0.00026988387,0.00042183077,0.000398405,0.0007687452,0.0060099987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049361226,0.00005530486,0.00041459387,0.004107785,0.00011577088,0.00015982737,0.000032376956,0.00020787927,0.005599447,0.0024965897,0.11209537,0.8742215],"study_design_scores_gemma":[0.00017882738,0.00030238501,0.0019690674,0.0014510576,0.000120484336,0.0005175793,0.000025595658,0.0000806865,0.0034466446,0.00029423233,0.9916011,0.000012156713],"about_ca_topic_score_codex":0.012399692,"about_ca_topic_score_gemma":0.033795033,"teacher_disagreement_score":0.016902737,"about_ca_system_score_codex":0.0018125803,"about_ca_system_score_gemma":0.0013528906,"threshold_uncertainty_score":0.056545317},"labels":[],"label_agreement":null},{"id":"W4391723502","doi":"10.51731/cjht.2024.827","title":"Mirikizumab (Omvoh)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dosing; Syringe; Ulcerative colitis; Tofacitinib; Vial; Drug; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.01076456973361453,"score_gpt":0.25980991371157675,"score_spread":0.2490453439779622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723502","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018980324,0.94320905,0.0009815694,0.002309081,0.0004043938,0.00014600235,0.000707928,0.000117435746,0.03314428],"genre_scores_gemma":[0.2660745,0.6861246,0.005784419,0.0034227911,0.0004329473,0.0002064262,0.0015171821,0.000035605513,0.0364015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996402,0.0000729697,0.000028877568,0.000031518426,0.00018780987,0.000038679584],"domain_scores_gemma":[0.9997428,0.00005553866,0.0000953379,0.000007678854,0.00007080352,0.000027796874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003368,0.00019081516,0.00030245967,0.00083370047,0.00016799486,0.0005658509,0.00021214271,0.00032028454,0.0033859145],"category_scores_gemma":[0.00059497845,0.000081336075,0.00035123932,0.00050284574,0.00018291571,0.00026294886,0.00018624814,0.00037480742,0.0006288484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005821836,0.00005307258,0.0011914577,0.004633459,0.00016788072,0.00017596867,0.000030854982,0.00015800033,0.011164278,0.0017185885,0.019385869,0.96073824],"study_design_scores_gemma":[0.00041343473,0.0011289222,0.016601164,0.0036259103,0.00047060504,0.0022932189,0.000073343814,0.00026977886,0.013326404,0.00060526194,0.9611616,0.000030352585],"about_ca_topic_score_codex":0.0065569743,"about_ca_topic_score_gemma":0.034661375,"teacher_disagreement_score":0.0065569743,"about_ca_system_score_codex":0.001288474,"about_ca_system_score_gemma":0.0014202793,"threshold_uncertainty_score":0.013037622},"labels":[],"label_agreement":null},{"id":"W4391840542","doi":"10.51731/cjht.2024.829","title":"Cabozantinib (Cabometyx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cabozantinib; Reimbursement; Medicine; Nivolumab; Renal cell carcinoma; Drug; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Cancer; Immunotherapy; Political science","score_opus":0.04342577596772945,"score_gpt":0.25924637735701594,"score_spread":0.2158206013892865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391840542","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008061216,0.8199928,0.0020905174,0.017018229,0.0014279999,0.00014875985,0.0054139625,0.00026601303,0.14558047],"genre_scores_gemma":[0.21251515,0.6793555,0.004848832,0.007186038,0.0015049814,0.00015566015,0.006757176,0.000062482395,0.08761412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997044,0.00006246367,0.000027241085,0.000043585882,0.00012515527,0.000037100308],"domain_scores_gemma":[0.9993943,0.00017864617,0.00013588855,0.000019870045,0.00020122653,0.000070023445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262685,0.00035364268,0.00030320458,0.0010604161,0.00026154864,0.000954986,0.00030819525,0.00049522996,0.016678814],"category_scores_gemma":[0.0015580085,0.00007782278,0.00042524445,0.00089901715,0.00030695368,0.00038649738,0.00023979793,0.0005978463,0.0021946286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063232,0.000046794135,0.0015016589,0.0036572602,0.00016027612,0.00009923283,0.000025799525,0.0005750058,0.0012763899,0.0114519335,0.20218328,0.77839],"study_design_scores_gemma":[0.00026824538,0.00022890086,0.009180052,0.001973758,0.00020583393,0.00044388568,0.00003795295,0.0004074113,0.0012352002,0.0016079581,0.984391,0.000019816283],"about_ca_topic_score_codex":0.11904991,"about_ca_topic_score_gemma":0.20177354,"teacher_disagreement_score":0.11904991,"about_ca_system_score_codex":0.0042904625,"about_ca_system_score_gemma":0.0042309184,"threshold_uncertainty_score":0.23671395},"labels":[],"label_agreement":null},{"id":"W4392110465","doi":"10.51731/cjht.2024.839","title":"Timing of Antibiotic Therapy for Neisseria Gonorrhoeae Infection","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gonorrhea; Neisseria gonorrhoeae; Medicine; Antibiotic resistance; Antibiotics; Antibiotic therapy; Empiric therapy; Intensive care medicine; Internal medicine; Family medicine; Microbiology; Biology; Alternative medicine; Pathology","score_opus":0.05951706191556892,"score_gpt":0.3567738861029935,"score_spread":0.29725682418742455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392110465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008907746,0.95789367,0.0009025387,0.022556214,0.0036576933,0.0002298325,0.0004227704,0.000059814844,0.0053697354],"genre_scores_gemma":[0.12012768,0.8476113,0.008584114,0.016513847,0.0051654517,0.0003801502,0.00045778704,0.00005504166,0.0011047572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934395,0.0028636807,0.0015961563,0.00041899976,0.0014531034,0.00022852884],"domain_scores_gemma":[0.9688044,0.0178044,0.0071062185,0.0004745548,0.0048065656,0.0010037504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00789638,0.0003813517,0.0016927103,0.0019333914,0.00057862233,0.002383313,0.0014027948,0.0019047663,0.0039425557],"category_scores_gemma":[0.05268918,0.00035830255,0.0013009661,0.0019550305,0.00059780525,0.0028141995,0.0006539979,0.0022818053,0.0009902819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00286341,0.00052723906,0.02229476,0.04246325,0.000493448,0.0003589055,0.00057540985,0.0003414686,0.0005523326,0.002571665,0.04098295,0.8859753],"study_design_scores_gemma":[0.0019839199,0.007193736,0.10204693,0.25707778,0.00495841,0.004664725,0.0037636573,0.0013309128,0.0034587986,0.005586135,0.60763764,0.00029738058],"about_ca_topic_score_codex":0.008318799,"about_ca_topic_score_gemma":0.012884308,"teacher_disagreement_score":0.008318799,"about_ca_system_score_codex":0.00292772,"about_ca_system_score_gemma":0.0057207267,"threshold_uncertainty_score":0.041760564},"labels":[],"label_agreement":null},{"id":"W4392198582","doi":"10.51731/cjht.2024.840","title":"Cost-Effectiveness of Respiratory Syncytial Virus Vaccines for Adults","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic evaluation; Medicine; Cost effectiveness; Vaccination; Generalizability theory; Economic cost; Cost-effectiveness analysis; Willingness to pay; Health care; Cost–benefit analysis; Incremental cost-effectiveness ratio; Economic impact analysis; Environmental health; Immunology; Psychology; Economic growth; Biology","score_opus":0.12123472138849099,"score_gpt":0.43188661654562244,"score_spread":0.31065189515713143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392198582","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19480574,0.75102997,0.0034598312,0.010625869,0.0015136232,0.0025677674,0.008026547,0.00010002788,0.027870541],"genre_scores_gemma":[0.8391464,0.1464136,0.0053326716,0.0021181235,0.00044136838,0.0015905187,0.002978741,0.000019895955,0.0019587378],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9913157,0.0063808993,0.00088230707,0.00025459248,0.0009151987,0.0002513261],"domain_scores_gemma":[0.9906961,0.006569439,0.0015079688,0.00012873951,0.0007584051,0.0003393329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011555448,0.0006819567,0.0016340681,0.0019205824,0.00019397294,0.001586131,0.0005920344,0.001061216,0.0043025734],"category_scores_gemma":[0.033493377,0.00024443454,0.004360922,0.0013919452,0.0002835466,0.0011730872,0.00065491407,0.0011626452,0.00016465045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059611928,0.0011527296,0.026317347,0.087630875,0.03351487,0.0006256688,0.00030906312,0.022680864,0.0011204692,0.010192395,0.02761561,0.72922814],"study_design_scores_gemma":[0.06602159,0.05261088,0.21419838,0.26089966,0.15689842,0.0031240042,0.0017217627,0.054847807,0.009357846,0.030455053,0.14926669,0.0005978471],"about_ca_topic_score_codex":0.0039029336,"about_ca_topic_score_gemma":0.0057364823,"teacher_disagreement_score":0.011555448,"about_ca_system_score_codex":0.0041104234,"about_ca_system_score_gemma":0.0026301187,"threshold_uncertainty_score":0.061111808},"labels":[],"label_agreement":null},{"id":"W4392233481","doi":"10.51731/cjht.2024.843","title":"Photon-Counting CT: High Resolution, Less Radiation","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical physics; Medicine; Photon counting; Nuclear medicine; Photon; Optics; Physics","score_opus":0.01203413001560574,"score_gpt":0.23713297620603022,"score_spread":0.22509884619042447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392233481","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030542856,0.47715712,0.07907098,0.31226838,0.012780703,0.00034803047,0.0010945961,0.002122195,0.084615216],"genre_scores_gemma":[0.30474555,0.3452422,0.15906373,0.1269081,0.030210514,0.00037054176,0.0013564853,0.0016693013,0.030433696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929763,0.002206703,0.00055064395,0.000767176,0.0031986283,0.00030047513],"domain_scores_gemma":[0.97318697,0.014864368,0.0024753024,0.0017849937,0.006386955,0.0013014093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008915002,0.00061438675,0.0012646429,0.0018118678,0.00075285725,0.004913734,0.0019617428,0.003269374,0.012694444],"category_scores_gemma":[0.03037189,0.00073171145,0.0009070582,0.0018029622,0.0030276133,0.0073263873,0.001817758,0.004633099,0.0047751316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995592,0.00015473018,0.020204946,0.0071738022,0.00045856755,0.0020041484,0.00049216027,0.00090617186,0.008024957,0.03380468,0.17050861,0.75527155],"study_design_scores_gemma":[0.00029041452,0.00075514085,0.03208484,0.0098603405,0.0007621276,0.058903556,0.0008101823,0.002509732,0.017314807,0.052928306,0.82336015,0.00042045335],"about_ca_topic_score_codex":0.0029901182,"about_ca_topic_score_gemma":0.003248555,"teacher_disagreement_score":0.012694444,"about_ca_system_score_codex":0.001835549,"about_ca_system_score_gemma":0.0018018787,"threshold_uncertainty_score":0.04714763},"labels":[],"label_agreement":null},{"id":"W4392239323","doi":"10.51731/cjht.2024.842","title":"Polatuzumab Vedotin (Polivy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Rituximab; Prednisone; Lymphoma; Internal medicine; Doxorubicin; Cyclophosphamide; Oncology; Chemotherapy; Political science","score_opus":0.023820182957066567,"score_gpt":0.3022941830101228,"score_spread":0.2784740000530562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392239323","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013506375,0.6410448,0.0033338696,0.014608376,0.0034920569,0.00035166455,0.0032662798,0.0005895134,0.31980714],"genre_scores_gemma":[0.2091834,0.516582,0.0072874743,0.01934952,0.0010866784,0.00026956652,0.0069288467,0.00009864702,0.23921394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979717,0.00003492369,0.000018499217,0.000032802734,0.0000879661,0.000028639171],"domain_scores_gemma":[0.99975246,0.00004881687,0.00004820389,0.000009250126,0.00010068029,0.000040614206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037860742,0.00022027259,0.00019795794,0.0006167315,0.000206725,0.00082125637,0.0003823655,0.0004904339,0.015254452],"category_scores_gemma":[0.0006649902,0.000081636324,0.00030956545,0.00042987836,0.0002834263,0.00037491624,0.0002606935,0.00055920065,0.0032536215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048530402,0.00004912408,0.0008061894,0.001714783,0.00006989174,0.00020161088,0.000027012771,0.00017043202,0.0045657665,0.004306879,0.1442508,0.84335226],"study_design_scores_gemma":[0.00018588534,0.0002449046,0.002157763,0.00075367256,0.00005331752,0.00069568434,0.000019505518,0.00010559688,0.0026964208,0.00030215795,0.9927776,0.000007560294],"about_ca_topic_score_codex":0.019762533,"about_ca_topic_score_gemma":0.052361295,"teacher_disagreement_score":0.019762533,"about_ca_system_score_codex":0.002118388,"about_ca_system_score_gemma":0.0024167865,"threshold_uncertainty_score":0.051031172},"labels":[],"label_agreement":null},{"id":"W4392239670","doi":"10.51731/cjht.2024.841","title":"General Ultrasound Examination Volumes per Sonographer 8-Hour Workday","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sonographer; Staffing; Medicine; Ultrasound; Economic shortage; Physical examination; Physical therapy; Nursing; Radiology","score_opus":0.038221375877079,"score_gpt":0.33891159690041023,"score_spread":0.3006902210233312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392239670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87786716,0.0029470753,0.0061673485,0.005609531,0.0003815385,0.0003261446,0.048287097,0.0021850588,0.056229036],"genre_scores_gemma":[0.92274517,0.002532257,0.0063962624,0.0011792581,0.00017723876,0.00017480039,0.020001821,0.00012470233,0.046668526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985222,0.00030609343,0.00012398041,0.00019840605,0.0005726551,0.00027655187],"domain_scores_gemma":[0.99569786,0.0006796501,0.0010966456,0.00016606874,0.0016209272,0.0007388238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009715687,0.0002409675,0.00022903825,0.0016972221,0.00052553974,0.00088059914,0.0010737547,0.00027861606,0.01683545],"category_scores_gemma":[0.0046089417,0.00020582482,0.00036520424,0.0014287496,0.0003233585,0.00040402502,0.000742659,0.00045109406,0.0036932656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031217677,0.00015667157,0.753023,0.0004447,0.00010227475,0.0004630351,0.001970316,0.0014864464,0.003118826,0.00057718594,0.07191085,0.16643456],"study_design_scores_gemma":[0.000014843289,0.00015647024,0.9655477,0.00011449289,0.000032581465,0.0005252217,0.0018638761,0.00087264605,0.00079944666,0.00012827256,0.029911961,0.0000323921],"about_ca_topic_score_codex":0.33435175,"about_ca_topic_score_gemma":0.3987391,"teacher_disagreement_score":0.33435175,"about_ca_system_score_codex":0.0031637826,"about_ca_system_score_gemma":0.0027873327,"threshold_uncertainty_score":0.66481125},"labels":[],"label_agreement":null},{"id":"W4392294844","doi":"10.51731/cjht.2024.844","title":"Working Together for Better Health: A United Effort to Support the National Strategy for Drugs for Rare Diseases in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rare disease; Government (linguistics); Orphan drug; Business; Investment (military); Medicine; Disease; Economic growth; Political science; Bioinformatics; Economics","score_opus":0.3593393142149555,"score_gpt":0.4259854495159906,"score_spread":0.06664613530103508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392294844","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013455303,0.0081425635,0.0008424487,0.9472417,0.007737168,0.00029970074,0.0021051066,0.00018139738,0.032104384],"genre_scores_gemma":[0.04728918,0.026884176,0.016847374,0.7600623,0.004440525,0.0005833952,0.005185465,0.00034874343,0.1383589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9773702,0.0021641653,0.0009164321,0.000816904,0.013097478,0.005634751],"domain_scores_gemma":[0.88723725,0.0050469954,0.002069728,0.0013644295,0.03429617,0.069985405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020656472,0.0012730835,0.0013865802,0.0033964526,0.012320436,0.015623424,0.005057279,0.018486654,0.021402543],"category_scores_gemma":[0.042561,0.0009942458,0.0025398557,0.0041051074,0.005498127,0.0054478715,0.010491739,0.017632846,0.0039228667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058106507,0.000084304695,0.0013230026,0.00025693476,0.000056171513,0.00020380452,0.00031637744,0.00025524033,0.0001478853,0.020510634,0.9472552,0.029532306],"study_design_scores_gemma":[0.00021356365,0.000061231374,0.00941929,0.00075479463,0.000051791252,0.00009338308,0.00073536433,0.00073049805,0.00016118247,0.004816384,0.9828798,0.000082732666],"about_ca_topic_score_codex":0.97600085,"about_ca_topic_score_gemma":0.9825645,"teacher_disagreement_score":0.8641513,"about_ca_system_score_codex":0.1358487,"about_ca_system_score_gemma":0.6716045,"threshold_uncertainty_score":0.9856559},"labels":[],"label_agreement":null},{"id":"W4392517675","doi":"10.51731/cjht.2024.850","title":"2024 Watch List: Top 10 Technologies and Issues Related to Caring for Children and Youth With Medical Complexity","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Service (business); Psychology; Public relations; Nursing; Medicine; Business; Political science; Marketing","score_opus":0.051200532128178294,"score_gpt":0.37804314311212683,"score_spread":0.3268426109839485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392517675","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004739399,0.07196868,0.002573136,0.44303817,0.0471473,0.0010550239,0.02543158,0.0025882558,0.40145847],"genre_scores_gemma":[0.034303624,0.22085796,0.018442526,0.16358608,0.017794652,0.0017124566,0.0538778,0.0015543671,0.48787054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948259,0.00022195329,0.00021983993,0.00018914534,0.00296357,0.0015794999],"domain_scores_gemma":[0.9630841,0.001611994,0.0009570894,0.0003461411,0.019976722,0.014024025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030515941,0.0010033553,0.00078069844,0.0033904086,0.0051009073,0.00810441,0.0026781224,0.005394736,0.086400345],"category_scores_gemma":[0.0141717065,0.0005747571,0.0014083795,0.0036874728,0.0013387238,0.0049898303,0.00424773,0.005627428,0.028184693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012687535,0.000023268347,0.0010711609,0.00037215475,0.000003459217,0.00004878481,0.00006607909,0.000030367331,0.00010196233,0.0010617176,0.9388385,0.05836993],"study_design_scores_gemma":[0.00001216211,0.000023603929,0.0059537305,0.001210912,0.000013634432,0.000104976454,0.00039355792,0.00007560861,0.00012243133,0.0005555601,0.991504,0.000029773268],"about_ca_topic_score_codex":0.4357809,"about_ca_topic_score_gemma":0.71522707,"teacher_disagreement_score":0.5642191,"about_ca_system_score_codex":0.014100609,"about_ca_system_score_gemma":0.08694363,"threshold_uncertainty_score":0.86648875},"labels":[],"label_agreement":null},{"id":"W4392706460","doi":"10.51731/cjht.2024.852","title":"Andexanet Alfa (Ondexxya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Reimbursement; Apixaban; Medicine; Intensive care medicine; Internal medicine; Health care; Warfarin; Political science","score_opus":0.09033240018256643,"score_gpt":0.3655339634611459,"score_spread":0.2752015632785795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392706460","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007838519,0.71714616,0.0017115382,0.024812179,0.0051668035,0.00024493985,0.005447597,0.00017818563,0.23745416],"genre_scores_gemma":[0.0818401,0.7670264,0.0060099917,0.014217469,0.0017521937,0.00024007444,0.0062688976,0.000064565946,0.12258028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932826,0.00015516144,0.00011779185,0.00004784154,0.00028851477,0.00006247424],"domain_scores_gemma":[0.9983353,0.00048876874,0.00039229763,0.000046812715,0.0006292516,0.000107683576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011895762,0.00020720434,0.00031138348,0.00076689105,0.00023578889,0.000984277,0.00036774256,0.00047467867,0.020562038],"category_scores_gemma":[0.0029427232,0.000068166664,0.00067709066,0.00081577204,0.00032336928,0.0005332268,0.00035744262,0.00058021833,0.0026043395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003636725,0.000033807395,0.00078383944,0.0061572692,0.00015652506,0.000100547106,0.00004016654,0.00010114792,0.0010816397,0.005937283,0.15165925,0.83358485],"study_design_scores_gemma":[0.000111336216,0.00017499199,0.0039741206,0.0036478925,0.00019718363,0.00026743163,0.00004789379,0.000060872728,0.0010663419,0.00063048897,0.9898107,0.000010673206],"about_ca_topic_score_codex":0.025484266,"about_ca_topic_score_gemma":0.07539658,"teacher_disagreement_score":0.025484266,"about_ca_system_score_codex":0.0018807306,"about_ca_system_score_gemma":0.004306902,"threshold_uncertainty_score":0.0687868},"labels":[],"label_agreement":null},{"id":"W4392706467","doi":"10.51731/cjht.2024.854","title":"Reprocessed Single-Use Semicritical and Critical Medical Devices","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioburden; Medical device; Single use; Medicine; Medical emergency; Patient safety; Risk analysis (engineering); Business; Operations management; Health care; Surgery; Engineering","score_opus":0.032269279161308076,"score_gpt":0.31307223649321736,"score_spread":0.2808029573319093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392706467","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030392788,0.97281474,0.0010252286,0.015223267,0.0011287186,0.00030766477,0.001891451,0.00003329495,0.004536351],"genre_scores_gemma":[0.034199893,0.9389192,0.004566629,0.017294098,0.0013374173,0.00028341383,0.0016026028,0.00005180977,0.0017450323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98018354,0.003880625,0.006322459,0.0012427911,0.007644283,0.00072633947],"domain_scores_gemma":[0.8802991,0.06149926,0.02218628,0.0021200005,0.032478277,0.0014170817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018038189,0.0007741801,0.0029357236,0.010835996,0.001288626,0.0062396857,0.0026649665,0.0030522572,0.010155441],"category_scores_gemma":[0.09638595,0.0007143823,0.0032635569,0.012451341,0.0039949487,0.0069865556,0.0025558686,0.0024613065,0.0018857896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034433827,0.000071543174,0.012908792,0.32604444,0.00096403295,0.00055392977,0.0023552105,0.00018344472,0.00053945894,0.004344531,0.049253367,0.60243684],"study_design_scores_gemma":[0.00008556866,0.0001537842,0.016322846,0.5415929,0.0025406322,0.001833571,0.0047500078,0.00013344831,0.0009804959,0.003517154,0.4279767,0.000112864924],"about_ca_topic_score_codex":0.08740216,"about_ca_topic_score_gemma":0.12986651,"teacher_disagreement_score":0.08740216,"about_ca_system_score_codex":0.007142383,"about_ca_system_score_gemma":0.028175462,"threshold_uncertainty_score":0.17378688},"labels":[],"label_agreement":null},{"id":"W4392850800","doi":"10.51731/cjht.2024.856","title":"Upadacitinib (Rinvoq)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Health care; Political science","score_opus":0.01283136766829396,"score_gpt":0.2641328023146,"score_spread":0.25130143464630605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392850800","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015222625,0.8079398,0.0019121816,0.006681955,0.0015505785,0.00031802687,0.0048486115,0.00052182,0.16100433],"genre_scores_gemma":[0.18214378,0.69809365,0.0042610485,0.0076513095,0.0006545938,0.00027591313,0.009053597,0.000073426716,0.09779275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971443,0.000055633667,0.000026862845,0.000038953327,0.0001194694,0.00004473225],"domain_scores_gemma":[0.9997603,0.000040286548,0.00005958112,0.000010897673,0.00009663789,0.00003218952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048727036,0.00030490325,0.00037311777,0.0009561891,0.00025815258,0.0009096646,0.00047291888,0.00047924285,0.016990596],"category_scores_gemma":[0.00071834185,0.000086567146,0.00055619195,0.000713912,0.00027628642,0.0005362634,0.00042721318,0.00063646986,0.003554096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057416735,0.000051107232,0.0005783059,0.004609024,0.0001451314,0.00016739286,0.0000271654,0.0002511166,0.0040294603,0.003148142,0.09607574,0.8903432],"study_design_scores_gemma":[0.0002358467,0.00044548095,0.0041843695,0.0020223209,0.0002080679,0.000985582,0.000043514938,0.0001852609,0.004685331,0.0004849142,0.98649627,0.000023050363],"about_ca_topic_score_codex":0.012667108,"about_ca_topic_score_gemma":0.037100423,"teacher_disagreement_score":0.016990596,"about_ca_system_score_codex":0.0015662757,"about_ca_system_score_gemma":0.0019063097,"threshold_uncertainty_score":0.056839228},"labels":[],"label_agreement":null},{"id":"W4393004377","doi":"10.51731/cjht.2024.859","title":"Optune (NovoTTF-200A)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Environmental science","score_opus":0.030041368006209396,"score_gpt":0.31045276515305475,"score_spread":0.2804113971468454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393004377","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077773132,0.20867038,0.0037022892,0.07543854,0.025015362,0.0038609677,0.027405398,0.0020728228,0.646057],"genre_scores_gemma":[0.09755693,0.20613167,0.01183405,0.061199464,0.013054968,0.0045308666,0.034267213,0.001306226,0.5701187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712163,0.000719331,0.00043697713,0.00038157045,0.001096085,0.00024443702],"domain_scores_gemma":[0.99071866,0.00204746,0.0019519161,0.000462769,0.003176523,0.0016427707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039423364,0.0004442171,0.0011704682,0.001813236,0.0005807821,0.004276178,0.0016840582,0.0032016402,0.1913179],"category_scores_gemma":[0.01834618,0.00029399473,0.0014068553,0.0009947517,0.0006752232,0.0024241484,0.0012090736,0.0018975881,0.043148484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016551564,0.00007270804,0.0004512029,0.007118084,0.000119202,0.00021964262,0.00006336654,0.000117220836,0.0011922081,0.004508107,0.5150377,0.46944538],"study_design_scores_gemma":[0.0006647235,0.00020677423,0.0007352887,0.00301361,0.00008336661,0.00034953852,0.00002641606,0.00008830211,0.0003802598,0.00091880205,0.9935189,0.00001406196],"about_ca_topic_score_codex":0.0021272392,"about_ca_topic_score_gemma":0.005381448,"teacher_disagreement_score":0.1913179,"about_ca_system_score_codex":0.0023390462,"about_ca_system_score_gemma":0.0068309614,"threshold_uncertainty_score":0.64002216},"labels":[],"label_agreement":null},{"id":"W4393004755","doi":"10.51731/cjht.2024.861","title":"Formulary Management of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Glucagon-like peptide-1; Pharmacology; Chemistry; Glucagon-like peptide 1 receptor; Receptor; Endocrinology; Internal medicine; Medicine; Diabetes mellitus; Type 2 diabetes; Agonist","score_opus":0.014926110689431131,"score_gpt":0.25872166032681004,"score_spread":0.2437955496373789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393004755","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07847354,0.256444,0.021507487,0.12121901,0.005236144,0.0026422648,0.009627213,0.0036240774,0.5012262],"genre_scores_gemma":[0.40060917,0.18701842,0.05499711,0.08135123,0.0059355525,0.0017477687,0.018048707,0.0008428859,0.24944916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986299,0.00017972472,0.00012049864,0.00008753705,0.0007737509,0.00020855988],"domain_scores_gemma":[0.9986681,0.00013799305,0.00028245992,0.000063327665,0.0005302431,0.00031789215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013427333,0.00031738228,0.00063199684,0.00094798434,0.00077746046,0.0014453675,0.000783163,0.001184311,0.016271813],"category_scores_gemma":[0.0030150898,0.00015193348,0.00079441845,0.0006095402,0.0004051335,0.0007526076,0.00091886095,0.0017035722,0.005050084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012495198,0.0006394912,0.007975613,0.0011578542,0.00011628165,0.0032484082,0.0001826529,0.00026786208,0.005981459,0.0051686326,0.33105937,0.6429528],"study_design_scores_gemma":[0.00052629306,0.0006395425,0.010030174,0.001261492,0.00014565347,0.0037004931,0.00012533311,0.0005803184,0.0037132301,0.0014521652,0.9777893,0.000036089772],"about_ca_topic_score_codex":0.032508377,"about_ca_topic_score_gemma":0.06843125,"teacher_disagreement_score":0.032508377,"about_ca_system_score_codex":0.0038879965,"about_ca_system_score_gemma":0.005000806,"threshold_uncertainty_score":0.06463832},"labels":[],"label_agreement":null},{"id":"W4393876948","doi":"10.51731/cjht.2024.865","title":"Ibrutinib (Imbruvica)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Leukemia","score_opus":0.0390365717984071,"score_gpt":0.34989368745113497,"score_spread":0.3108571156527279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393876948","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005310398,0.89422226,0.001159103,0.0035303342,0.0012439861,0.00016477262,0.002025066,0.00041648257,0.09192752],"genre_scores_gemma":[0.14526054,0.7231521,0.0067155417,0.008384267,0.001074954,0.00032512384,0.007159741,0.00010395021,0.10782378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996834,0.000066680695,0.000036498583,0.000053607047,0.00010670942,0.00005323387],"domain_scores_gemma":[0.99982953,0.00003200163,0.00005628488,0.0000074378954,0.00004864092,0.000026107165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537505,0.0005611307,0.0004274949,0.0009614227,0.00023100946,0.0008914775,0.0005816045,0.00055887236,0.01505789],"category_scores_gemma":[0.0006234516,0.000103934755,0.0005654292,0.00071781804,0.00020781907,0.00043940477,0.00039850437,0.0008379478,0.005187928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005866563,0.000067432375,0.00043900704,0.0046977084,0.00017978092,0.00013141154,0.000033636104,0.00038030863,0.0051343725,0.0027234284,0.09418492,0.8914413],"study_design_scores_gemma":[0.0002698646,0.0003005623,0.0017530108,0.0017270305,0.00018832635,0.00049240276,0.000022510852,0.00010869111,0.003015119,0.00034912786,0.9917613,0.0000121753865],"about_ca_topic_score_codex":0.008818574,"about_ca_topic_score_gemma":0.021879343,"teacher_disagreement_score":0.01505789,"about_ca_system_score_codex":0.0020242233,"about_ca_system_score_gemma":0.0014419031,"threshold_uncertainty_score":0.050373673},"labels":[],"label_agreement":null},{"id":"W4393902627","doi":"10.51731/cjht.2024.866","title":"Calaspargase Pegol (Asparlas)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mediterranean and Iberian flora and fauna","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.029404317920824062,"score_gpt":0.23292624826558128,"score_spread":0.2035219303447572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393902627","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015579154,0.86834985,0.0019661356,0.005786073,0.0012149111,0.00022415492,0.0018601402,0.00022329422,0.104796305],"genre_scores_gemma":[0.12473023,0.76884705,0.0074994373,0.00709005,0.0004965102,0.00015442914,0.0032029653,0.00005739471,0.087921925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995765,0.00007542528,0.000047129273,0.000048762122,0.00021085648,0.000041242984],"domain_scores_gemma":[0.9996352,0.00006459239,0.000110133224,0.000010827196,0.00014406444,0.00003511694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072841404,0.00029727633,0.00027271308,0.0009477427,0.00023896057,0.0009091084,0.00035495963,0.00049371796,0.008094974],"category_scores_gemma":[0.00077554025,0.000075274766,0.00046844524,0.0006979041,0.00027057642,0.0004551712,0.00030033733,0.0005030538,0.0019408829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045352202,0.0000794138,0.0013239713,0.0039742347,0.00018292185,0.00016083497,0.00003330578,0.0002083981,0.007509182,0.0036915112,0.06287337,0.9195093],"study_design_scores_gemma":[0.00011208685,0.00056677125,0.0059169503,0.0014049492,0.00019551221,0.0007091803,0.00006558219,0.00014306625,0.0095988065,0.00035126816,0.9809218,0.000013992689],"about_ca_topic_score_codex":0.026280154,"about_ca_topic_score_gemma":0.0689979,"teacher_disagreement_score":0.026280154,"about_ca_system_score_codex":0.0022750814,"about_ca_system_score_gemma":0.0027422665,"threshold_uncertainty_score":0.05225438},"labels":[],"label_agreement":null},{"id":"W4393991885","doi":"10.51731/cjht.2024.868","title":"Efgartigimod Alfa (Vyvgart)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Nematode management and characterization studies","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02504345589370992,"score_gpt":0.23338023896011686,"score_spread":0.20833678306640693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393991885","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015012928,0.9543381,0.0006840144,0.0025136045,0.0003824333,0.00015513999,0.0012241876,0.00008547796,0.025604118],"genre_scores_gemma":[0.18867281,0.7825299,0.004155612,0.003223395,0.00045136086,0.00017427967,0.0020300637,0.000029013001,0.018733576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992317,0.00018837032,0.00008111447,0.0000486707,0.00038582616,0.00006428075],"domain_scores_gemma":[0.99928445,0.00020581875,0.00021875909,0.000019318524,0.00022035629,0.00005132212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013905672,0.00024947646,0.00056081364,0.0014605743,0.00019985391,0.00090262294,0.00032927791,0.00046048185,0.00336824],"category_scores_gemma":[0.0015480047,0.00007544975,0.0006955297,0.001101215,0.00022892232,0.00036290512,0.00019081717,0.0003980605,0.0006320366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067151425,0.00006912385,0.0018410902,0.0062694624,0.0005174369,0.00020465435,0.000029624569,0.00022402688,0.0030291113,0.0012399916,0.022251224,0.9636528],"study_design_scores_gemma":[0.00078334345,0.0025637858,0.031691734,0.009724011,0.002263122,0.002495322,0.00016240677,0.00045047555,0.005875253,0.0009098025,0.94303155,0.00004924776],"about_ca_topic_score_codex":0.014781914,"about_ca_topic_score_gemma":0.07691153,"teacher_disagreement_score":0.014781914,"about_ca_system_score_codex":0.0024168969,"about_ca_system_score_gemma":0.0024763767,"threshold_uncertainty_score":0.029391766},"labels":[],"label_agreement":null},{"id":"W4394606699","doi":"10.51731/cjht.2024.869","title":"Renal Denervation for Uncontrolled Hypertension","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denervation; Medicine; Resistant hypertension; Internal medicine; Cardiology; Blood pressure","score_opus":0.061873099196899366,"score_gpt":0.3025412099882627,"score_spread":0.24066811079136335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394606699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003984035,0.9816845,0.000095100026,0.011947286,0.0031193788,0.00007689297,0.0000855659,0.000010154485,0.002582688],"genre_scores_gemma":[0.011194703,0.9608988,0.000586869,0.01959507,0.0059303897,0.00022589724,0.00013197132,0.000014102362,0.0014221979],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994447,0.002375491,0.001524516,0.00025084478,0.0012409721,0.00016116038],"domain_scores_gemma":[0.97164595,0.019475473,0.004689373,0.00042432945,0.0032948076,0.0004701084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0090460265,0.0004204221,0.0025623366,0.0028804045,0.00068466057,0.0031938094,0.0019302176,0.0043811197,0.013379612],"category_scores_gemma":[0.03464897,0.00036330684,0.0023765222,0.0019868163,0.0017103368,0.003936512,0.0011034376,0.0028787202,0.001698023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064272893,0.00007097768,0.001066005,0.34531826,0.0011559802,0.00058319955,0.00058352307,0.00008556408,0.0003246013,0.005669714,0.12295394,0.5215456],"study_design_scores_gemma":[0.0005701063,0.00030727446,0.0035749893,0.6385763,0.0018806416,0.0023360844,0.00085747923,0.0000904164,0.0003378142,0.0038657084,0.347547,0.000056138837],"about_ca_topic_score_codex":0.0034505576,"about_ca_topic_score_gemma":0.005746627,"teacher_disagreement_score":0.013379612,"about_ca_system_score_codex":0.0022664648,"about_ca_system_score_gemma":0.004725426,"threshold_uncertainty_score":0.047840595},"labels":[],"label_agreement":null},{"id":"W4394922115","doi":"10.51731/cjht.2024.872","title":"Evinacumab (Evkeeza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Pharmacology; Political science","score_opus":0.023581426086268297,"score_gpt":0.29115975924483933,"score_spread":0.26757833315857105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394922115","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0150619745,0.70933855,0.0022419526,0.013023955,0.0034298685,0.00042138138,0.0041698623,0.00055473275,0.25175774],"genre_scores_gemma":[0.21036597,0.55900675,0.006748646,0.02289236,0.0015794643,0.00041787006,0.007643193,0.00014069409,0.19120504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996811,0.00006509888,0.00002791113,0.00004204591,0.00013539167,0.00004843943],"domain_scores_gemma":[0.9996619,0.00006846406,0.00007815099,0.000013703314,0.00011903177,0.000058669644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006163424,0.00029131284,0.00033367012,0.0007515427,0.0002279807,0.0008124119,0.00047425285,0.0007060526,0.017938334],"category_scores_gemma":[0.0009271111,0.0000922877,0.00049781456,0.00037484834,0.00033092257,0.00039249277,0.00036273737,0.0009688017,0.00424195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078915304,0.00008549277,0.0005802693,0.003308764,0.000110707326,0.00018844886,0.000033949418,0.00014113089,0.0037192563,0.004598285,0.16455059,0.82189393],"study_design_scores_gemma":[0.00047856773,0.00045924366,0.0025649618,0.0018627397,0.00011460842,0.00065070123,0.000030753938,0.00010799433,0.002714404,0.00061414036,0.9903874,0.000014612725],"about_ca_topic_score_codex":0.013060787,"about_ca_topic_score_gemma":0.047771472,"teacher_disagreement_score":0.017938334,"about_ca_system_score_codex":0.0013976257,"about_ca_system_score_gemma":0.0019551318,"threshold_uncertainty_score":0.060009718},"labels":[],"label_agreement":null},{"id":"W4395081939","doi":"10.51731/cjht.2024.873","title":"Glofitamab (Columvi)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Refractory (planetary science); Lymphoma; Follicular lymphoma; Drug; Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.05172994418768404,"score_gpt":0.35660408707546454,"score_spread":0.3048741428877805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395081939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027345715,0.75210005,0.0017292607,0.0063428334,0.0013653941,0.0008916492,0.0051922738,0.00093846506,0.20409432],"genre_scores_gemma":[0.29695743,0.46474087,0.0065418063,0.016894251,0.00078686327,0.00071325933,0.016032495,0.00021023447,0.19712274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996137,0.00007134697,0.000025134821,0.00006098173,0.00016263346,0.00006623798],"domain_scores_gemma":[0.9997168,0.000035644873,0.00006791194,0.000014186976,0.00009081246,0.00007463051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006521978,0.00044292325,0.00045409662,0.001129004,0.00038544065,0.0015327666,0.0006659254,0.0010685179,0.02430115],"category_scores_gemma":[0.0009182404,0.00013094785,0.00067442184,0.00074717164,0.00032514276,0.00061279896,0.0004863159,0.0011303396,0.0066366256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001131341,0.00014174182,0.0012555425,0.00327328,0.0001038573,0.00035382117,0.000087389744,0.00021220738,0.007474628,0.0030200253,0.11217333,0.87077296],"study_design_scores_gemma":[0.000657085,0.0009994732,0.0035234208,0.0017308516,0.00011132446,0.001994814,0.000059497004,0.00011744758,0.0026993884,0.00027731166,0.9878099,0.000019549689],"about_ca_topic_score_codex":0.014080331,"about_ca_topic_score_gemma":0.042731863,"teacher_disagreement_score":0.02430115,"about_ca_system_score_codex":0.0019378655,"about_ca_system_score_gemma":0.0022128767,"threshold_uncertainty_score":0.08129543},"labels":[],"label_agreement":null},{"id":"W4395464611","doi":"10.51731/cjht.2024.875","title":"Sacituzumab Govitecan (Trodelvy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Immunohistochemistry; Medicine; Human Epidermal Growth Factor Receptor 2; Oncology; Metastatic breast cancer; Internal medicine; Family medicine; Cancer; Breast cancer; Political science","score_opus":0.060535617426535994,"score_gpt":0.3863126043444558,"score_spread":0.3257769869179198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395464611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028330877,0.8634068,0.0012022963,0.004078837,0.0006952055,0.0003009349,0.0016640051,0.00019463961,0.10012646],"genre_scores_gemma":[0.27790472,0.6577558,0.0033809138,0.004107879,0.00049508555,0.000189664,0.0030177818,0.00004355143,0.053104624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996183,0.000073104195,0.000024966606,0.000032252483,0.00021519802,0.000036140536],"domain_scores_gemma":[0.99972147,0.000055516182,0.00006702204,0.000007897295,0.00011905703,0.000029025372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586769,0.00020374746,0.00026484442,0.0010419452,0.0001728629,0.00068874453,0.00027967637,0.00032317356,0.0048493315],"category_scores_gemma":[0.0007088154,0.00006565288,0.00034063938,0.000786415,0.0002216067,0.00024629247,0.00016775573,0.00043138186,0.0010346337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045899116,0.0000574652,0.0011162513,0.0029858495,0.0001533034,0.00016959482,0.00003822853,0.00033656464,0.0059303483,0.002569692,0.03938471,0.94679904],"study_design_scores_gemma":[0.0003489646,0.00084548915,0.006953319,0.0022808188,0.00029882873,0.0015114058,0.00006640255,0.0002676855,0.005416973,0.0004964178,0.98149544,0.000018296943],"about_ca_topic_score_codex":0.016675342,"about_ca_topic_score_gemma":0.08659583,"teacher_disagreement_score":0.016675342,"about_ca_system_score_codex":0.0020408293,"about_ca_system_score_gemma":0.002143241,"threshold_uncertainty_score":0.033156574},"labels":[],"label_agreement":null},{"id":"W4395685966","doi":"10.51731/cjht.2024.876","title":"Olaparib (Lynparza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Medicine; Computer science; Physics; Nuclear magnetic resonance","score_opus":0.041689355697901456,"score_gpt":0.34693427468736254,"score_spread":0.3052449189894611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395685966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013465219,0.894938,0.0013291147,0.003564214,0.00056279195,0.0002497175,0.0021721008,0.00028815478,0.08343063],"genre_scores_gemma":[0.21413983,0.71874917,0.0047940095,0.0054763462,0.00049819896,0.00024843364,0.0045837336,0.000054668904,0.05145563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997906,0.00003900351,0.000028504188,0.000037055488,0.00008248669,0.000022374134],"domain_scores_gemma":[0.9997825,0.00004809798,0.00006179614,0.000008103401,0.00006906709,0.00003045287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004153894,0.00023815084,0.00028816215,0.0007234235,0.00023001364,0.0008403471,0.0002754629,0.0003589802,0.0098289],"category_scores_gemma":[0.0005920592,0.00008346802,0.0003211067,0.00067663006,0.00015250665,0.00034806726,0.00028867085,0.00063930685,0.0025445581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000605762,0.00006936083,0.0006172099,0.0043193293,0.000090799535,0.00026036976,0.0000381595,0.00025845104,0.0050737197,0.002449976,0.04088061,0.9453364],"study_design_scores_gemma":[0.00040220798,0.00054714683,0.0030416693,0.0019320284,0.00017044238,0.0019444176,0.000042547897,0.0001597796,0.003558012,0.00067535526,0.98751056,0.000015798612],"about_ca_topic_score_codex":0.004748642,"about_ca_topic_score_gemma":0.015912423,"teacher_disagreement_score":0.0098289,"about_ca_system_score_codex":0.0010790506,"about_ca_system_score_gemma":0.0014888133,"threshold_uncertainty_score":0.032880902},"labels":[],"label_agreement":null},{"id":"W4396514034","doi":"10.51731/cjht.2024.878","title":"Vutrisiran (Amvuttra)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Syringe; Stage (stratigraphy); Family medicine; Intensive care medicine; Political science; Psychiatry; Health care","score_opus":0.01796420021912586,"score_gpt":0.2907013560597264,"score_spread":0.27273715584060054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514034","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029866163,0.8214252,0.0011381133,0.0054696584,0.0019341792,0.00045167524,0.0057238275,0.0007681848,0.13322295],"genre_scores_gemma":[0.42337766,0.42580426,0.008386231,0.0092671905,0.0011229797,0.00057768676,0.009995484,0.00025561778,0.121212885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940515,0.00017014124,0.000047656373,0.000080840015,0.00023562867,0.000060598362],"domain_scores_gemma":[0.9994986,0.00012733988,0.0001251658,0.000019888386,0.000119961886,0.00010902412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083501317,0.00030858952,0.00058623764,0.0009248728,0.00037392662,0.0011904298,0.0006284069,0.0007939712,0.028244928],"category_scores_gemma":[0.0016828568,0.00013539368,0.000654029,0.0006929233,0.00028712905,0.00038503905,0.0004998144,0.001293145,0.003421733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017252925,0.00027514854,0.0016808286,0.0052614883,0.00027616802,0.00046072388,0.00011349522,0.00026023627,0.004785188,0.0045714616,0.0856334,0.8949566],"study_design_scores_gemma":[0.0016953524,0.0022737223,0.00737538,0.00576452,0.00041673818,0.002925285,0.00012020628,0.00025869327,0.0038275907,0.0009335325,0.9743687,0.000040336163],"about_ca_topic_score_codex":0.015359369,"about_ca_topic_score_gemma":0.054884296,"teacher_disagreement_score":0.028244928,"about_ca_system_score_codex":0.0015101798,"about_ca_system_score_gemma":0.002837972,"threshold_uncertainty_score":0.09448874},"labels":[],"label_agreement":null},{"id":"W4396514095","doi":"10.51731/cjht.2024.879","title":"Niraparib and Abiraterone Acetate (Akeega)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abiraterone acetate; Reimbursement; Medicine; Abiraterone; Prostate cancer; Asymptomatic; Internal medicine; Oncology; Chemotherapy; Cancer; Gynecology; Political science; Androgen deprivation therapy; Health care","score_opus":0.03726430238214361,"score_gpt":0.32689288200919125,"score_spread":0.28962857962704763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514095","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006433129,0.9431168,0.000643326,0.0024558725,0.00041465444,0.00020677423,0.0016060099,0.00005789917,0.045065586],"genre_scores_gemma":[0.07670709,0.89577085,0.0038859437,0.0021556742,0.00038802743,0.00016265699,0.0018901022,0.000019241357,0.019020518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982133,0.00037927896,0.00018325819,0.00007941965,0.0010532257,0.00009156913],"domain_scores_gemma":[0.9978934,0.0005861949,0.0004932221,0.000048739756,0.00088270655,0.000095878815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019014584,0.00027696686,0.00058031763,0.0016676362,0.00034393405,0.0013016522,0.0004242421,0.00041050755,0.0050275573],"category_scores_gemma":[0.0036714484,0.000115516144,0.0007461637,0.0020757567,0.0002797257,0.00042944954,0.00026636713,0.0006440225,0.0007721231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051172375,0.00006677712,0.0015500844,0.008710872,0.00034774872,0.00013996675,0.000050833187,0.00037815448,0.0018940807,0.0028459292,0.02733055,0.9561733],"study_design_scores_gemma":[0.00024683538,0.00071417337,0.013416099,0.0067689936,0.0008300199,0.0011934284,0.00012350993,0.00024234389,0.0027757438,0.0009159945,0.9727377,0.00003509019],"about_ca_topic_score_codex":0.03550634,"about_ca_topic_score_gemma":0.16775449,"teacher_disagreement_score":0.03550634,"about_ca_system_score_codex":0.0035030209,"about_ca_system_score_gemma":0.007370412,"threshold_uncertainty_score":0.07059932},"labels":[],"label_agreement":null},{"id":"W4396514411","doi":"10.51731/cjht.2024.877","title":"Artificial Intelligence for Patient Flow","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Health care; Medical emergency; Medicine; Workflow; Acute care; Health information technology; Computer science; Nursing","score_opus":0.1340610564882069,"score_gpt":0.4347832521283983,"score_spread":0.3007221956401914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514411","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00961468,0.07399771,0.51803964,0.2103081,0.008016051,0.0008196287,0.0033686403,0.0026044096,0.17323121],"genre_scores_gemma":[0.41700885,0.06260169,0.4411464,0.024647407,0.0067575867,0.0019199968,0.004785797,0.000503008,0.040629145],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945332,0.0027535774,0.00042232696,0.00084474415,0.0012367046,0.00020947594],"domain_scores_gemma":[0.9881919,0.00902864,0.00051810144,0.0009815049,0.0010014992,0.0002783337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060347435,0.00135378,0.0012242076,0.0021540022,0.0012243924,0.006564918,0.0021979902,0.004693061,0.013509329],"category_scores_gemma":[0.024272703,0.00047491473,0.0012714729,0.0025998806,0.0044945483,0.007284255,0.0037081528,0.0051318635,0.0030955768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012965761,0.00012723338,0.002710312,0.0015954359,0.00019896263,0.0003102193,0.000510125,0.032765,0.0003762452,0.5684226,0.08389055,0.3089637],"study_design_scores_gemma":[0.000042245152,0.000043780416,0.0007144681,0.0005794147,0.000035460955,0.0002341747,0.00022919312,0.047561955,0.0002208642,0.8279306,0.12235708,0.00005062944],"about_ca_topic_score_codex":0.0040525785,"about_ca_topic_score_gemma":0.0024343205,"teacher_disagreement_score":0.013509329,"about_ca_system_score_codex":0.0028093383,"about_ca_system_score_gemma":0.0028016637,"threshold_uncertainty_score":0.045193195},"labels":[],"label_agreement":null},{"id":"W4396568439","doi":"10.51731/cjht.2024.881","title":"Belumosudil (Rezurock)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.026215156772497517,"score_gpt":0.30275199556516397,"score_spread":0.27653683879266644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396568439","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03339809,0.89472985,0.0013248809,0.005473537,0.00059769396,0.00030227064,0.0018889412,0.00032063265,0.061964042],"genre_scores_gemma":[0.41307634,0.5335045,0.0041577327,0.006329748,0.00040910562,0.00033418133,0.0038553851,0.00005241473,0.038280535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997118,0.00007696067,0.000028822791,0.000033009394,0.000104874445,0.000044449465],"domain_scores_gemma":[0.9998141,0.000034378634,0.00007118394,0.000005841361,0.000051130748,0.000023464187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000554983,0.00021902776,0.00044630902,0.0007877391,0.00024440518,0.00053930865,0.00034819738,0.00035564337,0.008074486],"category_scores_gemma":[0.0005425869,0.00007741657,0.00041750635,0.0005705095,0.0002387442,0.0004479924,0.00023045068,0.00074454886,0.0017196636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018346591,0.000208937,0.0010136134,0.0061798454,0.000264108,0.00026465463,0.000068586996,0.00030999994,0.012253197,0.0052156774,0.057391193,0.91499555],"study_design_scores_gemma":[0.001976991,0.003016172,0.009468507,0.003220051,0.00057481753,0.0026907276,0.00013554878,0.00029828653,0.0086856885,0.0012864588,0.9685998,0.000046929003],"about_ca_topic_score_codex":0.006186408,"about_ca_topic_score_gemma":0.03481979,"teacher_disagreement_score":0.008074486,"about_ca_system_score_codex":0.0013021866,"about_ca_system_score_gemma":0.001148727,"threshold_uncertainty_score":0.027011871},"labels":[],"label_agreement":null},{"id":"W4396597402","doi":"10.51731/cjht.2024.882","title":"Nivolumab and Relatlimab (Opdualag)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Medicine; Internal medicine; Cancer; Immunotherapy","score_opus":0.020883726419394413,"score_gpt":0.2905325456342415,"score_spread":0.2696488192148471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396597402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002387463,0.9520809,0.0007518277,0.0026368604,0.0008957086,0.00027734978,0.0017773517,0.00008877932,0.039103754],"genre_scores_gemma":[0.04503459,0.9040376,0.004774499,0.0052743154,0.0006947554,0.0004789135,0.0041012918,0.00005403956,0.035549983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986217,0.00035515093,0.00015178214,0.00009984634,0.00065811165,0.000113483504],"domain_scores_gemma":[0.99863654,0.0003343898,0.00028924955,0.000038814338,0.0006188791,0.00008203058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002106898,0.00044512018,0.0006494113,0.0018016703,0.00030278225,0.0013873992,0.00054089015,0.0007362587,0.0096963905],"category_scores_gemma":[0.0031098821,0.00016829323,0.0012347572,0.0015277076,0.0002612795,0.0007221568,0.00042116822,0.0007961387,0.0019860647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176848,0.00006355841,0.00079788984,0.012714319,0.0003911993,0.00008598542,0.000039761097,0.00028130793,0.0011021752,0.0032995692,0.072219916,0.9085866],"study_design_scores_gemma":[0.00017323224,0.00019989743,0.0020219255,0.005711915,0.00040741486,0.00028257052,0.000029030964,0.000105570354,0.0007173843,0.0005232511,0.9898144,0.000013352263],"about_ca_topic_score_codex":0.02874182,"about_ca_topic_score_gemma":0.09291962,"teacher_disagreement_score":0.02874182,"about_ca_system_score_codex":0.0032259738,"about_ca_system_score_gemma":0.0058563203,"threshold_uncertainty_score":0.057148993},"labels":[],"label_agreement":null},{"id":"W4396613915","doi":"10.51731/cjht.2024.884","title":"Anticytokine Therapy and Corticosteroids for Cytokine Release Syndrome and for Neurotoxicity Following T-Cell Engager or CAR T-Cell Therapy","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine release syndrome; Medicine; Anakinra; Internal medicine; Oncology; Chimeric antigen receptor; T cell; Immunology; Immune system","score_opus":0.07920129161709988,"score_gpt":0.3448582712694659,"score_spread":0.265656979652366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396613915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037198307,0.916957,0.0028632735,0.04927425,0.010883838,0.0064200317,0.0035825153,0.000109424305,0.0061899014],"genre_scores_gemma":[0.024682047,0.89456445,0.013590331,0.046476122,0.00684467,0.008512113,0.0017907673,0.00010418636,0.00343532],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.95910287,0.009912593,0.02420332,0.0011738342,0.0050020963,0.00060522946],"domain_scores_gemma":[0.7509236,0.15670174,0.04200345,0.0040335865,0.045009993,0.0013276333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04103457,0.0012581779,0.009547204,0.026062392,0.0013556579,0.0049684173,0.0035857912,0.0058169756,0.008201009],"category_scores_gemma":[0.15897566,0.0015285915,0.007190455,0.017167944,0.0024942078,0.0064770593,0.002505673,0.0020018523,0.0017066402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000338737,0.000024849563,0.0011570622,0.8594725,0.0024310772,0.0005604528,0.0008095712,0.00008526668,0.00042862815,0.0011567611,0.030070959,0.10346418],"study_design_scores_gemma":[0.0004670939,0.00018694458,0.0024286755,0.84833974,0.007996143,0.00091598567,0.0010238498,0.000095793504,0.00029139558,0.0026659349,0.1355023,0.00008618132],"about_ca_topic_score_codex":0.005551286,"about_ca_topic_score_gemma":0.016238688,"teacher_disagreement_score":0.04103457,"about_ca_system_score_codex":0.0047604106,"about_ca_system_score_gemma":0.020310406,"threshold_uncertainty_score":0.21701413},"labels":[],"label_agreement":null},{"id":"W4396801928","doi":"10.51731/cjht.2024.890","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; Atherosclerotic cardiovascular disease; Clinical trial; Cause of death; Drug; Adverse effect; Disease; Cholesterol; Quality of life (healthcare); Pharmacology","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396801928","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07099013,0.2402064,0.0063441964,0.08313246,0.006368237,0.0033107086,0.022108905,0.0049862415,0.56255275],"genre_scores_gemma":[0.37708285,0.1116411,0.022707174,0.16111293,0.003740015,0.0042673675,0.03698086,0.00083068095,0.2816369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909174,0.0002547666,0.00009651516,0.00016299188,0.00026578893,0.00012825373],"domain_scores_gemma":[0.99877733,0.00031321234,0.0002740545,0.00010580776,0.00023104346,0.00029850125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018048553,0.00042069232,0.0009262286,0.0010534328,0.00049823185,0.0017732801,0.0018823856,0.0028938074,0.032605946],"category_scores_gemma":[0.003397418,0.000232415,0.0010137757,0.0006503202,0.00045815608,0.0011164125,0.00094983453,0.0040546535,0.010420624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011799076,0.000974854,0.0020629521,0.0027468817,0.00026933115,0.00053576083,0.0001313909,0.00038200905,0.005110077,0.009445293,0.19402298,0.7725194],"study_design_scores_gemma":[0.017063666,0.0028709194,0.00461835,0.0019848526,0.00033462764,0.0012838126,0.00007638354,0.0003735933,0.00205137,0.0028676616,0.9664198,0.000054943648],"about_ca_topic_score_codex":0.0033182066,"about_ca_topic_score_gemma":0.009744875,"teacher_disagreement_score":0.032605946,"about_ca_system_score_codex":0.0012303806,"about_ca_system_score_gemma":0.0024139096,"threshold_uncertainty_score":0.10907775},"labels":[],"label_agreement":null},{"id":"W4396827093","doi":"10.51731/cjht.2024.893","title":"Odevixibat (Bylvay)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.037984929529660115,"score_gpt":0.3380933450141672,"score_spread":0.3001084154845071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827093","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011458312,0.69811994,0.001102916,0.0061429446,0.0016147696,0.0005755178,0.008557708,0.00043637148,0.27199152],"genre_scores_gemma":[0.14485738,0.57524943,0.0045498465,0.0073631806,0.0007112305,0.00050506234,0.010806089,0.00015498973,0.25580278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995467,0.00009166601,0.00003663377,0.000052521318,0.00021877268,0.000053672047],"domain_scores_gemma":[0.999671,0.00006864591,0.00006874254,0.000012129881,0.000114449096,0.00006512604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005856228,0.00030581857,0.000513506,0.0012288217,0.0004095093,0.0012227579,0.00047134937,0.0008200063,0.04893202],"category_scores_gemma":[0.0012527962,0.00012772044,0.00065157865,0.0008585238,0.00027569753,0.00046820712,0.00053612795,0.0009929371,0.0072246124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010291775,0.00009650361,0.00071863,0.0060505164,0.00010690577,0.00028613015,0.00010617969,0.000101009406,0.0031870436,0.0046191793,0.11044327,0.87325555],"study_design_scores_gemma":[0.0004806868,0.00037545798,0.0027838664,0.0017948444,0.0001093014,0.00055860064,0.000062253894,0.000046564506,0.00096489524,0.00029364886,0.9925175,0.000012322974],"about_ca_topic_score_codex":0.035337217,"about_ca_topic_score_gemma":0.10731625,"teacher_disagreement_score":0.04893202,"about_ca_system_score_codex":0.0018494882,"about_ca_system_score_gemma":0.0035804708,"threshold_uncertainty_score":0.1636939},"labels":[],"label_agreement":null},{"id":"W4396957301","doi":"10.51731/cjht.2024.894","title":"Point-of-Care Tests for COVID-19 and Influenza in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Point-of-care testing; Intensive care medicine; Diagnostic test; Point of care; Test (biology); Emergency medicine; Pathology","score_opus":0.07325829680857208,"score_gpt":0.36639433975587743,"score_spread":0.29313604294730533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396957301","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02320386,0.26144096,0.0037716152,0.6052824,0.0185817,0.0005634399,0.019779334,0.000642569,0.06673409],"genre_scores_gemma":[0.3613658,0.3299266,0.02781277,0.22915699,0.008114122,0.00042941511,0.016717503,0.000562452,0.025914408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899187,0.0009088843,0.0010487895,0.00076658744,0.005633354,0.0017237874],"domain_scores_gemma":[0.9263752,0.0036786858,0.0034965246,0.00069867366,0.055752493,0.009998389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063590254,0.0007489766,0.0015083825,0.002872244,0.0037207718,0.0065754065,0.0033495987,0.002925313,0.015087146],"category_scores_gemma":[0.030177666,0.0006989497,0.0016787698,0.0045223054,0.0026892615,0.0042216475,0.001784146,0.0043503596,0.0019811494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027506548,0.0001408227,0.099848785,0.004135376,0.00033395126,0.000749989,0.00079256296,0.00072303007,0.00055437506,0.008587759,0.64846104,0.2353972],"study_design_scores_gemma":[0.00030154255,0.0002745139,0.3345288,0.021480292,0.000620866,0.0023501443,0.00550204,0.0032228925,0.0010922872,0.005719441,0.6243471,0.0005600585],"about_ca_topic_score_codex":0.98544914,"about_ca_topic_score_gemma":0.9875759,"teacher_disagreement_score":0.06936505,"about_ca_system_score_codex":0.06936505,"about_ca_system_score_gemma":0.2083136,"threshold_uncertainty_score":0.503281},"labels":[],"label_agreement":null},{"id":"W4397007674","doi":"10.51731/cjht.2024.895","title":"Newborn Screening for Congenital Cytomegalovirus","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Deafness and Other Communication Disorders","keywords":"Cytomegalovirus; Medicine; Virology; Cytomegalovirus infections; Pediatrics; Human cytomegalovirus; Virus; Herpesviridae; Viral disease","score_opus":0.07184159967942559,"score_gpt":0.36145888329948683,"score_spread":0.2896172836200612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397007674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017337241,0.9690202,0.00028395813,0.023153653,0.0029161067,0.00046649872,0.0006348882,0.000015501968,0.0017754443],"genre_scores_gemma":[0.03450542,0.9285561,0.0031472628,0.027232355,0.004418111,0.001113696,0.00040960862,0.000022431357,0.0005950368],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9751948,0.01055695,0.009681465,0.00084268907,0.0033590354,0.00036514562],"domain_scores_gemma":[0.8647034,0.10339835,0.011861606,0.0014186916,0.017490448,0.0011275653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026731715,0.00071388006,0.0050724056,0.0077055106,0.00065646856,0.00350597,0.0023726784,0.0045114732,0.004841417],"category_scores_gemma":[0.18390736,0.00072011544,0.0035177292,0.0050200326,0.0014933157,0.004980022,0.0011975231,0.0021531477,0.0005511422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080283824,0.000056617322,0.006078144,0.57954115,0.0035077203,0.0006501384,0.0013027014,0.00020865617,0.00028201524,0.0028905207,0.052432053,0.35224754],"study_design_scores_gemma":[0.00031592377,0.00018396715,0.006717402,0.9093124,0.004668486,0.0008812217,0.00092727115,0.0001232392,0.00019217764,0.001599558,0.07502098,0.000057342713],"about_ca_topic_score_codex":0.012983653,"about_ca_topic_score_gemma":0.013992096,"teacher_disagreement_score":0.9870163,"about_ca_system_score_codex":0.0053975997,"about_ca_system_score_gemma":0.011348846,"threshold_uncertainty_score":0.1413725},"labels":[],"label_agreement":null},{"id":"W4398208078","doi":"10.51731/cjht.2024.897","title":"2023 Abstracts of the Canadian Association for Population Therapeutics","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Association (psychology); Medicine; Psychology; Psychotherapist","score_opus":0.32982172614975364,"score_gpt":0.4222050936713442,"score_spread":0.09238336752159054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398208078","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004990996,0.011797353,0.0025035304,0.02407694,0.01808412,0.0012951853,0.07762606,0.0017745275,0.8623432],"genre_scores_gemma":[0.0031972511,0.008670821,0.0020023969,0.0048841215,0.001952841,0.0006633159,0.024224972,0.00039137877,0.95401293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980926,0.00019072239,0.00016161843,0.0002741221,0.0010017739,0.00027911528],"domain_scores_gemma":[0.99230206,0.0004985985,0.00031957202,0.0005346993,0.0050612367,0.0012837955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002488985,0.0012364232,0.0017506976,0.0032940533,0.00197321,0.0041132425,0.0019671745,0.0033453081,0.6844384],"category_scores_gemma":[0.0069896793,0.00075706246,0.0011175696,0.0037685689,0.0007721036,0.0011197723,0.0025311594,0.0026530053,0.4878779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021808271,0.000019884419,0.00026817995,0.00012785764,0.000006967478,0.000022167786,0.00001111892,0.000028494798,0.000054613287,0.0010797282,0.93819803,0.06016114],"study_design_scores_gemma":[0.000012449329,0.0000042313754,0.0011907102,0.000120550496,0.0000034357527,0.000018990946,0.000013641786,0.000055582652,0.0000136986255,0.00021880772,0.9983425,0.0000052263667],"about_ca_topic_score_codex":0.34504953,"about_ca_topic_score_gemma":0.2666245,"teacher_disagreement_score":0.9935876,"about_ca_system_score_codex":0.0064123976,"about_ca_system_score_gemma":0.029723534,"threshold_uncertainty_score":0.68608224},"labels":[],"label_agreement":null},{"id":"W4398238741","doi":"10.51731/cjht.2024.899","title":"Newborn Screening for Congenital Cytomegalovirus in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytomegalovirus; Virology; Medicine; Pediatrics; Virus; Herpesviridae; Viral disease","score_opus":0.05442502672261114,"score_gpt":0.33045883323314146,"score_spread":0.27603380651053033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398238741","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103386186,0.4175972,0.0014499272,0.31105208,0.010060263,0.00065678864,0.06655983,0.0005738164,0.088664],"genre_scores_gemma":[0.5571025,0.3216433,0.006213353,0.077668086,0.002165378,0.0003147234,0.023523616,0.00021809881,0.011151012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553114,0.00026773624,0.00052874343,0.00046636263,0.0021028842,0.0011032147],"domain_scores_gemma":[0.98219717,0.0011174947,0.0011810437,0.0001923151,0.010839195,0.004472782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002108591,0.00053056213,0.0007360732,0.0029663495,0.003139721,0.0031625195,0.0020382893,0.0014443988,0.0070180795],"category_scores_gemma":[0.012600305,0.00048324504,0.0010023047,0.005781981,0.0011654644,0.0012703151,0.0013879053,0.0020656676,0.0006315151],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018215526,0.00008388212,0.3308206,0.0048870537,0.00033549056,0.0012233064,0.0017522454,0.0005889034,0.00048216514,0.0044627683,0.4056314,0.24955009],"study_design_scores_gemma":[0.00012592427,0.00010860705,0.72263986,0.023116885,0.0005129639,0.0020611412,0.006081576,0.0011943968,0.0005114999,0.00147427,0.24191786,0.00025498195],"about_ca_topic_score_codex":0.99513584,"about_ca_topic_score_gemma":0.99559754,"teacher_disagreement_score":0.91412985,"about_ca_system_score_codex":0.08587017,"about_ca_system_score_gemma":0.20526855,"threshold_uncertainty_score":0.6230346},"labels":[],"label_agreement":null},{"id":"W4398781678","doi":"10.51731/cjht.2024.900","title":"Nabilone for Chronic Non-Cancer Pain","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Medicine; Cancer pain; Cancer; Physical therapy; Internal medicine","score_opus":0.02872035352823543,"score_gpt":0.3403305924569421,"score_spread":0.31161023892870665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398781678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005680847,0.9885948,0.00012309656,0.007389161,0.0015492546,0.00019534508,0.0002075875,0.000013455281,0.0013592567],"genre_scores_gemma":[0.009993514,0.97014725,0.0010275148,0.015026032,0.0021847584,0.00043728726,0.00016845715,0.000016239708,0.000998973],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99245477,0.0029225454,0.0028859335,0.0002983701,0.0012821526,0.00015627505],"domain_scores_gemma":[0.96429515,0.023809094,0.0061222054,0.00046183597,0.0049208463,0.00039101276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012758448,0.00064476376,0.004775605,0.004427222,0.00065436633,0.0038968802,0.0018702184,0.004204497,0.007839776],"category_scores_gemma":[0.046153594,0.0006270028,0.0036460923,0.0041550817,0.0011754346,0.0045425394,0.0010931961,0.0024175122,0.0014406466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011600347,0.000060407787,0.0012462768,0.59888566,0.0026443417,0.00033072056,0.00049798994,0.00008459948,0.0005139316,0.0016706021,0.038164556,0.35474086],"study_design_scores_gemma":[0.0010290518,0.00042981005,0.0032254036,0.70669174,0.008195703,0.0008648659,0.00072602177,0.00010465661,0.0005195016,0.0022866095,0.27584815,0.00007838927],"about_ca_topic_score_codex":0.004069867,"about_ca_topic_score_gemma":0.010770699,"teacher_disagreement_score":0.012758448,"about_ca_system_score_codex":0.002357948,"about_ca_system_score_gemma":0.0063885082,"threshold_uncertainty_score":0.06747395},"labels":[],"label_agreement":null},{"id":"W4399260785","doi":"10.51731/cjht.2024.909","title":"Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Retrospective cohort study; Medicine; Cohort; Compliance (psychology); Drug; Family medicine; Oncology; Internal medicine; Pharmacology; Political science; Psychology; Law","score_opus":0.22660802685067075,"score_gpt":0.43486762120975414,"score_spread":0.2082595943590834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502995,0.0033896249,0.0028685268,0.0013760875,0.00010008715,0.0009073732,0.035675313,0.000053637814,0.005329824],"genre_scores_gemma":[0.9885628,0.00071974046,0.0013206359,0.0006095497,0.000047714857,0.0002677124,0.007260215,0.000031978685,0.0011795798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98599446,0.0034944634,0.0020871658,0.0027043372,0.003877834,0.0018417451],"domain_scores_gemma":[0.9294941,0.019039467,0.025443584,0.0120037235,0.011634097,0.0023850761],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017587846,0.00046210643,0.00088326086,0.002472361,0.0017099784,0.0021403336,0.0013752038,0.0009910832,0.003859906],"category_scores_gemma":[0.04672564,0.0008272613,0.0020359433,0.004544405,0.0009918635,0.0008806843,0.0011857909,0.001941281,0.0005539149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010969889,0.00008748928,0.9846015,0.00015496794,0.00085611746,0.00016565286,0.00029833554,0.00052830257,0.00013612803,0.000908273,0.0056687943,0.005497416],"study_design_scores_gemma":[0.00023808518,0.0005143656,0.97754353,0.00037329286,0.001386938,0.000683032,0.0008523988,0.0028263316,0.0003900616,0.0004974991,0.014585384,0.0001090073],"about_ca_topic_score_codex":0.40695274,"about_ca_topic_score_gemma":0.39912385,"teacher_disagreement_score":0.99341017,"about_ca_system_score_codex":0.006589812,"about_ca_system_score_gemma":0.013507684,"threshold_uncertainty_score":0.80916804},"labels":[],"label_agreement":null},{"id":"W4399260815","doi":"10.51731/cjht.2024.905","title":"Virtual Medicine Wards and Hospital-at-Home Programs","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hospital medicine; Medical emergency; Medicine; Family medicine","score_opus":0.030115565730325245,"score_gpt":0.33197276797157554,"score_spread":0.3018572022412503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260815","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07421328,0.86781734,0.0012356186,0.02584877,0.0026610026,0.00038762117,0.0016447661,0.00006555027,0.026126027],"genre_scores_gemma":[0.47655535,0.5023005,0.004525548,0.009905019,0.0026551704,0.00063679164,0.0010362107,0.000045393386,0.0023399796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931265,0.0043483824,0.00077557296,0.00030673703,0.0011490299,0.0002938145],"domain_scores_gemma":[0.979341,0.012989448,0.0044599436,0.00035881228,0.001339694,0.0015111316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039161122,0.00022983388,0.0006460983,0.0011736203,0.00056930416,0.003170833,0.0012883327,0.00094831455,0.011490794],"category_scores_gemma":[0.031276133,0.00022142504,0.0015359026,0.002195022,0.0008887855,0.00274855,0.0020104207,0.0015331724,0.00040883955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001260047,0.00055719574,0.027878117,0.053936124,0.0012626374,0.0002037842,0.0014655723,0.000528872,0.0000729374,0.012947464,0.031083489,0.86880386],"study_design_scores_gemma":[0.0020439213,0.0027255989,0.21226975,0.27666926,0.004817352,0.0018785041,0.008863644,0.001127354,0.00057013927,0.015214465,0.47357944,0.00024060806],"about_ca_topic_score_codex":0.006828898,"about_ca_topic_score_gemma":0.010101682,"teacher_disagreement_score":0.011490794,"about_ca_system_score_codex":0.0021397867,"about_ca_system_score_gemma":0.0036022163,"threshold_uncertainty_score":0.038440526},"labels":[],"label_agreement":null},{"id":"W4399260929","doi":"10.51731/cjht.2024.908","title":"Viewpoint: Reflections on an Analysis of Health Canada’s NOC/c Policy for Oncology Drug Approvals","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Drug; Medicine; Drug approval; Oncology; Business; Internal medicine; Pharmacology","score_opus":0.41845352415323434,"score_gpt":0.5129235683561644,"score_spread":0.09447004420293004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260929","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063743796,0.002144902,0.001104419,0.9702923,0.0017658254,0.00012122119,0.0010216939,0.000049342347,0.017125817],"genre_scores_gemma":[0.1253891,0.0020895568,0.0046819146,0.8556377,0.0031853127,0.00018939731,0.00044412393,0.00016019797,0.008222637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7664024,0.06093185,0.0108049745,0.015820969,0.11311495,0.032924883],"domain_scores_gemma":[0.42076182,0.37084338,0.025322348,0.011471682,0.13922824,0.032372553],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21540628,0.00092528306,0.001956895,0.0062441733,0.016650029,0.038996954,0.0086659035,0.031247132,0.009356637],"category_scores_gemma":[0.39587292,0.0014882038,0.0031941617,0.009581361,0.021528918,0.012325368,0.0052960613,0.035557684,0.0009098913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003386457,0.00012873574,0.007960513,0.00032362403,0.0001830203,0.00045734286,0.004104667,0.0021628796,0.00035533754,0.28753966,0.67676014,0.019685376],"study_design_scores_gemma":[0.0004671951,0.0002295236,0.02936752,0.0026932515,0.00030043916,0.00025690842,0.010122074,0.005484624,0.0012704948,0.10810213,0.84076244,0.00094342965],"about_ca_topic_score_codex":0.9314478,"about_ca_topic_score_gemma":0.9180626,"teacher_disagreement_score":0.7845937,"about_ca_system_score_codex":0.22303104,"about_ca_system_score_gemma":0.4540333,"threshold_uncertainty_score":0.9675437},"labels":[],"label_agreement":null},{"id":"W4399461713","doi":"10.51731/cjht.2024.914","title":"Fidanacogene Elaparvovec (Beqvez)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Test (biology); Pediatrics; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Biology","score_opus":0.023130261508214334,"score_gpt":0.3167561389790502,"score_spread":0.29362587747083585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399461713","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008094136,0.8156053,0.0027553926,0.005465056,0.0012773891,0.00041166352,0.003630887,0.0004810024,0.16227926],"genre_scores_gemma":[0.106229566,0.67179936,0.0099118985,0.007851185,0.0006163042,0.0005149675,0.0068246643,0.00025489033,0.19599721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993986,0.000080462596,0.000029196814,0.00006809432,0.0003517805,0.00007179426],"domain_scores_gemma":[0.99927,0.00016483126,0.000098428056,0.000021322625,0.00034219623,0.00010320958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011227593,0.00041989543,0.00050898496,0.0015733293,0.0004213668,0.0014640292,0.0005682398,0.0011014438,0.020395007],"category_scores_gemma":[0.0014328279,0.00014162902,0.00047529762,0.001000646,0.00044498613,0.0005898578,0.00035195175,0.0009467314,0.004958049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005575292,0.00007826801,0.0006711497,0.0046272734,0.0000819195,0.00023332218,0.00007416771,0.000227631,0.007945599,0.0058460697,0.14320783,0.8364492],"study_design_scores_gemma":[0.000102660575,0.00016300671,0.0011379833,0.0011840326,0.00007556826,0.00051376177,0.000027919705,0.000060240975,0.00225164,0.00023240442,0.9942399,0.000010900105],"about_ca_topic_score_codex":0.057281908,"about_ca_topic_score_gemma":0.14970109,"teacher_disagreement_score":0.9427181,"about_ca_system_score_codex":0.0040328936,"about_ca_system_score_gemma":0.0060938783,"threshold_uncertainty_score":0.113896966},"labels":[],"label_agreement":null},{"id":"W4399461858","doi":"10.51731/cjht.2024.913","title":"Treosulfan (Trecondyv)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Treosulfan; Medicine; Myelodysplastic syndromes; Fludarabine; Reimbursement; Myeloid leukemia; Hematopoietic stem cell transplantation; Hematopoietic cell; Intensive care medicine; Transplantation; Oncology; Family medicine; Internal medicine; Chemotherapy; Busulfan; Stem cell; Haematopoiesis; Bone marrow; Health care; Political science","score_opus":0.03023603101204567,"score_gpt":0.32433378395190454,"score_spread":0.29409775293985885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399461858","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052266587,0.83156574,0.0020096693,0.004136157,0.00046104315,0.00033061704,0.0036492655,0.00019166846,0.10538933],"genre_scores_gemma":[0.42059427,0.51609755,0.0056071347,0.0036943948,0.00031725527,0.00020144385,0.005099257,0.000041109768,0.04834766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995683,0.000091555274,0.00003143793,0.000034546654,0.00023689838,0.000037278318],"domain_scores_gemma":[0.999616,0.00008578312,0.0001115636,0.000011778414,0.00014177276,0.000033057204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000546806,0.00019384334,0.00020856746,0.00068007613,0.00014611203,0.0004694235,0.0002456314,0.00022894546,0.00514366],"category_scores_gemma":[0.00075404916,0.00004144987,0.00041585218,0.00073079095,0.00014977541,0.00020319707,0.00012812029,0.00035665513,0.000593795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058218854,0.00008401663,0.0015628523,0.002804343,0.00024097781,0.00016796206,0.000029116143,0.00047549253,0.0056345053,0.0028879163,0.030539058,0.95499146],"study_design_scores_gemma":[0.00039094983,0.0013767409,0.015474834,0.0029274554,0.00048675007,0.0017772957,0.000074675096,0.00043139423,0.012607577,0.0006483546,0.963776,0.000028090732],"about_ca_topic_score_codex":0.022476401,"about_ca_topic_score_gemma":0.095076025,"teacher_disagreement_score":0.9775236,"about_ca_system_score_codex":0.0020820175,"about_ca_system_score_gemma":0.0024275421,"threshold_uncertainty_score":0.044691145},"labels":[],"label_agreement":null},{"id":"W4399583434","doi":"10.51731/cjht.2024.916","title":"Advisory Panel Guidance on Minimum Retesting Intervals for Lab Tests","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lupus Canada; Strong; Diabetes Canada; Juvenile Diabetes Research Foundation Canada","keywords":"Test (biology); Medicine; Natriuretic peptide; Family medicine; Medical education; Internal medicine","score_opus":0.6766051998361999,"score_gpt":0.5436428878656937,"score_spread":0.13296231197050623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399583434","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021416976,0.01360985,0.011904211,0.79898125,0.03977861,0.0059189796,0.004262082,0.0017270627,0.12167625],"genre_scores_gemma":[0.024456356,0.0196599,0.072349235,0.73135644,0.018725066,0.0072707385,0.007637606,0.0007575069,0.11778711],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9317127,0.02455418,0.007592956,0.002771133,0.026986465,0.006382474],"domain_scores_gemma":[0.612841,0.065145314,0.010342466,0.0080175735,0.27719575,0.02645793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.067413464,0.0014796596,0.0020296867,0.003314651,0.0051541827,0.00665465,0.010838756,0.035902407,0.02651582],"category_scores_gemma":[0.16469498,0.0017327127,0.0045480975,0.0034032625,0.004022986,0.0048631807,0.0027796836,0.023173328,0.018625652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051350657,0.0000619064,0.0004905024,0.00026831485,0.000014782347,0.00013914934,0.00020426961,0.00016387094,0.00034778396,0.0019017428,0.9750659,0.021290494],"study_design_scores_gemma":[0.00010776046,0.000057234538,0.0017226439,0.0017960859,0.000035827354,0.00014818761,0.0003551371,0.00033005534,0.00034143106,0.0019272404,0.9931102,0.00006815723],"about_ca_topic_score_codex":0.1501818,"about_ca_topic_score_gemma":0.19919786,"teacher_disagreement_score":0.98620236,"about_ca_system_score_codex":0.013797623,"about_ca_system_score_gemma":0.10144653,"threshold_uncertainty_score":0.3565207},"labels":[],"label_agreement":null},{"id":"W4399677219","doi":"10.51731/cjht.2024.917","title":"Trifluridine-Tipiracil (Lonsurf)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.0462622084322977,"score_gpt":0.35016247322176103,"score_spread":0.3039002647894633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399677219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027679013,0.91341907,0.0011576732,0.0022852814,0.00042610374,0.00039942638,0.001956762,0.00016473087,0.052511998],"genre_scores_gemma":[0.3240181,0.6195597,0.0074963826,0.004479986,0.0004883286,0.00044923314,0.0045499327,0.000048251073,0.038910102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999529,0.00013332968,0.000049809212,0.00003701383,0.00020619019,0.000044721477],"domain_scores_gemma":[0.9996086,0.00008314275,0.00013810549,0.00001074007,0.000116125026,0.000043308744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087598467,0.00029241727,0.00042486453,0.0009780122,0.00021645344,0.0005103625,0.0003895669,0.0004545542,0.0064615947],"category_scores_gemma":[0.0008716862,0.00007363409,0.0006747491,0.0006813013,0.00020223255,0.00030670912,0.00018380229,0.00044609484,0.0010586593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012598414,0.00012502284,0.0011730326,0.0060072606,0.00024816833,0.0002376457,0.000039639774,0.00017061127,0.007035417,0.0015431579,0.023538187,0.95862204],"study_design_scores_gemma":[0.0013083017,0.004901448,0.016515866,0.00446017,0.0009028043,0.0030305998,0.00013427131,0.00031445507,0.010377855,0.00041104064,0.9576028,0.00004051401],"about_ca_topic_score_codex":0.01033767,"about_ca_topic_score_gemma":0.048714012,"teacher_disagreement_score":0.01033767,"about_ca_system_score_codex":0.001467249,"about_ca_system_score_gemma":0.001829798,"threshold_uncertainty_score":0.02161616},"labels":[],"label_agreement":null},{"id":"W4399677806","doi":"10.51731/cjht.2024.919","title":"Ravulizumab (Ultomiris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Neuromyelitis optica; Medicine; Family medicine; Political science; Antibody; Immunology; Health care","score_opus":0.01225614560277016,"score_gpt":0.27120583394361875,"score_spread":0.2589496883408486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399677806","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011465462,0.9611095,0.0009523866,0.0015345035,0.0002970255,0.00007914492,0.00034846523,0.00014751106,0.024065992],"genre_scores_gemma":[0.13903518,0.826351,0.0042067473,0.0022989407,0.00031395222,0.00010647268,0.00081697403,0.000029150322,0.026841575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999778,0.00004193001,0.000022251706,0.000028310858,0.0000983664,0.000031132415],"domain_scores_gemma":[0.99986017,0.00002791038,0.000045127344,0.0000051294887,0.000044681805,0.000016959719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049314625,0.00027239005,0.00031663003,0.0008879805,0.0002049815,0.0005453504,0.0002827443,0.00031935,0.0030882321],"category_scores_gemma":[0.00044684645,0.000078994264,0.00041138916,0.0005596448,0.00018034602,0.000279257,0.00018370924,0.0004769858,0.0009802819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031032777,0.000053357,0.0005788372,0.0027119427,0.0001239964,0.00024525757,0.000036548794,0.00020227529,0.009554025,0.0016320789,0.015584793,0.96896654],"study_design_scores_gemma":[0.0002932876,0.0010026222,0.007595355,0.0016936145,0.00042198328,0.0030227494,0.00006917565,0.00024347648,0.012214574,0.00058065186,0.9728353,0.000027181235],"about_ca_topic_score_codex":0.009178773,"about_ca_topic_score_gemma":0.036754917,"teacher_disagreement_score":0.009178773,"about_ca_system_score_codex":0.0014745861,"about_ca_system_score_gemma":0.0013541095,"threshold_uncertainty_score":0.018250644},"labels":[],"label_agreement":null},{"id":"W4400088938","doi":"10.51731/cjht.2024.926","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabidiol; Medicine; Psychiatry; Cannabis","score_opus":0.029463786262326673,"score_gpt":0.335494869673096,"score_spread":0.30603108341076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400088938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03828736,0.80285686,0.0017024826,0.002453474,0.000636621,0.0004415312,0.0043919855,0.00024236592,0.14898743],"genre_scores_gemma":[0.28132123,0.6255651,0.0052854083,0.0031801444,0.0002535629,0.00019873305,0.0031643673,0.000050998777,0.08098052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977845,0.000030242574,0.000023042292,0.000026194164,0.00012016266,0.000021932721],"domain_scores_gemma":[0.99979633,0.00004793745,0.000056850036,0.000008452591,0.00006463398,0.000025878571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003340562,0.00024333932,0.0002677178,0.0011821892,0.00031262983,0.00061367307,0.00034470612,0.00031018228,0.010122448],"category_scores_gemma":[0.0006288628,0.00007916906,0.00032051027,0.0006443003,0.00019828249,0.00025198652,0.00026950357,0.0004158417,0.0013545888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066244754,0.00013963059,0.0013326702,0.0063616713,0.00015490787,0.00039371548,0.000054252687,0.00016497016,0.009118346,0.0030198272,0.020655671,0.9579418],"study_design_scores_gemma":[0.00028029236,0.0006923449,0.010448994,0.0033523561,0.00041306336,0.002398331,0.000121052355,0.00013717683,0.013499692,0.0005273582,0.9680986,0.000030783165],"about_ca_topic_score_codex":0.027471296,"about_ca_topic_score_gemma":0.11084509,"teacher_disagreement_score":0.027471296,"about_ca_system_score_codex":0.0017068345,"about_ca_system_score_gemma":0.0021374626,"threshold_uncertainty_score":0.05462283},"labels":[],"label_agreement":null},{"id":"W4400378609","doi":"10.51731/cjht.2024.927","title":"National and International Policies on the Use of Biosimilars: An Environmental Scan","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Environmental policy; Business; Medicine; Environmental planning; Environmental science; Internal medicine","score_opus":0.11366115682620082,"score_gpt":0.3321419509867425,"score_spread":0.21848079416054167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400378609","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066309962,0.41139358,0.0076370756,0.28316405,0.0067655733,0.00053438975,0.004232593,0.00033245597,0.27930936],"genre_scores_gemma":[0.1400376,0.4412828,0.043011084,0.33177412,0.0031733308,0.0031292648,0.0067987577,0.0006481727,0.030144861],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.923779,0.031694703,0.010655022,0.0036337902,0.025381811,0.004855658],"domain_scores_gemma":[0.8042559,0.1174658,0.020495301,0.012324549,0.04050722,0.004951175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.081523895,0.0010393502,0.0018063164,0.0061990153,0.0024862518,0.00900648,0.0039525637,0.008811904,0.014504315],"category_scores_gemma":[0.10514933,0.0012854934,0.0019458698,0.013795299,0.007966128,0.017039213,0.007855134,0.008750892,0.0024292471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026278468,0.00021206759,0.0021937164,0.02112885,0.00017914029,0.00045255135,0.0037026154,0.0009994378,0.0009065692,0.39788747,0.20464818,0.3674267],"study_design_scores_gemma":[0.000030982934,0.000048706657,0.0016702194,0.020337675,0.00008512385,0.000156359,0.0011632438,0.00006174263,0.00033910904,0.015079896,0.96099514,0.000031822718],"about_ca_topic_score_codex":0.01457905,"about_ca_topic_score_gemma":0.0120487325,"teacher_disagreement_score":0.081523895,"about_ca_system_score_codex":0.008812017,"about_ca_system_score_gemma":0.037880834,"threshold_uncertainty_score":0.4311447},"labels":[],"label_agreement":null},{"id":"W4400498312","doi":"10.51731/cjht.2024.928","title":"Nirmatrelvir-Ritonavir (Paxlovid)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ritonavir; Medicine; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load","score_opus":0.024730642294590738,"score_gpt":0.32302462594105297,"score_spread":0.2982939836464622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400498312","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015205003,0.93020374,0.0014160657,0.0028969552,0.00050879864,0.0002777374,0.0017732198,0.00011465073,0.04760372],"genre_scores_gemma":[0.2378318,0.7246254,0.007459296,0.002960071,0.00045594558,0.00026759945,0.002484558,0.00004011826,0.023875132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986308,0.00045596654,0.00011755371,0.000075182514,0.0006374326,0.00008296374],"domain_scores_gemma":[0.9991155,0.0002753061,0.00025518145,0.000029021503,0.00027353357,0.000051343308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023287295,0.0002746319,0.00044308451,0.0012135936,0.00017908312,0.0010969568,0.00035746614,0.0004532803,0.0052086143],"category_scores_gemma":[0.002437543,0.000117311996,0.0007613966,0.0009713401,0.00021996051,0.00042435032,0.00023519881,0.00050191814,0.00070016505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006478102,0.00006650501,0.001561565,0.006491652,0.0004879051,0.000097960874,0.000036634992,0.00041933983,0.0028841607,0.0032110184,0.018339286,0.9657561],"study_design_scores_gemma":[0.00045394685,0.001428788,0.012002852,0.0065430873,0.0012069087,0.0011000432,0.00011380838,0.0005151137,0.0053062453,0.0009766382,0.9703166,0.00003608979],"about_ca_topic_score_codex":0.008121627,"about_ca_topic_score_gemma":0.040686514,"teacher_disagreement_score":0.008121627,"about_ca_system_score_codex":0.0025888078,"about_ca_system_score_gemma":0.0030480842,"threshold_uncertainty_score":0.018783212},"labels":[],"label_agreement":null},{"id":"W4400607151","doi":"10.51731/cjht.2024.929","title":"Trends in Public Drug Plan Expenditures for Patients With Crohn Disease and Ulcerative Colitis Initiating Targeted Immune Modulator Therapy","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ulcerative colitis; Medicine; Drug; Disease; Immune system; Crohn's disease; Pharmacotherapy; Immunology; Internal medicine; Pharmacology","score_opus":0.05527035259973597,"score_gpt":0.2868505913691179,"score_spread":0.2315802387693819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400607151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589251,0.0012745953,0.00018664333,0.00094942405,0.000014255103,0.000027187476,0.03469179,0.000023080664,0.0039078738],"genre_scores_gemma":[0.9767155,0.0010816178,0.00023194564,0.00012870431,0.000023326096,0.000027206288,0.020779127,0.0000069794532,0.0010056664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990761,0.00010239756,0.000093908755,0.00011525929,0.00027680057,0.0003355931],"domain_scores_gemma":[0.9959001,0.00056349166,0.0022111097,0.0000846789,0.0007620876,0.00047862588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050739106,0.0001701965,0.00031789255,0.0019168768,0.00037785183,0.001057369,0.0004893396,0.00027124406,0.0024500974],"category_scores_gemma":[0.0047040214,0.00019299591,0.0006794578,0.0049475916,0.00022673294,0.00045953342,0.00041357544,0.0009478845,0.00019098553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011194388,0.000036277444,0.99146444,0.00004865916,0.00012530366,0.000059528116,0.000090833106,0.0011127437,0.000054793818,0.0004932206,0.0024131604,0.003989062],"study_design_scores_gemma":[0.00000871609,0.000025646466,0.9953601,0.000030730684,0.000046609774,0.00011664402,0.00025869109,0.0014176731,0.00004664548,0.000057146663,0.0026256335,0.000005823658],"about_ca_topic_score_codex":0.7334144,"about_ca_topic_score_gemma":0.80262446,"teacher_disagreement_score":0.2665856,"about_ca_system_score_codex":0.008933158,"about_ca_system_score_gemma":0.006395471,"threshold_uncertainty_score":0.5363111},"labels":[],"label_agreement":null},{"id":"W4400920309","doi":"10.51731/cjht.2024.935","title":"Inebilizumab (Uplizna)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03787821221735176,"score_gpt":0.354476057902202,"score_spread":0.3165978456848502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400920309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016853271,0.8767108,0.0016319511,0.0055474984,0.0010455279,0.00053259253,0.0036553917,0.0003313572,0.0936917],"genre_scores_gemma":[0.25898707,0.65136254,0.007268102,0.008948115,0.00090196164,0.0005561129,0.007561007,0.00006705613,0.06434809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950683,0.00011829961,0.000057088942,0.000046701138,0.00021612829,0.000054937045],"domain_scores_gemma":[0.9994048,0.00013373994,0.00016772446,0.000015576245,0.0002189403,0.000059225862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010585953,0.00031959947,0.00040839295,0.0009277853,0.00022125032,0.0007575907,0.00048798433,0.0006169342,0.008230071],"category_scores_gemma":[0.0015498955,0.00009931075,0.0006966747,0.0005439065,0.0001919169,0.00038371095,0.00030945597,0.0007293264,0.0018899399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011297424,0.00009628439,0.0011940324,0.0060740495,0.00018711717,0.00017484988,0.00004724084,0.00021311408,0.0036330197,0.0019221357,0.059891075,0.92543733],"study_design_scores_gemma":[0.0009701147,0.0011316255,0.0043065236,0.004695718,0.00047152568,0.0012337025,0.000051203424,0.00013614328,0.0034871781,0.00041845875,0.9830792,0.000018479786],"about_ca_topic_score_codex":0.012862808,"about_ca_topic_score_gemma":0.03850163,"teacher_disagreement_score":0.012862808,"about_ca_system_score_codex":0.0018603039,"about_ca_system_score_gemma":0.002555555,"threshold_uncertainty_score":0.02753228},"labels":[],"label_agreement":null},{"id":"W4400921067","doi":"10.51731/cjht.2024.934","title":"Sotorasib (Lumakras)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.01154900914302178,"score_gpt":0.26793361778506275,"score_spread":0.256384608642041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400921067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025896734,0.85638463,0.0014208694,0.0045189704,0.00091602537,0.00040435322,0.0030007786,0.00038784643,0.10706976],"genre_scores_gemma":[0.22358674,0.70338684,0.0042118584,0.006799751,0.0005027743,0.00039793365,0.005270822,0.00006032294,0.055782955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998265,0.000037622645,0.000016550594,0.000026199545,0.00007041241,0.000022766206],"domain_scores_gemma":[0.99988246,0.000026497224,0.00003332828,0.0000040506393,0.000030285608,0.000023295863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002749958,0.0002934671,0.00034938182,0.0008588085,0.00020682202,0.0006787741,0.0002651135,0.00035137293,0.010195268],"category_scores_gemma":[0.00047878007,0.00009212654,0.0004216553,0.00057076867,0.00022395959,0.00036726502,0.00025525258,0.000781636,0.003038582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011283007,0.00010033217,0.00054475316,0.0050369613,0.00018253915,0.0003218008,0.00004872353,0.00031424916,0.0081059495,0.0029338726,0.06304998,0.91823244],"study_design_scores_gemma":[0.0011978456,0.0013052223,0.0047335173,0.0022403642,0.0003686163,0.0033977055,0.000065582084,0.0001953909,0.0053629833,0.0008028127,0.98030096,0.000028964043],"about_ca_topic_score_codex":0.0041810703,"about_ca_topic_score_gemma":0.018012986,"teacher_disagreement_score":0.010195268,"about_ca_system_score_codex":0.00079525466,"about_ca_system_score_gemma":0.0009642021,"threshold_uncertainty_score":0.034106553},"labels":[],"label_agreement":null},{"id":"W4400954704","doi":"10.51731/cjht.2024.936","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabidiol; Psychology; Medicine; Psychiatry; Cannabis","score_opus":0.029463786262326673,"score_gpt":0.335494869673096,"score_spread":0.30603108341076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400954704","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031640768,0.7466008,0.0022794825,0.0034856796,0.0009746976,0.0006623937,0.006289146,0.00036130234,0.20770572],"genre_scores_gemma":[0.2483355,0.61951613,0.0063668597,0.0045224614,0.0003629563,0.0003254224,0.004921125,0.00007877528,0.11557081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997222,0.000036847367,0.000026151432,0.00003234967,0.00015482845,0.000027701692],"domain_scores_gemma":[0.9997472,0.000055269116,0.00006133699,0.000010741663,0.000092136324,0.000033281307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004256494,0.00029469177,0.00030276636,0.0013292682,0.0003465067,0.0007167913,0.00039816636,0.00040172337,0.015648363],"category_scores_gemma":[0.00078875397,0.00009317045,0.00040104688,0.0006870469,0.00022879118,0.00032566924,0.00031411528,0.0005472349,0.0021465048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007181964,0.00017136837,0.0009850078,0.0064894473,0.00015596247,0.00031694476,0.000044639954,0.00016454754,0.008007916,0.0036678421,0.03516539,0.9441128],"study_design_scores_gemma":[0.00032411132,0.0006191984,0.0065246336,0.003030753,0.00033301915,0.0016831182,0.00008266482,0.00012041123,0.0109628355,0.0005723882,0.97572,0.000026835443],"about_ca_topic_score_codex":0.026609328,"about_ca_topic_score_gemma":0.09500524,"teacher_disagreement_score":0.026609328,"about_ca_system_score_codex":0.0018157822,"about_ca_system_score_gemma":0.0022932214,"threshold_uncertainty_score":0.052908897},"labels":[],"label_agreement":null},{"id":"W4400983956","doi":"10.51731/cjht.2024.938","title":"Dostarlimab (Jemperli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.06930665629754058,"score_gpt":0.2910968766942391,"score_spread":0.22179022039669855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400983956","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021453168,0.9218917,0.0009690726,0.0028378675,0.00037586296,0.00031174906,0.001320145,0.00017620274,0.05066421],"genre_scores_gemma":[0.2698303,0.66951424,0.00533698,0.0052974196,0.00041113744,0.00040140096,0.0028296555,0.00004616738,0.04633271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997526,0.00006580641,0.00002574157,0.000030863852,0.00010323165,0.000021781512],"domain_scores_gemma":[0.99980503,0.000055603803,0.00007172879,0.0000057701122,0.000041504452,0.000020330173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000483383,0.00020700885,0.00029855076,0.0007277819,0.0001455465,0.00051618466,0.00025093328,0.0002788712,0.0059438855],"category_scores_gemma":[0.00060245115,0.000080087855,0.00037138278,0.00044479695,0.00014683984,0.00026749328,0.00017792726,0.00046064018,0.0012586921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082967733,0.000084831394,0.0007638161,0.004941228,0.00018018988,0.00014963759,0.000039878574,0.00019742953,0.005750686,0.0014040953,0.02424225,0.9614162],"study_design_scores_gemma":[0.0012763471,0.0025054882,0.00833951,0.0030442362,0.00058906386,0.0028354453,0.00006992921,0.0002661558,0.008382679,0.0005301137,0.9721377,0.000023378629],"about_ca_topic_score_codex":0.0021529787,"about_ca_topic_score_gemma":0.010957561,"teacher_disagreement_score":0.0059438855,"about_ca_system_score_codex":0.0007868449,"about_ca_system_score_gemma":0.00081934436,"threshold_uncertainty_score":0.019884288},"labels":[],"label_agreement":null},{"id":"W4401029234","doi":"10.51731/cjht.2024.939","title":"Drospirenone (Slynd)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Internal medicine","score_opus":0.03349572096903707,"score_gpt":0.35530262858401573,"score_spread":0.32180690761497865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401029234","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026913833,0.8932527,0.0016208694,0.0026423486,0.0005687551,0.00033098905,0.0040987213,0.00014653329,0.07042535],"genre_scores_gemma":[0.24945338,0.6917593,0.0046818354,0.0027749261,0.0003343695,0.00019787965,0.0026860647,0.000024034436,0.048088156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968445,0.000048016907,0.00003301353,0.00003434357,0.00017475436,0.000025448431],"domain_scores_gemma":[0.9997547,0.000073139425,0.00006562048,0.0000078043495,0.000067004454,0.000031665157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038776564,0.00022685294,0.00021921055,0.0007093303,0.00023138375,0.000478875,0.0001875741,0.00027223895,0.0074365125],"category_scores_gemma":[0.00070410565,0.000084925145,0.00040197698,0.00043238513,0.0001850074,0.00017548384,0.00016761215,0.00044586035,0.00078803685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005473283,0.000072082075,0.0017416701,0.0073803486,0.00017745273,0.00040003817,0.000058753954,0.000213555,0.009122319,0.002349579,0.021073567,0.9568633],"study_design_scores_gemma":[0.00040103498,0.0012554169,0.015467322,0.0046024513,0.0004715126,0.0034119454,0.0001643871,0.0002074883,0.013054381,0.0006609062,0.9602672,0.00003589734],"about_ca_topic_score_codex":0.018452296,"about_ca_topic_score_gemma":0.093574636,"teacher_disagreement_score":0.018452296,"about_ca_system_score_codex":0.00087367557,"about_ca_system_score_gemma":0.0014266777,"threshold_uncertainty_score":0.03668976},"labels":[],"label_agreement":null},{"id":"W4401127229","doi":"10.51731/cjht.2024.941","title":"Directly Observed Therapy in Correctional Settings","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Possession (linguistics); Methadone; Buprenorphine; Health care; Pharmacotherapy; Psychiatry; Nova scotia; Intensive care medicine; Family medicine; Opioid","score_opus":0.06058462218499515,"score_gpt":0.3275037893453404,"score_spread":0.26691916716034525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401127229","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06581925,0.7327786,0.0029443586,0.10556032,0.0031260666,0.0013955092,0.0063550244,0.00018891729,0.081831925],"genre_scores_gemma":[0.52321404,0.4217642,0.00935419,0.036586232,0.0011430338,0.001233425,0.0019583679,0.0001214522,0.0046250774],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9768598,0.010399391,0.0046502855,0.0015238075,0.0051412764,0.0014254849],"domain_scores_gemma":[0.8898903,0.058477655,0.022417417,0.0045187115,0.020690685,0.0040052105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01097659,0.00034621582,0.0008270115,0.002558795,0.002604103,0.0051392233,0.002112616,0.0016878046,0.010647697],"category_scores_gemma":[0.09907088,0.00049322145,0.0009157887,0.00613911,0.0026742113,0.004446809,0.0027095631,0.0021606742,0.000770317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026250794,0.00020786416,0.053813085,0.09611574,0.0004543133,0.0011048197,0.016328307,0.00035772647,0.00030772525,0.011314012,0.085892275,0.73384166],"study_design_scores_gemma":[0.00019903756,0.0002661307,0.11517937,0.32258713,0.00086801616,0.00315013,0.028389372,0.00033910474,0.00055983616,0.0053216065,0.5229529,0.0001873702],"about_ca_topic_score_codex":0.25010225,"about_ca_topic_score_gemma":0.35684717,"teacher_disagreement_score":0.7498977,"about_ca_system_score_codex":0.016332626,"about_ca_system_score_gemma":0.047181346,"threshold_uncertainty_score":0.497293},"labels":[],"label_agreement":null},{"id":"W4401220050","doi":"10.51731/cjht.2024.945","title":"Drug Shortages: A Scoring System to Evaluate and Prioritize the Clinical Importance of Drugs in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Health care; Economic shortage; Psychological intervention; Population; Risk analysis (engineering); Intensive care medicine; Actuarial science; Business; Adverse effect; Environmental health; Nursing; Pharmacology","score_opus":0.0839966089288163,"score_gpt":0.3449682227445677,"score_spread":0.2609716138157514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401220050","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8502775,0.0031181045,0.03829687,0.0045892736,0.00023525298,0.0068805506,0.025803756,0.0013119993,0.06948672],"genre_scores_gemma":[0.8762977,0.0012425805,0.112299025,0.00031065964,0.000036405774,0.0009565934,0.0044726115,0.00004681835,0.004337485],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956215,0.0008008756,0.0006682746,0.00019721089,0.0022742788,0.00043775223],"domain_scores_gemma":[0.9856337,0.0024671054,0.001602149,0.00019125981,0.009012646,0.0010931022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048384317,0.00064399117,0.0005393187,0.007837676,0.0016444636,0.0019900827,0.0012887795,0.0004328396,0.0037386564],"category_scores_gemma":[0.01818698,0.00024785666,0.0008038545,0.0068081543,0.0006440268,0.0007472688,0.0015726074,0.00053672894,0.0004675671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007859484,0.00033762303,0.64543325,0.0010106319,0.00024399739,0.00034632356,0.001624425,0.0056479215,0.001715759,0.0023775995,0.030221194,0.31025535],"study_design_scores_gemma":[0.00026224248,0.0007213776,0.89688474,0.0006282248,0.00033433348,0.00049598666,0.0046396144,0.055223074,0.0041111745,0.0020705645,0.034408852,0.00021973473],"about_ca_topic_score_codex":0.7838282,"about_ca_topic_score_gemma":0.86750156,"teacher_disagreement_score":0.2161718,"about_ca_system_score_codex":0.01991043,"about_ca_system_score_gemma":0.039929967,"threshold_uncertainty_score":0.43488973},"labels":[],"label_agreement":null},{"id":"W4401220131","doi":"10.51731/cjht.2024.943","title":"Strategies to Reduce Alternate Level of Care","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Medicine; Health care; Population; Grey literature; Population ageing; Gerontology; Older people; Environmental health; MEDLINE; Nursing","score_opus":0.14059879157591404,"score_gpt":0.44171814601301823,"score_spread":0.3011193544371042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401220131","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06476558,0.043896385,0.01863626,0.76037216,0.0039478634,0.0031863628,0.008497631,0.00096936064,0.09572843],"genre_scores_gemma":[0.6031396,0.04965407,0.051811483,0.2622202,0.0022277262,0.0042586615,0.005214232,0.00039115336,0.021082882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9728433,0.0074202623,0.0024081278,0.0018067902,0.0102758985,0.005245526],"domain_scores_gemma":[0.94610226,0.010344059,0.0077224304,0.0025246611,0.023608956,0.009697597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015281141,0.0009179946,0.00090401387,0.0051218043,0.0041379356,0.007501182,0.0063862023,0.0033118338,0.014546785],"category_scores_gemma":[0.074633405,0.0006453998,0.0019134614,0.0058452566,0.0026985547,0.0054534655,0.008622112,0.0055337423,0.0014899026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014708271,0.0005708715,0.10598188,0.008571472,0.0006514623,0.00080525875,0.016741183,0.0019596575,0.0006760277,0.06217388,0.37092552,0.43079573],"study_design_scores_gemma":[0.00018916387,0.00022800683,0.09607224,0.02239958,0.00048459327,0.00054593536,0.029563216,0.0025798087,0.0008408594,0.02128525,0.8256224,0.0001890874],"about_ca_topic_score_codex":0.71797556,"about_ca_topic_score_gemma":0.804962,"teacher_disagreement_score":0.28202444,"about_ca_system_score_codex":0.050874803,"about_ca_system_score_gemma":0.16902734,"threshold_uncertainty_score":0.56737065},"labels":[],"label_agreement":null},{"id":"W4401596042","doi":"10.51731/cjht.2024.947","title":"Canadian Medical Imaging Inventory 2022–2023: Methods","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Descriptive statistics; Medical imaging; Unit (ring theory); Per capita; Jurisdiction; Ranking (information retrieval); Population; Medicine; Medical physics; Geography; Nuclear medicine; Computer science; Environmental health; Statistics; Psychology; Radiology; Political science; Artificial intelligence; Mathematics","score_opus":0.025474372200581873,"score_gpt":0.3759987163988628,"score_spread":0.35052434419828093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596042","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012802223,0.0021035667,0.0057564145,0.0019928217,0.000269406,0.008260795,0.8950546,0.00042453094,0.07333576],"genre_scores_gemma":[0.10766484,0.0046585114,0.046347447,0.001606024,0.0002296007,0.01694012,0.76857054,0.00047379633,0.053509112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938471,0.00034345215,0.0006163305,0.0007132009,0.0036356598,0.0008442753],"domain_scores_gemma":[0.9839522,0.0005975756,0.0008447762,0.00053785346,0.013311207,0.0007563633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041678036,0.0014266764,0.00093932654,0.018011793,0.0033710776,0.005965939,0.004262796,0.0007463593,0.042117354],"category_scores_gemma":[0.013326232,0.0008715193,0.0017578657,0.024450554,0.0006877269,0.0014459369,0.0023653014,0.0016635536,0.0060324185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025684596,0.00026899364,0.076563254,0.0027037938,0.00032664844,0.00037330843,0.0010554949,0.005200575,0.00020001992,0.027566222,0.7529775,0.1325074],"study_design_scores_gemma":[0.00008396081,0.000048651822,0.13370384,0.0013187651,0.00019375433,0.00019564826,0.0019439183,0.004297728,0.00038028054,0.0024219789,0.8552525,0.00015891748],"about_ca_topic_score_codex":0.97235537,"about_ca_topic_score_gemma":0.96606654,"teacher_disagreement_score":0.9486343,"about_ca_system_score_codex":0.051365647,"about_ca_system_score_gemma":0.11495246,"threshold_uncertainty_score":0.37268555},"labels":[],"label_agreement":null},{"id":"W4401596058","doi":"10.51731/cjht.2024.949","title":"Canadian Medical Imaging Inventory 2022–2023: PET-CT and PET-MRI","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; PET-CT; Nuclear medicine; Population; Positron emission tomography; Medical physics; Environmental health","score_opus":0.019727449983219063,"score_gpt":0.3240361774305268,"score_spread":0.30430872744730775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596058","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052063987,0.032183427,0.008731392,0.030062763,0.0031340742,0.0016084763,0.49697936,0.0052377414,0.41685635],"genre_scores_gemma":[0.06971423,0.06404491,0.040052764,0.015444566,0.0021403164,0.0017930008,0.62185305,0.0030290654,0.18192808],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9932233,0.0003743755,0.0003364292,0.00033948894,0.0051043634,0.0006220802],"domain_scores_gemma":[0.9470116,0.0013415323,0.0015431565,0.000987685,0.045359064,0.00375699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036898735,0.0015639919,0.0014419066,0.010112328,0.002769165,0.004839247,0.004482993,0.0017129203,0.053672783],"category_scores_gemma":[0.016545432,0.0010678616,0.0015595334,0.01369762,0.0007841902,0.0013549326,0.0015906276,0.002256669,0.019610368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121855126,0.000040472158,0.004377438,0.0005678836,0.000076975564,0.000119946846,0.00003185005,0.0004913931,0.00024140297,0.0036506392,0.9047073,0.085572965],"study_design_scores_gemma":[0.000030863204,0.000018507233,0.013318971,0.00046138675,0.000051377127,0.00023646666,0.000035756086,0.00068003393,0.00027467182,0.0006119007,0.984236,0.000044032655],"about_ca_topic_score_codex":0.92827964,"about_ca_topic_score_gemma":0.9340726,"teacher_disagreement_score":0.96017337,"about_ca_system_score_codex":0.039826613,"about_ca_system_score_gemma":0.124085225,"threshold_uncertainty_score":0.28896368},"labels":[],"label_agreement":null},{"id":"W4401596115","doi":"10.51731/cjht.2024.950","title":"Canadian Medical Imaging Inventory 2022–2023: CT","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Computed tomography; Nuclear medicine; Environmental health; Geography; Demography; Radiology","score_opus":0.01575142923157614,"score_gpt":0.3011301623496166,"score_spread":0.28537873311804046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596115","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024592436,0.010459095,0.0020393254,0.02511774,0.004331719,0.00077102875,0.44872233,0.00256204,0.5035374],"genre_scores_gemma":[0.04552753,0.031579666,0.01704357,0.014847275,0.0025487198,0.0010331962,0.5991581,0.0017112732,0.2865507],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99297535,0.0002663281,0.00028378126,0.00029181212,0.0053737457,0.0008090855],"domain_scores_gemma":[0.9619905,0.0008819574,0.0009500092,0.00061781914,0.03154506,0.004014607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017665244,0.0013756303,0.0010655599,0.009651465,0.003967526,0.005879477,0.0038523304,0.0016376901,0.14081421],"category_scores_gemma":[0.014961365,0.0009695256,0.0013950419,0.01551993,0.00088127895,0.0016565803,0.0020610853,0.002402541,0.03837061],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024221252,0.000013629497,0.0015375966,0.00015422732,0.000013894233,0.000027908736,0.000015939451,0.00010007493,0.000040432617,0.0020792256,0.9673362,0.028656717],"study_design_scores_gemma":[0.00001421788,0.0000066054054,0.006141829,0.00022996642,0.000012768829,0.00008596012,0.000045364766,0.00027410293,0.00006287999,0.00036250803,0.99274385,0.000020042222],"about_ca_topic_score_codex":0.95450467,"about_ca_topic_score_gemma":0.9650097,"teacher_disagreement_score":0.9517764,"about_ca_system_score_codex":0.048223626,"about_ca_system_score_gemma":0.1731124,"threshold_uncertainty_score":0.47107047},"labels":[],"label_agreement":null},{"id":"W4401596249","doi":"10.51731/cjht.2024.948","title":"Canadian Medical Imaging Inventory 2022–2023: Provincial and Territorial Overview","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Government of Alberta","keywords":"Staffing; Population; Economic shortage; Workforce; Medical imaging; Medicine; Nuclear medicine; Business; Radiology; Economic growth; Economics; Environmental health; Government (linguistics)","score_opus":0.026829073111530433,"score_gpt":0.3377059065997919,"score_spread":0.31087683348826145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596249","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006327457,0.016842362,0.0031998341,0.018983882,0.0024109383,0.0008651413,0.6179182,0.002713828,0.33073837],"genre_scores_gemma":[0.08271608,0.043756973,0.019203734,0.006532847,0.00086328044,0.0010650939,0.61735195,0.0015983541,0.22691175],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99452966,0.0001701815,0.00021569224,0.00021751769,0.003917171,0.00094990246],"domain_scores_gemma":[0.97906005,0.0003788383,0.00046348092,0.00027756157,0.017260188,0.0025598826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022341008,0.0014999221,0.000979605,0.012968579,0.003567213,0.0054216287,0.0031297852,0.0011336538,0.047486935],"category_scores_gemma":[0.007697482,0.000999706,0.0015396711,0.020659763,0.0007441523,0.0014943747,0.002329464,0.0020225113,0.014690445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006642071,0.000020763264,0.0045138868,0.00047631358,0.000044524808,0.000067833134,0.000061639555,0.00080241513,0.00014873824,0.004666541,0.9358109,0.053320043],"study_design_scores_gemma":[0.00001671878,0.000010245836,0.016973555,0.00030437956,0.000024247973,0.00010308145,0.00014991812,0.000828408,0.00013554933,0.00044440696,0.9809714,0.000038167906],"about_ca_topic_score_codex":0.98729604,"about_ca_topic_score_gemma":0.9879915,"teacher_disagreement_score":0.92843485,"about_ca_system_score_codex":0.07156515,"about_ca_system_score_gemma":0.22935134,"threshold_uncertainty_score":0.51924396},"labels":[],"label_agreement":null},{"id":"W4401596293","doi":"10.51731/cjht.2024.951","title":"Canadian Medical Imaging Inventory 2022–2023: MRI","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Population; Magnetic resonance imaging; Nuclear medicine; Medical imaging; Demography; Radiology; Environmental health","score_opus":0.014169327658130735,"score_gpt":0.2982021297440637,"score_spread":0.28403280208593296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596293","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050958353,0.008476613,0.002506448,0.021888599,0.002929586,0.0010713547,0.5875486,0.002764573,0.36771837],"genre_scores_gemma":[0.058213923,0.020705687,0.017340707,0.018388037,0.0014957236,0.0012958193,0.68606204,0.0013563011,0.19514176],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9917469,0.00030040983,0.00035347405,0.00036267712,0.0062681246,0.0009684297],"domain_scores_gemma":[0.94785833,0.0010817094,0.0015929496,0.0006547801,0.043191787,0.005620417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024662884,0.0012587095,0.001055123,0.009367158,0.004007504,0.004813721,0.0036766534,0.001442914,0.069016896],"category_scores_gemma":[0.017961355,0.00089057756,0.0012059916,0.016858367,0.0007464531,0.001586956,0.0019244957,0.0020755266,0.022515265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038340855,0.00002012005,0.004192529,0.0001733616,0.00002150151,0.00003495989,0.00002620113,0.000112079455,0.000060162547,0.001552385,0.96832186,0.025446473],"study_design_scores_gemma":[0.000024197796,0.000013460384,0.02507952,0.00028518325,0.000021701253,0.00010207122,0.00009833737,0.00035833562,0.00011339683,0.00031455417,0.97354805,0.000041260875],"about_ca_topic_score_codex":0.96933424,"about_ca_topic_score_gemma":0.97868365,"teacher_disagreement_score":0.95501995,"about_ca_system_score_codex":0.04498006,"about_ca_system_score_gemma":0.18407838,"threshold_uncertainty_score":0.32635474},"labels":[],"label_agreement":null},{"id":"W4401596315","doi":"10.51731/cjht.2024.953","title":"Canadian Medical Imaging Inventory 2022–2023: The Medical Imaging Team","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Workforce; Medical imaging; Economic shortage; Business; Service delivery framework; Service (business); Medicine; Nursing; Radiology; Marketing; Political science; Government (linguistics)","score_opus":0.012535751706954389,"score_gpt":0.29933768290074503,"score_spread":0.28680193119379066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596315","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015669843,0.0090291565,0.0050640525,0.050949525,0.0061821807,0.0022305846,0.32382637,0.0041826316,0.58286566],"genre_scores_gemma":[0.12798423,0.014682703,0.026728174,0.022842057,0.0016700668,0.0018361312,0.3587442,0.0017453489,0.44376707],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99003613,0.00030234776,0.00031193875,0.0003434515,0.007271968,0.0017340544],"domain_scores_gemma":[0.9655934,0.0008185311,0.0010108937,0.00050765695,0.024590647,0.007478838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035764484,0.0013160005,0.0006283248,0.006873175,0.0051694717,0.0055325353,0.0034615612,0.001793336,0.05246812],"category_scores_gemma":[0.012512875,0.0010486671,0.0015574374,0.008095008,0.00083083916,0.0013326716,0.0022268964,0.002263214,0.012670221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007016158,0.0000278442,0.0039175055,0.00018202417,0.00002463145,0.00005724914,0.0000777347,0.000309506,0.00023645752,0.003213388,0.9567992,0.03508423],"study_design_scores_gemma":[0.000028190423,0.000024061736,0.025332103,0.0001771735,0.000021573122,0.000089307134,0.00017168807,0.0006063169,0.00022046025,0.000322823,0.97296554,0.000040686533],"about_ca_topic_score_codex":0.98231196,"about_ca_topic_score_gemma":0.9841224,"teacher_disagreement_score":0.90885377,"about_ca_system_score_codex":0.09114623,"about_ca_system_score_gemma":0.3060264,"threshold_uncertainty_score":0.6613153},"labels":[],"label_agreement":null},{"id":"W4401596345","doi":"10.51731/cjht.2024.952","title":"Canadian Medical Imaging Inventory 2022–2023: SPECT and SPECT-CT","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear medicine; Spect imaging; Medicine; Single-photon emission computed tomography; Medical imaging; Radiology; Medical physics","score_opus":0.020609166738610966,"score_gpt":0.3232990369580813,"score_spread":0.30268987021947036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596345","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021330556,0.013370575,0.006711897,0.015411318,0.0013950844,0.0020702458,0.67024565,0.003931151,0.2655336],"genre_scores_gemma":[0.11864331,0.021522459,0.031311065,0.008921054,0.00090532517,0.0018096473,0.72586584,0.0012304409,0.08979084],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99306834,0.00023849403,0.0003571765,0.00028083942,0.0053077936,0.0007473405],"domain_scores_gemma":[0.95174426,0.001047687,0.0019187158,0.0006293627,0.040386382,0.004273648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002792225,0.0013490275,0.0010205106,0.012218395,0.0032517107,0.0032916446,0.0040681763,0.0010269817,0.033565383],"category_scores_gemma":[0.011892017,0.0008502161,0.0014832267,0.016240554,0.00073085155,0.0010073425,0.0017209298,0.0015906427,0.0092574805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002039222,0.00009302715,0.0379716,0.00067004655,0.00012368613,0.00020122743,0.000099026125,0.00064441556,0.00048562436,0.0027956106,0.86004233,0.09666949],"study_design_scores_gemma":[0.00007139556,0.00005148087,0.15683508,0.0006244793,0.0001026089,0.00052246806,0.0001745894,0.0016142261,0.0006386909,0.00055441336,0.83870524,0.0001054145],"about_ca_topic_score_codex":0.9659214,"about_ca_topic_score_gemma":0.97362626,"teacher_disagreement_score":0.96113706,"about_ca_system_score_codex":0.038862918,"about_ca_system_score_gemma":0.115815766,"threshold_uncertainty_score":0.2819715},"labels":[],"label_agreement":null},{"id":"W4401643305","doi":"10.51731/cjht.2024.954","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dravet syndrome; Cannabidiol; Tuberous sclerosis; Medicine; Psychiatry; Lennox–Gastaut syndrome; Epilepsy; Family medicine; Pediatrics; Cannabis; Political science","score_opus":0.03851485464450901,"score_gpt":0.3462713254877497,"score_spread":0.3077564708432407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401643305","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03801922,0.7437511,0.002122324,0.0037058592,0.0008994145,0.0005747725,0.006639907,0.00034683206,0.2039406],"genre_scores_gemma":[0.27193052,0.62329835,0.006188672,0.0044517023,0.00033259043,0.0002770078,0.0047563594,0.00006598231,0.088698804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997819,0.000029893275,0.00002196145,0.000025882318,0.00011725621,0.000023080245],"domain_scores_gemma":[0.99981326,0.000041629548,0.00004814971,0.000006692519,0.00006352459,0.000026761423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029196875,0.0002459295,0.00026861622,0.0009366379,0.0002739193,0.0005438671,0.000338856,0.0003307018,0.010927525],"category_scores_gemma":[0.0006418166,0.00007310236,0.00030376244,0.000586179,0.00018356407,0.0002454528,0.00024708017,0.0004782346,0.0017342874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000959702,0.00015943908,0.00093171373,0.0062283245,0.00013977232,0.0003977164,0.000044484517,0.00015100125,0.009065262,0.0029664775,0.036759682,0.9421965],"study_design_scores_gemma":[0.00049222144,0.0007056488,0.007807651,0.0031258524,0.00033907016,0.002199006,0.00008765035,0.00010806604,0.009847269,0.00047225144,0.9747883,0.000027101432],"about_ca_topic_score_codex":0.03178779,"about_ca_topic_score_gemma":0.11633136,"teacher_disagreement_score":0.9682122,"about_ca_system_score_codex":0.0014887701,"about_ca_system_score_gemma":0.002060955,"threshold_uncertainty_score":0.06320554},"labels":[],"label_agreement":null},{"id":"W4401836024","doi":"10.51731/cjht.2024.957","title":"Aging in Place","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aging in place; Gerontology; Medicine","score_opus":0.037708329081717604,"score_gpt":0.3634149897123307,"score_spread":0.3257066606306131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401836024","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030161748,0.09813331,0.0016085191,0.5293204,0.033899322,0.00016285284,0.002451976,0.00029418815,0.3311132],"genre_scores_gemma":[0.101930104,0.25976858,0.004161903,0.34828755,0.011550576,0.00024331156,0.0041697994,0.00048377624,0.26940447],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994383,0.0010423512,0.0003531674,0.0004502629,0.0023229017,0.0014483238],"domain_scores_gemma":[0.9866001,0.00091252057,0.00042615202,0.0005511862,0.0077782213,0.0037317735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004616261,0.00069267536,0.0009048911,0.0018822898,0.00898906,0.011058442,0.0025858188,0.004455584,0.05158055],"category_scores_gemma":[0.016464414,0.0003353025,0.0010964955,0.0025371271,0.006246697,0.00926839,0.0068290276,0.0061439127,0.013423171],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025404575,0.000019196397,0.0018574017,0.00071262143,0.000018424551,0.00023844471,0.0035563349,0.00003777204,0.000061853425,0.026845954,0.780419,0.1862076],"study_design_scores_gemma":[0.0000032528912,0.000007849617,0.00094073004,0.0012430496,0.000011083001,0.0001661549,0.0027188729,0.0000073035967,0.000025932542,0.0020362113,0.99282855,0.000011072458],"about_ca_topic_score_codex":0.5090559,"about_ca_topic_score_gemma":0.6972798,"teacher_disagreement_score":0.5090559,"about_ca_system_score_codex":0.023598943,"about_ca_system_score_gemma":0.07217304,"threshold_uncertainty_score":0.9876707},"labels":[],"label_agreement":null},{"id":"W4401999141","doi":"10.51731/cjht.2024.960","title":"Infliximab (Remsima SC)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Reimbursement; Medicine; Maintenance therapy; Disease; Crohn's disease; Intensive care medicine; Drug; Family medicine; Surgery; Internal medicine; Pharmacology; Health care; Political science; Chemotherapy","score_opus":0.010920370304103644,"score_gpt":0.25982153471275776,"score_spread":0.24890116440865412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401999141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006458258,0.91075397,0.0013758092,0.0044403193,0.0010466529,0.00019950923,0.0020447122,0.00025175634,0.07342894],"genre_scores_gemma":[0.12443409,0.77690923,0.006656413,0.007326954,0.0012215615,0.00023490778,0.006347812,0.000053421238,0.076815665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999458,0.000108120556,0.000052619227,0.000053193657,0.0002745207,0.000053485794],"domain_scores_gemma":[0.99956065,0.00007453819,0.000114305025,0.0000189526,0.00017451574,0.00005704592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007196838,0.00032595498,0.0004156041,0.0011802202,0.00025587928,0.000729948,0.00038048945,0.00057782786,0.011942876],"category_scores_gemma":[0.0009383172,0.00009691465,0.00050512905,0.0010143737,0.0002473439,0.00033296563,0.0003044481,0.00065943704,0.004378857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044131366,0.000066462126,0.0006702311,0.0067919726,0.0001321393,0.00029350317,0.000050223873,0.00014318983,0.005537893,0.0028411013,0.0960006,0.8870315],"study_design_scores_gemma":[0.00015345743,0.00024260479,0.0022267753,0.0014538398,0.00011809505,0.001166417,0.000021836971,0.000035432095,0.0018509183,0.00020974941,0.9925122,0.000008669058],"about_ca_topic_score_codex":0.016026936,"about_ca_topic_score_gemma":0.043642055,"teacher_disagreement_score":0.016026936,"about_ca_system_score_codex":0.0013334868,"about_ca_system_score_gemma":0.0021745947,"threshold_uncertainty_score":0.039952874},"labels":[],"label_agreement":null},{"id":"W4402052589","doi":"10.51731/cjht.2024.961","title":"An Inventory of Rare Disease Registries in the Canadian Landscape","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Environmental DNA in Biodiversity Studies","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.021789243557623225,"score_gpt":0.24050434204874171,"score_spread":0.21871509849111848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402052589","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2975579,0.042194862,0.018611463,0.048212774,0.0009316277,0.006913334,0.43664148,0.002496921,0.14643969],"genre_scores_gemma":[0.6453214,0.046075385,0.09287677,0.008392811,0.00046828264,0.0031312348,0.18524696,0.0005356135,0.017951502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96989506,0.0041919705,0.004101807,0.0027943363,0.015397833,0.003619003],"domain_scores_gemma":[0.7985152,0.020204157,0.02106436,0.007067866,0.13055274,0.022595704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027853796,0.00072172785,0.0009738986,0.035886105,0.007190226,0.006806197,0.0032136051,0.0007296288,0.005913883],"category_scores_gemma":[0.07258132,0.0010259334,0.0012516117,0.052580647,0.0015522313,0.0029083511,0.005827864,0.0012731265,0.00097559486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002685761,0.00013617935,0.45571595,0.004486793,0.00042706705,0.0009084036,0.00993855,0.0024767003,0.00078031485,0.02603853,0.23541194,0.263411],"study_design_scores_gemma":[0.00007759953,0.00009694152,0.48944104,0.004772161,0.00037978345,0.0007124068,0.008886303,0.0025924754,0.00047438222,0.0016147217,0.49063578,0.00031638978],"about_ca_topic_score_codex":0.98242974,"about_ca_topic_score_gemma":0.98949206,"teacher_disagreement_score":0.8984049,"about_ca_system_score_codex":0.10159509,"about_ca_system_score_gemma":0.33809182,"threshold_uncertainty_score":0.7371274},"labels":[],"label_agreement":null},{"id":"W4402332430","doi":"10.51731/cjht.2024.968","title":"Methoxyflurane Inhalation as an Analgesic for Minor Gynecological, Ambulatory, or Emergency Procedures","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Airway Management and Intubation Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methoxyflurane; Analgesic; Ambulatory; Medicine; Inhalation; Anesthesia; Minor (academic); Surgery; Halothane; Art","score_opus":0.06002260778740687,"score_gpt":0.3905191772450101,"score_spread":0.33049656945760325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402332430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012341425,0.99540603,0.00014843504,0.0014864851,0.00037862698,0.0004925589,0.00032921167,0.000007887516,0.0005165617],"genre_scores_gemma":[0.024854977,0.96753734,0.0011024891,0.0041879117,0.0006199662,0.0011539791,0.00023209212,0.000009920182,0.0003013339],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864659,0.0046855332,0.0060306587,0.0006377495,0.0019396616,0.00024048635],"domain_scores_gemma":[0.93734074,0.045589242,0.012351869,0.000635167,0.003810817,0.00027223653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014352543,0.00093065336,0.008978349,0.0072185067,0.0005178516,0.003057699,0.0018828436,0.003608935,0.0044627837],"category_scores_gemma":[0.06987358,0.0010022736,0.006700759,0.007552665,0.0012092389,0.0034838382,0.0009245362,0.0014992016,0.00039928372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031987496,0.000013955623,0.0006780267,0.9534484,0.004847866,0.00009578319,0.00014921816,0.000040745796,0.00013769543,0.0002503466,0.0020503923,0.037967768],"study_design_scores_gemma":[0.00070029264,0.00023924027,0.0028025908,0.95137733,0.027311964,0.00034063644,0.00027298788,0.00006209674,0.00022679692,0.000397447,0.016238647,0.00002995286],"about_ca_topic_score_codex":0.0077436566,"about_ca_topic_score_gemma":0.016971024,"teacher_disagreement_score":0.014352543,"about_ca_system_score_codex":0.0040646424,"about_ca_system_score_gemma":0.0087792,"threshold_uncertainty_score":0.07590443},"labels":[],"label_agreement":null},{"id":"W4402393947","doi":"10.51731/cjht.2024.969","title":"The Paige Prostate Suite: Assistive Artificial Intelligence for Prostate Cancer Diagnosis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Suite; Prostate cancer; Prostate; Medicine; Artificial intelligence; Cancer; Computer science; Internal medicine; Archaeology; Geography","score_opus":0.16458749205818846,"score_gpt":0.4392394186078883,"score_spread":0.27465192654969983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402393947","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029553797,0.071304664,0.52664524,0.054580677,0.006142795,0.002166267,0.016831737,0.15044507,0.14232983],"genre_scores_gemma":[0.18880834,0.052503202,0.65695125,0.019584995,0.0041817813,0.0011962914,0.023476496,0.0068020257,0.046495702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743015,0.0007441409,0.00012313257,0.0002928201,0.0012221544,0.00018749243],"domain_scores_gemma":[0.99599624,0.0014996061,0.00017709026,0.0004571556,0.0013295617,0.00054027274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003265875,0.0013247512,0.001021136,0.002459296,0.00075806514,0.0040738485,0.0020573197,0.0017242695,0.014974886],"category_scores_gemma":[0.012121859,0.0006630913,0.001028936,0.0019484385,0.00089159043,0.0028616386,0.003365915,0.0028636707,0.010243549],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033892476,0.00015783757,0.0057110465,0.0007662863,0.00019001025,0.00038598897,0.00027759114,0.0032036141,0.0028857714,0.005617218,0.2733459,0.7071197],"study_design_scores_gemma":[0.00024631133,0.00071789115,0.009840729,0.001129305,0.0002317867,0.0027731226,0.0004815675,0.061146766,0.010484531,0.029816266,0.8828075,0.0003241548],"about_ca_topic_score_codex":0.009514852,"about_ca_topic_score_gemma":0.013628219,"teacher_disagreement_score":0.99048513,"about_ca_system_score_codex":0.0011541793,"about_ca_system_score_gemma":0.002929023,"threshold_uncertainty_score":0.050095975},"labels":[],"label_agreement":null},{"id":"W4402413658","doi":"10.51731/cjht.2024.970","title":"Drug Shortages and Patient Harms","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Economic shortage; Medicine; Intensive care medicine; Business; Pharmacology; Government (linguistics)","score_opus":0.05190415301851258,"score_gpt":0.2854990001977715,"score_spread":0.23359484717925894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402413658","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010288111,0.7977298,0.00058949325,0.17881787,0.0016483511,0.00027612713,0.0007263615,0.000015662663,0.00990827],"genre_scores_gemma":[0.15960756,0.7703784,0.0019178757,0.062083907,0.0039733923,0.00050743076,0.00039281647,0.000017837192,0.0011208082],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.943178,0.03061196,0.01394471,0.0013223805,0.009850471,0.0010924586],"domain_scores_gemma":[0.6615032,0.25563675,0.056390207,0.0038629868,0.020019084,0.0025877105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045627184,0.0005111273,0.0027320513,0.0077189463,0.0016819407,0.006102535,0.0015879725,0.0055330154,0.007498477],"category_scores_gemma":[0.23907058,0.00078478595,0.0028980165,0.009141712,0.0048249476,0.01208809,0.0037005558,0.0044865184,0.0006386139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007392805,0.00037581104,0.064969994,0.28114754,0.0031492827,0.0012775363,0.008390854,0.0005813098,0.00010473504,0.021958502,0.061692387,0.5556128],"study_design_scores_gemma":[0.00037554908,0.00077740836,0.056823615,0.6736215,0.003858051,0.0046377415,0.022543702,0.0004197021,0.00043379984,0.038874604,0.19741498,0.00021938689],"about_ca_topic_score_codex":0.006457849,"about_ca_topic_score_gemma":0.0059442297,"teacher_disagreement_score":0.99354213,"about_ca_system_score_codex":0.0061722435,"about_ca_system_score_gemma":0.012639788,"threshold_uncertainty_score":0.24130255},"labels":[],"label_agreement":null},{"id":"W4402488118","doi":"10.51731/cjht.2024.972","title":"Teclistamab (Tecvayli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Refractory (planetary science); Drug; Multiple myeloma; Subcutaneous injection; Monoclonal antibody; Internal medicine; Pharmacology; Family medicine; Oncology; Antibody; Health care; Immunology; Chemistry; Political science","score_opus":0.045761241313877425,"score_gpt":0.3538396592666456,"score_spread":0.3080784179527682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402488118","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015158945,0.8784,0.0013249663,0.0034410972,0.0006810952,0.00027813207,0.0037495552,0.000281078,0.09668511],"genre_scores_gemma":[0.23660134,0.661187,0.004530999,0.0072092344,0.00060692406,0.00031012073,0.0090055205,0.00007531386,0.08047358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960834,0.000059348757,0.000030174397,0.000040798637,0.00021404537,0.000047360925],"domain_scores_gemma":[0.99966645,0.00006289119,0.0000931938,0.000010110676,0.00011896944,0.000048488448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056757155,0.00029154262,0.00034540234,0.0011409388,0.00032813035,0.0010021185,0.00038303976,0.00046350906,0.011221607],"category_scores_gemma":[0.0008159182,0.00007429569,0.00052171334,0.0009199068,0.00024670167,0.0004240274,0.00030415275,0.0006989444,0.0024858224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008065192,0.00008532732,0.001091375,0.0048422473,0.0001529974,0.00024849447,0.00004536279,0.00026051287,0.005831281,0.0029700021,0.062632695,0.92103314],"study_design_scores_gemma":[0.0004781526,0.0005685095,0.00395168,0.0020506587,0.00020410595,0.0015599884,0.000041748208,0.00012109634,0.004061389,0.00043255943,0.98651403,0.000016108635],"about_ca_topic_score_codex":0.016129058,"about_ca_topic_score_gemma":0.049962793,"teacher_disagreement_score":0.016129058,"about_ca_system_score_codex":0.0021370924,"about_ca_system_score_gemma":0.0024063466,"threshold_uncertainty_score":0.03754008},"labels":[],"label_agreement":null},{"id":"W4402533840","doi":"10.51731/cjht.2024.975","title":"Measuring and Valuing Health for Children: A Review of the Evidence","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Global Health Care Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.3532562923029029,"score_gpt":0.5248495744493564,"score_spread":0.17159328214645353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402533840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016414489,0.9990514,0.00007934471,0.00038064437,0.00003707243,0.00003741693,0.00007450967,0.0000017644653,0.00017374729],"genre_scores_gemma":[0.0020644332,0.9969367,0.00047968412,0.00032576255,0.000033096243,0.000081008395,0.00005543381,0.0000018317766,0.000021991353],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9879275,0.0043203393,0.004218802,0.00074907066,0.0025226932,0.000261648],"domain_scores_gemma":[0.9372944,0.052773464,0.0054899217,0.0005211962,0.003543688,0.00037731157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018431498,0.0014489092,0.0051554274,0.011362726,0.0006290978,0.0043926327,0.002079842,0.0028565247,0.0040858453],"category_scores_gemma":[0.06024151,0.0011662324,0.0059838938,0.013241843,0.001496134,0.004321215,0.0020432645,0.0027719554,0.00048487447],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023002527,0.00006605807,0.0019275297,0.58788925,0.0024287796,0.00012201204,0.00044854506,0.0002969562,0.00010729607,0.0027605996,0.0063517434,0.39737114],"study_design_scores_gemma":[0.00008175941,0.00011998513,0.004957938,0.92023015,0.00557082,0.00048212602,0.0005276019,0.00012220877,0.00012687503,0.0014655191,0.06626017,0.000054889628],"about_ca_topic_score_codex":0.010705938,"about_ca_topic_score_gemma":0.018398289,"teacher_disagreement_score":0.018431498,"about_ca_system_score_codex":0.0057348073,"about_ca_system_score_gemma":0.011124321,"threshold_uncertainty_score":0.097476244},"labels":[],"label_agreement":null},{"id":"W4402620951","doi":"10.51731/cjht.2024.978","title":"Continuous Diffused Oxygen Therapy for Wound Healing","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxygen therapy; Medicine; Wound care; Intensive care medicine; Wound healing; Health care; Surgery; Internal medicine","score_opus":0.03537621756336913,"score_gpt":0.324699520967545,"score_spread":0.2893233034041759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402620951","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033300027,0.9847246,0.00032914768,0.00926688,0.003420945,0.00049507094,0.00018094484,0.000011054941,0.0012383733],"genre_scores_gemma":[0.0058895284,0.97576183,0.0027551614,0.010594055,0.0030096145,0.0009441748,0.00013353943,0.000016725662,0.000895355],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9815159,0.0071522105,0.006846277,0.0007324254,0.003547939,0.00020520632],"domain_scores_gemma":[0.93261456,0.045687716,0.008213651,0.00088828907,0.012057751,0.0005379882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025548397,0.00081430067,0.0052081672,0.006985262,0.00080198457,0.0052148323,0.0023975952,0.0040774834,0.0055883005],"category_scores_gemma":[0.079089776,0.0007958733,0.004243783,0.0058585834,0.0019725433,0.006223628,0.0014036087,0.0030502104,0.0011468694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045053966,0.00004855019,0.00080483034,0.6505948,0.0016891138,0.00023086488,0.0006239868,0.000061928324,0.0005855821,0.003239925,0.048507795,0.2931621],"study_design_scores_gemma":[0.0004500388,0.0002983507,0.002703348,0.69225585,0.0051493044,0.0005526774,0.000885097,0.000109632805,0.00045781714,0.0031487646,0.29391605,0.00007300425],"about_ca_topic_score_codex":0.0035329624,"about_ca_topic_score_gemma":0.008431538,"teacher_disagreement_score":0.025548397,"about_ca_system_score_codex":0.00320664,"about_ca_system_score_gemma":0.010187885,"threshold_uncertainty_score":0.13511443},"labels":[],"label_agreement":null},{"id":"W4402644752","doi":"10.51731/cjht.2024.981","title":"Cemiplimab (Libtayo)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.020648046148322174,"score_gpt":0.26516243236839404,"score_spread":0.24451438622007188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402644752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021498738,0.83893377,0.0022292368,0.005294846,0.0011393671,0.0007705587,0.0040369574,0.000565502,0.12553105],"genre_scores_gemma":[0.2829544,0.55403477,0.0123511255,0.010478259,0.0012690164,0.0013740616,0.010888957,0.00012946819,0.1265199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994855,0.00012898516,0.000046128607,0.000055799013,0.00021064735,0.00007293008],"domain_scores_gemma":[0.99941015,0.000103176615,0.00017778474,0.000019656909,0.00019088313,0.00009835627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009759993,0.0004227355,0.00046302707,0.0014110478,0.00031917865,0.0013038043,0.0004282448,0.0007063938,0.013978492],"category_scores_gemma":[0.0011736965,0.0001474246,0.00045711154,0.00087543513,0.00027611788,0.00048619535,0.00043660065,0.00081287697,0.0038558454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012306562,0.00013347172,0.0011314896,0.0046190536,0.000117435295,0.00021321501,0.00004659294,0.00020069658,0.009081735,0.0025906006,0.082258396,0.8983767],"study_design_scores_gemma":[0.0007782001,0.0012937974,0.0040071122,0.0022563345,0.00016457011,0.0018245608,0.000043328124,0.00010892421,0.00713769,0.0003263128,0.9820393,0.000019854986],"about_ca_topic_score_codex":0.0065143965,"about_ca_topic_score_gemma":0.020297177,"teacher_disagreement_score":0.013978492,"about_ca_system_score_codex":0.0018057817,"about_ca_system_score_gemma":0.0030019674,"threshold_uncertainty_score":0.046762705},"labels":[],"label_agreement":null},{"id":"W4402644953","doi":"10.51731/cjht.2024.980","title":"Tralokinumab (Adtralza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology; Geography","score_opus":0.038193925976586225,"score_gpt":0.3464458702473919,"score_spread":0.30825194427080566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402644953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010462735,0.881571,0.001194213,0.0043198066,0.0011264133,0.0003609979,0.003891931,0.00037100122,0.09670198],"genre_scores_gemma":[0.16579814,0.7152729,0.006097252,0.0075739613,0.0007748534,0.00040316043,0.006801944,0.000062359235,0.09721543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964,0.00006292551,0.00002996052,0.000049075374,0.00017446834,0.0000435923],"domain_scores_gemma":[0.9996668,0.000057227007,0.00006964583,0.000010816764,0.00014816727,0.00004740084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006020792,0.0003554781,0.0002797556,0.0009202417,0.00028191658,0.00087844033,0.00045142916,0.00047501593,0.012815892],"category_scores_gemma":[0.0007621192,0.00009338838,0.0005270663,0.0006703016,0.00021499656,0.00043938696,0.00023282088,0.00076586794,0.0035218152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049561873,0.0000756198,0.0005092767,0.0050057154,0.00011020174,0.0001403404,0.00003509277,0.00014874333,0.0045313463,0.0017293893,0.09091725,0.89630145],"study_design_scores_gemma":[0.00040975417,0.00058250554,0.0034493576,0.001973077,0.0002393816,0.0013193112,0.00003191791,0.00009850329,0.0023088173,0.00021711817,0.9893534,0.00001673206],"about_ca_topic_score_codex":0.020455083,"about_ca_topic_score_gemma":0.08479082,"teacher_disagreement_score":0.020455083,"about_ca_system_score_codex":0.0016477869,"about_ca_system_score_gemma":0.002539486,"threshold_uncertainty_score":0.042873442},"labels":[],"label_agreement":null},{"id":"W4402663829","doi":"10.51731/cjht.2024.983","title":"Bimekizumab (Bimzelx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.036952607970333055,"score_gpt":0.3438340482654081,"score_spread":0.306881440295075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402663829","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009788698,0.88533175,0.002023714,0.005110162,0.001635835,0.00048368733,0.0031154742,0.00035993743,0.0921507],"genre_scores_gemma":[0.1692629,0.71770245,0.008756559,0.012108295,0.0017154635,0.0007128452,0.0075006294,0.00006895753,0.082171924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994522,0.00010281045,0.00004954483,0.000055469907,0.00027697897,0.00006302791],"domain_scores_gemma":[0.99967694,0.00006373802,0.00009614806,0.000011131538,0.000102348,0.000049625873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088470953,0.00038335644,0.00043462552,0.0009922425,0.000274596,0.00077271013,0.00050357555,0.0006216431,0.012490259],"category_scores_gemma":[0.0011599113,0.00010869524,0.0005909894,0.0006399363,0.00020016934,0.00045836926,0.00043820406,0.0008246637,0.0036772664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060969,0.0001220686,0.0005229719,0.0044851126,0.00012041427,0.00013237575,0.000029603776,0.00020907857,0.0031237153,0.0024466733,0.0781646,0.9100337],"study_design_scores_gemma":[0.0005242003,0.0006648396,0.0019665165,0.0016433947,0.0001744251,0.0011078558,0.000022685204,0.000101189704,0.0029305313,0.0005334334,0.9903183,0.000012643762],"about_ca_topic_score_codex":0.005005128,"about_ca_topic_score_gemma":0.012523013,"teacher_disagreement_score":0.012490259,"about_ca_system_score_codex":0.0012841613,"about_ca_system_score_gemma":0.0017987406,"threshold_uncertainty_score":0.041784108},"labels":[],"label_agreement":null},{"id":"W4402681860","doi":"10.51731/cjht.2024.982","title":"Optimal Team for Diagnostic Imaging Equipment Installation","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Engineering Diagnostics and Reliability","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Engineering","score_opus":0.009412333758549628,"score_gpt":0.23984359221717866,"score_spread":0.23043125845862902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402681860","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29151103,0.012450451,0.3277896,0.12292211,0.0076050027,0.008433184,0.0015188935,0.0038524682,0.22391726],"genre_scores_gemma":[0.6193808,0.0065210904,0.32357222,0.0080941245,0.0014473475,0.0033077437,0.0015649922,0.00051400077,0.035597682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99188083,0.0031610453,0.00065275823,0.0007445922,0.0019791955,0.0015814266],"domain_scores_gemma":[0.9854252,0.0014189192,0.0014313865,0.00047350588,0.004195564,0.007055493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007116063,0.0006968188,0.0005042057,0.002793294,0.006067213,0.0042824214,0.002114227,0.0017427333,0.035268173],"category_scores_gemma":[0.019096868,0.0006750128,0.0008172301,0.0010434492,0.0009851997,0.0032108098,0.005339603,0.002733342,0.0074197706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005371125,0.001931478,0.07870109,0.0015300894,0.00011989548,0.00739093,0.012939905,0.0056837304,0.006041714,0.016041895,0.21707106,0.65201104],"study_design_scores_gemma":[0.00047772902,0.0026755794,0.21668366,0.007727576,0.00025420776,0.023235176,0.12681551,0.021489182,0.006416184,0.059404537,0.5341734,0.00064730184],"about_ca_topic_score_codex":0.015792357,"about_ca_topic_score_gemma":0.03692392,"teacher_disagreement_score":0.035268173,"about_ca_system_score_codex":0.0064313775,"about_ca_system_score_gemma":0.022528702,"threshold_uncertainty_score":0.11798376},"labels":[],"label_agreement":null},{"id":"W4402698098","doi":"10.51731/cjht.2024.985","title":"Maralixibat (Livmarli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.027999714835361657,"score_gpt":0.3060256705592148,"score_spread":0.27802595572385314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402698098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014710482,0.9375448,0.0014559844,0.0040791784,0.00057841756,0.00025117383,0.0012155225,0.00037136985,0.039793137],"genre_scores_gemma":[0.31988674,0.6258972,0.007387341,0.00714783,0.00061302364,0.0003786443,0.003219735,0.00007524179,0.035394195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959165,0.00012529283,0.000043909873,0.000050345803,0.00014689805,0.00004199935],"domain_scores_gemma":[0.9996815,0.000076896715,0.00010622114,0.000009651887,0.00008802087,0.000037719496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063431705,0.00024785195,0.00048270568,0.0006695926,0.00019691128,0.0006293572,0.00042534393,0.0004727172,0.007211935],"category_scores_gemma":[0.00097583566,0.00008188019,0.00054602895,0.00045908726,0.00019203807,0.00028226702,0.00023954021,0.00078317005,0.0016866984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018648098,0.00012437195,0.0007078378,0.0071580876,0.0002540364,0.00030305664,0.00004918567,0.0002836336,0.006346796,0.0022641586,0.045005463,0.93563855],"study_design_scores_gemma":[0.0016219958,0.0024988977,0.005394081,0.004191426,0.0004452305,0.0028917254,0.00007040483,0.00026551555,0.0054933056,0.0005956788,0.976498,0.00003365417],"about_ca_topic_score_codex":0.0058344626,"about_ca_topic_score_gemma":0.021530828,"teacher_disagreement_score":0.007211935,"about_ca_system_score_codex":0.0012038122,"about_ca_system_score_gemma":0.0012382064,"threshold_uncertainty_score":0.024126291},"labels":[],"label_agreement":null},{"id":"W4402815998","doi":"10.51731/cjht.2024.987","title":"Avatrombopag (Doptelet)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Business","score_opus":0.018967762409276518,"score_gpt":0.29302047160474726,"score_spread":0.27405270919547076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402815998","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007799871,0.952612,0.00053791236,0.0019106093,0.00028524484,0.000118463235,0.0018059604,0.00009142116,0.03483848],"genre_scores_gemma":[0.115694,0.8510625,0.0037731733,0.0033056831,0.00031243404,0.00015185418,0.003084749,0.000035857433,0.022579825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947995,0.0001060457,0.00005313738,0.00004099768,0.00028416104,0.00003575036],"domain_scores_gemma":[0.99943537,0.0001930574,0.00013468109,0.000012022578,0.00017841921,0.000046430207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075161894,0.00025399143,0.00049957697,0.0011822174,0.00024343816,0.0007871254,0.00033124388,0.00039916992,0.0060020364],"category_scores_gemma":[0.0013873773,0.00007934956,0.00058140274,0.0011922091,0.00021882591,0.00025952197,0.00020570082,0.0006301945,0.0011119536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065360934,0.00007354768,0.001235007,0.006899124,0.00027937483,0.0002780909,0.000039332597,0.00014768113,0.0021685674,0.001370314,0.035490405,0.95136493],"study_design_scores_gemma":[0.0005719333,0.0010608572,0.016328827,0.007977833,0.00095262413,0.0029494124,0.00011378607,0.00016690303,0.002986602,0.00061168603,0.9662474,0.000032116175],"about_ca_topic_score_codex":0.030850727,"about_ca_topic_score_gemma":0.10709772,"teacher_disagreement_score":0.030850727,"about_ca_system_score_codex":0.0018161373,"about_ca_system_score_gemma":0.0022676715,"threshold_uncertainty_score":0.06134236},"labels":[],"label_agreement":null},{"id":"W4402848531","doi":"10.51731/cjht.2024.986","title":"Short-Cycle Autoclave Sterilization of Instruments in Same-Day Ophthalmic Surgeries","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sterilization (economics); Medicine; Autoclave; Materials science; Metallurgy; Business","score_opus":0.03181342894197042,"score_gpt":0.3258453124441941,"score_spread":0.2940318835022237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402848531","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023911793,0.9803396,0.0006568779,0.01113001,0.0026049095,0.0010911166,0.00044125647,0.000025578998,0.001319418],"genre_scores_gemma":[0.022670995,0.9513635,0.005623935,0.015297743,0.0026825543,0.001512404,0.00027629948,0.00004073339,0.0005317456],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9559813,0.013985027,0.021486584,0.0014589955,0.0066452003,0.0004428374],"domain_scores_gemma":[0.7957202,0.12531404,0.040704254,0.002515445,0.03458404,0.0011620362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046988934,0.0012637976,0.0077937446,0.010192878,0.0009912938,0.0060426397,0.0033932098,0.0061943196,0.0047067795],"category_scores_gemma":[0.14651607,0.0013927546,0.007939027,0.008473733,0.002501286,0.0072520724,0.0017457453,0.0024352924,0.0009165176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081961515,0.0000646619,0.0022448828,0.8360869,0.0031051834,0.00020189132,0.00044814576,0.00008251294,0.0006643728,0.0005900689,0.009840706,0.145851],"study_design_scores_gemma":[0.0008138856,0.0006585649,0.005679551,0.87710583,0.013697225,0.0005539187,0.0012663411,0.00013500836,0.0010386496,0.0013500161,0.097608335,0.00009265451],"about_ca_topic_score_codex":0.0056273695,"about_ca_topic_score_gemma":0.014628331,"teacher_disagreement_score":0.046988934,"about_ca_system_score_codex":0.0037012028,"about_ca_system_score_gemma":0.013499305,"threshold_uncertainty_score":0.24850422},"labels":[],"label_agreement":null},{"id":"W4402924504","doi":"10.51731/cjht.2024.991","title":"Nivolumab (Opdivo)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Medicine; Immunology; Immunotherapy; Immune system","score_opus":0.026593800618034187,"score_gpt":0.3047002063446103,"score_spread":0.27810640572657613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402924504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01921681,0.88366437,0.0021341993,0.004306081,0.0015710522,0.00039817125,0.0028320178,0.0002728182,0.08560452],"genre_scores_gemma":[0.29016244,0.6317522,0.0082795685,0.008773674,0.0009476322,0.0005498756,0.0059657567,0.000077124394,0.053491767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970335,0.00006522586,0.000024996654,0.00004179562,0.00012332566,0.00004125176],"domain_scores_gemma":[0.9998196,0.000033232114,0.000037314727,0.000008037295,0.000075255215,0.000026710597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004546575,0.0003338515,0.00036539504,0.00068339554,0.00026546407,0.0008584829,0.0003836965,0.0003924963,0.005516037],"category_scores_gemma":[0.00067936233,0.00007700058,0.0004913552,0.0005257722,0.0001964432,0.000413324,0.0003721907,0.0007506272,0.001966288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048478728,0.00007776632,0.0008709232,0.0041911453,0.00015210811,0.00013868832,0.000033361976,0.0002963205,0.004008937,0.0022484036,0.05040868,0.9370888],"study_design_scores_gemma":[0.00026773548,0.00039317706,0.0023829776,0.0021115234,0.00019109153,0.0009205988,0.00002966413,0.0001475018,0.003419585,0.0006836907,0.9894385,0.000013995982],"about_ca_topic_score_codex":0.010532554,"about_ca_topic_score_gemma":0.028856104,"teacher_disagreement_score":0.010532554,"about_ca_system_score_codex":0.0013163628,"about_ca_system_score_gemma":0.0018056261,"threshold_uncertainty_score":0.02094251},"labels":[],"label_agreement":null},{"id":"W4402924664","doi":"10.51731/cjht.2024.988","title":"Lenvatinib for the Treatment of Hepatocellular Carcinoma After Liver Transplant","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Liver transplantation; Oncology; Internal medicine; Carcinoma; Sorafenib; Transplantation","score_opus":0.03972847074739106,"score_gpt":0.27603342845020606,"score_spread":0.236304957702815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402924664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021136669,0.98327154,0.0002555995,0.009766752,0.0012379927,0.0004267075,0.0007133358,0.000019074967,0.002195343],"genre_scores_gemma":[0.027285121,0.9536768,0.0015313135,0.012729502,0.0024488717,0.0005849233,0.00071717444,0.000020258543,0.0010060521],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902023,0.0033527957,0.0041775014,0.00034906875,0.0017537229,0.00016459146],"domain_scores_gemma":[0.9423885,0.03265937,0.015379989,0.0010280546,0.008058737,0.00048538888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014709886,0.00037944407,0.0033036687,0.009082029,0.0006102081,0.0028320462,0.0012811908,0.0019666154,0.0037022172],"category_scores_gemma":[0.055967197,0.00039272872,0.003316906,0.009106638,0.0010218468,0.0033943567,0.0007895213,0.0011211524,0.0005854066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084029883,0.00004430173,0.006411073,0.5583179,0.0047110403,0.0009595969,0.0008610019,0.00012301731,0.00082435727,0.0022415447,0.054847628,0.36981827],"study_design_scores_gemma":[0.00079286855,0.0005200826,0.016350795,0.7018846,0.012992632,0.0028547572,0.0010426405,0.00012581462,0.00060220266,0.0027919277,0.25993767,0.00010400578],"about_ca_topic_score_codex":0.0044826376,"about_ca_topic_score_gemma":0.0107473275,"teacher_disagreement_score":0.014709886,"about_ca_system_score_codex":0.002793962,"about_ca_system_score_gemma":0.009903537,"threshold_uncertainty_score":0.077794254},"labels":[],"label_agreement":null},{"id":"W4402925364","doi":"10.51731/cjht.2024.989","title":"Cost-Effectiveness of Conjugate Pneumococcal Vaccines in At-Risk Adults Aged 18 to 64 Years","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Conjugate; Pneumococcal conjugate vaccine; Medicine; Pneumococcal disease; Virology; Streptococcus pneumoniae; Biology; Mathematics; Microbiology; Antibiotics","score_opus":0.03914414147732651,"score_gpt":0.33787295240153004,"score_spread":0.2987288109242035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925364","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02771694,0.9673652,0.00020981707,0.0007933092,0.0002888299,0.0003617636,0.0014171584,0.00000847835,0.0018384816],"genre_scores_gemma":[0.35263336,0.6427867,0.0010915877,0.0007859454,0.00026183992,0.00067538524,0.0013743591,0.000008051127,0.00038276293],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9930889,0.0040425197,0.0011265437,0.00031952906,0.001105139,0.00031735588],"domain_scores_gemma":[0.98837507,0.008649723,0.0017820812,0.00010951858,0.00087180827,0.00021181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008607288,0.0011788101,0.00434372,0.0040017394,0.00026553267,0.0020185392,0.0008026662,0.0014631016,0.002492857],"category_scores_gemma":[0.033071306,0.00050743966,0.008899773,0.0036730797,0.0003761223,0.0012379545,0.0007488871,0.0014828235,0.00016754998],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018927108,0.00045212227,0.018461945,0.52658737,0.13121262,0.0004897072,0.00029237123,0.0060517704,0.000466672,0.0022734646,0.006762814,0.28802204],"study_design_scores_gemma":[0.012720007,0.009266968,0.11015005,0.41469622,0.40073046,0.0017961456,0.00078887295,0.0050070155,0.0017207284,0.00461546,0.038286377,0.00022164542],"about_ca_topic_score_codex":0.0066982424,"about_ca_topic_score_gemma":0.011360632,"teacher_disagreement_score":0.008607288,"about_ca_system_score_codex":0.0035767455,"about_ca_system_score_gemma":0.0024509006,"threshold_uncertainty_score":0.045520186},"labels":[],"label_agreement":null},{"id":"W4402925909","doi":"10.51731/cjht.2024.990","title":"Etranacogene Dezaparvovec (Hemgenix)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04367960532597456,"score_gpt":0.33157483962306206,"score_spread":0.2878952342970875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010776771,0.95570576,0.00078476034,0.0024687632,0.00032733587,0.00013821413,0.0014375066,0.00006947345,0.028291492],"genre_scores_gemma":[0.11136077,0.86295944,0.0032430333,0.0029533475,0.0003734601,0.00015570449,0.0022673232,0.000025610625,0.016661255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994368,0.00014235424,0.000043675063,0.00004242403,0.00029964303,0.000034994035],"domain_scores_gemma":[0.99935704,0.00027150413,0.0001528668,0.000015512247,0.00016573971,0.000037411963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092101406,0.00016329662,0.00034401604,0.00078021694,0.0001516041,0.0006664174,0.00026303134,0.0003544409,0.0053801336],"category_scores_gemma":[0.0016563896,0.00006476892,0.00039963325,0.00077382656,0.00018372465,0.00030898635,0.00013950485,0.00049809535,0.0007143513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009274639,0.000078647514,0.0012791337,0.007995108,0.0003386385,0.00019275029,0.000041174702,0.00024055628,0.0036529158,0.0034626548,0.043059994,0.93873096],"study_design_scores_gemma":[0.0006126681,0.0008377407,0.008197424,0.0045141247,0.0006127061,0.0013553519,0.000047597678,0.00016049195,0.0034638965,0.0003961625,0.9797831,0.000018622426],"about_ca_topic_score_codex":0.013324665,"about_ca_topic_score_gemma":0.046543792,"teacher_disagreement_score":0.013324665,"about_ca_system_score_codex":0.0016148807,"about_ca_system_score_gemma":0.001653273,"threshold_uncertainty_score":0.026494265},"labels":[],"label_agreement":null},{"id":"W4402939154","doi":"10.51731/cjht.2024.993","title":"Insulin icodec (Awiqli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Medicine; Internal medicine","score_opus":0.041581416693938854,"score_gpt":0.33948135706398647,"score_spread":0.29789994037004763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402939154","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012782763,0.80914927,0.0040938477,0.0026580743,0.001660574,0.00053954334,0.003963948,0.00052451715,0.1646274],"genre_scores_gemma":[0.15652819,0.7106717,0.012961221,0.00839524,0.00072365446,0.0004568264,0.0082755415,0.00015805267,0.10182952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999268,0.000082014456,0.00004664743,0.000087045046,0.00044269604,0.00007355494],"domain_scores_gemma":[0.9995561,0.000072021816,0.00008085593,0.000017020873,0.00020707863,0.00006678472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000778911,0.00051666365,0.00047869547,0.0019051371,0.00040694146,0.0011880078,0.00065236184,0.0006313313,0.013311049],"category_scores_gemma":[0.0011264472,0.00012574153,0.00065746316,0.0016603944,0.00036114323,0.00057634857,0.00043158422,0.001257501,0.002938192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067900884,0.00011483874,0.00069080666,0.0045615076,0.000097465534,0.00017887309,0.000045945286,0.00012363159,0.004589449,0.0026278114,0.062093537,0.9241971],"study_design_scores_gemma":[0.00028416098,0.00061049085,0.0045333384,0.0032832818,0.0002242999,0.0011859473,0.000061197024,0.00015213944,0.005542118,0.00033977395,0.9837535,0.000029828238],"about_ca_topic_score_codex":0.07831669,"about_ca_topic_score_gemma":0.13071884,"teacher_disagreement_score":0.07831669,"about_ca_system_score_codex":0.002789328,"about_ca_system_score_gemma":0.003322755,"threshold_uncertainty_score":0.15572166},"labels":[],"label_agreement":null},{"id":"W4403443158","doi":"10.51731/cjht.2024.997","title":"Metreleptin (Myalepta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Malaria Research and Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.02805504402960337,"score_gpt":0.32141526167126067,"score_spread":0.2933602176416573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403443158","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01973664,0.9325896,0.0014498901,0.0026213513,0.0004574581,0.00016524356,0.0016723087,0.0001803976,0.041127097],"genre_scores_gemma":[0.34841254,0.58743006,0.006294419,0.0053919177,0.0006131981,0.0002648978,0.0028366463,0.000055081826,0.048701152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973494,0.000054402757,0.000025557,0.000030257354,0.00013106271,0.000023756427],"domain_scores_gemma":[0.99979335,0.00006727148,0.00006250963,0.000007040957,0.000043826352,0.000026037373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036209472,0.00023221187,0.00033855555,0.00057847484,0.0001342718,0.000490011,0.0002626835,0.00035259285,0.0044862335],"category_scores_gemma":[0.00075836893,0.00007330914,0.00032295487,0.00045879174,0.00017241236,0.00022737047,0.00017871312,0.00046212383,0.0012546972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012065556,0.00011582231,0.0014575409,0.005013813,0.00022863159,0.00078454847,0.0000540537,0.00032124209,0.017230876,0.0015973567,0.028194888,0.9437947],"study_design_scores_gemma":[0.0009429484,0.0023521276,0.018959526,0.0026650007,0.00036490895,0.007966742,0.00009830752,0.0002672365,0.010458961,0.0005446651,0.9553334,0.000046180157],"about_ca_topic_score_codex":0.006338465,"about_ca_topic_score_gemma":0.024508882,"teacher_disagreement_score":0.006338465,"about_ca_system_score_codex":0.0009291132,"about_ca_system_score_gemma":0.00065627025,"threshold_uncertainty_score":0.015007973},"labels":[],"label_agreement":null},{"id":"W4403489647","doi":"10.51731/cjht.2024.999","title":"CRISPR Technologies for In Vivo and Ex Vivo Gene Editing","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Ex vivo; Genome editing; Biology; In vivo; Gene; Genetics; Computational biology","score_opus":0.011123602297740065,"score_gpt":0.3030946579556271,"score_spread":0.29197105565788706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403489647","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011617718,0.14960526,0.73943835,0.016616743,0.006931173,0.00080811395,0.0031135534,0.015488504,0.056380555],"genre_scores_gemma":[0.14088194,0.2504755,0.51244956,0.012550611,0.0033370554,0.00191323,0.0059028664,0.0027028152,0.069786415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968508,0.0008173882,0.00024007597,0.00048857863,0.0013699293,0.00023327663],"domain_scores_gemma":[0.9986078,0.0005564678,0.00024126157,0.00025195727,0.00019061603,0.00015190078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022822763,0.0010165466,0.0015179436,0.0012906515,0.00058025314,0.0031400316,0.0016974516,0.0020857987,0.009308706],"category_scores_gemma":[0.0020558108,0.00097404985,0.0010173479,0.00089178246,0.0017126438,0.0021471914,0.0015586399,0.0048212926,0.0074093025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002933624,0.00020412219,0.0008228662,0.004144341,0.00020055972,0.0008275855,0.00046173827,0.0027400495,0.36446822,0.08556591,0.09560968,0.44466156],"study_design_scores_gemma":[0.00006379985,0.0003464749,0.0006291003,0.00046146216,0.00008050664,0.0026204218,0.00010095032,0.002055759,0.15027201,0.019434953,0.8238006,0.00013391994],"about_ca_topic_score_codex":0.00046511728,"about_ca_topic_score_gemma":0.00053899415,"teacher_disagreement_score":0.009308706,"about_ca_system_score_codex":0.000978398,"about_ca_system_score_gemma":0.00076522486,"threshold_uncertainty_score":0.031140685},"labels":[],"label_agreement":null},{"id":"W4403544229","doi":"10.51731/cjht.2024.998","title":"Bimekizumab (Bimzelx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.036952607970333055,"score_gpt":0.3438340482654081,"score_spread":0.306881440295075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403544229","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011238365,0.89057535,0.001766163,0.004668579,0.0013532818,0.00047543182,0.0031602597,0.00031554277,0.086447075],"genre_scores_gemma":[0.18644658,0.7057661,0.009053132,0.010561924,0.0012917848,0.000649531,0.007640343,0.000057704874,0.07853289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994475,0.00009643726,0.00004472005,0.000050260736,0.00029302726,0.00006813495],"domain_scores_gemma":[0.99970645,0.00005104919,0.000082793165,0.000009679247,0.00010162069,0.000048282414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009493971,0.00036005676,0.00044231268,0.0010574472,0.00028381002,0.0007198217,0.00050308806,0.0005245631,0.009768514],"category_scores_gemma":[0.0010425508,0.000104286,0.00050679484,0.00071364397,0.00021142,0.00038457703,0.0004131841,0.0006890528,0.002847072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061288674,0.00012674612,0.0007004952,0.0040325234,0.00012110023,0.00014449401,0.000027293157,0.00022141883,0.0034721072,0.0022315884,0.07134416,0.91696525],"study_design_scores_gemma":[0.00051763933,0.0008175802,0.0031831493,0.0017235007,0.000180935,0.0012155531,0.000028326758,0.00012106484,0.0034254566,0.00045534366,0.9883166,0.0000149142315],"about_ca_topic_score_codex":0.01040546,"about_ca_topic_score_gemma":0.027028626,"teacher_disagreement_score":0.01040546,"about_ca_system_score_codex":0.0017341552,"about_ca_system_score_gemma":0.0025013816,"threshold_uncertainty_score":0.03267896},"labels":[],"label_agreement":null},{"id":"W4403566031","doi":"10.51731/cjht.2024.1005","title":"Development of an Evaluation Instrument on Artificial Intelligence Search Tools for Evidence Synthesis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Systems engineering; Engineering","score_opus":0.56733717002908,"score_gpt":0.5086916951041844,"score_spread":0.05864547492489558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566031","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08534002,0.007830835,0.4644356,0.014031532,0.0020608369,0.3190297,0.02661948,0.008173621,0.07247844],"genre_scores_gemma":[0.069313996,0.0012744582,0.7605238,0.0014358871,0.00015329383,0.16041256,0.005152912,0.00036002276,0.001373052],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.56046706,0.26246873,0.11320897,0.0049742684,0.054775756,0.0041052275],"domain_scores_gemma":[0.2599242,0.5348212,0.042668864,0.021674324,0.13564955,0.005261911],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.38726652,0.0016748075,0.004069077,0.019773649,0.002449028,0.007849774,0.002314939,0.0021823687,0.0063753817],"category_scores_gemma":[0.55088025,0.0014214903,0.008513174,0.016961306,0.0026756858,0.008859669,0.0072705825,0.003887557,0.0022220733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063686203,0.002324274,0.05202011,0.023195375,0.003349966,0.00020156085,0.0051899264,0.009493231,0.0024064633,0.027815258,0.063233726,0.80440146],"study_design_scores_gemma":[0.016899789,0.01785131,0.272439,0.048633967,0.011394069,0.0010140608,0.010727897,0.08347107,0.03705802,0.070953496,0.4278294,0.0017278797],"about_ca_topic_score_codex":0.0039932304,"about_ca_topic_score_gemma":0.00519337,"teacher_disagreement_score":0.6127335,"about_ca_system_score_codex":0.012113114,"about_ca_system_score_gemma":0.032191627,"threshold_uncertainty_score":0.7556095},"labels":[],"label_agreement":null},{"id":"W4403566032","doi":"10.51731/cjht.2024.1004","title":"Development of an Evaluation Instrument on Artificial Intelligence Search Tools for Evidence Synthesis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Artificial intelligence","score_opus":0.56733717002908,"score_gpt":0.5086916951041844,"score_spread":0.05864547492489558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566032","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064680874,0.0066907774,0.56346303,0.014631273,0.0020572196,0.29906005,0.0068148733,0.003615062,0.038986877],"genre_scores_gemma":[0.060751643,0.0011610229,0.7620994,0.0012142679,0.00011920435,0.17263414,0.0013291461,0.00016652065,0.00052465475],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.3452986,0.42241502,0.16414541,0.0068470095,0.056912698,0.004381349],"domain_scores_gemma":[0.16079998,0.6337789,0.043367833,0.028764602,0.12911382,0.004174896],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5763092,0.0019804197,0.0047830106,0.023560155,0.0033278419,0.011856567,0.0032944807,0.0036307117,0.0055544665],"category_scores_gemma":[0.6957069,0.0018068057,0.009478489,0.019723576,0.0052960436,0.012734404,0.009880504,0.004937913,0.0020851535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043134247,0.0014872205,0.030772202,0.038803913,0.0025083232,0.0002564319,0.0123648755,0.009487154,0.0028854425,0.05821595,0.031337142,0.80756795],"study_design_scores_gemma":[0.012552189,0.016781028,0.13887925,0.09038643,0.008969918,0.0012760863,0.023274124,0.09878899,0.040302396,0.17543091,0.39069065,0.0026680592],"about_ca_topic_score_codex":0.0018189446,"about_ca_topic_score_gemma":0.0024146207,"teacher_disagreement_score":0.4236908,"about_ca_system_score_codex":0.016430581,"about_ca_system_score_gemma":0.03932135,"threshold_uncertainty_score":0.5224862},"labels":[],"label_agreement":null},{"id":"W4403687222","doi":"10.51731/cjht.2024.1006","title":"Osimertinib (Tagrisso)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Chemistry","score_opus":0.025332631547092532,"score_gpt":0.3596782912347435,"score_spread":0.33434565968765095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403687222","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11836248,0.12586983,0.0034388928,0.017930858,0.004897927,0.0015036468,0.025514765,0.004396549,0.6980851],"genre_scores_gemma":[0.43735796,0.051968616,0.0040389574,0.01937128,0.0011009392,0.0010640413,0.05344029,0.00028076174,0.43137714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979514,0.00001865866,0.000013402659,0.000029188906,0.00006146308,0.00008221556],"domain_scores_gemma":[0.9998791,0.000008576311,0.000020788262,0.000009173878,0.000030063526,0.000052357715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029390614,0.00058930315,0.00046487746,0.00052290596,0.00035734673,0.0009407533,0.000502128,0.0007935098,0.031223755],"category_scores_gemma":[0.00040331157,0.00011891083,0.00043643737,0.00048251156,0.00018312685,0.0005473079,0.0005629124,0.0012318804,0.01590881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019479448,0.0005111072,0.001670423,0.00095184316,0.00011387172,0.00045087852,0.0000557349,0.0008773596,0.00951536,0.0042185797,0.3439095,0.63577735],"study_design_scores_gemma":[0.004744263,0.0017158862,0.0046989145,0.00040488117,0.00009625855,0.0022019842,0.000047043803,0.00086523045,0.005691511,0.0019698178,0.9775344,0.000029770094],"about_ca_topic_score_codex":0.002941737,"about_ca_topic_score_gemma":0.0104955025,"teacher_disagreement_score":0.031223755,"about_ca_system_score_codex":0.0014084231,"about_ca_system_score_gemma":0.0012663184,"threshold_uncertainty_score":0.1044538},"labels":[],"label_agreement":null},{"id":"W4403687451","doi":"10.51731/cjht.2024.1007","title":"Abemaciclib (Verzenio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02564525981457516,"score_gpt":0.3288999898054583,"score_spread":0.30325472999088315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403687451","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.081680804,0.12611325,0.004272572,0.012747578,0.0034523148,0.0020960825,0.011131282,0.0042000627,0.754306],"genre_scores_gemma":[0.46135288,0.076853596,0.008059598,0.01883021,0.00086959696,0.00084375066,0.017480195,0.0004446408,0.41526553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997888,0.00002541325,0.000011687158,0.000041804455,0.0000859975,0.000046248784],"domain_scores_gemma":[0.9998399,0.000014830949,0.000021549022,0.000013767364,0.000039990286,0.000069828886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023882299,0.0004261575,0.00062739133,0.0010718257,0.00054759224,0.0010313012,0.00073602196,0.0007926834,0.054444127],"category_scores_gemma":[0.00048568792,0.00019484694,0.00043086562,0.00061316503,0.0004062395,0.0005254436,0.00050775806,0.0020194482,0.014735764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049980017,0.0011557813,0.0008065181,0.0014440387,0.000097871605,0.00075267866,0.00006523324,0.0003497521,0.018809108,0.0056484393,0.18109864,0.7847739],"study_design_scores_gemma":[0.0064101275,0.0025759991,0.00574505,0.00059542444,0.00012255709,0.0032521288,0.000064499705,0.0006874367,0.00930168,0.0015973136,0.9695879,0.000059729788],"about_ca_topic_score_codex":0.015512232,"about_ca_topic_score_gemma":0.03977944,"teacher_disagreement_score":0.054444127,"about_ca_system_score_codex":0.0013644802,"about_ca_system_score_gemma":0.0022749244,"threshold_uncertainty_score":0.1821338},"labels":[],"label_agreement":null},{"id":"W4403732382","doi":"10.51731/cjht.2024.1009","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.028657323898609394,"score_gpt":0.3193534515525259,"score_spread":0.2906961276539165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403732382","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09640248,0.36090443,0.006801111,0.039448686,0.004269454,0.0013775724,0.0083346125,0.0022489906,0.4802127],"genre_scores_gemma":[0.59346837,0.123928115,0.012179769,0.022337712,0.0012701846,0.0007265492,0.009559094,0.00014069199,0.23638953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998074,0.0000195239,0.000012454322,0.000032618736,0.000076736804,0.000051345945],"domain_scores_gemma":[0.99982953,0.000020638547,0.000026266098,0.0000098487435,0.000047542482,0.00006612868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028347876,0.000217397,0.00030565972,0.00044385096,0.00041316624,0.00063695293,0.00043387382,0.00053581706,0.016224617],"category_scores_gemma":[0.0005396324,0.00010020379,0.0003108641,0.00030984447,0.00016992763,0.00044012562,0.00034521255,0.0016021829,0.0045930482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013838639,0.00034059104,0.0016228745,0.0008473637,0.00008468479,0.00071077805,0.000048874474,0.00027192925,0.012016065,0.0030289416,0.15925762,0.82038635],"study_design_scores_gemma":[0.001840963,0.0009575867,0.008043033,0.00047590648,0.00010839165,0.0029443162,0.000037141992,0.00033216338,0.0050000083,0.00082585745,0.9794128,0.000021883847],"about_ca_topic_score_codex":0.013899353,"about_ca_topic_score_gemma":0.03434272,"teacher_disagreement_score":0.016224617,"about_ca_system_score_codex":0.0015017412,"about_ca_system_score_gemma":0.0015412911,"threshold_uncertainty_score":0.054276764},"labels":[],"label_agreement":null},{"id":"W4403850901","doi":"10.51731/cjht.2024.1012","title":"Relugolix (Orgovyx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.038491625551458554,"score_gpt":0.3554205771460136,"score_spread":0.31692895159455503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403850901","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012211919,0.93534815,0.0006426091,0.0028116908,0.0004010748,0.00020417977,0.0024456435,0.00016133797,0.04577346],"genre_scores_gemma":[0.15679309,0.797196,0.0033324962,0.0051328577,0.0004541737,0.00020746603,0.0044185338,0.000054827316,0.032410618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996909,0.00006134588,0.00002545646,0.000032385757,0.00015493408,0.00003491938],"domain_scores_gemma":[0.9997421,0.000061847764,0.00008647928,0.000006438879,0.00006631526,0.000036830745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110584,0.00026840094,0.00041492007,0.000836478,0.00018665152,0.0007186863,0.00031656242,0.0003280603,0.007731246],"category_scores_gemma":[0.00078420097,0.00007786762,0.00048269282,0.00077167037,0.00021846691,0.0003358417,0.00025883107,0.00070758467,0.0013014445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011254478,0.000095070034,0.0008849623,0.008696953,0.00022666476,0.00023743664,0.00004803518,0.00020003323,0.0043422976,0.002748968,0.06295812,0.91843605],"study_design_scores_gemma":[0.0009108283,0.001274763,0.0077596544,0.0035408768,0.00045408818,0.0018419129,0.00006869521,0.000109884306,0.002643453,0.00041054483,0.98095924,0.00002613286],"about_ca_topic_score_codex":0.018129282,"about_ca_topic_score_gemma":0.06400943,"teacher_disagreement_score":0.018129282,"about_ca_system_score_codex":0.0012162878,"about_ca_system_score_gemma":0.0017466738,"threshold_uncertainty_score":0.03604752},"labels":[],"label_agreement":null},{"id":"W4403896352","doi":"10.51731/cjht.2024.1014","title":"Review of Guidelines on Bupropion for Depression","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Network for Mood and Anxiety Treatments","keywords":"Bupropion; Depression (economics); Medicine; Psychiatry; Psychology; Smoking cessation; Economics","score_opus":0.09958524636766677,"score_gpt":0.4229304188080985,"score_spread":0.3233451724404317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403896352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014923791,0.9870293,0.00046636586,0.006890932,0.001839765,0.00039667243,0.0005473391,0.000034174274,0.0026462402],"genre_scores_gemma":[0.0014466398,0.98703426,0.002738623,0.006262272,0.0006327391,0.0006109904,0.0005969484,0.000019492953,0.0006580271],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838562,0.004904358,0.007026409,0.0006190382,0.0032186182,0.00037533906],"domain_scores_gemma":[0.9518567,0.026544875,0.0079498775,0.0006783313,0.012230376,0.00073987036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013034193,0.0016286279,0.005207515,0.013764637,0.0010622091,0.0034047975,0.004962419,0.004922863,0.011442639],"category_scores_gemma":[0.063636385,0.0013812924,0.006355055,0.011456079,0.001278624,0.0036433444,0.002361809,0.003853604,0.0029637262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010966063,0.000038307986,0.00032689137,0.59709203,0.0012361052,0.00025326395,0.00040906217,0.0002446611,0.00024084798,0.002730394,0.094741955,0.3025768],"study_design_scores_gemma":[0.000092935945,0.000050306597,0.0006090876,0.7386353,0.002681164,0.00023582803,0.0001204525,0.00004796303,0.00010375034,0.0012694374,0.25612238,0.00003147233],"about_ca_topic_score_codex":0.012792,"about_ca_topic_score_gemma":0.02999421,"teacher_disagreement_score":0.013764637,"about_ca_system_score_codex":0.0056113084,"about_ca_system_score_gemma":0.017558202,"threshold_uncertainty_score":0.068932235},"labels":[],"label_agreement":null},{"id":"W4403896689","doi":"10.51731/cjht.2024.1013","title":"Burosumab (Crysvita)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03131719817347778,"score_gpt":0.29654389724201785,"score_spread":0.2652266990685401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403896689","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04826747,0.22082241,0.009517416,0.027935274,0.006639566,0.0026849576,0.017100664,0.010220523,0.6568118],"genre_scores_gemma":[0.2591606,0.07192452,0.016304724,0.02948123,0.0013790915,0.0012702855,0.033196907,0.0014624975,0.5858201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990958,0.00011320426,0.00004672527,0.00014260456,0.0004191921,0.0001824255],"domain_scores_gemma":[0.99925536,0.00009761223,0.000080068436,0.00004137437,0.00020630995,0.00031927042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096721906,0.0009616265,0.0008618725,0.00147544,0.00083228527,0.0014784139,0.00130935,0.0017980369,0.117930956],"category_scores_gemma":[0.0019309381,0.00046854105,0.00053670566,0.00050051877,0.00056865637,0.00075143774,0.001483245,0.0031247446,0.041857954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001953581,0.00067800534,0.0021060146,0.0014060325,0.000083668005,0.0022911504,0.000136723,0.0006706747,0.013477312,0.0051865876,0.44226706,0.5297433],"study_design_scores_gemma":[0.001679856,0.0008454809,0.0025015736,0.0006852517,0.00006252621,0.0037941851,0.00008320479,0.00046333123,0.0030485054,0.0013718406,0.9854409,0.00002335329],"about_ca_topic_score_codex":0.011785987,"about_ca_topic_score_gemma":0.019800438,"teacher_disagreement_score":0.117930956,"about_ca_system_score_codex":0.0016485206,"about_ca_system_score_gemma":0.0038158458,"threshold_uncertainty_score":0.39451832},"labels":[],"label_agreement":null},{"id":"W4403966203","doi":"10.51731/cjht.2024.1015","title":"Epcoritamab (Epkinly)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03514424862429699,"score_gpt":0.3569083070650617,"score_spread":0.3217640584407647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966203","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0282546,0.889278,0.0018437145,0.0025388554,0.0005591979,0.00028143387,0.002020188,0.00018671065,0.07503739],"genre_scores_gemma":[0.31659213,0.61904085,0.004984432,0.0049291765,0.00045433154,0.0003943764,0.0035334975,0.000050468814,0.05002072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997781,0.00004712925,0.000018587922,0.000027551087,0.000105329855,0.000023340239],"domain_scores_gemma":[0.99982506,0.00004664669,0.00004879523,0.000006592994,0.00004976314,0.000023123675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038992192,0.0002644604,0.00026631253,0.0006627,0.00013862833,0.0005308666,0.00022958725,0.0002752408,0.004865766],"category_scores_gemma":[0.00059002393,0.00006887707,0.00034700622,0.00057171116,0.00015038892,0.00034665424,0.00020933211,0.00059914653,0.001174679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005940317,0.000059205504,0.00057901227,0.0027681398,0.0001392554,0.00022338808,0.000020277344,0.00023365147,0.0059445165,0.0012602917,0.022105554,0.9660727],"study_design_scores_gemma":[0.0010482344,0.001223371,0.008506406,0.0027041724,0.00044448025,0.0033714601,0.000042848325,0.00022901081,0.009419726,0.0008182864,0.972169,0.000022878714],"about_ca_topic_score_codex":0.0043546367,"about_ca_topic_score_gemma":0.013624957,"teacher_disagreement_score":0.004865766,"about_ca_system_score_codex":0.0010558004,"about_ca_system_score_gemma":0.0009700935,"threshold_uncertainty_score":0.016277611},"labels":[],"label_agreement":null},{"id":"W4404070843","doi":"10.51731/cjht.2024.1016","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Computer science; Internal medicine; Cystic fibrosis","score_opus":0.023704979657390646,"score_gpt":0.33266858670483407,"score_spread":0.3089636070474434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404070843","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09381473,0.117645055,0.018421378,0.10317682,0.0059220814,0.0017631158,0.008433483,0.0040623536,0.64676106],"genre_scores_gemma":[0.37550646,0.058869876,0.037250575,0.02885363,0.0015786905,0.00042025466,0.0052393517,0.00040835136,0.4918728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994293,0.00006690233,0.00004475657,0.000049883627,0.00031471008,0.00009441933],"domain_scores_gemma":[0.9989643,0.0001800725,0.0001855887,0.000058427537,0.00032267813,0.00028897607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075796765,0.00018816163,0.00030927162,0.00068384834,0.00059025,0.0008677648,0.00042044997,0.00083776785,0.02497971],"category_scores_gemma":[0.0024899915,0.000103610975,0.00040147605,0.00039591454,0.000533975,0.00024198675,0.0003465011,0.0011863586,0.0061391424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010075432,0.00026443895,0.0068266885,0.00037183077,0.000060359842,0.0010724547,0.0000809405,0.00019486142,0.01253279,0.0055352664,0.23922034,0.73283255],"study_design_scores_gemma":[0.00042630942,0.00047216332,0.016506877,0.00034660066,0.00004320932,0.0026701167,0.000071189934,0.00026294586,0.004369734,0.00066836935,0.97414035,0.00002207918],"about_ca_topic_score_codex":0.060376372,"about_ca_topic_score_gemma":0.15237285,"teacher_disagreement_score":0.060376372,"about_ca_system_score_codex":0.0017433638,"about_ca_system_score_gemma":0.0051360526,"threshold_uncertainty_score":0.120049894},"labels":[],"label_agreement":null},{"id":"W4404110461","doi":"10.51731/cjht.2024.1018","title":"Danicopan (Voydeya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chemical synthesis and alkaloids","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.019192173322738544,"score_gpt":0.2563885265742544,"score_spread":0.2371963532515159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404110461","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03991284,0.09350748,0.008757359,0.009032556,0.0037532938,0.0013275933,0.011853039,0.0058928514,0.8259631],"genre_scores_gemma":[0.23144656,0.047470726,0.013104511,0.006302734,0.00047163802,0.00046411942,0.011626696,0.0008515253,0.6882615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975914,0.000018439738,0.000007914851,0.000059408794,0.00010779592,0.000047441306],"domain_scores_gemma":[0.999785,0.000012896458,0.0000216029,0.000017790646,0.00006495333,0.00009779866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028762937,0.0005971743,0.00043683566,0.0014119416,0.00085259875,0.00077903084,0.00075049273,0.0006895718,0.091875106],"category_scores_gemma":[0.0004337216,0.0002464602,0.00041536923,0.0004664115,0.00040142363,0.00042932323,0.000852684,0.0014176522,0.02217488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001056267,0.00045196904,0.0011235024,0.0017372583,0.0000757673,0.00075961417,0.00011694961,0.00042604827,0.048033196,0.014520083,0.32234702,0.60935235],"study_design_scores_gemma":[0.00024690243,0.00030049158,0.0012242116,0.00016373943,0.000024275754,0.0008619744,0.000028491118,0.00020357675,0.008343002,0.0006755018,0.9879138,0.000014088357],"about_ca_topic_score_codex":0.018712012,"about_ca_topic_score_gemma":0.040541973,"teacher_disagreement_score":0.091875106,"about_ca_system_score_codex":0.0016105581,"about_ca_system_score_gemma":0.0025854215,"threshold_uncertainty_score":0.30735284},"labels":[],"label_agreement":null},{"id":"W4404122679","doi":"10.51731/cjht.2024.1021","title":"Sotatercept (Winrevair)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04567324693324143,"score_gpt":0.33956812718622065,"score_spread":0.2938948802529792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404122679","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1752442,0.17616346,0.011975777,0.026608491,0.009304047,0.0038335938,0.031301055,0.011189716,0.55437976],"genre_scores_gemma":[0.6342056,0.049023774,0.012966881,0.022048742,0.0021073567,0.0018132338,0.035970353,0.0006132491,0.24125077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944705,0.00007079817,0.00004073211,0.000096873126,0.0002317633,0.000112793205],"domain_scores_gemma":[0.99964786,0.000034415596,0.00006316223,0.000032226013,0.00009291201,0.00012935081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727185,0.00049296714,0.00074154825,0.0010506616,0.00045768902,0.0011002938,0.00084484206,0.0010965252,0.038267385],"category_scores_gemma":[0.00082410866,0.0002193222,0.0005813606,0.0005893453,0.0002662181,0.00083173823,0.0005398793,0.002020369,0.019335689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006377037,0.0015426339,0.0017918022,0.0012607625,0.00023544182,0.0005092544,0.00006967789,0.0006689974,0.020209247,0.004080774,0.37027305,0.59298134],"study_design_scores_gemma":[0.01083274,0.00413377,0.0068008685,0.00046601743,0.00030598522,0.0050388305,0.00005211881,0.0015809846,0.015036422,0.0023136958,0.953364,0.00007450781],"about_ca_topic_score_codex":0.003056971,"about_ca_topic_score_gemma":0.00673606,"teacher_disagreement_score":0.038267385,"about_ca_system_score_codex":0.0010409679,"about_ca_system_score_gemma":0.001521657,"threshold_uncertainty_score":0.12801713},"labels":[],"label_agreement":null},{"id":"W4404141856","doi":"10.51731/cjht.2024.1020","title":"Eplontersen (Wainua)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01707836537499913,"score_gpt":0.2876893261619645,"score_spread":0.2706109607869654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404141856","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01020681,0.06503356,0.0024172068,0.017477922,0.0032890707,0.0004665081,0.015391612,0.0032737681,0.88244355],"genre_scores_gemma":[0.034093287,0.018632872,0.0032188268,0.004475245,0.00029386353,0.00014338725,0.007483058,0.00048734996,0.9311721],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917066,0.00007318032,0.000036194873,0.0001831045,0.00038670393,0.00015010028],"domain_scores_gemma":[0.99878675,0.0001418927,0.00007868733,0.000083358274,0.00042892084,0.00048039923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008246023,0.0008548187,0.0005939903,0.0014028236,0.0011113865,0.0019458409,0.0011790196,0.0016406095,0.36995387],"category_scores_gemma":[0.0022292484,0.0003234954,0.0005077152,0.0007740359,0.000642672,0.00090218574,0.0013104434,0.0016288745,0.09118981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007971857,0.00019594157,0.0017102817,0.00071732036,0.00004836672,0.0011792353,0.00012790368,0.00017924649,0.0023037894,0.0073100417,0.5159996,0.46943107],"study_design_scores_gemma":[0.000118026044,0.000109981214,0.0020963817,0.00026588832,0.000017892935,0.0006371848,0.000049143553,0.00008982887,0.000613211,0.00068106817,0.99531144,0.000009979702],"about_ca_topic_score_codex":0.07550261,"about_ca_topic_score_gemma":0.14526233,"teacher_disagreement_score":0.36995387,"about_ca_system_score_codex":0.0026811042,"about_ca_system_score_gemma":0.00773387,"threshold_uncertainty_score":0.8986843},"labels":[],"label_agreement":null},{"id":"W4404163529","doi":"10.51731/cjht.2024.1022","title":"Aflibercept 8 mg/0.07 mL (Eylea HD)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Medicine; Internal medicine","score_opus":0.03733900008348816,"score_gpt":0.3430989103266301,"score_spread":0.3057599102431419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404163529","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027189316,0.90625256,0.0016253015,0.0021222008,0.00037856936,0.00027454048,0.0013768901,0.00018686216,0.060593713],"genre_scores_gemma":[0.31408536,0.62248284,0.00815244,0.004040946,0.00040055698,0.0002907764,0.0022690557,0.000060337057,0.048217677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966776,0.00007259009,0.00002716584,0.000034359706,0.00016242154,0.000035745314],"domain_scores_gemma":[0.9997762,0.00006741412,0.00006674931,0.0000053448434,0.000062029445,0.000022311848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006132401,0.00022506608,0.00035539866,0.00084205315,0.00017220681,0.000633653,0.00030006887,0.00045373404,0.006758875],"category_scores_gemma":[0.0006157359,0.00007225482,0.00033076957,0.00058650563,0.00023483782,0.00037275636,0.00015522906,0.00053511886,0.001531673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009770623,0.00013240325,0.00046725085,0.004748686,0.00008832121,0.00017005503,0.00004115681,0.000098844524,0.0148974415,0.0010705877,0.021562692,0.9557455],"study_design_scores_gemma":[0.0011998067,0.0031467283,0.010323542,0.00431728,0.00042973753,0.0029654845,0.0001251876,0.00021456518,0.012627461,0.0004961589,0.96412015,0.000033959735],"about_ca_topic_score_codex":0.011056847,"about_ca_topic_score_gemma":0.044289593,"teacher_disagreement_score":0.011056847,"about_ca_system_score_codex":0.0009922785,"about_ca_system_score_gemma":0.0010504724,"threshold_uncertainty_score":0.022610664},"labels":[],"label_agreement":null},{"id":"W4404186508","doi":"10.51731/cjht.2024.1023","title":"Elranatamab (Elrexfio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02548443029172805,"score_gpt":0.3087367537867053,"score_spread":0.28325232349497725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404186508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011275518,0.91019773,0.0013942979,0.0029079416,0.00033096166,0.0001976741,0.0015372364,0.0001828497,0.07197573],"genre_scores_gemma":[0.1843294,0.73920006,0.00568076,0.0066089984,0.00055834494,0.00026748786,0.003588682,0.000045096924,0.059721094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963474,0.00007172273,0.00002552168,0.000040480663,0.0001866018,0.00004092254],"domain_scores_gemma":[0.99973327,0.000064518565,0.0000828536,0.000008470068,0.0000812382,0.000029667968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006328944,0.00026283832,0.00031901314,0.00089644163,0.00019521348,0.0006791736,0.0003536056,0.00032763084,0.006048195],"category_scores_gemma":[0.000772737,0.00008704544,0.00037544183,0.00073044415,0.00020479082,0.00037467416,0.00022168086,0.00057055545,0.0018379966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043489292,0.00005174635,0.0006113725,0.0024252264,0.00009724645,0.00014646602,0.000024624103,0.00016462969,0.0038848922,0.0016820276,0.028739309,0.9617376],"study_design_scores_gemma":[0.00042442323,0.00051698775,0.004713535,0.0015421618,0.00022192446,0.001568591,0.000025626026,0.00012389662,0.004118945,0.0004056792,0.98632264,0.000015622758],"about_ca_topic_score_codex":0.010697047,"about_ca_topic_score_gemma":0.037243437,"teacher_disagreement_score":0.010697047,"about_ca_system_score_codex":0.0016703018,"about_ca_system_score_gemma":0.0015133151,"threshold_uncertainty_score":0.02126956},"labels":[],"label_agreement":null},{"id":"W4404205526","doi":"10.51731/cjht.2024.1024","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Computer science; Medicine; Internal medicine; Cancer","score_opus":0.028657323898609394,"score_gpt":0.3193534515525259,"score_spread":0.2906961276539165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404205526","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011549955,0.948543,0.0008639583,0.0026529701,0.00039544638,0.00019079365,0.001275464,0.000098832556,0.034429565],"genre_scores_gemma":[0.22377126,0.7401994,0.00455749,0.0040825247,0.00039738097,0.00025849242,0.0023645728,0.000022686401,0.024346214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967647,0.0000696283,0.000035127094,0.000044524895,0.00013738786,0.00003688351],"domain_scores_gemma":[0.9996747,0.00007210644,0.00010382654,0.000010462395,0.00010618123,0.000032842756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065042276,0.0002055622,0.00030176123,0.00077896996,0.00018670011,0.0006537984,0.00025519298,0.00030736192,0.004441239],"category_scores_gemma":[0.0011384235,0.000079526435,0.00035789426,0.0006724304,0.00015105678,0.00042437922,0.00022439283,0.00055448676,0.0009525569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059959944,0.00005074689,0.0010386448,0.0040056123,0.00019391018,0.00012462342,0.000025079762,0.00014353015,0.0031165588,0.0014006984,0.02781454,0.96148646],"study_design_scores_gemma":[0.00059227913,0.00089324516,0.010587185,0.0043207454,0.0005854203,0.0018559666,0.00004746177,0.00016345813,0.00502288,0.00064765516,0.9752652,0.000018633968],"about_ca_topic_score_codex":0.008927638,"about_ca_topic_score_gemma":0.032829043,"teacher_disagreement_score":0.008927638,"about_ca_system_score_codex":0.0013665283,"about_ca_system_score_gemma":0.0011573789,"threshold_uncertainty_score":0.017751336},"labels":[],"label_agreement":null},{"id":"W4404393548","doi":"10.51731/cjht.2024.1025","title":"Overview of Systematic Reviews of ICIs in NSCLC With EGFR, ALK, ROS1, and RET Actionable Driver Mutations","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"ROS1; Medicine; Cancer research; Oncology; Internal medicine; Cancer; Adenocarcinoma","score_opus":0.07018628142857407,"score_gpt":0.38070954589236666,"score_spread":0.3105232644637926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404393548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011038323,0.9958116,0.00030380485,0.0003825701,0.00021146788,0.00067099585,0.001048529,0.000026637896,0.0004407058],"genre_scores_gemma":[0.013192211,0.98219395,0.0011942404,0.0009471726,0.00012421767,0.0014931002,0.0006118506,0.00001745477,0.0002258198],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9894811,0.0036022048,0.0043846234,0.00078764,0.0014370169,0.00030741203],"domain_scores_gemma":[0.96821994,0.022062425,0.005874659,0.00043895136,0.003088266,0.000315758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011195717,0.002272041,0.010220735,0.011326488,0.00063101307,0.002699697,0.002029983,0.0018623936,0.0049148365],"category_scores_gemma":[0.046995327,0.0014013542,0.01040013,0.009887448,0.00084995927,0.0023009595,0.0017701852,0.001417821,0.00048360284],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019702378,0.000008161012,0.00023655663,0.97567356,0.009218081,0.000045515004,0.00009278757,0.000074892705,0.00015268264,0.0001452409,0.0011599393,0.012995612],"study_design_scores_gemma":[0.0003075595,0.00021166567,0.0021083837,0.8577904,0.11902687,0.00024164312,0.0001420567,0.00008329916,0.00024991404,0.0003423137,0.019461736,0.000034033215],"about_ca_topic_score_codex":0.010363735,"about_ca_topic_score_gemma":0.026369685,"teacher_disagreement_score":0.011326488,"about_ca_system_score_codex":0.0048162984,"about_ca_system_score_gemma":0.01163034,"threshold_uncertainty_score":0.059209347},"labels":[],"label_agreement":null},{"id":"W4404435811","doi":"10.51731/cjht.2024.1026","title":"Lebrikizumab (Ebglyss)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.026680093527297718,"score_gpt":0.3047469040962092,"score_spread":0.27806681056891147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404435811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07291321,0.5730033,0.0040827333,0.05363894,0.0055162623,0.002408041,0.016643435,0.0013041169,0.27048996],"genre_scores_gemma":[0.61765873,0.1934621,0.010712023,0.037378374,0.0022733142,0.0008607114,0.01656032,0.00011220816,0.12098218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991867,0.00016837129,0.000062690015,0.00008720189,0.0003589589,0.00013610258],"domain_scores_gemma":[0.9989373,0.00017710357,0.00016848683,0.000040786494,0.00042482206,0.00025149848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016510331,0.00035375578,0.0004955889,0.0009891344,0.00058266975,0.0008710253,0.00053288206,0.0010296352,0.0137239015],"category_scores_gemma":[0.0019662357,0.000105324376,0.0007502518,0.00044380676,0.00047222828,0.0004038192,0.00064445415,0.0014544064,0.0022096953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036625762,0.00035755496,0.004163926,0.004130498,0.00023646421,0.0005014022,0.00010790611,0.00030721712,0.0053040283,0.0041436045,0.140822,0.8362629],"study_design_scores_gemma":[0.0051375283,0.002683135,0.0130462805,0.0029430797,0.00039603765,0.0012225064,0.000114940376,0.00026767878,0.0047933427,0.0009913296,0.9683707,0.00003336115],"about_ca_topic_score_codex":0.06493705,"about_ca_topic_score_gemma":0.13631955,"teacher_disagreement_score":0.06493705,"about_ca_system_score_codex":0.003551932,"about_ca_system_score_gemma":0.006532042,"threshold_uncertainty_score":0.12911814},"labels":[],"label_agreement":null},{"id":"W4404494745","doi":"10.51731/cjht.2024.1027","title":"Alectinib (Alecensaro)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alectinib; Medicine; Internal medicine","score_opus":0.03220771378287877,"score_gpt":0.31660962255069,"score_spread":0.2844019087678112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404494745","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10183014,0.36914128,0.0087977415,0.029911136,0.00409969,0.0020649552,0.022160497,0.006930292,0.4550642],"genre_scores_gemma":[0.5939491,0.11725081,0.00928075,0.017334023,0.0015123802,0.0013234839,0.03360813,0.00024475326,0.22549656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979,0.000023508106,0.00001516974,0.000033634682,0.00007855033,0.000059146958],"domain_scores_gemma":[0.9998816,0.000009169648,0.00002495295,0.000008998306,0.00002688456,0.00004840167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024103529,0.0004954587,0.00053509127,0.0007428104,0.0003727052,0.0008684824,0.00057568727,0.0007481588,0.017783204],"category_scores_gemma":[0.00047602877,0.0001238045,0.0005088297,0.00050873373,0.00020175453,0.00039425152,0.00053672894,0.0015034942,0.012211669],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039633466,0.00082773645,0.002462775,0.0016009222,0.00025439644,0.0008666715,0.000051569008,0.0010520327,0.019089898,0.0052706185,0.3304195,0.6341404],"study_design_scores_gemma":[0.0039298874,0.0015037397,0.004478508,0.0004332274,0.00015418122,0.0037060233,0.000021234693,0.0006455356,0.010065545,0.0013179302,0.97370636,0.00003776745],"about_ca_topic_score_codex":0.0031910338,"about_ca_topic_score_gemma":0.007029264,"teacher_disagreement_score":0.9988763,"about_ca_system_score_codex":0.0011237288,"about_ca_system_score_gemma":0.0012752443,"threshold_uncertainty_score":0.05949074},"labels":[],"label_agreement":null},{"id":"W4404564780","doi":"10.51731/cjht.2024.1028","title":"Avapritinib (Ayvakyt)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systemic mastocytosis; Medicine; Cutaneous Mastocytosis; Internal medicine; Oncology; Bone marrow","score_opus":0.01671379464688355,"score_gpt":0.24949761866987108,"score_spread":0.23278382402298753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564780","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24243352,0.33013916,0.008830779,0.02615576,0.0047423434,0.0019419849,0.015046883,0.006813063,0.36389658],"genre_scores_gemma":[0.80355716,0.049734216,0.0062725563,0.008539776,0.0008579232,0.0006992155,0.019504689,0.00020099225,0.11063336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976,0.000030202875,0.000015752408,0.000054909415,0.00008064029,0.000058453108],"domain_scores_gemma":[0.99984574,0.0000161066,0.000024476742,0.000009740531,0.000033946664,0.00006993839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387599,0.0003718873,0.0007317366,0.0006366377,0.00038036396,0.0007345512,0.00051181106,0.0009169504,0.014994895],"category_scores_gemma":[0.00038935343,0.00013203883,0.0005789663,0.00034576096,0.00023308986,0.0004386835,0.00045849686,0.0015884951,0.006652059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036024249,0.0008137343,0.003101601,0.0018093359,0.00025227337,0.0013443195,0.00007629646,0.0013310764,0.034951556,0.0035739543,0.19512074,0.7540228],"study_design_scores_gemma":[0.009247037,0.0057492065,0.016655408,0.0004794614,0.00024613825,0.01412411,0.0000825674,0.0024292758,0.023650141,0.0022231662,0.9250244,0.000089070934],"about_ca_topic_score_codex":0.0040192395,"about_ca_topic_score_gemma":0.010513082,"teacher_disagreement_score":0.014994895,"about_ca_system_score_codex":0.0012429298,"about_ca_system_score_gemma":0.0010257179,"threshold_uncertainty_score":0.05016291},"labels":[],"label_agreement":null},{"id":"W4404564918","doi":"10.51731/cjht.2024.1029","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenalidomide; Medicine; Chimeric antigen receptor; Drug; Refractory (planetary science); Multiple myeloma; Disease; Thalidomide; Internal medicine; Oncology; Intensive care medicine; Pharmacology; Immunotherapy; Cancer","score_opus":0.05463637822091671,"score_gpt":0.35592399706672717,"score_spread":0.30128761884581046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564918","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23799032,0.2779853,0.014241963,0.027405253,0.008126028,0.002843891,0.015135355,0.013249358,0.40302256],"genre_scores_gemma":[0.67380327,0.04675014,0.010816937,0.0147055425,0.0014609781,0.00091557164,0.023398722,0.0008035644,0.2273452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964094,0.000033667435,0.00002217067,0.000058642345,0.00014872348,0.000095882264],"domain_scores_gemma":[0.9996612,0.000037149897,0.000047911868,0.000023938976,0.00006312574,0.00016663216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040589538,0.00036904955,0.00071085594,0.00088725187,0.00041262066,0.0012537105,0.00055272965,0.00082613167,0.025748571],"category_scores_gemma":[0.0007027351,0.00014480452,0.0005225034,0.0005450394,0.00030852275,0.0005389207,0.0007168725,0.002127723,0.010192695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044600465,0.0007968039,0.0030223087,0.0009673725,0.00013199379,0.001325624,0.00008232513,0.0005301689,0.03223934,0.0047937375,0.18623829,0.7654121],"study_design_scores_gemma":[0.005308352,0.002630637,0.008050106,0.00027897017,0.00013009767,0.0051459707,0.000041694093,0.0010911837,0.01636216,0.0009305175,0.9599905,0.000039732873],"about_ca_topic_score_codex":0.0065367627,"about_ca_topic_score_gemma":0.012763808,"teacher_disagreement_score":0.025748571,"about_ca_system_score_codex":0.0015493887,"about_ca_system_score_gemma":0.0022705,"threshold_uncertainty_score":0.08613759},"labels":[],"label_agreement":null},{"id":"W4404639239","doi":"10.51731/cjht.2024.1030","title":"Aflibercept (Eylea HD)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Reimbursement; Diabetic macular edema; Medicine; Drug; Family medicine; Optometry; Intensive care medicine; Political science; Pharmacology; Surgery; Diabetic retinopathy; Diabetes mellitus; Health care","score_opus":0.025289213416362345,"score_gpt":0.3209214808373789,"score_spread":0.29563226742101656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404639239","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012890509,0.9049459,0.0010596715,0.0018626304,0.00035012641,0.00014413324,0.0013458466,0.00015574119,0.07724542],"genre_scores_gemma":[0.20685837,0.7044873,0.004711974,0.0053856894,0.0003905013,0.00016505343,0.0033739104,0.000043573313,0.074583665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971956,0.000040158357,0.00002187983,0.000035196816,0.00014456714,0.000038591974],"domain_scores_gemma":[0.9997855,0.00004555515,0.00005234043,0.0000051034945,0.000084087085,0.00002739166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047137475,0.00035990647,0.0003379994,0.0011623235,0.00027224622,0.0007884379,0.00034979905,0.00046176562,0.008324088],"category_scores_gemma":[0.0005673862,0.0000784732,0.0003157453,0.00084875745,0.00021710432,0.00041813846,0.00018960999,0.00061229663,0.0023184172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004415253,0.000087763874,0.000451695,0.0029846164,0.00006672682,0.00021190596,0.000035166253,0.00011585705,0.008419139,0.0009987026,0.028357107,0.9578298],"study_design_scores_gemma":[0.00039455813,0.00077123044,0.0063206404,0.0022930745,0.00020391769,0.0028843207,0.00006186308,0.00010629697,0.0072479597,0.00030018445,0.97939384,0.0000220358],"about_ca_topic_score_codex":0.028866835,"about_ca_topic_score_gemma":0.08731098,"teacher_disagreement_score":0.028866835,"about_ca_system_score_codex":0.0015412391,"about_ca_system_score_gemma":0.0014245271,"threshold_uncertainty_score":0.057397604},"labels":[],"label_agreement":null},{"id":"W4404639336","doi":"10.51731/cjht.2024.1031","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Gemcitabine; Drug; Vial; Audit; Family medicine; Chemotherapy; Medical physics; Internal medicine; Business; Pharmacology; Accounting; Cancer; Political science; Health care; Immunotherapy","score_opus":0.0493223292658819,"score_gpt":0.3740354626978171,"score_spread":0.3247131334319352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404639336","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0107726725,0.92846954,0.0013329631,0.0043756682,0.0008919049,0.00024812933,0.0016823667,0.00019527411,0.05203143],"genre_scores_gemma":[0.16938907,0.7711262,0.0053293398,0.005182678,0.0005269303,0.0002981708,0.0025479677,0.000037114416,0.045562495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999783,0.000040580562,0.000023325047,0.0000347689,0.00008756453,0.00003077432],"domain_scores_gemma":[0.9998066,0.000042974774,0.00005208897,0.000008611552,0.00006358326,0.00002622267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048122343,0.0002314228,0.00032870928,0.00073530123,0.00024312946,0.00075056887,0.00029556965,0.0003775087,0.008291857],"category_scores_gemma":[0.0008545483,0.00008124382,0.00037337857,0.00060444657,0.00015751734,0.00053379615,0.00029746402,0.00080182037,0.002131666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005076572,0.00006113189,0.00046511705,0.0033832195,0.00011106565,0.0001609516,0.00002877116,0.00013200926,0.0036122277,0.0016807648,0.03703007,0.9528269],"study_design_scores_gemma":[0.00045680415,0.0005442636,0.0037795096,0.0026594324,0.00030298406,0.0013828458,0.000039565086,0.00010241733,0.0044621844,0.00065977545,0.9855958,0.00001442582],"about_ca_topic_score_codex":0.006006425,"about_ca_topic_score_gemma":0.018330285,"teacher_disagreement_score":0.008291857,"about_ca_system_score_codex":0.0010820719,"about_ca_system_score_gemma":0.0010053895,"threshold_uncertainty_score":0.027739048},"labels":[],"label_agreement":null},{"id":"W4404643885","doi":"10.51731/cjht.2024.1032","title":"RapidAI for Stroke Detection and AI Implementation Review","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Vector Institute","keywords":"Stroke (engine); Medicine; Intensive care medicine; Inclusion and exclusion criteria; Systematic review; MEDLINE; Alternative medicine; Pathology","score_opus":0.024362976827991788,"score_gpt":0.35515252006587805,"score_spread":0.3307895432378863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404643885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002278762,0.9819903,0.00091405713,0.008454057,0.0019262146,0.0013764736,0.0009819779,0.00008485628,0.0040443023],"genre_scores_gemma":[0.0032084791,0.98549867,0.0030714627,0.0042345705,0.0006786943,0.0018114246,0.00060067885,0.000031155985,0.0008648637],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9705283,0.01256376,0.009632445,0.0010646107,0.005373569,0.0008372482],"domain_scores_gemma":[0.83792377,0.109646685,0.016360953,0.0025004318,0.03169662,0.0018714798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03453271,0.0016274801,0.0056351796,0.021387232,0.0010595487,0.0058316533,0.00468264,0.003961866,0.019894153],"category_scores_gemma":[0.17320785,0.0013971592,0.007858048,0.014780622,0.0012810163,0.00643723,0.0036629583,0.0033052312,0.0031380919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000135049,0.00003519136,0.00023347019,0.69399774,0.0015227995,0.000095677366,0.00037141202,0.00026940447,0.00012082278,0.0035169888,0.039828636,0.25987288],"study_design_scores_gemma":[0.000101263155,0.000103405946,0.00067171705,0.81960773,0.004116389,0.00013999645,0.00018127309,0.00008462814,0.000086037195,0.0015727688,0.1732981,0.00003671718],"about_ca_topic_score_codex":0.010115347,"about_ca_topic_score_gemma":0.021962943,"teacher_disagreement_score":0.03453271,"about_ca_system_score_codex":0.011575551,"about_ca_system_score_gemma":0.04946698,"threshold_uncertainty_score":0.18262863},"labels":[],"label_agreement":null},{"id":"W4404716728","doi":"10.51731/cjht.2024.1033","title":"Remdesivir (Veklury)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine","score_opus":0.1986343850936048,"score_gpt":0.45803941880608745,"score_spread":0.2594050337124827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404716728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02708098,0.84266406,0.0021947566,0.004527776,0.00067643693,0.00047288073,0.0040545096,0.0004324946,0.117896125],"genre_scores_gemma":[0.34786287,0.5688153,0.009184043,0.0076373615,0.00045216177,0.0003916199,0.006512008,0.00006771624,0.059076916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966156,0.00009360156,0.000041661835,0.00004170588,0.00012489631,0.000036585607],"domain_scores_gemma":[0.99977905,0.000054155236,0.0000696773,0.00000871589,0.000067765875,0.000020575366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006649582,0.00030806157,0.0003688195,0.00060161884,0.00012985042,0.00057388924,0.00045852724,0.00036488267,0.008342537],"category_scores_gemma":[0.00078164495,0.000085228574,0.0005568901,0.0003488857,0.0001625486,0.0003718148,0.00021249293,0.0007706055,0.0019005592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001062424,0.00012822442,0.00062644115,0.0063148537,0.00026533369,0.00021002779,0.00004729681,0.00041960276,0.004302612,0.002797328,0.0424149,0.94141096],"study_design_scores_gemma":[0.0014655429,0.0016295095,0.0048741023,0.005097922,0.0004941613,0.0026477287,0.000079205194,0.00035590827,0.005354745,0.0009707306,0.9769966,0.0000337849],"about_ca_topic_score_codex":0.005365685,"about_ca_topic_score_gemma":0.02162933,"teacher_disagreement_score":0.008342537,"about_ca_system_score_codex":0.001114295,"about_ca_system_score_gemma":0.0011057805,"threshold_uncertainty_score":0.027908564},"labels":[],"label_agreement":null},{"id":"W4404965869","doi":"10.51731/cjht.2024.1036","title":"Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Medicine; Colorectal cancer; Randomized controlled trial; Gold standard (test); MEDLINE; Cost effectiveness; Cancer; Internal medicine","score_opus":0.0641731189824856,"score_gpt":0.3514271536074059,"score_spread":0.2872540346249203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404965869","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000338317,0.9961279,0.00016120002,0.0020106765,0.00045015762,0.00025555573,0.00019091384,0.000008645775,0.00045673669],"genre_scores_gemma":[0.008765544,0.98326105,0.0020131278,0.0042255176,0.0006361279,0.00068942655,0.00016553655,0.000009185329,0.0002344287],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.974378,0.010048382,0.009923428,0.00091814005,0.0044260276,0.00030590835],"domain_scores_gemma":[0.88093597,0.091902815,0.014443054,0.0012625769,0.01086023,0.0005953906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023518534,0.0010809937,0.0072406875,0.01529305,0.0007075324,0.004036448,0.002284535,0.0033766176,0.0044287504],"category_scores_gemma":[0.11258575,0.0011124028,0.0070533617,0.011077692,0.0016926256,0.0048985067,0.0016730656,0.0023140626,0.00052167533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033249072,0.000019054663,0.00076390716,0.8771451,0.005639403,0.00010970535,0.00021259738,0.00010219268,0.00022061897,0.0009798908,0.005588438,0.108886644],"study_design_scores_gemma":[0.0003140278,0.0002554187,0.0027818987,0.93370444,0.021892047,0.00032953452,0.00023669792,0.00012967874,0.00018017266,0.0012644765,0.038865373,0.000046196943],"about_ca_topic_score_codex":0.007923333,"about_ca_topic_score_gemma":0.018030848,"teacher_disagreement_score":0.023518534,"about_ca_system_score_codex":0.004745731,"about_ca_system_score_gemma":0.0123763215,"threshold_uncertainty_score":0.1243794},"labels":[],"label_agreement":null},{"id":"W4404998522","doi":"10.51731/cjht.2024.1037","title":"Etrasimod (Velsipity)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Family medicine; Political science; Health care; Internal medicine","score_opus":0.0116962134788563,"score_gpt":0.2591476059987694,"score_spread":0.2474513925199131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404998522","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025836077,0.91748405,0.0017601079,0.0023930734,0.0005544408,0.000195172,0.0018639797,0.0002787398,0.049634352],"genre_scores_gemma":[0.24998489,0.70580596,0.0043319818,0.0040887278,0.00039952126,0.00017050205,0.0024518266,0.000034805762,0.032731794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984145,0.000032255684,0.000017958608,0.00002430321,0.00006764755,0.000016317694],"domain_scores_gemma":[0.9998803,0.000035844034,0.000033755947,0.000004092625,0.000030464971,0.000015499218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025826754,0.0002000766,0.00029543386,0.0005903888,0.00012802333,0.000462347,0.0002707204,0.00025948015,0.005495752],"category_scores_gemma":[0.0004260318,0.000059272836,0.00036089492,0.00042254757,0.00015878423,0.0002382919,0.00017118474,0.00061465474,0.0013548797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011708243,0.0001242182,0.0005704357,0.0045993086,0.0001992096,0.00035399845,0.00003331251,0.00023088958,0.010605855,0.0017102817,0.026522111,0.9538796],"study_design_scores_gemma":[0.0016374639,0.002917274,0.010780135,0.0030863604,0.0006166687,0.004966221,0.0000904821,0.0003285382,0.012358447,0.00080853276,0.96236914,0.00004073722],"about_ca_topic_score_codex":0.00417901,"about_ca_topic_score_gemma":0.01232787,"teacher_disagreement_score":0.005495752,"about_ca_system_score_codex":0.00058192445,"about_ca_system_score_gemma":0.00058509666,"threshold_uncertainty_score":0.018385112},"labels":[],"label_agreement":null},{"id":"W4405076128","doi":"10.51731/cjht.2024.1038","title":"Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Alzheimer's disease; Psychology; Internal medicine","score_opus":0.3957357735027015,"score_gpt":0.44773036010382655,"score_spread":0.05199458660112505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405076128","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022786125,0.023075653,0.00041442568,0.93913656,0.0061709364,0.00027119846,0.0027620026,0.00021543962,0.025675278],"genre_scores_gemma":[0.058576632,0.057405174,0.009554316,0.8326775,0.009786806,0.00079291913,0.0052982764,0.00025768575,0.02565066],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98177135,0.0035182913,0.0014159451,0.001041729,0.009064806,0.0031878871],"domain_scores_gemma":[0.790325,0.020519398,0.012613189,0.0036457418,0.12235479,0.050541937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015147314,0.00042670706,0.0013418352,0.0021511118,0.0046293223,0.008796998,0.0034405326,0.0077948947,0.03475691],"category_scores_gemma":[0.0792952,0.0004915239,0.0017701968,0.0028868637,0.002944236,0.0051336433,0.0036695842,0.009352051,0.005690791],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009807215,0.0001715275,0.008860221,0.0018893657,0.00013460303,0.000113353075,0.00046971472,0.00010713759,0.00022609175,0.0066875992,0.79487723,0.18636505],"study_design_scores_gemma":[0.00015056104,0.00014846081,0.029841859,0.0078930035,0.00014736688,0.00014048898,0.0010380541,0.00016450581,0.00020079027,0.0025160713,0.95764434,0.00011446436],"about_ca_topic_score_codex":0.4248356,"about_ca_topic_score_gemma":0.6655099,"teacher_disagreement_score":0.9683619,"about_ca_system_score_codex":0.03163806,"about_ca_system_score_gemma":0.19464102,"threshold_uncertainty_score":0.84472555},"labels":[],"label_agreement":null},{"id":"W4405323691","doi":"10.51731/cjht.2024.1040","title":"Evolocumab (Repatha)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Evolocumab; Medicine; Reimbursement; Statin; Hyperlipidemia; Internal medicine; Discontinuation; Physical therapy; Endocrinology; Cholesterol; Lipoprotein; Diabetes mellitus; Health care","score_opus":0.019935744332750752,"score_gpt":0.28352586770971805,"score_spread":0.2635901233769673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405323691","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02533639,0.853317,0.0020421776,0.0049403766,0.0014931761,0.00045978173,0.003802341,0.00041026293,0.108198486],"genre_scores_gemma":[0.31803375,0.5647834,0.0071139,0.010976964,0.0012430234,0.00051211973,0.0072474945,0.000088519475,0.09000088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970466,0.00006375547,0.000027207809,0.000038337632,0.00013162527,0.000034519417],"domain_scores_gemma":[0.9996941,0.000073116156,0.00006849481,0.00001419231,0.00010665034,0.00004342056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057771115,0.0002930564,0.00036375615,0.00081620744,0.00020309536,0.0007933684,0.00039653815,0.00037102398,0.010633341],"category_scores_gemma":[0.0007748392,0.00008654667,0.0005701891,0.00056023453,0.00020472659,0.00039625002,0.00024612347,0.0007712612,0.0031918944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065645267,0.00008449332,0.000762028,0.0029479242,0.00013777478,0.00017947622,0.000031636566,0.00019508436,0.0022727011,0.0014514006,0.04212818,0.9491528],"study_design_scores_gemma":[0.0009382434,0.0008636776,0.004447135,0.002128645,0.00032466612,0.0024437164,0.000038242342,0.00018020588,0.002850533,0.0004953325,0.9852674,0.000022113685],"about_ca_topic_score_codex":0.0054003294,"about_ca_topic_score_gemma":0.01896928,"teacher_disagreement_score":0.010633341,"about_ca_system_score_codex":0.0010736729,"about_ca_system_score_gemma":0.0012222317,"threshold_uncertainty_score":0.03557211},"labels":[],"label_agreement":null},{"id":"W4405389006","doi":"10.51731/cjht.2024.1043","title":"Emerging Antiviral Drugs to Prevent or Treat Influenza","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Intensive care medicine; Placebo; Drug; Alternative medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.0864022376009829,"score_gpt":0.4259711340832469,"score_spread":0.33956889648226396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405389006","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015857327,0.94834936,0.0005069849,0.033945207,0.0020125406,0.0003008586,0.0013104654,0.000033178523,0.011955781],"genre_scores_gemma":[0.028211119,0.91364753,0.005751889,0.044402037,0.0031196803,0.00035520777,0.0009870261,0.000027630163,0.0034979172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922552,0.00272037,0.002097004,0.00032988001,0.0022411805,0.00035638004],"domain_scores_gemma":[0.9618971,0.022443626,0.003992779,0.0009467271,0.009671866,0.0010479355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013603543,0.0003690891,0.0020421653,0.0036190916,0.00058362936,0.0040218383,0.0011007226,0.0025432922,0.012160527],"category_scores_gemma":[0.044388533,0.00043694375,0.001978079,0.0028615177,0.0012030154,0.0040027373,0.00094188657,0.0031402986,0.0021201547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011137616,0.00018041483,0.005234238,0.12204997,0.0013416546,0.00051636825,0.0006341288,0.00023407923,0.0013459479,0.012312433,0.10553073,0.7495063],"study_design_scores_gemma":[0.0008331525,0.00043628598,0.009024095,0.19433467,0.0024955359,0.0008956764,0.0008493496,0.00017676501,0.00082721346,0.005762439,0.7842974,0.00006753029],"about_ca_topic_score_codex":0.016251788,"about_ca_topic_score_gemma":0.05430686,"teacher_disagreement_score":0.016251788,"about_ca_system_score_codex":0.004254684,"about_ca_system_score_gemma":0.012489594,"threshold_uncertainty_score":0.07194322},"labels":[],"label_agreement":null},{"id":"W4405389146","doi":"10.51731/cjht.2024.1042","title":"Fruquintinib (Fruzaqla)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.038644650356632254,"score_gpt":0.35176466344841517,"score_spread":0.31312001309178294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405389146","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07443241,0.22680387,0.0052985377,0.041051432,0.0058905836,0.0013918076,0.02140458,0.005215432,0.61851126],"genre_scores_gemma":[0.5532897,0.059378535,0.011674917,0.03307375,0.0021549526,0.0006934811,0.03731096,0.00042313477,0.30200052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968505,0.00004617933,0.000015115786,0.000047196107,0.00012275032,0.00008365738],"domain_scores_gemma":[0.9995796,0.000034403365,0.000050667186,0.00002275121,0.00014603058,0.00016649038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006449906,0.00035666773,0.00039496322,0.00055973063,0.0004267083,0.0007372986,0.0006300426,0.0008288165,0.029257942],"category_scores_gemma":[0.000992432,0.00011537238,0.0004740016,0.00039220718,0.00026685366,0.00031444695,0.00047979687,0.0012233515,0.00840346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010513496,0.00027214203,0.001983177,0.0005637427,0.000068321366,0.0003871053,0.000058302372,0.0003066387,0.0063509364,0.0038089014,0.37510684,0.61004245],"study_design_scores_gemma":[0.0019895013,0.0008285649,0.005062716,0.0002428139,0.00005397951,0.0018502997,0.000025048617,0.00032731539,0.0025766387,0.0006572192,0.9863651,0.00002088747],"about_ca_topic_score_codex":0.017247844,"about_ca_topic_score_gemma":0.043951716,"teacher_disagreement_score":0.029257942,"about_ca_system_score_codex":0.002141011,"about_ca_system_score_gemma":0.0022535427,"threshold_uncertainty_score":0.09787762},"labels":[],"label_agreement":null},{"id":"W4405396598","doi":"10.51731/cjht.2024.1045","title":"Atogepant (Qulipta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Family medicine; Medicine; Drug class; Drug; Psychiatry; Political science; Health care","score_opus":0.04343733291579114,"score_gpt":0.33127145157457966,"score_spread":0.2878341186587885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405396598","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01858534,0.85834605,0.00134974,0.0041635744,0.0012550594,0.0005564206,0.0055648824,0.0002545092,0.10992445],"genre_scores_gemma":[0.17842191,0.7539403,0.004988266,0.00780851,0.0008519622,0.00060659595,0.0065816767,0.000055996232,0.046744898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966085,0.00007850843,0.000034197394,0.00004423277,0.00014692379,0.00003528502],"domain_scores_gemma":[0.99967206,0.00012508643,0.00007655464,0.000008416583,0.00007419564,0.00004367759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055629003,0.00024207214,0.00039847987,0.0009908953,0.00030853832,0.0008462476,0.00035653956,0.00048572983,0.020440266],"category_scores_gemma":[0.0012418589,0.00008722093,0.0006492281,0.00089942757,0.00017992212,0.0004574408,0.00030553094,0.0008968393,0.0024390216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015809945,0.00015277858,0.0007032374,0.012225651,0.00039622156,0.0002755136,0.0000651342,0.00016929573,0.0032130806,0.0030485848,0.069649525,0.9085199],"study_design_scores_gemma":[0.0024104682,0.0016306879,0.0075552035,0.008113996,0.0012182948,0.0020169886,0.00008960469,0.00019052804,0.002007007,0.0011700724,0.97356683,0.00003041102],"about_ca_topic_score_codex":0.0076722796,"about_ca_topic_score_gemma":0.027999524,"teacher_disagreement_score":0.020440266,"about_ca_system_score_codex":0.00072724815,"about_ca_system_score_gemma":0.001103076,"threshold_uncertainty_score":0.06837946},"labels":[],"label_agreement":null},{"id":"W4405500642","doi":"10.51731/cjht.2024.1047","title":"Brentuximab Vedotin (Adcetris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Reimbursement; Dacarbazine; Vinblastine; Medicine; Hodgkin lymphoma; Doxorubicin; Oncology; Internal medicine; Pharmacology; Lymphoma; Chemotherapy; Political science","score_opus":0.0252575892802914,"score_gpt":0.30406359354986845,"score_spread":0.278806004269577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405500642","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012520445,0.94696,0.0011317612,0.002282119,0.00036907126,0.0001277503,0.0011427996,0.00008964576,0.03537644],"genre_scores_gemma":[0.20834702,0.75778246,0.005050456,0.002666182,0.00030954854,0.00010829284,0.0021988,0.000026783378,0.023510424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952304,0.00007150056,0.000034519268,0.00003764309,0.0002854461,0.000047746795],"domain_scores_gemma":[0.99946207,0.00012710568,0.00011272038,0.00001011723,0.00023797815,0.000050128438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070120045,0.0002125977,0.0002921634,0.0008341419,0.00020593357,0.0006496911,0.00029556997,0.00026669848,0.0031227996],"category_scores_gemma":[0.0010419601,0.000064859654,0.00027592314,0.00079864316,0.00018464895,0.0003011476,0.00015856423,0.00045856985,0.00056937255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038731733,0.000057232486,0.0018130551,0.0036716345,0.00014192058,0.0002289891,0.000039721097,0.0003740523,0.0047087925,0.0021859454,0.035714414,0.95067686],"study_design_scores_gemma":[0.00023033448,0.0005647524,0.00891223,0.0021454543,0.00025083774,0.0015934815,0.000070035996,0.0001918967,0.0051297224,0.00037027145,0.9805222,0.000018733337],"about_ca_topic_score_codex":0.03157261,"about_ca_topic_score_gemma":0.12153229,"teacher_disagreement_score":0.03157261,"about_ca_system_score_codex":0.0024865274,"about_ca_system_score_gemma":0.0026229487,"threshold_uncertainty_score":0.0627777},"labels":[],"label_agreement":null},{"id":"W4405500883","doi":"10.51731/cjht.2024.1046","title":"Venetoclax (Venclexta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Chronic lymphocytic leukemia; Reimbursement; Ibrutinib; Chlorambucil; Internal medicine; Intensive care medicine; Leukemia; Oncology; Chemotherapy; Health care; Political science","score_opus":0.03855962024480177,"score_gpt":0.35098683390007007,"score_spread":0.3124272136552683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405500883","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030477002,0.15881382,0.0067425827,0.020620065,0.004580928,0.0012857207,0.020493157,0.008882782,0.7481039],"genre_scores_gemma":[0.31685907,0.086132936,0.013016423,0.018511122,0.0029436536,0.00074940204,0.03666454,0.0011084721,0.5240144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993845,0.000081064616,0.00001699727,0.00009034921,0.00030260268,0.00012445796],"domain_scores_gemma":[0.9990584,0.00013316146,0.00009066018,0.00007358098,0.00017933964,0.00046483235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000750112,0.00035416445,0.0003968878,0.0010565816,0.0008027997,0.0016581852,0.0007070474,0.0010118629,0.10834174],"category_scores_gemma":[0.0019407286,0.00017775378,0.00041992683,0.0007420216,0.00044533555,0.00060827326,0.0008186818,0.0021090235,0.019482186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012953427,0.00032508097,0.0020066258,0.00060500525,0.00004564409,0.00059029297,0.00006908576,0.000202367,0.0039310725,0.00702678,0.54819953,0.43570313],"study_design_scores_gemma":[0.0006754951,0.00031870598,0.0034354215,0.00029762753,0.00003696608,0.0014193857,0.00002625045,0.00025107796,0.0013592157,0.0008407674,0.9913264,0.00001257458],"about_ca_topic_score_codex":0.02582229,"about_ca_topic_score_gemma":0.04731385,"teacher_disagreement_score":0.10834174,"about_ca_system_score_codex":0.0020235423,"about_ca_system_score_gemma":0.0035709504,"threshold_uncertainty_score":0.36243922},"labels":[],"label_agreement":null},{"id":"W4405543459","doi":"10.51731/cjht.2024.1048","title":"Enfortumab Vedotin (Padcev)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine; Computer science","score_opus":0.03084868347907145,"score_gpt":0.3204241996970247,"score_spread":0.28957551621795324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405543459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09467824,0.5846564,0.008046995,0.020848557,0.0050069485,0.0015704284,0.008173396,0.0018956482,0.27512348],"genre_scores_gemma":[0.58875334,0.23766759,0.012745041,0.011918326,0.0009699654,0.00081431743,0.011932058,0.00019521044,0.13500418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976474,0.00004327356,0.000017628121,0.000029921426,0.00010155599,0.000042894688],"domain_scores_gemma":[0.99978346,0.000033889177,0.0000431277,0.000013824727,0.00006447746,0.00006127414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004172607,0.0002590362,0.00032301832,0.0006505216,0.00031691726,0.00076987274,0.00042476717,0.0005704911,0.012729975],"category_scores_gemma":[0.0008726905,0.000108938155,0.00034631402,0.0003965457,0.00020961132,0.00036345422,0.00047128016,0.0014209916,0.0035295545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011167942,0.00027112206,0.001377247,0.0015758382,0.000102904356,0.00062463805,0.000051307707,0.00043971985,0.013099664,0.004489464,0.11203336,0.864818],"study_design_scores_gemma":[0.001603017,0.00069237885,0.0028425432,0.0007139058,0.00009295268,0.0029369765,0.000034959892,0.0003694676,0.008517689,0.0009078437,0.9812726,0.000015590333],"about_ca_topic_score_codex":0.004013054,"about_ca_topic_score_gemma":0.009780616,"teacher_disagreement_score":0.99598694,"about_ca_system_score_codex":0.0009664936,"about_ca_system_score_gemma":0.0014301457,"threshold_uncertainty_score":0.04258603},"labels":[],"label_agreement":null},{"id":"W4405573853","doi":"10.51731/cjht.2024.1049","title":"Canadian Trends in Estimated Drug Purchases and Projections: 2024 and 2025","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Audit; Business; Biosimilar; Specialty; Agricultural economics; Medicine; Accounting; Economics; Family medicine","score_opus":0.08836610602824099,"score_gpt":0.3365487014798369,"score_spread":0.2481825954515959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405573853","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1256454,0.033012148,0.005905103,0.042538594,0.0013302095,0.00022552215,0.7146901,0.0016018703,0.075050995],"genre_scores_gemma":[0.60959816,0.036992323,0.014598318,0.006674362,0.00047866313,0.0002031916,0.31335568,0.0003990096,0.017700264],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977169,0.000120463585,0.00015433542,0.0001822502,0.0013466332,0.00047944277],"domain_scores_gemma":[0.99012065,0.0002494495,0.00052659446,0.00012856981,0.008371013,0.0006038167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020395527,0.0010437733,0.00054565066,0.0045705982,0.0016079113,0.0033515256,0.001623746,0.0007460294,0.008368392],"category_scores_gemma":[0.0071430192,0.0004749018,0.0020340667,0.009872744,0.00059846195,0.0016714352,0.0011180077,0.0019570924,0.0018248004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041659366,0.00009213853,0.32116663,0.0023220335,0.0009832662,0.00041716162,0.0010796436,0.014138483,0.0004859647,0.014939221,0.5362511,0.10770779],"study_design_scores_gemma":[0.00007399586,0.000068453,0.6431056,0.0015328353,0.0004245472,0.00035630004,0.0022890498,0.019985937,0.0009889656,0.002256303,0.32861948,0.00029853656],"about_ca_topic_score_codex":0.995195,"about_ca_topic_score_gemma":0.9942788,"teacher_disagreement_score":0.057471815,"about_ca_system_score_codex":0.057471815,"about_ca_system_score_gemma":0.084583655,"threshold_uncertainty_score":0.41698915},"labels":[],"label_agreement":null},{"id":"W4405641897","doi":"10.51731/cjht.2024.1050","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Syringe; Disease; Intensive care medicine; Family medicine; Internal medicine; Cholesterol; Pharmacology; Political science; Psychiatry","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405641897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019697603,0.7964072,0.0012952711,0.0042111515,0.0009701289,0.0006636722,0.004264015,0.00039192903,0.17209895],"genre_scores_gemma":[0.18690838,0.6606845,0.006408962,0.009706728,0.00079829333,0.0006981882,0.0072201625,0.00013794556,0.12743688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994748,0.00014772729,0.000055698467,0.000072458584,0.00019968828,0.00004964348],"domain_scores_gemma":[0.9995578,0.00014291398,0.000109278946,0.00001436403,0.000120855504,0.000054857228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007705086,0.00036839466,0.0004908515,0.001132337,0.00027916304,0.0011085564,0.000716456,0.00090175256,0.024157593],"category_scores_gemma":[0.0015259251,0.00012683666,0.0007577419,0.0007353836,0.0002462089,0.00061138516,0.0004075094,0.001100471,0.0040843906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017278843,0.00017806448,0.00067465525,0.010457414,0.00020632826,0.0003249586,0.000091013244,0.00017873924,0.0031775185,0.0034918054,0.055780802,0.9237108],"study_design_scores_gemma":[0.0013618678,0.0010964219,0.0024387273,0.0061121145,0.000402532,0.0013020226,0.00009068448,0.00012112262,0.0022509971,0.0005281088,0.98426765,0.000027703849],"about_ca_topic_score_codex":0.0074127824,"about_ca_topic_score_gemma":0.025971087,"teacher_disagreement_score":0.9925872,"about_ca_system_score_codex":0.0010985872,"about_ca_system_score_gemma":0.0016967504,"threshold_uncertainty_score":0.080815196},"labels":[],"label_agreement":null},{"id":"W4406146809","doi":"10.51731/cjht.25.1054","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Anemia; Iron-deficiency anemia; Hypophosphatemia; Pediatrics; Iron deficiency; Drug; Internal medicine; Pharmacology; Health care","score_opus":0.0114566010590819,"score_gpt":0.27536329185759706,"score_spread":0.26390669079851514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146809","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16931804,0.2873087,0.03529614,0.026465297,0.0057469015,0.0022417107,0.0071816235,0.012029313,0.45441234],"genre_scores_gemma":[0.58345807,0.066473894,0.03502323,0.013064621,0.0009878414,0.0004509248,0.007329832,0.00044242037,0.2927691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995555,0.000038891016,0.00001834326,0.0000631614,0.00025438488,0.00006960507],"domain_scores_gemma":[0.99969184,0.00003395381,0.00005266081,0.000020914087,0.00011931892,0.000081306294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046950945,0.0004660495,0.00044804302,0.001376243,0.0006144514,0.00048605754,0.0006708062,0.00080585975,0.021123737],"category_scores_gemma":[0.0009082058,0.00014944814,0.00044843418,0.00044497976,0.0003201667,0.00029512984,0.0005727092,0.0011408704,0.0067320513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016290239,0.0008334599,0.0032270676,0.0013935853,0.00015647843,0.002220833,0.00015657753,0.00027011312,0.08144697,0.0049082986,0.24627028,0.6574874],"study_design_scores_gemma":[0.0006670219,0.00206111,0.008915002,0.00055996276,0.00016052768,0.012649784,0.000080608836,0.0006371347,0.07423849,0.00088474655,0.8990904,0.00005515866],"about_ca_topic_score_codex":0.017568585,"about_ca_topic_score_gemma":0.02014031,"teacher_disagreement_score":0.021123737,"about_ca_system_score_codex":0.001163597,"about_ca_system_score_gemma":0.0013243145,"threshold_uncertainty_score":0.070665956},"labels":[],"label_agreement":null},{"id":"W4406146832","doi":"10.51731/cjht.25.1055","title":"Capivasertib (Truqap)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Reimbursement; Medicine; Oncology; Metastatic breast cancer; Regimen; Internal medicine; Anastrozole; Cancer; Breast cancer; Tamoxifen; Political science","score_opus":0.01585888414316502,"score_gpt":0.3169227501187481,"score_spread":0.3010638659755831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146832","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010636045,0.78345376,0.0013817928,0.005870657,0.000987716,0.0006160042,0.008112752,0.00050430594,0.1884369],"genre_scores_gemma":[0.18410483,0.71326935,0.0056749545,0.008824342,0.0008375069,0.00061733753,0.013274052,0.00009564314,0.073302045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995004,0.00008297123,0.000030360397,0.00005462704,0.00027471097,0.00005690029],"domain_scores_gemma":[0.99947995,0.00009059003,0.00009726976,0.000017482369,0.00024219022,0.00007250534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074769836,0.00043367117,0.0004180191,0.001503908,0.00039850018,0.0011448031,0.0006439409,0.0004979648,0.015392698],"category_scores_gemma":[0.0012142244,0.00010847003,0.0005958427,0.001599973,0.00025837566,0.00045649646,0.00033150043,0.00085066626,0.0029083884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003995641,0.000075204494,0.000650171,0.00361643,0.00017255919,0.00014635971,0.000029897656,0.0003464883,0.0017051004,0.002342421,0.12554428,0.8649715],"study_design_scores_gemma":[0.0004007199,0.0004110792,0.0027184465,0.0017557319,0.00022960464,0.00089306943,0.000028271455,0.00018311232,0.0015602122,0.00040779362,0.9913948,0.000017177654],"about_ca_topic_score_codex":0.0370928,"about_ca_topic_score_gemma":0.11739909,"teacher_disagreement_score":0.0370928,"about_ca_system_score_codex":0.00314991,"about_ca_system_score_gemma":0.004777793,"threshold_uncertainty_score":0.073753774},"labels":[],"label_agreement":null},{"id":"W4406146939","doi":"10.51731/cjht.25.1053","title":"Exagamglogene autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thalassemia; Medicine; Hematologist; Beta thalassemia; Red Cell; Malignancy; Pediatrics; Hematopoietic stem cell; Hemoglobinopathy; Hematopoietic stem cell transplantation; Internal medicine; Stem cell; Transplantation; Haematopoiesis; Hemolytic anemia; Biology; Genetics; Disease","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146939","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08305614,0.07365835,0.021929424,0.00747728,0.0025503188,0.0012796633,0.021774093,0.017199468,0.77107525],"genre_scores_gemma":[0.31225482,0.030747201,0.027801413,0.0070893588,0.0007241455,0.00060113834,0.027858369,0.0026183315,0.5903052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969196,0.000038986942,0.000013916741,0.00005401106,0.00015627142,0.000044847257],"domain_scores_gemma":[0.99959415,0.00007157018,0.000043532225,0.00004513931,0.00010415496,0.0001414952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036950948,0.00039252342,0.00043257765,0.0009144594,0.0004702431,0.0010074865,0.00048705697,0.00054026436,0.10224591],"category_scores_gemma":[0.00089054956,0.00015943249,0.00032858708,0.00050534145,0.00035034525,0.00034899366,0.0006938124,0.000877526,0.033703927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016938307,0.00032001917,0.0033011283,0.00068310386,0.00004224845,0.0012144839,0.0001256132,0.00019536364,0.031273074,0.005574478,0.27706984,0.67850685],"study_design_scores_gemma":[0.00024389304,0.0002539511,0.002900661,0.00013164109,0.000031463755,0.0024999713,0.000026267175,0.00022987532,0.010474221,0.0003742576,0.9828231,0.000010691535],"about_ca_topic_score_codex":0.008710327,"about_ca_topic_score_gemma":0.014150817,"teacher_disagreement_score":0.10224591,"about_ca_system_score_codex":0.0007903234,"about_ca_system_score_gemma":0.0019873022,"threshold_uncertainty_score":0.34204668},"labels":[],"label_agreement":null},{"id":"W4406146972","doi":"10.51731/cjht.25.1052","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematologist; Internal medicine; Disease; Transcranial Doppler; Stem cell; Hematopoietic stem cell transplantation; Oncology; Pediatrics; Surgery","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146972","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.104103416,0.105692595,0.017556882,0.009443146,0.0034965244,0.0012279095,0.015229525,0.011944669,0.73130524],"genre_scores_gemma":[0.4109375,0.036903087,0.025081202,0.008152395,0.0013132896,0.0005161302,0.017792776,0.0018121564,0.49749148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996891,0.000039060218,0.000014701056,0.000049897073,0.00016025445,0.000047003956],"domain_scores_gemma":[0.9994711,0.00009857403,0.000058877922,0.000055026,0.00012647879,0.0001899066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039671204,0.00034193957,0.00039387846,0.0010173697,0.0005360845,0.0009685041,0.00040315225,0.0005962697,0.08548701],"category_scores_gemma":[0.0010294645,0.00013982206,0.00033644756,0.0004994353,0.0003909041,0.0003574249,0.0006435816,0.00092493446,0.022770062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016251546,0.0003738709,0.0041721584,0.00058798806,0.000040836767,0.0016982363,0.000119674114,0.00017760941,0.020384083,0.0046769334,0.23730046,0.7288431],"study_design_scores_gemma":[0.0002933731,0.00037580682,0.004636762,0.00018764671,0.000032568947,0.0041340175,0.000032695796,0.00023819128,0.008848677,0.00042033396,0.98078763,0.000012234784],"about_ca_topic_score_codex":0.008054521,"about_ca_topic_score_gemma":0.013730441,"teacher_disagreement_score":0.08548701,"about_ca_system_score_codex":0.00074416085,"about_ca_system_score_gemma":0.0018392543,"threshold_uncertainty_score":0.28598255},"labels":[],"label_agreement":null},{"id":"W4406174727","doi":"10.51731/cjht.25.1056","title":"Spesolimab (Spevigo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.00952296609788956,"score_gpt":0.26550730500820074,"score_spread":0.2559843389103112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406174727","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11312662,0.45011628,0.015353152,0.016198166,0.006509984,0.0018621843,0.019310804,0.0065570953,0.37096572],"genre_scores_gemma":[0.54631966,0.11984592,0.017148511,0.01575898,0.0019274597,0.0008998671,0.037005216,0.00041090345,0.26068348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996598,0.000040710132,0.00002057048,0.00005413638,0.00014820551,0.00007650284],"domain_scores_gemma":[0.9997373,0.00002587956,0.00003915228,0.000020940084,0.00008158208,0.000095024036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042695002,0.0005558562,0.0004973403,0.0012847217,0.00044099728,0.0008346996,0.0004942274,0.0011139935,0.029211998],"category_scores_gemma":[0.0004610267,0.00018092645,0.0006139705,0.0006303582,0.00024205577,0.00038684794,0.00056882255,0.0017091044,0.011697127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002079136,0.0008765556,0.00093612354,0.002395377,0.000121937424,0.00097137294,0.000070963535,0.0005792483,0.063764505,0.0035311922,0.16027574,0.7643979],"study_design_scores_gemma":[0.0014594311,0.0021737264,0.0032489463,0.0004866332,0.000089193294,0.004796503,0.000038846894,0.0003116996,0.018228423,0.0009534456,0.9681898,0.00002323298],"about_ca_topic_score_codex":0.0028460422,"about_ca_topic_score_gemma":0.0055599976,"teacher_disagreement_score":0.029211998,"about_ca_system_score_codex":0.0008596801,"about_ca_system_score_gemma":0.0010839496,"threshold_uncertainty_score":0.09772384},"labels":[],"label_agreement":null},{"id":"W4406218158","doi":"10.51731/cjht.25.1057","title":"Remdesivir (Veklury)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Coronavirus disease 2019 (COVID-19); Pneumonia; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.059734840009306206,"score_gpt":0.4505808174288163,"score_spread":0.3908459774195101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406218158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024585849,0.8408205,0.0015024672,0.0046188724,0.0007121452,0.00052802655,0.004798411,0.0003417125,0.12209206],"genre_scores_gemma":[0.34239185,0.5715677,0.009161567,0.008161392,0.0005059886,0.00046357836,0.007926642,0.000066232096,0.05975498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956805,0.00012114859,0.000052600735,0.000053172276,0.00015970763,0.000045453427],"domain_scores_gemma":[0.99967265,0.00008229985,0.00009422147,0.000011824079,0.00010778176,0.000031185886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008921169,0.00029596587,0.00041371246,0.000659007,0.00015585806,0.00061950024,0.00050594367,0.00038219386,0.0100117745],"category_scores_gemma":[0.0011545505,0.00008567994,0.0005668028,0.00041258743,0.00017584449,0.00039831785,0.0002282604,0.0007680269,0.002013862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015031622,0.00016702901,0.0008441929,0.008504689,0.00032597696,0.00019991327,0.00005914759,0.00029149078,0.0041603046,0.0028523863,0.05865395,0.92243785],"study_design_scores_gemma":[0.0020236792,0.0020127755,0.0066518714,0.0071427687,0.00063404476,0.0024585617,0.00010053517,0.00029288293,0.0049048383,0.0007829001,0.9729571,0.000037970734],"about_ca_topic_score_codex":0.009674204,"about_ca_topic_score_gemma":0.03899534,"teacher_disagreement_score":0.0100117745,"about_ca_system_score_codex":0.0013597128,"about_ca_system_score_gemma":0.001531253,"threshold_uncertainty_score":0.033492684},"labels":[],"label_agreement":null},{"id":"W4406285138","doi":"10.51731/cjht.25.1058","title":"Ravulizumab (Ultomiris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.008815170847852714,"score_gpt":0.2506433297686746,"score_spread":0.24182815892082188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406285138","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26167092,0.31799617,0.021032274,0.016225418,0.0036315843,0.00251826,0.008067463,0.018555181,0.35030267],"genre_scores_gemma":[0.7977661,0.048727024,0.01609119,0.01305419,0.0012030401,0.0009584944,0.013097256,0.0003940806,0.10870853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966395,0.000046704514,0.000027042488,0.00006411603,0.00010964341,0.00008852308],"domain_scores_gemma":[0.9998573,0.000017028062,0.000036170764,0.000015650914,0.000027672666,0.000046277764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004900367,0.00056993775,0.0006985409,0.0006586328,0.0003390415,0.000594372,0.0006675597,0.0008827321,0.015479699],"category_scores_gemma":[0.0005757084,0.00017499295,0.00060313253,0.00037633354,0.0002575068,0.0005669349,0.00045905443,0.0021887857,0.011377987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035126193,0.0009734546,0.0015096895,0.0012853445,0.00020624817,0.0012366006,0.00007363577,0.00045176473,0.03289388,0.0023535946,0.08790127,0.8676019],"study_design_scores_gemma":[0.0144315185,0.009208181,0.021188559,0.001028074,0.00048575396,0.017727822,0.00008082126,0.0021625722,0.03216177,0.0027980309,0.89861596,0.00011101483],"about_ca_topic_score_codex":0.0017469057,"about_ca_topic_score_gemma":0.0023659742,"teacher_disagreement_score":0.015479699,"about_ca_system_score_codex":0.0007801541,"about_ca_system_score_gemma":0.0005448148,"threshold_uncertainty_score":0.051784813},"labels":[],"label_agreement":null},{"id":"W4406494073","doi":"10.51731/cjht.25.1059","title":"Cabotegravir (Apretude)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.014424990178748594,"score_gpt":0.2988635952017083,"score_spread":0.2844386050229597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406494073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070378985,0.9011329,0.0011242422,0.0030354946,0.00043862054,0.00034546663,0.0045525883,0.00023325016,0.082099475],"genre_scores_gemma":[0.13134995,0.80742246,0.0068148454,0.0055969753,0.0003159429,0.00031502105,0.0062136417,0.00006023542,0.04191095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947923,0.0001213169,0.000049518396,0.000046877798,0.00026008708,0.00004296517],"domain_scores_gemma":[0.9995602,0.00012379982,0.00008240627,0.000010955569,0.00017975186,0.00004280599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008221528,0.00030273636,0.00045359478,0.0012984482,0.0002704704,0.00081791374,0.0004955182,0.0004669549,0.008115476],"category_scores_gemma":[0.0013787288,0.00012684669,0.00064407225,0.0010544198,0.00021404219,0.0002990721,0.00023877746,0.00073325104,0.0013740107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006681441,0.00007258261,0.0005469533,0.010804856,0.00022800754,0.00016832337,0.000060042512,0.00026872617,0.0023242421,0.0029302277,0.06057799,0.9213499],"study_design_scores_gemma":[0.00041036465,0.00035548187,0.0029167267,0.0046644867,0.00041973614,0.0009461521,0.00004085432,0.00014555955,0.0014437605,0.00041415764,0.98822474,0.00001793105],"about_ca_topic_score_codex":0.060602102,"about_ca_topic_score_gemma":0.18091628,"teacher_disagreement_score":0.060602102,"about_ca_system_score_codex":0.0023948322,"about_ca_system_score_gemma":0.0037445347,"threshold_uncertainty_score":0.12049872},"labels":[],"label_agreement":null},{"id":"W4406494084","doi":"10.51731/cjht.25.1060","title":"Cariprazine (Vraylar)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.024610940232256535,"score_gpt":0.332200500069454,"score_spread":0.3075895598371975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406494084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009598179,0.93219084,0.0011401463,0.0025805598,0.0004051264,0.00021413564,0.0022103905,0.0002470871,0.051413625],"genre_scores_gemma":[0.1498814,0.80135405,0.0050724926,0.0052482174,0.00038606548,0.0001941924,0.0029156918,0.000035859754,0.034912024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965835,0.00007714217,0.00003409603,0.00006829531,0.0001259342,0.000036172845],"domain_scores_gemma":[0.9997646,0.00006604215,0.0000674136,0.0000074946297,0.000066745604,0.0000277002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043105503,0.0003769055,0.0003803754,0.0009941298,0.00025812624,0.0005190285,0.0004887194,0.00048480867,0.011490328],"category_scores_gemma":[0.00092266354,0.000099191035,0.0004927607,0.00063186674,0.00020558594,0.00026896477,0.00026503968,0.00065978157,0.0022596247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006120252,0.000116349336,0.00050618185,0.011629055,0.00025310865,0.00031113336,0.0000656364,0.00032288933,0.0057325275,0.0036952444,0.05712518,0.91963065],"study_design_scores_gemma":[0.0005666304,0.00073504,0.005087139,0.0038007624,0.00043154188,0.002374995,0.000054984346,0.0001450815,0.0039406135,0.0005413065,0.9822964,0.000025440157],"about_ca_topic_score_codex":0.022922926,"about_ca_topic_score_gemma":0.08113133,"teacher_disagreement_score":0.022922926,"about_ca_system_score_codex":0.0011811486,"about_ca_system_score_gemma":0.0014487788,"threshold_uncertainty_score":0.045579016},"labels":[],"label_agreement":null},{"id":"W4406555837","doi":"10.51731/cjht.25.1061","title":"Virtual Mental Health Counselling","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mental health; Psychology; Applied psychology; Psychotherapist","score_opus":0.03241794645001042,"score_gpt":0.3764964738512954,"score_spread":0.344078527401285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555837","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004891054,0.92389876,0.0018871676,0.027192045,0.0070579834,0.0014479023,0.0016279204,0.00017738825,0.03181981],"genre_scores_gemma":[0.109385796,0.81340456,0.010829264,0.04948552,0.004809322,0.0035067045,0.0012561801,0.000096748125,0.007225943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874068,0.008291431,0.002003373,0.00048446018,0.0015075298,0.00030647017],"domain_scores_gemma":[0.96958613,0.022692677,0.0029827137,0.0009155502,0.0030538107,0.00076902896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010315882,0.0005809341,0.0019496017,0.0025982736,0.0008573192,0.005196216,0.0021294327,0.0032301378,0.034243543],"category_scores_gemma":[0.07531789,0.00047082975,0.0037776486,0.0019408404,0.0010511561,0.0055696107,0.0035019892,0.0027298813,0.0030049072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008465638,0.00014401742,0.0011146229,0.24745147,0.0014034695,0.00018064091,0.0016716993,0.00015896962,0.00017631675,0.0056072776,0.060911164,0.6803338],"study_design_scores_gemma":[0.0015926288,0.0004936384,0.0038712637,0.53172404,0.00415184,0.0011326001,0.003276078,0.00016085072,0.00033066428,0.0055168187,0.44765,0.0000995542],"about_ca_topic_score_codex":0.0033964396,"about_ca_topic_score_gemma":0.0057962467,"teacher_disagreement_score":0.034243543,"about_ca_system_score_codex":0.0029712163,"about_ca_system_score_gemma":0.0058999136,"threshold_uncertainty_score":0.114556074},"labels":[],"label_agreement":null},{"id":"W4406555849","doi":"10.51731/cjht.25.1062","title":"Secukinumab (Cosentyx)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Secukinumab; Medicine; Dermatology","score_opus":0.01896513563315761,"score_gpt":0.31425843574670986,"score_spread":0.29529330011355226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555849","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017522845,0.9340641,0.00094039115,0.0017828181,0.000894238,0.00018084659,0.0011365426,0.00012383083,0.04335447],"genre_scores_gemma":[0.17836991,0.7734457,0.0031165415,0.003110917,0.00066407316,0.00022488993,0.002533527,0.000027488617,0.038506974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963355,0.00007693689,0.000041767118,0.00003544513,0.0001818374,0.000030543666],"domain_scores_gemma":[0.9997285,0.000065882436,0.000078506775,0.0000097968195,0.00009054396,0.000026748261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050751417,0.00033217584,0.0003460774,0.00091281504,0.00019502985,0.0006033541,0.00021914912,0.0003090665,0.00725607],"category_scores_gemma":[0.0005897965,0.00007569333,0.00049450516,0.0006924239,0.00017836584,0.00032826397,0.00026800486,0.00039991358,0.001727555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043046975,0.000070438386,0.00094791135,0.007243318,0.00017789661,0.00018825282,0.00003757251,0.00014721195,0.0050728917,0.001248361,0.03295342,0.95148224],"study_design_scores_gemma":[0.00030180102,0.0010735687,0.009569832,0.003640641,0.000378907,0.0022047262,0.00007361366,0.00012857479,0.0055314647,0.00036803706,0.97670823,0.00002063057],"about_ca_topic_score_codex":0.0037353828,"about_ca_topic_score_gemma":0.01660409,"teacher_disagreement_score":0.00725607,"about_ca_system_score_codex":0.00060063973,"about_ca_system_score_gemma":0.0008302183,"threshold_uncertainty_score":0.024273932},"labels":[],"label_agreement":null},{"id":"W4406615403","doi":"10.51731/cjht.25.1063","title":"Severity Weighting of Quality-Adjusted Life-Years for Economic Evaluation: What, How, and Where Next?","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weighting; Quality (philosophy); Quality of life (healthcare); Actuarial science; Psychology; Economics; Medicine; Nursing","score_opus":0.34709072831738885,"score_gpt":0.43675221642879947,"score_spread":0.08966148811141061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406615403","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040299878,0.38201967,0.34228432,0.14610529,0.011290254,0.008159321,0.0068439096,0.00052673474,0.062470596],"genre_scores_gemma":[0.42458063,0.1659055,0.3750052,0.01737962,0.0033329686,0.0073149367,0.0029214926,0.0005284441,0.0030311618],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.82388073,0.13958643,0.015812784,0.0021453917,0.017027505,0.0015471153],"domain_scores_gemma":[0.7787965,0.14994301,0.01860549,0.008472018,0.040847626,0.0033353637],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1726863,0.0021999395,0.0047147116,0.008121313,0.0013242471,0.010399296,0.0026438248,0.0022874246,0.0050214073],"category_scores_gemma":[0.37761673,0.0009023074,0.005306839,0.01120962,0.0029060275,0.009454867,0.0035189982,0.0067242826,0.0009780313],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015477753,0.00020153662,0.013553187,0.016633442,0.0033788597,0.0000893,0.0020943757,0.008142556,0.00049221213,0.079760365,0.03877407,0.8353323],"study_design_scores_gemma":[0.0023535332,0.0018660428,0.04682464,0.12678188,0.0064031146,0.00072836364,0.0058464324,0.030876704,0.0028478813,0.4992838,0.2747971,0.0013904969],"about_ca_topic_score_codex":0.01829349,"about_ca_topic_score_gemma":0.018352354,"teacher_disagreement_score":0.8273137,"about_ca_system_score_codex":0.011675467,"about_ca_system_score_gemma":0.0099766115,"threshold_uncertainty_score":0.9132633},"labels":[],"label_agreement":null},{"id":"W4406698363","doi":"10.51731/cjht.25.1064","title":"Ivosidenib (Tibsovo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.016761126834953326,"score_gpt":0.35869270102917783,"score_spread":0.3419315741942245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406698363","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013297566,0.91999257,0.00088640506,0.0021306043,0.00045728328,0.00023235366,0.0023635621,0.000102093596,0.060537577],"genre_scores_gemma":[0.16423707,0.79881734,0.004742848,0.0035897684,0.0003012805,0.0002232583,0.0038673833,0.000034752306,0.024186362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977285,0.00006271973,0.000024024766,0.000025801422,0.000093337316,0.000021278067],"domain_scores_gemma":[0.99981433,0.000051587347,0.00005079376,0.000005340971,0.0000509595,0.000026971395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041818112,0.00019643533,0.00034905702,0.00078179134,0.00018579957,0.00073458266,0.0002713535,0.0002982964,0.0053711543],"category_scores_gemma":[0.0006773905,0.000065449094,0.00038407985,0.00089504535,0.00016932274,0.00020367987,0.00019704331,0.00059117563,0.00079553586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083081867,0.00006925619,0.0010751629,0.00568209,0.00022217125,0.00014393513,0.0000470514,0.00030336672,0.0036437144,0.0032224017,0.04280567,0.9419543],"study_design_scores_gemma":[0.0006975972,0.0007781862,0.004271537,0.005277225,0.0004909157,0.0009872924,0.00007046637,0.00015465885,0.0028056493,0.00079330493,0.9836559,0.000017153829],"about_ca_topic_score_codex":0.013106215,"about_ca_topic_score_gemma":0.058131218,"teacher_disagreement_score":0.013106215,"about_ca_system_score_codex":0.0011488704,"about_ca_system_score_gemma":0.0015306773,"threshold_uncertainty_score":0.026059866},"labels":[],"label_agreement":null},{"id":"W4406907125","doi":"10.51731/cjht.2025.1065","title":"Osimertinib (Tagrisso)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Receptor","score_opus":0.01814201831550905,"score_gpt":0.3576238266743232,"score_spread":0.33948180835881414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406907125","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025845494,0.76763785,0.001386576,0.004255306,0.0010584125,0.0003157816,0.004880161,0.00034556727,0.1942748],"genre_scores_gemma":[0.2822232,0.5736699,0.0045215385,0.006087928,0.0005896431,0.00024917166,0.009111006,0.000052083506,0.12349548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982125,0.000024854591,0.000018949228,0.000022825525,0.000085039785,0.00002712284],"domain_scores_gemma":[0.99987376,0.000021021182,0.000034071778,0.0000045871834,0.00004602101,0.000020506752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032979503,0.00025492936,0.00022573335,0.00078610587,0.000206439,0.0005908726,0.00021608557,0.0002863958,0.0078329835],"category_scores_gemma":[0.00038791166,0.00005153826,0.00029678585,0.00072582567,0.00013321967,0.00026272432,0.00022582723,0.0003672321,0.0017982475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038458736,0.00004862018,0.0007978102,0.0026584633,0.00008189705,0.00016130891,0.00004241447,0.00022830511,0.0040763724,0.0027307454,0.065966204,0.9228233],"study_design_scores_gemma":[0.00018080362,0.00026143584,0.0028764964,0.00083170505,0.00013103575,0.0007105045,0.000029743498,0.00008040324,0.0024120077,0.00029242,0.99218607,0.000007357253],"about_ca_topic_score_codex":0.011730943,"about_ca_topic_score_gemma":0.05198925,"teacher_disagreement_score":0.011730943,"about_ca_system_score_codex":0.0014309495,"about_ca_system_score_gemma":0.0017201075,"threshold_uncertainty_score":0.02620393},"labels":[],"label_agreement":null},{"id":"W4406986856","doi":"10.51731/cjht.2025.1066","title":"Mapping the Landscape of Infusion Care for People Prescribed IV Medicines in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Geography","score_opus":0.03165195297929813,"score_gpt":0.32867252413714615,"score_spread":0.297020571157848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406986856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97951114,0.001309398,0.00030138105,0.006007913,0.000019418349,0.000089364956,0.0019085782,0.000016009255,0.010836922],"genre_scores_gemma":[0.99720204,0.00087954424,0.00040958836,0.00040953798,0.000004254348,0.00002440818,0.00036736173,0.000007756589,0.00069543446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736565,0.00036669493,0.00009957697,0.00021646291,0.0006278825,0.0013237268],"domain_scores_gemma":[0.996406,0.00044403833,0.00064797467,0.000065947526,0.001013193,0.001422859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009015056,0.00017918389,0.00036193957,0.002458206,0.0070933755,0.004230874,0.0015475751,0.00051150576,0.003594166],"category_scores_gemma":[0.0034570568,0.00035646293,0.00043963315,0.0072721625,0.0026790726,0.001226594,0.00302887,0.0012653327,0.00015188739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017371937,0.00022741161,0.831231,0.00034536197,0.000096563235,0.00090121967,0.07361974,0.0011403175,0.0006571712,0.010692475,0.014917739,0.06599718],"study_design_scores_gemma":[0.000014026857,0.000047392004,0.8470193,0.00034487163,0.000023979863,0.00021071319,0.13477436,0.0013561078,0.00010096785,0.00089942286,0.015154642,0.00005427202],"about_ca_topic_score_codex":0.9932035,"about_ca_topic_score_gemma":0.99713755,"teacher_disagreement_score":0.09377096,"about_ca_system_score_codex":0.09377096,"about_ca_system_score_gemma":0.11770934,"threshold_uncertainty_score":0.6803591},"labels":[],"label_agreement":null},{"id":"W4407006763","doi":"10.51731/cjht.2025.1068","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.13011247310058613,"score_gpt":0.4548316854798537,"score_spread":0.3247192123792676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407006763","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31640837,0.33210173,0.009787899,0.014434722,0.0035407222,0.0018484109,0.0067307637,0.0043511004,0.31079632],"genre_scores_gemma":[0.77234226,0.063640006,0.007234934,0.007851585,0.0006913541,0.0006432383,0.010024883,0.00020608678,0.13736571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981874,0.00003333461,0.000013418426,0.000034702072,0.00006282846,0.000036990255],"domain_scores_gemma":[0.99987686,0.000016046126,0.000030365838,0.000010709237,0.000021884587,0.00004403745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002944376,0.00035661977,0.00050517934,0.0005875533,0.00030431896,0.00054180267,0.00046848302,0.0007991007,0.012603657],"category_scores_gemma":[0.00042971407,0.00014878443,0.00047429174,0.00035613665,0.00020527489,0.00033852572,0.00040736646,0.0017752032,0.0064483318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004763578,0.001372023,0.0024256848,0.0014021017,0.0002603487,0.0022004424,0.000098534714,0.0008428229,0.090268426,0.004839997,0.06541086,0.8261152],"study_design_scores_gemma":[0.0065489584,0.009031001,0.016794803,0.00058607763,0.00026291274,0.015331399,0.000070407266,0.0014950269,0.055186827,0.0015528231,0.8930497,0.00009008318],"about_ca_topic_score_codex":0.0034554212,"about_ca_topic_score_gemma":0.005469158,"teacher_disagreement_score":0.012603657,"about_ca_system_score_codex":0.00071023335,"about_ca_system_score_gemma":0.0006580123,"threshold_uncertainty_score":0.04216349},"labels":[],"label_agreement":null},{"id":"W4407006797","doi":"10.51731/cjht.2025.1067","title":"Erdafitinib (Balversa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.025151317670980115,"score_gpt":0.3267555524490281,"score_spread":0.301604234778048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407006797","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1415384,0.20115165,0.005975336,0.042463508,0.0045254333,0.0021267238,0.036822934,0.0081122825,0.5572838],"genre_scores_gemma":[0.5901603,0.07056202,0.007527579,0.02021818,0.0008560926,0.00090876856,0.052671287,0.0003312888,0.25676444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973613,0.000028428361,0.000019494693,0.000044018445,0.000101721926,0.00007008282],"domain_scores_gemma":[0.9998248,0.000013000009,0.000028877585,0.000015181628,0.00004707876,0.000071073795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040133254,0.00043820468,0.0006434363,0.00081295747,0.00045011364,0.00097350247,0.0006504584,0.0010575948,0.030610817],"category_scores_gemma":[0.00059081794,0.00017360736,0.00061040674,0.00056377205,0.00022977099,0.0006368142,0.0005484201,0.0016528952,0.0137491925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026707847,0.0006077881,0.002876395,0.0010482265,0.00015611619,0.00070488785,0.00004982046,0.00071003335,0.008900966,0.0030060075,0.32883212,0.6504368],"study_design_scores_gemma":[0.0050385967,0.0018386847,0.009433977,0.00061769335,0.00016235985,0.0046572033,0.000060787075,0.0012061511,0.007882871,0.0013946802,0.96765244,0.00005466594],"about_ca_topic_score_codex":0.0055784653,"about_ca_topic_score_gemma":0.016359614,"teacher_disagreement_score":0.030610817,"about_ca_system_score_codex":0.0015356359,"about_ca_system_score_gemma":0.0015688535,"threshold_uncertainty_score":0.1024034},"labels":[],"label_agreement":null},{"id":"W4407034836","doi":"10.51731/cjht.2025.1069","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Drug; Vial; Chemotherapy; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Cancer; Political science","score_opus":0.020298250381991106,"score_gpt":0.30338636799249236,"score_spread":0.28308811761050123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407034836","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008668659,0.951748,0.0006155885,0.0031872508,0.00037166607,0.00014161054,0.000994262,0.00006249648,0.034210514],"genre_scores_gemma":[0.1429143,0.83331937,0.0027840864,0.0031611966,0.00029402686,0.00016153544,0.0013160736,0.0000129131695,0.016036551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996731,0.00007150441,0.000036594825,0.000037416445,0.00014494432,0.00003641838],"domain_scores_gemma":[0.99965656,0.0000844508,0.000108234475,0.000009245957,0.000109271925,0.000032293603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006202497,0.00017388105,0.0002656841,0.00071058876,0.00018279417,0.0006157004,0.00023822668,0.000256224,0.004560437],"category_scores_gemma":[0.0011617385,0.00006323269,0.00035661977,0.0007527651,0.0001473258,0.0004087211,0.00022615043,0.0004983812,0.0006926602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039455452,0.000039944396,0.0007585434,0.005246465,0.00018560544,0.000104664556,0.000029254898,0.000128007,0.0017685617,0.0016002288,0.029564539,0.96017957],"study_design_scores_gemma":[0.00042598014,0.0006491656,0.009122583,0.006218374,0.00061394164,0.0012808951,0.00006272514,0.00011986435,0.0027206342,0.00063357403,0.9781366,0.000015702912],"about_ca_topic_score_codex":0.013647435,"about_ca_topic_score_gemma":0.05080054,"teacher_disagreement_score":0.013647435,"about_ca_system_score_codex":0.0014837232,"about_ca_system_score_gemma":0.0016417376,"threshold_uncertainty_score":0.027136028},"labels":[],"label_agreement":null},{"id":"W4407266958","doi":"10.51731/cjht.2025.1072","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Breast cancer; Internal medicine; Disease; Adjuvant; Human Epidermal Growth Factor Receptor 2; Drug; Cancer; Family medicine; Oestrogen receptor; Gynecology; Pharmacology; Political science; Health care","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407266958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027276967,0.83448946,0.0013767675,0.002362173,0.0007593982,0.00055696344,0.0026438236,0.0003410678,0.13019334],"genre_scores_gemma":[0.2850876,0.6436419,0.004094417,0.0049837627,0.000485885,0.0003531812,0.0042922017,0.00006910308,0.056992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979395,0.000039573373,0.000020698799,0.00003278208,0.000089908994,0.000023108936],"domain_scores_gemma":[0.9998721,0.000030611212,0.000037275004,0.0000045732413,0.000033452823,0.000021894251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002730492,0.00025629756,0.0004112443,0.00096948125,0.00022888456,0.0007099251,0.00034625575,0.0003376194,0.0128425835],"category_scores_gemma":[0.00047064247,0.000083996354,0.0003663932,0.0006400467,0.00020155401,0.00041822257,0.00021709998,0.00068729976,0.0019913958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014027237,0.00016177361,0.00037273724,0.0067893835,0.00014017319,0.0002259649,0.000040374423,0.00021016317,0.009272591,0.0030539467,0.044158384,0.93417186],"study_design_scores_gemma":[0.0013599253,0.0014388722,0.005066518,0.003762563,0.00043205742,0.0020575924,0.00006602603,0.00024418253,0.006762058,0.00091436645,0.97786134,0.00003452965],"about_ca_topic_score_codex":0.0065759392,"about_ca_topic_score_gemma":0.023639545,"teacher_disagreement_score":0.0128425835,"about_ca_system_score_codex":0.0008706341,"about_ca_system_score_gemma":0.0010345392,"threshold_uncertainty_score":0.04296279},"labels":[],"label_agreement":null},{"id":"W4407266966","doi":"10.51731/cjht.2025.1071","title":"Baricitinib (Olumiant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.013385074642773423,"score_gpt":0.29305047799045036,"score_spread":0.2796654033476769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407266966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017084379,0.86567837,0.0008928585,0.0057348073,0.0011667452,0.00027942593,0.0036594905,0.0003511046,0.105152726],"genre_scores_gemma":[0.202502,0.71656424,0.0032129306,0.0072821532,0.00080759206,0.00023150348,0.008455788,0.000057318022,0.060886547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997869,0.000024168088,0.000014710868,0.0000266324,0.00011444948,0.00003325214],"domain_scores_gemma":[0.99984455,0.000020929334,0.000037519632,0.000003788275,0.00006063408,0.0000325199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031470848,0.0003211082,0.00035165227,0.0012388569,0.00031541404,0.00079191587,0.0003771914,0.00045548173,0.011106123],"category_scores_gemma":[0.00056995923,0.00007205789,0.00044870056,0.00090119423,0.00016362392,0.00040199404,0.00034917917,0.0007945392,0.002638362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006310027,0.00009774368,0.00071546924,0.0046769166,0.00015749347,0.00028623806,0.000033339635,0.00019330985,0.0045640664,0.0018169776,0.10811396,0.87871355],"study_design_scores_gemma":[0.00048645848,0.00049894577,0.0058854185,0.002782478,0.00031118083,0.002280356,0.000043632663,0.00015169432,0.0027367766,0.0003580515,0.9844381,0.000026780413],"about_ca_topic_score_codex":0.020760594,"about_ca_topic_score_gemma":0.07534258,"teacher_disagreement_score":0.020760594,"about_ca_system_score_codex":0.0016192201,"about_ca_system_score_gemma":0.0015651694,"threshold_uncertainty_score":0.041279495},"labels":[],"label_agreement":null},{"id":"W4407408614","doi":"10.51731/cjht.2025.1074","title":"Lebrikizumab (Ebglyss)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01890364514807176,"score_gpt":0.30303255137561497,"score_spread":0.2841289062275432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407408614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006829432,0.916564,0.0011701668,0.004786345,0.00081273826,0.00045798128,0.0038363426,0.00017634557,0.06536655],"genre_scores_gemma":[0.12700956,0.81468046,0.005635962,0.0062280674,0.0009055064,0.00044881023,0.005542526,0.00004802041,0.039501112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988739,0.0002631604,0.0001270161,0.00007721259,0.0005697578,0.00008885547],"domain_scores_gemma":[0.9987827,0.00031038144,0.00030320536,0.000029213208,0.0004887966,0.00008572207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018967947,0.0003391878,0.00045974043,0.001462151,0.00027269305,0.0010358568,0.00045242562,0.0005933973,0.009519181],"category_scores_gemma":[0.0025812725,0.00010179035,0.00084305473,0.0009891617,0.00025808119,0.00047693757,0.00039852998,0.000584363,0.002019184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047271096,0.00005212359,0.0011829884,0.009194769,0.00020708819,0.00011267869,0.000044231445,0.00018431315,0.0017142225,0.001982146,0.0616493,0.92320347],"study_design_scores_gemma":[0.0003766515,0.00057574833,0.0047859093,0.0069399676,0.00047212036,0.0005535252,0.00005101093,0.00010473543,0.0018260984,0.00044200945,0.9838563,0.000015772666],"about_ca_topic_score_codex":0.02397487,"about_ca_topic_score_gemma":0.06020634,"teacher_disagreement_score":0.02397487,"about_ca_system_score_codex":0.0026112974,"about_ca_system_score_gemma":0.003957256,"threshold_uncertainty_score":0.047670662},"labels":[],"label_agreement":null},{"id":"W4407408699","doi":"10.51731/cjht.2025.1073","title":"Zilucoplan (Zilbrysq)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.007438099556752454,"score_gpt":0.2584332955643642,"score_spread":0.2509951960076117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407408699","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21464665,0.26638475,0.01780344,0.013633069,0.0030280873,0.0035255232,0.021029614,0.011125492,0.4488234],"genre_scores_gemma":[0.68591213,0.065097064,0.012654852,0.010018505,0.00060596125,0.0011038095,0.02439274,0.00038735833,0.19982746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998331,0.000028266366,0.0000115405755,0.000031368203,0.0000600007,0.000035724606],"domain_scores_gemma":[0.9999229,0.000009968401,0.000016408945,0.00000697736,0.000016262766,0.000027503565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020284843,0.00035584194,0.0004675546,0.0006079209,0.0001948644,0.00047615648,0.00048534683,0.00055884576,0.027350862],"category_scores_gemma":[0.0003614308,0.00015314974,0.00037691928,0.00034764296,0.00013190683,0.00031534128,0.00043731334,0.0016085368,0.012776799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029878244,0.00077143655,0.0015664286,0.0018616947,0.00018625027,0.000916561,0.000068019974,0.00050828356,0.042148452,0.0030465533,0.1350011,0.8109374],"study_design_scores_gemma":[0.00799194,0.004282518,0.0123308,0.0005428585,0.00019336298,0.006507577,0.000056097695,0.0012268047,0.018638173,0.0012155147,0.94697076,0.000043501383],"about_ca_topic_score_codex":0.0020294674,"about_ca_topic_score_gemma":0.0032649033,"teacher_disagreement_score":0.027350862,"about_ca_system_score_codex":0.00047300657,"about_ca_system_score_gemma":0.00038476972,"threshold_uncertainty_score":0.09149778},"labels":[],"label_agreement":null},{"id":"W4407489911","doi":"10.51731/cjht.2025.1076","title":"Burosumab (Crysvita)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Intensive care medicine; Business; Economic growth; Health care; Economics","score_opus":0.06656303316153739,"score_gpt":0.40391335139295653,"score_spread":0.33735031823141914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407489911","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0163198,0.8360813,0.0019373203,0.0060921665,0.0011108207,0.00064482266,0.0058111716,0.00070197525,0.13130064],"genre_scores_gemma":[0.21058866,0.6320182,0.008351379,0.009730859,0.0007082811,0.00063621224,0.010054279,0.00015496684,0.1277571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993954,0.00011236652,0.00004036774,0.00005819955,0.00032514238,0.000068526206],"domain_scores_gemma":[0.99955326,0.00008902376,0.000111427405,0.000012615252,0.00015488424,0.00007876934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008814415,0.00033801602,0.0004414103,0.0012921952,0.0003045927,0.0008582183,0.000526782,0.00067390176,0.02152466],"category_scores_gemma":[0.0011794897,0.000105435,0.00053722184,0.0008399688,0.0002694396,0.00042649705,0.0005096187,0.000993282,0.004259333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008111022,0.00012268766,0.0007376991,0.006108041,0.0001208752,0.00023991405,0.00007292013,0.00015733842,0.004297117,0.002801797,0.11165758,0.872873],"study_design_scores_gemma":[0.000615198,0.000626893,0.0032627136,0.0033088748,0.00016289018,0.0011556237,0.00006916861,0.000084855834,0.0021923548,0.0003822931,0.9881224,0.000016782986],"about_ca_topic_score_codex":0.02110984,"about_ca_topic_score_gemma":0.066050865,"teacher_disagreement_score":0.02152466,"about_ca_system_score_codex":0.001484552,"about_ca_system_score_gemma":0.0031284988,"threshold_uncertainty_score":0.07200718},"labels":[],"label_agreement":null},{"id":"W4407563556","doi":"10.51731/cjht.2025.1075","title":"Momelotinib (Ojjaara)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Medicine; Polycythemia vera; Essential thrombocythemia; Anemia; Drug; Internal medicine; Surgery; Pharmacology; Bone marrow","score_opus":0.02145489802086633,"score_gpt":0.31894452950270036,"score_spread":0.29748963148183405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407563556","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08364877,0.19984536,0.0025253585,0.026406065,0.0033628268,0.0012872108,0.021156332,0.0031580683,0.65861],"genre_scores_gemma":[0.5442389,0.087359205,0.008248682,0.027212124,0.0022113489,0.00086272525,0.042957745,0.00022712417,0.28668198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997633,0.000020998825,0.000015386542,0.000034357417,0.000095194766,0.000070748],"domain_scores_gemma":[0.99973565,0.000018904413,0.000036433652,0.000013717349,0.00006192445,0.00013325225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003519373,0.0003134365,0.00041438328,0.0006776797,0.00048502124,0.0009277416,0.00055669877,0.00066807907,0.029529544],"category_scores_gemma":[0.0007680986,0.00010983278,0.00043539784,0.0004993689,0.0001890156,0.0004301698,0.00053184817,0.0012887513,0.008283866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021440412,0.0005210751,0.003435049,0.0008284925,0.00013226426,0.0005986871,0.00004574406,0.0003547496,0.0056807296,0.0037744052,0.25473595,0.7277488],"study_design_scores_gemma":[0.0029737714,0.0010408431,0.009177243,0.0005041728,0.00015522167,0.0028440135,0.000032880223,0.0004345696,0.0028753048,0.0011918312,0.97874695,0.000023248691],"about_ca_topic_score_codex":0.0077651865,"about_ca_topic_score_gemma":0.030780409,"teacher_disagreement_score":0.029529544,"about_ca_system_score_codex":0.0017991491,"about_ca_system_score_gemma":0.001960549,"threshold_uncertainty_score":0.098786175},"labels":[],"label_agreement":null},{"id":"W4407593771","doi":"10.51731/cjht.2025.1077","title":"Zolbetuximab for Injection (Vyloy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.017664576821286273,"score_gpt":0.31315935413502666,"score_spread":0.2954947773137404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407593771","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0575335,0.046979107,0.01657354,0.025651958,0.0052673365,0.0020349654,0.008528358,0.009501328,0.8279299],"genre_scores_gemma":[0.328958,0.013777826,0.02280493,0.024148569,0.000992398,0.0008090001,0.008739668,0.0006901255,0.59907943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973565,0.000028163357,0.0000116381,0.000046555906,0.00012303854,0.000054955755],"domain_scores_gemma":[0.99965096,0.00004375605,0.000038239537,0.000025714564,0.000076102966,0.00016520765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039273023,0.00025938664,0.00026766062,0.00061602937,0.0005036235,0.00065816817,0.00042753015,0.0009970203,0.066516645],"category_scores_gemma":[0.0006856416,0.00014812278,0.00030444402,0.00020998999,0.00023010005,0.00040977506,0.0005374958,0.0012449097,0.016597878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011477536,0.0003738797,0.0019096837,0.00045480227,0.0000487582,0.0007301482,0.00006854821,0.0003094217,0.017217146,0.004763358,0.30338365,0.66959286],"study_design_scores_gemma":[0.000638751,0.0006632051,0.004799029,0.00016577322,0.000030411733,0.0016215213,0.000018829647,0.0004681343,0.00462732,0.0007115759,0.986241,0.000014484702],"about_ca_topic_score_codex":0.006347126,"about_ca_topic_score_gemma":0.015858654,"teacher_disagreement_score":0.066516645,"about_ca_system_score_codex":0.0010151642,"about_ca_system_score_gemma":0.0014559549,"threshold_uncertainty_score":0.22252029},"labels":[],"label_agreement":null},{"id":"W4407745846","doi":"10.51731/cjht.2025.1079","title":"Eplontersen (Wainua)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.012324526351937747,"score_gpt":0.2861330350591976,"score_spread":0.27380850870725987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407745846","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009778977,0.2701521,0.0030511082,0.0068558534,0.002960804,0.0003200461,0.01094979,0.0016986153,0.69423276],"genre_scores_gemma":[0.038738795,0.09780192,0.0041104285,0.0027731122,0.00032046472,0.00018677003,0.0062766243,0.00046493555,0.84932697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949384,0.000050148872,0.00003249777,0.00011980491,0.00022705249,0.00007655137],"domain_scores_gemma":[0.9994325,0.00013267744,0.00006437018,0.000040283936,0.00019592584,0.00013431873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061062723,0.00086318626,0.0006455004,0.001389925,0.00059921166,0.001755439,0.0008500561,0.0012689081,0.25345892],"category_scores_gemma":[0.0015465991,0.00027877337,0.00038704032,0.0010170868,0.00037907113,0.0012216443,0.0010025143,0.0013291099,0.06912664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005632798,0.000093013834,0.0005743451,0.0025464848,0.000059281334,0.0010693388,0.000099302546,0.00022242258,0.0031055645,0.005907075,0.17445306,0.8113068],"study_design_scores_gemma":[0.00008622893,0.00010789044,0.001399356,0.0010756605,0.000035515233,0.0007343129,0.000047553876,0.000089725654,0.0013473465,0.00086341664,0.99420184,0.000011283925],"about_ca_topic_score_codex":0.018652579,"about_ca_topic_score_gemma":0.035228856,"teacher_disagreement_score":0.25345892,"about_ca_system_score_codex":0.0011144707,"about_ca_system_score_gemma":0.0035500457,"threshold_uncertainty_score":0.84790456},"labels":[],"label_agreement":null},{"id":"W4407758786","doi":"10.51731/cjht.2025.1078","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407758786","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078185804,0.37670013,0.0071670595,0.041460004,0.004895195,0.0016172278,0.010974566,0.0025494336,0.47645056],"genre_scores_gemma":[0.545508,0.15797962,0.012232641,0.023943394,0.0018214283,0.00089104474,0.012645552,0.00018567823,0.24479264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997799,0.000025035359,0.000015005714,0.00003256767,0.000093605675,0.000053899614],"domain_scores_gemma":[0.9997793,0.000026622041,0.00003776977,0.000012995277,0.000059447626,0.00008383434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035532378,0.00020692911,0.000329004,0.0004639998,0.00034014517,0.0006928774,0.00048088934,0.00062762335,0.018632127],"category_scores_gemma":[0.0006695077,0.00010495161,0.00034304056,0.00033461337,0.00016906059,0.00043287425,0.00038170104,0.0015988058,0.004843794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015679431,0.00030920628,0.0010509194,0.0010640619,0.000076977434,0.0005371317,0.000040595296,0.0002448191,0.01130332,0.0032263265,0.17578754,0.8047911],"study_design_scores_gemma":[0.0019380919,0.00081565365,0.007152695,0.0005556862,0.00009751085,0.0019562605,0.000027245169,0.00030698415,0.0037946035,0.0007403375,0.9825953,0.000019463057],"about_ca_topic_score_codex":0.014286647,"about_ca_topic_score_gemma":0.03035376,"teacher_disagreement_score":0.018632127,"about_ca_system_score_codex":0.001421087,"about_ca_system_score_gemma":0.0017041642,"threshold_uncertainty_score":0.062330604},"labels":[],"label_agreement":null},{"id":"W4407772294","doi":"10.51731/cjht.2025.1080","title":"Sotatercept (Winrevair)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.03244276372578249,"score_gpt":0.3376472932874215,"score_spread":0.305204529561639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407772294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02585093,0.8958526,0.002151533,0.0033066066,0.001628133,0.00046728493,0.003417294,0.00037774752,0.06694776],"genre_scores_gemma":[0.24305935,0.6967238,0.00511998,0.006154447,0.0007611238,0.00048388043,0.0047988165,0.00006366056,0.042834964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996056,0.000088114975,0.000046721525,0.00005228238,0.00016743528,0.000039843624],"domain_scores_gemma":[0.9997453,0.00006316032,0.000076539895,0.000008997268,0.000076805394,0.000029291126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061317696,0.0003024323,0.0005120409,0.0009784284,0.00021980747,0.0007254861,0.00039397556,0.00042210027,0.009823147],"category_scores_gemma":[0.000692681,0.00009893191,0.00056315714,0.0006685382,0.00016274695,0.00049684796,0.00025401832,0.0007416172,0.0024823816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018451634,0.00017980018,0.0006592014,0.007987478,0.00038832746,0.00019120547,0.000041748357,0.00026440006,0.0058214,0.0024611715,0.059771664,0.92038834],"study_design_scores_gemma":[0.0019916815,0.0020972267,0.0061537107,0.0034719077,0.00089726195,0.0024184105,0.00007666462,0.00033423258,0.0057431115,0.0009794493,0.97579986,0.00003648342],"about_ca_topic_score_codex":0.0041711754,"about_ca_topic_score_gemma":0.017762985,"teacher_disagreement_score":0.009823147,"about_ca_system_score_codex":0.00070343324,"about_ca_system_score_gemma":0.0010681668,"threshold_uncertainty_score":0.03286171},"labels":[],"label_agreement":null},{"id":"W4407772423","doi":"10.51731/cjht.2025.1081","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407772423","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18411982,0.3341518,0.006811118,0.033407856,0.0038779469,0.0012865886,0.0076230154,0.0024408808,0.426281],"genre_scores_gemma":[0.7529593,0.071840554,0.007920409,0.013996234,0.0009202335,0.0004868993,0.005995311,0.000114610506,0.1457665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998447,0.000017475893,0.000010831221,0.000027431737,0.000056897967,0.00004273491],"domain_scores_gemma":[0.9998548,0.00001961572,0.00002608896,0.000009928332,0.000031561412,0.000057898054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024635709,0.00018972628,0.00030631345,0.0003630096,0.0003185497,0.0004935403,0.0003608239,0.0005343958,0.014243441],"category_scores_gemma":[0.00050622754,0.0000888622,0.0002586986,0.00023780573,0.00014997477,0.00039694208,0.00029374956,0.001392329,0.0038954976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019142738,0.00034324246,0.0017258017,0.0007638981,0.00008131044,0.0009777265,0.000050804756,0.00033600588,0.019676397,0.0027501737,0.1103697,0.8610107],"study_design_scores_gemma":[0.0024544033,0.00196245,0.012749968,0.00057943346,0.000115712195,0.005299947,0.000047232545,0.0005277784,0.008850914,0.0009770067,0.966408,0.000027190863],"about_ca_topic_score_codex":0.005655519,"about_ca_topic_score_gemma":0.012408636,"teacher_disagreement_score":0.014243441,"about_ca_system_score_codex":0.0009141319,"about_ca_system_score_gemma":0.00080365466,"threshold_uncertainty_score":0.047649086},"labels":[],"label_agreement":null},{"id":"W4407850244","doi":"10.51731/cjht.2025.1085","title":"Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adapalene; Benzoyl peroxide; Clindamycin; Dermatology; Chemistry; Medicine; Organic chemistry; Antibiotics","score_opus":0.026654558932749726,"score_gpt":0.3470699517471535,"score_spread":0.3204153928144038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407850244","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014049303,0.96787685,0.0004377196,0.0010668044,0.00022427319,0.00014281485,0.00056017394,0.000028499924,0.015613485],"genre_scores_gemma":[0.13216929,0.855605,0.0028676246,0.00087059377,0.000156814,0.000098245095,0.0005128765,0.000011956357,0.00770763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993092,0.00014809534,0.00006293745,0.00005238509,0.00038124833,0.000046214784],"domain_scores_gemma":[0.999413,0.00018588199,0.00014146457,0.000011259221,0.00021472662,0.00003380478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069975783,0.00020940098,0.0005043117,0.00088306103,0.00024548345,0.00050463434,0.00020901179,0.00023986494,0.0026244475],"category_scores_gemma":[0.0011466776,0.0000813443,0.0005746268,0.00092501246,0.00014517808,0.00024013796,0.0001631805,0.0003435025,0.00031251597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007764963,0.000110845154,0.0017371101,0.020309431,0.00048354638,0.00016107324,0.00006038162,0.0002235031,0.010645805,0.0012399912,0.015350307,0.9489015],"study_design_scores_gemma":[0.00046745062,0.0023993792,0.035340074,0.012978427,0.0020440735,0.00219108,0.00027606048,0.00025600274,0.010502204,0.0004273568,0.9330777,0.000040279014],"about_ca_topic_score_codex":0.020330857,"about_ca_topic_score_gemma":0.1267087,"teacher_disagreement_score":0.020330857,"about_ca_system_score_codex":0.0015319131,"about_ca_system_score_gemma":0.0020793849,"threshold_uncertainty_score":0.040425003},"labels":[],"label_agreement":null},{"id":"W4407967855","doi":"10.51731/cjht.2025.1087","title":"Clascoterone (Winlevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.023119683710470604,"score_gpt":0.31215251029477653,"score_spread":0.2890328265843059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407967855","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3438852,0.42377478,0.005525059,0.01944327,0.0030439033,0.0022167973,0.007569775,0.0019097006,0.19263157],"genre_scores_gemma":[0.871315,0.050426804,0.003122735,0.006655027,0.0004892071,0.00030713514,0.004016154,0.00008271225,0.063585185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997868,0.0000372859,0.000018412287,0.000044659355,0.00007379645,0.000039192928],"domain_scores_gemma":[0.99983585,0.000038978873,0.000032780146,0.0000088417,0.000032943168,0.00005063776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028615916,0.00024386097,0.00045849558,0.00081527315,0.00032000555,0.0005283399,0.0003763023,0.0006463653,0.013441989],"category_scores_gemma":[0.00067474815,0.00010092878,0.00038618746,0.0003834374,0.00018929351,0.0003797922,0.00042454372,0.0010571259,0.0031977042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014353923,0.0016744882,0.002676016,0.006203269,0.00043178082,0.0014517022,0.00017414786,0.00064045266,0.050789006,0.0036441323,0.05263424,0.8653268],"study_design_scores_gemma":[0.025782395,0.019913487,0.028535428,0.0029119328,0.00087186287,0.015988668,0.00038398601,0.0013964433,0.06500636,0.0029094513,0.8361523,0.0001477008],"about_ca_topic_score_codex":0.0041813427,"about_ca_topic_score_gemma":0.011002514,"teacher_disagreement_score":0.013441989,"about_ca_system_score_codex":0.0006341227,"about_ca_system_score_gemma":0.00083469367,"threshold_uncertainty_score":0.04496789},"labels":[],"label_agreement":null},{"id":"W4408026696","doi":"10.51731/cjht.2025.1088","title":"Crushed Buprenorphine-Naloxone Tablets","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; (+)-Naloxone; Medicine; Anesthesia; Opioid; Internal medicine","score_opus":0.015234740472624573,"score_gpt":0.29161165684631285,"score_spread":0.2763769163736883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408026696","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016696622,0.9602405,0.0006579239,0.027933156,0.003134396,0.0015574285,0.0014324024,0.000041562173,0.003332933],"genre_scores_gemma":[0.017582541,0.9312202,0.005523285,0.038229696,0.0032044412,0.00217712,0.00070689176,0.00006874313,0.001287092],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.95383424,0.012565456,0.023375317,0.001441314,0.008258467,0.000525238],"domain_scores_gemma":[0.7918686,0.1186764,0.04756479,0.002785917,0.03774941,0.0013549076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039777063,0.0011348007,0.007636842,0.010627884,0.0012200384,0.007649081,0.0037848318,0.0064409366,0.010833911],"category_scores_gemma":[0.18164651,0.0017136363,0.0071385256,0.009630855,0.0024347883,0.0086473,0.0026090145,0.0031744628,0.0020671554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048183228,0.000035476936,0.0014883396,0.8197374,0.0026947462,0.00027347123,0.00060195784,0.000047914356,0.0003176127,0.0010355144,0.020504242,0.15278155],"study_design_scores_gemma":[0.0005363233,0.00018728236,0.0023805185,0.87881607,0.008584623,0.00045967638,0.0008491364,0.000062091,0.00030668173,0.0014199733,0.106339775,0.000057706307],"about_ca_topic_score_codex":0.0074899374,"about_ca_topic_score_gemma":0.021072183,"teacher_disagreement_score":0.039777063,"about_ca_system_score_codex":0.00467277,"about_ca_system_score_gemma":0.017330162,"threshold_uncertainty_score":0.21036369},"labels":[],"label_agreement":null},{"id":"W4408113763","doi":"10.51731/cjht.2025.1090","title":"Planning for the Introduction of New CT Services in Rural and Remote Communities in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental planning; Business; Medicine; Geography; Computer science","score_opus":0.03175689798182077,"score_gpt":0.326745204668316,"score_spread":0.2949883066864952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408113763","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6792107,0.008711416,0.0074768486,0.13623294,0.000640483,0.0029391581,0.003689814,0.000495843,0.16060284],"genre_scores_gemma":[0.94602084,0.006041952,0.016706549,0.009480396,0.000119204946,0.0004934292,0.0013485095,0.00010132879,0.019687846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748456,0.00037047398,0.00007977645,0.00011843138,0.00054914196,0.0013976402],"domain_scores_gemma":[0.99005085,0.0006454605,0.0003788777,0.000049627342,0.0016203702,0.0072548524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014146348,0.0002531781,0.00025552118,0.001751682,0.009285929,0.0028339024,0.0017826359,0.00090053893,0.009003152],"category_scores_gemma":[0.0050907703,0.00037158924,0.0006869141,0.0015728178,0.0012557816,0.0010613742,0.0030826237,0.0018978034,0.0005641948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037837023,0.000989366,0.3582435,0.0013253973,0.00017214325,0.012738462,0.01960749,0.007088204,0.0039532655,0.013816694,0.21124202,0.37044504],"study_design_scores_gemma":[0.00021980604,0.0004809891,0.6066144,0.0027537546,0.00017022363,0.0026210297,0.11558186,0.012253771,0.0013952316,0.0082959,0.24924873,0.00036430996],"about_ca_topic_score_codex":0.9726725,"about_ca_topic_score_gemma":0.9919796,"teacher_disagreement_score":0.04906308,"about_ca_system_score_codex":0.04906308,"about_ca_system_score_gemma":0.17712939,"threshold_uncertainty_score":0.3559792},"labels":[],"label_agreement":null},{"id":"W4408164497","doi":"10.51731/cjht.2025.1091","title":"Faricimab (Vabysmo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.008818780460101457,"score_gpt":0.24638145107353843,"score_spread":0.23756267061343697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408164497","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.192958,0.5185815,0.004967682,0.0148015395,0.004536639,0.00087125564,0.006382269,0.0021276388,0.25477362],"genre_scores_gemma":[0.81784844,0.062162336,0.004935816,0.0092524225,0.0008219306,0.00024489104,0.008352844,0.00008368351,0.096297614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998056,0.000025425024,0.000014759849,0.00003907394,0.000060806018,0.00005428999],"domain_scores_gemma":[0.99987435,0.000015784772,0.000023258955,0.000009757508,0.000027386754,0.00004939852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000190458,0.00039591565,0.0005001096,0.00043779908,0.00032635394,0.0004859894,0.00046648283,0.00088029087,0.014161139],"category_scores_gemma":[0.0004155241,0.00011788479,0.00038446704,0.00025928378,0.00017229008,0.00027771224,0.00029291786,0.0014801268,0.0071561076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030726942,0.000828892,0.0027962315,0.0013389273,0.0002124078,0.0028837859,0.00009253958,0.0006789353,0.0875429,0.0027259234,0.08766349,0.8101632],"study_design_scores_gemma":[0.0029187745,0.003968044,0.016442325,0.0005920631,0.00013883946,0.016143443,0.00007918396,0.00063204276,0.03210393,0.0010514394,0.92586935,0.000060625895],"about_ca_topic_score_codex":0.0037712064,"about_ca_topic_score_gemma":0.006250958,"teacher_disagreement_score":0.014161139,"about_ca_system_score_codex":0.00082449394,"about_ca_system_score_gemma":0.0005029449,"threshold_uncertainty_score":0.047373712},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4408194139","doi":"10.51731/cjht.2025.1092","title":"Alectinib (Alecensaro)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alectinib; Medicine; Internal medicine","score_opus":0.022852287882387443,"score_gpt":0.31484878507832437,"score_spread":0.2919964971959369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408194139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017124264,0.8643256,0.00158075,0.0069813747,0.00095844746,0.00039351077,0.0048420816,0.00037496493,0.10341914],"genre_scores_gemma":[0.2503287,0.6600711,0.0042580497,0.008464627,0.0008105113,0.00039042975,0.008054535,0.00004207398,0.06758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997565,0.00004466243,0.000024713205,0.000034854565,0.000100753896,0.000038584054],"domain_scores_gemma":[0.99982256,0.00002736372,0.00005537205,0.0000065665035,0.000057743335,0.000030477275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041713598,0.0003266674,0.00036136433,0.00085831236,0.0002606244,0.00074692426,0.00033544606,0.0003742647,0.0084044775],"category_scores_gemma":[0.0007159847,0.00007484123,0.0004860626,0.0007331039,0.00018302909,0.0003134712,0.00029909206,0.00071892777,0.0025120035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014373487,0.00013139794,0.0012933325,0.005110402,0.00032121892,0.00024878347,0.00003566047,0.00043531437,0.005726319,0.0033176222,0.096266456,0.88567615],"study_design_scores_gemma":[0.00081721926,0.0005915114,0.0040819775,0.0020361487,0.0003393853,0.0014059539,0.000021576141,0.000137344,0.0030316892,0.00044129248,0.9870788,0.000017199145],"about_ca_topic_score_codex":0.013225673,"about_ca_topic_score_gemma":0.05262234,"teacher_disagreement_score":0.013225673,"about_ca_system_score_codex":0.0015132768,"about_ca_system_score_gemma":0.002128895,"threshold_uncertainty_score":0.02811575},"labels":[],"label_agreement":null},{"id":"W4408247275","doi":"10.51731/cjht.2025.1095","title":"Environmental Scan of Genetic and Genomic Biomarker Testing Assessment Frameworks, Processes, and Inventories in Cancer Care","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Cancer; Genetic testing; Computational biology; Medicine; Genetics; Biology; Internal medicine","score_opus":0.011932026990877725,"score_gpt":0.25361355347762266,"score_spread":0.24168152648674493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408247275","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08157477,0.15475066,0.055020336,0.4729079,0.0015931297,0.002735326,0.023176054,0.00058754365,0.20765425],"genre_scores_gemma":[0.771487,0.058863096,0.109105214,0.045162458,0.00034109462,0.0024431557,0.006533284,0.0003394209,0.005725292],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.8495046,0.06747105,0.012915527,0.008708989,0.051458318,0.009941521],"domain_scores_gemma":[0.6352257,0.21914324,0.01301725,0.009223806,0.11774115,0.005648825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11107118,0.0010564347,0.0014538483,0.019944195,0.014747601,0.020070715,0.0051734657,0.0025715858,0.004162896],"category_scores_gemma":[0.22764562,0.001249488,0.002194524,0.04221016,0.017435972,0.008582657,0.0104469545,0.0053967293,0.00031790376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028271953,0.0001139119,0.059660513,0.016107963,0.000557756,0.000995094,0.0814927,0.0060494747,0.00061426224,0.48406884,0.07259145,0.27746537],"study_design_scores_gemma":[0.00011836976,0.000109580884,0.057424773,0.050940197,0.0012058113,0.00049104705,0.10195029,0.006064967,0.0019131406,0.14122376,0.6380665,0.00049160887],"about_ca_topic_score_codex":0.95353645,"about_ca_topic_score_gemma":0.9604217,"teacher_disagreement_score":0.2905374,"about_ca_system_score_codex":0.2905374,"about_ca_system_score_gemma":0.4879082,"threshold_uncertainty_score":0.8228761},"labels":[],"label_agreement":null},{"id":"W4408410037","doi":"10.51731/cjht.2025.1096","title":"Virtual Remote Imaging Services: CT and MRI Scanning","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Remote sensing; Computer vision; Radiology; Geology; Medical physics; Medicine","score_opus":0.015620295828686615,"score_gpt":0.32079845710943716,"score_spread":0.30517816128075054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408410037","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040088315,0.01704991,0.07767177,0.048154537,0.0036303187,0.00095604255,0.008486478,0.01292536,0.7910373],"genre_scores_gemma":[0.5038654,0.027304647,0.114246346,0.023018116,0.0053156344,0.0007359982,0.010169438,0.003690248,0.3116542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888545,0.00016419779,0.000070568814,0.00012769725,0.00051868625,0.00023330624],"domain_scores_gemma":[0.9971539,0.000287484,0.00021343266,0.00024663084,0.00082720135,0.001271331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010928962,0.000647692,0.00032259827,0.0018127459,0.0017647964,0.002456107,0.0017855164,0.0016626702,0.11687877],"category_scores_gemma":[0.003852398,0.0004250215,0.0005296251,0.0017537444,0.0012393177,0.0016266366,0.0038695657,0.0014736463,0.02361656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000391119,0.00020672986,0.0130594075,0.000715634,0.00004755587,0.0018771547,0.0005132683,0.00141164,0.004686956,0.011100868,0.44709587,0.51889384],"study_design_scores_gemma":[0.00014987502,0.00016814207,0.027303562,0.0007340089,0.000055119748,0.013184458,0.00083583023,0.002842343,0.002529151,0.008766086,0.94330865,0.00012271633],"about_ca_topic_score_codex":0.10417934,"about_ca_topic_score_gemma":0.13368393,"teacher_disagreement_score":0.11687877,"about_ca_system_score_codex":0.0032448962,"about_ca_system_score_gemma":0.009928255,"threshold_uncertainty_score":0.39099848},"labels":[],"label_agreement":null},{"id":"W4408545865","doi":"10.51731/cjht.2025.1098","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Internal medicine; Cystic fibrosis","score_opus":0.016675598816513777,"score_gpt":0.3309302250631296,"score_spread":0.3142546262466158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408545865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039468072,0.970917,0.0004262247,0.000998769,0.00025884892,0.0001803436,0.001448426,0.000043259235,0.021780377],"genre_scores_gemma":[0.04609205,0.9342482,0.002710942,0.001204008,0.00017528614,0.00016217535,0.0019190487,0.000017928667,0.013470388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838436,0.00036550246,0.00020493778,0.00010071285,0.00081423594,0.00013028066],"domain_scores_gemma":[0.998351,0.00054989156,0.0003868273,0.000034258668,0.0005966823,0.00008142491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016571388,0.00039149204,0.0007263993,0.0019307827,0.00031312497,0.0013832123,0.0004649652,0.00047704056,0.007923306],"category_scores_gemma":[0.0032510862,0.00013662678,0.001312302,0.001954343,0.00033545741,0.0006027734,0.00030487624,0.0006092631,0.001027947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006880804,0.00006869019,0.0020223886,0.02892558,0.0008750878,0.00022688105,0.00009015594,0.0003874323,0.0022736157,0.0038777422,0.04631327,0.914251],"study_design_scores_gemma":[0.00031572074,0.0005273574,0.0117133,0.018300861,0.0013998777,0.0009494461,0.0001363505,0.00013160972,0.0012078437,0.00057265017,0.9647167,0.00002825007],"about_ca_topic_score_codex":0.057697177,"about_ca_topic_score_gemma":0.19444457,"teacher_disagreement_score":0.9423028,"about_ca_system_score_codex":0.0035823681,"about_ca_system_score_gemma":0.00667597,"threshold_uncertainty_score":0.11472267},"labels":[],"label_agreement":null},{"id":"W4408546184","doi":"10.51731/cjht.2025.1097","title":"Comparative Effectiveness of Real-Time Teleultrasound Versus In-Person Ultrasound","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Flow Measurement and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ultrasound; Psychology; Medicine; Radiology","score_opus":0.026870403669671576,"score_gpt":0.26901858000114304,"score_spread":0.24214817633147145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408546184","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3904947,0.5378807,0.0044556716,0.02026319,0.009191743,0.01332573,0.0051897108,0.00020048142,0.018998004],"genre_scores_gemma":[0.90442777,0.06614858,0.008685073,0.007493976,0.004086742,0.0061617726,0.0012532483,0.000103117614,0.001639826],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9574125,0.02893529,0.007454415,0.0016366933,0.0035672637,0.0009938997],"domain_scores_gemma":[0.87778294,0.089421764,0.020589141,0.0034143252,0.006157551,0.0026343232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02887342,0.0008798887,0.0044779144,0.001808907,0.000495501,0.0030782747,0.0017299067,0.003725675,0.012745092],"category_scores_gemma":[0.11997896,0.0005168907,0.01020259,0.0020108426,0.0014577932,0.004241529,0.0011374977,0.002128126,0.0014698866],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28723145,0.0078104218,0.021582121,0.12578559,0.03916103,0.00037083722,0.0012293794,0.0019088857,0.00087630755,0.0024093047,0.0077043986,0.5039303],"study_design_scores_gemma":[0.19430156,0.33553085,0.102488995,0.11176435,0.1723194,0.0013685648,0.0040328256,0.005782747,0.0054978523,0.0076434654,0.058445357,0.00082409097],"about_ca_topic_score_codex":0.0026162611,"about_ca_topic_score_gemma":0.003046977,"teacher_disagreement_score":0.02887342,"about_ca_system_score_codex":0.002485729,"about_ca_system_score_gemma":0.0036009673,"threshold_uncertainty_score":0.15269905},"labels":[],"label_agreement":null},{"id":"W4408618859","doi":"10.51731/cjht.2025.1099","title":"Talquetamab (Talvey)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.2889593708010012,"score_gpt":0.42972959860994586,"score_spread":0.14077022780894466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408618859","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14098775,0.33503237,0.0061868117,0.043466553,0.007074431,0.004464609,0.01860749,0.006928065,0.43725193],"genre_scores_gemma":[0.5710027,0.11045297,0.008217574,0.04195109,0.0018839728,0.0014880983,0.021130817,0.0006364205,0.24323633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994773,0.00008852783,0.00002869764,0.00007757228,0.00020426,0.00012368347],"domain_scores_gemma":[0.9994912,0.0000619269,0.00006678568,0.000028075441,0.00013855836,0.00021338362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008574267,0.0005771002,0.0010391783,0.0015391345,0.0008830854,0.0018025555,0.0010999324,0.0016951123,0.055621088],"category_scores_gemma":[0.0013858296,0.0002289996,0.0010781356,0.0008091619,0.00062273303,0.00075751776,0.00095499324,0.00291523,0.013029967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008727351,0.001546378,0.0016447323,0.003692985,0.0003374184,0.0011180952,0.00024342886,0.0005803311,0.016232636,0.0058962563,0.22598132,0.7339992],"study_design_scores_gemma":[0.014185061,0.0052056056,0.0062571126,0.0013238548,0.00036901445,0.0026803496,0.00017966534,0.00074708357,0.007715985,0.0020239956,0.9592393,0.00007298906],"about_ca_topic_score_codex":0.014579434,"about_ca_topic_score_gemma":0.03583168,"teacher_disagreement_score":0.055621088,"about_ca_system_score_codex":0.0020803637,"about_ca_system_score_gemma":0.0027298254,"threshold_uncertainty_score":0.1860711},"labels":[],"label_agreement":null},{"id":"W4408650636","doi":"10.51731/cjht.2025.1101","title":"Danicopan (Voydeya)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chemical synthesis and alkaloids","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.012827854740274846,"score_gpt":0.25479139510980947,"score_spread":0.24196354036953463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408650636","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04308556,0.60482955,0.0045776954,0.0037396816,0.0024976237,0.0007810934,0.006043757,0.0008467271,0.33359826],"genre_scores_gemma":[0.40299422,0.34773406,0.0120215,0.004223254,0.0004921127,0.00034549015,0.005639956,0.0001932434,0.22635625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998969,0.000014464263,0.000006600369,0.000027601753,0.000039608447,0.000014892386],"domain_scores_gemma":[0.99991584,0.000014948533,0.000017424549,0.0000045944867,0.000025638896,0.000021546424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017498409,0.00032548734,0.00026973107,0.0011501476,0.00036075214,0.0005708707,0.00035513734,0.0003168058,0.020159066],"category_scores_gemma":[0.00031017905,0.00009850915,0.0002667506,0.00043725417,0.0002181131,0.00030862275,0.00040429045,0.00068804855,0.003183216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045732147,0.0001275737,0.0006964673,0.0074307243,0.00009052854,0.00048058145,0.00010869394,0.00040844688,0.034169722,0.013030436,0.072771706,0.8702278],"study_design_scores_gemma":[0.00011080948,0.000362016,0.0021443893,0.0010613254,0.00007384256,0.00096983125,0.000041680003,0.00012449511,0.006613148,0.00074231357,0.9877413,0.000014769625],"about_ca_topic_score_codex":0.0065501407,"about_ca_topic_score_gemma":0.017952492,"teacher_disagreement_score":0.020159066,"about_ca_system_score_codex":0.0006399223,"about_ca_system_score_gemma":0.0010033982,"threshold_uncertainty_score":0.06743878},"labels":[],"label_agreement":null},{"id":"W4408650838","doi":"10.51731/cjht.2025.1100","title":"Tarlatamab (Imdelltra)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01959808958604087,"score_gpt":0.30008057881005523,"score_spread":0.28048248922401436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408650838","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16770694,0.35732082,0.0111436155,0.027323693,0.0042138663,0.0017672819,0.012814468,0.0077325115,0.40997675],"genre_scores_gemma":[0.7127801,0.06379402,0.010877846,0.017837072,0.0012711374,0.0007164995,0.017751206,0.00026317147,0.17470895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997744,0.000032185646,0.000017510034,0.00004207627,0.00007135994,0.00006238255],"domain_scores_gemma":[0.99981767,0.00002078292,0.00004051642,0.000015427213,0.00003838847,0.00006719861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035340505,0.00042551084,0.00052785286,0.000654676,0.00031972653,0.00089786144,0.0005360314,0.00086256047,0.025594011],"category_scores_gemma":[0.0005527362,0.00014311691,0.00048962253,0.00042375003,0.0002438591,0.00054392515,0.00043995492,0.0020264469,0.010554906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031465094,0.00069901126,0.0015315337,0.0010875269,0.00012240198,0.0012352859,0.00008440852,0.00051170564,0.023126483,0.00459825,0.10060791,0.86324906],"study_design_scores_gemma":[0.0072818184,0.0041303653,0.006844459,0.0005376167,0.0001807481,0.008685975,0.000058552632,0.0009827998,0.021004323,0.0017364887,0.94850904,0.00004790791],"about_ca_topic_score_codex":0.0026704052,"about_ca_topic_score_gemma":0.004232506,"teacher_disagreement_score":0.025594011,"about_ca_system_score_codex":0.001228714,"about_ca_system_score_gemma":0.00070900994,"threshold_uncertainty_score":0.08562052},"labels":[],"label_agreement":null},{"id":"W4408838287","doi":"10.51731/cjht.2025.1102","title":"Enfortumab Vedotin (Padcev)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.019832781524393564,"score_gpt":0.31844238124807966,"score_spread":0.2986095997236861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408838287","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035672434,0.86894226,0.001958097,0.003446085,0.000551933,0.00035957329,0.002569595,0.00020062846,0.08629936],"genre_scores_gemma":[0.3713053,0.583918,0.0065296427,0.0029035541,0.00025880046,0.00021477368,0.003967736,0.00004459999,0.030857736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996082,0.000081712,0.000029686447,0.000031950185,0.00020829448,0.00004022844],"domain_scores_gemma":[0.9996356,0.00008848394,0.00009641402,0.000010612498,0.0001301117,0.00003875824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006322451,0.00019288516,0.00023755597,0.0006916664,0.00021123202,0.00065678236,0.00034787453,0.00026315826,0.0047496674],"category_scores_gemma":[0.0010328414,0.00006383912,0.000336992,0.0006555689,0.000180933,0.00028679665,0.00022026566,0.0005544905,0.0006207082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006050274,0.00009803642,0.0018287644,0.0053089675,0.00017575192,0.00023569468,0.00004521114,0.00039155895,0.00697103,0.0036164017,0.032968953,0.94775456],"study_design_scores_gemma":[0.00039405056,0.0008149989,0.006718943,0.0028755122,0.00029350928,0.001878197,0.00008049167,0.00024338318,0.0077191503,0.00050601776,0.97846013,0.00001558866],"about_ca_topic_score_codex":0.01507636,"about_ca_topic_score_gemma":0.055024907,"teacher_disagreement_score":0.01507636,"about_ca_system_score_codex":0.0015553923,"about_ca_system_score_gemma":0.00234405,"threshold_uncertainty_score":0.029977202},"labels":[],"label_agreement":null},{"id":"W4408871724","doi":"10.51731/cjht.2025.1103","title":"2025 Watch List: Artificial Intelligence in Health Care","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Artificial intelligence; Computer science; Psychology","score_opus":0.12810152704414343,"score_gpt":0.4406847268809778,"score_spread":0.31258319983683436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408871724","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027500404,0.16455121,0.002109377,0.4519994,0.09155468,0.0002253311,0.00365054,0.0016131016,0.28402147],"genre_scores_gemma":[0.0093061635,0.28346983,0.0062919455,0.22164208,0.055690575,0.00049888605,0.010425475,0.0013216636,0.41135347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920581,0.0010614481,0.0004259222,0.0004906748,0.0045609623,0.0014030517],"domain_scores_gemma":[0.9598055,0.007496878,0.0012211554,0.001025211,0.023225851,0.0072252913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071756146,0.0015322297,0.0017887318,0.0058824574,0.004145425,0.017973412,0.0033731305,0.013387616,0.13484202],"category_scores_gemma":[0.022673877,0.0007085993,0.0011715244,0.0077780224,0.003415196,0.014095333,0.0039394544,0.009601808,0.07812494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000682616,0.000008711015,0.00005044393,0.00014187492,0.0000024245574,0.000008625373,0.000011376755,0.000024153987,0.000023269902,0.005199457,0.96770054,0.02682231],"study_design_scores_gemma":[0.000006649787,0.000009934807,0.00028962584,0.00085558294,0.0000040656,0.000015511061,0.000051633127,0.000079145546,0.000028423407,0.0029427584,0.99570197,0.000014649434],"about_ca_topic_score_codex":0.16816045,"about_ca_topic_score_gemma":0.21092375,"teacher_disagreement_score":0.16816045,"about_ca_system_score_codex":0.017955957,"about_ca_system_score_gemma":0.036536794,"threshold_uncertainty_score":0.45109153},"labels":[],"label_agreement":null},{"id":"W4408940911","doi":"10.51731/cjht.2025.1104","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Philosophy; Medicine; Psychology; Internal medicine; Leukemia","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940911","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017980546,0.8435696,0.0015155944,0.003850053,0.0012535312,0.0003859817,0.0041747293,0.0004310958,0.12683885],"genre_scores_gemma":[0.24480934,0.62895256,0.0058783195,0.006850792,0.0010586173,0.00038877985,0.008695036,0.00010012078,0.10326655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971,0.000061083476,0.000013546411,0.000038752405,0.00013488639,0.000041570227],"domain_scores_gemma":[0.9997856,0.00005676854,0.00004859608,0.000009634517,0.00004922292,0.000050158913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422374,0.00020495101,0.0003270354,0.0007986877,0.00033467717,0.0009009475,0.0003739435,0.00043740383,0.01649772],"category_scores_gemma":[0.0007431577,0.00007408712,0.00031490476,0.0008501942,0.00025188708,0.00028929987,0.00026737063,0.0011790224,0.002165489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072669965,0.0001529935,0.0008242144,0.00403822,0.0001149169,0.00033429667,0.000054140364,0.00024053927,0.0046940115,0.0054221437,0.13800853,0.8453893],"study_design_scores_gemma":[0.0006212487,0.000557279,0.003968762,0.0017515229,0.00011700803,0.0015112952,0.000033955097,0.00011068223,0.0019851585,0.00052864355,0.98880076,0.000013747597],"about_ca_topic_score_codex":0.020069623,"about_ca_topic_score_gemma":0.069845326,"teacher_disagreement_score":0.020069623,"about_ca_system_score_codex":0.0011375579,"about_ca_system_score_gemma":0.0017206464,"threshold_uncertainty_score":0.055190384},"labels":[],"label_agreement":null},{"id":"W4409040539","doi":"10.51731/cjht.2025.1108","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04058088739669979,"score_gpt":0.3538447205249171,"score_spread":0.3132638331282173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409040539","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012030994,0.93568635,0.0009419413,0.0023047926,0.00049378135,0.00021080002,0.0018911883,0.00018140428,0.046258684],"genre_scores_gemma":[0.15208562,0.8050163,0.00447144,0.0034915637,0.00045635286,0.00026308055,0.0040572826,0.000061105064,0.030097356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995222,0.00007776865,0.000039283124,0.000042038464,0.00026728655,0.000051404637],"domain_scores_gemma":[0.9994746,0.00014307936,0.00013045751,0.000010977304,0.00017808775,0.00006283487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006851475,0.00019115898,0.00040702877,0.0011689807,0.00020151018,0.0010533986,0.00033797877,0.00038166431,0.004977065],"category_scores_gemma":[0.00097311346,0.000073809,0.0004584678,0.0010595658,0.00019954448,0.0003581282,0.00019753994,0.0005223451,0.0008199739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053619914,0.00006804082,0.00098154,0.0065234643,0.00015758393,0.00013802802,0.000036300276,0.00022207218,0.004195157,0.0021669269,0.050498422,0.9344763],"study_design_scores_gemma":[0.00029681227,0.00063191366,0.0048033977,0.0024923254,0.00029524317,0.00075685035,0.000047002664,0.00014838511,0.0030152162,0.00023682721,0.98725986,0.000016248954],"about_ca_topic_score_codex":0.019168373,"about_ca_topic_score_gemma":0.085715786,"teacher_disagreement_score":0.019168373,"about_ca_system_score_codex":0.002342145,"about_ca_system_score_gemma":0.0031305696,"threshold_uncertainty_score":0.038113594},"labels":[],"label_agreement":null},{"id":"W4409040555","doi":"10.51731/cjht.2025.1105","title":"Iptacopan (Fabhalta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.011168223352784949,"score_gpt":0.2755146141664529,"score_spread":0.26434639081366795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409040555","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08424447,0.156632,0.009207995,0.015240331,0.0041018003,0.0019707445,0.013543328,0.013218392,0.7018408],"genre_scores_gemma":[0.48692524,0.06695042,0.014331635,0.027117424,0.0019333214,0.0012689851,0.025471324,0.0011782118,0.37482336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998024,0.000019487605,0.000010046178,0.000037392634,0.00008220408,0.000048459173],"domain_scores_gemma":[0.99983823,0.000020146408,0.00002205702,0.000011756038,0.000031383173,0.00007647425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023134008,0.00058386556,0.0005355987,0.0009032557,0.00037533912,0.0008235379,0.0006799303,0.00088373397,0.0714709],"category_scores_gemma":[0.0006695547,0.00017340618,0.000610803,0.000406384,0.00022079259,0.0005212103,0.0006840654,0.0018756943,0.032957204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002910907,0.0008073932,0.0013509151,0.0011699225,0.00013050438,0.0017729352,0.000066737106,0.00041870394,0.015455284,0.0025399856,0.22515698,0.7482198],"study_design_scores_gemma":[0.003690436,0.0021606819,0.0064897304,0.0004133965,0.00016828049,0.00800211,0.00003393663,0.0007904975,0.009056451,0.0015403117,0.96761894,0.000035176017],"about_ca_topic_score_codex":0.0029504057,"about_ca_topic_score_gemma":0.004737664,"teacher_disagreement_score":0.0714709,"about_ca_system_score_codex":0.0009007213,"about_ca_system_score_gemma":0.0008098948,"threshold_uncertainty_score":0.23909396},"labels":[],"label_agreement":null},{"id":"W4409070048","doi":"10.51731/cjht.2025.1107","title":"Lisocabtagene Maraleucel (Breyanzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.017356380450986045,"score_gpt":0.2815971523766693,"score_spread":0.2642407719256833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409070048","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030169852,0.76528925,0.0030219506,0.006260838,0.0009866947,0.00051945046,0.00406492,0.0010734879,0.18861356],"genre_scores_gemma":[0.35833442,0.40985215,0.0068997643,0.006396868,0.0006613929,0.0004713638,0.0069106505,0.00023023179,0.21024314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970657,0.00007017625,0.00001547067,0.000041001113,0.00013108399,0.000035625646],"domain_scores_gemma":[0.99971527,0.00006455101,0.000063881154,0.0000111024165,0.00008722971,0.000057899142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054291054,0.00028891533,0.00046362734,0.0010924152,0.00029655336,0.0008297014,0.00043709768,0.00062379125,0.021409482],"category_scores_gemma":[0.0008013165,0.000109640765,0.00039117996,0.0007076339,0.0003368754,0.00034154535,0.00034641853,0.0010961227,0.004551285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021275496,0.00024279354,0.00078598905,0.0052160546,0.00011299535,0.00042252845,0.00010556711,0.00028516498,0.013832992,0.004488562,0.082399346,0.88998055],"study_design_scores_gemma":[0.0006429733,0.0010462521,0.0024541179,0.0012398761,0.00011229979,0.0011084053,0.00004692732,0.00016763991,0.0048427903,0.00030442086,0.9880179,0.000016534803],"about_ca_topic_score_codex":0.017270127,"about_ca_topic_score_gemma":0.058360398,"teacher_disagreement_score":0.98272985,"about_ca_system_score_codex":0.0016044147,"about_ca_system_score_gemma":0.0018683332,"threshold_uncertainty_score":0.071621835},"labels":[],"label_agreement":null},{"id":"W4409183810","doi":"10.51731/cjht.2025.1110","title":"Fruquintinib (Fruzaqla)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.025099684938005035,"score_gpt":0.3499035703777737,"score_spread":0.3248038854397687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409183810","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011759512,0.8740487,0.0011936162,0.006281077,0.00081313646,0.00034471956,0.0047150664,0.0002596142,0.10058458],"genre_scores_gemma":[0.28129676,0.64274377,0.006961713,0.008430881,0.0009908498,0.00036244432,0.008612314,0.00006569989,0.050535582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993049,0.00017834864,0.000052299405,0.00007023555,0.00033021288,0.00006395257],"domain_scores_gemma":[0.9992986,0.00015615734,0.00017963798,0.000017656723,0.0002855584,0.000062467145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013024495,0.00026250572,0.00031704752,0.00086582877,0.00023920742,0.0007905987,0.00036608367,0.00038466172,0.009394281],"category_scores_gemma":[0.0019667982,0.00007587385,0.00059570646,0.00088712975,0.00020810244,0.00036419908,0.0002285008,0.00047522582,0.0013636545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034680357,0.000036870024,0.00096202956,0.0031280636,0.00016314644,0.0000765194,0.0000331894,0.00020085103,0.0015289452,0.0024876993,0.0810983,0.90993756],"study_design_scores_gemma":[0.00040632163,0.0004373284,0.00511101,0.0020575724,0.00026694557,0.0008021194,0.000034388908,0.0001242105,0.0012443702,0.00045755564,0.98904026,0.000017955574],"about_ca_topic_score_codex":0.027427018,"about_ca_topic_score_gemma":0.09665875,"teacher_disagreement_score":0.027427018,"about_ca_system_score_codex":0.0023355826,"about_ca_system_score_gemma":0.0027709182,"threshold_uncertainty_score":0.054534733},"labels":[],"label_agreement":null},{"id":"W4409266272","doi":"10.51731/cjht.2025.1111","title":"Spesolimab (Spevigo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.00952296609788956,"score_gpt":0.26550730500820074,"score_spread":0.2559843389103112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409266272","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017037096,0.8938109,0.002193372,0.0030691742,0.00096085283,0.0003307695,0.003613134,0.0004203704,0.07856434],"genre_scores_gemma":[0.19359604,0.6906462,0.006499929,0.006099553,0.0007022588,0.00031268495,0.008403563,0.00007981046,0.09365989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996954,0.000049725804,0.00002249502,0.000040242692,0.00014894422,0.000043096275],"domain_scores_gemma":[0.9997625,0.00004043575,0.000053802847,0.000009140855,0.000096002346,0.000038151422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047221888,0.0003590278,0.0003638184,0.001231655,0.00026210686,0.00066598697,0.00033016186,0.00055661064,0.013270172],"category_scores_gemma":[0.00045837535,0.000103870465,0.00055724266,0.0008392104,0.00020899644,0.00033151841,0.000305811,0.00070899306,0.0038629542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076634705,0.00013430767,0.00055454177,0.005930275,0.000119943856,0.00030171976,0.000040606927,0.00022112929,0.019019164,0.0018499224,0.063851826,0.9072102],"study_design_scores_gemma":[0.00028724284,0.0008539669,0.0026950564,0.0013925977,0.00014883898,0.0020496096,0.00003703662,0.00007055555,0.007951213,0.00035889525,0.984143,0.000011932883],"about_ca_topic_score_codex":0.006135422,"about_ca_topic_score_gemma":0.023560587,"teacher_disagreement_score":0.013270172,"about_ca_system_score_codex":0.0010435197,"about_ca_system_score_gemma":0.0013137031,"threshold_uncertainty_score":0.044393122},"labels":[],"label_agreement":null},{"id":"W4409268403","doi":"10.51731/cjht.2025.1112","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409268403","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0282569,0.84662247,0.0024253915,0.0028109127,0.00072538166,0.0003295556,0.0041519306,0.00034204856,0.11433542],"genre_scores_gemma":[0.24762684,0.6618576,0.008995203,0.003443197,0.0005666371,0.0002673887,0.00840667,0.00015006258,0.0686864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99946374,0.000081912796,0.000030135152,0.000041134244,0.0003442504,0.000038897495],"domain_scores_gemma":[0.99925953,0.00022966103,0.00012100636,0.000023888679,0.0002955931,0.00007034825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095717306,0.00023830144,0.0003386887,0.0011419626,0.00025856073,0.00092485914,0.00036268894,0.00043537212,0.010936585],"category_scores_gemma":[0.0013586127,0.00007248297,0.00038157628,0.00093128625,0.00029908124,0.00040504715,0.00025370004,0.00048345124,0.0014692799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060439174,0.00009921887,0.0015562855,0.0050998745,0.00010726072,0.00028180206,0.00008504075,0.00022114256,0.007571381,0.004383474,0.06937264,0.9106175],"study_design_scores_gemma":[0.00011983892,0.00044372914,0.0053094006,0.0016906841,0.00013014695,0.0010658181,0.00006225646,0.00010385476,0.0054539526,0.00021473573,0.9853914,0.000014221231],"about_ca_topic_score_codex":0.03418599,"about_ca_topic_score_gemma":0.09212835,"teacher_disagreement_score":0.965814,"about_ca_system_score_codex":0.0020660728,"about_ca_system_score_gemma":0.0030137629,"threshold_uncertainty_score":0.06797403},"labels":[],"label_agreement":null},{"id":"W4409333523","doi":"10.51731/cjht.2025.1113","title":"Avapritinib (Ayvakyt)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.021525077236918103,"score_gpt":0.31111903087100845,"score_spread":0.28959395363409035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409333523","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011612886,0.933521,0.00082136435,0.0029789747,0.00046890593,0.00017581426,0.002225647,0.00018668502,0.048008785],"genre_scores_gemma":[0.19991313,0.76395625,0.0033680657,0.0033336056,0.00041658492,0.00021746881,0.0042269146,0.00003441174,0.024533642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956256,0.000087850996,0.000045068162,0.00006123374,0.00020545552,0.00003786104],"domain_scores_gemma":[0.9996506,0.00009041456,0.00008554655,0.000008734164,0.00012507172,0.000039554983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605948,0.0002544927,0.0004960884,0.0010161817,0.00028630026,0.0008055991,0.00033106995,0.00040573505,0.00572815],"category_scores_gemma":[0.0009174738,0.000076905184,0.00062000676,0.00080862705,0.00019959548,0.00044804366,0.00022387588,0.000662092,0.0012779343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006597155,0.00006210674,0.0009685803,0.0068679424,0.0002934455,0.0001807848,0.000041580464,0.0003419497,0.003627292,0.0016968048,0.050271768,0.934988],"study_design_scores_gemma":[0.0006036248,0.001074085,0.008583834,0.0030045935,0.00067317486,0.0025556306,0.000064623455,0.00027250234,0.0034977964,0.0006512661,0.97898704,0.00003181225],"about_ca_topic_score_codex":0.012842331,"about_ca_topic_score_gemma":0.06092667,"teacher_disagreement_score":0.012842331,"about_ca_system_score_codex":0.001617131,"about_ca_system_score_gemma":0.001869269,"threshold_uncertainty_score":0.025535166},"labels":[],"label_agreement":null},{"id":"W4409767758","doi":"10.51731/cjht.2025.1115","title":"Trastuzumab Deruxtecan (Enhertu)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.019601184163762185,"score_gpt":0.30275716874635483,"score_spread":0.28315598458259267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409767758","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07651545,0.10030117,0.004823468,0.050449952,0.0028158005,0.001081288,0.0118204625,0.0014800822,0.75071234],"genre_scores_gemma":[0.50980735,0.055399876,0.011485677,0.023312015,0.0011891434,0.00041344017,0.015462998,0.000176631,0.38275278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996686,0.00004880919,0.000016817907,0.00003432518,0.0001649777,0.00006654529],"domain_scores_gemma":[0.99950624,0.00007025982,0.00006153316,0.000027856473,0.00013753503,0.0001967141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051205506,0.0001549874,0.00023167714,0.0005566574,0.00039131218,0.00059054885,0.00039070682,0.0005212702,0.019206142],"category_scores_gemma":[0.0012375059,0.00008442349,0.00023557969,0.00039569003,0.0002545888,0.00025167607,0.0003825473,0.00093258626,0.003203823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093184126,0.00020094831,0.0036770678,0.00041803374,0.00004168555,0.0006184599,0.000053344655,0.00046770516,0.0055549815,0.0070778276,0.27604786,0.7049102],"study_design_scores_gemma":[0.00044181643,0.00027793995,0.0059885923,0.00019345962,0.00002363474,0.0010098158,0.000016190144,0.00027407275,0.0021192837,0.00059923256,0.9890456,0.000010542294],"about_ca_topic_score_codex":0.03253431,"about_ca_topic_score_gemma":0.1042931,"teacher_disagreement_score":0.03253431,"about_ca_system_score_codex":0.003143011,"about_ca_system_score_gemma":0.0031832915,"threshold_uncertainty_score":0.064689875},"labels":[],"label_agreement":null},{"id":"W4409805181","doi":"10.51731/cjht.2025.1116","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Computer science; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409805181","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14294615,0.36182225,0.0066835857,0.032319076,0.0042983703,0.0014979875,0.007971279,0.0024745949,0.43998677],"genre_scores_gemma":[0.6857178,0.09610639,0.00889939,0.016435357,0.0011570537,0.0006764048,0.0077037085,0.000102282094,0.18320161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998535,0.000015925498,0.000010392146,0.000025115833,0.00005333171,0.000041805884],"domain_scores_gemma":[0.9998789,0.000014036331,0.000021108757,0.0000075751523,0.000027897144,0.00005053144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022809766,0.00020705878,0.0002944963,0.0003678493,0.0002920999,0.000507995,0.00034443018,0.00049607496,0.015225654],"category_scores_gemma":[0.00044234938,0.00008538517,0.0002692791,0.00025676176,0.00013344431,0.00040179575,0.0003131853,0.0013500083,0.0048296875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017873405,0.0003698851,0.0013064658,0.00082941365,0.00008331051,0.00066740724,0.00003889974,0.00024603782,0.015550031,0.0023236207,0.119628906,0.85716873],"study_design_scores_gemma":[0.003082637,0.0017292934,0.010986494,0.00055932015,0.00012437465,0.0038746123,0.000037091544,0.00046578067,0.00769029,0.00096769596,0.97045714,0.000025248466],"about_ca_topic_score_codex":0.004843989,"about_ca_topic_score_gemma":0.0108429035,"teacher_disagreement_score":0.015225654,"about_ca_system_score_codex":0.0008930286,"about_ca_system_score_gemma":0.00084515766,"threshold_uncertainty_score":0.05093485},"labels":[],"label_agreement":null},{"id":"W4409927225","doi":"10.51731/cjht.2025.1118","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409927225","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009168601,0.9314222,0.0015362778,0.0036853198,0.0006269903,0.00017930375,0.0011214023,0.00027210213,0.051987845],"genre_scores_gemma":[0.14242435,0.78210425,0.0077260463,0.005900308,0.0006822635,0.00019273504,0.002722572,0.000066254506,0.058181215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935585,0.00009244653,0.000041010146,0.00005622507,0.00039814677,0.000056303623],"domain_scores_gemma":[0.99932325,0.0001321998,0.00015847464,0.000017049315,0.00030786425,0.000061208455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008845082,0.0003904486,0.00043683732,0.0017074138,0.00035009297,0.0005388337,0.0004580561,0.000601667,0.007370862],"category_scores_gemma":[0.0014180804,0.000096074924,0.00047527178,0.00076667074,0.00028828633,0.00031472617,0.00029362526,0.0005594712,0.0017402073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046363001,0.00010083836,0.0012424054,0.005462652,0.00014688849,0.00029886083,0.00004842524,0.00011285094,0.005902011,0.0018702805,0.09247091,0.89188033],"study_design_scores_gemma":[0.00017697884,0.0006597521,0.0069530336,0.0031626148,0.0002697275,0.0022750064,0.00004582654,0.000088560206,0.007239066,0.00030866894,0.9787982,0.00002254114],"about_ca_topic_score_codex":0.035760842,"about_ca_topic_score_gemma":0.081880316,"teacher_disagreement_score":0.035760842,"about_ca_system_score_codex":0.0017935912,"about_ca_system_score_gemma":0.0019068542,"threshold_uncertainty_score":0.07110542},"labels":[],"label_agreement":null},{"id":"W4409927674","doi":"10.51731/cjht.2025.1117","title":"Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mometasone furoate; Nasal spray; Medicine; Pharmacology; Nasal administration; Internal medicine; Corticosteroid","score_opus":0.014258613155299492,"score_gpt":0.3029630974076635,"score_spread":0.288704484252364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409927674","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3514223,0.61532927,0.0016880934,0.004545724,0.00068915146,0.0011628526,0.0017352962,0.000115154806,0.02331214],"genre_scores_gemma":[0.84343904,0.14227903,0.005145641,0.0028025222,0.00036348074,0.0004076238,0.0010000485,0.000013136778,0.00454945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915063,0.0004048725,0.00012341885,0.00010190551,0.00016876582,0.000050429186],"domain_scores_gemma":[0.9987282,0.0007022012,0.00034650983,0.000033925062,0.00011040477,0.00007881204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020449269,0.0002038347,0.0007608663,0.00046642774,0.00018767497,0.000498634,0.000297645,0.00063103985,0.0028816771],"category_scores_gemma":[0.0023642303,0.00014042869,0.0010605084,0.00038200885,0.00027276142,0.00034000314,0.00024606904,0.0008364254,0.00022954808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06469899,0.0017871924,0.008866516,0.030768756,0.004767542,0.00048785043,0.00023055064,0.0005182012,0.015054815,0.002596292,0.006577191,0.8636462],"study_design_scores_gemma":[0.16741997,0.19118035,0.23275618,0.02820841,0.023829622,0.0070044263,0.0012901714,0.0028821374,0.036073886,0.0025686033,0.3065708,0.00021547113],"about_ca_topic_score_codex":0.0036179067,"about_ca_topic_score_gemma":0.012524364,"teacher_disagreement_score":0.0036179067,"about_ca_system_score_codex":0.00068133924,"about_ca_system_score_gemma":0.0008812274,"threshold_uncertainty_score":0.010814786},"labels":[],"label_agreement":null},{"id":"W4410122503","doi":"10.51731/cjht.2025.1121","title":"Ravulizumab (Ultomiris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.008815170847852714,"score_gpt":0.2506433297686746,"score_spread":0.24182815892082188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410122503","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013346827,0.93445736,0.001620854,0.0026522381,0.00040549686,0.00015710042,0.0007748045,0.0003250686,0.046260335],"genre_scores_gemma":[0.22065122,0.73066753,0.007148928,0.004593696,0.00054988416,0.00019844141,0.0016714451,0.00005352083,0.034465373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996294,0.00007775282,0.000034087498,0.000041514777,0.00017280462,0.000044451186],"domain_scores_gemma":[0.9997662,0.000056479075,0.00007344389,0.000008548684,0.00006983166,0.000025530197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007406983,0.0002582853,0.00034874654,0.00077399495,0.00017687547,0.00057167956,0.00031825525,0.00034568118,0.0039005284],"category_scores_gemma":[0.0007047021,0.000079575366,0.0004090986,0.0006048056,0.00020585583,0.00028614883,0.00020444999,0.0006211767,0.0013767639],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034361178,0.000046873152,0.00042438484,0.0026461561,0.00009968328,0.00016247053,0.000031944295,0.00014038064,0.005931474,0.0013229828,0.022544457,0.9663056],"study_design_scores_gemma":[0.00040841903,0.00088592165,0.0068121105,0.0022364252,0.00034401988,0.0023453787,0.000046340065,0.00017562382,0.007533074,0.00055906945,0.9786291,0.00002445968],"about_ca_topic_score_codex":0.009087231,"about_ca_topic_score_gemma":0.02771156,"teacher_disagreement_score":0.009087231,"about_ca_system_score_codex":0.0012555688,"about_ca_system_score_gemma":0.0011939455,"threshold_uncertainty_score":0.018068671},"labels":[],"label_agreement":null},{"id":"W4410160242","doi":"10.51731/cjht.2025.1122","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410160242","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18306656,0.25506404,0.033911668,0.03046953,0.005318933,0.0022080063,0.0071966196,0.012992343,0.46977228],"genre_scores_gemma":[0.58210194,0.059163783,0.035723925,0.012976581,0.0010288936,0.00041953317,0.006901136,0.00046645597,0.3012177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995895,0.00003808245,0.000017669023,0.00005177894,0.00023445109,0.00006852207],"domain_scores_gemma":[0.99962425,0.000038285296,0.000054952037,0.000025649024,0.00015133552,0.00010557127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048784248,0.00039115237,0.00041810318,0.0012523517,0.00063109276,0.0005145962,0.0006590186,0.0007882201,0.019335011],"category_scores_gemma":[0.0010189945,0.00012621953,0.00039533185,0.00036273233,0.00030096737,0.00024217651,0.00054565485,0.0009426434,0.0063779084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014886382,0.0006982529,0.003355098,0.0011313244,0.00012378905,0.0015105264,0.00012665625,0.00021321299,0.05125674,0.0036712743,0.24683492,0.6895895],"study_design_scores_gemma":[0.00069857057,0.0019708609,0.009926319,0.00061270385,0.00015563362,0.0072572506,0.00007740665,0.00056760304,0.05069559,0.0008424819,0.9271515,0.000044125885],"about_ca_topic_score_codex":0.025153574,"about_ca_topic_score_gemma":0.027502371,"teacher_disagreement_score":0.025153574,"about_ca_system_score_codex":0.0010899169,"about_ca_system_score_gemma":0.001577712,"threshold_uncertainty_score":0.06468201},"labels":[],"label_agreement":null},{"id":"W4410259368","doi":"10.51731/cjht.2025.1123","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410259368","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014747128,0.9229852,0.0011899841,0.003206905,0.000435494,0.00021055026,0.0012154939,0.00015240033,0.05585679],"genre_scores_gemma":[0.23115836,0.7235552,0.00555694,0.003922748,0.00034327622,0.00021932436,0.0018774179,0.000034355835,0.033332366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996699,0.000062667,0.000029274144,0.000040299426,0.00016113193,0.000036649122],"domain_scores_gemma":[0.9996921,0.000067999565,0.000086989516,0.000010494916,0.000109577726,0.00003292606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006048794,0.0002003429,0.00028285457,0.00073708605,0.0002013792,0.00070586655,0.00025127325,0.00033046672,0.005202103],"category_scores_gemma":[0.0010097894,0.00007704671,0.00028887982,0.0006067161,0.00016224154,0.0004216191,0.00023078514,0.00051473133,0.0011325415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047071913,0.000048004556,0.00076447526,0.0031143983,0.00011276172,0.0001361578,0.000029730396,0.00012826976,0.0048267185,0.0016401728,0.025505757,0.9632228],"study_design_scores_gemma":[0.00040733968,0.0009124063,0.00899027,0.0034572894,0.00038492808,0.002032271,0.00006443004,0.0001549986,0.00720302,0.00054734456,0.9758261,0.000019619172],"about_ca_topic_score_codex":0.012740136,"about_ca_topic_score_gemma":0.043008678,"teacher_disagreement_score":0.012740136,"about_ca_system_score_codex":0.0015436332,"about_ca_system_score_gemma":0.0013836352,"threshold_uncertainty_score":0.025331974},"labels":[],"label_agreement":null},{"id":"W4410368827","doi":"10.51731/cjht.2025.1124","title":"Troponin | Point of Care Testing in Rural and Remote Community Health Centres","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Point-of-care testing; Medicine; Point of care; Troponin I; Troponin; Rural community; Medical emergency; Business; Cardiology; Nursing; Socioeconomics; Sociology; Pathology; Myocardial infarction","score_opus":0.036374549501811786,"score_gpt":0.3530584278254763,"score_spread":0.3166838783236645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410368827","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20040426,0.109393366,0.0027177818,0.6372312,0.006947542,0.00041505613,0.002674311,0.00038858576,0.03982794],"genre_scores_gemma":[0.8759013,0.042685065,0.0038655105,0.06548884,0.007906156,0.00025892069,0.0014603923,0.00015667296,0.0022771847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921582,0.003046176,0.00096911413,0.00079123495,0.0019914717,0.0010437323],"domain_scores_gemma":[0.9715062,0.0053128772,0.007237274,0.0006383809,0.007177879,0.00812755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005954074,0.00044651792,0.00072514673,0.0012817126,0.0011932845,0.0035876965,0.002576342,0.0026965404,0.009284569],"category_scores_gemma":[0.032833155,0.00038185137,0.00060171523,0.0021827943,0.0016793429,0.0027600653,0.0019851895,0.0030159801,0.0015134873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066403794,0.0004922413,0.5404879,0.0038072774,0.0002773625,0.004275303,0.0035105906,0.00044749552,0.00048254812,0.002551679,0.18785258,0.25515094],"study_design_scores_gemma":[0.00040099758,0.0013096095,0.8126575,0.018508462,0.00021460486,0.015346267,0.022677869,0.0016048303,0.00025199464,0.0063416213,0.12044071,0.0002455813],"about_ca_topic_score_codex":0.05037603,"about_ca_topic_score_gemma":0.040573746,"teacher_disagreement_score":0.05037603,"about_ca_system_score_codex":0.0029976019,"about_ca_system_score_gemma":0.004965962,"threshold_uncertainty_score":0.100165606},"labels":[],"label_agreement":null},{"id":"W4410439249","doi":"10.51731/cjht.2025.1125","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Cancer; Internal medicine","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410439249","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007456525,0.9524568,0.0007128575,0.0024266262,0.000425635,0.00014554037,0.000917779,0.00008734633,0.035370894],"genre_scores_gemma":[0.1312791,0.8370223,0.0030136995,0.0034425636,0.0002973015,0.00016238063,0.0013294053,0.000017779385,0.023435542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975127,0.00004680272,0.000025340178,0.00003505984,0.00011103531,0.000030397892],"domain_scores_gemma":[0.99977964,0.000049517315,0.00006299483,0.0000070486003,0.00007505518,0.000025696081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046269046,0.00019477692,0.00026865106,0.00065350626,0.00020036811,0.00062190596,0.000254558,0.00030554435,0.00536322],"category_scores_gemma":[0.00083731336,0.00007063314,0.00030940288,0.0005751679,0.00014901187,0.00041919213,0.00022402343,0.0005367126,0.0010918087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043967128,0.00004521803,0.00048140634,0.0045783436,0.00012479028,0.000120493365,0.00002850979,0.00013036244,0.003331799,0.0016219962,0.033427823,0.95566964],"study_design_scores_gemma":[0.0003666349,0.00056678744,0.005176906,0.0038277572,0.00033839792,0.0013463501,0.000043285738,0.00009569188,0.0037244176,0.0004803004,0.9840199,0.00001366045],"about_ca_topic_score_codex":0.013582565,"about_ca_topic_score_gemma":0.04559252,"teacher_disagreement_score":0.013582565,"about_ca_system_score_codex":0.0013034386,"about_ca_system_score_gemma":0.001308514,"threshold_uncertainty_score":0.027006984},"labels":[],"label_agreement":null},{"id":"W4410439602","doi":"10.51731/cjht.2025.1126","title":"Voice Prostheses and Heat and Moisture Exchangers for Adults After Total Laryngectomy: An Updated Rapid Review","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Voice and Speech Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laryngectomy; Voice prosthesis; Moisture; Medicine; Heat exchanger; Environmental science; Meteorology; Surgery; Engineering; Mechanical engineering; Geography; Larynx","score_opus":0.015258366812773197,"score_gpt":0.28932130464229283,"score_spread":0.2740629378295196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410439602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020336968,0.99617106,0.00006605004,0.0014396906,0.0006724965,0.0001445282,0.00073418365,0.000014901316,0.00055371836],"genre_scores_gemma":[0.0016514132,0.9950748,0.0003694539,0.0017142814,0.00030341797,0.00020161497,0.00036719808,0.000005260552,0.0003124604],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954466,0.0008540899,0.001707894,0.00032483827,0.001423511,0.0002430484],"domain_scores_gemma":[0.97011614,0.01767582,0.005615666,0.0003249892,0.0058690207,0.00039821453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067112017,0.0011891639,0.0049289544,0.012859286,0.0005333755,0.0028397215,0.0019745522,0.0025173035,0.009408207],"category_scores_gemma":[0.02829951,0.000966922,0.0054642297,0.012115569,0.00054662983,0.0035532722,0.0014906746,0.0017909664,0.0010237552],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016996052,0.000023006392,0.0005549784,0.8382614,0.0018772134,0.00014567943,0.000203432,0.00008920462,0.00021476723,0.0005871956,0.03828102,0.119592115],"study_design_scores_gemma":[0.00016928409,0.00015261461,0.003552102,0.7930269,0.014539955,0.0005398311,0.00022948543,0.00008056664,0.00014218832,0.0004663529,0.18705201,0.000048731876],"about_ca_topic_score_codex":0.015469543,"about_ca_topic_score_gemma":0.042895444,"teacher_disagreement_score":0.015469543,"about_ca_system_score_codex":0.004017709,"about_ca_system_score_gemma":0.017755881,"threshold_uncertainty_score":0.03549266},"labels":[],"label_agreement":null},{"id":"W4410561918","doi":"10.51731/cjht.2025.1127","title":"Blinatumomab (Blincyto)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine","score_opus":0.03682501354495821,"score_gpt":0.359285618137245,"score_spread":0.3224606045922868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410561918","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16430672,0.4017926,0.0072515863,0.03375559,0.0046233092,0.0027195136,0.014730535,0.0056425934,0.36517754],"genre_scores_gemma":[0.61591524,0.09137198,0.013979275,0.015345084,0.0009513093,0.0011365709,0.018643726,0.00041463342,0.2422421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997625,0.000037826594,0.000011167857,0.000037626694,0.00009445333,0.0000564077],"domain_scores_gemma":[0.99967504,0.000031471405,0.000044461693,0.000020741585,0.00007644908,0.00015184603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050306576,0.00025873262,0.00043370802,0.0009828536,0.0005800552,0.00069572224,0.0004390893,0.00076030317,0.021020884],"category_scores_gemma":[0.00064399117,0.0001235097,0.00027638074,0.0006439731,0.00028370885,0.0003128221,0.00063659187,0.0015689565,0.007334157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023215816,0.00087105314,0.0021678216,0.00091590185,0.000055995246,0.0005222908,0.00008915213,0.00015679248,0.017090086,0.0029857708,0.13363376,0.8391898],"study_design_scores_gemma":[0.0020192675,0.001796978,0.007504358,0.000451763,0.00006744399,0.0021826674,0.000058824065,0.00019605854,0.009908417,0.0007575743,0.97503847,0.000018186489],"about_ca_topic_score_codex":0.013771582,"about_ca_topic_score_gemma":0.032564707,"teacher_disagreement_score":0.021020884,"about_ca_system_score_codex":0.0016716516,"about_ca_system_score_gemma":0.0020490198,"threshold_uncertainty_score":0.07032186},"labels":[],"label_agreement":null},{"id":"W4410598518","doi":"10.51731/cjht.2025.1129","title":"Urgent Care Centres: A Scan of Models of Care and Literature on Their Effectiveness","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computer science","score_opus":0.012340006215536695,"score_gpt":0.2851717403605384,"score_spread":0.27283173414500167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014158943,0.78754336,0.003384656,0.10931385,0.001131099,0.00044716438,0.0016050145,0.000142576,0.08227331],"genre_scores_gemma":[0.2912551,0.6724462,0.008307739,0.022647142,0.0012786048,0.001243415,0.00074007345,0.00022325222,0.0018585644],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.95654774,0.023769995,0.0027778593,0.0026588256,0.011709398,0.0025360808],"domain_scores_gemma":[0.79757756,0.15896785,0.00993104,0.005088078,0.023103122,0.005332308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051453717,0.0015451676,0.0033257818,0.014494816,0.004742361,0.016602758,0.009536844,0.004184487,0.018434966],"category_scores_gemma":[0.14650945,0.0013285138,0.003400681,0.022407295,0.012887917,0.014147318,0.0071250773,0.0059996364,0.0011555139],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007667202,0.00056060916,0.026153332,0.06957498,0.002007773,0.00027526496,0.02131368,0.0032689334,0.000059718066,0.25178364,0.07456806,0.5496673],"study_design_scores_gemma":[0.0010380889,0.0006708949,0.04221305,0.30011934,0.003221687,0.0006382147,0.037678532,0.002958733,0.00026146547,0.1036403,0.5071259,0.00043383535],"about_ca_topic_score_codex":0.4908381,"about_ca_topic_score_gemma":0.41205996,"teacher_disagreement_score":0.4908381,"about_ca_system_score_codex":0.11267124,"about_ca_system_score_gemma":0.10383192,"threshold_uncertainty_score":0.9759622},"labels":[],"label_agreement":null},{"id":"W4410598538","doi":"10.51731/cjht.2025.1130","title":"Daratumumab (Darzalex SC)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Psychology; Medicine; Internal medicine; Multiple myeloma","score_opus":0.035072396872024375,"score_gpt":0.354769225012068,"score_spread":0.31969682814004363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598538","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09163308,0.20956576,0.005113286,0.028190454,0.0061406638,0.0020960132,0.015908148,0.0045922883,0.63676035],"genre_scores_gemma":[0.53190976,0.06709798,0.01892131,0.026158202,0.0017722977,0.0010175518,0.028781982,0.0003232387,0.3240177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978286,0.000028334847,0.000017478347,0.00003478034,0.00008761455,0.000048899245],"domain_scores_gemma":[0.99970907,0.000026526708,0.00003615844,0.000017585162,0.00008712799,0.00012354921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003261415,0.00037603697,0.00037154782,0.0005132941,0.00042366824,0.00082378637,0.00038759268,0.0006071754,0.023829104],"category_scores_gemma":[0.00069402665,0.00012550027,0.00036347727,0.00046057097,0.00015875077,0.00035018614,0.00039100638,0.0011379041,0.010873058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016948702,0.00037296937,0.0020642793,0.0006108149,0.000085782056,0.00053391326,0.000037563892,0.00034275113,0.0076114866,0.0022910465,0.2844198,0.69993466],"study_design_scores_gemma":[0.0020213039,0.0006971859,0.0031285854,0.00018281554,0.00006631264,0.0018539587,0.000012970284,0.0002612924,0.0030537082,0.00049346924,0.9882158,0.000012685715],"about_ca_topic_score_codex":0.008096188,"about_ca_topic_score_gemma":0.020359859,"teacher_disagreement_score":0.023829104,"about_ca_system_score_codex":0.0014876844,"about_ca_system_score_gemma":0.0017776036,"threshold_uncertainty_score":0.079716265},"labels":[],"label_agreement":null},{"id":"W4410598584","doi":"10.51731/cjht.2025.1128","title":"Automated Chest Compression Devices","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Compression (physics); Computer science; Materials science; Composite material","score_opus":0.022884453724203873,"score_gpt":0.3398952993815379,"score_spread":0.317010845657334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598584","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010642364,0.9845419,0.000393088,0.0053862585,0.0019049761,0.00014583007,0.00046602337,0.00002684046,0.006070849],"genre_scores_gemma":[0.026242672,0.9519394,0.002749921,0.012174147,0.003356668,0.00041819748,0.0006290602,0.000023139402,0.0024668584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889409,0.0032869903,0.003057125,0.0008172405,0.0036478427,0.00024986378],"domain_scores_gemma":[0.9648121,0.022545261,0.0064599644,0.0006612287,0.005198331,0.00032319198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006667135,0.0006242971,0.0017792695,0.0027250175,0.00051087065,0.003253286,0.001970737,0.003582503,0.011414943],"category_scores_gemma":[0.041289072,0.00048619168,0.0028314202,0.0024199132,0.0012529041,0.0041971286,0.0011538919,0.0021882807,0.0023252491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074212474,0.00007378435,0.002113031,0.20373365,0.0010673895,0.00023809784,0.00042178223,0.00016667125,0.0006531158,0.0047017545,0.081689365,0.7043992],"study_design_scores_gemma":[0.00080991635,0.00054224365,0.007961065,0.32271945,0.0032678922,0.0026113905,0.00066924916,0.00015955196,0.001090656,0.0040373923,0.65602267,0.000108362394],"about_ca_topic_score_codex":0.0038287768,"about_ca_topic_score_gemma":0.0041297125,"teacher_disagreement_score":0.011414943,"about_ca_system_score_codex":0.0017588482,"about_ca_system_score_gemma":0.0031074998,"threshold_uncertainty_score":0.03818679},"labels":[],"label_agreement":null},{"id":"W4410644984","doi":"10.51731/cjht.2025.1132","title":"Pemigatinib (Pemazyre)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03601682565298907,"score_gpt":0.3585972738525122,"score_spread":0.32258044819952314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410644984","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038913436,0.31047913,0.0041160146,0.035010897,0.003467321,0.0011473093,0.01038287,0.0022939371,0.594189],"genre_scores_gemma":[0.42010105,0.18341911,0.013622026,0.028722659,0.0019140888,0.0008986781,0.017498108,0.00020265345,0.3336216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976367,0.000027962726,0.0000162446,0.000034326942,0.000107125765,0.000050704213],"domain_scores_gemma":[0.99978954,0.000025181786,0.000030706044,0.000012948227,0.00006010965,0.00008149334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032002782,0.00027411288,0.0003624349,0.00055128377,0.00047549588,0.0007767832,0.00041282448,0.00072865636,0.03383376],"category_scores_gemma":[0.0007611068,0.0001002015,0.00040545067,0.00038881376,0.00016941011,0.00047768556,0.00046321846,0.0016386737,0.012963496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010530483,0.00030479464,0.0010516469,0.0009250093,0.000091752336,0.00061140495,0.000039217575,0.0002801878,0.006777718,0.0028168284,0.2609858,0.7250626],"study_design_scores_gemma":[0.00081657025,0.00041615384,0.0034424216,0.00032944942,0.000058726317,0.0020710784,0.000022578264,0.00014889412,0.0026114925,0.00069983775,0.98936987,0.000012975428],"about_ca_topic_score_codex":0.006702463,"about_ca_topic_score_gemma":0.01599645,"teacher_disagreement_score":0.03383376,"about_ca_system_score_codex":0.0010404602,"about_ca_system_score_gemma":0.0011719866,"threshold_uncertainty_score":0.11318523},"labels":[],"label_agreement":null},{"id":"W4410646231","doi":"10.51731/cjht.2025.1131","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.13011247310058613,"score_gpt":0.4548316854798537,"score_spread":0.3247192123792676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410646231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03726992,0.9081796,0.0017291434,0.0020912462,0.00041741284,0.00020154528,0.0009855285,0.00016700216,0.048958503],"genre_scores_gemma":[0.32712933,0.6295593,0.004351291,0.0027752076,0.0003302839,0.0002157671,0.002580561,0.00003186923,0.033026416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976295,0.00006580207,0.000023355697,0.000029904115,0.000095907686,0.00002201608],"domain_scores_gemma":[0.9998492,0.00004159025,0.000053038064,0.0000054020456,0.000036582285,0.000014173668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004105563,0.0002336873,0.00028700207,0.0005830806,0.000133618,0.00042385852,0.00024386213,0.0003417383,0.0041433917],"category_scores_gemma":[0.0004668427,0.00007200178,0.00043740528,0.00040728573,0.00013077741,0.00028900403,0.00017377829,0.0005653748,0.0010366791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007666184,0.0001017274,0.0008239688,0.0038499774,0.00024085499,0.00035332542,0.000044233373,0.00039839093,0.019940257,0.0024829484,0.018130945,0.95286685],"study_design_scores_gemma":[0.00060505315,0.002542219,0.008586079,0.0019696464,0.00050740136,0.004732912,0.00005283468,0.00033067624,0.014576429,0.00064712274,0.9654179,0.000031806358],"about_ca_topic_score_codex":0.0037594922,"about_ca_topic_score_gemma":0.013775339,"teacher_disagreement_score":0.0041433917,"about_ca_system_score_codex":0.0006193884,"about_ca_system_score_gemma":0.0006241445,"threshold_uncertainty_score":0.013861001},"labels":[],"label_agreement":null},{"id":"W4410646356","doi":"10.51731/cjht.2025.1133","title":"Durvalumab (Imfinzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Cancer","score_opus":0.020596970468108097,"score_gpt":0.31009797314778254,"score_spread":0.28950100267967444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410646356","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25684214,0.27927047,0.008023955,0.023030126,0.0027551968,0.0012655859,0.012889761,0.0027947333,0.41312805],"genre_scores_gemma":[0.773934,0.04826107,0.009352316,0.00998119,0.0005421983,0.00056954334,0.012700076,0.00015402335,0.14450553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985313,0.000014020449,0.000009752705,0.00002278545,0.00006054233,0.000039691226],"domain_scores_gemma":[0.9998821,0.00001512426,0.000022058533,0.000008985833,0.000021120142,0.00005061195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029412282,0.00026322177,0.00041026948,0.00033966848,0.00024614905,0.00058982294,0.00046395024,0.00048332586,0.008992268],"category_scores_gemma":[0.00046585719,0.00008906802,0.0002770432,0.0002639785,0.00015522091,0.0003481363,0.00028446343,0.0013136325,0.003453614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003075633,0.00045845308,0.00350791,0.00067873485,0.00016635912,0.00093880965,0.00007894213,0.0006276819,0.019222619,0.004575579,0.115887105,0.8507822],"study_design_scores_gemma":[0.005584506,0.0016544206,0.012572715,0.00037649358,0.00020894318,0.0061089788,0.00005719379,0.0012338817,0.016483739,0.001803913,0.9538825,0.000032723103],"about_ca_topic_score_codex":0.00690615,"about_ca_topic_score_gemma":0.025623925,"teacher_disagreement_score":0.008992268,"about_ca_system_score_codex":0.0020254026,"about_ca_system_score_gemma":0.0010402327,"threshold_uncertainty_score":0.030082107},"labels":[],"label_agreement":null},{"id":"W4410706903","doi":"10.51731/cjht.2025.1134","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Business; Medicine; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410706903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34944272,0.43395448,0.00265051,0.01780807,0.0016994589,0.001767911,0.018444873,0.0014990543,0.17273292],"genre_scores_gemma":[0.8928971,0.060413063,0.0024204399,0.005819819,0.00054039335,0.00050927483,0.011333603,0.00003337833,0.026032817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996886,0.00006852886,0.00003254644,0.00004982458,0.00008509966,0.0000754626],"domain_scores_gemma":[0.99962234,0.00008624796,0.000108602064,0.000024491188,0.00007655924,0.00008177085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056658586,0.00022713885,0.00053561304,0.00064165756,0.00029913514,0.00067804864,0.00036888703,0.00050367176,0.008868437],"category_scores_gemma":[0.0010810524,0.00008184741,0.00048287527,0.00048317475,0.00018330854,0.0003441766,0.00028905174,0.00096721994,0.0016548699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080443015,0.00069661223,0.009771553,0.0034323905,0.0005821279,0.0004833084,0.00008400981,0.0005616845,0.0051467028,0.0024383203,0.06776163,0.90099734],"study_design_scores_gemma":[0.024102882,0.012327457,0.081485964,0.0043689357,0.0021432033,0.0073884334,0.00023458558,0.0019984997,0.012759897,0.0020518189,0.85103357,0.00010482634],"about_ca_topic_score_codex":0.0060821436,"about_ca_topic_score_gemma":0.023300381,"teacher_disagreement_score":0.9988747,"about_ca_system_score_codex":0.0011252643,"about_ca_system_score_gemma":0.00121822,"threshold_uncertainty_score":0.029667854},"labels":[],"label_agreement":null},{"id":"W4410823174","doi":"10.51731/cjht.2025.1136","title":"Momelotinib (Ojjaara)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.021987287900746253,"score_gpt":0.3110414981013667,"score_spread":0.28905421020062044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823174","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010698436,0.92554945,0.00048044184,0.002338338,0.00044263082,0.00018965716,0.0021366365,0.000112449095,0.05805208],"genre_scores_gemma":[0.14547725,0.81076866,0.0034757901,0.0042016697,0.0005463231,0.0002149785,0.0038415561,0.000022609267,0.03145123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997179,0.00004796986,0.000032276435,0.000029384777,0.00013994076,0.000032536034],"domain_scores_gemma":[0.99972016,0.00006252676,0.00008330197,0.000007153304,0.00009128782,0.000035574794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048738834,0.0001970587,0.00033223286,0.0009733536,0.00024780352,0.0007034352,0.0002874232,0.0002953311,0.008077813],"category_scores_gemma":[0.0010281296,0.00006744133,0.0004392312,0.00087412907,0.00013896768,0.00032935294,0.00023587009,0.00046468322,0.0010109947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063936936,0.00006772925,0.0009359137,0.0071289334,0.00023798854,0.00014819014,0.00003642099,0.00014425321,0.0022714254,0.0019000057,0.03903651,0.9474534],"study_design_scores_gemma":[0.00051115203,0.00050913426,0.00718651,0.0049981577,0.0006199745,0.0013096335,0.000050723833,0.000094601244,0.0018182928,0.00047019843,0.98241687,0.000014791112],"about_ca_topic_score_codex":0.011246523,"about_ca_topic_score_gemma":0.06101915,"teacher_disagreement_score":0.011246523,"about_ca_system_score_codex":0.0012069839,"about_ca_system_score_gemma":0.0019709892,"threshold_uncertainty_score":0.027022958},"labels":[],"label_agreement":null},{"id":"W4410823711","doi":"10.51731/cjht.2025.1137","title":"Erdafitinib (Balversa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.025151317670980115,"score_gpt":0.3267555524490281,"score_spread":0.301604234778048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823711","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1415384,0.20115165,0.005975336,0.042463508,0.0045254333,0.0021267238,0.036822934,0.0081122825,0.5572838],"genre_scores_gemma":[0.5901603,0.07056202,0.007527579,0.02021818,0.0008560926,0.00090876856,0.052671287,0.0003312888,0.25676444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973613,0.000028428361,0.000019494693,0.000044018445,0.000101721926,0.00007008282],"domain_scores_gemma":[0.9998248,0.000013000009,0.000028877585,0.000015181628,0.00004707876,0.000071073795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040133254,0.00043820468,0.0006434363,0.00081295747,0.00045011364,0.00097350247,0.0006504584,0.0010575948,0.030610817],"category_scores_gemma":[0.00059081794,0.00017360736,0.00061040674,0.00056377205,0.00022977099,0.0006368142,0.0005484201,0.0016528952,0.0137491925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026707847,0.0006077881,0.002876395,0.0010482265,0.00015611619,0.00070488785,0.00004982046,0.00071003335,0.008900966,0.0030060075,0.32883212,0.6504368],"study_design_scores_gemma":[0.0050385967,0.0018386847,0.009433977,0.00061769335,0.00016235985,0.0046572033,0.000060787075,0.0012061511,0.007882871,0.0013946802,0.96765244,0.00005466594],"about_ca_topic_score_codex":0.0055784653,"about_ca_topic_score_gemma":0.016359614,"teacher_disagreement_score":0.030610817,"about_ca_system_score_codex":0.0015356359,"about_ca_system_score_gemma":0.0015688535,"threshold_uncertainty_score":0.1024034},"labels":[],"label_agreement":null},{"id":"W4410826115","doi":"10.51731/cjht.2025.1138","title":"Zolbetuximab for Injection (Vyloy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.017664576821286273,"score_gpt":0.31315935413502666,"score_spread":0.2954947773137404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410826115","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0575335,0.046979107,0.01657354,0.025651958,0.0052673365,0.0020349654,0.008528358,0.009501328,0.8279299],"genre_scores_gemma":[0.328958,0.013777826,0.02280493,0.024148569,0.000992398,0.0008090001,0.008739668,0.0006901255,0.59907943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973565,0.000028163357,0.0000116381,0.000046555906,0.00012303854,0.000054955755],"domain_scores_gemma":[0.99965096,0.00004375605,0.000038239537,0.000025714564,0.000076102966,0.00016520765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039273023,0.00025938664,0.00026766062,0.00061602937,0.0005036235,0.00065816817,0.00042753015,0.0009970203,0.066516645],"category_scores_gemma":[0.0006856416,0.00014812278,0.00030444402,0.00020998999,0.00023010005,0.00040977506,0.0005374958,0.0012449097,0.016597878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011477536,0.0003738797,0.0019096837,0.00045480227,0.0000487582,0.0007301482,0.00006854821,0.0003094217,0.017217146,0.004763358,0.30338365,0.66959286],"study_design_scores_gemma":[0.000638751,0.0006632051,0.004799029,0.00016577322,0.000030411733,0.0016215213,0.000018829647,0.0004681343,0.00462732,0.0007115759,0.986241,0.000014484702],"about_ca_topic_score_codex":0.006347126,"about_ca_topic_score_gemma":0.015858654,"teacher_disagreement_score":0.066516645,"about_ca_system_score_codex":0.0010151642,"about_ca_system_score_gemma":0.0014559549,"threshold_uncertainty_score":0.22252029},"labels":[],"label_agreement":null},{"id":"W4411028159","doi":"10.51731/cjht.2025.1139","title":"Rozanolixizumab (Rystiggo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014735107386983273,"score_gpt":0.28782373180523996,"score_spread":0.2730886244182567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411028159","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31716582,0.37145934,0.015119367,0.01840894,0.0031413785,0.0021055462,0.007889987,0.009262358,0.25544727],"genre_scores_gemma":[0.74603355,0.08337375,0.016774587,0.012536975,0.0008229523,0.0009237021,0.014846267,0.00026895365,0.12441925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998386,0.000021969063,0.000015465748,0.000031529253,0.00004849948,0.000043905813],"domain_scores_gemma":[0.99991035,0.000008429475,0.000024883893,0.000009118618,0.000019257668,0.000027898075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002695871,0.0004521391,0.00059419643,0.00051010423,0.00023894964,0.00054953597,0.00043917092,0.0006176917,0.008819325],"category_scores_gemma":[0.00026479218,0.0001361038,0.0005213728,0.0003034799,0.00023074925,0.0002819545,0.00032947198,0.0015671543,0.0074450774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036441688,0.000861501,0.0020533942,0.0012610027,0.00019685335,0.0014823043,0.000059608763,0.0004740586,0.05612968,0.0021464804,0.072784126,0.8589068],"study_design_scores_gemma":[0.013009963,0.008855236,0.029471422,0.0008512522,0.00041100316,0.0134103075,0.00009935299,0.0017940267,0.033568073,0.0012927376,0.89715517,0.00008141368],"about_ca_topic_score_codex":0.0044070976,"about_ca_topic_score_gemma":0.008101286,"teacher_disagreement_score":0.008819325,"about_ca_system_score_codex":0.00074072654,"about_ca_system_score_gemma":0.00068827707,"threshold_uncertainty_score":0.029503524},"labels":[],"label_agreement":null},{"id":"W4411060929","doi":"10.51731/cjht.2025.1140","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411060929","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037480213,0.74481356,0.004417653,0.0035648567,0.0010810324,0.00049916335,0.0076669226,0.0007862316,0.19969037],"genre_scores_gemma":[0.2880764,0.5475943,0.013291229,0.004973481,0.00067524676,0.00040275246,0.014705368,0.00028726956,0.12999386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995346,0.00006986345,0.00002535956,0.000039316972,0.00029716254,0.000033701697],"domain_scores_gemma":[0.9994331,0.00017172119,0.000087946995,0.000024523475,0.00022680842,0.000055817593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081992,0.00027223636,0.000334011,0.0010374513,0.00025151533,0.0009951907,0.0004153421,0.00046273414,0.015938018],"category_scores_gemma":[0.0011623281,0.00008287074,0.00038063616,0.0007914003,0.0002813766,0.0004509492,0.0003051909,0.0004938029,0.0025482543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055586686,0.000092960036,0.0014939831,0.0039562215,0.00008457249,0.00026948098,0.000077565164,0.00018643613,0.00892013,0.004055471,0.080521755,0.8997856],"study_design_scores_gemma":[0.000087796354,0.00030042607,0.0038792947,0.0011066701,0.0000902905,0.0008447997,0.000044020362,0.00008975178,0.006292548,0.00019530072,0.9870581,0.000011048057],"about_ca_topic_score_codex":0.02463122,"about_ca_topic_score_gemma":0.05858103,"teacher_disagreement_score":0.9753688,"about_ca_system_score_codex":0.0015588877,"about_ca_system_score_gemma":0.002373936,"threshold_uncertainty_score":0.053317964},"labels":[],"label_agreement":null},{"id":"W4411092246","doi":"10.51731/cjht.2025.1141","title":"Efanesoctocog Alfa (ALTUVIIIO)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.014698170256361148,"score_gpt":0.3238205944217282,"score_spread":0.30912242416536706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411092246","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3081319,0.302582,0.008700589,0.020116094,0.004077144,0.0008884696,0.00854463,0.0021529282,0.34480625],"genre_scores_gemma":[0.71704924,0.052304856,0.008433062,0.007170539,0.0006934198,0.0002817307,0.008151966,0.00013636469,0.2057788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998659,0.00001911674,0.000007789208,0.00001587449,0.00005890578,0.000032521122],"domain_scores_gemma":[0.9998832,0.000016258262,0.000019628567,0.000007069736,0.000026246245,0.000047574515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025312405,0.00021209415,0.00022643911,0.00035660499,0.0002524966,0.00041510718,0.00018487108,0.00034161928,0.011404154],"category_scores_gemma":[0.00039585642,0.00006652771,0.0002766391,0.00019519952,0.00020353892,0.00014687597,0.00025892435,0.0007170775,0.0036243722],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050719795,0.00071368116,0.0044846367,0.0006760469,0.0001205289,0.0012241937,0.00006178086,0.00039383274,0.034575295,0.0049809203,0.092768796,0.8549283],"study_design_scores_gemma":[0.00214005,0.0021686456,0.014737397,0.0003192228,0.0000961615,0.005591918,0.00006473562,0.00042410445,0.029192006,0.0008960551,0.9443407,0.000028899918],"about_ca_topic_score_codex":0.0075455015,"about_ca_topic_score_gemma":0.009768749,"teacher_disagreement_score":0.011404154,"about_ca_system_score_codex":0.0007209978,"about_ca_system_score_gemma":0.0010138173,"threshold_uncertainty_score":0.038150728},"labels":[],"label_agreement":null},{"id":"W4411093106","doi":"10.51731/cjht.2025.1142","title":"Antiviral Drugs for Post-Exposure Prophylaxis Against Influenza A or Influenza B","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine; Antiviral treatment; Pre-exposure prophylaxis; Virus; Human immunodeficiency virus (HIV)","score_opus":0.0718018418478302,"score_gpt":0.39860109585627396,"score_spread":0.3267992540084438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411093106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004077557,0.9922214,0.000110257155,0.00529481,0.0008727193,0.000093172515,0.00024063919,0.0000073277397,0.0007519042],"genre_scores_gemma":[0.008637507,0.9772563,0.00086703495,0.011005445,0.0013901199,0.00021366192,0.00016994972,0.000010720521,0.00044927764],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913065,0.0027908757,0.0033069693,0.00053103955,0.0018095284,0.0002550071],"domain_scores_gemma":[0.9425573,0.039770503,0.009641775,0.0007515871,0.0068038204,0.00047504416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009781243,0.0007959825,0.005527275,0.0047850967,0.0005189629,0.0034411834,0.0015182998,0.004209855,0.007844547],"category_scores_gemma":[0.056144018,0.0007848525,0.0048878794,0.0048385854,0.0013601214,0.0064211017,0.0010997514,0.0028106582,0.0010928316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044895828,0.000043406948,0.0011756993,0.74293244,0.0037504467,0.0001425741,0.00035313907,0.00010052103,0.0003064837,0.0016036055,0.018818501,0.23032418],"study_design_scores_gemma":[0.0004782414,0.00018137616,0.003017832,0.8228337,0.011816744,0.0004462481,0.0006484638,0.00009459265,0.00027582364,0.002122817,0.158034,0.000050076436],"about_ca_topic_score_codex":0.011916173,"about_ca_topic_score_gemma":0.024884753,"teacher_disagreement_score":0.011916173,"about_ca_system_score_codex":0.003320988,"about_ca_system_score_gemma":0.009686386,"threshold_uncertainty_score":0.051728785},"labels":[],"label_agreement":null},{"id":"W4411238587","doi":"10.51731/cjht.2025.1144","title":"Cerliponase Alfa for Pediatric Patients With Neuronal Ceroid Lipofuscinosis Type 2 Disease","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuronal ceroid lipofuscinosis; Medicine; Disease; Pediatrics; Internal medicine","score_opus":0.01919168497419601,"score_gpt":0.29307934242704003,"score_spread":0.27388765745284405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411238587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065941564,0.8720245,0.0017284065,0.10264799,0.0047766385,0.004843381,0.0015522774,0.000051906245,0.005780714],"genre_scores_gemma":[0.08937368,0.81451994,0.021711737,0.051591683,0.0069776555,0.012772213,0.001084865,0.000060229846,0.0019080052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95210016,0.029444495,0.013713999,0.00072765077,0.0034532438,0.0005604366],"domain_scores_gemma":[0.84023494,0.10870678,0.021184431,0.0029081733,0.024153156,0.0028124324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06662414,0.0006569602,0.0043599615,0.0051334733,0.0011829006,0.00549422,0.0021082568,0.0041311635,0.0064301034],"category_scores_gemma":[0.18863055,0.00073163334,0.0034639353,0.0047243717,0.0017048102,0.005546142,0.002657823,0.0029011476,0.00097177236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001769155,0.00011079903,0.0069200913,0.42832905,0.0022180644,0.0011135491,0.0037272202,0.00024590222,0.0004109615,0.002951367,0.065208584,0.4869952],"study_design_scores_gemma":[0.0019635763,0.0007851845,0.009856185,0.71170616,0.0057208873,0.0013785319,0.0049859765,0.0002184208,0.0006157731,0.0050712824,0.25757107,0.00012697579],"about_ca_topic_score_codex":0.0040365974,"about_ca_topic_score_gemma":0.011736379,"teacher_disagreement_score":0.06662414,"about_ca_system_score_codex":0.004999639,"about_ca_system_score_gemma":0.022910466,"threshold_uncertainty_score":0.35234636},"labels":[],"label_agreement":null},{"id":"W4411279283","doi":"10.51731/cjht.2025.1145","title":"Drugs for Adults With Spinal Muscular Atrophy: A Focused Review and Critical Appraisal of Recent Evidence (2021 to 2025) on Nusinersen and Risdiplam","year":2025,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spinal muscular atrophy; Critical appraisal; Medicine; Atrophy; Progressive muscular atrophy; Physical medicine and rehabilitation; Intensive care medicine; Neuroscience; Psychology; Pathology; Alternative medicine; Disease; Amyotrophic lateral sclerosis","score_opus":0.07669452397681137,"score_gpt":0.4370018286103673,"score_spread":0.3603073046335559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411279283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007258412,0.99877554,0.000023478586,0.0006706858,0.00021865997,0.000032039894,0.00005630346,0.0000025248119,0.00014823832],"genre_scores_gemma":[0.0010783115,0.9968079,0.00014650266,0.0014121092,0.0003090525,0.00007116482,0.00008559371,0.0000022559004,0.00008709489],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960567,0.0011482348,0.0015305775,0.0002505065,0.0008235358,0.00019047898],"domain_scores_gemma":[0.97417223,0.017309153,0.004480578,0.00020968057,0.003435277,0.00039309467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007894856,0.001151698,0.006358408,0.00690583,0.00049574545,0.0026378063,0.0019493233,0.0026146625,0.008144815],"category_scores_gemma":[0.02460163,0.0007793037,0.0054471404,0.005630607,0.0007639541,0.0028558008,0.0015539245,0.002160297,0.0009332049],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006989304,0.000046039902,0.00040646835,0.708518,0.004016158,0.00020604354,0.00018386285,0.000109469394,0.0003357884,0.0009830986,0.019744765,0.2647514],"study_design_scores_gemma":[0.0005579848,0.00035199578,0.0027292802,0.82116103,0.018018112,0.0005120002,0.00025501836,0.00007816137,0.00019314542,0.0009539605,0.15513735,0.00005209471],"about_ca_topic_score_codex":0.0049248654,"about_ca_topic_score_gemma":0.013858075,"teacher_disagreement_score":0.008144815,"about_ca_system_score_codex":0.0029626302,"about_ca_system_score_gemma":0.008104127,"threshold_uncertainty_score":0.041752517},"labels":[],"label_agreement":null},{"id":"W4411307213","doi":"10.51731/cjht.2025.1146","title":"Isatuximab (Sarclisa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.01793494157968234,"score_gpt":0.3010390455350337,"score_spread":0.28310410395535135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411307213","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12909833,0.25623557,0.00947481,0.017373152,0.0043650656,0.0017165976,0.009115255,0.007996591,0.56462467],"genre_scores_gemma":[0.63824064,0.055348184,0.010546417,0.0142173,0.0016332516,0.0006041636,0.025526907,0.00032809048,0.25355506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996617,0.000036643087,0.000019323312,0.000041255942,0.00014303031,0.000098162476],"domain_scores_gemma":[0.9997973,0.0000137098505,0.00003330012,0.00001131674,0.00005906605,0.000085354295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004009666,0.00052285136,0.0004610487,0.0007489909,0.00038042272,0.00074720825,0.00044206108,0.0006096355,0.026408192],"category_scores_gemma":[0.00040640935,0.00014757917,0.00047881663,0.00039787177,0.00019725929,0.00038617366,0.0006282709,0.001523634,0.015580428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001556343,0.00075002474,0.0025382484,0.0010564442,0.00013571502,0.0009060356,0.00007130274,0.0007376126,0.012348571,0.0028500964,0.22976598,0.7472836],"study_design_scores_gemma":[0.0021374058,0.001982247,0.008392509,0.00061763707,0.00013506584,0.004966824,0.000051563078,0.0010205972,0.007266115,0.0011641155,0.9722373,0.000028646018],"about_ca_topic_score_codex":0.0025979413,"about_ca_topic_score_gemma":0.0049346383,"teacher_disagreement_score":0.026408192,"about_ca_system_score_codex":0.0009398633,"about_ca_system_score_gemma":0.0009934603,"threshold_uncertainty_score":0.08834422},"labels":[],"label_agreement":null},{"id":"W4411417714","doi":"10.51731/cjht.2025.1147","title":"Durvalumab (Imfinzi) and Tremelimumab (Imjudo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Chemotherapy; Durvalumab; Gemcitabine; Internal medicine; Lung cancer; Regimen; Immunotherapy; Cancer; Pembrolizumab","score_opus":0.015955109993478225,"score_gpt":0.33904363239080565,"score_spread":0.32308852239732744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411417714","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26256213,0.25919533,0.01007762,0.03312458,0.0032928672,0.0013657057,0.012442491,0.0020500275,0.41588926],"genre_scores_gemma":[0.7785375,0.04146489,0.014106185,0.009916682,0.0008188517,0.0006093634,0.012469696,0.00010827842,0.14196852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997522,0.000026532864,0.000019162992,0.000038911694,0.00010303401,0.000060078524],"domain_scores_gemma":[0.99969745,0.000028228078,0.000061003357,0.000018999554,0.000059723465,0.00013466978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004150051,0.00022442002,0.00034019153,0.0004379913,0.00029496587,0.0004857514,0.00046830953,0.00050003716,0.008345776],"category_scores_gemma":[0.00073729194,0.00011351276,0.00040166787,0.00034197967,0.00021580966,0.000294306,0.00034120312,0.0011246786,0.0023002548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003184285,0.00044379444,0.005836426,0.0006523754,0.00017725142,0.0007447995,0.00006691992,0.00057206274,0.018212998,0.006920603,0.10553314,0.85765535],"study_design_scores_gemma":[0.003532318,0.0014330089,0.02262793,0.00023773347,0.00015534692,0.004898552,0.000040803614,0.000845937,0.0087895915,0.0012289076,0.95617896,0.00003081064],"about_ca_topic_score_codex":0.013030329,"about_ca_topic_score_gemma":0.0537156,"teacher_disagreement_score":0.013030329,"about_ca_system_score_codex":0.0023815597,"about_ca_system_score_gemma":0.0019632548,"threshold_uncertainty_score":0.027919412},"labels":[],"label_agreement":null},{"id":"W4411452762","doi":"10.51731/cjht.2025.1148","title":"Faricimab (Vabysmo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Macular edema; Family medicine; Ophthalmology; Political science; Retinal; Health care","score_opus":0.0159759840667287,"score_gpt":0.3057363182005016,"score_spread":0.28976033413377295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411452762","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012704893,0.95226216,0.0005448952,0.001738942,0.00040861647,0.0000894511,0.00082840497,0.00007429589,0.03134832],"genre_scores_gemma":[0.2756729,0.68296856,0.0028679895,0.003994846,0.00038408054,0.00011268183,0.0027242054,0.000019778758,0.031254906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997726,0.000039921637,0.000020978323,0.00003617843,0.00009689608,0.000033437787],"domain_scores_gemma":[0.99982905,0.000035022866,0.000053653475,0.000005952703,0.00005155933,0.000024697045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003335108,0.00026607167,0.00032690357,0.000615317,0.00021358309,0.00047536765,0.00028243364,0.00042565484,0.0056234887],"category_scores_gemma":[0.0005415386,0.00006992829,0.00033496448,0.00044518447,0.00014021166,0.00024367782,0.00017809648,0.00048699082,0.0014209787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006836653,0.00008504312,0.0008962132,0.0034880613,0.00014145784,0.00034264236,0.00003442829,0.00021883339,0.009922263,0.0013727527,0.029585296,0.95322937],"study_design_scores_gemma":[0.00057262974,0.0013606111,0.012547227,0.0033193252,0.0003044307,0.0041379062,0.00007136514,0.00015768252,0.008082955,0.00042917975,0.9689891,0.000027587488],"about_ca_topic_score_codex":0.014800627,"about_ca_topic_score_gemma":0.048746027,"teacher_disagreement_score":0.014800627,"about_ca_system_score_codex":0.0011736249,"about_ca_system_score_gemma":0.0010535903,"threshold_uncertainty_score":0.029428959},"labels":[],"label_agreement":null},{"id":"W4411470437","doi":"10.51731/cjht.2025.1149","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Endometrial cancer; Paclitaxel; Carcinosarcoma; Oncology; Internal medicine; Stage (stratigraphy); Pembrolizumab; Carcinoma; Cancer; Gynecology; Chemotherapy; Cisplatin; Immunotherapy","score_opus":0.02653310924636881,"score_gpt":0.32487161992958985,"score_spread":0.29833851068322104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411470437","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13114664,0.3966115,0.0065452596,0.03829682,0.0033444362,0.0012257221,0.0065400186,0.0015132062,0.41477636],"genre_scores_gemma":[0.6690119,0.12691239,0.010499002,0.01726048,0.0011543276,0.0006926372,0.006178373,0.00008568379,0.16820522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998549,0.000017815593,0.0000100288335,0.000024630459,0.000054133525,0.000038472546],"domain_scores_gemma":[0.99988306,0.000015317944,0.000021263453,0.000006310498,0.00003043526,0.000043718403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025986962,0.00017035252,0.00025243353,0.0003309784,0.00031538037,0.00048193053,0.00031401648,0.00047034086,0.011257573],"category_scores_gemma":[0.00048478186,0.00007754091,0.00023475836,0.00022979267,0.00012754179,0.0003499618,0.00025768118,0.0012034114,0.0027791471],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017743682,0.00034733818,0.0015864992,0.00089100725,0.000093296294,0.0006946176,0.000049994662,0.0002744438,0.013784578,0.0027466808,0.115363054,0.8623941],"study_design_scores_gemma":[0.0024762682,0.0017317665,0.012062166,0.0006604522,0.00014071618,0.0037003395,0.000046615194,0.0004559665,0.006641953,0.0010385606,0.97102004,0.00002508928],"about_ca_topic_score_codex":0.008213103,"about_ca_topic_score_gemma":0.019791258,"teacher_disagreement_score":0.011257573,"about_ca_system_score_codex":0.0009529087,"about_ca_system_score_gemma":0.00093498576,"threshold_uncertainty_score":0.0376603},"labels":[],"label_agreement":null},{"id":"W4411506783","doi":"10.51731/cjht.2025.1151","title":"Clascoterone (Winlevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Acne; Family medicine; Political science; Dermatology; Health care","score_opus":0.015604395554090792,"score_gpt":0.30535708040542686,"score_spread":0.2897526848513361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411506783","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032708745,0.887267,0.0014277175,0.003874866,0.0008310309,0.0004758212,0.0025985907,0.00033051585,0.070485644],"genre_scores_gemma":[0.4010928,0.50613606,0.0035460102,0.005893088,0.00052306993,0.00029783513,0.0042226375,0.00007341291,0.078215115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971193,0.000047863785,0.000024389283,0.00004797154,0.00012998014,0.000037719205],"domain_scores_gemma":[0.9998305,0.000033893422,0.000042984615,0.000004614178,0.00005512001,0.0000329271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033361255,0.00030061434,0.0003985904,0.00105882,0.0002805154,0.00066528877,0.00036072003,0.0004861889,0.011239006],"category_scores_gemma":[0.00056897197,0.000087383756,0.00044460365,0.00054509816,0.0001577222,0.00036115476,0.0003068264,0.0007128644,0.0026896836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019748793,0.00025075133,0.00083706307,0.010449015,0.00022730623,0.00050815346,0.00008465501,0.00026369267,0.02025015,0.0018303115,0.052655336,0.9106687],"study_design_scores_gemma":[0.0017874162,0.002577242,0.008880201,0.006197875,0.000599409,0.0051803538,0.0001657106,0.0003147605,0.018714473,0.00067863567,0.95485604,0.000047941558],"about_ca_topic_score_codex":0.009929895,"about_ca_topic_score_gemma":0.03751864,"teacher_disagreement_score":0.011239006,"about_ca_system_score_codex":0.00091119873,"about_ca_system_score_gemma":0.001112619,"threshold_uncertainty_score":0.037598193},"labels":[],"label_agreement":null},{"id":"W4411506827","doi":"10.51731/cjht.2025.1150","title":"Zilucoplan (Zilbrysq)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Myasthenia gravis; Drug; Clinical trial; Thymectomy; Family medicine; Internal medicine; Pharmacology; Political science; Law","score_opus":0.014917105700351152,"score_gpt":0.29620265931650336,"score_spread":0.2812855536161522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411506827","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013309441,0.90387666,0.001756712,0.0028884478,0.00051394146,0.0004258513,0.002687126,0.0002951523,0.07424667],"genre_scores_gemma":[0.17625104,0.75515735,0.004912023,0.004522113,0.00041344823,0.00030511824,0.004568549,0.00004368506,0.05382665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997696,0.000048537688,0.00002120774,0.000027520942,0.00010804302,0.000025055522],"domain_scores_gemma":[0.99985695,0.000035513152,0.000044585035,0.000004206612,0.000038831728,0.000019834251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036909123,0.00021100696,0.0002744654,0.00069847394,0.00015334628,0.000551442,0.0003205891,0.000301388,0.010990653],"category_scores_gemma":[0.00064859574,0.00007630835,0.00034863153,0.00055984483,0.00013475356,0.00027050934,0.00022213471,0.0006387971,0.002153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006021483,0.000062087194,0.00046813182,0.0061580883,0.00015796672,0.00015014895,0.000033856617,0.00015481209,0.0058113593,0.0024401152,0.04723223,0.93672913],"study_design_scores_gemma":[0.0006942417,0.00071435183,0.0041095978,0.002176366,0.00024565952,0.0011390162,0.000031620395,0.00013506359,0.0032478576,0.0003776399,0.98711526,0.000013243488],"about_ca_topic_score_codex":0.007244562,"about_ca_topic_score_gemma":0.023734901,"teacher_disagreement_score":0.010990653,"about_ca_system_score_codex":0.00096038537,"about_ca_system_score_gemma":0.00082145515,"threshold_uncertainty_score":0.036767364},"labels":[],"label_agreement":null},{"id":"W4411625452","doi":"10.51731/cjht.2025.1152","title":"Dostarlimab (Jemperli)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.046075261996101735,"score_gpt":0.2892892159167715,"score_spread":0.24321395392066975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411625452","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17708725,0.24764179,0.0077256975,0.02306849,0.0040487885,0.002674494,0.010641882,0.0075153033,0.5195963],"genre_scores_gemma":[0.63269377,0.061817117,0.010479527,0.01969116,0.0010388532,0.0015370409,0.019778837,0.00046837196,0.25249535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997657,0.000029998513,0.000015409034,0.000036586,0.0000866604,0.00006572103],"domain_scores_gemma":[0.9998646,0.000016460226,0.000020926898,0.000010235291,0.000023757446,0.00006397203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029080585,0.00038525826,0.00051250233,0.0006097029,0.00027845966,0.0006573836,0.0004966117,0.0006812983,0.023836166],"category_scores_gemma":[0.00051924895,0.0001524716,0.00036711694,0.000302132,0.0002366867,0.00042554995,0.00049183576,0.0017780776,0.010604019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029144117,0.0010409132,0.0016560366,0.0010999006,0.00010547647,0.00080300367,0.00007735199,0.00082004466,0.015915902,0.0031557472,0.19690561,0.77550554],"study_design_scores_gemma":[0.008632452,0.0040322193,0.0066681555,0.00045886502,0.00012076779,0.0059328084,0.00005480936,0.0013648374,0.015175125,0.0017535692,0.95576024,0.000046048677],"about_ca_topic_score_codex":0.0016681699,"about_ca_topic_score_gemma":0.0038643177,"teacher_disagreement_score":0.023836166,"about_ca_system_score_codex":0.00079187256,"about_ca_system_score_gemma":0.0009519191,"threshold_uncertainty_score":0.07973993},"labels":[],"label_agreement":null},{"id":"W4411712991","doi":"10.51731/cjht.2025.1153","title":"Cost-Effectiveness of Antiviral Drugs to Prevent or Treat Influenza A, Influenza B, or Zoonotic Influenza","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine; Microbiology; Biology","score_opus":0.14469101172175794,"score_gpt":0.4492545859597756,"score_spread":0.3045635742380176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712991","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031727436,0.99108654,0.0001872985,0.0017050372,0.0004286837,0.00022477469,0.0009626091,0.000007866047,0.002224353],"genre_scores_gemma":[0.09951502,0.8947107,0.0013423751,0.0019221501,0.0006154263,0.00063806784,0.00070294715,0.000018779405,0.0005345789],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9822887,0.009133876,0.004291209,0.00069353986,0.0030225283,0.00057020586],"domain_scores_gemma":[0.9562772,0.03512675,0.0046166875,0.0003272451,0.0032973927,0.00035474251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012850874,0.0014573435,0.0074331453,0.007856506,0.00041830514,0.0043958537,0.0016352035,0.002112771,0.0072926464],"category_scores_gemma":[0.06590306,0.0009170019,0.010964752,0.0062525873,0.0008461052,0.002917833,0.0011856485,0.0026102716,0.00031814934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048331753,0.00013262503,0.003189917,0.7146184,0.05475303,0.00021896136,0.00014945203,0.0023639146,0.0002241776,0.004510006,0.0084538935,0.20655249],"study_design_scores_gemma":[0.004380887,0.001267775,0.016798262,0.72225666,0.1851277,0.0009153325,0.00051923527,0.0018621876,0.0009032207,0.007722485,0.058118775,0.00012755583],"about_ca_topic_score_codex":0.010754235,"about_ca_topic_score_gemma":0.013144441,"teacher_disagreement_score":0.012850874,"about_ca_system_score_codex":0.009308425,"about_ca_system_score_gemma":0.0052622976,"threshold_uncertainty_score":0.067962766},"labels":[],"label_agreement":null},{"id":"W4411713030","doi":"10.51731/cjht.2025.1155","title":"Alternate Level of Care in Canada: Evidence Assessment Report","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology; Medicine; History; Political science","score_opus":0.13715368792694693,"score_gpt":0.45040458907630576,"score_spread":0.31325090114935883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411713030","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028227395,0.9507334,0.0015207394,0.005682629,0.0014770597,0.004747462,0.0147915855,0.0001498066,0.018074693],"genre_scores_gemma":[0.10157539,0.85219616,0.019813623,0.004027284,0.0003918195,0.0063388683,0.013063037,0.00012090311,0.0024728617],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9709962,0.00354914,0.0058986326,0.0012090114,0.017046722,0.0013003373],"domain_scores_gemma":[0.89173716,0.021273177,0.013102949,0.001566441,0.06758119,0.004739047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016453747,0.0011193047,0.00414241,0.011749554,0.0032619827,0.0062040607,0.0046973377,0.0023543763,0.0127503965],"category_scores_gemma":[0.08859853,0.0010784243,0.0061538084,0.015253527,0.0019322443,0.0023082593,0.002613244,0.0037176618,0.0010066307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010573177,0.00017544221,0.011615789,0.59527445,0.005156725,0.00015020873,0.00049739954,0.0007578638,0.00029124832,0.0048511056,0.079632945,0.30053952],"study_design_scores_gemma":[0.0010066653,0.00028092373,0.037978843,0.7770774,0.012211735,0.0002386778,0.0007205628,0.00056320336,0.00039529268,0.001867249,0.16750321,0.00015631854],"about_ca_topic_score_codex":0.76625925,"about_ca_topic_score_gemma":0.88504475,"teacher_disagreement_score":0.9393548,"about_ca_system_score_codex":0.06064525,"about_ca_system_score_gemma":0.20731007,"threshold_uncertainty_score":0.47023457},"labels":[],"label_agreement":null},{"id":"W4411713042","doi":"10.51731/cjht.2025.1154","title":"Talquetamab (Talvey)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.2889593708010012,"score_gpt":0.42972959860994586,"score_spread":0.14077022780894466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411713042","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04790526,0.5474943,0.006876471,0.035869583,0.002871804,0.0014370123,0.01668823,0.0028541116,0.3380032],"genre_scores_gemma":[0.4872817,0.2576043,0.009610191,0.02237446,0.0014153945,0.0010970776,0.0142289745,0.00034549684,0.20604241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955446,0.00016095238,0.000030373625,0.000056627174,0.0001471691,0.000050375143],"domain_scores_gemma":[0.9994011,0.00015941804,0.0001217534,0.000027500122,0.00015371577,0.00013649004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010192464,0.0003057454,0.00049614516,0.0012440532,0.0002893222,0.0012807284,0.0004697071,0.0007543665,0.07227377],"category_scores_gemma":[0.0022835233,0.000104131475,0.0007037343,0.00069533783,0.00029530376,0.0006677929,0.0006718039,0.0011954198,0.009217845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022915602,0.00022870045,0.00091348984,0.0034799783,0.000235863,0.00023867401,0.00007478342,0.00040584174,0.0017746805,0.0079924585,0.15358043,0.8287835],"study_design_scores_gemma":[0.0024829374,0.0011828945,0.0032305398,0.002190279,0.00033196076,0.00093211397,0.000071788985,0.00046583457,0.0019829033,0.0028826955,0.98422146,0.000024600064],"about_ca_topic_score_codex":0.0037953749,"about_ca_topic_score_gemma":0.006889139,"teacher_disagreement_score":0.07227377,"about_ca_system_score_codex":0.001329589,"about_ca_system_score_gemma":0.0014985586,"threshold_uncertainty_score":0.2417798},"labels":[],"label_agreement":null},{"id":"W4411749003","doi":"10.51731/cjht.2025.1157","title":"Trends in CT Exam Volumes Between 2007 and 2022–2023 in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear medicine; Medicine; Medical physics; Environmental science","score_opus":0.009899713950787196,"score_gpt":0.2395912448993541,"score_spread":0.2296915309485669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411749003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73350394,0.010677334,0.0011356521,0.013843284,0.00020771957,0.00011352075,0.21616831,0.00044529515,0.023904892],"genre_scores_gemma":[0.93788487,0.004651176,0.001182014,0.0014743274,0.00007394244,0.000054902954,0.050874397,0.00007208651,0.003732354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815995,0.00007275263,0.00013339642,0.00016101793,0.0008897273,0.0005832515],"domain_scores_gemma":[0.9906838,0.00038710298,0.0012286023,0.00011076755,0.006418601,0.0011711904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834475,0.00037533644,0.00038852193,0.0038793357,0.0011968942,0.0020154957,0.0015638109,0.00054770685,0.0022202367],"category_scores_gemma":[0.005084174,0.0003443392,0.0009214055,0.009973599,0.0007003693,0.0008909345,0.00094205077,0.0012084696,0.00040231185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012165952,0.000030724634,0.9409822,0.00025608687,0.00014362158,0.00018610011,0.0006628946,0.0014129647,0.00031246198,0.0009945697,0.033226684,0.021670077],"study_design_scores_gemma":[0.000005701832,0.000013552696,0.98336226,0.000117785545,0.000045147917,0.00015072532,0.0011445421,0.0014981803,0.00021475754,0.00006996369,0.013349219,0.00002813929],"about_ca_topic_score_codex":0.9940263,"about_ca_topic_score_gemma":0.9958703,"teacher_disagreement_score":0.050082672,"about_ca_system_score_codex":0.050082672,"about_ca_system_score_gemma":0.05014298,"threshold_uncertainty_score":0.36337692},"labels":[],"label_agreement":null},{"id":"W4411749041","doi":"10.51731/cjht.2025.1156","title":"Tarlatamab (Imdelltra)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cancer Care Ontario","keywords":"Computer science","score_opus":0.01959808958604087,"score_gpt":0.30008057881005523,"score_spread":0.28048248922401436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411749041","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018632444,0.9022126,0.0019348031,0.004766038,0.0007750986,0.00036741857,0.0033498618,0.00055184105,0.067409866],"genre_scores_gemma":[0.3180024,0.5901694,0.007830876,0.009673632,0.00079086627,0.00052810414,0.006701055,0.00008005639,0.066223584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999713,0.000069763584,0.000031147254,0.000038021393,0.000109914305,0.000038207643],"domain_scores_gemma":[0.99974734,0.00006448158,0.0000827162,0.000010503185,0.00006219518,0.000032756805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059743214,0.00028538675,0.00047670057,0.00079359114,0.000202867,0.00086155755,0.00038064364,0.00047829133,0.012034851],"category_scores_gemma":[0.0008699226,0.00009186512,0.0004963374,0.0005707485,0.00018898802,0.00052945147,0.00027101944,0.0009246291,0.0027074316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010171386,0.00008556948,0.0004361414,0.003834686,0.00012802232,0.0002074922,0.00004425371,0.00025880904,0.005412327,0.0020482398,0.03738263,0.94914466],"study_design_scores_gemma":[0.0013670448,0.0015089951,0.0034841828,0.0027951882,0.00039289272,0.0021934465,0.00004558285,0.0002604367,0.006190424,0.00075080385,0.9809879,0.000023079785],"about_ca_topic_score_codex":0.0037820318,"about_ca_topic_score_gemma":0.011926204,"teacher_disagreement_score":0.012034851,"about_ca_system_score_codex":0.0012114495,"about_ca_system_score_gemma":0.0008326652,"threshold_uncertainty_score":0.040260613},"labels":[],"label_agreement":null},{"id":"W4412048074","doi":"10.51731/cjht.2025.1159","title":"Semaglutide (Wegovy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Endocrinology","score_opus":0.02301648044997576,"score_gpt":0.35637882620294414,"score_spread":0.33336234575296836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412048074","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23430073,0.23122308,0.010811312,0.023170639,0.0041394224,0.0016399728,0.017211584,0.008475956,0.46902722],"genre_scores_gemma":[0.6982787,0.053763155,0.008488359,0.017395953,0.0008251837,0.0005816145,0.017683912,0.00036228893,0.20262086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983764,0.000027094744,0.000012286012,0.00003035903,0.000060431328,0.000032182917],"domain_scores_gemma":[0.9998946,0.000014556807,0.000015547865,0.0000072971525,0.000024229219,0.000043836393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023420238,0.00031921547,0.0005772474,0.0005670978,0.0002908957,0.00067347416,0.0003908398,0.0008576526,0.02033779],"category_scores_gemma":[0.00041570497,0.00009966291,0.0004849905,0.0004607956,0.00021619994,0.00051761226,0.0003529095,0.0017477126,0.010024074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055019027,0.0009894093,0.0020682458,0.0013947872,0.00021732003,0.0010850846,0.0000756631,0.00051976414,0.021579307,0.0034330778,0.17670704,0.7864284],"study_design_scores_gemma":[0.0103883175,0.0062448904,0.015247959,0.00082420325,0.00031321225,0.008564725,0.00010990204,0.0018272012,0.019649876,0.002580938,0.9341617,0.000087104825],"about_ca_topic_score_codex":0.003894619,"about_ca_topic_score_gemma":0.010231606,"teacher_disagreement_score":0.02033779,"about_ca_system_score_codex":0.00068326894,"about_ca_system_score_gemma":0.0008651171,"threshold_uncertainty_score":0.068036675},"labels":[],"label_agreement":null},{"id":"W4412117824","doi":"10.51731/cjht.2025.1163","title":"Trends in MRI Exam Volumes Between 2007 and 2022–2023 in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science; Medicine","score_opus":0.02081533778254828,"score_gpt":0.3241183519524455,"score_spread":0.3033030141698972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412117824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.645967,0.011644832,0.0013549213,0.018821185,0.0002537286,0.00014125813,0.29329047,0.0005651231,0.027961388],"genre_scores_gemma":[0.9249873,0.0058013787,0.0018049099,0.002262444,0.00009602744,0.000081886115,0.059348714,0.00009878378,0.005518596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979785,0.00008265171,0.00014741163,0.00018101686,0.0010142217,0.0005962745],"domain_scores_gemma":[0.9891376,0.00043367958,0.0012442304,0.00011518674,0.0077872165,0.0012821434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010572744,0.00040703264,0.00044038938,0.0040569035,0.0013728674,0.0020663855,0.0015341436,0.00051715533,0.0023695133],"category_scores_gemma":[0.0054976135,0.00033243085,0.0009688137,0.010485513,0.00068576285,0.0009749333,0.0009375999,0.0012214362,0.0004558053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016456224,0.000039253562,0.9027594,0.00045736504,0.0002170416,0.00024300134,0.0010811152,0.0017292592,0.00042614053,0.001656693,0.058602627,0.032623615],"study_design_scores_gemma":[0.000008594952,0.000018860332,0.97232527,0.00020113966,0.00007637815,0.00017873224,0.0015948799,0.0019459813,0.00031485973,0.000118296695,0.023168858,0.000048013095],"about_ca_topic_score_codex":0.99566627,"about_ca_topic_score_gemma":0.99697006,"teacher_disagreement_score":0.9430582,"about_ca_system_score_codex":0.056941785,"about_ca_system_score_gemma":0.063035734,"threshold_uncertainty_score":0.41314352},"labels":[],"label_agreement":null},{"id":"W4412158966","doi":"10.51731/cjht.2025.1165","title":"Hourly MRI Exam Volumes Across Canada in 2022–2023","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.009638817110730492,"score_gpt":0.3077956371914655,"score_spread":0.298156820080735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412158966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65378344,0.018495917,0.002500137,0.034887753,0.0009964457,0.0002999546,0.24653703,0.0012568152,0.04124239],"genre_scores_gemma":[0.93937737,0.0064554936,0.0018583117,0.004419415,0.00020519899,0.00011191002,0.036820516,0.00021347027,0.010538369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970276,0.00017307284,0.00015307542,0.00026803362,0.0013889332,0.0009892845],"domain_scores_gemma":[0.9885018,0.00054874114,0.001263554,0.00018490375,0.0067741494,0.0027267959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015348361,0.00046616257,0.0004993439,0.0025350582,0.0020056437,0.0021416508,0.0018327014,0.0005505644,0.0052055935],"category_scores_gemma":[0.009294944,0.00046248367,0.00079830503,0.006394974,0.0007615061,0.0008071982,0.00113209,0.0014404586,0.0009006737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035293095,0.00006250745,0.7583411,0.00051118905,0.00021088503,0.0004778992,0.0016643199,0.0017877785,0.00051276083,0.001774189,0.16163671,0.07266783],"study_design_scores_gemma":[0.000019922336,0.000026251728,0.9618772,0.00023275283,0.000051196446,0.00027824796,0.0018204777,0.0012065032,0.00029013312,0.00018112328,0.03396053,0.00005563595],"about_ca_topic_score_codex":0.99478036,"about_ca_topic_score_gemma":0.9955713,"teacher_disagreement_score":0.060781814,"about_ca_system_score_codex":0.060781814,"about_ca_system_score_gemma":0.06432711,"threshold_uncertainty_score":0.441005},"labels":[],"label_agreement":null},{"id":"W4412159003","doi":"10.51731/cjht.2025.1164","title":"Hourly CT Exam Volumes Across Canada in 2022–2023","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.014067817810169195,"score_gpt":0.3049822047060123,"score_spread":0.2909143868958431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412159003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6153932,0.014289337,0.0042943177,0.03746968,0.0011297879,0.0002963808,0.27636153,0.0017956436,0.04897007],"genre_scores_gemma":[0.9351967,0.004117772,0.002118091,0.0038934671,0.00020212885,0.000089154484,0.045541536,0.00023615353,0.008605031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977773,0.00010910386,0.000093722105,0.00018859908,0.0010494682,0.00078183034],"domain_scores_gemma":[0.9918514,0.00038436908,0.0007093604,0.00013264589,0.0052479464,0.0016743349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280859,0.0004945999,0.00041071736,0.0020156617,0.0017231093,0.00253322,0.0016191624,0.00054435147,0.0047468846],"category_scores_gemma":[0.0069063725,0.00042522457,0.00079005264,0.004555242,0.0006605781,0.00082700205,0.0010492952,0.0013039042,0.00090234046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036451052,0.00006194483,0.7085788,0.00043446705,0.00020366674,0.0004830292,0.0014372391,0.004406388,0.0007275732,0.0023342848,0.2107634,0.07020461],"study_design_scores_gemma":[0.000025145317,0.000027231617,0.94426656,0.00021494467,0.000060815903,0.00029430268,0.0022763114,0.0037787461,0.0004525693,0.00032559005,0.04820836,0.00006945911],"about_ca_topic_score_codex":0.9930046,"about_ca_topic_score_gemma":0.9932088,"teacher_disagreement_score":0.05478975,"about_ca_system_score_codex":0.05478975,"about_ca_system_score_gemma":0.053999204,"threshold_uncertainty_score":0.3975293},"labels":[],"label_agreement":null},{"id":"W4412200300","doi":"10.51731/cjht.2025.1167","title":"MRI Service Delivery in Canada: Units, Exam Volumes, and Medical Radiation Technologist Staffing","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Medical physics; Service (business); Medicine; Service delivery framework; Nuclear medicine; Radiology; Business; Nursing","score_opus":0.013955953458555118,"score_gpt":0.2562306730184207,"score_spread":0.24227471955986557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412200300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8516656,0.019076584,0.0017198824,0.08697744,0.00040673194,0.00022388206,0.02126531,0.00015393164,0.0185107],"genre_scores_gemma":[0.9882824,0.003435411,0.001173598,0.0033423863,0.0000711894,0.000045770168,0.0022353877,0.000046299006,0.0013675544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935028,0.00072285434,0.00051396136,0.0005537155,0.00251098,0.0021957406],"domain_scores_gemma":[0.9727456,0.0025279822,0.0047750273,0.0003714281,0.011922714,0.0076573268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043076486,0.00034008292,0.00062621123,0.002623383,0.0036577503,0.0034999312,0.0028248818,0.0008140951,0.003504784],"category_scores_gemma":[0.020201938,0.0005641919,0.0011020252,0.010183246,0.0017916416,0.0018578776,0.001883185,0.002041212,0.00030574395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007784262,0.000058085538,0.9467717,0.00042993636,0.00016964652,0.00017427996,0.0044234204,0.00053576345,0.000098592696,0.00145976,0.021227948,0.024573158],"study_design_scores_gemma":[0.000015289068,0.000032511492,0.97935426,0.0007047894,0.00009043406,0.00010778742,0.0090762405,0.0011850935,0.00011045882,0.00027420494,0.008998198,0.000050643597],"about_ca_topic_score_codex":0.9977355,"about_ca_topic_score_gemma":0.99857605,"teacher_disagreement_score":0.8866341,"about_ca_system_score_codex":0.11336592,"about_ca_system_score_gemma":0.16910072,"threshold_uncertainty_score":0.82253116},"labels":[],"label_agreement":null},{"id":"W4412200350","doi":"10.51731/cjht.2025.1166","title":"MRI Usage Patterns by Clinical Specialty Across Canada: Geographic and Temporal Trends","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Specialty; Geography; Cartography; Data science; Medicine; Computer science; Family medicine","score_opus":0.033633275085445204,"score_gpt":0.38137493116195026,"score_spread":0.34774165607650503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412200350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9019485,0.014355485,0.0012799249,0.02200522,0.0001386973,0.00016046828,0.047625188,0.0002019992,0.012284513],"genre_scores_gemma":[0.9837261,0.004929242,0.0009481313,0.001690243,0.000045357825,0.00006071841,0.007046586,0.000051780014,0.0015018544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654883,0.00025915547,0.00038633827,0.0005198348,0.0013523089,0.000933608],"domain_scores_gemma":[0.982882,0.0016823829,0.003871629,0.00044143887,0.008933236,0.0021893154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023613079,0.00025714198,0.00052302534,0.0034904128,0.0020233113,0.0019287559,0.0017973379,0.000569292,0.0026234628],"category_scores_gemma":[0.009774392,0.00043625932,0.000916957,0.012075353,0.0011700183,0.001138751,0.0013603431,0.0017482868,0.00028854236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000804521,0.000020184427,0.97161657,0.00029564893,0.00012645272,0.00010026338,0.002164733,0.00024830954,0.00021125207,0.0004260793,0.0078013185,0.01690871],"study_design_scores_gemma":[0.00000350895,0.000013828187,0.99198455,0.00017949502,0.00003158856,0.00009941673,0.0031410335,0.00035354728,0.000072950184,0.00005477114,0.0040430855,0.000022146747],"about_ca_topic_score_codex":0.99025166,"about_ca_topic_score_gemma":0.9940975,"teacher_disagreement_score":0.9697971,"about_ca_system_score_codex":0.03020295,"about_ca_system_score_gemma":0.043519106,"threshold_uncertainty_score":0.21913874},"labels":[],"label_agreement":null},{"id":"W4412360437","doi":"10.51731/cjht.2025.1162","title":"Elafibranor (Iqirvo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.013830898907577311,"score_gpt":0.31496099364087377,"score_spread":0.30113009473329644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412360437","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11558336,0.29751164,0.008307507,0.031759873,0.0035126924,0.0014847866,0.019899165,0.006754133,0.51518685],"genre_scores_gemma":[0.60249084,0.07715073,0.011624878,0.028087594,0.0018246094,0.0007306136,0.025553213,0.00038535162,0.25215232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995914,0.000048270824,0.0000323233,0.00006083353,0.00017507271,0.00009217593],"domain_scores_gemma":[0.99958915,0.00005463309,0.000089022535,0.000026394031,0.00011379468,0.000126998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005048898,0.00035623615,0.00061490486,0.00076078007,0.0004727046,0.00089798943,0.00050447584,0.00094643974,0.028732304],"category_scores_gemma":[0.0011372995,0.000116058036,0.00056909426,0.00047240502,0.00026147586,0.0004956333,0.0005551803,0.0016359409,0.009473083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005784645,0.000791547,0.0025410433,0.0012474343,0.00012470757,0.0010363522,0.00009529934,0.00031071904,0.021639176,0.0037448893,0.1716279,0.7910562],"study_design_scores_gemma":[0.0051047886,0.0022875632,0.010632158,0.0007388165,0.00018696487,0.004221238,0.00007373524,0.0005936096,0.013169203,0.0012094332,0.96174407,0.000038305727],"about_ca_topic_score_codex":0.010622722,"about_ca_topic_score_gemma":0.017128292,"teacher_disagreement_score":0.028732304,"about_ca_system_score_codex":0.0015558352,"about_ca_system_score_gemma":0.0014177698,"threshold_uncertainty_score":0.096119106},"labels":[],"label_agreement":null},{"id":"W4412427405","doi":"10.51731/cjht.2025.1168","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412427405","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011695035,0.929007,0.0017747094,0.004057607,0.0006568739,0.0002124904,0.0012638757,0.0003044066,0.05102807],"genre_scores_gemma":[0.18220879,0.738872,0.009122932,0.006688839,0.00076373754,0.00023186939,0.0031885295,0.00007437563,0.058848992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935263,0.000104287115,0.000043583925,0.000057252302,0.00038561792,0.000056596084],"domain_scores_gemma":[0.9992613,0.00014331921,0.00017747944,0.000018132829,0.00033572028,0.00006404897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094664085,0.0003833086,0.00045009475,0.0017371031,0.00034082943,0.00054657203,0.00046825578,0.0006224787,0.007005789],"category_scores_gemma":[0.0015393785,0.0000978996,0.000494475,0.0007446997,0.0002760226,0.00031216283,0.0002894223,0.0005453785,0.0016917515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005990773,0.00011527882,0.0016373802,0.005430947,0.00018667377,0.0003152821,0.000048117545,0.00012143376,0.0059235543,0.0016221446,0.08762875,0.8963715],"study_design_scores_gemma":[0.00026692028,0.0008613906,0.009645181,0.0036993562,0.00038708845,0.0025920095,0.000054565135,0.00011597912,0.008654752,0.00034437524,0.9733507,0.000027721338],"about_ca_topic_score_codex":0.030826276,"about_ca_topic_score_gemma":0.07182271,"teacher_disagreement_score":0.030826276,"about_ca_system_score_codex":0.0016809579,"about_ca_system_score_gemma":0.0017665557,"threshold_uncertainty_score":0.06129366},"labels":[],"label_agreement":null},{"id":"W4412495459","doi":"10.51731/cjht.2025.1171","title":"Naloxegol","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Traditional medicine; Medicine","score_opus":0.025132346049566018,"score_gpt":0.33082840259772517,"score_spread":0.3056960565481591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412495459","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23535007,0.22570308,0.0034437098,0.02236328,0.0047816234,0.004387404,0.019494642,0.0008581981,0.48361802],"genre_scores_gemma":[0.6273792,0.09601472,0.008321047,0.0140749095,0.00064672966,0.0027526054,0.007978441,0.00007000908,0.24276248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996302,0.00009596521,0.00003657992,0.000044849534,0.00015429435,0.000038096423],"domain_scores_gemma":[0.9996803,0.0000743974,0.000052096395,0.000025044708,0.000104469254,0.00006372377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045584593,0.00019483115,0.00025903794,0.0004655826,0.00042315217,0.00050926645,0.00039111843,0.00056196545,0.032362398],"category_scores_gemma":[0.0012953343,0.00007927143,0.0003030852,0.00025303283,0.00018890244,0.000372973,0.00033497022,0.00071945274,0.0044527682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010879387,0.0012947677,0.0026163955,0.004836221,0.0001461817,0.0004023604,0.00016221085,0.0000880798,0.009490038,0.00466137,0.06801644,0.89740664],"study_design_scores_gemma":[0.0043200203,0.008872009,0.015217425,0.0030695207,0.00029095984,0.0014954228,0.0003030953,0.0001236638,0.009068175,0.0010614466,0.9561343,0.000043915756],"about_ca_topic_score_codex":0.0051066168,"about_ca_topic_score_gemma":0.010699399,"teacher_disagreement_score":0.032362398,"about_ca_system_score_codex":0.0008668008,"about_ca_system_score_gemma":0.0014591786,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4412525820","doi":"10.51731/cjht.2025.1172","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412525820","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14515637,0.43047687,0.007896347,0.031531885,0.004987191,0.001618335,0.00877795,0.003115137,0.36643994],"genre_scores_gemma":[0.68302286,0.106487416,0.011740439,0.01707872,0.0013057042,0.00079050614,0.009740539,0.00014500535,0.16968882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998116,0.000019233868,0.000014231904,0.00003360376,0.000067034605,0.000054408076],"domain_scores_gemma":[0.9998511,0.000015784992,0.00002631503,0.000010219928,0.00003760937,0.00005884601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029513604,0.00023946141,0.00031450271,0.00044046287,0.00036649522,0.00057786284,0.00036343088,0.0005295443,0.01457077],"category_scores_gemma":[0.00050540164,0.00010590356,0.00032602492,0.00027428672,0.00014894921,0.00038779856,0.0003505218,0.0014771663,0.0054422733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017549758,0.00041263038,0.001705903,0.00087778753,0.00009620848,0.00062906917,0.00005188386,0.00026765466,0.018464874,0.0022358063,0.12259033,0.8509128],"study_design_scores_gemma":[0.0023977594,0.0016538417,0.010625387,0.00053605484,0.00014763174,0.0035750368,0.000040586576,0.00038877202,0.009023167,0.0009016775,0.9706844,0.00002562313],"about_ca_topic_score_codex":0.0056338464,"about_ca_topic_score_gemma":0.0114554735,"teacher_disagreement_score":0.01457077,"about_ca_system_score_codex":0.0009823504,"about_ca_system_score_gemma":0.0008456039,"threshold_uncertainty_score":0.048744082},"labels":[],"label_agreement":null},{"id":"W4412557774","doi":"10.51731/cjht.2025.1173","title":"Lazertinib and Amivantamab (Lazcluze and Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014318388167044858,"score_gpt":0.2930609854070025,"score_spread":0.27874259723995765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412557774","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17997605,0.25203243,0.0068397494,0.040100332,0.003806629,0.0020608725,0.017010082,0.0031429455,0.49503088],"genre_scores_gemma":[0.6548977,0.06436657,0.0078864675,0.014492533,0.0011206793,0.0008277106,0.02184233,0.00013531631,0.23443072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974114,0.000030381587,0.000022498321,0.000038378388,0.00009697485,0.00007050006],"domain_scores_gemma":[0.9998018,0.000014210201,0.00004154713,0.000012472118,0.00004241015,0.00008755625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043329972,0.00026888656,0.00041770897,0.00068922783,0.00033167933,0.0007251903,0.0005005474,0.0008014426,0.017148396],"category_scores_gemma":[0.0005046047,0.00012348109,0.0006895071,0.0004050659,0.00022045056,0.000361291,0.0005113649,0.001173108,0.0067236167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030712404,0.00051722134,0.0032971965,0.0007935255,0.00019499625,0.00055025826,0.000050932616,0.00073121575,0.014533574,0.007210356,0.16344605,0.8056034],"study_design_scores_gemma":[0.0042987145,0.0019088669,0.014822152,0.0003986489,0.00016040237,0.0031150181,0.000035199388,0.0009919367,0.0069696647,0.0014894049,0.96576804,0.000041942538],"about_ca_topic_score_codex":0.0098397145,"about_ca_topic_score_gemma":0.028059198,"teacher_disagreement_score":0.017148396,"about_ca_system_score_codex":0.0020683322,"about_ca_system_score_gemma":0.0021071567,"threshold_uncertainty_score":0.057367146},"labels":[],"label_agreement":null},{"id":"W4412612589","doi":"10.51731/cjht.2025.1174","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesylate; Medicine; Medical physics; Chemistry","score_opus":0.024821458400973634,"score_gpt":0.36169274152501346,"score_spread":0.3368712831240398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412612589","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24083832,0.3838225,0.009130719,0.0121986605,0.002659487,0.0013750205,0.013550417,0.004042252,0.33238265],"genre_scores_gemma":[0.7710422,0.08049145,0.010455725,0.0071436306,0.0005954485,0.00043933428,0.011069512,0.00019615707,0.11856654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998179,0.000025079851,0.000011588154,0.000037302143,0.000075772514,0.000032344993],"domain_scores_gemma":[0.99989676,0.000013345043,0.000020121704,0.000006598581,0.000014503823,0.00004853807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010186628,0.0003448524,0.00039520487,0.00073487114,0.0003100398,0.0003342569,0.00037955405,0.0005408512,0.018765183],"category_scores_gemma":[0.00031280544,0.000116264506,0.00029911372,0.0004416045,0.00022237713,0.00024014297,0.00034776266,0.0014193848,0.0067771967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048860954,0.0011242109,0.001869567,0.0022265492,0.00015368742,0.0031555428,0.00009100878,0.00050766184,0.12998278,0.0035192168,0.0734671,0.7790165],"study_design_scores_gemma":[0.004338309,0.0059756152,0.016379261,0.00063939096,0.00016889423,0.021027377,0.000121745696,0.0007763724,0.13107602,0.0011990789,0.81819427,0.00010367147],"about_ca_topic_score_codex":0.0041072234,"about_ca_topic_score_gemma":0.008484108,"teacher_disagreement_score":0.018765183,"about_ca_system_score_codex":0.00055052503,"about_ca_system_score_gemma":0.00059863884,"threshold_uncertainty_score":0.06277579},"labels":[],"label_agreement":null},{"id":"W4412632527","doi":"10.51731/cjht.2025.1175","title":"Polatuzumab Vedotin (Polivy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.012518927495771085,"score_gpt":0.29539388877317135,"score_spread":0.28287496127740025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412632527","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24058364,0.26069582,0.015610178,0.025291167,0.0041555106,0.0016341689,0.009591953,0.0050373883,0.4374002],"genre_scores_gemma":[0.8219322,0.041140582,0.008070455,0.008334862,0.00051854795,0.0003657481,0.0068541057,0.00016963443,0.11261388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998505,0.000016786384,0.000007456027,0.00002934549,0.00005695693,0.000038825958],"domain_scores_gemma":[0.9998299,0.000028308683,0.00002134143,0.000011298151,0.000033498916,0.00007561778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022541269,0.00020078351,0.0003176193,0.00048636502,0.00028691016,0.0006708455,0.00037431056,0.0004809457,0.010163621],"category_scores_gemma":[0.00043174945,0.00009843355,0.00025275748,0.00027154942,0.0002536882,0.00025242224,0.00031329071,0.001190926,0.0032886034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002123658,0.00045174256,0.003178112,0.0004695319,0.000081108185,0.0010088601,0.00006285464,0.0008546942,0.024099803,0.004184944,0.08292922,0.88055557],"study_design_scores_gemma":[0.0033894153,0.0023366187,0.008725643,0.00037038772,0.000080070036,0.006622658,0.000042304302,0.0013802857,0.016458953,0.0014617147,0.95910573,0.000026190222],"about_ca_topic_score_codex":0.0061213216,"about_ca_topic_score_gemma":0.011454659,"teacher_disagreement_score":0.010163621,"about_ca_system_score_codex":0.0014694416,"about_ca_system_score_gemma":0.0011342398,"threshold_uncertainty_score":0.034000754},"labels":[],"label_agreement":null},{"id":"W4412632949","doi":"10.51731/cjht.2025.1176","title":"Pasireotide (Signifor LAR)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pasireotide; Environmental science; Psychology; Medicine; Internal medicine; Acromegaly","score_opus":0.017207793994875185,"score_gpt":0.29169148275675866,"score_spread":0.27448368876188345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412632949","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09225993,0.19699065,0.014444389,0.013805039,0.0030430448,0.0011169325,0.010476572,0.0041734707,0.66369],"genre_scores_gemma":[0.5518206,0.0657213,0.023150641,0.02087293,0.0011294963,0.0010675637,0.019759595,0.00049396843,0.315984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998474,0.000026525522,0.000008768838,0.000031304462,0.00005694361,0.0000289783],"domain_scores_gemma":[0.9998908,0.000019763207,0.000016046244,0.000008491104,0.000021296491,0.000043541244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029236652,0.0002904077,0.00033631208,0.0003544514,0.00024234116,0.0004705018,0.00035057976,0.00069126545,0.03026001],"category_scores_gemma":[0.0003870368,0.0001117155,0.0003523244,0.00025711747,0.00019476967,0.00043306765,0.00034516747,0.0015368719,0.014766298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029247403,0.00043124866,0.0011297244,0.000896836,0.000093579096,0.0012170664,0.00005470485,0.0005994874,0.034677938,0.005928293,0.16937055,0.78267586],"study_design_scores_gemma":[0.0031774838,0.002562921,0.004152097,0.00038602966,0.00011875468,0.011322642,0.000049635448,0.0012163575,0.017887766,0.0019721761,0.9571099,0.00004421713],"about_ca_topic_score_codex":0.0023390183,"about_ca_topic_score_gemma":0.004967887,"teacher_disagreement_score":0.03026001,"about_ca_system_score_codex":0.00050503877,"about_ca_system_score_gemma":0.00064628676,"threshold_uncertainty_score":0.10122979},"labels":[],"label_agreement":null},{"id":"W4412633024","doi":"10.51731/cjht.2025.1177","title":"Iptacopan (Fabhalta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.011168223352784949,"score_gpt":0.2755146141664529,"score_spread":0.26434639081366795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412633024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0205277,0.8143287,0.0019183718,0.0034635537,0.0011237214,0.0005620201,0.004696443,0.0006506373,0.1527289],"genre_scores_gemma":[0.24624708,0.66242963,0.0070443237,0.0077711646,0.0008230105,0.0004480231,0.0069681997,0.00009937968,0.06816918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998134,0.000031585696,0.000014743363,0.000024465282,0.00009102456,0.000024760708],"domain_scores_gemma":[0.9998149,0.00005048033,0.00004546006,0.0000057491975,0.00004483002,0.000038615166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033437132,0.0002708598,0.00036488404,0.00096763385,0.00022507315,0.000693984,0.00037716317,0.0004379642,0.018577185],"category_scores_gemma":[0.0008336433,0.00007868969,0.00050896703,0.0006533633,0.00015654648,0.0003276733,0.00029499677,0.00073933584,0.0027190386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000837835,0.00009429668,0.0004388849,0.005704134,0.00014770393,0.0003095421,0.00004347825,0.00014837185,0.003169152,0.0016564678,0.05710844,0.9303418],"study_design_scores_gemma":[0.0011109323,0.0010385029,0.0056137373,0.003915979,0.0005476556,0.0024234618,0.000042335105,0.00017816675,0.002557653,0.0005686468,0.9819806,0.000022246697],"about_ca_topic_score_codex":0.009553388,"about_ca_topic_score_gemma":0.028074197,"teacher_disagreement_score":0.018577185,"about_ca_system_score_codex":0.00090711605,"about_ca_system_score_gemma":0.0012499313,"threshold_uncertainty_score":0.062146902},"labels":[],"label_agreement":null},{"id":"W4412697740","doi":"10.51731/cjht.2025.1178","title":"Omaveloxolone (Skyclarys)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01966521098273077,"score_gpt":0.30985834869944173,"score_spread":0.29019313771671096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412697740","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23925965,0.364207,0.0097481385,0.0146471765,0.0034882317,0.0016278512,0.010426631,0.0046004956,0.3519948],"genre_scores_gemma":[0.7553836,0.065564595,0.006648959,0.010179405,0.0006886768,0.00048736052,0.007360555,0.00018937275,0.15349744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999808,0.000032122418,0.000015241257,0.000036629168,0.00007359855,0.000034403485],"domain_scores_gemma":[0.9998815,0.0000165624,0.000025661473,0.000009419402,0.00002759288,0.000039313436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017847489,0.00034653628,0.00040713043,0.0010027756,0.00029165632,0.00033666557,0.00039244242,0.00061985815,0.025064606],"category_scores_gemma":[0.00039152132,0.00010214993,0.00037193781,0.00048330493,0.0001746807,0.00029569172,0.00039465653,0.0012688852,0.007462748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003764325,0.0010935479,0.0014821731,0.0020284248,0.00013401547,0.0015196027,0.00008793745,0.000265126,0.0401677,0.003003488,0.065594204,0.8808595],"study_design_scores_gemma":[0.009918558,0.0137587,0.021922816,0.00175801,0.00023272507,0.017223066,0.00021760903,0.0010339022,0.048586074,0.0024812408,0.8827657,0.000101632824],"about_ca_topic_score_codex":0.0021817798,"about_ca_topic_score_gemma":0.003923092,"teacher_disagreement_score":0.025064606,"about_ca_system_score_codex":0.0003663122,"about_ca_system_score_gemma":0.000530832,"threshold_uncertainty_score":0.08384949},"labels":[],"label_agreement":null},{"id":"W4412788885","doi":"10.51731/cjht.2025.1181","title":"Fidaxomicin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fidaxomicin; Biology","score_opus":0.06982554547290536,"score_gpt":0.40967264471255066,"score_spread":0.3398470992396453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412788885","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045167025,0.66462094,0.0037797894,0.02466518,0.002760806,0.0006410859,0.006530725,0.00053211534,0.25130233],"genre_scores_gemma":[0.51082426,0.33815095,0.013729909,0.01852142,0.0012146069,0.0004818236,0.008862807,0.00010499248,0.1081092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995796,0.00009097126,0.000035033798,0.000054771597,0.00017547933,0.000064047796],"domain_scores_gemma":[0.9995912,0.00008170796,0.00011015211,0.000013459993,0.00014031683,0.000063250816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000616747,0.00026568054,0.00027360895,0.0008166034,0.00031888575,0.00076564203,0.00027297347,0.0006180074,0.011860596],"category_scores_gemma":[0.0014952382,0.00008009572,0.00046586563,0.00059292157,0.00023931032,0.00037326277,0.00029412957,0.0006215453,0.002057826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012871024,0.0001257612,0.0018732712,0.0032878357,0.000101994316,0.0005477127,0.00006281812,0.00028550153,0.008767566,0.0055110613,0.12648453,0.85166484],"study_design_scores_gemma":[0.0003391191,0.0007564908,0.00586298,0.0015148926,0.00010799292,0.0027707808,0.00006283937,0.00017935174,0.004792498,0.0005871487,0.983001,0.00002487815],"about_ca_topic_score_codex":0.0069738072,"about_ca_topic_score_gemma":0.016578805,"teacher_disagreement_score":0.011860596,"about_ca_system_score_codex":0.001909177,"about_ca_system_score_gemma":0.0019208941,"threshold_uncertainty_score":0.03967768},"labels":[],"label_agreement":null},{"id":"W4412789017","doi":"10.51731/cjht.2025.1179","title":"Fidaxomicin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fidaxomicin; Geology","score_opus":0.03065298352446918,"score_gpt":0.33521955252870417,"score_spread":0.304566569004235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789017","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13366891,0.17931636,0.02023906,0.054009676,0.012520186,0.0029336896,0.028976424,0.008495185,0.5598405],"genre_scores_gemma":[0.5404828,0.061822586,0.027799277,0.0319034,0.0020501502,0.001354075,0.032864083,0.0007251181,0.30099848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993343,0.000081475184,0.000045313922,0.000114047885,0.00029058591,0.00013440636],"domain_scores_gemma":[0.9995523,0.000043155782,0.00007613428,0.000034370743,0.00015152016,0.00014241906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004972768,0.0006228336,0.00050117046,0.00091902853,0.0004742868,0.0009759668,0.00057812425,0.0013191766,0.033825267],"category_scores_gemma":[0.0013847451,0.0001794123,0.00066724006,0.00052133156,0.00035496452,0.0005110126,0.0006960014,0.0014591689,0.018103145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043840976,0.00071929436,0.0018365434,0.0016403014,0.00008469829,0.0013204577,0.000096576754,0.00047850038,0.07670945,0.0054941596,0.26673704,0.6404989],"study_design_scores_gemma":[0.0006171167,0.0015817237,0.002759967,0.00034067917,0.00005006835,0.0034049677,0.000035991383,0.0003699559,0.020519031,0.0005474212,0.96973264,0.00004048264],"about_ca_topic_score_codex":0.002578941,"about_ca_topic_score_gemma":0.002591597,"teacher_disagreement_score":0.033825267,"about_ca_system_score_codex":0.0012853856,"about_ca_system_score_gemma":0.0013740171,"threshold_uncertainty_score":0.113156855},"labels":[],"label_agreement":null},{"id":"W4412789053","doi":"10.51731/cjht.2025.1180","title":"Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mometasone furoate; Nasal spray; Medicine; Dermatology; Pharmacology; Nasal administration; Internal medicine; Corticosteroid","score_opus":0.01495177589674096,"score_gpt":0.271694093505273,"score_spread":0.25674231760853206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789053","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006133402,0.9733984,0.00042115437,0.0009968695,0.00020688222,0.00014877837,0.0009336325,0.000038318994,0.017722664],"genre_scores_gemma":[0.07468045,0.90852356,0.003283988,0.0011457468,0.0001970916,0.00013016851,0.0011125582,0.000017057597,0.0109094465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979019,0.00038666994,0.00021892256,0.00011093016,0.0012759395,0.00010566915],"domain_scores_gemma":[0.99844164,0.0005254339,0.0003977027,0.000021733833,0.0005518318,0.00006171408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016678561,0.00034876168,0.0006872948,0.001985749,0.00029134506,0.0009242262,0.00045997123,0.0005069393,0.0044224723],"category_scores_gemma":[0.0026214048,0.00011789637,0.0011100782,0.0015542278,0.0002595821,0.00039268646,0.00023863315,0.00045991378,0.00055455364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004917569,0.00008420699,0.0018317552,0.02750821,0.00063435966,0.0002272676,0.00007952586,0.00020932562,0.0042168894,0.0015137007,0.02174584,0.94145715],"study_design_scores_gemma":[0.00028450065,0.0013737646,0.034910917,0.01809136,0.002214747,0.0018301669,0.00029166575,0.00025571836,0.0039154286,0.00040237012,0.9363809,0.000048404818],"about_ca_topic_score_codex":0.069612645,"about_ca_topic_score_gemma":0.2603168,"teacher_disagreement_score":0.069612645,"about_ca_system_score_codex":0.002874114,"about_ca_system_score_gemma":0.0048278174,"threshold_uncertainty_score":0.13841492},"labels":[],"label_agreement":null},{"id":"W4412825568","doi":"10.51731/cjht.2025.1182","title":"Naloxegol","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.018251024890165442,"score_gpt":0.29671374668066547,"score_spread":0.2784627217905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825568","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023023194,0.81903905,0.0018792049,0.012132221,0.001602191,0.00040695534,0.0017627571,0.00015011338,0.14000429],"genre_scores_gemma":[0.22348788,0.6547528,0.0068351217,0.009203417,0.0006515649,0.00041493084,0.001670849,0.000034844026,0.10294872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953794,0.00013759028,0.000045502627,0.00003847561,0.00020429517,0.00003609334],"domain_scores_gemma":[0.9995664,0.00013517747,0.00011883802,0.000011958397,0.0001338324,0.00003391444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057888404,0.00018194993,0.00021265485,0.00053738523,0.00027048175,0.000650642,0.00029093868,0.00038077863,0.012918162],"category_scores_gemma":[0.0016855291,0.00006838849,0.00032186494,0.00029213887,0.00016983936,0.0004113735,0.0003069604,0.0005520002,0.0012408309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061125366,0.00007376977,0.001058388,0.0051565287,0.00008268735,0.0003060782,0.000062363215,0.0001718955,0.0026194106,0.0059762723,0.04234682,0.94153446],"study_design_scores_gemma":[0.0002514743,0.0005683558,0.006964899,0.0060353917,0.00016984505,0.0012385136,0.00014202757,0.00014867677,0.0025561638,0.0010771835,0.9808249,0.0000225722],"about_ca_topic_score_codex":0.0072538103,"about_ca_topic_score_gemma":0.026607294,"teacher_disagreement_score":0.012918162,"about_ca_system_score_codex":0.0013931593,"about_ca_system_score_gemma":0.0022672745,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4412825923","doi":"10.51731/cjht.2025.1183","title":"Trastuzumab Deruxtecan (Enhertu)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.021606057420086727,"score_gpt":0.3036627743687614,"score_spread":0.2820567169486746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825923","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008725752,0.91393936,0.00094218034,0.0043040174,0.0005784887,0.00014375676,0.0014186132,0.00011504051,0.06983292],"genre_scores_gemma":[0.105907686,0.8384575,0.0025699134,0.003321647,0.0004918019,0.00012185576,0.0025533126,0.000025016594,0.046551205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963355,0.0000618558,0.000029694647,0.000031801308,0.00019692293,0.00004610105],"domain_scores_gemma":[0.99974006,0.00005367393,0.00005675697,0.0000068700265,0.00011103883,0.000031552525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005415195,0.00021105786,0.0002842238,0.0009611313,0.0002221489,0.0006603946,0.00027160585,0.00026368166,0.005423228],"category_scores_gemma":[0.0008199782,0.000069488364,0.00029876488,0.00089902565,0.00019875987,0.0002634766,0.00027275493,0.00047575386,0.00084305473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021593223,0.000037529404,0.001113278,0.003165572,0.000121787,0.00019221754,0.00004859826,0.00032072116,0.0019386882,0.0032878336,0.07779434,0.9117635],"study_design_scores_gemma":[0.00011484796,0.00014513893,0.004269924,0.0019952103,0.0001238928,0.0007903259,0.000031323932,0.00013368248,0.0015940787,0.00038044588,0.9904103,0.000010726217],"about_ca_topic_score_codex":0.043125436,"about_ca_topic_score_gemma":0.1262339,"teacher_disagreement_score":0.043125436,"about_ca_system_score_codex":0.003315513,"about_ca_system_score_gemma":0.0032154631,"threshold_uncertainty_score":0.08574885},"labels":[],"label_agreement":null},{"id":"W4412973990","doi":"10.51731/cjht.2025.1184","title":"Dupilumab (Dupixent)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Psychology; Dermatology; Medicine; Atopic dermatitis","score_opus":0.01494595144243069,"score_gpt":0.30183851782731863,"score_spread":0.2868925663848879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412973990","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09584128,0.24158259,0.007187524,0.019824507,0.0054993024,0.00200097,0.018564533,0.0058716647,0.6036276],"genre_scores_gemma":[0.5669927,0.06506063,0.013533207,0.023905031,0.0021455477,0.0010483509,0.025454734,0.0004188833,0.3014409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957234,0.00004458442,0.000018505643,0.00007520511,0.00019491286,0.00009442807],"domain_scores_gemma":[0.9996474,0.00004258857,0.000047393954,0.000023113878,0.0000969298,0.0001426139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043290624,0.00053968997,0.00052398443,0.0009291804,0.0006257971,0.0010458322,0.0006895133,0.0010666578,0.035605986],"category_scores_gemma":[0.0006904977,0.00017475567,0.00057128,0.0004050481,0.00027338575,0.0005230333,0.00049177883,0.0016449303,0.014494184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016144926,0.00057520985,0.0016401391,0.0011894666,0.000092030365,0.0008901887,0.00006509967,0.0003018259,0.013517822,0.0021081176,0.27516595,0.7028397],"study_design_scores_gemma":[0.0021287813,0.0018492207,0.006094019,0.00050627155,0.00013789673,0.0056885285,0.000037485202,0.0006170409,0.008172211,0.0005525088,0.97417647,0.000039671406],"about_ca_topic_score_codex":0.006671949,"about_ca_topic_score_gemma":0.016464684,"teacher_disagreement_score":0.035605986,"about_ca_system_score_codex":0.0012876047,"about_ca_system_score_gemma":0.0011594798,"threshold_uncertainty_score":0.11911392},"labels":[],"label_agreement":null},{"id":"W4413006781","doi":"10.51731/cjht.2025.1185","title":"Nivolumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Computer science; Medicine; Internal medicine; Cancer; Immunotherapy","score_opus":0.017837409268314727,"score_gpt":0.3032496467341336,"score_spread":0.2854122374658189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413006781","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02812548,0.5442578,0.0048185047,0.02246239,0.005442489,0.0007567437,0.0042867833,0.0007807244,0.38906896],"genre_scores_gemma":[0.46604434,0.26049417,0.015503882,0.028542385,0.0033747677,0.00073627324,0.00978067,0.00019118786,0.21533234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996264,0.00010946984,0.00003015958,0.00004737859,0.00013014725,0.000056449964],"domain_scores_gemma":[0.9997248,0.000051565366,0.00004263767,0.000012656198,0.000114026974,0.000054241147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000567127,0.00023672666,0.00027827732,0.00042663308,0.0002804804,0.0008265195,0.00040490777,0.0004925158,0.017776001],"category_scores_gemma":[0.0012024764,0.000078538185,0.00047576067,0.00031659353,0.0001380133,0.0004160796,0.00028229042,0.0008331461,0.0056641097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081854674,0.00009194285,0.001583008,0.001395644,0.00013797953,0.0002349738,0.000032432403,0.00031771997,0.002594669,0.005239071,0.14078203,0.84677196],"study_design_scores_gemma":[0.00026733126,0.00021298855,0.0016296633,0.0006535416,0.00008536129,0.0008041616,0.000018965351,0.00015265406,0.0016066431,0.0008803316,0.9936784,0.000009889243],"about_ca_topic_score_codex":0.004134133,"about_ca_topic_score_gemma":0.011218714,"teacher_disagreement_score":0.017776001,"about_ca_system_score_codex":0.0015175432,"about_ca_system_score_gemma":0.0017479347,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4413041529","doi":"10.51731/cjht.2025.1186","title":"Dupilumab (Dupixent)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dupilumab; Nasal polyps; Chronic rhinosinusitis; Refractory (planetary science); Nasal administration; Internal medicine; Nose; Sinusitis; Dermatology; Surgery; Asthma; Immunology","score_opus":0.018571479739598322,"score_gpt":0.31258562199054946,"score_spread":0.2940141422509511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413041529","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12806112,0.27100182,0.006996448,0.022495003,0.006565147,0.0021370423,0.01827823,0.005181961,0.5392832],"genre_scores_gemma":[0.62199384,0.061119054,0.013660295,0.022878576,0.002546554,0.0011777219,0.023820661,0.00032200041,0.2524814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996729,0.00003505876,0.000017870898,0.00006264592,0.00013348297,0.000078127996],"domain_scores_gemma":[0.9996953,0.000035325626,0.000039713996,0.000019022067,0.00007433653,0.00013636146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000372591,0.00054105127,0.0005210102,0.0008159738,0.000526062,0.0009878809,0.000601671,0.0009450566,0.029624213],"category_scores_gemma":[0.0006529599,0.00016154241,0.0005580867,0.0003735203,0.00022927878,0.00050440803,0.00047847466,0.001591026,0.012930175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017664095,0.00057601405,0.002263021,0.00096827024,0.000103940874,0.0009637598,0.000063850915,0.00032587533,0.009655804,0.001832992,0.20211622,0.7793639],"study_design_scores_gemma":[0.003227501,0.0026670126,0.008122178,0.000495273,0.00018223099,0.007325495,0.000046257574,0.0007700142,0.007317144,0.0006356484,0.9691683,0.000043074302],"about_ca_topic_score_codex":0.004382761,"about_ca_topic_score_gemma":0.011722157,"teacher_disagreement_score":0.029624213,"about_ca_system_score_codex":0.0011560627,"about_ca_system_score_gemma":0.0010148706,"threshold_uncertainty_score":0.099102914},"labels":[],"label_agreement":null},{"id":"W4413057309","doi":"10.51731/cjht.2025.1169","title":"Technologies to Address Wait Times in the Emergency Department","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Vital signs; Emergency department; Medical emergency; Telemedicine; Medicine; Patient safety; Computer science; Health care; Nursing","score_opus":0.024786946572379835,"score_gpt":0.3290218648300725,"score_spread":0.30423491825769267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413057309","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.077661924,0.19665174,0.3008942,0.26219895,0.024571497,0.0009976568,0.0028154966,0.012116323,0.1220922],"genre_scores_gemma":[0.57809556,0.10404277,0.23675996,0.036848105,0.014063349,0.0016295881,0.0026089763,0.0011377318,0.02481402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644583,0.0011827811,0.000370932,0.0003760161,0.0013020423,0.00032244777],"domain_scores_gemma":[0.9809755,0.009488677,0.0025227119,0.0007837978,0.004709043,0.0015203926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005185345,0.0010494471,0.00069394795,0.002552505,0.0012076199,0.005386675,0.0020316897,0.0024123865,0.009121935],"category_scores_gemma":[0.03459476,0.0005501091,0.000773738,0.0017227295,0.0006798108,0.007841378,0.0028733723,0.003079918,0.003750053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048774402,0.00030286767,0.014800385,0.0019886892,0.0001395644,0.00028861107,0.0017092752,0.0027064013,0.0028855908,0.024117075,0.11664558,0.8339282],"study_design_scores_gemma":[0.00036329654,0.0012862623,0.020873033,0.0065921536,0.00082792784,0.003851414,0.007133139,0.026974764,0.01032059,0.0803115,0.84100646,0.00045951924],"about_ca_topic_score_codex":0.0020297705,"about_ca_topic_score_gemma":0.002179712,"teacher_disagreement_score":0.009121935,"about_ca_system_score_codex":0.0016461146,"about_ca_system_score_gemma":0.0025432743,"threshold_uncertainty_score":0.03051585},"labels":[],"label_agreement":null},{"id":"W4413118800","doi":"10.51731/cjht.2025.1187","title":"Crovalimab (Piasky)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01764724544898367,"score_gpt":0.36121228104006936,"score_spread":0.3435650355910857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413118800","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08851262,0.33906546,0.012620248,0.029144017,0.0070685367,0.0026580358,0.011699442,0.0062163007,0.5030153],"genre_scores_gemma":[0.62569714,0.0819205,0.015488883,0.031369954,0.0031819094,0.0016759745,0.024669284,0.00040383573,0.21559255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995685,0.000057420417,0.000027383916,0.00006319392,0.00016377112,0.000119692006],"domain_scores_gemma":[0.99967706,0.000038189806,0.00005889533,0.00001958358,0.00008145349,0.00012474744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000435686,0.0005328971,0.00055214594,0.000922548,0.00041101503,0.0010273679,0.0005839388,0.00115866,0.02731268],"category_scores_gemma":[0.000932528,0.00013730055,0.00053151627,0.00040802,0.00022593878,0.0005558507,0.0005671443,0.002075329,0.015818205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023589374,0.0007080464,0.0014481567,0.0010726871,0.00012300225,0.00092947914,0.00004490942,0.0005940047,0.010719421,0.0029002964,0.17735168,0.80174935],"study_design_scores_gemma":[0.006250918,0.0024974132,0.005881593,0.00066733646,0.0001174138,0.0068957303,0.000037509173,0.0007968795,0.0070073125,0.0016457271,0.9681705,0.000031713294],"about_ca_topic_score_codex":0.0026201347,"about_ca_topic_score_gemma":0.004857106,"teacher_disagreement_score":0.02731268,"about_ca_system_score_codex":0.0010749107,"about_ca_system_score_gemma":0.0011035127,"threshold_uncertainty_score":0.09136999},"labels":[],"label_agreement":null},{"id":"W4413118804","doi":"10.51731/cjht.2025.1188","title":"Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Enzyme Production and Characterization","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0068652297927767865,"score_gpt":0.2434365113207348,"score_spread":0.236571281527958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413118804","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.605427,0.10772777,0.06502097,0.010327269,0.0021636041,0.0041888496,0.019522391,0.012571358,0.1730508],"genre_scores_gemma":[0.8164269,0.020804076,0.05989314,0.0028199619,0.00024455867,0.0008990639,0.021303184,0.0005445217,0.07706468],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997181,0.00002468484,0.000020434105,0.00005612232,0.00013093669,0.000049686067],"domain_scores_gemma":[0.9998592,0.000009186775,0.000028717284,0.000017381275,0.000027765638,0.000057710382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036633402,0.00064206653,0.0004890265,0.0007427177,0.00033395816,0.0006247471,0.0004266961,0.00045172448,0.0063794227],"category_scores_gemma":[0.000362911,0.00019074259,0.00052055693,0.00047193785,0.00038843902,0.00027410922,0.00044446552,0.001061268,0.0039036125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049592904,0.00093348266,0.0034146418,0.00081459957,0.0001601767,0.0014455767,0.00004920438,0.0006525422,0.5921721,0.0016177553,0.035149064,0.35863158],"study_design_scores_gemma":[0.002093324,0.00501582,0.028472226,0.00040706716,0.00023907046,0.01176553,0.000075602,0.0029241508,0.54332185,0.000896643,0.4046949,0.000093824594],"about_ca_topic_score_codex":0.00793171,"about_ca_topic_score_gemma":0.010512581,"teacher_disagreement_score":0.00793171,"about_ca_system_score_codex":0.0012173697,"about_ca_system_score_gemma":0.001336539,"threshold_uncertainty_score":0.021341324},"labels":[],"label_agreement":null},{"id":"W4413127968","doi":"10.51731/cjht.2025.1189","title":"Quizartinib (Vanflyta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.022377522746083685,"score_gpt":0.3158917955807999,"score_spread":0.2935142728347162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413127968","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21546519,0.19200522,0.0067007644,0.032810975,0.00457741,0.001997437,0.021743992,0.0060806917,0.51861835],"genre_scores_gemma":[0.74823546,0.041212615,0.006062521,0.011880522,0.0006533377,0.00057330006,0.024319414,0.00016145722,0.16690125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997993,0.000020412137,0.000013679435,0.000034038614,0.00007047331,0.00006213521],"domain_scores_gemma":[0.99987805,0.000010170517,0.000020261414,0.000008235598,0.000032630654,0.000050634677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026836843,0.00027430477,0.00048672745,0.00066913967,0.00040671052,0.00081796705,0.00055537693,0.00068907806,0.019825311],"category_scores_gemma":[0.00044347328,0.00012818798,0.0003815099,0.00039122286,0.00017419584,0.0003766061,0.00041361884,0.0011101834,0.0060786596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025259457,0.00062131236,0.0029944729,0.0010216874,0.0001586352,0.00069444766,0.00004748411,0.00094872544,0.014149981,0.0043529677,0.29111055,0.6813739],"study_design_scores_gemma":[0.005088936,0.0021399448,0.012865429,0.0005333706,0.00020892889,0.005358096,0.000059262384,0.002186613,0.014757463,0.001716252,0.95502967,0.00005605565],"about_ca_topic_score_codex":0.007756079,"about_ca_topic_score_gemma":0.022063324,"teacher_disagreement_score":0.019825311,"about_ca_system_score_codex":0.001627456,"about_ca_system_score_gemma":0.0015076797,"threshold_uncertainty_score":0.06632227},"labels":[],"label_agreement":null},{"id":"W4413345437","doi":"10.51731/cjht.2025.1190","title":"Nivolumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.017837409268314727,"score_gpt":0.3032496467341336,"score_spread":0.2854122374658189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413345437","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08963781,0.16209236,0.00896502,0.031796314,0.009037178,0.0017190806,0.010693576,0.003938288,0.68212044],"genre_scores_gemma":[0.55911374,0.040309593,0.015014871,0.037928846,0.0025404356,0.001216148,0.023012107,0.00049463374,0.3203697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997216,0.000044601966,0.00001785315,0.000052765085,0.000082178936,0.00008097936],"domain_scores_gemma":[0.99985266,0.000016215847,0.000014363691,0.000011870297,0.000046132045,0.000058739628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031885292,0.00034903342,0.00038117744,0.00027277495,0.0003730466,0.001101747,0.0005446907,0.00070182286,0.03149378],"category_scores_gemma":[0.0006075642,0.000119541124,0.00052419724,0.00020898988,0.00012388195,0.0004941101,0.00041817932,0.0013828975,0.016653737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020014008,0.00051602995,0.002908872,0.00066380616,0.00013131616,0.00032582541,0.000047187652,0.0006673779,0.01020891,0.0030116155,0.23545909,0.74405867],"study_design_scores_gemma":[0.00087230594,0.0006336158,0.0020335468,0.00020467839,0.000080202066,0.0009881948,0.00002065586,0.0005622564,0.0038422022,0.00093820866,0.9898093,0.000014934906],"about_ca_topic_score_codex":0.0018092031,"about_ca_topic_score_gemma":0.0039313906,"teacher_disagreement_score":0.03149378,"about_ca_system_score_codex":0.0013117215,"about_ca_system_score_gemma":0.0009443491,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4413412436","doi":"10.51731/cjht.2025.1197","title":"Daratumumab (Darzalex SC)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Multiple myeloma; Lenalidomide","score_opus":0.035072396872024375,"score_gpt":0.354769225012068,"score_spread":0.31969682814004363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413412436","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047787363,0.95498616,0.0005735681,0.0018807901,0.0004954688,0.00013909972,0.0010378229,0.0000869843,0.036021348],"genre_scores_gemma":[0.103199646,0.85362464,0.004384743,0.004478321,0.0004409209,0.00018302881,0.0021394838,0.000021454438,0.031527735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996979,0.00006683931,0.000034686032,0.000033319964,0.00014209734,0.000025180849],"domain_scores_gemma":[0.9997316,0.00006339631,0.000065401495,0.000007211787,0.00010722749,0.00002505789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004663888,0.00029883723,0.00032723282,0.00079945294,0.00020589096,0.0006579386,0.00024442616,0.0002885968,0.0061736857],"category_scores_gemma":[0.0008240293,0.000084305146,0.0004000158,0.0008059964,0.00012990306,0.0002821578,0.00020207433,0.0003646436,0.0015098772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003712042,0.00003646584,0.0004915436,0.0058282837,0.00016582022,0.00012596244,0.000023946925,0.00013652493,0.0025965227,0.0015262737,0.050673187,0.93802434],"study_design_scores_gemma":[0.0002594722,0.0002564001,0.0020287442,0.001951486,0.00026085315,0.0008316102,0.00001928481,0.00006287298,0.0020182976,0.00025302725,0.99205023,0.00000768189],"about_ca_topic_score_codex":0.011890649,"about_ca_topic_score_gemma":0.04243022,"teacher_disagreement_score":0.011890649,"about_ca_system_score_codex":0.0012208488,"about_ca_system_score_gemma":0.0017915778,"threshold_uncertainty_score":0.023642898},"labels":[],"label_agreement":null},{"id":"W4413429415","doi":"10.51731/cjht.2025.1198","title":"Trofinetide (Daybue)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Language, Linguistics, Cultural Analysis","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.02364859590659034,"score_gpt":0.2541799723220076,"score_spread":0.23053137641541727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413429415","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120703466,0.5497699,0.0033528372,0.080171995,0.010842461,0.0009849631,0.006118503,0.0010451251,0.2270108],"genre_scores_gemma":[0.65299284,0.18262486,0.009529964,0.07508908,0.0050973236,0.0008783245,0.006783384,0.00017147048,0.0668327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964595,0.00007649543,0.000042661275,0.00006325434,0.00010568538,0.000065908294],"domain_scores_gemma":[0.99961346,0.00012816451,0.000074499556,0.000021783177,0.00007129899,0.000090865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074351125,0.00023462523,0.00086475565,0.00037876805,0.00037754508,0.00084903,0.0005095352,0.001420079,0.01681684],"category_scores_gemma":[0.0012346808,0.00012655673,0.00049464236,0.0002812666,0.0003182173,0.00074575533,0.00029419575,0.002399301,0.0032679306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010140153,0.0005148139,0.0016179675,0.0029475875,0.00026181294,0.0009216105,0.00009552059,0.00017143147,0.0066294256,0.0036049199,0.09321922,0.8798756],"study_design_scores_gemma":[0.024453009,0.010109646,0.024915408,0.008706853,0.0007483476,0.009636508,0.00048133972,0.00084852724,0.008696853,0.0049419473,0.9062351,0.00022641866],"about_ca_topic_score_codex":0.0030269918,"about_ca_topic_score_gemma":0.0076620523,"teacher_disagreement_score":0.01681684,"about_ca_system_score_codex":0.00067742856,"about_ca_system_score_gemma":0.0007601866,"threshold_uncertainty_score":0.056257904},"labels":[],"label_agreement":null},{"id":"W4413684499","doi":"10.51731/cjht.2025.1204","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Computer science; Medicine; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413684499","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25013226,0.46327165,0.003859516,0.022726953,0.0018629623,0.0016505363,0.0114754075,0.0025000817,0.24252057],"genre_scores_gemma":[0.8482699,0.07672417,0.0036395534,0.007173427,0.00060204277,0.00054624985,0.009412936,0.00005821683,0.05357344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997882,0.000030769348,0.000015459676,0.00003563467,0.000066473265,0.000063431165],"domain_scores_gemma":[0.99983454,0.000026714106,0.00003967243,0.000011178402,0.000040427673,0.00004745774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004059283,0.00026820015,0.0005461981,0.0006896391,0.00037155187,0.0006351023,0.00042950007,0.000526452,0.00849603],"category_scores_gemma":[0.00060392695,0.00008418882,0.00042063373,0.0004266359,0.00019724951,0.00031663667,0.00037315988,0.0011182565,0.0019660466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036826872,0.0005588432,0.003434965,0.0017426052,0.00019122369,0.0004310127,0.00007042494,0.0004974418,0.0077204285,0.0024787332,0.08806201,0.8911297],"study_design_scores_gemma":[0.0118435435,0.0063424795,0.04127261,0.0019554133,0.00057930127,0.0068521737,0.00013938166,0.0017105654,0.012872,0.0014110906,0.9149299,0.00009151968],"about_ca_topic_score_codex":0.011337824,"about_ca_topic_score_gemma":0.03516783,"teacher_disagreement_score":0.011337824,"about_ca_system_score_codex":0.0013010808,"about_ca_system_score_gemma":0.0011116845,"threshold_uncertainty_score":0.028421998},"labels":[],"label_agreement":null},{"id":"W4413684526","doi":"10.51731/cjht.2025.1205","title":"Pemigatinib (Pemazyre)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03601682565298907,"score_gpt":0.3585972738525122,"score_spread":0.32258044819952314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413684526","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044677057,0.92854196,0.0006969465,0.0037146986,0.00048965606,0.00015178489,0.0019342187,0.00010801475,0.059894964],"genre_scores_gemma":[0.07015488,0.890524,0.0028899005,0.003833737,0.00037483123,0.00015968917,0.0020889607,0.000018392533,0.029955564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970394,0.000053651165,0.000030401092,0.000033399705,0.00014802194,0.00003059795],"domain_scores_gemma":[0.99973994,0.000072820825,0.000058391874,0.000007866254,0.000092016846,0.00002891567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000490932,0.00023687971,0.00032270406,0.00083109253,0.0002675685,0.00067647983,0.00025767798,0.0003467678,0.010132334],"category_scores_gemma":[0.001011672,0.000074141826,0.00039251838,0.0007818256,0.00014977298,0.00046425598,0.00025684157,0.0006853251,0.0020973713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026465917,0.000046822654,0.00040690452,0.005829005,0.00014443355,0.00014115761,0.000029855588,0.00016540718,0.0015746233,0.0017450474,0.06569577,0.9239563],"study_design_scores_gemma":[0.00015669513,0.00016227762,0.0025253233,0.0024787004,0.00018576109,0.0009016193,0.000031530286,0.000049829843,0.0012255439,0.00040081082,0.9918727,0.000009029831],"about_ca_topic_score_codex":0.011719093,"about_ca_topic_score_gemma":0.051207896,"teacher_disagreement_score":0.011719093,"about_ca_system_score_codex":0.0011731924,"about_ca_system_score_gemma":0.00147489,"threshold_uncertainty_score":0.03389609},"labels":[],"label_agreement":null},{"id":"W4413745708","doi":"10.51731/cjht.2025.1210","title":"Durvalumab (Imfinzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Immunology; Immune system","score_opus":0.020596970468108097,"score_gpt":0.31009797314778254,"score_spread":0.28950100267967444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413745708","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23566918,0.403953,0.007869511,0.020653188,0.0032080375,0.0010937148,0.01298638,0.0029517547,0.31161526],"genre_scores_gemma":[0.7978007,0.064116955,0.0065990044,0.010603007,0.00066100486,0.0006418727,0.013107552,0.00013751787,0.106332384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998722,0.000016058068,0.000009388087,0.000022034472,0.000043649485,0.00003665416],"domain_scores_gemma":[0.99990916,0.000014595693,0.000017199833,0.000006601262,0.000015253836,0.00003720958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024052543,0.0003547453,0.00058047444,0.00031838298,0.00023958154,0.0005949396,0.0004791193,0.0004892694,0.009282069],"category_scores_gemma":[0.0004633046,0.000090449976,0.0003121643,0.0002793174,0.00014633553,0.00043026515,0.0002908796,0.0017172392,0.0047710296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038913959,0.00052499486,0.0026219834,0.0010600952,0.00023749328,0.0009632881,0.00007893807,0.0006566562,0.013133493,0.0039201886,0.11026378,0.8626478],"study_design_scores_gemma":[0.013228779,0.0032427069,0.014120261,0.00066169037,0.00033325134,0.009385665,0.000079992256,0.0017655193,0.016319199,0.0034116688,0.9373939,0.0000573924],"about_ca_topic_score_codex":0.0028685618,"about_ca_topic_score_gemma":0.009839422,"teacher_disagreement_score":0.009282069,"about_ca_system_score_codex":0.0012788391,"about_ca_system_score_gemma":0.0006145993,"threshold_uncertainty_score":0.031051636},"labels":[],"label_agreement":null},{"id":"W4413753339","doi":"10.51731/cjht.2025.1209","title":"Portable CT for Use in the Hospital","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical physics","score_opus":0.01357242150678052,"score_gpt":0.25108548720778257,"score_spread":0.23751306570100206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413753339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006758503,0.6219496,0.004777187,0.25404766,0.016061908,0.0003830107,0.0037041171,0.00070618,0.09161184],"genre_scores_gemma":[0.0662336,0.7628842,0.016309306,0.11532955,0.016757665,0.00045205269,0.0034292757,0.00074189785,0.017862547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613285,0.0011416677,0.0007204385,0.000352955,0.0013668482,0.00028524644],"domain_scores_gemma":[0.96996754,0.011316462,0.003464887,0.0015316568,0.011974466,0.0017449915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004842782,0.0005114636,0.00095948315,0.0033736678,0.0009853475,0.005735957,0.001732092,0.0033414438,0.0347844],"category_scores_gemma":[0.04002609,0.00045939436,0.0013958904,0.003457683,0.0021867922,0.008187356,0.0015495414,0.0037347544,0.012066107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013411314,0.000047218513,0.0072441194,0.0064352117,0.000075151336,0.0011647524,0.00047517792,0.00011264717,0.00036738714,0.003981837,0.3306401,0.6493223],"study_design_scores_gemma":[0.00007698191,0.00012246074,0.010255194,0.05989806,0.00016615886,0.008454023,0.0028629773,0.0001491656,0.00058888714,0.006628457,0.9106945,0.000103120816],"about_ca_topic_score_codex":0.01536983,"about_ca_topic_score_gemma":0.023239637,"teacher_disagreement_score":0.0347844,"about_ca_system_score_codex":0.0028493283,"about_ca_system_score_gemma":0.007203381,"threshold_uncertainty_score":0.11636543},"labels":[],"label_agreement":null},{"id":"W4413927988","doi":"10.51731/cjht.2025.1211","title":"Relugolix–Estradiol–Norethindrone Acetate (Myfembree)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Environmental chemistry; Chromatography","score_opus":0.029234205271672614,"score_gpt":0.34878129655109763,"score_spread":0.31954709127942504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24665178,0.43661922,0.0072964546,0.019370342,0.0025863377,0.001648053,0.013612976,0.0032703697,0.2689446],"genre_scores_gemma":[0.6757724,0.10972998,0.014750122,0.013875101,0.0010447395,0.0005799941,0.010386334,0.00019198818,0.17366934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985194,0.000024756471,0.000009046395,0.000022222519,0.00006782836,0.000024122775],"domain_scores_gemma":[0.99985874,0.000025112418,0.00003623016,0.0000101685855,0.000018003093,0.000051785628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028494062,0.00019572303,0.0003536661,0.0006155728,0.00028312276,0.00028424925,0.00031165316,0.0004892815,0.014785047],"category_scores_gemma":[0.00057236187,0.00010484589,0.00030401564,0.00027855474,0.00021043894,0.00018438452,0.00032161037,0.0008650863,0.0034104185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004736495,0.0010708205,0.003625067,0.0014732168,0.00017402254,0.00090961595,0.000076282646,0.0002537256,0.026617877,0.0027601158,0.08112333,0.87717944],"study_design_scores_gemma":[0.0045262976,0.0056676036,0.030979175,0.000741655,0.0001326559,0.007423949,0.00008651567,0.0002913659,0.01044079,0.00071815006,0.93894786,0.00004390078],"about_ca_topic_score_codex":0.006732976,"about_ca_topic_score_gemma":0.01867568,"teacher_disagreement_score":0.014785047,"about_ca_system_score_codex":0.00042542035,"about_ca_system_score_gemma":0.00085503457,"threshold_uncertainty_score":0.049460948},"labels":[],"label_agreement":null},{"id":"W4413952869","doi":"10.51731/cjht.2025.1213","title":"Blinatumomab (Blincyto)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine","score_opus":0.03682501354495821,"score_gpt":0.359285618137245,"score_spread":0.3224606045922868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413952869","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014381914,0.9168633,0.00096471346,0.0039909547,0.000584425,0.0003266152,0.001756619,0.00021869743,0.060912747],"genre_scores_gemma":[0.22191168,0.6952322,0.005095727,0.006450599,0.00049307256,0.00040263875,0.003631415,0.000065465036,0.06671719],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997608,0.000053381616,0.000016970362,0.000027081785,0.00010835029,0.000033420973],"domain_scores_gemma":[0.9997788,0.000048688806,0.00006849257,0.000006181887,0.00005493302,0.000042820295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005134614,0.00022253112,0.00035396428,0.0008046669,0.00024908286,0.00063868903,0.00027710342,0.000416508,0.009510934],"category_scores_gemma":[0.00053713965,0.00007419529,0.00032495157,0.0006992595,0.00020661349,0.0002992746,0.00027295365,0.0007624294,0.0019862433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008082373,0.00012718553,0.0005927419,0.0038615316,0.00008317994,0.0001615841,0.000036356407,0.00013938536,0.005092671,0.0018355432,0.04432802,0.9429336],"study_design_scores_gemma":[0.00068997225,0.0010855761,0.004077494,0.0020161676,0.00015707065,0.001169323,0.000049942162,0.00008576143,0.0041252063,0.00043713953,0.986093,0.00001341803],"about_ca_topic_score_codex":0.009005373,"about_ca_topic_score_gemma":0.03766245,"teacher_disagreement_score":0.009510934,"about_ca_system_score_codex":0.0014414678,"about_ca_system_score_gemma":0.0015097283,"threshold_uncertainty_score":0.031817257},"labels":[],"label_agreement":null},{"id":"W4413952983","doi":"10.51731/cjht.2025.1212","title":"Risperidone (Longavo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Psychology; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.025301566400228324,"score_gpt":0.3330000398480029,"score_spread":0.30769847344777457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413952983","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07070778,0.2692147,0.010019893,0.017016744,0.0027885973,0.001090901,0.019516122,0.010353606,0.59929174],"genre_scores_gemma":[0.51362115,0.10305558,0.029459624,0.020008296,0.0009712599,0.00073578325,0.020316908,0.00052452437,0.31130683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963105,0.000046417867,0.000031248983,0.00006706591,0.00017560906,0.000048540955],"domain_scores_gemma":[0.9997099,0.000028100443,0.00006895053,0.00002018082,0.000101068974,0.00007170131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029122288,0.00058815395,0.0005542212,0.000708525,0.00044958774,0.00060142047,0.0005847976,0.00058167655,0.01973985],"category_scores_gemma":[0.00062294194,0.00013378283,0.0006131206,0.0003872361,0.00025222808,0.00028069707,0.0005499494,0.0011425932,0.014302906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010823373,0.0005091803,0.0018117047,0.0012382236,0.00012749275,0.0007363042,0.00008857877,0.00018008532,0.009007529,0.0040405677,0.13749391,0.84368414],"study_design_scores_gemma":[0.00084617204,0.0014066299,0.010721691,0.00056824036,0.00018108079,0.0048660645,0.00005292309,0.000365615,0.008693971,0.002152746,0.9700908,0.000054029526],"about_ca_topic_score_codex":0.013460117,"about_ca_topic_score_gemma":0.033171747,"teacher_disagreement_score":0.01973985,"about_ca_system_score_codex":0.001449745,"about_ca_system_score_gemma":0.0017440029,"threshold_uncertainty_score":0.06603634},"labels":[],"label_agreement":null},{"id":"W4413986548","doi":"10.51731/cjht.2025.1214","title":"CT and MRI Services in Urban, Rural, and Remote Settings: 24-Hour and Weekend Operations","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Computer science; Medical emergency; Optometry; Medicine","score_opus":0.014142590530189831,"score_gpt":0.30925975100834924,"score_spread":0.2951171604781594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413986548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7361034,0.023685738,0.0011377741,0.19991978,0.001028509,0.0003047844,0.01308162,0.000110267116,0.024628088],"genre_scores_gemma":[0.97393936,0.009846325,0.0015755802,0.010115454,0.0005073323,0.00011432169,0.0022664783,0.00007367673,0.0015614303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99300236,0.0010299894,0.00056460407,0.00050059904,0.0020218266,0.002880534],"domain_scores_gemma":[0.97217697,0.0043684957,0.0065131015,0.0005764845,0.0055674985,0.010797474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031989554,0.00028060397,0.00046000237,0.001887351,0.0038203583,0.0047527654,0.0024057797,0.0010248051,0.0057275034],"category_scores_gemma":[0.015043773,0.00050658133,0.0009391539,0.0060398197,0.0022838493,0.0037086883,0.0024051152,0.00265857,0.00045910105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014568161,0.000106348496,0.88667303,0.0010306353,0.00014111356,0.0005010199,0.006910366,0.0003498528,0.00023487647,0.0012916655,0.03955214,0.06306332],"study_design_scores_gemma":[0.000013754857,0.00003587397,0.9473482,0.0013727666,0.000051474206,0.0004519829,0.03075045,0.00035999872,0.00009711946,0.00050370453,0.018961778,0.000052905663],"about_ca_topic_score_codex":0.8814364,"about_ca_topic_score_gemma":0.9538874,"teacher_disagreement_score":0.8814364,"about_ca_system_score_codex":0.021863582,"about_ca_system_score_gemma":0.04935913,"threshold_uncertainty_score":0.2385236},"labels":[],"label_agreement":null},{"id":"W4414016490","doi":"10.51731/cjht.2025.1215","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Medicine; Internal medicine; Myelofibrosis","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414016490","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01017311,0.9095312,0.0008378281,0.0032941126,0.00046362926,0.0001829306,0.0023038175,0.0001893087,0.073024005],"genre_scores_gemma":[0.1755808,0.7708871,0.003695509,0.0036028156,0.0005018681,0.00018819675,0.0038023842,0.000032599906,0.041708756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965894,0.000058323312,0.000032640215,0.000043037366,0.00016387047,0.000043181506],"domain_scores_gemma":[0.99975926,0.00005098917,0.000066230634,0.000007967684,0.00008965783,0.000025914926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048202107,0.00022198269,0.00031678917,0.0010766684,0.00022986741,0.00071958307,0.00034369525,0.00033134592,0.008859791],"category_scores_gemma":[0.0008296517,0.000074326155,0.00039033676,0.0007868018,0.00015916895,0.00032486516,0.00027195827,0.0005399681,0.0017487304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002813656,0.000042218908,0.0006020513,0.0039797584,0.00010003489,0.00012243037,0.000033413256,0.00012284557,0.0022607907,0.0018846788,0.043400165,0.9471702],"study_design_scores_gemma":[0.0001970095,0.00026253445,0.0047207754,0.0032714533,0.0002666728,0.0010560149,0.000039518785,0.00010220962,0.0019133242,0.000272401,0.9878846,0.00001357461],"about_ca_topic_score_codex":0.022291465,"about_ca_topic_score_gemma":0.07767211,"teacher_disagreement_score":0.022291465,"about_ca_system_score_codex":0.0014096912,"about_ca_system_score_gemma":0.0016913386,"threshold_uncertainty_score":0.044323385},"labels":[],"label_agreement":null},{"id":"W4414036123","doi":"10.51731/cjht.2025.1216","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02653310924636881,"score_gpt":0.32487161992958985,"score_spread":0.29833851068322104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414036123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065258825,0.96425337,0.00055658905,0.0019001582,0.00029309437,0.000109153385,0.0006384619,0.000054295397,0.02566896],"genre_scores_gemma":[0.11441795,0.860728,0.002794545,0.0026926966,0.00025898445,0.0001475877,0.00094727345,0.00001257135,0.018000461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997428,0.000051323146,0.000025529795,0.000033446617,0.00011616888,0.000030708532],"domain_scores_gemma":[0.99978346,0.000053919244,0.000062770065,0.000006188322,0.00007098048,0.000022624545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051541993,0.00020048622,0.0002793249,0.0007309174,0.00022510813,0.0006110441,0.0002221972,0.00030280737,0.0044026454],"category_scores_gemma":[0.00087152014,0.00007778806,0.00032680167,0.000635006,0.00014981927,0.00037332892,0.00020555357,0.0005087713,0.00078953337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049766095,0.000052422845,0.0006294042,0.0051062326,0.00016018841,0.00014815544,0.000031555603,0.00014640075,0.00381446,0.0016487882,0.029084232,0.9586805],"study_design_scores_gemma":[0.00038441046,0.0007018333,0.0068378756,0.0046742703,0.00044479777,0.0017075512,0.000054132375,0.00011937681,0.0044916025,0.00052565185,0.9800417,0.000016934688],"about_ca_topic_score_codex":0.015339132,"about_ca_topic_score_gemma":0.05296247,"teacher_disagreement_score":0.015339132,"about_ca_system_score_codex":0.001391635,"about_ca_system_score_gemma":0.0013412456,"threshold_uncertainty_score":0.030499697},"labels":[],"label_agreement":null},{"id":"W4414089718","doi":"10.51731/cjht.2025.1220","title":"Guselkumab (Tremfya)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Crohn disease; Public health; Disease; Crohn's disease","score_opus":0.01239833022196209,"score_gpt":0.28669265546221623,"score_spread":0.27429432524025416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414089718","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3600279,0.34760183,0.00670721,0.026527353,0.0033886882,0.00097631966,0.011019926,0.004253096,0.23949765],"genre_scores_gemma":[0.8229439,0.057366025,0.0053029344,0.010102144,0.0006276806,0.00052427925,0.011665415,0.00013395405,0.09133373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998228,0.00002322852,0.000010875657,0.000030688705,0.000047628437,0.00006481087],"domain_scores_gemma":[0.9998611,0.000018557459,0.000026303851,0.000009873506,0.000021435804,0.00006268491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026156736,0.00028667747,0.0005170546,0.00046662518,0.00031179102,0.00045180455,0.00037043676,0.00062867673,0.012186617],"category_scores_gemma":[0.00036907644,0.00009255007,0.0004901995,0.00039963517,0.00024489878,0.00036306985,0.00039103304,0.0019171105,0.006875854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069457088,0.0013936142,0.0038102963,0.0015891457,0.0004220283,0.00218239,0.00008886569,0.0007372577,0.023305872,0.0042659175,0.14355531,0.8117036],"study_design_scores_gemma":[0.012988108,0.00806194,0.039964255,0.0010263819,0.00061784417,0.021453083,0.00012510498,0.0015686929,0.02417117,0.004136952,0.88575864,0.00012777188],"about_ca_topic_score_codex":0.0027266173,"about_ca_topic_score_gemma":0.0059126527,"teacher_disagreement_score":0.012186617,"about_ca_system_score_codex":0.0010241298,"about_ca_system_score_gemma":0.0007228264,"threshold_uncertainty_score":0.040768266},"labels":[],"label_agreement":null},{"id":"W4414125020","doi":"10.51731/cjht.2025.1221","title":"Trabectedin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trabectedin; Reimbursement; Doxorubicin; Drug; Clinical Practice; Soft tissue sarcoma","score_opus":0.02697847165995515,"score_gpt":0.314905090837416,"score_spread":0.2879266191774609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414125020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010911633,0.8802607,0.0018586388,0.008623783,0.0012216856,0.0004496409,0.004834822,0.0002270658,0.09161204],"genre_scores_gemma":[0.16902411,0.7595014,0.0069121397,0.009054113,0.0015657956,0.00066211435,0.0071607577,0.00006459884,0.046054937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943775,0.00012139832,0.00005096679,0.000059094666,0.00028846276,0.00004226283],"domain_scores_gemma":[0.9995234,0.00014330512,0.00013534643,0.000018751243,0.00013358973,0.000045644607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071661,0.00023060871,0.00036914911,0.00091946346,0.0002441355,0.00053981086,0.0003293627,0.0003921711,0.013815309],"category_scores_gemma":[0.0015308762,0.00008067285,0.0005473327,0.0008543509,0.00022060236,0.00045989803,0.00021647387,0.00059237704,0.001990759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005370803,0.00005802282,0.0010989218,0.005226822,0.0002916565,0.00016592762,0.0000425823,0.00027836877,0.0030389796,0.0035374307,0.12562981,0.86009437],"study_design_scores_gemma":[0.00056350237,0.0006593862,0.0052536824,0.0023885588,0.00036067315,0.0018372266,0.000037014557,0.0001883767,0.0027743794,0.0008015784,0.98511964,0.000016016858],"about_ca_topic_score_codex":0.003963789,"about_ca_topic_score_gemma":0.020009238,"teacher_disagreement_score":0.013815309,"about_ca_system_score_codex":0.0010230177,"about_ca_system_score_gemma":0.0015643896,"threshold_uncertainty_score":0.046216846},"labels":[],"label_agreement":null},{"id":"W4414239951","doi":"10.51731/cjht.2025.1224","title":"Osimertinib (Tagrisso)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Osimertinib; Exon; Disease; Cancer; Drug; T790M","score_opus":0.01814201831550905,"score_gpt":0.3576238266743232,"score_spread":0.33948180835881414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414239951","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07175866,0.09505947,0.0027533807,0.021388453,0.003914504,0.0011613294,0.023442145,0.002735601,0.77778643],"genre_scores_gemma":[0.40156505,0.04828924,0.004726372,0.016764538,0.0010347799,0.00058816804,0.0444299,0.00020674935,0.48239535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997892,0.000014799495,0.00001109224,0.000026294936,0.00008565703,0.00007294724],"domain_scores_gemma":[0.99981827,0.0000096018375,0.000021580454,0.000012638299,0.00005377102,0.00008417787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002940174,0.00035084123,0.00033143407,0.00056025933,0.00041668452,0.00078696077,0.00044025382,0.000656907,0.030402552],"category_scores_gemma":[0.00046721622,0.00008637354,0.0003509386,0.0005330716,0.00019922282,0.00034341426,0.0004663106,0.0009901196,0.011258948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012371704,0.0002912289,0.0017804112,0.00052090874,0.000059742724,0.0003374104,0.000043893466,0.00045156814,0.006365232,0.0047451807,0.36192128,0.622246],"study_design_scores_gemma":[0.0015076612,0.0005888156,0.004527582,0.00020139989,0.000047251673,0.0010316224,0.00002797909,0.00036106582,0.0027772663,0.0008476916,0.98806655,0.000014958],"about_ca_topic_score_codex":0.017172595,"about_ca_topic_score_gemma":0.063310474,"teacher_disagreement_score":0.030402552,"about_ca_system_score_codex":0.0024531693,"about_ca_system_score_gemma":0.002984829,"threshold_uncertainty_score":0.101706624},"labels":[],"label_agreement":null},{"id":"W4414240310","doi":"10.51731/cjht.2025.1223","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Metastatic breast cancer; Breast cancer; Crizotinib; Cancer; Population; Drug; Chemotherapy","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414240310","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1228729,0.15285271,0.0084389895,0.009774781,0.004379301,0.0025731623,0.014386343,0.0076307203,0.677091],"genre_scores_gemma":[0.55826646,0.07817325,0.010848417,0.011642907,0.00090637914,0.0010192619,0.026092254,0.0007039084,0.3123472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.000022351674,0.000013714569,0.000045247532,0.00008065967,0.000049467537],"domain_scores_gemma":[0.99987745,0.00001068742,0.000017716942,0.000012784423,0.00002743677,0.000053917218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020042773,0.0005503548,0.00062917516,0.001063681,0.00047022136,0.00091090833,0.00074602896,0.00072441867,0.0487765],"category_scores_gemma":[0.0004021533,0.00023628061,0.00044556803,0.0005603619,0.00034955452,0.00054161344,0.0005164982,0.0019299282,0.017296521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052879467,0.0015006346,0.00082097406,0.0019420034,0.00012832387,0.00095688674,0.00007839832,0.00056873285,0.0665039,0.005731577,0.17105708,0.7454236],"study_design_scores_gemma":[0.004898226,0.0028010067,0.004454725,0.00046067478,0.00015357892,0.0043432596,0.00005312503,0.0008296972,0.032028217,0.0015566263,0.94835955,0.00006133605],"about_ca_topic_score_codex":0.005933949,"about_ca_topic_score_gemma":0.012236704,"teacher_disagreement_score":0.0487765,"about_ca_system_score_codex":0.0010305125,"about_ca_system_score_gemma":0.0015101483,"threshold_uncertainty_score":0.16317368},"labels":[],"label_agreement":null},{"id":"W4414258520","doi":"10.51731/cjht.2025.1222","title":"Pertuzumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Reimbursement; Trastuzumab; Cancer; Breast cancer","score_opus":0.01588028164398096,"score_gpt":0.29660047442051346,"score_spread":0.2807201927765325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414258520","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016620297,0.5929904,0.0063063586,0.028545836,0.0044096475,0.00058968103,0.0023518128,0.0007352009,0.34745076],"genre_scores_gemma":[0.2649567,0.41327322,0.012571939,0.027407749,0.0051382007,0.00061742374,0.005059064,0.00019150184,0.2707842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917275,0.00021001327,0.00007537267,0.00007672357,0.00037634512,0.00008870279],"domain_scores_gemma":[0.99918324,0.0001830265,0.00017065868,0.000045059092,0.00029929203,0.00011869337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087182946,0.00026298597,0.00033705964,0.0009354134,0.00035474246,0.0009909973,0.0005444753,0.00083779613,0.025775764],"category_scores_gemma":[0.0030373905,0.00012365772,0.0004206869,0.00076882984,0.00024671177,0.00056524656,0.00050016516,0.00091034966,0.008812037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045931299,0.00008534657,0.0011577008,0.0014006009,0.000130819,0.00075400627,0.000071072645,0.00023109333,0.002568703,0.008856584,0.14693211,0.83735275],"study_design_scores_gemma":[0.00013386615,0.00016213632,0.0014212757,0.00058876764,0.000063804335,0.002335705,0.000025470297,0.00008183066,0.0013622319,0.0013835652,0.9924315,0.000009961345],"about_ca_topic_score_codex":0.0025073003,"about_ca_topic_score_gemma":0.0046740514,"teacher_disagreement_score":0.025775764,"about_ca_system_score_codex":0.0011062593,"about_ca_system_score_gemma":0.0019615924,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4414282985","doi":"10.51731/cjht.2025.1226","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Drug; Chemotherapy; Aromatase; Cancer","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414282985","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10818062,0.1556275,0.0066865343,0.0103092585,0.004196125,0.0024703117,0.013029766,0.0068197506,0.69268006],"genre_scores_gemma":[0.5498207,0.077448025,0.009307039,0.014916235,0.0010750355,0.0011720661,0.022766503,0.00062531146,0.322869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980956,0.000022785196,0.000013019586,0.00003990431,0.00007287786,0.000041947096],"domain_scores_gemma":[0.9998951,0.000009585017,0.000016405282,0.000010573989,0.000022585633,0.000045785247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019087085,0.00048932346,0.0006447598,0.0009858096,0.00042193793,0.0008774147,0.0006643992,0.00071117416,0.052974287],"category_scores_gemma":[0.00043672847,0.00020522223,0.0004472464,0.0005365052,0.00030039175,0.00059026637,0.00047801968,0.0019189834,0.019600116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054300753,0.0014734118,0.0007761792,0.0018628272,0.00012423919,0.00089578127,0.00006841564,0.00042998977,0.032980356,0.0048383838,0.17342581,0.7776945],"study_design_scores_gemma":[0.0075898026,0.0035207912,0.004864752,0.000569561,0.00015843673,0.0053626453,0.00005819808,0.00089608796,0.020254795,0.0019892945,0.9546703,0.000065393564],"about_ca_topic_score_codex":0.0035847367,"about_ca_topic_score_gemma":0.0076691867,"teacher_disagreement_score":0.99641526,"about_ca_system_score_codex":0.00085105293,"about_ca_system_score_gemma":0.0011546754,"threshold_uncertainty_score":0.17721665},"labels":[],"label_agreement":null},{"id":"W4414283050","doi":"10.51731/cjht.2025.1225","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exon; Lung cancer; Pemetrexed; Carboplatin; Drug; Disease; Mutation; Epidermal growth factor receptor","score_opus":0.014489350832959812,"score_gpt":0.3545799191784978,"score_spread":0.34009056834553797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414283050","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18922557,0.33173832,0.0071299938,0.019132387,0.0042580576,0.0015908165,0.009343537,0.004460432,0.43312097],"genre_scores_gemma":[0.6658065,0.077173814,0.006803318,0.012245142,0.0011261809,0.0006993143,0.017447513,0.00023971555,0.21845858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997999,0.000027347447,0.0000130913,0.000038996357,0.00007439417,0.00004625318],"domain_scores_gemma":[0.9998779,0.000013117943,0.000023206198,0.000009229731,0.000024249526,0.000052291834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029835757,0.000374416,0.00048093655,0.0005822931,0.00032183732,0.0006712736,0.00051374047,0.0008765123,0.021861952],"category_scores_gemma":[0.00043442298,0.00015581526,0.00051320676,0.00033616237,0.000218717,0.00039813409,0.00043156507,0.0017976016,0.011120649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035100954,0.00077682966,0.0021120277,0.0010830419,0.00020912813,0.0015658105,0.00007607209,0.0006049794,0.045543958,0.004921845,0.12089156,0.8187047],"study_design_scores_gemma":[0.005192002,0.003689457,0.008915256,0.00039579716,0.0001782059,0.009002926,0.000041842464,0.00088612473,0.020484034,0.0012698042,0.949888,0.000056471465],"about_ca_topic_score_codex":0.0039830282,"about_ca_topic_score_gemma":0.006871759,"teacher_disagreement_score":0.996017,"about_ca_system_score_codex":0.0009022863,"about_ca_system_score_gemma":0.00079612434,"threshold_uncertainty_score":0.073135495},"labels":[],"label_agreement":null},{"id":"W4414327544","doi":"10.51731/cjht.2025.1227","title":"Antihemophilic Factor VIII (Recombinant, B-Domain Deleted), Fc-VWF-XTEN Fusion Protein (Altuviiio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Perioperative; Hemostasis; Clinical Practice","score_opus":0.028186656899974665,"score_gpt":0.31714906017491484,"score_spread":0.28896240327494016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414327544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029101965,0.9799517,0.0003759129,0.0010026256,0.00022417176,0.000068854104,0.0006167214,0.000022506127,0.014827416],"genre_scores_gemma":[0.023759928,0.968555,0.0014253835,0.00058548636,0.0000935945,0.000042680127,0.00049605634,0.0000073368883,0.005034534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988649,0.00023051149,0.000095882046,0.000056877783,0.00067937624,0.00007261623],"domain_scores_gemma":[0.998752,0.00045513248,0.0002142033,0.000019753486,0.00051408395,0.000044830987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013858766,0.0003334135,0.0005950525,0.0015032551,0.00029423134,0.0011785255,0.0004145929,0.0004392193,0.0039000413],"category_scores_gemma":[0.0025485624,0.000094324,0.0007190333,0.0017259324,0.0002502712,0.000351957,0.00018322379,0.00039270832,0.0005553772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024265752,0.000053342108,0.0013374098,0.024979161,0.0005686673,0.00014910525,0.000056566456,0.00030538766,0.0026675495,0.003319184,0.043276217,0.9230449],"study_design_scores_gemma":[0.00007850956,0.0002478728,0.007068051,0.013100536,0.0010974059,0.000579744,0.000098724675,0.0001321348,0.0027118078,0.00037479113,0.97449344,0.000016996653],"about_ca_topic_score_codex":0.06737617,"about_ca_topic_score_gemma":0.19340277,"teacher_disagreement_score":0.06737617,"about_ca_system_score_codex":0.00314571,"about_ca_system_score_gemma":0.0065395837,"threshold_uncertainty_score":0.133968},"labels":[],"label_agreement":null},{"id":"W4414351418","doi":"10.51731/cjht.2025.1228","title":"Isatuximab (Sarclisa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Reimbursement; Drug approval; Drug; MEDLINE","score_opus":0.01793494157968234,"score_gpt":0.3010390455350337,"score_spread":0.28310410395535135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414351418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021906283,0.8815864,0.0018353738,0.0030540344,0.0007361203,0.00025513777,0.0017025957,0.00047402628,0.08845006],"genre_scores_gemma":[0.32039732,0.59360623,0.0060548633,0.0060880263,0.0008287556,0.0002719652,0.00673129,0.00006661877,0.06595494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975246,0.000050710223,0.00002285728,0.000027102049,0.00011108289,0.000035727822],"domain_scores_gemma":[0.99984014,0.000023616021,0.000051159834,0.0000046577093,0.000056414992,0.000024093613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004053036,0.0003098885,0.00029491298,0.00085025496,0.00019078916,0.0005290686,0.0002799071,0.00029533953,0.008223138],"category_scores_gemma":[0.00035028163,0.00007557865,0.00039640663,0.0006353547,0.0001467732,0.000253605,0.00027818023,0.00054904644,0.0026763298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046925206,0.000102067264,0.00084472704,0.0043218024,0.00014799167,0.00026094806,0.00003976974,0.00026141034,0.005359714,0.001438733,0.055509135,0.9312443],"study_design_scores_gemma":[0.0004205111,0.00080339913,0.0056508724,0.0021860593,0.00025252413,0.0026043616,0.000048703507,0.00018166147,0.004255087,0.00037616442,0.98320687,0.000013723248],"about_ca_topic_score_codex":0.0038475078,"about_ca_topic_score_gemma":0.013401138,"teacher_disagreement_score":0.008223138,"about_ca_system_score_codex":0.00085121515,"about_ca_system_score_gemma":0.0010656228,"threshold_uncertainty_score":0.027509153},"labels":[],"label_agreement":null},{"id":"W4414565348","doi":"10.51731/cjht.2025.1232","title":"Mirikizumab (Omvoh)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Public health; Disease; Pharmacotherapy","score_opus":0.010457072088659793,"score_gpt":0.2574572150895341,"score_spread":0.24700014300087433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414565348","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39357027,0.35597548,0.0100796595,0.013028222,0.0041170116,0.0014665656,0.0051086685,0.0045917938,0.2120623],"genre_scores_gemma":[0.85817635,0.049268275,0.009357771,0.0053244736,0.0005547128,0.00045098306,0.0062065762,0.000119004464,0.07054184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999845,0.00001798277,0.000009997566,0.000026494032,0.00006127816,0.000039165465],"domain_scores_gemma":[0.9999331,0.000005936229,0.0000145802105,0.0000055336122,0.00001419343,0.000026672544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001993678,0.0002773352,0.00040913784,0.0005155661,0.00030361736,0.00042465606,0.0002988512,0.0005283809,0.006077168],"category_scores_gemma":[0.00020357851,0.00012033872,0.00035364318,0.00025989264,0.00021198195,0.0002704142,0.00031129323,0.0013315609,0.002862632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036867764,0.0010626921,0.0026385116,0.0016182445,0.00020126168,0.0010904879,0.00006829779,0.00037318093,0.15960401,0.0038814691,0.0679624,0.7578126],"study_design_scores_gemma":[0.0058369627,0.0066198464,0.031027263,0.00058845937,0.00030422062,0.01056692,0.00007471839,0.0013915562,0.09304188,0.0022209825,0.8482391,0.000088094785],"about_ca_topic_score_codex":0.0017767332,"about_ca_topic_score_gemma":0.004080457,"teacher_disagreement_score":0.006077168,"about_ca_system_score_codex":0.0006071346,"about_ca_system_score_gemma":0.00053648296,"threshold_uncertainty_score":0.020330131},"labels":[],"label_agreement":null},{"id":"W4414657396","doi":"10.51731/cjht.2025.1234","title":"Odevixibat (Bylvay)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Alagille syndrome; Cholestasis; Liver transplantation; Nice","score_opus":0.046098280041625375,"score_gpt":0.23217355328673686,"score_spread":0.18607527324511147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414657396","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012185283,0.11323678,0.0042152014,0.031077791,0.0051235287,0.00096124085,0.04453007,0.005485252,0.7831849],"genre_scores_gemma":[0.12581076,0.06800373,0.007985859,0.0146058295,0.0021306074,0.0008046129,0.036082212,0.0012873928,0.74328893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993774,0.000082339124,0.000038494753,0.00011143246,0.0002649431,0.000125427],"domain_scores_gemma":[0.99894816,0.00013929595,0.0001099971,0.00008132263,0.0002550981,0.00046612605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008959182,0.00048798852,0.0006792209,0.0012533183,0.00056369655,0.001959591,0.0008415358,0.001617874,0.25096294],"category_scores_gemma":[0.0028931994,0.00026378906,0.00085166097,0.0006317674,0.00041379017,0.00088013517,0.0012165577,0.0018755167,0.06554365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020649983,0.00021224032,0.0015573906,0.0011956344,0.000074984506,0.00040292772,0.00008172681,0.00021915794,0.0017842291,0.0100246165,0.48129815,0.50108385],"study_design_scores_gemma":[0.00064769265,0.00015358753,0.0013203538,0.00022965478,0.000027374625,0.00035744347,0.00001927554,0.00011464241,0.0004896732,0.00086991274,0.99576294,0.000007523034],"about_ca_topic_score_codex":0.018058732,"about_ca_topic_score_gemma":0.024057852,"teacher_disagreement_score":0.25096294,"about_ca_system_score_codex":0.0022893308,"about_ca_system_score_gemma":0.005545458,"threshold_uncertainty_score":0.83955467},"labels":[],"label_agreement":null},{"id":"W4414695975","doi":"10.51731/cjht.2025.1246","title":"Myoelectric and Microprocessor-Enabled Prostheses","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Muscle activation and electromyography studies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Rehabilitation; Quality of life (healthcare); Clinical effectiveness; Evidence-based medicine; Prosthesis","score_opus":0.007813723457086306,"score_gpt":0.21795934282737145,"score_spread":0.21014561937028514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414695975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002223632,0.99760556,0.00005938913,0.0009813028,0.00037273203,0.000017619195,0.00004557328,0.0000024193482,0.0006930099],"genre_scores_gemma":[0.0034877018,0.9934303,0.00025578504,0.0019297388,0.00058494473,0.000041354822,0.000039335595,0.0000030913798,0.00022773696],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935017,0.0016199114,0.0024220704,0.0004991932,0.0017794606,0.00017752204],"domain_scores_gemma":[0.971991,0.020634457,0.0038598892,0.00029891892,0.002997535,0.0002182302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580141,0.00079306006,0.004584499,0.005568103,0.00054043205,0.0040790583,0.0017702136,0.004122807,0.006720666],"category_scores_gemma":[0.026671492,0.0007812097,0.0036482462,0.005995028,0.0011778713,0.0046469425,0.0011428974,0.0021933205,0.001109891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002779371,0.000052701176,0.0011343001,0.55603755,0.0020493171,0.00030426597,0.00027761376,0.00012425966,0.00043361017,0.003023606,0.011969148,0.4243157],"study_design_scores_gemma":[0.00024441004,0.00028691217,0.005324,0.75774235,0.0072226976,0.001653776,0.0008146197,0.00012062007,0.0005915329,0.0036529289,0.22228013,0.0000660447],"about_ca_topic_score_codex":0.0032651718,"about_ca_topic_score_gemma":0.005798465,"teacher_disagreement_score":0.006720666,"about_ca_system_score_codex":0.0018909366,"about_ca_system_score_gemma":0.0045483457,"threshold_uncertainty_score":0.030681133},"labels":[],"label_agreement":null},{"id":"W4414696025","doi":"10.51731/cjht.2025.1245","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Mantle cell lymphoma; Drug; Lymphoma; Public health","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414696025","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03938493,0.21899396,0.009629728,0.019947097,0.006526858,0.0017928117,0.019169858,0.009074755,0.67547995],"genre_scores_gemma":[0.3223414,0.10593909,0.019282935,0.01981222,0.0033347951,0.0010154268,0.029212933,0.0011969855,0.49786422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948406,0.00008559611,0.000016920712,0.000081746824,0.00024171705,0.00008994519],"domain_scores_gemma":[0.9993767,0.0001035826,0.00006905691,0.000054778968,0.0001279632,0.00026791877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006774502,0.00034514608,0.0004614514,0.0009290042,0.0007101829,0.0014983781,0.0006347038,0.0009413985,0.0949412],"category_scores_gemma":[0.001467845,0.00018080298,0.0004724289,0.0006427167,0.000415809,0.0005764658,0.00070151826,0.0026864072,0.01869743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001582477,0.0005200299,0.0015610268,0.0009443933,0.000065833934,0.0006958016,0.000090421825,0.0002780165,0.008312667,0.0076338043,0.4269719,0.5513436],"study_design_scores_gemma":[0.00093357573,0.00054343086,0.002520991,0.00032361352,0.00004702722,0.0016322536,0.000026382271,0.00026760506,0.002667057,0.0008562734,0.99016833,0.000013304734],"about_ca_topic_score_codex":0.0125794625,"about_ca_topic_score_gemma":0.023549149,"teacher_disagreement_score":0.0949412,"about_ca_system_score_codex":0.0011937943,"about_ca_system_score_gemma":0.0022121652,"threshold_uncertainty_score":0.31760997},"labels":[],"label_agreement":null},{"id":"W4414798455","doi":"10.51731/cjht.2025.1247","title":"Canada’s Early Experiences With Low-Field MRI: Insights From a Cross-Country Survey","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Respondent; Context (archaeology); Health care; Agency (philosophy); Survey data collection; Patient experience","score_opus":0.013614347841877513,"score_gpt":0.31233735750632247,"score_spread":0.2987230096644449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414798455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777728,0.0012080013,0.00019699872,0.009871444,0.000078186975,0.00009187321,0.0008175979,0.00001503105,0.009948016],"genre_scores_gemma":[0.9931022,0.0013750399,0.00021256442,0.0027700067,0.000017017703,0.000040881783,0.00029398972,0.000022575989,0.0021656875],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.993606,0.0013210914,0.00023094933,0.00028840682,0.001800354,0.002753118],"domain_scores_gemma":[0.98264366,0.0028658584,0.0018139196,0.00028509786,0.005905889,0.006485562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048619257,0.00037181552,0.000637426,0.0018715328,0.016264783,0.00552318,0.0018092463,0.001152577,0.003565776],"category_scores_gemma":[0.012233494,0.0006942919,0.0005504946,0.0041243033,0.005288077,0.0021489167,0.0044949497,0.0038604543,0.00032970044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094358395,0.00012287352,0.21605721,0.00023709101,0.000036990456,0.0011955717,0.7572446,0.00007001476,0.0005124537,0.00082550093,0.010377777,0.013225501],"study_design_scores_gemma":[0.000004321595,0.00004157514,0.1340844,0.0002552975,0.000011142281,0.00018900764,0.85085666,0.00007833966,0.00007657741,0.00005714004,0.014288309,0.000057186102],"about_ca_topic_score_codex":0.9876008,"about_ca_topic_score_gemma":0.99281657,"teacher_disagreement_score":0.9495898,"about_ca_system_score_codex":0.050410215,"about_ca_system_score_gemma":0.08719627,"threshold_uncertainty_score":0.3657534},"labels":[],"label_agreement":null},{"id":"W4414853065","doi":"10.51731/cjht.2025.1250","title":"Dostarlimab (Jemperli)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Carboplatin; Drug; Paclitaxel; Drug approval","score_opus":0.046075261996101735,"score_gpt":0.2892892159167715,"score_spread":0.24321395392066975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414853065","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013903293,0.9265434,0.0010388233,0.0028283733,0.000418647,0.00030796157,0.0016280868,0.00017522273,0.05315611],"genre_scores_gemma":[0.1941902,0.7472862,0.0046794084,0.0050456556,0.00042555472,0.00038519688,0.003371888,0.000045592937,0.04457035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973935,0.000061460356,0.000028234188,0.000032651187,0.000116189185,0.000022123808],"domain_scores_gemma":[0.99980074,0.00005694399,0.000064663,0.0000060508473,0.000050743973,0.000020778603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047364566,0.0002038825,0.00029957065,0.00082395785,0.00015080893,0.0005095563,0.00027682298,0.00027840683,0.0072760396],"category_scores_gemma":[0.0006794827,0.00007848383,0.0003991448,0.00051453465,0.00015540188,0.00028203434,0.00019518146,0.0005429273,0.0014700344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000725677,0.00007768705,0.0006434236,0.005904818,0.0001678458,0.0001590395,0.000043435502,0.00018551783,0.004340174,0.0017008105,0.03723504,0.9488166],"study_design_scores_gemma":[0.0008987516,0.0012726972,0.0054051266,0.0028910707,0.0004006412,0.002056593,0.0000501054,0.0001678147,0.005251675,0.00047110918,0.9811173,0.00001717603],"about_ca_topic_score_codex":0.0031751147,"about_ca_topic_score_gemma":0.013930032,"teacher_disagreement_score":0.0072760396,"about_ca_system_score_codex":0.0008080032,"about_ca_system_score_gemma":0.0008850056,"threshold_uncertainty_score":0.024340749},"labels":[],"label_agreement":null},{"id":"W4414853071","doi":"10.51731/cjht.2025.1249","title":"Cabozantinib","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabozantinib; Drug; Compassionate Use; Drug approval","score_opus":0.02085405706881028,"score_gpt":0.31206519005522676,"score_spread":0.2912111329864165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414853071","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033741945,0.94649506,0.00039963095,0.0043308777,0.0006399173,0.000100267,0.001842584,0.0000728657,0.04274446],"genre_scores_gemma":[0.06387504,0.9035845,0.001742147,0.004847836,0.00065397244,0.00012601394,0.0029497815,0.000020443462,0.022200245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949646,0.00010786127,0.00006747868,0.00004940326,0.00022968439,0.000049043814],"domain_scores_gemma":[0.99937963,0.0001420078,0.00014391009,0.000016962953,0.00026522684,0.000052248484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000590972,0.00030653138,0.0005043472,0.0008904634,0.00027756084,0.00075816084,0.0003791667,0.0004293871,0.010199692],"category_scores_gemma":[0.0016900644,0.00007747528,0.000650451,0.0009909756,0.00017448228,0.00038220265,0.00019211609,0.00073025975,0.0017507809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009463871,0.000049941653,0.00067722437,0.0097901095,0.00034260575,0.00017263794,0.000036699646,0.00016298071,0.0014933248,0.0028414286,0.111633494,0.87185323],"study_design_scores_gemma":[0.00045053306,0.00024448216,0.003803469,0.0048139403,0.00054035464,0.0008026574,0.000035479778,0.00007560224,0.00081953115,0.0005916291,0.9878088,0.000013485008],"about_ca_topic_score_codex":0.030408781,"about_ca_topic_score_gemma":0.10309961,"teacher_disagreement_score":0.030408781,"about_ca_system_score_codex":0.0023977938,"about_ca_system_score_gemma":0.002997827,"threshold_uncertainty_score":0.060463548},"labels":[],"label_agreement":null},{"id":"W4414937175","doi":"10.51731/cjht.2025.1251","title":"Rozanolixizumab (Rystiggo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Drug approval; Antibody therapy; Tyrosine kinase","score_opus":0.014735107386983273,"score_gpt":0.28782373180523996,"score_spread":0.2730886244182567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414937175","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011074286,0.95455813,0.00077991124,0.001756988,0.0001938225,0.0001603225,0.0010505703,0.00009238649,0.030333629],"genre_scores_gemma":[0.12136891,0.85592514,0.0036368973,0.0017937074,0.00019707096,0.00014713792,0.001517842,0.00002273077,0.015390629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940777,0.00012738029,0.00005489384,0.00004292778,0.0003142139,0.00005284635],"domain_scores_gemma":[0.9995127,0.00011871451,0.00017644606,0.000011268851,0.00015229615,0.000028597213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000868419,0.00022581323,0.00040099834,0.001017488,0.00013990195,0.0006149313,0.00028138087,0.00030102333,0.0033999116],"category_scores_gemma":[0.0010436906,0.000072115705,0.00048220673,0.0009047756,0.00019002882,0.00024899928,0.00016360675,0.00035165276,0.00086655753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044399835,0.00005201161,0.0010260895,0.008199898,0.0001953627,0.0001923128,0.000036383404,0.00017525448,0.0051849023,0.0015255787,0.021586038,0.9613822],"study_design_scores_gemma":[0.00036299674,0.0011236807,0.017447999,0.006678535,0.00065000943,0.0019220511,0.00008778006,0.00017883904,0.004919322,0.0004137756,0.96618706,0.000027816495],"about_ca_topic_score_codex":0.01727092,"about_ca_topic_score_gemma":0.064220876,"teacher_disagreement_score":0.01727092,"about_ca_system_score_codex":0.0015013124,"about_ca_system_score_gemma":0.0018688418,"threshold_uncertainty_score":0.0343408},"labels":[],"label_agreement":null},{"id":"W4415195696","doi":"10.51731/cjht.2025.1254","title":"Durvalumab (Imfinzi), Carboplatin, Paclitaxel","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Paclitaxel; Drug; Cancer; Carboplatin","score_opus":0.020214382825669973,"score_gpt":0.31799889678956045,"score_spread":0.2977845139638905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415195696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009123667,0.96337575,0.00039989382,0.0014610011,0.00015945635,0.00010697595,0.0009855261,0.00003549764,0.024352202],"genre_scores_gemma":[0.12738907,0.8532141,0.0030322003,0.0016773875,0.00017534566,0.000111362024,0.0017058062,0.000015892221,0.012678859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996697,0.00007246476,0.000038857866,0.000030904026,0.0001651266,0.000022917855],"domain_scores_gemma":[0.99964786,0.000117111646,0.000100143865,0.000008389502,0.0001039146,0.000022627259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056488276,0.00019062804,0.00035313042,0.00086199894,0.00015881936,0.0006060078,0.00022500235,0.00024179003,0.0033755663],"category_scores_gemma":[0.0013400345,0.00006676152,0.00040418524,0.00095795677,0.00011835504,0.00026374604,0.00013714825,0.00036523817,0.00043263953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087378477,0.00004652434,0.0014829126,0.007963876,0.00043397993,0.00014080816,0.000032132502,0.00023152793,0.0023998187,0.001668174,0.022230562,0.9624958],"study_design_scores_gemma":[0.00076537335,0.0008121656,0.015363307,0.008782354,0.0018231445,0.0018929935,0.000095799725,0.00030654855,0.0044717933,0.0008867934,0.9647766,0.000023051605],"about_ca_topic_score_codex":0.024841502,"about_ca_topic_score_gemma":0.111593924,"teacher_disagreement_score":0.024841502,"about_ca_system_score_codex":0.0022222342,"about_ca_system_score_gemma":0.0021451418,"threshold_uncertainty_score":0.049393773},"labels":[],"label_agreement":null},{"id":"W4415314362","doi":"10.51731/cjht.2025.1255","title":"Semaglutide (Wegovy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Weight loss; Comorbidity; Body mass index; Type 2 diabetes; Clinical Practice; Body weight","score_opus":0.025126934297497214,"score_gpt":0.35846029367518983,"score_spread":0.3333333593776926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415314362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019053211,0.8873493,0.0017877561,0.0038522384,0.0007938872,0.00035832525,0.0045194635,0.00039102798,0.08189479],"genre_scores_gemma":[0.19905369,0.72288764,0.005772119,0.0074376073,0.00043284864,0.00028595745,0.0067152153,0.000065069216,0.057349928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970216,0.00005690076,0.000031888256,0.000033567096,0.00014243524,0.000032976386],"domain_scores_gemma":[0.999739,0.00005281403,0.00005689233,0.000008027931,0.00010329957,0.00004003452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048392193,0.00025290163,0.00040490297,0.00092228164,0.0002174648,0.0006733243,0.0002989196,0.0004142407,0.00776267],"category_scores_gemma":[0.0006939982,0.000070795926,0.00047419977,0.00090902654,0.00021586112,0.00038277637,0.0002139718,0.00062013237,0.0016097632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007644407,0.000073362506,0.00086509174,0.005110773,0.00018021988,0.00016684282,0.000030711344,0.0001726269,0.0031210186,0.0018141541,0.056017518,0.9316833],"study_design_scores_gemma":[0.0008876557,0.0008977784,0.008904487,0.0042916983,0.0005305001,0.001410998,0.000069465335,0.0002639788,0.0038688472,0.00062359957,0.9782218,0.000029206682],"about_ca_topic_score_codex":0.031258825,"about_ca_topic_score_gemma":0.12833285,"teacher_disagreement_score":0.031258825,"about_ca_system_score_codex":0.0014248074,"about_ca_system_score_gemma":0.0026748423,"threshold_uncertainty_score":0.062153757},"labels":[],"label_agreement":null},{"id":"W4415350852","doi":"10.51731/cjht.2025.1257","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemoradiotherapy; Cervical cancer; Pembrolizumab; Stage (stratigraphy); Cancer; Adenosquamous carcinoma; Radiation therapy","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415350852","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23113468,0.42534646,0.008304409,0.025575154,0.0034630133,0.0015016078,0.0062284176,0.002139399,0.29630694],"genre_scores_gemma":[0.7944365,0.085636474,0.0073429053,0.010095874,0.00078737905,0.000635267,0.004803717,0.000065180495,0.09619663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998766,0.000015554764,0.000009945729,0.000023109302,0.0000405485,0.00003432293],"domain_scores_gemma":[0.99991953,0.000011378969,0.000017369217,0.000005261318,0.000016942393,0.00002951311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019830177,0.0002194341,0.00032230528,0.00033145648,0.0002591837,0.0004499333,0.0003122795,0.00044713364,0.009273922],"category_scores_gemma":[0.00037743922,0.000085558284,0.00026724115,0.00022843956,0.00011780534,0.00039191774,0.0002482675,0.0013410999,0.0028557614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026596186,0.0005500386,0.0016886044,0.0011715565,0.00015010832,0.00079237885,0.000047517366,0.0003835017,0.02195574,0.0022946103,0.07553448,0.8927719],"study_design_scores_gemma":[0.0065255775,0.004808834,0.019417299,0.0009029725,0.000288748,0.00817082,0.000075022384,0.0010776151,0.017973678,0.0018346375,0.9388763,0.00004858262],"about_ca_topic_score_codex":0.0026122786,"about_ca_topic_score_gemma":0.0057488126,"teacher_disagreement_score":0.009273922,"about_ca_system_score_codex":0.0006444228,"about_ca_system_score_gemma":0.00050871406,"threshold_uncertainty_score":0.031024337},"labels":[],"label_agreement":null},{"id":"W4415403106","doi":"10.51731/cjht.2025.1258","title":"Acalabrutinib (Calquence)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Debulking; Rituximab; Lymphoma; Primary central nervous system lymphoma","score_opus":0.028257548079617105,"score_gpt":0.35518305201837175,"score_spread":0.32692550393875464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415403106","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03568729,0.13405879,0.0025460212,0.031920943,0.002708808,0.0009186854,0.015251246,0.0025278877,0.7743803],"genre_scores_gemma":[0.37749818,0.082596146,0.010722547,0.036593474,0.0022347504,0.00071725145,0.04360513,0.00037014895,0.4456624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996928,0.000031661624,0.000012250797,0.000048357648,0.00014612176,0.000068859656],"domain_scores_gemma":[0.9995497,0.000032024698,0.000052210096,0.000024357667,0.00014796578,0.00019373871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465439,0.0003136978,0.0003239923,0.0008400513,0.00053702394,0.0009835098,0.0006796029,0.0008793586,0.045437686],"category_scores_gemma":[0.0010007151,0.00010422168,0.00038705432,0.00061305397,0.0002943175,0.00037226506,0.0005295607,0.0014328832,0.0130091775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000788544,0.00023133625,0.001594203,0.00040597565,0.000048098955,0.0003619056,0.000030172552,0.00020575139,0.004833706,0.0038160605,0.39014274,0.5975415],"study_design_scores_gemma":[0.00084444997,0.00027714387,0.003603816,0.0001217874,0.00002850996,0.0008852211,0.000011199148,0.00014630567,0.0013106429,0.0004931092,0.99226964,0.00000805303],"about_ca_topic_score_codex":0.03554582,"about_ca_topic_score_gemma":0.08722455,"teacher_disagreement_score":0.045437686,"about_ca_system_score_codex":0.0029077178,"about_ca_system_score_gemma":0.0031931326,"threshold_uncertainty_score":0.15200424},"labels":[],"label_agreement":null},{"id":"W4415438746","doi":"10.51731/cjht.2025.1261","title":"Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ipilimumab; Nivolumab; Colorectal cancer; Microsatellite instability; Drug; Metastatic melanoma; Systemic therapy; Disease","score_opus":0.024514835644645905,"score_gpt":0.30273002263953375,"score_spread":0.27821518699488784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438746","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67327833,0.123701915,0.009195279,0.0055654743,0.0023974227,0.0024410288,0.006534483,0.003336962,0.17354907],"genre_scores_gemma":[0.9426898,0.011206434,0.0060654976,0.001733903,0.00023575727,0.00042178566,0.0042495457,0.00009540537,0.033301946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998363,0.000022201666,0.000011341016,0.000030636165,0.000040962306,0.000058485846],"domain_scores_gemma":[0.9999424,0.0000050581493,0.000008845063,0.000005561354,0.000009369033,0.00002872362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022590562,0.00026836383,0.0005117779,0.0003125589,0.00021078093,0.0005107491,0.0003848565,0.00039238334,0.0071778228],"category_scores_gemma":[0.00025349742,0.000115323106,0.000532069,0.00020319434,0.00015294834,0.0003391758,0.0003720373,0.000884874,0.0032470515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010962667,0.0012497391,0.0050349217,0.0010475524,0.00036694182,0.000762357,0.000059386162,0.0022669975,0.052880242,0.0014653812,0.042456806,0.881447],"study_design_scores_gemma":[0.017880134,0.027235052,0.044001333,0.00087751454,0.00081537507,0.009133803,0.00016196807,0.0066169645,0.07412816,0.0020026085,0.8170219,0.00012526537],"about_ca_topic_score_codex":0.0037972142,"about_ca_topic_score_gemma":0.008268536,"teacher_disagreement_score":0.0071778228,"about_ca_system_score_codex":0.0008940038,"about_ca_system_score_gemma":0.0006830511,"threshold_uncertainty_score":0.024012208},"labels":[],"label_agreement":null},{"id":"W4415438756","doi":"10.51731/cjht.2025.1260","title":"Asciminib (Scemblix)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Cancer; Disease; Drug; Public health; Cancer treatment","score_opus":0.026783171320781837,"score_gpt":0.31906480387779484,"score_spread":0.292281632557013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438756","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090336636,0.21406162,0.0067108013,0.03008479,0.004739088,0.0030654354,0.037022963,0.0060294,0.60794926],"genre_scores_gemma":[0.46943033,0.109703265,0.011369588,0.027468223,0.0022198267,0.0016410763,0.06368962,0.0003920266,0.3140861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997826,0.000030989453,0.00001250463,0.00003069728,0.00009004905,0.000053041458],"domain_scores_gemma":[0.9997826,0.000021001033,0.00003364643,0.000012539799,0.000052428506,0.00009777939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003194243,0.0004016085,0.00043607948,0.00076997944,0.0003726677,0.00092553603,0.0004170036,0.00064019766,0.044827297],"category_scores_gemma":[0.000617393,0.000112660535,0.0004421325,0.0006718743,0.00022736419,0.00043489676,0.0005735158,0.0017174737,0.016036557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024048393,0.0005318262,0.0015398453,0.0011089576,0.00012002613,0.00046611336,0.00004970702,0.00055852905,0.0066427235,0.0040681856,0.37992078,0.6025885],"study_design_scores_gemma":[0.004733659,0.0013972326,0.0042144554,0.00040656477,0.00008379363,0.0022833028,0.000022598717,0.00049019395,0.003845125,0.0014194436,0.9810831,0.000020616142],"about_ca_topic_score_codex":0.0031340506,"about_ca_topic_score_gemma":0.008667504,"teacher_disagreement_score":0.044827297,"about_ca_system_score_codex":0.0014353174,"about_ca_system_score_gemma":0.0015134072,"threshold_uncertainty_score":0.1499623},"labels":[],"label_agreement":null},{"id":"W4415438775","doi":"10.51731/cjht.2025.1259","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Radiation therapy; Head and neck; Cancer; Stage (stratigraphy); Head and neck cancer; Disease; Basal cell","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438775","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13653712,0.38359675,0.0071542975,0.04010364,0.0040625236,0.001602644,0.009481286,0.0022806572,0.415181],"genre_scores_gemma":[0.6696031,0.115629435,0.01064645,0.019736955,0.0012014369,0.0007688521,0.008839198,0.000116290495,0.17345832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983585,0.000019602743,0.000012279091,0.00002881848,0.000060267765,0.000043083426],"domain_scores_gemma":[0.9998369,0.000020603165,0.000029511433,0.000009966775,0.000042425312,0.000060544637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029324365,0.0001899951,0.00032298136,0.00036818543,0.00030336127,0.0005200972,0.00038751253,0.0005096246,0.013065035],"category_scores_gemma":[0.00058729213,0.0000868438,0.00028841663,0.0002608444,0.00014012412,0.00038999383,0.00032806373,0.0013119295,0.0034592242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017896151,0.000339902,0.0015149816,0.0009431954,0.000079976526,0.0005995332,0.000042492677,0.00029913874,0.011464586,0.0025580714,0.12138087,0.85898757],"study_design_scores_gemma":[0.0026750073,0.0015263362,0.011908024,0.0006887341,0.00011658673,0.0029324244,0.00003936328,0.00043361698,0.005554388,0.00091252755,0.97319025,0.000022735574],"about_ca_topic_score_codex":0.008946119,"about_ca_topic_score_gemma":0.020037046,"teacher_disagreement_score":0.013065035,"about_ca_system_score_codex":0.0011255136,"about_ca_system_score_gemma":0.001127442,"threshold_uncertainty_score":0.043706894},"labels":[],"label_agreement":null},{"id":"W4415517288","doi":"10.51731/cjht.2025.1264","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Drug; Lung cancer; Chemotherapy; Stage (stratigraphy); Compassionate Use","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415517288","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076089078,0.9568991,0.0007052027,0.0024044865,0.00039685663,0.00014382135,0.0008489666,0.00008248465,0.03091016],"genre_scores_gemma":[0.13291296,0.83768636,0.0031170559,0.0033965255,0.00029566526,0.00018222166,0.0012186175,0.000016696478,0.021173915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974793,0.0000501565,0.000026415903,0.000034790006,0.00010896898,0.00003177693],"domain_scores_gemma":[0.99977106,0.000054150358,0.00006706877,0.000007564128,0.00007569082,0.000024440253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048914185,0.00019765468,0.00027913268,0.000648064,0.0001930859,0.0006204223,0.00024389027,0.00031056756,0.0049226508],"category_scores_gemma":[0.00083385466,0.00007220055,0.00031467338,0.00059711194,0.00014788104,0.0004207795,0.00021557049,0.00052803324,0.0010213567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004999108,0.000045549634,0.0004637128,0.0047660694,0.00012891406,0.000118141805,0.000026485055,0.00012885185,0.0035320956,0.0015278055,0.029960036,0.9588024],"study_design_scores_gemma":[0.00047317435,0.000644386,0.0056140604,0.0042773536,0.00041845752,0.0014194602,0.000045632605,0.000115078234,0.0044962047,0.0005343111,0.9819463,0.000015572334],"about_ca_topic_score_codex":0.011731148,"about_ca_topic_score_gemma":0.03995679,"teacher_disagreement_score":0.011731148,"about_ca_system_score_codex":0.001303181,"about_ca_system_score_gemma":0.0013062853,"threshold_uncertainty_score":0.023325741},"labels":[],"label_agreement":null},{"id":"W4415619201","doi":"10.51731/cjht.2025.1265","title":"Elafibranor (Iqirvo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ursodeoxycholic acid; Reimbursement; Drug; Clinical trial; Compassionate Use; Clinical Practice","score_opus":0.018665533839666907,"score_gpt":0.2979552200978029,"score_spread":0.279289686258136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619201","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006120431,0.95970297,0.00060191326,0.002249191,0.0002709413,0.00010565967,0.0012771161,0.00008813508,0.029583639],"genre_scores_gemma":[0.116626866,0.8515269,0.0034686606,0.004048586,0.00040020156,0.0001640267,0.0021284579,0.000023417588,0.021612858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999387,0.00013552222,0.00007748276,0.00006176257,0.00027299958,0.000065344415],"domain_scores_gemma":[0.99941385,0.00018288044,0.00016820413,0.000014522084,0.00017730334,0.00004328586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009970526,0.00023263958,0.00054539903,0.0012094934,0.00025111376,0.0008904549,0.0004059728,0.00046174973,0.008787178],"category_scores_gemma":[0.0016619659,0.000079415564,0.00070074585,0.0009596175,0.00021431215,0.0004270646,0.0002808786,0.0006009813,0.0011694406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008152951,0.00006339386,0.0007243979,0.008776667,0.00026724965,0.00013383264,0.000048724665,0.00015030555,0.0023447357,0.0020398146,0.024887146,0.95974827],"study_design_scores_gemma":[0.00065391697,0.0007956617,0.0061590755,0.008187467,0.0009753511,0.0011006929,0.0000878132,0.00012257256,0.0026198097,0.00061916985,0.9786542,0.000024229113],"about_ca_topic_score_codex":0.01794993,"about_ca_topic_score_gemma":0.059390105,"teacher_disagreement_score":0.01794993,"about_ca_system_score_codex":0.0015854427,"about_ca_system_score_gemma":0.001916563,"threshold_uncertainty_score":0.035690904},"labels":[],"label_agreement":null},{"id":"W4415619203","doi":"10.51731/cjht.2025.1266","title":"Durvalumab (Imfinzi) and Tremelimumab (Imjudo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Tremelimumab; Vinorelbine; Epidermal growth factor receptor; Drug; Clinical Oncology; Reimbursement; Lymphoma; Discontinuation","score_opus":0.020021908016387844,"score_gpt":0.2969294342109829,"score_spread":0.276907526194595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619203","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005020942,0.9617368,0.0006861947,0.0031367154,0.00035800625,0.0001743391,0.0019111255,0.00005185024,0.026923895],"genre_scores_gemma":[0.070305645,0.9091862,0.004548495,0.0024288872,0.00035661785,0.00023468473,0.0023543616,0.000026767186,0.010558467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824595,0.0004233297,0.00017679797,0.0000820524,0.0009727669,0.00009911794],"domain_scores_gemma":[0.9970072,0.0010429503,0.00071493833,0.000051976916,0.0010515881,0.0001313519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002195327,0.00031961375,0.00075165223,0.0019552016,0.00026609527,0.0012105526,0.00044404017,0.00046940206,0.0048390427],"category_scores_gemma":[0.0055673663,0.00012843894,0.0009961221,0.0023788512,0.00023535025,0.00059336505,0.00028692026,0.00059586915,0.00066587713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057451095,0.000039184495,0.001337474,0.014815227,0.0007516102,0.000093181516,0.000053167,0.00028838433,0.0012049526,0.0035576508,0.037207607,0.9400771],"study_design_scores_gemma":[0.00032143565,0.00044959827,0.010690802,0.012971994,0.001679519,0.00066062214,0.00008885028,0.00021854632,0.0012721742,0.0009807115,0.97063565,0.000030026875],"about_ca_topic_score_codex":0.03393611,"about_ca_topic_score_gemma":0.13435827,"teacher_disagreement_score":0.03393611,"about_ca_system_score_codex":0.003775869,"about_ca_system_score_gemma":0.0064874366,"threshold_uncertainty_score":0.06747717},"labels":[],"label_agreement":null},{"id":"W4415619222","doi":"10.51731/cjht.2025.1270","title":"Daridorexant (Quviviq)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insomnia; Placebo; Sleep (system call); Sleep disorder; Drug treatment; Clinical trial","score_opus":0.0507086726703228,"score_gpt":0.34454736222711513,"score_spread":0.2938386895567923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619222","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19888173,0.5079262,0.007745104,0.016810225,0.003246653,0.002142409,0.008733375,0.0014788768,0.25303546],"genre_scores_gemma":[0.8273853,0.08339381,0.008769861,0.0093837315,0.0006704757,0.0004916273,0.0048930435,0.00004345737,0.06496876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997669,0.000049048103,0.00002600586,0.00003730472,0.000093421455,0.0000273736],"domain_scores_gemma":[0.9998062,0.00004306346,0.000039944385,0.0000110881565,0.000053381296,0.000046363966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041990902,0.0002398398,0.00045229428,0.0004184463,0.00029474826,0.0003485755,0.00039203634,0.0004905344,0.009503359],"category_scores_gemma":[0.0006824008,0.00008003136,0.000344599,0.00022388849,0.00024702153,0.00023333222,0.00027069327,0.000966647,0.0014978318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004872969,0.0005922187,0.0018355147,0.004553458,0.00023478897,0.00062664476,0.00012612564,0.00035174508,0.023982586,0.0054680835,0.04764785,0.90970796],"study_design_scores_gemma":[0.014171694,0.013014199,0.02599446,0.0019736355,0.0004228613,0.007947307,0.00021376497,0.0010157677,0.026655775,0.0019040304,0.9065868,0.00009961238],"about_ca_topic_score_codex":0.01227653,"about_ca_topic_score_gemma":0.053258583,"teacher_disagreement_score":0.01227653,"about_ca_system_score_codex":0.0008319126,"about_ca_system_score_gemma":0.0013280805,"threshold_uncertainty_score":0.031791925},"labels":[],"label_agreement":null},{"id":"W4415665454","doi":"10.51731/cjht.2025.1273","title":"Polatuzumab Vedotin (Polivy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Clinical trial; Anticancer drug; Drug approval","score_opus":0.0167420741400342,"score_gpt":0.3023423456240574,"score_spread":0.28560027148402317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009299906,0.9542414,0.0012706034,0.0020029931,0.0003127849,0.00013830433,0.0012432295,0.000114080576,0.03137676],"genre_scores_gemma":[0.14551023,0.8311054,0.003676398,0.0021566555,0.00022484954,0.00013965195,0.0016481932,0.000024316612,0.015514221],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996563,0.000074874784,0.000034936824,0.000035935318,0.00016966205,0.000028205981],"domain_scores_gemma":[0.99955004,0.00015876067,0.00011521767,0.000010485862,0.00013334583,0.000032085787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065522967,0.0001840887,0.0002899847,0.00081948057,0.00014215709,0.000749489,0.0002493131,0.0002627732,0.0033984643],"category_scores_gemma":[0.001026127,0.00007348938,0.0003493052,0.000791064,0.00019535665,0.0002977469,0.00016907268,0.000424323,0.0005707442],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043345857,0.000036528363,0.0010027416,0.0051914626,0.00017664679,0.00012059138,0.000028877883,0.00028534193,0.0034272673,0.0018513423,0.024013683,0.9634321],"study_design_scores_gemma":[0.0002466223,0.000562834,0.005563195,0.0035564417,0.00037169846,0.0012220378,0.00004547463,0.00017676981,0.003948117,0.00048673,0.9838066,0.000013311096],"about_ca_topic_score_codex":0.012786882,"about_ca_topic_score_gemma":0.040483948,"teacher_disagreement_score":0.9982039,"about_ca_system_score_codex":0.0017961371,"about_ca_system_score_gemma":0.0021368798,"threshold_uncertainty_score":0.025424957},"labels":[],"label_agreement":null},{"id":"W4415665455","doi":"10.51731/cjht.2025.1272","title":"Belantamab Mafodotin, Pomalidomide, Dexamethasone","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Dexamethasone; Regimen; Multiple myeloma; Refractory (planetary science); Combination therapy","score_opus":0.03492998391048633,"score_gpt":0.34642810840904276,"score_spread":0.3114981244985564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665455","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09581241,0.29840875,0.016833693,0.037006374,0.004831374,0.0013760672,0.00693981,0.003913726,0.5348778],"genre_scores_gemma":[0.71567655,0.077168144,0.015739968,0.013042993,0.0013342865,0.00042744304,0.0065538012,0.0002230145,0.16983394],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975353,0.000026520755,0.000016933462,0.000039509745,0.00010903238,0.000054459317],"domain_scores_gemma":[0.99980396,0.000021698621,0.000031038,0.000011256044,0.00004977324,0.00008229763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023911554,0.00029353288,0.00038068302,0.0005776096,0.00054994185,0.00074236566,0.00052524655,0.0005181921,0.016392011],"category_scores_gemma":[0.0006982014,0.000097648706,0.00039279953,0.00033621927,0.0003119656,0.00042457186,0.00037501456,0.0014678632,0.007824783],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044244616,0.0008663199,0.003924602,0.00086179766,0.00012380492,0.0028892977,0.000057032634,0.000723749,0.023541315,0.009074345,0.1412515,0.8122618],"study_design_scores_gemma":[0.0017733834,0.0015450033,0.007986929,0.00032016815,0.0001075935,0.012424938,0.00005898641,0.000807367,0.017489547,0.00386565,0.95358586,0.000034533947],"about_ca_topic_score_codex":0.013523216,"about_ca_topic_score_gemma":0.018412279,"teacher_disagreement_score":0.99832153,"about_ca_system_score_codex":0.0016784797,"about_ca_system_score_gemma":0.0016507163,"threshold_uncertainty_score":0.05483675},"labels":[],"label_agreement":null},{"id":"W4415665469","doi":"10.51731/cjht.2025.1274","title":"Mirvetuximab Soravtansine (Elahere)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fallopian tube; Cancer; Disease; Fallopian tube cancer; Primary care; Drug; First line","score_opus":0.028885706885149767,"score_gpt":0.3440581177649768,"score_spread":0.31517241087982706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665469","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10848143,0.17435862,0.0064286334,0.034251276,0.0033103589,0.00096052646,0.010563513,0.0030981416,0.65854734],"genre_scores_gemma":[0.60212445,0.055253815,0.01352798,0.016821492,0.0007917512,0.0003694401,0.014718013,0.00021225683,0.29618087],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997135,0.000035749435,0.000015294198,0.00003518653,0.00015066701,0.000049674516],"domain_scores_gemma":[0.99974436,0.000025400199,0.00003630726,0.0000146607745,0.000083021645,0.000096200216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004037884,0.0001790727,0.00029961378,0.00049573765,0.00031228786,0.0004904818,0.0003740225,0.0005226503,0.018851925],"category_scores_gemma":[0.0006419925,0.000108283704,0.0003280143,0.00030176554,0.00017997943,0.00022832418,0.0003577566,0.0010223269,0.004388897],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016585472,0.0003061197,0.0027576496,0.00064150395,0.00008921855,0.00044210991,0.000045884575,0.0005133745,0.009434256,0.0051218322,0.18979648,0.7891929],"study_design_scores_gemma":[0.0010590466,0.0008386334,0.009007496,0.00022588178,0.000052703504,0.0014614217,0.000018742276,0.00049180083,0.004010062,0.00053889956,0.9822809,0.000014520912],"about_ca_topic_score_codex":0.024870554,"about_ca_topic_score_gemma":0.078469574,"teacher_disagreement_score":0.99795204,"about_ca_system_score_codex":0.0020479641,"about_ca_system_score_gemma":0.0022937125,"threshold_uncertainty_score":0.063066006},"labels":[],"label_agreement":null},{"id":"W4415701669","doi":"10.51731/cjht.2025.1279","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mesylate; Drug; Prostate cancer; Clinical Practice; Patient care","score_opus":0.023287962214125102,"score_gpt":0.3173228180496364,"score_spread":0.2940348558355113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415701669","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016102662,0.94832104,0.0006671498,0.0012568741,0.00026543305,0.0001447631,0.0012128347,0.000081997176,0.031947237],"genre_scores_gemma":[0.17466427,0.7942785,0.002921895,0.0024230452,0.0002596041,0.000125214,0.0021272427,0.00002367588,0.02317656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997696,0.00003760085,0.000016283986,0.000027424867,0.0001269726,0.000022109774],"domain_scores_gemma":[0.99983335,0.000045795696,0.000046638048,0.0000042046763,0.000047084366,0.000022920383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002479609,0.00023283398,0.00032187137,0.00065462955,0.0001667046,0.0004121322,0.00023509571,0.0002565528,0.005477586],"category_scores_gemma":[0.00051486556,0.00006825291,0.00031637624,0.0006215406,0.0001633572,0.00020516684,0.00016695673,0.0004749962,0.0007060735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084143924,0.00010319411,0.0009144034,0.006929575,0.00015990912,0.0003543683,0.00003959146,0.00023492816,0.014313604,0.0015138282,0.02625165,0.94834346],"study_design_scores_gemma":[0.0006418667,0.0017664311,0.015424465,0.003469485,0.00039116558,0.0036996037,0.00010147026,0.00021795991,0.015609981,0.00039228183,0.95825267,0.00003263581],"about_ca_topic_score_codex":0.016819851,"about_ca_topic_score_gemma":0.07759549,"teacher_disagreement_score":0.016819851,"about_ca_system_score_codex":0.00094528974,"about_ca_system_score_gemma":0.0014075643,"threshold_uncertainty_score":0.033443928},"labels":[],"label_agreement":null},{"id":"W4415701678","doi":"10.51731/cjht.2025.1277","title":"Pasireotide (Signifor LAR)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pasireotide; Acromegaly; Drug; Reimbursement; Clinical trial","score_opus":0.0184588778501626,"score_gpt":0.29283037601966344,"score_spread":0.27437149816950085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415701678","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010475551,0.84594226,0.0026244405,0.0042616283,0.0007547228,0.00033237776,0.0032382058,0.00021899922,0.13215181],"genre_scores_gemma":[0.11878327,0.7820542,0.009219205,0.007007918,0.0007083063,0.00037364813,0.0053888937,0.00007434155,0.07639024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960226,0.00008237768,0.00003084494,0.00004120823,0.00021346797,0.000029840938],"domain_scores_gemma":[0.9996668,0.000102978556,0.00006211678,0.000008636732,0.00012274647,0.00003671281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008306092,0.00023812153,0.00031074614,0.00059809623,0.00018579373,0.00055132137,0.00027073637,0.00039194405,0.011273917],"category_scores_gemma":[0.000980912,0.00007748769,0.00043356206,0.0005648467,0.00017431466,0.0003838745,0.00022791853,0.00066548475,0.0026485918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003939034,0.00004106862,0.00045204745,0.0030574098,0.000080547135,0.00014263391,0.000026778378,0.00015039477,0.0041473643,0.0019193363,0.060656488,0.928932],"study_design_scores_gemma":[0.00028748528,0.00052223704,0.0030102623,0.0022623222,0.00019291206,0.0017752056,0.000039944545,0.00016159208,0.0030037656,0.00045399668,0.9882733,0.000016940447],"about_ca_topic_score_codex":0.0134316925,"about_ca_topic_score_gemma":0.047662564,"teacher_disagreement_score":0.0134316925,"about_ca_system_score_codex":0.0010047815,"about_ca_system_score_gemma":0.0018952497,"threshold_uncertainty_score":0.037715018},"labels":[],"label_agreement":null},{"id":"W4415739209","doi":"10.51731/cjht.2025.1280","title":"CT and MRI Examination Volumes in Canada: National Performance Insights","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workload; Computed tomography; Rural area; Mri scan; Medical imaging","score_opus":0.021320663810881987,"score_gpt":0.28460327527161977,"score_spread":0.2632826114607378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415739209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71162224,0.02841762,0.0031220654,0.07209759,0.00048536793,0.00029938988,0.122235216,0.0005639515,0.06115658],"genre_scores_gemma":[0.9599205,0.009296236,0.0025732054,0.0031999864,0.00018970207,0.0000717662,0.02221285,0.0001445232,0.002391168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99072534,0.0006644256,0.0006530585,0.0008642095,0.0051889354,0.0019040507],"domain_scores_gemma":[0.9500536,0.0044552237,0.005114973,0.0010903864,0.032964498,0.006321403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005596033,0.0005031104,0.0006773217,0.0055624344,0.0025964233,0.003738255,0.0026652655,0.0005830409,0.0025082617],"category_scores_gemma":[0.027052581,0.0006378581,0.0009378917,0.0204025,0.0017054789,0.0017849708,0.0022492153,0.0016879468,0.00045101668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007422394,0.000057221143,0.9124498,0.00039591407,0.00016489397,0.000102913225,0.0016503729,0.0014068609,0.0001105575,0.001933001,0.039368197,0.042285927],"study_design_scores_gemma":[0.000008538712,0.000021027927,0.9801721,0.000352146,0.000078829435,0.000099895704,0.0022825133,0.0016428792,0.00015133584,0.0002959256,0.01484488,0.00004993454],"about_ca_topic_score_codex":0.9965868,"about_ca_topic_score_gemma":0.9973041,"teacher_disagreement_score":0.09096348,"about_ca_system_score_codex":0.09096348,"about_ca_system_score_gemma":0.12930834,"threshold_uncertainty_score":0.65998936},"labels":[],"label_agreement":null},{"id":"W4415739231","doi":"10.51731/cjht.2025.1278","title":"Belantamab Mafodotin (Blenrep), Bortezomib, Dexamethasone","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dexamethasone; Bortezomib; Multiple myeloma; Refractory (planetary science); Drug","score_opus":0.034661680369379236,"score_gpt":0.3464443294400952,"score_spread":0.31178264907071596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415739231","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14711505,0.31452855,0.020539107,0.044340905,0.003752821,0.0012494036,0.007360448,0.0040502455,0.45706344],"genre_scores_gemma":[0.7286179,0.07390531,0.018975288,0.010974592,0.00090182194,0.0003965858,0.0054941946,0.00020763972,0.16052665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979204,0.000023465282,0.000016765676,0.00003528756,0.000084798005,0.000047665864],"domain_scores_gemma":[0.99975854,0.000025841588,0.000044225537,0.000012305243,0.00005320275,0.00010590605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024293525,0.000196523,0.00026920822,0.00046741823,0.0005164123,0.000565708,0.00035738267,0.00043421413,0.012695724],"category_scores_gemma":[0.00059789844,0.0000885266,0.0003159657,0.0003061955,0.0002760418,0.0003349916,0.0003520254,0.0010573082,0.004541712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003397105,0.00067317544,0.0061862567,0.000918336,0.00011217354,0.0024969652,0.00006676581,0.00075050467,0.039791588,0.007744416,0.14684929,0.7910134],"study_design_scores_gemma":[0.0011471075,0.0014095528,0.014348892,0.00028687835,0.00008386444,0.0088455435,0.00005771031,0.0005868761,0.019120134,0.0025328398,0.9515495,0.00003108746],"about_ca_topic_score_codex":0.016061692,"about_ca_topic_score_gemma":0.02718873,"teacher_disagreement_score":0.016061692,"about_ca_system_score_codex":0.0016396077,"about_ca_system_score_gemma":0.001670724,"threshold_uncertainty_score":0.04247147},"labels":[],"label_agreement":null},{"id":"W4415877972","doi":"10.51731/cjht.2025.1282","title":"Risankizumab (Skyrizi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ulcerative colitis; Drug; Population; Disease; Orphan drug; Tofacitinib","score_opus":0.008277496548169965,"score_gpt":0.2622596702949909,"score_spread":0.25398217374682097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415877972","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14122254,0.31708202,0.007674978,0.026030177,0.0055203037,0.0017014429,0.019220412,0.006263878,0.47528425],"genre_scores_gemma":[0.6551802,0.07190656,0.008803868,0.018076798,0.0019275214,0.0005744137,0.029254008,0.00021819123,0.21405847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967015,0.000039544062,0.000025557121,0.00004737135,0.00014171489,0.00007580077],"domain_scores_gemma":[0.9997423,0.000024347079,0.000053803145,0.000017242452,0.00006885263,0.00009344179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004109022,0.00037305977,0.00045824278,0.00061848137,0.00028481838,0.0006670674,0.0004409716,0.00073143333,0.018456463],"category_scores_gemma":[0.00064197875,0.0001234087,0.0005554455,0.00031144018,0.00022694014,0.00026459357,0.00050441816,0.0012532974,0.0112121785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030424555,0.0005473284,0.004007834,0.0015059062,0.00016973012,0.001066107,0.000074297255,0.00064198894,0.020478865,0.0039688135,0.2158666,0.74863],"study_design_scores_gemma":[0.0036419737,0.003274071,0.011446501,0.00052140834,0.00019357157,0.0055392827,0.000050647213,0.0005784162,0.011375455,0.0009772693,0.9623628,0.00003875177],"about_ca_topic_score_codex":0.0035338923,"about_ca_topic_score_gemma":0.006914593,"teacher_disagreement_score":0.018456463,"about_ca_system_score_codex":0.0010604697,"about_ca_system_score_gemma":0.0012914016,"threshold_uncertainty_score":0.06174302},"labels":[],"label_agreement":null},{"id":"W4415877993","doi":"10.51731/cjht.2025.1281","title":"Ibrutinib","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Reimbursement; Cancer; Antineoplastic Drugs; Cancer drugs; Drug","score_opus":0.02848752115301347,"score_gpt":0.3536033925155721,"score_spread":0.32511587136255865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415877993","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008003095,0.85446095,0.0021439565,0.011593221,0.0015247401,0.00021489152,0.0016604399,0.00019473929,0.12020398],"genre_scores_gemma":[0.19473252,0.7168434,0.010139666,0.011803959,0.0017574357,0.0003075433,0.0038267828,0.00007569576,0.06051305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991629,0.0002743078,0.000103462415,0.000069246424,0.00029401915,0.00009606215],"domain_scores_gemma":[0.9993316,0.00018651175,0.00018833848,0.000021285414,0.00021149672,0.00006080612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014591279,0.00032711524,0.0003952367,0.00097346486,0.00028595625,0.0009646556,0.0004739467,0.0006102351,0.009801349],"category_scores_gemma":[0.0024186277,0.00010351864,0.000602786,0.0009109952,0.00018783916,0.000430803,0.00034962085,0.00089244335,0.0023271113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006873574,0.000048775328,0.0007800763,0.0032822634,0.00018142014,0.00022158427,0.000047970978,0.00031222237,0.0019876026,0.005693255,0.07147822,0.9152792],"study_design_scores_gemma":[0.000252439,0.00018724677,0.0021424722,0.0023664352,0.00021542827,0.00083670614,0.000035382494,0.00011511542,0.0011495474,0.0009443493,0.99174213,0.000012814861],"about_ca_topic_score_codex":0.0052846866,"about_ca_topic_score_gemma":0.014463824,"teacher_disagreement_score":0.009801349,"about_ca_system_score_codex":0.0020186969,"about_ca_system_score_gemma":0.002177817,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4415963750","doi":"10.51731/cjht.2025.1283","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen deprivation therapy; Abiraterone acetate; Abiraterone; Placebo","score_opus":0.032991687298584586,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415963750","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030984947,0.5898318,0.005935283,0.022914143,0.0037397142,0.0021057068,0.021518787,0.002050815,0.3209189],"genre_scores_gemma":[0.38895193,0.2530697,0.02182137,0.033453204,0.0009923528,0.0016701336,0.03703612,0.00040747755,0.26259768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992526,0.00014793889,0.000047662277,0.000119535216,0.00032403145,0.00010817815],"domain_scores_gemma":[0.99924326,0.00009028864,0.00011916237,0.00005257833,0.00032103894,0.00017377584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012062065,0.00038712335,0.00063423486,0.0013181983,0.0007467901,0.0010510124,0.0009415833,0.0010658457,0.019107046],"category_scores_gemma":[0.0020245307,0.00020092867,0.00067548,0.0009923928,0.0004775278,0.0004909039,0.0007545167,0.0020089974,0.004408037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021977937,0.00036503407,0.0012670009,0.0023913074,0.00017143005,0.00039458534,0.00009699367,0.0004083882,0.010555438,0.00938586,0.25641087,0.71635526],"study_design_scores_gemma":[0.0009781095,0.0003965412,0.0020458363,0.0004527844,0.00005053972,0.00057702046,0.000019235216,0.00010837878,0.0023983885,0.0006009527,0.9923569,0.00001531351],"about_ca_topic_score_codex":0.07321434,"about_ca_topic_score_gemma":0.18886906,"teacher_disagreement_score":0.07321434,"about_ca_system_score_codex":0.003913357,"about_ca_system_score_gemma":0.0069676056,"threshold_uncertainty_score":0.14557642},"labels":[],"label_agreement":null},{"id":"W4416122867","doi":"10.51731/cjht.2025.1284","title":"Tofacitinib","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tofacitinib; Reimbursement; Psoriatic arthritis; Drug; Rheumatoid arthritis; Tocilizumab; Alternative medicine; Cancer; Plaque psoriasis","score_opus":0.029908767246662703,"score_gpt":0.33742750736823446,"score_spread":0.30751874012157177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416122867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013326127,0.72769856,0.0030895125,0.037878707,0.003645731,0.00037762886,0.0043163993,0.00025173745,0.20941561],"genre_scores_gemma":[0.23110726,0.64754283,0.009841278,0.021434492,0.003494237,0.00037594666,0.0072485325,0.000087473934,0.078867935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998971,0.0002801047,0.00010848742,0.00007505272,0.0004577992,0.00010762643],"domain_scores_gemma":[0.9986929,0.0003681612,0.000276006,0.000029638059,0.0005054147,0.00012792638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016908685,0.00026208936,0.0003720242,0.00090329966,0.0003539557,0.0012818476,0.00035242466,0.0006993682,0.01513443],"category_scores_gemma":[0.0049126875,0.0000863756,0.0006594091,0.0009243076,0.00020949343,0.0006443427,0.0003478286,0.001111025,0.0022250344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005688797,0.000052191164,0.0012238566,0.0022257837,0.00015095822,0.00020699686,0.00004252226,0.00028946064,0.0006679055,0.0075676925,0.119837396,0.8671664],"study_design_scores_gemma":[0.0002603362,0.0001665162,0.0026605774,0.002030641,0.00017041397,0.0008721573,0.00004020871,0.00015993636,0.00059100013,0.0016810364,0.9913531,0.000014041065],"about_ca_topic_score_codex":0.0067425845,"about_ca_topic_score_gemma":0.014555858,"teacher_disagreement_score":0.01513443,"about_ca_system_score_codex":0.0022243052,"about_ca_system_score_gemma":0.0036808022,"threshold_uncertainty_score":0.050629675},"labels":[],"label_agreement":null},{"id":"W4416187047","doi":"10.51731/cjht.2025.1285","title":"Guselkumab (Tremfya)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Population; Disease; Ulcerative colitis; Public health; Orphan drug","score_opus":0.008829841954949316,"score_gpt":0.260861636096316,"score_spread":0.2520317941413667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416187047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31778097,0.40811408,0.008448338,0.019263588,0.0041772523,0.0010670568,0.009460774,0.0056353556,0.22605261],"genre_scores_gemma":[0.7860948,0.07213503,0.006148614,0.0104137,0.00062300713,0.0006590382,0.012482201,0.00016178048,0.11128183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984443,0.000017442224,0.00000870263,0.000027684928,0.000037119094,0.00006461379],"domain_scores_gemma":[0.9999242,0.0000081056305,0.000013704087,0.0000057644575,0.000011625196,0.00003660241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018849903,0.00037818952,0.0005660766,0.0004993601,0.00033202325,0.0004619208,0.00042171637,0.000679104,0.012603805],"category_scores_gemma":[0.00023772365,0.00012608769,0.00051160523,0.00040565865,0.0002487238,0.00039341295,0.00043534845,0.0020730372,0.009235844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006406082,0.0012861739,0.0024837502,0.002227631,0.00039430385,0.0027032725,0.00008575338,0.0009666716,0.045017175,0.004655882,0.13857561,0.79519784],"study_design_scores_gemma":[0.01149022,0.005921188,0.018059932,0.0006727782,0.00041317203,0.019883594,0.00008839299,0.0014454415,0.03576145,0.0029220225,0.90322876,0.0001131078],"about_ca_topic_score_codex":0.0015405766,"about_ca_topic_score_gemma":0.0031036718,"teacher_disagreement_score":0.012603805,"about_ca_system_score_codex":0.0008853674,"about_ca_system_score_gemma":0.00058027776,"threshold_uncertainty_score":0.042163968},"labels":[],"label_agreement":null},{"id":"W4416247422","doi":"10.51731/cjht.2025.1286","title":"Belzutifan (Welireg)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug approval; MEDLINE; Drug; Clinical trial","score_opus":0.02073411329293563,"score_gpt":0.3122605198815232,"score_spread":0.2915264065885876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416247422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030227207,0.8385529,0.0021358486,0.006525171,0.0010963742,0.0005319469,0.0052531622,0.0006287257,0.11504873],"genre_scores_gemma":[0.34153387,0.5277944,0.007836374,0.011366809,0.00046319282,0.00045515184,0.010532578,0.000095827025,0.09992181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997409,0.000051474904,0.00001854396,0.000037453898,0.00010912192,0.000042347834],"domain_scores_gemma":[0.99981266,0.00003170065,0.000050487924,0.0000051691,0.00006480657,0.000035144112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005326396,0.00029484637,0.00037556837,0.0008762518,0.00031198937,0.00061101146,0.00040344827,0.0005420036,0.013047314],"category_scores_gemma":[0.00061964494,0.000093238,0.0004401214,0.0006084803,0.00021509499,0.00044617907,0.0002519834,0.0008559561,0.0026873692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015936885,0.00017811872,0.00068433926,0.005081922,0.00015937844,0.00027507884,0.000073067786,0.00030636485,0.00939229,0.0032819523,0.08729265,0.89168113],"study_design_scores_gemma":[0.0013704253,0.0013815266,0.004768172,0.0025000905,0.00027066254,0.0017711516,0.00006393825,0.0001879689,0.0041463673,0.0005585936,0.98295236,0.00002868003],"about_ca_topic_score_codex":0.017125892,"about_ca_topic_score_gemma":0.07798638,"teacher_disagreement_score":0.017125892,"about_ca_system_score_codex":0.0017030711,"about_ca_system_score_gemma":0.0017879988,"threshold_uncertainty_score":0.043647587},"labels":[],"label_agreement":null},{"id":"W4416333304","doi":"10.51731/cjht.2025.1287","title":"Quetiapine for Insomnia","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quetiapine; Quetiapine Fumarate; Insomnia; Atypical antipsychotic; Antipsychotic; Schizophrenia (object-oriented programming); Bipolar disorder","score_opus":0.020782159443599214,"score_gpt":0.3343337592579555,"score_spread":0.31355159981435626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005604145,0.978292,0.00017075466,0.0062484364,0.0012207639,0.000069112946,0.0006911578,0.00007785175,0.012669519],"genre_scores_gemma":[0.015908722,0.9576989,0.0009386477,0.010569561,0.0020930327,0.000113604656,0.0009053307,0.00003638684,0.011735839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898106,0.00019645836,0.0002185363,0.0001319553,0.00038445133,0.00008760467],"domain_scores_gemma":[0.997959,0.00081319193,0.00051615934,0.00006665194,0.00046311397,0.00018178437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012541602,0.0005670168,0.0011717387,0.0030819087,0.00068911683,0.0014449691,0.0009170042,0.0018031072,0.037573125],"category_scores_gemma":[0.005416843,0.00022751013,0.0019174645,0.0022960685,0.00042113103,0.0008823276,0.00078585197,0.001749378,0.0063273893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006685894,0.00008003749,0.0006276274,0.037511077,0.00045894977,0.0005499551,0.00011554971,0.00005957521,0.00071778137,0.002489477,0.14192602,0.81479543],"study_design_scores_gemma":[0.00089519355,0.0003042397,0.0063065123,0.035153825,0.0014141822,0.0028364223,0.000117740565,0.00006638766,0.0008119428,0.0022106126,0.94984293,0.00004012662],"about_ca_topic_score_codex":0.016810203,"about_ca_topic_score_gemma":0.052928712,"teacher_disagreement_score":0.037573125,"about_ca_system_score_codex":0.002701265,"about_ca_system_score_gemma":0.0032267836,"threshold_uncertainty_score":0.12569463},"labels":[],"label_agreement":null},{"id":"W4416333309","doi":"10.51731/cjht.2025.1289","title":"Talazoparib (Talzenna)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Drug; Prostate; Cancer","score_opus":0.0350540873413844,"score_gpt":0.3577037633705603,"score_spread":0.32264967602917594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333309","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08699381,0.27616087,0.007662229,0.031627033,0.0037624047,0.0012440109,0.020954471,0.009136286,0.562459],"genre_scores_gemma":[0.55277485,0.10134438,0.008190275,0.02519811,0.00097142847,0.00063016795,0.02436442,0.00040337018,0.286123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998281,0.000017298977,0.000009718981,0.000030558123,0.00006455977,0.00004961028],"domain_scores_gemma":[0.99988437,0.000010947861,0.00001995379,0.0000060992743,0.000028237288,0.000050413208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021380192,0.00046393988,0.00053030526,0.0007339379,0.00038261258,0.0008763474,0.00055333483,0.000637776,0.040977895],"category_scores_gemma":[0.00041128707,0.00014496892,0.00050759857,0.00060049316,0.00021672375,0.0003974864,0.00044423807,0.0015422916,0.013973708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027129801,0.00051921903,0.0014501151,0.0016310475,0.00020773118,0.00088212744,0.00007112473,0.0007480209,0.016601454,0.0054590045,0.27509493,0.69462234],"study_design_scores_gemma":[0.0050230334,0.0017389959,0.0061841956,0.0005775032,0.0002226336,0.004769941,0.00006343102,0.0010140218,0.009875689,0.0022020347,0.96827567,0.000052863274],"about_ca_topic_score_codex":0.006905388,"about_ca_topic_score_gemma":0.018535063,"teacher_disagreement_score":0.040977895,"about_ca_system_score_codex":0.0013788299,"about_ca_system_score_gemma":0.0011136942,"threshold_uncertainty_score":0.13708472},"labels":[],"label_agreement":null},{"id":"W4416422277","doi":"10.51731/cjht.2025.1290","title":"Asynchronous Teleultrasound and In-Person Ultrasound: Comparing Diagnostic Accuracy","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Comparability; Asynchronous communication; Economic shortage; Health care; Quality (philosophy); Variety (cybernetics); Ultrasound","score_opus":0.042321628627171835,"score_gpt":0.34297256021545847,"score_spread":0.30065093158828665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416422277","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040556705,0.9887194,0.00044659709,0.0041652145,0.0005086969,0.00013817001,0.00075166876,0.0000094952575,0.0012050328],"genre_scores_gemma":[0.14628486,0.839191,0.0038710963,0.006097784,0.002446698,0.00050373975,0.0013235095,0.00004930037,0.00023203794],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.93896437,0.022952395,0.021359622,0.004190954,0.01139571,0.001136918],"domain_scores_gemma":[0.5557038,0.354208,0.0375721,0.0052289413,0.045556936,0.0017302172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056494694,0.000683719,0.0047805435,0.010168468,0.00059938704,0.0058576334,0.0034758782,0.0030833872,0.004056911],"category_scores_gemma":[0.29987568,0.0008849702,0.006192459,0.010035836,0.0025152804,0.0052217105,0.0018884004,0.002128984,0.0006627179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026802022,0.000105690015,0.038120512,0.48657283,0.016916081,0.00022727998,0.001498856,0.00038606656,0.000268909,0.0017321412,0.011579437,0.43991196],"study_design_scores_gemma":[0.0015027489,0.0019419901,0.122799866,0.6901606,0.08835038,0.002337911,0.0044145817,0.0010996432,0.0009867108,0.0039170696,0.08212775,0.00036069308],"about_ca_topic_score_codex":0.021055857,"about_ca_topic_score_gemma":0.029418644,"teacher_disagreement_score":0.056494694,"about_ca_system_score_codex":0.0052369214,"about_ca_system_score_gemma":0.011206491,"threshold_uncertainty_score":0.2987761},"labels":[],"label_agreement":null},{"id":"W4416504022","doi":"10.51731/cjht.2025.1291","title":"Flexible Dentures for Edentulism","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental materials and restorations","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Edentulism; Dentures; Removable partial denture; Clinical trial; Randomized controlled trial; Prosthodontics","score_opus":0.027524304142649624,"score_gpt":0.33960887139606766,"score_spread":0.31208456725341804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416504022","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003370872,0.99696463,0.000041741103,0.0014920677,0.00026730858,0.000055664914,0.00009374174,0.0000037404334,0.000744021],"genre_scores_gemma":[0.0067505743,0.98750955,0.00052564824,0.0040108333,0.00043690624,0.00009413207,0.000118303404,0.000003707625,0.00055038126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708134,0.00070068135,0.00097225624,0.00019394416,0.0009454135,0.00010630325],"domain_scores_gemma":[0.9863041,0.0087085655,0.0028141714,0.0002086779,0.0017675684,0.00019699316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047050775,0.00058302534,0.0029079015,0.0045831697,0.00047307942,0.0021404263,0.0011539009,0.0022808416,0.008331192],"category_scores_gemma":[0.018119808,0.00042947842,0.0040564504,0.0031305961,0.0008416229,0.001978479,0.0007810847,0.0017511401,0.0006563231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047292592,0.000074603646,0.001259515,0.44521487,0.0021052551,0.00030135646,0.00023092992,0.000109219516,0.0005659786,0.002059641,0.021588832,0.52601683],"study_design_scores_gemma":[0.0008050358,0.00039918468,0.0071907938,0.7180259,0.011294073,0.0015076885,0.00041880258,0.00009124118,0.0005125261,0.0019359335,0.25776866,0.00005004097],"about_ca_topic_score_codex":0.013985545,"about_ca_topic_score_gemma":0.036487,"teacher_disagreement_score":0.013985545,"about_ca_system_score_codex":0.0032427683,"about_ca_system_score_gemma":0.008638749,"threshold_uncertainty_score":0.027870595},"labels":[],"label_agreement":null},{"id":"W4416744877","doi":"10.51731/cjht.2025.1292","title":"Quetiapine for Major Depressive Disorder","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Science and Technology Department of Zhejiang Province; National Laboratory of Pattern Recognition; U.S. Department of Defense; Canadian Network for Mood and Anxiety Treatments; China Postdoctoral Science Foundation; U.S. Department of Veterans Affairs; West China Hospital, Sichuan University; Department of Science and Technology of Sichuan Province; National Natural Science Foundation of China","keywords":"Quetiapine; Atypical antipsychotic; Major depressive disorder; Guideline; Quetiapine Fumarate; Anxiety; Schizophrenia (object-oriented programming); Bipolar disorder","score_opus":0.018287283221420477,"score_gpt":0.31778504392077667,"score_spread":0.2994977606993562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416744877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024585268,0.8846795,0.00053645874,0.07942309,0.0043370854,0.00010981867,0.0010696151,0.00019851125,0.027187381],"genre_scores_gemma":[0.07117756,0.78521895,0.0024683229,0.10761922,0.014444403,0.00019504294,0.002001841,0.00009681373,0.016777819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990018,0.00025436448,0.00025952267,0.00010127246,0.00029469284,0.00008833107],"domain_scores_gemma":[0.99739885,0.0010523649,0.000647425,0.00009673593,0.0005461274,0.00025853165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013264454,0.0002700895,0.0011190285,0.0011045065,0.00039721557,0.0010937892,0.00075563026,0.0018733506,0.014261448],"category_scores_gemma":[0.00690898,0.00013383693,0.0011879422,0.0011083754,0.0004157955,0.001229276,0.00046660073,0.0019017264,0.0047518457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007436254,0.00011109278,0.0020702765,0.011836552,0.00041588163,0.0016109004,0.000094436924,0.00005430664,0.00061795814,0.0021484094,0.3577687,0.6225279],"study_design_scores_gemma":[0.0011114808,0.00028082423,0.009531969,0.016304556,0.0007860474,0.0057878913,0.00012546078,0.00008556082,0.00039399363,0.0037137745,0.9618277,0.000050725754],"about_ca_topic_score_codex":0.004649731,"about_ca_topic_score_gemma":0.012761602,"teacher_disagreement_score":0.014261448,"about_ca_system_score_codex":0.001249156,"about_ca_system_score_gemma":0.0016660634,"threshold_uncertainty_score":0.047709346},"labels":[],"label_agreement":null},{"id":"W4416744889","doi":"10.51731/cjht.2025.1295","title":"Injectable Opioid Agonist Treatment for Patients With Opioid Use Disorder: An Updated Review of Clinical and Cost-Effectiveness","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Hydromorphone; Opioid; Adverse effect; Agonist; Opioid use disorder; Disease","score_opus":0.04495310668926925,"score_gpt":0.37513746105256024,"score_spread":0.33018435436329097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416744889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001586401,0.998971,0.000033732358,0.0002783355,0.0000803116,0.000026704172,0.00019043859,0.0000046419404,0.00025627925],"genre_scores_gemma":[0.0017289357,0.9974935,0.00020874536,0.00025260355,0.00006433523,0.000040399424,0.00014525653,0.0000030149047,0.00006314078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967728,0.00082114316,0.0011440442,0.0002091108,0.00092767633,0.00012523976],"domain_scores_gemma":[0.9836754,0.010693082,0.0029496273,0.00016548662,0.0023167883,0.00019960737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053921933,0.0011329262,0.006268191,0.009234251,0.00032669574,0.0022779221,0.0018219583,0.0014502407,0.008003422],"category_scores_gemma":[0.019402802,0.0007063349,0.0059104976,0.012489741,0.0004918391,0.0021085537,0.00086724735,0.0016266435,0.0006148747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007346054,0.00006908624,0.00074789143,0.4696732,0.005673341,0.00009942206,0.00006763437,0.00046150666,0.00015355558,0.0011196621,0.02240036,0.49879983],"study_design_scores_gemma":[0.001015733,0.0006966005,0.0114464015,0.6967969,0.051500577,0.001095935,0.00024351661,0.0005674597,0.0002808308,0.0017868847,0.23446137,0.00010785491],"about_ca_topic_score_codex":0.009236114,"about_ca_topic_score_gemma":0.019200094,"teacher_disagreement_score":0.009236114,"about_ca_system_score_codex":0.0039843074,"about_ca_system_score_gemma":0.0059087244,"threshold_uncertainty_score":0.028908253},"labels":[],"label_agreement":null},{"id":"W4416817506","doi":"10.51731/cjht.2025.1296","title":"Omaveloxolone (Skyclarys)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; MEDLINE; Clinical Practice; Drug approval","score_opus":0.03355986091341648,"score_gpt":0.301689674879214,"score_spread":0.2681298139657975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416817506","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016765226,0.9175997,0.0010193286,0.0026964901,0.00064569997,0.00027651712,0.0024540634,0.00020579192,0.05833726],"genre_scores_gemma":[0.193818,0.74543405,0.00339279,0.0055381,0.00054447853,0.00023155636,0.0034710458,0.00004543164,0.047524497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996667,0.00006945094,0.000035882815,0.000044126264,0.00015041747,0.000033492997],"domain_scores_gemma":[0.99971193,0.00007060909,0.000081831146,0.0000072463504,0.0000907476,0.000037628815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004021782,0.00028505907,0.00043483605,0.0013881942,0.00025054003,0.000553204,0.0003527166,0.0005241208,0.012884672],"category_scores_gemma":[0.00063965854,0.0000862588,0.0004593937,0.0007682424,0.00021281226,0.00035723686,0.00028206338,0.00063890545,0.0021497132],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010113558,0.00011482342,0.0005669962,0.010023887,0.00016503538,0.0003216966,0.00005569713,0.00017692446,0.00964415,0.00230291,0.043048114,0.9325684],"study_design_scores_gemma":[0.0012519705,0.001953605,0.00608979,0.0063588675,0.00041073968,0.0023482642,0.00011354083,0.00014826575,0.0063839196,0.000679369,0.97422385,0.00003782163],"about_ca_topic_score_codex":0.0100543145,"about_ca_topic_score_gemma":0.045244243,"teacher_disagreement_score":0.012884672,"about_ca_system_score_codex":0.0007775886,"about_ca_system_score_gemma":0.0012627417,"threshold_uncertainty_score":0.043103516},"labels":[],"label_agreement":null},{"id":"W4416864806","doi":"10.51731/cjht.2025.1298","title":"Delgocitinib (Anzupgo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Clinical trial; Public health; Pharmacotherapy; MEDLINE","score_opus":0.01991656212034417,"score_gpt":0.29696586819643467,"score_spread":0.2770493060760905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416864806","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14623421,0.26449397,0.0044447714,0.030260654,0.0041978997,0.0024989825,0.02467645,0.0063192737,0.5168738],"genre_scores_gemma":[0.62394136,0.082295865,0.004188744,0.01952436,0.00081856665,0.0012595849,0.03469504,0.00027724163,0.23299927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978215,0.000020309768,0.000014810899,0.00003555536,0.00007961233,0.000067580026],"domain_scores_gemma":[0.999882,0.000010185651,0.000021570613,0.0000074182376,0.0000323943,0.000046380213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024706722,0.00040003407,0.0006570422,0.00081192976,0.0005136352,0.0009859045,0.00058171677,0.0009946418,0.034861065],"category_scores_gemma":[0.00040272277,0.00015778522,0.000499057,0.00045707903,0.00018765155,0.0006105821,0.00062713755,0.0017379748,0.014866352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020907435,0.000630705,0.0021092454,0.002243068,0.00017721187,0.0010440082,0.000067242414,0.0006931928,0.0124157835,0.0036260365,0.3042903,0.6706126],"study_design_scores_gemma":[0.0062304754,0.0020853183,0.008423138,0.0010727326,0.00020370897,0.0070507987,0.00008883614,0.0014615431,0.011161315,0.0020131238,0.9601431,0.00006582586],"about_ca_topic_score_codex":0.0030162712,"about_ca_topic_score_gemma":0.010173935,"teacher_disagreement_score":0.034861065,"about_ca_system_score_codex":0.0011424506,"about_ca_system_score_gemma":0.00084289897,"threshold_uncertainty_score":0.11662185},"labels":[],"label_agreement":null},{"id":"W4416917498","doi":"10.51731/cjht.2025.1299","title":"Fecal Microbiota (Rebyota)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridioides; Antibiotics; Antibiotic therapy; Drug; Public health; Pharmacotherapy","score_opus":0.02828175753638394,"score_gpt":0.3278995271824078,"score_spread":0.2996177696460238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416917498","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25949717,0.05615948,0.016151397,0.020539885,0.005518077,0.004027563,0.07761138,0.006444826,0.5540502],"genre_scores_gemma":[0.51494604,0.03825905,0.05175993,0.011126153,0.0010649054,0.0014445549,0.04480112,0.0012886792,0.33530957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766374,0.00023434398,0.00013895682,0.0002710348,0.0013631484,0.00032885288],"domain_scores_gemma":[0.9976109,0.00009587371,0.00036208058,0.00015285956,0.001380692,0.00039752078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014094837,0.0010271805,0.0007375277,0.003141099,0.0014304823,0.0022770392,0.00091258326,0.00090697303,0.027284341],"category_scores_gemma":[0.003072427,0.00028024302,0.00068570796,0.0020981259,0.00062991376,0.00066780276,0.0016052336,0.0011034427,0.010239363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094342383,0.0007716405,0.08125831,0.001728396,0.00011250341,0.0015733099,0.0007085903,0.00017363923,0.026328787,0.0028372072,0.1995337,0.6840306],"study_design_scores_gemma":[0.00009514858,0.0010232071,0.16246364,0.0012686756,0.00014175907,0.0030651428,0.0007651129,0.00028208346,0.01135558,0.0007922968,0.8186583,0.0000890722],"about_ca_topic_score_codex":0.071775176,"about_ca_topic_score_gemma":0.08907991,"teacher_disagreement_score":0.071775176,"about_ca_system_score_codex":0.0020356781,"about_ca_system_score_gemma":0.0047170795,"threshold_uncertainty_score":0.1427148},"labels":[],"label_agreement":null},{"id":"W4417044153","doi":"10.51731/cjht.2025.1301","title":"Vanzacaftor-Tezacaftor-Deutivacaftor (Alyftrek)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystic fibrosis; Drug; Mutation; Cystic fibrosis transmembrane conductance regulator; Public health","score_opus":0.02383383768169574,"score_gpt":0.3518872957391622,"score_spread":0.3280534580574665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417044153","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.100319,0.2446445,0.012065568,0.041557115,0.004892874,0.001063218,0.010219593,0.0031200373,0.58211815],"genre_scores_gemma":[0.61087257,0.082913905,0.01278292,0.010740365,0.0011301734,0.00033302492,0.008040089,0.00029608636,0.2728908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995777,0.000052377884,0.00002772118,0.000045363275,0.00021783178,0.000078971956],"domain_scores_gemma":[0.99955136,0.00007344953,0.000082749924,0.000026236587,0.00012054221,0.0001456405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005149659,0.00017041102,0.0002951079,0.00049201446,0.00029678983,0.0008716472,0.0004081867,0.0006749652,0.024259929],"category_scores_gemma":[0.001542064,0.0000897518,0.0003968683,0.00031095243,0.00034288917,0.00029016472,0.00037563586,0.0010115997,0.0065342085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019906738,0.0002241131,0.0029901373,0.0006715514,0.0000874363,0.00080790475,0.0000655503,0.00031638186,0.015047357,0.009567044,0.17659563,0.7916362],"study_design_scores_gemma":[0.0012164268,0.00076463213,0.006945317,0.00049500837,0.00007061033,0.0023641894,0.000047453523,0.00042135202,0.0065837763,0.0011342731,0.9799341,0.000022925284],"about_ca_topic_score_codex":0.020619944,"about_ca_topic_score_gemma":0.040966485,"teacher_disagreement_score":0.024259929,"about_ca_system_score_codex":0.0015791871,"about_ca_system_score_gemma":0.0031409035,"threshold_uncertainty_score":0.081157506},"labels":[],"label_agreement":null},{"id":"W4417197298","doi":"10.51731/cjht.2025.1302","title":"Tofersen (Qalsody)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amyotrophic lateral sclerosis; Weakness; Public health; Agency (philosophy); Multidisciplinary approach; Riluzole","score_opus":0.03730431379994192,"score_gpt":0.3499477317441295,"score_spread":0.3126434179441876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417197298","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012007499,0.046152603,0.002977073,0.017666396,0.0039937417,0.000756376,0.02138735,0.003929972,0.891129],"genre_scores_gemma":[0.1001601,0.023756035,0.0063626207,0.011730972,0.00076441426,0.0003069026,0.014236013,0.0007803538,0.8419026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990503,0.00012051822,0.000054648703,0.00016006913,0.00046329488,0.0001511183],"domain_scores_gemma":[0.9988275,0.00020280964,0.000084897765,0.00008189734,0.00035736104,0.00044556914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011989104,0.0006854081,0.0006127195,0.0012869935,0.0010099568,0.0019232305,0.0009871917,0.0020162526,0.3606637],"category_scores_gemma":[0.002940385,0.00031290238,0.0006602596,0.00048183638,0.00054299046,0.00082830724,0.001457526,0.001452961,0.11517052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018217613,0.00028609583,0.001974745,0.0015289347,0.00007921981,0.0008850459,0.00017747992,0.00019484876,0.004035464,0.009955584,0.5167218,0.46233904],"study_design_scores_gemma":[0.00037425142,0.00018191403,0.0013221119,0.00033387952,0.000031236657,0.0005842896,0.00005397998,0.00010017555,0.0012882027,0.0007597414,0.99495775,0.0000124842945],"about_ca_topic_score_codex":0.021954514,"about_ca_topic_score_gemma":0.044222374,"teacher_disagreement_score":0.3606637,"about_ca_system_score_codex":0.0020126805,"about_ca_system_score_gemma":0.0051256595,"threshold_uncertainty_score":0.9119356},"labels":[],"label_agreement":null},{"id":"W4417278693","doi":"10.51731/cjht.2025.1303","title":"Vorasidenib (Voranigo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oligodendroglioma; Reimbursement; IDH2; Astrocytoma; Grading (engineering); IDH1; Radiation therapy; Quality of life (healthcare)","score_opus":0.02169489955527991,"score_gpt":0.3092425360839617,"score_spread":0.28754763652868176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417278693","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05465015,0.76267284,0.0025535058,0.011666906,0.0020425066,0.0011196709,0.01142016,0.000601094,0.15327317],"genre_scores_gemma":[0.4976439,0.40513486,0.0060239173,0.012417755,0.0008581053,0.0010016217,0.017180365,0.000095778276,0.059643727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997489,0.000067929665,0.000030060155,0.000037166483,0.00008424093,0.000031679047],"domain_scores_gemma":[0.9997652,0.0000586493,0.00006117436,0.000009090085,0.00007362194,0.000032241107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050674024,0.00023818377,0.00045667012,0.0005917473,0.00022943076,0.0006832536,0.00028367937,0.00038570198,0.010632378],"category_scores_gemma":[0.0009027799,0.000092047856,0.0005528964,0.0005850189,0.00016729359,0.00040261127,0.00023399992,0.0010323884,0.0018775166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004188861,0.00017582119,0.0017087366,0.008024276,0.00048813564,0.00032425567,0.000059518607,0.0008868869,0.006072658,0.0044323057,0.13134782,0.8422907],"study_design_scores_gemma":[0.0074892715,0.0025895478,0.011930137,0.0035021978,0.0008909239,0.0027134963,0.00010346964,0.0009366099,0.0053555607,0.002406292,0.9620347,0.000047808095],"about_ca_topic_score_codex":0.010256867,"about_ca_topic_score_gemma":0.042513438,"teacher_disagreement_score":0.010632378,"about_ca_system_score_codex":0.001335965,"about_ca_system_score_gemma":0.0013803351,"threshold_uncertainty_score":0.035568833},"labels":[],"label_agreement":null},{"id":"W4417329605","doi":"10.51731/cjht.2025.1306","title":"Inavolisib (Itovebi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Metastatic breast cancer; Regimen; Reimbursement; Cancer; Fulvestrant; Palbociclib","score_opus":0.017625129350615592,"score_gpt":0.3259197549193014,"score_spread":0.3082946255686858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417329605","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047054727,0.18320711,0.0063242605,0.025276573,0.006606243,0.0032287503,0.03278137,0.007567936,0.68795294],"genre_scores_gemma":[0.27396506,0.11124694,0.009572567,0.038173057,0.0017213857,0.0024404167,0.07966154,0.0011762651,0.48204273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995284,0.00006560757,0.000026087084,0.00007030118,0.00018766479,0.00012188799],"domain_scores_gemma":[0.99965024,0.000036238813,0.00004495989,0.000021743112,0.000107573345,0.00013925062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069080445,0.0007325914,0.0010688753,0.0010398999,0.00058942026,0.0022425607,0.0016645574,0.0019085013,0.0734042],"category_scores_gemma":[0.0013910785,0.0003157164,0.001064742,0.00068372686,0.00038648947,0.000979187,0.001012399,0.0037190572,0.029179433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041340226,0.0009711948,0.0013146445,0.00155574,0.00016850092,0.00036878468,0.00007293853,0.00070646225,0.005800599,0.005211456,0.44231436,0.53738135],"study_design_scores_gemma":[0.006880735,0.0014062678,0.0025074696,0.00079249317,0.00018828586,0.0012073768,0.00005880226,0.00091543247,0.0027778356,0.0022221282,0.9810127,0.000030470652],"about_ca_topic_score_codex":0.009921484,"about_ca_topic_score_gemma":0.020718621,"teacher_disagreement_score":0.0734042,"about_ca_system_score_codex":0.0024797583,"about_ca_system_score_gemma":0.002990589,"threshold_uncertainty_score":0.24556148},"labels":[],"label_agreement":null},{"id":"W4417329610","doi":"10.51731/cjht.2025.1305","title":"Federal Policies and Public Reimbursement of Pediatric Medicines in Canada","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Formulary; Medical prescription; Public health; Off-label use; Orphan drug; Prescription drug; MEDLINE","score_opus":0.06434924540929551,"score_gpt":0.3681667365483332,"score_spread":0.30381749113903767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417329610","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08998695,0.04841366,0.0020045324,0.25765628,0.0020793676,0.00072492217,0.026511092,0.00065765396,0.5719656],"genre_scores_gemma":[0.6815919,0.053059082,0.00986635,0.12184375,0.0010317698,0.00056421215,0.0117782205,0.00019025707,0.12007452],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98655313,0.0008243953,0.00061871734,0.0004949585,0.0077458317,0.0037629565],"domain_scores_gemma":[0.97142047,0.005139529,0.002541289,0.000514614,0.0144251315,0.0059589846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004948554,0.00034060012,0.0004416963,0.0033141847,0.00490792,0.00512289,0.0019357383,0.0029382622,0.010922152],"category_scores_gemma":[0.019272648,0.00060496444,0.00084252073,0.0048980443,0.001975869,0.0009805762,0.0014742891,0.0025725767,0.0005913366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00025628178,0.00019644175,0.06296166,0.0011536987,0.00013428544,0.0010496785,0.001955453,0.0024486922,0.0012029872,0.1958795,0.57739156,0.15536965],"study_design_scores_gemma":[0.00014873178,0.00009282497,0.15938354,0.001879264,0.00011554888,0.0003977222,0.0013243312,0.0016309011,0.0010028253,0.0033898412,0.83050895,0.0001256092],"about_ca_topic_score_codex":0.9904819,"about_ca_topic_score_gemma":0.9927619,"teacher_disagreement_score":0.8586615,"about_ca_system_score_codex":0.14133853,"about_ca_system_score_gemma":0.35237736,"threshold_uncertainty_score":0.9959256},"labels":[],"label_agreement":null},{"id":"W4417434215","doi":"10.51731/cjht.2025.1307","title":"Lazertinib and Amivantamab (Lazcluze and Rybrevant)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lung cancer; Drug; Clinical Practice; Cancer","score_opus":0.012612102283990068,"score_gpt":0.3396914984257826,"score_spread":0.32707939614179254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417434215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01056593,0.94486403,0.00087125204,0.0032822469,0.00032290944,0.00023474602,0.0020358295,0.00008509482,0.037737884],"genre_scores_gemma":[0.13521124,0.835713,0.0041209636,0.0026861476,0.00039247057,0.0002907942,0.0035195115,0.000029452842,0.018036446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984598,0.00039431735,0.00017048763,0.00008016638,0.0008036859,0.00009162765],"domain_scores_gemma":[0.9985958,0.00046198376,0.00040299745,0.000026515167,0.00043740997,0.00007540563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020251058,0.0002944716,0.00062522304,0.0018658389,0.0002455101,0.001134417,0.00039512385,0.00052854663,0.00545576],"category_scores_gemma":[0.0033955907,0.00010996546,0.0011856813,0.0016584488,0.00025682786,0.00064960564,0.00031926905,0.00066626817,0.00094018487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000800426,0.000056431865,0.0014558829,0.009622844,0.0006026019,0.000112300964,0.000053802236,0.00043811274,0.0021226318,0.0037606307,0.029868549,0.95110583],"study_design_scores_gemma":[0.0005724471,0.0012460653,0.01596994,0.0092998,0.0017766153,0.0012433617,0.00010611892,0.00038025845,0.0027689757,0.0011756896,0.9654134,0.000047404854],"about_ca_topic_score_codex":0.0154633215,"about_ca_topic_score_gemma":0.06860939,"teacher_disagreement_score":0.0154633215,"about_ca_system_score_codex":0.0027475215,"about_ca_system_score_gemma":0.0036887026,"threshold_uncertainty_score":0.030746639},"labels":[],"label_agreement":null},{"id":"W4417434479","doi":"10.51731/cjht.2025.1308","title":"Dupilumab (Dupixent)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Medical prescription; Drug; Disease; Syringe","score_opus":0.019273028663953005,"score_gpt":0.31211856573767205,"score_spread":0.292845537073719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417434479","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00725634,0.9283029,0.0010751716,0.0022672452,0.000793723,0.00027052933,0.0024897435,0.00017173126,0.05737262],"genre_scores_gemma":[0.11964114,0.82217777,0.0050300714,0.0046869284,0.0007732009,0.0003767556,0.0041638054,0.00004595385,0.043104444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996145,0.000076547825,0.000034017234,0.00004405685,0.00018874645,0.000042231335],"domain_scores_gemma":[0.9996567,0.000105642175,0.00007288931,0.000010229054,0.000110951354,0.0000435227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062231766,0.00035702236,0.0004267415,0.0012721113,0.00035708552,0.00090210536,0.0004029392,0.00043916568,0.01201739],"category_scores_gemma":[0.0008905653,0.00010699301,0.00061471824,0.00087174395,0.00020667122,0.00043919942,0.00031740923,0.0007188856,0.002229114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004096465,0.000061878876,0.00040874194,0.007977249,0.00012343156,0.00018346542,0.00004864735,0.00013432503,0.0024173872,0.0018903712,0.056161452,0.9301834],"study_design_scores_gemma":[0.00027464703,0.0004531238,0.0021721243,0.0027524552,0.00026442437,0.001391732,0.000032116797,0.0000943391,0.0019197047,0.00027770805,0.9903527,0.000014865838],"about_ca_topic_score_codex":0.011871152,"about_ca_topic_score_gemma":0.03824276,"teacher_disagreement_score":0.01201739,"about_ca_system_score_codex":0.0013676545,"about_ca_system_score_gemma":0.0018143187,"threshold_uncertainty_score":0.0402022},"labels":[],"label_agreement":null},{"id":"W4417464386","doi":"10.51731/cjht.2025.1309","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Enzalutamide; Agency (philosophy); Drug; Drug approval","score_opus":0.032991687298584586,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417464386","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04287707,0.33175352,0.009371952,0.058618627,0.0041701794,0.0029002319,0.03275834,0.0034157636,0.51413435],"genre_scores_gemma":[0.48990718,0.13634777,0.039573524,0.03949507,0.0018293463,0.0019158107,0.042338513,0.0006102801,0.24798246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979267,0.0004733957,0.00015504849,0.00017672272,0.0010699691,0.0001981894],"domain_scores_gemma":[0.9956697,0.000450758,0.0004802359,0.0002064388,0.002520404,0.00067244336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002912674,0.0002601713,0.000549563,0.0013544603,0.00071145105,0.0014501149,0.00089854136,0.0007930766,0.014559977],"category_scores_gemma":[0.007615006,0.00014567257,0.00056556676,0.0012604186,0.00044160787,0.00071156124,0.00090397894,0.001434631,0.0040038475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00103801,0.00018311727,0.0029154231,0.0010685889,0.00008687264,0.00021328633,0.000086209744,0.00021402843,0.0025713802,0.0066757016,0.21032336,0.774624],"study_design_scores_gemma":[0.00033478954,0.00021871459,0.0034799878,0.00042122754,0.000053747728,0.00038800028,0.00002053884,0.00012567679,0.0013003794,0.00061965967,0.99302363,0.000013688759],"about_ca_topic_score_codex":0.039603032,"about_ca_topic_score_gemma":0.121961504,"teacher_disagreement_score":0.039603032,"about_ca_system_score_codex":0.006059029,"about_ca_system_score_gemma":0.011810082,"threshold_uncertainty_score":0.07874501},"labels":[],"label_agreement":null},{"id":"W4417464387","doi":"10.51731/cjht.2025.1311","title":"Dupilumab (Dupixent)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Nasal administration; Drug; Chronic rhinosinusitis; Syringe; Drug injection","score_opus":0.020277960162260522,"score_gpt":0.3144775969370887,"score_spread":0.2941996367748282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417464387","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012976219,0.9082413,0.0012855679,0.00265777,0.0008797863,0.00033108814,0.0029702887,0.0002364971,0.07042153],"genre_scores_gemma":[0.19330579,0.7289342,0.006159671,0.0059519634,0.00087521033,0.00045149474,0.005773034,0.00005656608,0.05849207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996698,0.00006138748,0.000026332396,0.00004204688,0.0001627006,0.00003774014],"domain_scores_gemma":[0.999713,0.00007273544,0.00006232687,0.000008640212,0.00009925045,0.000043999466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055644196,0.00036303105,0.0004080832,0.0010979536,0.00032830058,0.0008605554,0.0004065545,0.00042562827,0.010632885],"category_scores_gemma":[0.00070379063,0.00009848162,0.00052924687,0.0007243932,0.00020354318,0.00041118157,0.00029548825,0.0006911281,0.0023637242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053378666,0.0000751185,0.0005306026,0.0058316356,0.00011877015,0.0002091161,0.000051618194,0.0001409887,0.003325213,0.0016842033,0.054705396,0.93279356],"study_design_scores_gemma":[0.00045973886,0.000768266,0.0031718109,0.0022532642,0.00030113745,0.00207126,0.000038570077,0.00012903356,0.0029686398,0.00027373544,0.9875458,0.000018671915],"about_ca_topic_score_codex":0.01106801,"about_ca_topic_score_gemma":0.03650947,"teacher_disagreement_score":0.01106801,"about_ca_system_score_codex":0.0013421114,"about_ca_system_score_gemma":0.00167859,"threshold_uncertainty_score":0.035570502},"labels":[],"label_agreement":null},{"id":"W7092477290","doi":"10.51731/cjht.2025.1256","title":"Glofitamab (Columvi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxaliplatin; Gemcitabine; Refractory (planetary science); Lymphoma; Drug; Chemotherapy; Diffuse large B-cell lymphoma","score_opus":0.0406180561604166,"score_gpt":0.3553585270236323,"score_spread":0.3147404708632157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7092477290","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032702245,0.09925423,0.007311918,0.027254576,0.005984019,0.0027111748,0.03129841,0.014374086,0.7791095],"genre_scores_gemma":[0.1424095,0.03687913,0.00878934,0.025490876,0.0010312541,0.0012421113,0.046174042,0.0016284996,0.73635536],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990244,0.00009711941,0.000037060436,0.00020276876,0.00039332762,0.0002453336],"domain_scores_gemma":[0.9991892,0.000054720138,0.00006438821,0.00006980641,0.00021893275,0.00040287751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011493892,0.0010581984,0.0010079459,0.001627642,0.0010982685,0.0025117097,0.0014845541,0.0023812423,0.19751303],"category_scores_gemma":[0.0015417484,0.00041930104,0.0009246203,0.000776013,0.0007514091,0.0010166875,0.0015692515,0.0032118568,0.10282054],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026815566,0.0005455194,0.002006236,0.00092632143,0.00008098867,0.0009232637,0.00013196592,0.00037138362,0.014822658,0.006312853,0.5134539,0.45774338],"study_design_scores_gemma":[0.0007851744,0.00048944727,0.0015257546,0.0001706127,0.000036153706,0.0009799355,0.00003800717,0.00020069412,0.003068094,0.00068217586,0.9920066,0.000017385606],"about_ca_topic_score_codex":0.014404652,"about_ca_topic_score_gemma":0.02463735,"teacher_disagreement_score":0.19751303,"about_ca_system_score_codex":0.0030457913,"about_ca_system_score_gemma":0.0053307135,"threshold_uncertainty_score":0.66074693},"labels":[],"label_agreement":null},{"id":"W7115022452","doi":"10.51731/cjht.2025.1304","title":"Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Nivolumab; Ipilimumab; Sorafenib; Lenvatinib; Immunotherapy; Clinical trial; Sunitinib","score_opus":0.06552939086128179,"score_gpt":0.28578960532171566,"score_spread":0.22026021446043387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115022452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21671233,0.5888763,0.008912344,0.0074738627,0.002625734,0.0021121416,0.0072734333,0.0014532743,0.16456057],"genre_scores_gemma":[0.78740525,0.13189432,0.012689703,0.00602385,0.00052413956,0.0009093878,0.010781572,0.00011783299,0.04965387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998035,0.000040543753,0.000019419445,0.000035936766,0.000058254864,0.000042316453],"domain_scores_gemma":[0.9999217,0.000011398228,0.00001921144,0.00000598527,0.000021022852,0.000020717085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004845883,0.00026457338,0.00043388538,0.0004287989,0.00016553371,0.00056319527,0.00032793396,0.00031196143,0.0052167443],"category_scores_gemma":[0.00034510053,0.00010925555,0.0006810961,0.000316205,0.00015490732,0.00036865132,0.00038915323,0.0008178638,0.0015660505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039919503,0.00031240887,0.00298963,0.002967864,0.00056352967,0.00028682727,0.000039233346,0.0010975586,0.018027596,0.0023583523,0.038562227,0.9288027],"study_design_scores_gemma":[0.0068818075,0.004832184,0.016224526,0.0015758151,0.0009035744,0.0033546016,0.00006592738,0.0013036461,0.022630975,0.0013280859,0.9408506,0.000048207614],"about_ca_topic_score_codex":0.0047528534,"about_ca_topic_score_gemma":0.014987529,"teacher_disagreement_score":0.0052167443,"about_ca_system_score_codex":0.001137604,"about_ca_system_score_gemma":0.00093441806,"threshold_uncertainty_score":0.017451763},"labels":[],"label_agreement":null},{"id":"W7116080493","doi":"10.51731/cjht.2025.1312","title":"Abemaciclib (Verzenio)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Reimbursement; Disease; Drug; Breast cancer; Metastatic breast cancer; Cancer","score_opus":0.018015218389356564,"score_gpt":0.32893630027680315,"score_spread":0.3109210818874466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116080493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021155147,0.81638247,0.0015102981,0.0030737368,0.0010299445,0.0005719075,0.0031165988,0.0004036967,0.15275617],"genre_scores_gemma":[0.2272871,0.6757495,0.004454346,0.006384089,0.00056478014,0.00037322892,0.0048516504,0.00008535538,0.08024998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979204,0.000035914774,0.00002022695,0.000032533517,0.00009447432,0.000024705176],"domain_scores_gemma":[0.99986815,0.000030039693,0.000035517107,0.0000050985213,0.000037226826,0.000023928089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026803705,0.0002529156,0.00037254265,0.0009660555,0.00024861094,0.0007889054,0.0003753647,0.00038005534,0.016013926],"category_scores_gemma":[0.00050611,0.00008807267,0.00035465302,0.00061047013,0.00022182504,0.00045780945,0.00024153979,0.00080141163,0.0025131735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001176227,0.00014286421,0.00031563212,0.006714757,0.00011668683,0.00023153333,0.000047792728,0.00019421865,0.008907417,0.004129012,0.053058565,0.92496526],"study_design_scores_gemma":[0.001012766,0.0009425513,0.002943096,0.0032114584,0.0002947954,0.001572776,0.000054286396,0.00016575382,0.0051081534,0.00083960744,0.98382884,0.000025904752],"about_ca_topic_score_codex":0.009200034,"about_ca_topic_score_gemma":0.031001668,"teacher_disagreement_score":0.016013926,"about_ca_system_score_codex":0.0009814533,"about_ca_system_score_gemma":0.0012622145,"threshold_uncertainty_score":0.05357188},"labels":[],"label_agreement":null},{"id":"W7116123103","doi":"10.51731/cjht.2025.1310","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Pemetrexed; Drug; Compassionate Use; Clinical Practice","score_opus":0.013036716158886795,"score_gpt":0.2886499990016752,"score_spread":0.2756132828427884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116123103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008603164,0.9654799,0.0005707911,0.0016197781,0.00029949597,0.000113007205,0.0006082597,0.00006532787,0.022640275],"genre_scores_gemma":[0.15320669,0.8227689,0.0029308847,0.0026279846,0.00022454957,0.00015138663,0.0009934666,0.000014327251,0.017081797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997782,0.00004543412,0.000025281965,0.000031955435,0.00009115418,0.000028016038],"domain_scores_gemma":[0.99983406,0.000040433668,0.00005416989,0.000005591456,0.000047882055,0.000017917044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004039574,0.00018940671,0.000268371,0.0006484743,0.00019076969,0.0005305657,0.00023439559,0.000292074,0.0041354955],"category_scores_gemma":[0.0006297529,0.00007215203,0.00032771984,0.00055576063,0.00013512929,0.0003194651,0.00020818996,0.0004712642,0.0008556038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005302119,0.000052229218,0.00057225185,0.00563939,0.00016820275,0.0001698981,0.000034122666,0.00013405792,0.0051633734,0.0012878996,0.022883734,0.9633646],"study_design_scores_gemma":[0.00054518663,0.00093260605,0.007735238,0.0047163167,0.00054477085,0.002188975,0.00006699866,0.000118687596,0.0055347113,0.0005152738,0.97708386,0.000017365215],"about_ca_topic_score_codex":0.009608953,"about_ca_topic_score_gemma":0.036684435,"teacher_disagreement_score":0.009608953,"about_ca_system_score_codex":0.0010342973,"about_ca_system_score_gemma":0.0010171308,"threshold_uncertainty_score":0.01910603},"labels":[],"label_agreement":null},{"id":"W7116849294","doi":"10.51731/cjht.2025.1315","title":"Abemaciclib (Verzenio)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Breast cancer; Metastatic breast cancer; Chemotherapy; Reimbursement; Regimen; Cancer; Aromatase","score_opus":0.018015218389356564,"score_gpt":0.32893630027680315,"score_spread":0.3109210818874466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116849294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015344315,0.76312214,0.0013890805,0.0040022423,0.0011153691,0.0006415584,0.00457488,0.0003372927,0.20947315],"genre_scores_gemma":[0.18962307,0.67918324,0.0046511157,0.007982766,0.00065718504,0.00041063747,0.007286648,0.0001143105,0.11009099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996842,0.000055437507,0.000030619645,0.000048263613,0.00014593502,0.000035467587],"domain_scores_gemma":[0.9997371,0.000053245716,0.000061929975,0.000009741107,0.00009629488,0.00004160534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004217023,0.00028679092,0.0004123034,0.0011295946,0.00028529915,0.001135575,0.0004285539,0.00044284936,0.018978538],"category_scores_gemma":[0.00081288,0.0001019799,0.0004241042,0.000887435,0.00025871018,0.00060236675,0.00027667472,0.0007992309,0.0027093713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008315473,0.000121933226,0.0004276552,0.0066635786,0.00011052938,0.00017762324,0.000049475184,0.00023272552,0.0052192784,0.0053757695,0.08987205,0.89091796],"study_design_scores_gemma":[0.0005161411,0.00042026408,0.0020770216,0.0026793126,0.00020122806,0.00069644564,0.00003845647,0.0001339135,0.0026322429,0.000659483,0.98992646,0.000018962244],"about_ca_topic_score_codex":0.021861397,"about_ca_topic_score_gemma":0.07196251,"teacher_disagreement_score":0.021861397,"about_ca_system_score_codex":0.0021423653,"about_ca_system_score_gemma":0.0026187794,"threshold_uncertainty_score":0.06348956},"labels":[],"label_agreement":null},{"id":"W7116912364","doi":"10.51731/cjht.2025.1314","title":"Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Reimbursement; Drug; Clinical Practice; Pharmacotherapy; Clinical trial","score_opus":0.02304819863146158,"score_gpt":0.31699144196907564,"score_spread":0.29394324333761407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116912364","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011114755,0.9310581,0.0011918127,0.003736297,0.0005534832,0.00037948904,0.0024028039,0.00015486902,0.04940846],"genre_scores_gemma":[0.14086473,0.8124784,0.008571375,0.004003352,0.00044812844,0.00040260944,0.003440061,0.000061899154,0.029729411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923825,0.00014987127,0.00007480394,0.00006772554,0.00040060267,0.000068715344],"domain_scores_gemma":[0.99914956,0.00018786437,0.00021644017,0.000019745055,0.0003529093,0.00007351263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012021345,0.00040528236,0.0005121004,0.0012396714,0.0003505365,0.0010367256,0.0003920132,0.00052292267,0.006228652],"category_scores_gemma":[0.0019929744,0.00011165777,0.0010057415,0.0012996695,0.00031401016,0.00043917153,0.00027345482,0.0006853705,0.0009910672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012310809,0.00010763838,0.0018138064,0.011575467,0.000698917,0.0002521565,0.00004767877,0.00036794282,0.0033861685,0.002770623,0.06610086,0.91164756],"study_design_scores_gemma":[0.00065857125,0.0008282611,0.012356411,0.009441401,0.0012357117,0.0014686852,0.000094911025,0.00032706527,0.0038355317,0.0005771614,0.96913785,0.00003840297],"about_ca_topic_score_codex":0.1097658,"about_ca_topic_score_gemma":0.27543446,"teacher_disagreement_score":0.1097658,"about_ca_system_score_codex":0.0053768097,"about_ca_system_score_gemma":0.0071590627,"threshold_uncertainty_score":0.21825379},"labels":[],"label_agreement":null},{"id":"W7117159139","doi":"10.51731/cjht.2025.1316","title":"Quizartinib (Vanflyta)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytarabine; Myeloid leukemia; Reimbursement; Drug; Food and drug administration","score_opus":0.024026374837483006,"score_gpt":0.3171629694084499,"score_spread":0.2931365945709669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117159139","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02608964,0.8967905,0.0010604544,0.0035423988,0.0006131221,0.00025932863,0.0033454583,0.00025898335,0.06804008],"genre_scores_gemma":[0.3261837,0.62866634,0.0036927613,0.0035665364,0.00035667926,0.00019725467,0.0052029192,0.000028168026,0.03210567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998092,0.00003663941,0.000019714687,0.000026853199,0.00008048276,0.000027152093],"domain_scores_gemma":[0.9998684,0.000030305926,0.000038316386,0.000003425102,0.00004190206,0.000017683898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033759666,0.00018301967,0.00031953517,0.0008563322,0.00021857275,0.0006301846,0.00032174346,0.00025128954,0.006583903],"category_scores_gemma":[0.0005799408,0.0000669952,0.0003792963,0.00058127695,0.000116519666,0.0002520567,0.00016515928,0.00039328475,0.0009052499],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007062503,0.000069313566,0.00089515373,0.0054612802,0.00026444055,0.00016893525,0.000032701406,0.0003827501,0.0035539973,0.0023127845,0.063899934,0.9222524],"study_design_scores_gemma":[0.00077341264,0.00082354277,0.007851786,0.003629776,0.00069980737,0.0019811194,0.000050616487,0.00037386862,0.0036933662,0.00061098184,0.9794884,0.000023329048],"about_ca_topic_score_codex":0.011227905,"about_ca_topic_score_gemma":0.05607964,"teacher_disagreement_score":0.011227905,"about_ca_system_score_codex":0.0011953493,"about_ca_system_score_gemma":0.0011693136,"threshold_uncertainty_score":0.022325099},"labels":[],"label_agreement":null},{"id":"W7133200569","doi":"10.51731/cjht.2025.1360","title":"Dihydropyrimidine Dehydrogenase Deficiency Testing for Patients Treated With 5-Fluorouracil and Capecitabine","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DPYD; Dihydropyrimidine dehydrogenase; Capecitabine; Genotyping; Adverse effect; Genetic testing; Glucose-6-phosphate dehydrogenase deficiency","score_opus":0.024465994639906945,"score_gpt":0.27863339870557463,"score_spread":0.2541674040656677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133200569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004040863,0.9487902,0.00028664342,0.03817459,0.0024458698,0.0007880109,0.00290461,0.000022569548,0.0025466634],"genre_scores_gemma":[0.08898429,0.85070986,0.003540622,0.04743577,0.004817542,0.001779919,0.0017979158,0.000031314936,0.0009028418],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.982298,0.0063006403,0.008260717,0.0007522261,0.002040115,0.0003482837],"domain_scores_gemma":[0.86572134,0.084569566,0.026198624,0.0015082788,0.020525098,0.0014769627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01756044,0.00045179573,0.004891866,0.0051548085,0.00062556635,0.0027549174,0.0018798064,0.003422839,0.0054161036],"category_scores_gemma":[0.13146366,0.00069951615,0.0048638363,0.005940098,0.0009488124,0.003305514,0.0010013927,0.0018427364,0.00054992794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018169394,0.000042559306,0.012482117,0.726241,0.005821902,0.0004530946,0.00059386675,0.0001210552,0.00025273275,0.00084688544,0.053145487,0.19818243],"study_design_scores_gemma":[0.0018676951,0.00038945934,0.026791155,0.84147507,0.016976807,0.0014100663,0.0011226553,0.00013984388,0.00025842738,0.0014186334,0.1080376,0.000112590504],"about_ca_topic_score_codex":0.023714423,"about_ca_topic_score_gemma":0.050506536,"teacher_disagreement_score":0.023714423,"about_ca_system_score_codex":0.0051229806,"about_ca_system_score_gemma":0.015640294,"threshold_uncertainty_score":0.09286958},"labels":[],"label_agreement":null},{"id":"W7160716020","doi":"10.51731/cjht.2025.1437","title":"Appropriate Use of Antipsychotics in Long-Term Care: Expert Panel Guidance","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Long-term care; Excellence; Antipsychotic; Quality (philosophy); Pro forma; Action (physics); Quality of life (healthcare)","score_opus":0.09185841985435168,"score_gpt":0.38397619332025684,"score_spread":0.2921177734659052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7160716020","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002130289,0.065523945,0.031221544,0.7550476,0.026693396,0.018612321,0.008285543,0.0005550436,0.091930255],"genre_scores_gemma":[0.05062411,0.1747216,0.28271103,0.35306376,0.015925284,0.04045165,0.018983131,0.00045202492,0.06306743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.91894066,0.047390584,0.012495529,0.0025680552,0.014555768,0.0040494567],"domain_scores_gemma":[0.79136246,0.058560748,0.009085695,0.0034639284,0.1269267,0.0106004905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12621352,0.0018591187,0.0026752353,0.004095469,0.0026615064,0.005303318,0.007931343,0.015960163,0.016426653],"category_scores_gemma":[0.18111236,0.0014208826,0.008854462,0.0032985464,0.001819071,0.004824343,0.004691064,0.012617544,0.008210458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015366463,0.00011788407,0.000726784,0.008910427,0.00015213866,0.00027442162,0.0012012947,0.0010201928,0.00037464403,0.0054488974,0.8697725,0.111847065],"study_design_scores_gemma":[0.0005189108,0.00012768534,0.0026948326,0.07267552,0.0003529071,0.00030375065,0.0010097598,0.0009983246,0.0004007777,0.011463458,0.9092721,0.0001819183],"about_ca_topic_score_codex":0.05875283,"about_ca_topic_score_gemma":0.09433021,"teacher_disagreement_score":0.12621352,"about_ca_system_score_codex":0.01192481,"about_ca_system_score_gemma":0.09102915,"threshold_uncertainty_score":0.6674889},"labels":[],"label_agreement":null}]}